course_id,course_code,docebo_code,course_name_input,course_name,test_id,test_name,type,question_title,answer_title,is_correct,score_if_correct,status,message,updated
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,This low-level disinfectant is incompatible with soap,a.	Alcohol,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SPD INTERNSHIP CHAPTER 9 - DISINFECTION- g13407,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,This low-level disinfectant is incompatible with soap,a.	Alcohol,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,This low-level disinfectant is incompatible with soap,b.	Phenol,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,This low-level disinfectant is incompatible with soap,c.	Quaternary ammonium compounds,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,This low-level disinfectant is incompatible with soap,d.	Ortho-phthalaldehyde,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,"When using glutaraldehyde, technicians should always wear latex gloves for protection",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,"When using glutaraldehyde, technicians should always wear latex gloves for protection",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,When using high-level disinfectants it is important to remember they may be deactivated by,a.	Alkylation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,When using high-level disinfectants it is important to remember they may be deactivated by,b.	Organic matter,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,When using high-level disinfectants it is important to remember they may be deactivated by,c.	Oxidation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,When using high-level disinfectants it is important to remember they may be deactivated by,d.	All the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,In an automated washer the key source of disinfection is,a.	Hydrogen peroxide,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,In an automated washer the key source of disinfection is,b.	Water temperature,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,In an automated washer the key source of disinfection is,c.	Heat,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,In an automated washer the key source of disinfection is,d.	Disinfecting detergent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,The use of test strips to test the minimum effective concentration in high-level disinfection solutions is required,"a.	Weekly, preferably daily",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,The use of test strips to test the minimum effective concentration in high-level disinfection solutions is required,b.	Daily,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,The use of test strips to test the minimum effective concentration in high-level disinfection solutions is required,c.	Each time the solution will be used,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,The use of test strips to test the minimum effective concentration in high-level disinfection solutions is required,d.	Only when manual soaking systems are used,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,"The use of heat to kill all microorganisms, except spores, is called",a.	Sterilization,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,"The use of heat to kill all microorganisms, except spores, is called",b.	Thermal disinfection,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,"The use of heat to kill all microorganisms, except spores, is called",c.	High-level disinfection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,"The use of heat to kill all microorganisms, except spores, is called",d.	Mechanical disinfection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,These chemicals are used on animate (living tissue) to slow the growth of microorganisms,a.	Glutaraldehydes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,These chemicals are used on animate (living tissue) to slow the growth of microorganisms,b.	Disinfectants,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,These chemicals are used on animate (living tissue) to slow the growth of microorganisms,c.	Halogens,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,These chemicals are used on animate (living tissue) to slow the growth of microorganisms,d.	Antiseptics,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Items that are introduced directly into the bloodstream or other normally sterile areas of the body are classified as,a.	Critical items,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Items that are introduced directly into the bloodstream or other normally sterile areas of the body are classified as,b.	Semi-critical items,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Items that are introduced directly into the bloodstream or other normally sterile areas of the body are classified as,c.	Non-critical items,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Items that are introduced directly into the bloodstream or other normally sterile areas of the body are classified as,d.	Equipment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,The process by which all forms of microorganisms are completely destroyed is,a.	High-level disinfection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,The process by which all forms of microorganisms are completely destroyed is,b.	Thermal disinfection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,The process by which all forms of microorganisms are completely destroyed is,c.	Sterilization,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,The process by which all forms of microorganisms are completely destroyed is,d.	Chemical disinfection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Iodophors are a member of this chemical family,a.	Halogens,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Iodophors are a member of this chemical family,b.	Quaternary ammonium compounds,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Iodophors are a member of this chemical family,c.	Alcohol,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Iodophors are a member of this chemical family,d.	Phenolics,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Phenolics are classified as,a.	Intermediate to low-level disinfectants,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Phenolics are classified as,b.	Intermediate to high-level disinfectants,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Phenolics are classified as,c.	High-level disinfectants,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Phenolics are classified as,d.	Sterilants,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Which of the following are classified as high-level disinfectants?,a.	Glutaraldehyde and phenolics,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Which of the following are classified as high-level disinfectants?,b.	Glutaraldehyde and ortho-phthalaldehydes,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Which of the following are classified as high-level disinfectants?,c.	Quaternary ammonium compounds and phenolics,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Which of the following are classified as high-level disinfectants?,d.	Halogens and ortho-phthaladehydes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Thermal disinfection is accomplished using,a.	Heated chemicals,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Thermal disinfection is accomplished using,b.	Heated glutaraldehyde,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Thermal disinfection is accomplished using,c.	Prolonged high pressure steam,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Thermal disinfection is accomplished using,d.	Heat,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,How long must alcohol remain in wet contact with an item to achieve a reasonable level of disinfection?,a.	One to two minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,How long must alcohol remain in wet contact with an item to achieve a reasonable level of disinfection?,b.	Two to three minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,How long must alcohol remain in wet contact with an item to achieve a reasonable level of disinfection?,c.	Five to 10 minutes,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,How long must alcohol remain in wet contact with an item to achieve a reasonable level of disinfection?,d.	10 to 20 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Which if the following would be the best choice for high-level disinfection of instruments?,a.	Phenolics,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Which if the following would be the best choice for high-level disinfection of instruments?,b.	Chlorine,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Which if the following would be the best choice for high-level disinfection of instruments?,c.	Iodophors,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8710,,Elearning-0000-157,SPD INTERNSHIP CHAPTER 9 - DISINFECTION,,n13407,,choice,Which if the following would be the best choice for high-level disinfection of instruments?,d.	Ortho-phthalaldehydes,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Microgrind or supercut scissors are usually identified with a black handle.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION- g13408,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Microgrind or supercut scissors are usually identified with a black handle.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Microgrind or supercut scissors are usually identified with a black handle.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Stainless steel jaw needle holders last longer than tungsten carbide jaw needle holders.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Stainless steel jaw needle holders last longer than tungsten carbide jaw needle holders.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,The place where the two parts of a ring handled instrument meet and pivot is called the box lock.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,The place where the two parts of a ring handled instrument meet and pivot is called the box lock.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Instruments are heat treated to give their surface a mirror (shiny) finish.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Instruments are heat treated to give their surface a mirror (shiny) finish.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Tissue forceps have teeth.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Tissue forceps have teeth.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,During instruments manufacturer the process of passivation helps build a protective chromium oxide layer on each instrument's surface.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,During instruments manufacturer the process of passivation helps build a protective chromium oxide layer on each instrument's surface.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,The part of a hemostat that locks and holds it in position is called the box lock.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,The part of a hemostat that locks and holds it in position is called the box lock.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,"After applying instrument identification tape, instruments should be autoclaved to help the tape bond to the instrument.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,"After applying instrument identification tape, instruments should be autoclaved to help the tape bond to the instrument.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Instrument marking tape should be wrapped approximately __________ around the instrument.,a.	1.5 times,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Instrument marking tape should be wrapped approximately __________ around the instrument.,b.	Two times,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Instrument marking tape should be wrapped approximately __________ around the instrument.,c.	2.5 times,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Instrument marking tape should be wrapped approximately __________ around the instrument.,d.	Three times,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,An osteotome is,a.	Used to cut or shave bone,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,An osteotome is,b.	A retractor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,An osteotome is,c.	A hemostatic forceps,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,An osteotome is,d.	Used to dissect soft tissue,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,The purpose of a suction stylet is to,a.	Unclog the suction during surgery,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,The purpose of a suction stylet is to,b.	Clean the suction in the decontamination area,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,The purpose of a suction stylet is to,c.	Facilitate the sterilization process,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,The purpose of a suction stylet is to,d.	Provide a measuring guide for the surgeon,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Kerrison/laminectomy rongeurs should be tested using,a.	Tissue paper,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Kerrison/laminectomy rongeurs should be tested using,b.	A plastic dowel rod,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Kerrison/laminectomy rongeurs should be tested using,c.	Rubber testing material,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Kerrison/laminectomy rongeurs should be tested using,d.	An index card,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Scissors with tungsten carbide cutting edges are usually identified by,a.	Black handles,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Scissors with tungsten carbide cutting edges are usually identified by,b.	Silver handles,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Scissors with tungsten carbide cutting edges are usually identified by,c.	Gold handles,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,Scissors with tungsten carbide cutting edges are usually identified by,"d.	The letters ""TC""�",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,The best way to clean a suction lumen is,a.	Using running warm water,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,The best way to clean a suction lumen is,b.	Using the proper sized brush,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,The best way to clean a suction lumen is,c.	Soaking in an enzyme solution for three minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,The best way to clean a suction lumen is,d.	Using the appropriate stylet,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,To properly test the sharpness of scissors four inches or less use,a.	Yellow test material,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,To properly test the sharpness of scissors four inches or less use,b.	Red test material,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,To properly test the sharpness of scissors four inches or less use,c.	An index cart,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8890,,Elearning-0000-177,SPD INTERNSHIP CHAPTER 10  SURGICAL INSTRUMENTATION,,n13408,,choice,To properly test the sharpness of scissors four inches or less use,d.	Orange test material,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,The first step to inspect the insulation of a laparoscopic instrument is to,a.	Check the collar at the distal tip,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS- g13411,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,The first step to inspect the insulation of a laparoscopic instrument is to,a.	Check the collar at the distal tip,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,The first step to inspect the insulation of a laparoscopic instrument is to,b.	Try to slide the insulation back,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,The first step to inspect the insulation of a laparoscopic instrument is to,c.	Check the handle for chipping or cracking,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,The first step to inspect the insulation of a laparoscopic instrument is to,d.	Visually check the instrument's shaft,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Which of the following steps happens first when processing flexible endoscopes?,a.	Leak-testing,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Which of the following steps happens first when processing flexible endoscopes?,b.	High-level disinfecting/sterilizing,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Which of the following steps happens first when processing flexible endoscopes?,c.	Manual cleaning,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Which of the following steps happens first when processing flexible endoscopes?,d.	Drying,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Which of the following should be used to thoroughly rinse (remove) all traces of disinfectant from an endoscope's channels?,a.	Forced air,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Which of the following should be used to thoroughly rinse (remove) all traces of disinfectant from an endoscope's channels?,b.	Water containing approved sterilant,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Which of the following should be used to thoroughly rinse (remove) all traces of disinfectant from an endoscope's channels?,c.	Treated water,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Which of the following should be used to thoroughly rinse (remove) all traces of disinfectant from an endoscope's channels?,d.	A heated glutaraldehyde,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,The purpose of using a decontamination battery or hose when cleaning powered surgical instruments is,a.	To keep fluid from entering the unit,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,The purpose of using a decontamination battery or hose when cleaning powered surgical instruments is,b.	To keep functioning batteries and cords clean,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,The purpose of using a decontamination battery or hose when cleaning powered surgical instruments is,c.	To prevent electrical shock,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,The purpose of using a decontamination battery or hose when cleaning powered surgical instruments is,d.	To test the unit while cleaning,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Endoscopes are often processed in a mechanical unit called,a.	An ultrasonic cleaner,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Endoscopes are often processed in a mechanical unit called,b.	A washer-decontaminator,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Endoscopes are often processed in a mechanical unit called,c.	A flush-pulse endoscope reprocessor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Endoscopes are often processed in a mechanical unit called,d.	An automatic endoscope reprocessor,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,The endoscope that would be dispensed for a procedure that required visualization of the lower part of the large intestine would be a,a.	Colonoscope,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,The endoscope that would be dispensed for a procedure that required visualization of the lower part of the large intestine would be a,b.	Sigmoidoscope,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,The endoscope that would be dispensed for a procedure that required visualization of the lower part of the large intestine would be a,c.	Gastroscope,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,The endoscope that would be dispensed for a procedure that required visualization of the lower part of the large intestine would be a,d.	Ureteroscope,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Loaner instruments should,a.	Be decontaminated if they appear soiled upon arrival,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Loaner instruments should,b.	Be sterilized using a low temperature process,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Loaner instruments should,c.	Be decontaminated before use,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Loaner instruments should,d.	Should not be used,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Information regarding cleaning processes for endoscope should be provided by,a.	The Society of Gastroenterology Nurses and Associates,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Information regarding cleaning processes for endoscope should be provided by,b.	The Association for Professionals in Infection Control and Epidemiology,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Information regarding cleaning processes for endoscope should be provided by,c.	The instrument manufacturer,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Information regarding cleaning processes for endoscope should be provided by,d.	The Operating Room staff,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Which of the following statements about endoscopes is true?,a.	Not all endoscopes can be processed in an automatic endoscope reprocessor,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Which of the following statements about endoscopes is true?,b.	Ultrasonic cleaning is the process of choice for endoscopes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Which of the following statements about endoscopes is true?,c.	Flexible endoscopes are not easily damaged,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Which of the following statements about endoscopes is true?,d.	All endoscopes should be steam sterilized,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Electronic testing of laparoscopic insulation should be done,a.	In the decontamination area prior to cleaning,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Electronic testing of laparoscopic insulation should be done,b.	In the clean assembly area prior to set assembly,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Electronic testing of laparoscopic insulation should be done,c.	At the factory or onsite repair unit,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Electronic testing of laparoscopic insulation should be done,d.	In the Operating Room at the end of the procedure,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Loaner instrumentation can cause receiving challenges.,a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Loaner instrumentation can cause receiving challenges.,b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Flexible endoscopes that fail a leak test may continue to be used until the break/hole impacts the scope's function.,a. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,Flexible endoscopes that fail a leak test may continue to be used until the break/hole impacts the scope's function.,b. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,All flexible endoscopes have internal channels.,a. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,All flexible endoscopes have internal channels.,b. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,"After use, loaner instrumentation must be decontaminated before it is shipped out.",a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,"After use, loaner instrumentation must be decontaminated before it is shipped out.",b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,The biggest advantage to battery-powered surgical instruments is that they can be immersed for cleaning.,a. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9855,,Questions-0000-146,SPD INTERNSHIP CHAPTER 11 - COMPLEX SURGICAL INSTRUMENTS,,n13411,,choice,The biggest advantage to battery-powered surgical instruments is that they can be immersed for cleaning.,b. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,The U.S. Food and Drug Administration classifies sterilization packaging as a,a.	Class I Medical Device,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING- g13412,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,The U.S. Food and Drug Administration classifies sterilization packaging as a,a.	Class I Medical Device,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,The U.S. Food and Drug Administration classifies sterilization packaging as a,b.	Class II Medical Device,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,The U.S. Food and Drug Administration classifies sterilization packaging as a,c.	Class III Medical Device,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,The U.S. Food and Drug Administration classifies sterilization packaging as a,d.	Class IV Medical Device,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Which of the following is NOT an acceptable sterilization packaging material?,a.	Muslin,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Which of the following is NOT an acceptable sterilization packaging material?,b.	Barrier cloth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Which of the following is NOT an acceptable sterilization packaging material?,c.	Canvas,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Which of the following is NOT an acceptable sterilization packaging material?,d.	Twills,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Count sheets,a.	Describe each instrument in detail,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Count sheets,b.	Are used only for Operating Room trays and large procedure packs,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Count sheets,c.	Provide a detailed  list of tray contents,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Count sheets,d.	Include manufacturer's Instructions for Use information,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,"When arranging paper/plastic pouches in the sterilizer, the pouches should be arranged",a.	Paper-to-plastic,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,"When arranging paper/plastic pouches in the sterilizer, the pouches should be arranged",b.	Paper-to-paper,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,"When arranging paper/plastic pouches in the sterilizer, the pouches should be arranged",c.	Plastic-to-plastic,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,"When arranging paper/plastic pouches in the sterilizer, the pouches should be arranged",d.	Flat,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,The relative humidity of the Central Service prep and pack area should be,a.	Less than 75%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,The relative humidity of the Central Service prep and pack area should be,b.	30% to 60%,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,The relative humidity of the Central Service prep and pack area should be,c.	40% to 80%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,The relative humidity of the Central Service prep and pack area should be,d.	Less than 35%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Some plastics including formulations of spun-bonded polyolefin are intended for use solely in these sterilization processes,a.	Steam,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Some plastics including formulations of spun-bonded polyolefin are intended for use solely in these sterilization processes,b.	Ozone and hydrogen peroxide,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Some plastics including formulations of spun-bonded polyolefin are intended for use solely in these sterilization processes,c.	Liquid,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Some plastics including formulations of spun-bonded polyolefin are intended for use solely in these sterilization processes,d.	Gravity,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,When placing hinged instruments in an instrument tray,a.	Lock the handles to prevent damage during sterilization,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,When placing hinged instruments in an instrument tray,b.	Arrange the instruments in alphabetical order,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,When placing hinged instruments in an instrument tray,c.	Arrange the instruments in the order of their use,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,When placing hinged instruments in an instrument tray,d.	Unlock the handles and open the instruments,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Gauze squares are the wicking material of choice for instrument sets.,A. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Gauze squares are the wicking material of choice for instrument sets.,b. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Temperatures in a sterile storage area should be 55 �F to 60 �F.,a. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Temperatures in a sterile storage area should be 55 �F to 60 �F.,b. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,"When placing instruments in a peel pack, the tips should always face the plastic side of the pack.",a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,"When placing instruments in a peel pack, the tips should always face the plastic side of the pack.",b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,All rigid sterilization containers have tamper-evident seals.,a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,All rigid sterilization containers have tamper-evident seals.,b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Cellulose materials cannot be processed within ozone sterilizers,a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Cellulose materials cannot be processed within ozone sterilizers,b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Reusable textile packaging requires less labor than disposable packaging.,a. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Reusable textile packaging requires less labor than disposable packaging.,b. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Using latex tubing to protect delicate instrumentation is the process of choice for items to be steam sterilized.,a. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,Using latex tubing to protect delicate instrumentation is the process of choice for items to be steam sterilized.,b. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,While the outside of all instruments must be dry before sterilization it is important to ensure all lumens are kept moist for sterilization.,a. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9856,,Questions-0000-147,SPD INTERNSHIP CHAPTER 12 - ASSEMBLY AND PACKAGING,,n13412,,choice,While the outside of all instruments must be dry before sterilization it is important to ensure all lumens are kept moist for sterilization.,b. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9317,,Elearning-0000-565,FY2021 LUNG CANCER DSC_CHEROKEE,,n13413,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 LUNG CANCER DSC_CHEROKEE CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 LUNG CANCER DSC_CHEROKEE- g13413,False
9317,,Elearning-0000-565,FY2021 LUNG CANCER DSC_CHEROKEE,,n13413,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 LUNG CANCER DSC_CHEROKEE CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9317,,Elearning-0000-565,FY2021 LUNG CANCER DSC_CHEROKEE,,n13413,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 LUNG CANCER DSC_CHEROKEE CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9688,,Elearning-0000-902,FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF,,n13415,,choice,Patient safety is a team effort and patient's should been at an arm's length and remain within line of sight at all times.,a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF- g13415,False
9688,,Elearning-0000-902,FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF,,n13415,,choice,Patient safety is a team effort and patient's should been at an arm's length and remain within line of sight at all times.,a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9688,,Elearning-0000-902,FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF,,n13415,,choice,Patient safety is a team effort and patient's should been at an arm's length and remain within line of sight at all times.,b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9688,,Elearning-0000-902,FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF,,n13415,,choice,"You assist your patient to a sitting position on the side of the stretcher. Prior to standing the patient, you should:","a. Observe your patient for dizziness, lightheadedness and changes in condition and report it to the RN",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9688,,Elearning-0000-902,FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF,,n13415,,choice,"You assist your patient to a sitting position on the side of the stretcher. Prior to standing the patient, you should:",b. Confirm the patient is wearing anti-slip socks,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9688,,Elearning-0000-902,FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF,,n13415,,choice,"You assist your patient to a sitting position on the side of the stretcher. Prior to standing the patient, you should:","c. Utilize assistive devices, if indicated",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9688,,Elearning-0000-902,FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF,,n13415,,choice,"You assist your patient to a sitting position on the side of the stretcher. Prior to standing the patient, you should:","d. Ensure the patient's tubes, lines and catheters are out of the way",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9688,,Elearning-0000-902,FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF,,n13415,,choice,"You assist your patient to a sitting position on the side of the stretcher. Prior to standing the patient, you should:",e. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9688,,Elearning-0000-902,FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF,,n13415,,choice,Risk factors for falls include,A. Orthostatic hypotension,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9688,,Elearning-0000-902,FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF,,n13415,,choice,Risk factors for falls include,B. Medications,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9688,,Elearning-0000-902,FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF,,n13415,,choice,Risk factors for falls include,C. Lines/ tubes/ drains/ catheters,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9688,,Elearning-0000-902,FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF,,n13415,,choice,Risk factors for falls include,D. Pain,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9688,,Elearning-0000-902,FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF,,n13415,,choice,Risk factors for falls include,E. Motor/ Sensory Impairment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9688,,Elearning-0000-902,FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF,,n13415,,choice,Risk factors for falls include,F. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9688,,Elearning-0000-902,FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF,,n13415,,choice,Gait belts are a good tool to use to help support the patient and staff member when standing and ambulating a patient?,a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9688,,Elearning-0000-902,FALL PREVENTION IN SURGICAL SERVICES FOR ANCILLARY STAFF,,n13415,,choice,Gait belts are a good tool to use to help support the patient and staff member when standing and ambulating a patient?,b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,Patient safety is a team effort and patient's should been at an arm's length and remain within line of sight at all times.,a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FALL PREVENTION IN SURGICAL SERVICES FOR NURSES- g13416,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,Patient safety is a team effort and patient's should been at an arm's length and remain within line of sight at all times.,a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,Patient safety is a team effort and patient's should been at an arm's length and remain within line of sight at all times.,b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,"You assist your patient to a sitting position on the side of the stretcher. Prior to standing the patient, you should:","a. Reassess your patient for dizziness, lightheadedness and changes in condition",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,"You assist your patient to a sitting position on the side of the stretcher. Prior to standing the patient, you should:",b. Confirm the patient is wearing anti-slip socks,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,"You assist your patient to a sitting position on the side of the stretcher. Prior to standing the patient, you should:","c. Utilize assistive devices, if indicated.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,"You assist your patient to a sitting position on the side of the stretcher. Prior to standing the patient, you should:","d. Ensure the patient's tubes, lines and catheters are out of the way",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,"You assist your patient to a sitting position on the side of the stretcher. Prior to standing the patient, you should:",e. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,Your patient received a PNB for a knee arthroscopy. You are assessing motor and sensory impairments prior to moving the patient to the next phase of care. You ask the patient to raise their leg straight off of the bed and hold it. The patient is able to raise their leg with their knee bent and is able to hold it for 2 seconds. Which of the following actions is most appropriate?,"a. Move forward with standing and ambulating the patient, this is a normal finding",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,Your patient received a PNB for a knee arthroscopy. You are assessing motor and sensory impairments prior to moving the patient to the next phase of care. You ask the patient to raise their leg straight off of the bed and hold it. The patient is able to raise their leg with their knee bent and is able to hold it for 2 seconds. Which of the following actions is most appropriate?,b. Have 3 staff members present when standing the patient incase the patient's knee buckles,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,Your patient received a PNB for a knee arthroscopy. You are assessing motor and sensory impairments prior to moving the patient to the next phase of care. You ask the patient to raise their leg straight off of the bed and hold it. The patient is able to raise their leg with their knee bent and is able to hold it for 2 seconds. Which of the following actions is most appropriate?,"c. The patient failed the straight leg raise test indicating their quad strength may not support them when standing, continue to assess the patient for return of motor strength.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,Your patient received a PNB for a knee arthroscopy. You are assessing motor and sensory impairments prior to moving the patient to the next phase of care. You ask the patient to raise their leg straight off of the bed and hold it. The patient is able to raise their leg with their knee bent and is able to hold it for 2 seconds. Which of the following actions is most appropriate?,d. Call Anesthesia and the surgeon to report the findings,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,Risk factors for falls include,a. Orthostatic hypotension,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,Risk factors for falls include,b. Medications,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,Risk factors for falls include,c. Lines/ tubes/ drains/ catheters,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,Risk factors for falls include,d. Pain,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,Risk factors for falls include,e. Motor/ Sensory Impairment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,Risk factors for falls include,f. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,It is required to document environmental safety measures taken to reduce the risk of patient falls?,a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9687,,Elearning-0000-901,FALL PREVENTION IN SURGICAL SERVICES FOR NURSES,,n13416,,choice,It is required to document environmental safety measures taken to reduce the risk of patient falls?,b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9521,,Elearning-0000-750,C-374 VERSION 4.0,,n13418,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is C-374 VERSION 4.0- g13418,False
9521,,Elearning-0000-750,C-374 VERSION 4.0,,n13418,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9521,,Elearning-0000-750,C-374 VERSION 4.0,,n13418,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9658,,Elearning-0000-875,FY2021 SURGICAL SERVICES: MURPHY DRIP / CONTINUOUS BLADDER IRRIGATION,,n13452,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the MURPHY DRIP / CONTINUOUS BLADDER IRRIGATION CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 SURGICAL SERVICES: MURPHY DRIP / CONTINUOUS BLADDER IRRIGATION- g13452,False
9658,,Elearning-0000-875,FY2021 SURGICAL SERVICES: MURPHY DRIP / CONTINUOUS BLADDER IRRIGATION,,n13452,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the MURPHY DRIP / CONTINUOUS BLADDER IRRIGATION CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9658,,Elearning-0000-875,FY2021 SURGICAL SERVICES: MURPHY DRIP / CONTINUOUS BLADDER IRRIGATION,,n13452,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the MURPHY DRIP / CONTINUOUS BLADDER IRRIGATION CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21- g13455,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss crash dynamics related to injury prevention.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss crash dynamics related to injury prevention.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss crash dynamics related to injury prevention.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss crash dynamics related to injury prevention.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss crash dynamics related to injury prevention.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize Georgia's and AAP's recommendations for child safety seat use.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize Georgia's and AAP's recommendations for child safety seat use.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize Georgia's and AAP's recommendations for child safety seat use.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize Georgia's and AAP's recommendations for child safety seat use.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize Georgia's and AAP's recommendations for child safety seat use.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand rationale for rear facing car seats.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand rationale for rear facing car seats.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand rationale for rear facing car seats.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand rationale for rear facing car seats.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand rationale for rear facing car seats.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize car safety recommendations for growing infants and children.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize car safety recommendations for growing infants and children.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize car safety recommendations for growing infants and children.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize car safety recommendations for growing infants and children.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize car safety recommendations for growing infants and children.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify infants at risk for airway obstruction.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify infants at risk for airway obstruction.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify infants at risk for airway obstruction.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify infants at risk for airway obstruction.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify infants at risk for airway obstruction.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe safe travel options for infants who fail the car seat challenge/angle tolerance test.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe safe travel options for infants who fail the car seat challenge/angle tolerance test.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe safe travel options for infants who fail the car seat challenge/angle tolerance test.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe safe travel options for infants who fail the car seat challenge/angle tolerance test.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe safe travel options for infants who fail the car seat challenge/angle tolerance test.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to utilize the recall list to identify if a car seat has a recall.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to utilize the recall list to identify if a car seat has a recall.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to utilize the recall list to identify if a car seat has a recall.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to utilize the recall list to identify if a car seat has a recall.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to utilize the recall list to identify if a car seat has a recall.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the dangers of air bags and car seats.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the dangers of air bags and car seats.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the dangers of air bags and car seats.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the dangers of air bags and car seats.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the dangers of air bags and car seats.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe car seat cleaning practices.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe car seat cleaning practices.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe car seat cleaning practices.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe car seat cleaning practices.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe car seat cleaning practices.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to State corrections needed when viewing pictures of children in car seats at car seat check events.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to State corrections needed when viewing pictures of children in car seats at car seat check events.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to State corrections needed when viewing pictures of children in car seats at car seat check events.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to State corrections needed when viewing pictures of children in car seats at car seat check events.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to State corrections needed when viewing pictures of children in car seats at car seat check events.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify simulated car seat misuses and discuss corrective actions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify simulated car seat misuses and discuss corrective actions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify simulated car seat misuses and discuss corrective actions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify simulated car seat misuses and discuss corrective actions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify simulated car seat misuses and discuss corrective actions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine qualities and qualifications for becoming CPST.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine qualities and qualifications for becoming CPST.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine qualities and qualifications for becoming CPST.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine qualities and qualifications for becoming CPST.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine qualities and qualifications for becoming CPST.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve parent education.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve parent education.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve parent education.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve parent education.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve parent education.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Alex McKeithan</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Alex McKeithan</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Alex McKeithan</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Alex McKeithan</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Alex McKeithan</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Suzanne Richter RN, CPST</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Suzanne Richter RN, CPST</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Suzanne Richter RN, CPST</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Suzanne Richter RN, CPST</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Suzanne Richter RN, CPST</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9931,,Questions-0000-65,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 3.12.21,,n13455,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21- g13457,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the importance of self-assessment and discuss barriers to providing compassionate bereavement care.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the importance of self-assessment and discuss barriers to providing compassionate bereavement care.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the importance of self-assessment and discuss barriers to providing compassionate bereavement care.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the importance of self-assessment and discuss barriers to providing compassionate bereavement care.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the importance of self-assessment and discuss barriers to providing compassionate bereavement care.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss positive ways to communicate with grieving families.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss positive ways to communicate with grieving families.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss positive ways to communicate with grieving families.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss positive ways to communicate with grieving families.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss positive ways to communicate with grieving families.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my nursing knowledge as it relates to the care of the family experiencing a perinatal loss.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my nursing knowledge as it relates to the care of the family experiencing a perinatal loss.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my nursing knowledge as it relates to the care of the family experiencing a perinatal loss.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my nursing knowledge as it relates to the care of the family experiencing a perinatal loss.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my nursing knowledge as it relates to the care of the family experiencing a perinatal loss.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of comfort as it relates to providing care and support to families experiencing perinatal loss.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of comfort as it relates to providing care and support to families experiencing perinatal loss.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of comfort as it relates to providing care and support to families experiencing perinatal loss.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of comfort as it relates to providing care and support to families experiencing perinatal loss.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of comfort as it relates to providing care and support to families experiencing perinatal loss.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Melissa Petersen, RNC, MS</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Melissa Petersen, RNC, MS</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Melissa Petersen, RNC, MS</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Melissa Petersen, RNC, MS</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Melissa Petersen, RNC, MS</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9874,,Questions-0000-163,TOUGH TALK: NAVIGATING DIFFICULT TOPICS IN PERINATAL LOSS (EVALUATION SURVEY 1.0) ONLINE - 3.16.21,,n13457,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,Do you complete a pre-clean at the bedside prior to bringing down the scope to GI Lab to process?,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 HLD BRONCHOSCOPE CLEANING TEST- g13458,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,Do you complete a pre-clean at the bedside prior to bringing down the scope to GI Lab to process?,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,Do you complete a pre-clean at the bedside prior to bringing down the scope to GI Lab to process?,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,PPE is not required in the GI Lab during processing of scope,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,PPE is not required in the GI Lab during processing of scope,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,The first step to processing the scope is?,Wiping it down with a lint free cloth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,The first step to processing the scope is?,Submerging it in water,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,The first step to processing the scope is?,Perform leak test,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,5 gallons of water in the sink is required to process a scope,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,5 gallons of water in the sink is required to process a scope,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,Once scope is submerged in water no bubbles are to be seen to pass the leak test,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,Once scope is submerged in water no bubbles are to be seen to pass the leak test,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,How much enzymatic solution is required to be placed in the 5 gallons of water in the sink to clean the scope,A. 25cc,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,How much enzymatic solution is required to be placed in the 5 gallons of water in the sink to clean the scope,B. 50cc,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,How much enzymatic solution is required to be placed in the 5 gallons of water in the sink to clean the scope,C. 75cc,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,How much enzymatic solution is required to be placed in the 5 gallons of water in the sink to clean the scope,D. 100cc,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,Tap water and enzymatic solution is what is in the two large canisters used during the cleaning process with the Scope Buddy,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,Tap water and enzymatic solution is what is in the two large canisters used during the cleaning process with the Scope Buddy,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,"When using the Scope Buddy, clean water is siphoned before the enzymatic solution",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,"When using the Scope Buddy, clean water is siphoned before the enzymatic solution",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,You must dry the scope prior to placing it in the washer,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,You must dry the scope prior to placing it in the washer,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,During ATP when do you cut the brush?,A. Once you have entered and exited the scope,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,During ATP when do you cut the brush?,B. Never cut the brush,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,During ATP when do you cut the brush?,C. There is no brush in ATP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,Digital read out on ATP should be less than what to be considered an acceptable level?,A. Less than 500,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,Digital read out on ATP should be less than what to be considered an acceptable level?,B. Less than 1000,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,Digital read out on ATP should be less than what to be considered an acceptable level?,C. Less than 100,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,Digital read out on ATP should be less than what to be considered an acceptable level?,D. Less than 1,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,If the digital read out on ATP is higher than the acceptable range you must then do what?,A. Wipe the scope down with a lint free cloth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,If the digital read out on ATP is higher than the acceptable range you must then do what?,B. Run the scope in the washer,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,If the digital read out on ATP is higher than the acceptable range you must then do what?,C. Redo all steps to processing the scope prior to ATP,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,What is the required information for the new washer to run?,A. Scan Scope,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,What is the required information for the new washer to run?,B. Scan Badge,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,What is the required information for the new washer to run?,C. Scan Scope and Badge,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,The testing strip of paper is printed after the washer has completed the cleaning cycle,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,The testing strip of paper is printed after the washer has completed the cleaning cycle,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,You should never touch a scope with your bare hands,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,You should never touch a scope with your bare hands,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,It is OK for the clean scope to touch another clean scope in the scope cabinet,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,It is OK for the clean scope to touch another clean scope in the scope cabinet,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,After hours and on weekends bronchoscopes should be cleaned by RT department.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,After hours and on weekends bronchoscopes should be cleaned by RT department.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,A cap for cleaning is not necessary on the high definition scope,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,A cap for cleaning is not necessary on the high definition scope,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,The high definition bronchoscopes do have built in leak test ports,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,The high definition bronchoscopes do have built in leak test ports,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,On the new washer you should make sure fluids are sufficient before starting wash,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9926,,Questions-0000-60,FY2021 HLD BRONCHOSCOPE CLEANING TEST,,n13458,,choice,On the new washer you should make sure fluids are sufficient before starting wash,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,Which of the following are correct?,a. The small bowel feeding tube can be inserted by any nurse who has completed the competency.,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES- g13459,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,Which of the following are correct?,a. The small bowel feeding tube can be inserted by any nurse who has completed the competency.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,Which of the following are correct?,b. The small bowel feeding tube can be inserted by interventional radiology only.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,Which of the following are correct?,c. The small bowel feeding tube can be inserted by interventional radiology and by the rapid response team utilizing the CorTrak system.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,Which of the following are correct?,d. The rapid response nurse can choose whether she inserts the small bowel feeding tube with the CorTrak device or not based on her assessment.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,The patient's head of bed should be elevated at all times during the administration of tube feeding.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,The patient's head of bed should be elevated at all times during the administration of tube feeding.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,Ms. Jones is receiving tube feeding at 45 ml per hour via a small bowel feeding tube. The MRI technologist calls to tell you that they are on the way to take your patient down to MRI. What should your response be?,a. Ms. Jones is receiving tube feeding and it must be stopped for 1 hour before she can lay flat. Please let me know what time I should turn the tube feeding off so that we can time it for one hour before you come to get her.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,Ms. Jones is receiving tube feeding at 45 ml per hour via a small bowel feeding tube. The MRI technologist calls to tell you that they are on the way to take your patient down to MRI. What should your response be?,b. I will turn her tube feeding off now and then you can come and get her since she is only receiving 45 ml per hour of tube feeding.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,Ms. Jones is receiving tube feeding at 45 ml per hour via a small bowel feeding tube. The MRI technologist calls to tell you that they are on the way to take your patient down to MRI. What should your response be?,"c. I am going on my lunch break now, you can come and get her whenever it is convenient for you but you will need to bring additional transporter to take the tube feeding down with you as well.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,Documentation of the cm marking on the tube should be done:,a. Once a shift,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,Documentation of the cm marking on the tube should be done:,b. Twice a shift,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,Documentation of the cm marking on the tube should be done:,c. Every 4 hours,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,Documentation of the cm marking on the tube should be done:,d. Every 12 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,The Centimeter marking on the tube is at the 50 cm mark. When you chart this you realize that the last time it was charted it was at the 76 cm mark. What should you do?,a. No action is required since the patient is not coughing and not having any s/s of aspiration.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,The Centimeter marking on the tube is at the 50 cm mark. When you chart this you realize that the last time it was charted it was at the 76 cm mark. What should you do?,b. Turn off the tube feeding and notify the MD immediately,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,The Centimeter marking on the tube is at the 50 cm mark. When you chart this you realize that the last time it was charted it was at the 76 cm mark. What should you do?,c. Turn off the tube feeding and notify the rapid response team to come back and re-insert the tube back to the 76 cm mark.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,The Centimeter marking on the tube is at the 50 cm mark. When you chart this you realize that the last time it was charted it was at the 76 cm mark. What should you do?,"d. Notify the MD, but do not turn off the tube feeding as the patient may become dehydrated.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,Once the radiologist calls and tell you the tube is in the stomach you can begin tube feeding.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9422,,Elearning-0000-660,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: NURSES,,n13459,,choice,Once the radiologist calls and tell you the tube is in the stomach you can begin tube feeding.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,Which of the following describes a small bowel feeding tube?,a. Frequently weighted,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS- g6015,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,Which of the following describes a small bowel feeding tube?,a. Frequently weighted,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,Which of the following describes a small bowel feeding tube?,b. Goes through the patient's nose into the stomach,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,Which of the following describes a small bowel feeding tube?,c. Stylet to assist with placement,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,Which of the following describes a small bowel feeding tube?,d. Dobhoff,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,Which of the following describes a small bowel feeding tube?,"e. A, C & D",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,Which of the following describes a small bowel feeding tube?,f. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,"You are called to the room of one of your patients who had a small bowel feeding tube placed within the last few hours.  The patient states they need to go to the bathroom and are now not able to get up by themselves, although they were able to do so prior to the tube being placed.  Which of the following will you do FIRST?","a.	Disconnect the tube and help them to the bathroom, since you were able to do so before the tube was placed",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,"You are called to the room of one of your patients who had a small bowel feeding tube placed within the last few hours.  The patient states they need to go to the bathroom and are now not able to get up by themselves, although they were able to do so prior to the tube being placed.  Which of the following will you do FIRST?",b.	Check the orders to verify presence of an ambulation order,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,"You are called to the room of one of your patients who had a small bowel feeding tube placed within the last few hours.  The patient states they need to go to the bathroom and are now not able to get up by themselves, although they were able to do so prior to the tube being placed.  Which of the following will you do FIRST?",c.	Notify the nurse,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,"You are called to the room of one of your patients who had a small bowel feeding tube placed within the last few hours.  The patient states they need to go to the bathroom and are now not able to get up by themselves, although they were able to do so prior to the tube being placed.  Which of the following will you do FIRST?","d.	Get a bedpan, since they are no longer able to get out of bed",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,It is not necessary for you to include presence of a small bowel feeding tube during hand off communication.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,It is not necessary for you to include presence of a small bowel feeding tube during hand off communication.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,"Upon arrival to your patient's room, you note the patient to be agitated and breathing fast.  Their vital signs are as follows:  Temp - 97.0; HR 123; RR 36; BP 148/82.  Which of the following will you do FIRST?",a. Offer the patient a warm blanket in attempt to make them more comfortable,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,"Upon arrival to your patient's room, you note the patient to be agitated and breathing fast.  Their vital signs are as follows:  Temp - 97.0; HR 123; RR 36; BP 148/82.  Which of the following will you do FIRST?",b. Notify the nurse,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,"Upon arrival to your patient's room, you note the patient to be agitated and breathing fast.  Their vital signs are as follows:  Temp - 97.0; HR 123; RR 36; BP 148/82.  Which of the following will you do FIRST?",c. Ask their family member to leave; it appears they need more rest,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,"Upon arrival to your patient's room, you note the patient to be agitated and breathing fast.  Their vital signs are as follows:  Temp - 97.0; HR 123; RR 36; BP 148/82.  Which of the following will you do FIRST?",d. Change the TV channel; that TV show must be agitating the patient,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,"While rounding on your patient you note they are sleeping quietly, vital signs are stable, and their pump for their feeding tube is alarming.  Which of the following will you do FIRST?",a. Silence the alarm,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,"While rounding on your patient you note they are sleeping quietly, vital signs are stable, and their pump for their feeding tube is alarming.  Which of the following will you do FIRST?",b. Turn off the pump,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,"While rounding on your patient you note they are sleeping quietly, vital signs are stable, and their pump for their feeding tube is alarming.  Which of the following will you do FIRST?",c. Ignore the alarm,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8895,,Elearning-0000-181,FY2021 SMALL BOWEL FEEDING TUBE EDUCATION: TECHS,,n6015,,choice,"While rounding on your patient you note they are sleeping quietly, vital signs are stable, and their pump for their feeding tube is alarming.  Which of the following will you do FIRST?",d. Notify the nurse,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9297,,Elearning-0000-547,FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE,,n13460,,choice,"Scenario:<br>  Patient admitted with failure to thrive with a history of opioid induced constipation taking laxatives at home. During stay, patient received three doses of miralax and bisacodyl suppository. Patient admitted on 5/1. On 5/4, day four of admission, patient reported loose stools. MD ordered C.Diff test. Specimen sent and tested positive for C.Diff. Patient had no reoccurrence of loose stools.<br>  Should have questioned the MD's order to send a stool specimen for C.Diff based on medications given above?",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE- g13460,False
9297,,Elearning-0000-547,FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE,,n13460,,choice,"Scenario:<br>  Patient admitted with failure to thrive with a history of opioid induced constipation taking laxatives at home. During stay, patient received three doses of miralax and bisacodyl suppository. Patient admitted on 5/1. On 5/4, day four of admission, patient reported loose stools. MD ordered C.Diff test. Specimen sent and tested positive for C.Diff. Patient had no reoccurrence of loose stools.<br>  Should have questioned the MD's order to send a stool specimen for C.Diff based on medications given above?",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9297,,Elearning-0000-547,FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE,,n13460,,choice,"Scenario:<br>  Patient admitted with failure to thrive with a history of opioid induced constipation taking laxatives at home. During stay, patient received three doses of miralax and bisacodyl suppository. Patient admitted on 5/1. On 5/4, day four of admission, patient reported loose stools. MD ordered C.Diff test. Specimen sent and tested positive for C.Diff. Patient had no reoccurrence of loose stools.<br>  Should have questioned the MD's order to send a stool specimen for C.Diff based on medications given above?",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9297,,Elearning-0000-547,FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE,,n13460,,choice,"Scenario:<br>  Patient admitted with failure to thrive with a history of opioid induced constipation taking laxatives at home. During stay, patient received three doses of miralax and bisacodyl suppository. Patient admitted on 5/1. On 5/4, day four of admission, patient reported loose stools. MD ordered C.Diff test. Specimen sent and tested positive for C.Diff. Patient had no reoccurrence of loose stools.<br>  What process would have potentially stopped the specimen from being sent?",a.	C.Diff specimen log,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9297,,Elearning-0000-547,FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE,,n13460,,choice,"Scenario:<br>  Patient admitted with failure to thrive with a history of opioid induced constipation taking laxatives at home. During stay, patient received three doses of miralax and bisacodyl suppository. Patient admitted on 5/1. On 5/4, day four of admission, patient reported loose stools. MD ordered C.Diff test. Specimen sent and tested positive for C.Diff. Patient had no reoccurrence of loose stools.<br>  What process would have potentially stopped the specimen from being sent?",b.	Using  appropriate C.Diff testing algorithm,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9297,,Elearning-0000-547,FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE,,n13460,,choice,"Scenario:<br>  Patient admitted with failure to thrive with a history of opioid induced constipation taking laxatives at home. During stay, patient received three doses of miralax and bisacodyl suppository. Patient admitted on 5/1. On 5/4, day four of admission, patient reported loose stools. MD ordered C.Diff test. Specimen sent and tested positive for C.Diff. Patient had no reoccurrence of loose stools.<br>  What process would have potentially stopped the specimen from being sent?",c.	Both A&B,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9297,,Elearning-0000-547,FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE,,n13460,,choice,"Scenario:<br>  75 yo female admitted through the ED. She states that she has been having diarrhea at home off and on for the last week. She describes her ""diarrhea""� as loose stools that she had once or twice a day 3 times last week. A c-diff test is ordered on admission. 3 days after admission there is no documentation of a stool. Per NSH policy the lab cancelled the order for the specimen after 2 days. The next day she was given miralax due to constipation. She had two liquid stools on the day the miralax was ordered.<br>  The nurse should:",A.	Send the stool for c-diff testing and place patient on modified contact isolation.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9297,,Elearning-0000-547,FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE,,n13460,,choice,"Scenario:<br>  75 yo female admitted through the ED. She states that she has been having diarrhea at home off and on for the last week. She describes her ""diarrhea""� as loose stools that she had once or twice a day 3 times last week. A c-diff test is ordered on admission. 3 days after admission there is no documentation of a stool. Per NSH policy the lab cancelled the order for the specimen after 2 days. The next day she was given miralax due to constipation. She had two liquid stools on the day the miralax was ordered.<br>  The nurse should:","B.	After discovering that the test had been cancelled by the lab, call the MD for a new order",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9297,,Elearning-0000-547,FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE,,n13460,,choice,"Scenario:<br>  75 yo female admitted through the ED. She states that she has been having diarrhea at home off and on for the last week. She describes her ""diarrhea""� as loose stools that she had once or twice a day 3 times last week. A c-diff test is ordered on admission. 3 days after admission there is no documentation of a stool. Per NSH policy the lab cancelled the order for the specimen after 2 days. The next day she was given miralax due to constipation. She had two liquid stools on the day the miralax was ordered.<br>  The nurse should:","C.	No actions are required, this would be considered an expected result after receiving the miralax.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9297,,Elearning-0000-547,FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE,,n13460,,choice,The c-diff log is required to be completed prior to sending any stool for c-diff testing.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9297,,Elearning-0000-547,FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE,,n13460,,choice,The c-diff log is required to be completed prior to sending any stool for c-diff testing.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9297,,Elearning-0000-547,FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE,,n13460,,choice,"Scenario:<br>  Your patient was admitted for cellulitis and was transferred from a nursing home. She is independently ambulatory, alert and oriented.  She is on IV Levaquin and has received 4 doses. During your morning assessment your patient states she had a loose stool during the night. <br>  What is your next step:",A. No actions needed she has only had one loose stool,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9297,,Elearning-0000-547,FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE,,n13460,,choice,"Scenario:<br>  Your patient was admitted for cellulitis and was transferred from a nursing home. She is independently ambulatory, alert and oriented.  She is on IV Levaquin and has received 4 doses. During your morning assessment your patient states she had a loose stool during the night. <br>  What is your next step:",B. Place stool collection cup in room and instruct patient to notify you if she has any additional stools.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9297,,Elearning-0000-547,FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE,,n13460,,choice,"Scenario:<br>  Your patient was admitted for cellulitis and was transferred from a nursing home. She is independently ambulatory, alert and oriented.  She is on IV Levaquin and has received 4 doses. During your morning assessment your patient states she had a loose stool during the night. <br>  What is your next step:","C. Continue to monitor for signs and symptoms of C-Diff such as 3 or more stools per day, abdominal pain, bloating etc. while recognizing that this patient is at high risk for C-Diff due to antibiotic and nursing home transfer.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9297,,Elearning-0000-547,FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE,,n13460,,choice,It is acceptable to chart x4 at the end of the shift if a patient has had 4 stools during the shift.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9297,,Elearning-0000-547,FY2021 C. DIFF ANNUAL EDUCATION: PATIENT CARE,,n13460,,choice,It is acceptable to chart x4 at the end of the shift if a patient has had 4 stools during the shift.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,The process by which instruments are steam sterilized for immediate use is called,a.	Emergency sterilization,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING- g13461,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,The process by which instruments are steam sterilized for immediate use is called,a.	Emergency sterilization,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,The process by which instruments are steam sterilized for immediate use is called,b.	Immediate use steam sterilization,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,The process by which instruments are steam sterilized for immediate use is called,c.	Core sterilization,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,The process by which instruments are steam sterilized for immediate use is called,d.	Rapid reprocessing,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Items to be disinfected or sterilized at the point of use must be,a.	Properly cleaned per Manufacturer's Instructions for Use,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Items to be disinfected or sterilized at the point of use must be,b.	Semi-critical devices,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Items to be disinfected or sterilized at the point of use must be,c.	non-critical devices,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Items to be disinfected or sterilized at the point of use must be,d.	heat sensitive,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,The best way to transport items that have been processed using immediate use steam sterilization at the point of use,a.	covered with a sterile towel,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,The best way to transport items that have been processed using immediate use steam sterilization at the point of use,b.	in a rigid container designed for immediate use steam sterilization,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,The best way to transport items that have been processed using immediate use steam sterilization at the point of use,c.	in a covered mesh bottom tray,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,The best way to transport items that have been processed using immediate use steam sterilization at the point of use,d.	in a kraft paper bag,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Before an item can be placed in a liquid chemical sterile processing system they must be,a.	heated,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Before an item can be placed in a liquid chemical sterile processing system they must be,b.	filled with air,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Before an item can be placed in a liquid chemical sterile processing system they must be,c.	sterilized,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Before an item can be placed in a liquid chemical sterile processing system they must be,d.	cleaned,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Which of the following statements about immediate use steam sterilization is true?,a.	It is the sterilization method of choice for mental instruments,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Which of the following statements about immediate use steam sterilization is true?,b.	It is recommended to be used as a primary sterilization process by the Association for the Advancement of Medical Instrumentation and the Association of periOperative Registered Nurses,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Which of the following statements about immediate use steam sterilization is true?,c.	It reduces turnaround time because cleaning is not required,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Which of the following statements about immediate use steam sterilization is true?,d.	It should be used only when there is not time to process items using the wrapped method,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Both the Association of periOperative Registered Nurses and The Joint Commission recommend that,a.	The use of immediate use steam sterilization be minimized or decreased,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Both the Association of periOperative Registered Nurses and The Joint Commission recommend that,b.	Immediate use steam sterilization be performed in only one sterilizer per facility,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Both the Association of periOperative Registered Nurses and The Joint Commission recommend that,c.	Healthcare facilities get U.S. Food and Drug Administration approval for immediate use steam sterilization,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Both the Association of periOperative Registered Nurses and The Joint Commission recommend that,d.	Only Central Service technicians operate immediate use steam sterilizers,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Implantable devices,a.	Should be immediate use steam sterilization in extended cycles,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Implantable devices,b.	Should only be sterilized using ethylene oxide,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Implantable devices,c.	Should not be immediate use steam sterilization sterilized unless there is a tracking system in place to trace the item to a patient,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Implantable devices,d.	Require double cycle sterilization to ensure sterility,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,"When transporting items that have been immediate use steam sterilized, it is required that",a.	They be transported in a metal container,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,"When transporting items that have been immediate use steam sterilized, it is required that",b.	They be transported to the patient area within five minutes of the completion of the sterilization cycle,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,"When transporting items that have been immediate use steam sterilized, it is required that",c.	They be allow to properly cooled before transport,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,"When transporting items that have been immediate use steam sterilized, it is required that",d.	They be transported in such a manner that reduces the potential for contamination,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,"When sterilizing items at the point-of-use, an abbreviated cleaning procedure may be used due to the urgent need for the instruments.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,"When sterilizing items at the point-of-use, an abbreviated cleaning procedure may be used due to the urgent need for the instruments.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Immediate use steam sterilization documentation should include,a.	The name of the patient for which the items were sterilized,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Immediate use steam sterilization documentation should include,b.	Sterilizer number and cycle,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Immediate use steam sterilization documentation should include,c.	Name of the instrument sterilized,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8889,,Elearning-0000-176,SPD INTERNSHIP CHAPTER 13 - POINT-OF-USE PROCESSING,,n13461,,choice,Immediate use steam sterilization documentation should include,d.	All the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,"When loading a steam sterilizer, basins should be",a.	Placed in an upright position,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION- g13462,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,"When loading a steam sterilizer, basins should be",a.	Placed in an upright position,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,"When loading a steam sterilizer, basins should be",b.	Loaded first,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,"When loading a steam sterilizer, basins should be",c.	Placed on edge,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,"When loading a steam sterilizer, basins should be",d.	Placed in a wire basket,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The higher the bioburden on an object,a.	The more difficult it will be to sterilize,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The higher the bioburden on an object,b.	The less time it will take to sterilize it,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The higher the bioburden on an object,c.	The more biological tests will be needed in the load,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The higher the bioburden on an object,d.	The longer it will take to cool after sterilization,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,"When combining loads, hard goods should be placed on the top shelves to allow for more efficient removal of the condensate",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,"When combining loads, hard goods should be placed on the top shelves to allow for more efficient removal of the condensate",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The steam sterilization process can be affected by the design of the medical device being sterilized,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The steam sterilization process can be affected by the design of the medical device being sterilized,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Central Service technicians need to understand the anatomy of a steam sterilizer to,a.	Know how to properly clean the chamber,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Central Service technicians need to understand the anatomy of a steam sterilizer to,b.	Understand how the sterilizer operates,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Central Service technicians need to understand the anatomy of a steam sterilizer to,c.	Understand how to test the thermostatic trap,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Central Service technicians need to understand the anatomy of a steam sterilizer to,d.	Know how to properly maintain the jacket,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The weakest part of a steam sterilizer is the,a.	Jacket,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The weakest part of a steam sterilizer is the,b.	Gasket,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The weakest part of a steam sterilizer is the,c.	Door,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The weakest part of a steam sterilizer is the,d.	Thermostatic valve,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Three of the main phases of a terminal steam sterilizer cycle are,"a.	Gravity, exposure and exhaust",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Three of the main phases of a terminal steam sterilizer cycle are,"b.	Pre-vacuum, exposure and exhaust",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Three of the main phases of a terminal steam sterilizer cycle are,"c.	Exposure, exhaust and dry",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Three of the main phases of a terminal steam sterilizer cycle are,"d.	Conditioning, exposure and exhaust",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The most common reason for steam sterilization failure is,a.	Lack of steam contact with the instrument,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The most common reason for steam sterilization failure is,b.	Insufficient temperature,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The most common reason for steam sterilization failure is,c.	Inadequate exposure time,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The most common reason for steam sterilization failure is,d.	Drying issues,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The coolest place in a steam sterilizer is the,a.	Gasket,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The coolest place in a steam sterilizer is the,b.	Thermostatic trap,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The coolest place in a steam sterilizer is the,c.	Jacket,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,The coolest place in a steam sterilizer is the,d.	Chamber,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Steam flush pressure pulse sterilizers are a type of gravity sterilizers,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Steam flush pressure pulse sterilizers are a type of gravity sterilizers,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Factors that can cause sterilant contact failure with the instrument are,"a.	Cleaning, loosely packed load",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Factors that can cause sterilant contact failure with the instrument are,"b.	Conditioning, size and weight of the instrument",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Factors that can cause sterilant contact failure with the instrument are,"c.	Solid bottom containers, exposure time",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Factors that can cause sterilant contact failure with the instrument are,"d.	Crowded loads, clogged drain strainer",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,One of the most frequent causes of a clogged drain screen is,a.	Tape,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,One of the most frequent causes of a clogged drain screen is,b.	Wrapper particles,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,One of the most frequent causes of a clogged drain screen is,c.	Poor steam quality,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,One of the most frequent causes of a clogged drain screen is,d.	Malfunctioning baffle plate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Peel pouches should be placed _______________________________________ for sterilization,"a.	On edge, paper to plastic",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Peel pouches should be placed _______________________________________ for sterilization,"b.	On edge, plastic to plastic",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Peel pouches should be placed _______________________________________ for sterilization,c.	Placed flat with the plastic side up,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Peel pouches should be placed _______________________________________ for sterilization,d.	Placed flat with the paper side up,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Items with a standard steam sterilization cycle recommended by the manufacturer can be damaged if run in an extended cycle.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Items with a standard steam sterilization cycle recommended by the manufacturer can be damaged if run in an extended cycle.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,How frequently should a sterilizer's strainer be removed and cleaned?,a.	Daily,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,How frequently should a sterilizer's strainer be removed and cleaned?,b.	After each use,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,How frequently should a sterilizer's strainer be removed and cleaned?,c.	Once weekly,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,How frequently should a sterilizer's strainer be removed and cleaned?,d.	Only when the machine's operating control gauge indicates cleaning is necessary,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Immediate use steam sterilization is the process to sterilize trays for future use.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Immediate use steam sterilization is the process to sterilize trays for future use.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Wood products should be sterilized in an extended steam cycle.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Wood products should be sterilized in an extended steam cycle.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,When water is seen on the outside of a pack after sterilization the pack is considered safe to use if all other packs in the load are dry.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,When water is seen on the outside of a pack after sterilization the pack is considered safe to use if all other packs in the load are dry.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Packs that are improperly packaged or loaded on the sterilizer cart frequently become wet packs.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,Packs that are improperly packaged or loaded on the sterilizer cart frequently become wet packs.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,After sterilization the load contents may take two hours or more to cool.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8888,,Elearning-0000-175,SPD INTERNSHIP CHAPTER 14 - HIGH-TEMPERATURE STERILIZATION,,n13462,,choice,After sterilization the load contents may take two hours or more to cool.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,Woven reusable fabrics are the packaging products of choice for ozone sterilization,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION- g13466,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,Woven reusable fabrics are the packaging products of choice for ozone sterilization,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,Woven reusable fabrics are the packaging products of choice for ozone sterilization,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,Ethylene kills microorganisms by a process called oxidation,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,Ethylene kills microorganisms by a process called oxidation,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,"Ethylene oxide, hydrogen peroxide and ozone sterilization process must all be monitored using chemical, physical and biological monitors.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,"Ethylene oxide, hydrogen peroxide and ozone sterilization process must all be monitored using chemical, physical and biological monitors.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,"Ethylene oxide, hydrogen peroxide and ozone sterilization can all use the same packaging materials.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,"Ethylene oxide, hydrogen peroxide and ozone sterilization can all use the same packaging materials.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,Lumens should be moist when using hydrogen peroxide as a sterilizing agent,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,Lumens should be moist when using hydrogen peroxide as a sterilizing agent,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,Ethylene oxide is a toxic gas,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,Ethylene oxide is a toxic gas,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,7.	Cellulose-containing packaging materials are not compatible with hydrogen peroxide sterilization.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,7.	Cellulose-containing packaging materials are not compatible with hydrogen peroxide sterilization.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,Information about device's compatibility with a specific sterilization process should be obtained from the device's manufacturer.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,Information about device's compatibility with a specific sterilization process should be obtained from the device's manufacturer.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,An extended aeration cycle is required for items sterilized in ozone sterilization processes.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,An extended aeration cycle is required for items sterilized in ozone sterilization processes.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,Permissible exposure levels for low-temperature sterilization methods are established by the,a.	U.S. Food and Drug Administration,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,Permissible exposure levels for low-temperature sterilization methods are established by the,b.	Centers for Disease Control,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,Permissible exposure levels for low-temperature sterilization methods are established by the,c.	Occupational Safety and Health Administration,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8882,,Elearning-0000-174,SPD INTERNSHIP CHAPTER 15 - LOW-TEMPERATURE STERILIZATION,,n13466,,choice,Permissible exposure levels for low-temperature sterilization methods are established by the,d.	Environmental Protection Agency,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The relative humidity of the Central Service sterile storage areas should be,a.	Less than 70%,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT- g13469,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The relative humidity of the Central Service sterile storage areas should be,a.	Less than 70%,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The relative humidity of the Central Service sterile storage areas should be,b.	Less than 60%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The relative humidity of the Central Service sterile storage areas should be,c.	Less than 50%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The relative humidity of the Central Service sterile storage areas should be,d.	Less than 35%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Temperatures in a sterile storage area should be 64 � to 75 �F.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Temperatures in a sterile storage area should be 64 � to 75 �F.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,"Because of event-related shelf-life, stock rotation is no longer necessary.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,"Because of event-related shelf-life, stock rotation is no longer necessary.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The sterile storage process starts,a.	When items are received in the decontamination area,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The sterile storage process starts,b.	After items are sterilized and cooled,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The sterile storage process starts,c.	When the sterilizer door is opened,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The sterile storage process starts,d.	When items are placed into the sterilizer,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Sterile storage areas should,a.	Have positive airflow and at least 10 air exchanges per hour,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Sterile storage areas should,b.	Have positive airflow and at least four air exchanges per hour,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Sterile storage areas should,c.	Have negative airflow and at least 10 air exchanges per hour,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Sterile storage areas should,d.	Have negative airflow and at least four air exchanges per hour,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Temperature and humidity levels in the sterile storage area should be checked and recorded at least weekly,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Temperature and humidity levels in the sterile storage area should be checked and recorded at least weekly,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The shelving system of choice for the sterile storage area is,a.	Closed,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The shelving system of choice for the sterile storage area is,b.	Semi closed,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The shelving system of choice for the sterile storage area is,c.	Open,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The shelving system of choice for the sterile storage area is,d.	Tracked,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Trays which overhang shelving,a.	Can become contaminated,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Trays which overhang shelving,"b.	Are ok for rigid containers, but not for flat wrapped trays",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Trays which overhang shelving,c.	Is the appropriate way to store trays as it allows for the use of proper body mechanics when lifting heavy trays,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Trays which overhang shelving,d.	None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The type of shelving that leaves packaging the most vulnerable is,a.	Open,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The type of shelving that leaves packaging the most vulnerable is,b.	Closed,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The type of shelving that leaves packaging the most vulnerable is,c.	Semi closed,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The type of shelving that leaves packaging the most vulnerable is,d.	Tracked,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The bottom shelf of any sterile storage system should be,a.	Solid and eight to 10 inches from the floor,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The bottom shelf of any sterile storage system should be,b.	Solid and two to four inches from the floor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The bottom shelf of any sterile storage system should be,c.	Cleaned weekly,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,The bottom shelf of any sterile storage system should be,d.	Wire and eight to 10 inches from the floor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Sterile trays should,a.	Not be touched until they are properly cooled,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Sterile trays should,b.	Be lifted not dragged off the sterilizer cart,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Sterile trays should,c.	Be checked to be sure the chemical indicators have turned the appropriate color,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Sterile trays should,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Wrapped trays should not be stacked because,a.	The tray contents may be damaged,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Wrapped trays should not be stacked because,b.	It can cause holes in the wrapper of the bottom tray,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Wrapped trays should not be stacked because,c.	It will cause the shelving to bend,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Wrapped trays should not be stacked because,d.	They will be more difficult to rotate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Outside shipping containers,a.	Should be removed prior to placing the items in storage,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Outside shipping containers,b.	May be stored in the sterile storage area as long as they are not stored near the in-house sterilized items,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Outside shipping containers,c.	Make good storage containers to help keep items from falling from the shelves,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Outside shipping containers,d.	All the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Event-related shelf life means items are safe until opened for use.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Event-related shelf life means items are safe until opened for use.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Sterilized packages may be jeopardized due to storage practices.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8872,,Elearning-0000-173,SPD INTERNSHIP CHAPTER 16 - STERILE STORAGE AND TRANSPORT,,n13469,,choice,Sterilized packages may be jeopardized due to storage practices.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,A Bronch Wash is any volume less than 20ml,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 ANNUAL BRONCHOSCOPY TEST- g13468,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,A Bronch Wash is any volume less than 20ml,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,A Bronch Wash is any volume less than 20ml,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,A Bronchial Alveolar Lavage is any volume 20ml or greater,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,A Bronchial Alveolar Lavage is any volume 20ml or greater,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,What do you need to be aware of before giving Phenylephrine,1. It can decrease blood pressure,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,What do you need to be aware of before giving Phenylephrine,2. It can increase blood pressure,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,What do you need to be aware of before giving Phenylephrine,3. It can cause a fast/irregular heartbeat,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,What do you need to be aware of before giving Phenylephrine,4. It can increase the blood pressure and cause a fast/irregular heartbeat.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,Correct mixture for Phenylephrine is,1. 10ml mixed with 1ml of 0.9% Sodium Chloride,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,Correct mixture for Phenylephrine is,2. 1ml mixed with 9ml of 0.9% Sodium Chloride,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,Correct mixture for Phenylephrine is,3. 1ml mixed with 9ml of 0.9% Sodium Bicarb,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,What is the best way to achieve hemostasis in the lung,1. CPAP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,What is the best way to achieve hemostasis in the lung,2. Iced normal saline lavage,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,What is the best way to achieve hemostasis in the lung,3. Hold pressure with the bronchoscope,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,"When prepping nares for a bronchoscopy, what % viscous lidocaine should be used",1. 10%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,"When prepping nares for a bronchoscopy, what % viscous lidocaine should be used",2. 1%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,"When prepping nares for a bronchoscopy, what % viscous lidocaine should be used",3. 5%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,"When prepping nares for a bronchoscopy, what % viscous lidocaine should be used",4. 2%,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,"When prepping a patient for a bronchoscopy, with platelets less than 50, you should prep the mouth instead of the nares",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,"When prepping a patient for a bronchoscopy, with platelets less than 50, you should prep the mouth instead of the nares",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,Cytology brushings are fixed on slides and sprayed with what fixative spray?,1. Formaldehyde,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,Cytology brushings are fixed on slides and sprayed with what fixative spray?,2. Alcohol,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,Cytology brushings are fixed on slides and sprayed with what fixative spray?,3. Peroxide,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,Cytology brushings are fixed on slides and sprayed with what fixative spray?,4. Hairspray,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,You should always wear gloves when touching a bronchoscope?,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,You should always wear gloves when touching a bronchoscope?,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,The Medication sheet should be:,1. Signed and dated only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,The Medication sheet should be:,2. Noted and timed only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,The Medication sheet should be:,"3. Signed, dated, timed, and noted",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,The Medication sheet should be:,4. None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,The bedside pre-clean of the bronchoscope can be done after you take the samples to the lab,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,The bedside pre-clean of the bronchoscope can be done after you take the samples to the lab,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,The enzymatic sponge is utilized during the bedside pre-clean,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,The enzymatic sponge is utilized during the bedside pre-clean,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,You should transport a bronchoscope in a closed bin,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,You should transport a bronchoscope in a closed bin,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,It is ok if a clean bronchoscope touches another clean bronchoscope while stored in gi lab,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,It is ok if a clean bronchoscope touches another clean bronchoscope while stored in gi lab,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,Physicians are responsible for placing bronch orders in to cerner,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9925,,Questions-0000-59,FY2021 ANNUAL BRONCHOSCOPY TEST,,n13468,,choice,Physicians are responsible for placing bronch orders in to cerner,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9524,,Elearning-0000-753,C369 VERSION 4.0,,n13471,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is C369 VERSION 4.0- g13471,False
9524,,Elearning-0000-753,C369 VERSION 4.0,,n13471,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9524,,Elearning-0000-753,C369 VERSION 4.0,,n13471,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Formal training should occur,a.	For new employees,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL- g13475,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Formal training should occur,a.	For new employees,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Formal training should occur,b.	At least monthly,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Formal training should occur,c.	For employees who move to a new positions,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Formal training should occur,d.	For new employees and those who move to new position,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Monitoring records must be,a.	Accurate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Monitoring records must be,b.	Legible,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Monitoring records must be,c.	Complete,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Monitoring records must be,d.	All the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Sterilizer load records should contain,a.	Items and quantity sterilized,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Sterilizer load records should contain,b.	Type of packaging used in the load,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Sterilizer load records should contain,c.	Preventative maintenance dates,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Sterilizer load records should contain,d.	All the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,External indicators can prove an item is sterile when the sterilization cycle is complete,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,External indicators can prove an item is sterile when the sterilization cycle is complete,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Temperature and humidity levels need to be monitored and recorded,"a.	Weekly, preferably daily",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Temperature and humidity levels need to be monitored and recorded,b.	For each shift,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Temperature and humidity levels need to be monitored and recorded,c.	At least daily,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Temperature and humidity levels need to be monitored and recorded,d.	At least monthly,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,The U.S. Food and Drug Administration Class II chemical indicator that is run daily in dynamic air removal sterilizers is called a,a.	Process challenge device,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,The U.S. Food and Drug Administration Class II chemical indicator that is run daily in dynamic air removal sterilizers is called a,b.	External chemical indicator,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,The U.S. Food and Drug Administration Class II chemical indicator that is run daily in dynamic air removal sterilizers is called a,c.	Biological indicator,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,The U.S. Food and Drug Administration Class II chemical indicator that is run daily in dynamic air removal sterilizers is called a,d.	Bowie-Dick test,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,One type of formal monitoring is monitoring the department temperature and humidity levels,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,One type of formal monitoring is monitoring the department temperature and humidity levels,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,A physical monitor on a washer-disinfector is the,a.	Thermostatic valve,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,A physical monitor on a washer-disinfector is the,b.	Printout,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,A physical monitor on a washer-disinfector is the,c.	Biological test,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,A physical monitor on a washer-disinfector is the,d.	All the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Cart washer screens should be cleaned at least,a.	Daily,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Cart washer screens should be cleaned at least,b.	During each shift,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Cart washer screens should be cleaned at least,"c.	Weekly, preferably daily",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,Cart washer screens should be cleaned at least,d.	Monthly,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,A biological indicator is called positive when,a.	The incubation process is complete,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,A biological indicator is called positive when,b.	There is no growth in the ampule after incubation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,A biological indicator is called positive when,c.	There is growth in the ampule after incubation,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8861,,Elearning-0000-172,SPD INTERNSHIP CHAPTER 17 - MONITORING AND RECORDKEEPING FOR CENTRAL,,n13475,,choice,A biological indicator is called positive when,d.	Prior to sterilization,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,Quality requires the efforts and participation of everyone in the healthcare facility.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE- g13478,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,Quality requires the efforts and participation of everyone in the healthcare facility.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,Quality requires the efforts and participation of everyone in the healthcare facility.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,A failure mode and effects analysis tried to predict failures before they occur.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,A failure mode and effects analysis tried to predict failures before they occur.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,The International Standards Organization uses routine and unannounced inspections to monitor standards in healthcare facilities.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,The International Standards Organization uses routine and unannounced inspections to monitor standards in healthcare facilities.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,Quality processes are limited to administration and the risk management department.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,Quality processes are limited to administration and the risk management department.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,Quality management is patient focused.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,Quality management is patient focused.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,Providing quality products and services directly impacts patient outcomes.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,Providing quality products and services directly impacts patient outcomes.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,Customer surveys are ineffective tools in establishing Central Service quality processes.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,Customer surveys are ineffective tools in establishing Central Service quality processes.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,"If everyone develops a quality-driven focus, written policies and procedures are not necessary in the Central Service department.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,"If everyone develops a quality-driven focus, written policies and procedures are not necessary in the Central Service department.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,A root cause analysis is a proactive approach to quality.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,A root cause analysis is a proactive approach to quality.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,Not following established policies and procedures will result in a lower quality program.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8850,,Elearning-0000-171,SPD INTERNSHIP CHAPTER 18 - QUALITY ASSURANCE,,n13478,,choice,Not following established policies and procedures will result in a lower quality program.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Which of the following systems provides supplies and instruments for individual surgical procedures?,a.	Exchange cart,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT- g13480,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Which of the following systems provides supplies and instruments for individual surgical procedures?,a.	Exchange cart,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Which of the following systems provides supplies and instruments for individual surgical procedures?,b.	Periodic automated replenishment system,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Which of the following systems provides supplies and instruments for individual surgical procedures?,c.	Case cart,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Which of the following systems provides supplies and instruments for individual surgical procedures?,d.	Requisition,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,The inventory system that stocks supplies by established stock levels is called,a.	A periodic automated replenishment system,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,The inventory system that stocks supplies by established stock levels is called,b.	Case cart,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,The inventory system that stocks supplies by established stock levels is called,c.	An ADT system,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,The inventory system that stocks supplies by established stock levels is called,d.	Exchange system,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,The inventory system that uses two identical carts to facilitate supply replenishment is called the,a.	Case cart system,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,The inventory system that uses two identical carts to facilitate supply replenishment is called the,b.	Exchange cart system,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,The inventory system that uses two identical carts to facilitate supply replenishment is called the,c.	Periodic automated replenishment system,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,The inventory system that uses two identical carts to facilitate supply replenishment is called the,d.	Requisition system,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Automated supply replenishment systems are,a.	No longer used,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Automated supply replenishment systems are,b.	Used only in surgery,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Automated supply replenishment systems are,c.	Difficult to manage,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Automated supply replenishment systems are,d.	Computerized,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,The movement of supplies throughout the healthcare facility is called,a.	Distribution,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,The movement of supplies throughout the healthcare facility is called,b.	Inventory management,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,The movement of supplies throughout the healthcare facility is called,c.	Case cart system,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,The movement of supplies throughout the healthcare facility is called,d.	Procurement,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Operational supplies are supplies that are dispensed for patient care,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Operational supplies are supplies that are dispensed for patient care,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Supplies such as disposable wraps are called,a.	Consumable,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Supplies such as disposable wraps are called,b.	Capital supplies,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Supplies such as disposable wraps are called,c.	Patient care supplies,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Supplies such as disposable wraps are called,d.	Non-refundable supplies,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Capital equipment items are,a.	Usually used for patient care,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Capital equipment items are,b.	Items with a lower purchase cost,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Capital equipment items are,c.	Items with a higher purchase count,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8839,,Elearning-0000-170,SPD INTERNSHIP CHAPTER 19 - MANAGING INVENTORY WITHIN THE CENTRAL SERVICE DEPARTMENT,,n13480,,choice,Capital equipment items are,"d.	Purchased, stored, consumed and recorded",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9125,,Elearning-0000-390,FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY,,n13481,,choice,T/F Anticoagulants are HIGH risk medications that are more likely to cause patient harm then most other classes of medications,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY- g13481,False
9125,,Elearning-0000-390,FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY,,n13481,,choice,T/F Anticoagulants are HIGH risk medications that are more likely to cause patient harm then most other classes of medications,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9125,,Elearning-0000-390,FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY,,n13481,,choice,T/F Anticoagulants are HIGH risk medications that are more likely to cause patient harm then most other classes of medications,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9125,,Elearning-0000-390,FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY,,n13481,,choice,T/F The Joint Commission created National Patient Safety Goal 03.05.01 to reduce the likelihood of patient harm associated with the use of anticoagulant therapy.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9125,,Elearning-0000-390,FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY,,n13481,,choice,T/F The Joint Commission created National Patient Safety Goal 03.05.01 to reduce the likelihood of patient harm associated with the use of anticoagulant therapy.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9125,,Elearning-0000-390,FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY,,n13481,,choice,Reversal agents may be used to reverse the effects of anticoagulants to:,a.	Reduce the risk of bleeding during scheduled surgeries or procedures,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9125,,Elearning-0000-390,FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY,,n13481,,choice,Reversal agents may be used to reverse the effects of anticoagulants to:,b.	Treatment of minor or moderate bleeding in a patient on anticoagulant therapy,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9125,,Elearning-0000-390,FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY,,n13481,,choice,Reversal agents may be used to reverse the effects of anticoagulants to:,"c.	Treatment of major, or life-threatening bleeding in a patient on anticoagulant therapy",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9125,,Elearning-0000-390,FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY,,n13481,,choice,Reversal agents may be used to reverse the effects of anticoagulants to:,"d.	Treatment of patients with elevated INR, anti-Xa, or aPTT who are not actively bleeding",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9125,,Elearning-0000-390,FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY,,n13481,,choice,Reversal agents may be used to reverse the effects of anticoagulants to:,e.	All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9125,,Elearning-0000-390,FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY,,n13481,,choice,Which of the following statements are true regarding the use of anticoagulants in the perioperative setting?,"a.	Special consideration should be taken to appropriately time the last dose prior to, and the first dose after a procedure.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9125,,Elearning-0000-390,FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY,,n13481,,choice,Which of the following statements are true regarding the use of anticoagulants in the perioperative setting?,b.	The use of therapeutic anticoagulation is generally contraindicated in patients with an epidural.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9125,,Elearning-0000-390,FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY,,n13481,,choice,Which of the following statements are true regarding the use of anticoagulants in the perioperative setting?,c.	Pharmacy and Pain Service should be contacted prior to administering any anticoagulant to a patient with an epidural.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9125,,Elearning-0000-390,FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY,,n13481,,choice,Which of the following statements are true regarding the use of anticoagulants in the perioperative setting?,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9125,,Elearning-0000-390,FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY,,n13481,,choice,T/F Northside Hospital Policy & Procedures on anticoagulant therapy as well as evidence-based guidelines and references may be found on Lucidoc,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9125,,Elearning-0000-390,FY2021 NPSG 03.05.01 SAFE USE OF ANTICOAGULANT THERAPY,,n13481,,choice,T/F Northside Hospital Policy & Procedures on anticoagulant therapy as well as evidence-based guidelines and references may be found on Lucidoc,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Technicians in the ______________________________ department perform safety inspections and functional tests on equipment.,a.	Materials Management,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT- g13482,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Technicians in the ______________________________ department perform safety inspections and functional tests on equipment.,a.	Materials Management,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Technicians in the ______________________________ department perform safety inspections and functional tests on equipment.,b.	Infection control,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Technicians in the ______________________________ department perform safety inspections and functional tests on equipment.,c.	Biomedical/Clinical Engineering,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Technicians in the ______________________________ department perform safety inspections and functional tests on equipment.,d.	Facilities and maintenance,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,"When patient equipment enters a healthcare facility, it must be safety checked by a _____________________________ before it is cleared for patient use.",a.	Biomedical technician,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,"When patient equipment enters a healthcare facility, it must be safety checked by a _____________________________ before it is cleared for patient use.",b.	infection control committee member,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,"When patient equipment enters a healthcare facility, it must be safety checked by a _____________________________ before it is cleared for patient use.",c.	Central Service technician,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,"When patient equipment enters a healthcare facility, it must be safety checked by a _____________________________ before it is cleared for patient use.",d.	Central Service director,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Which of the following requires that preventative maintenance standards be established for medical equipment?,a.	Occupational Safety and Health Administration,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Which of the following requires that preventative maintenance standards be established for medical equipment?,b.	The Joint Commission,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Which of the following requires that preventative maintenance standards be established for medical equipment?,c.	Association for the Advancement of Medical Instrumentation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Which of the following requires that preventative maintenance standards be established for medical equipment?,d.	National Institute for Occupational Safety and Health,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,"All patient care equipment that was dispensed for use must be Considered ______________________ and handled as such, regardless of its appearance.",a.	sterile,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,"All patient care equipment that was dispensed for use must be Considered ______________________ and handled as such, regardless of its appearance.",b.	clean,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,"All patient care equipment that was dispensed for use must be Considered ______________________ and handled as such, regardless of its appearance.",c.	contaminated,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,"All patient care equipment that was dispensed for use must be Considered ______________________ and handled as such, regardless of its appearance.",d.	visibly soiled,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Which of the following common items of patient care equipment limits the development of deep vein thrombosis and peripheral edema in immobile patients?,a.	Respirator,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Which of the following common items of patient care equipment limits the development of deep vein thrombosis and peripheral edema in immobile patients?,b.	Intermittent suction device,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Which of the following common items of patient care equipment limits the development of deep vein thrombosis and peripheral edema in immobile patients?,c.	Sequential compression device,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Which of the following common items of patient care equipment limits the development of deep vein thrombosis and peripheral edema in immobile patients?,d.	Defibrillator,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Disposable components such as pads and tubing on patient care equipment should be,a.	discarded at the point-of-use,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Disposable components such as pads and tubing on patient care equipment should be,b.	be reprocessed for re-use,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Disposable components such as pads and tubing on patient care equipment should be,c.	discarded during preventive maintenance,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Disposable components such as pads and tubing on patient care equipment should be,d.	removed in the biomedical engineering department,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Equipment should be inspected for obvious hazards such as cracked or frayed electrical cords,a.	only by trained biomedical engineering technicians,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Equipment should be inspected for obvious hazards such as cracked or frayed electrical cords,b.	only during preventative maintenance activities,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Equipment should be inspected for obvious hazards such as cracked or frayed electrical cords,c.	only when there are complaints from user department personnel,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Equipment should be inspected for obvious hazards such as cracked or frayed electrical cords,d.	whenever the equipment is inspected in Central Service,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,"If an equipment malfunction causes harm to patients, it should be",a.	discarded immediately,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,"If an equipment malfunction causes harm to patients, it should be",b.	sent to the manufacturer for repairs,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,"If an equipment malfunction causes harm to patients, it should be",c.	sequestered for inspection by Occupational Safety and Health Administration personnel,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,"If an equipment malfunction causes harm to patients, it should be",d.	returned immediately to the biomedical department,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Patient care equipment should be stored in a __________________________________ condition.,"a.	""ready to dispense""�",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Patient care equipment should be stored in a __________________________________ condition.,"b.	""ready to clean""�",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Patient care equipment should be stored in a __________________________________ condition.,"c.	""ready to inspect""�",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Patient care equipment should be stored in a __________________________________ condition.,"d.	""ready to sterilize""�",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Patient care equipment is typically stored,a.	in the Biomedical engineering department,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Patient care equipment is typically stored,b.	in patient units,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Patient care equipment is typically stored,c.	in the Central Service department,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Patient care equipment is typically stored,d.	in sterile storage areas of the Materiel Management department,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,"The ________________________ requires that the healthcare facility report malfunctions of medical devices that have contributed to patient injury, illness and/or death to the manufacturer and the U.S. Food and Drug Administration.",a.	Occupational Safety and Health Administration Patient Safety Act,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,"The ________________________ requires that the healthcare facility report malfunctions of medical devices that have contributed to patient injury, illness and/or death to the manufacturer and the U.S. Food and Drug Administration.",b.	Safe Medical Devices Act,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,"The ________________________ requires that the healthcare facility report malfunctions of medical devices that have contributed to patient injury, illness and/or death to the manufacturer and the U.S. Food and Drug Administration.",c.	Environmental Protection Agency  Patient Security Act,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,"The ________________________ requires that the healthcare facility report malfunctions of medical devices that have contributed to patient injury, illness and/or death to the manufacturer and the U.S. Food and Drug Administration.",d.	U.S. Food and Drug Administration Equipment Notification Act,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Which of the following statements is correct?,a.	Patient care equipment tracking requires a computer,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Which of the following statements is correct?,b.	Patient care equipment should only be tracked if it has a value in excess of an amount specified by the facility,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Which of the following statements is correct?,c.	Tracking patient care equipment can prevent equipment shortages,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Which of the following statements is correct?,d.	Patient care equipment must only be tracked if its usage will be charged to patients,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Equipment leasing and rental differ in that,a.	leasing involves purchase; rental does not require ownership,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Equipment leasing and rental differ in that,b.	equipment rental is usually done on a shorter-term basis than equipment leasing,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Equipment leasing and rental differ in that,c.	equipment leasing involves the most expensive equipment; equipment rental involves less expensive equipment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Equipment leasing and rental differ in that,d.	equipment leasing is an operating expense; equipment rental does not have cost implications,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Preventative maintenance is,a.	performed when a piece of equipment injures a patient,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Preventative maintenance is,b.	designed to identify potential problems before they occur,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Preventative maintenance is,c.	performed when a user unit notices a problem,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,Preventative maintenance is,d.	done by Central Services before equipment is dispensed,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,The decision to use reusable or disposable instruments in procedure tray is determined by,a.	where the instruments will be used,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,The decision to use reusable or disposable instruments in procedure tray is determined by,b.	the Infection Prevention department,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,The decision to use reusable or disposable instruments in procedure tray is determined by,"c.	several factors including physician preference, storage and cost",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8816,,Elearning-0000-168,SPD INTERNSHIP CHAPTER 20 - THE ROLE OF CENTRAL SERVICE IN ANCILLARY DEPARTMENT SUPPORT,,n13482,,choice,The decision to use reusable or disposable instruments in procedure tray is determined by,d.	amount of items to be used and delivery schedule,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,"In addition to providing financial and operational management, information technology and systems are used to help ensure patient safety.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE- g13484,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,"In addition to providing financial and operational management, information technology and systems are used to help ensure patient safety.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,"In addition to providing financial and operational management, information technology and systems are used to help ensure patient safety.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Information technology us often the cornerstone of initiatives to transform healthcare.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Information technology us often the cornerstone of initiatives to transform healthcare.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Which of the following is NOT a result of computer integration?,a.	Eliminating redundant entry of information,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Which of the following is NOT a result of computer integration?,b.	Promotes efficiency,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Which of the following is NOT a result of computer integration?,c.	Automatically provides critical update to industry standards,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Which of the following is NOT a result of computer integration?,d.	Reduced inaccurate and conflicting information,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Patient census information used in Central Service is obtained from the electronic health record.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Patient census information used in Central Service is obtained from the electronic health record.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Computer supply chain management systems are used to monitor facility assets.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Computer supply chain management systems are used to monitor facility assets.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Tracking individual instruments is important to help ensure specific instruments are kept with a specific set.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Tracking individual instruments is important to help ensure specific instruments are kept with a specific set.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,"Which of the following is NOT a reason for tracking supplies, equipment and instruments?",a.	Monitoring item use,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,"Which of the following is NOT a reason for tracking supplies, equipment and instruments?",b.	Ensuring that items can be quickly located,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,"Which of the following is NOT a reason for tracking supplies, equipment and instruments?",c.	Meeting Centers for Disease Control and Occupational Safety and Health Administration requirements,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,"Which of the following is NOT a reason for tracking supplies, equipment and instruments?",d.	Assisting with quality processes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Which of the following tracking methods provides real-time information?,a.	Radio frequency identification tags,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Which of the following tracking methods provides real-time information?,b.	Laser-etched bar codes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Which of the following tracking methods provides real-time information?,c.	Standard bar codes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Which of the following tracking methods provides real-time information?,d.	Dot matrix applications,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Point-of-use computing,a.	is impossible in Central Service because of infection control requirements,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Point-of-use computing,b.	provides no benefit to the Central Service department,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Point-of-use computing,c.	moves computers into Central Service work areas,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Point-of-use computing,d.	eliminates data entry jobs,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Which of the following is NOT a feature of an instrument tracking system?,a.	Productivity information,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Which of the following is NOT a feature of an instrument tracking system?,b.	Financial data,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Which of the following is NOT a feature of an instrument tracking system?,c.	Quality assurance information,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Which of the following is NOT a feature of an instrument tracking system?,d.	Product updates and recall information,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,"Computerized tracking systems are fast, but manual tracking systems are more effective for tracking.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,"Computerized tracking systems are fast, but manual tracking systems are more effective for tracking.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,"Once a tracking system is implemented, there is generally no need to update system information.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,"Once a tracking system is implemented, there is generally no need to update system information.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,"At this time, tracking systems are unable to track worker productivity information.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,"At this time, tracking systems are unable to track worker productivity information.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Tracking systems can help manage preventative maintenance schedules.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Tracking systems can help manage preventative maintenance schedules.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Most Central Service departments employ some sort of automated information management system.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8805,,Elearning-0000-167,SPD INTERNSHIP CHAPTER 21 - THE ROLE OF INFORMATION TECHNOLOGY IN CENTRAL SERVICE,,n13484,,choice,Most Central Service departments employ some sort of automated information management system.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Risk management programs are designed to prevent accidents and injury.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE- g13485,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Risk management programs are designed to prevent accidents and injury.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Risk management programs are designed to prevent accidents and injury.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Which of the following is NOT a component of risk management?,a.	Injury prevention,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Which of the following is NOT a component of risk management?,b.	Claims management,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Which of the following is NOT a component of risk management?,c.	Staff management,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Which of the following is NOT a component of risk management?,d.	Risk assessment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Which of the following is NOT considered one of the three occupational hazards?,a.	Physical hazards,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Which of the following is NOT considered one of the three occupational hazards?,b.	Ergonomic hazards,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Which of the following is NOT considered one of the three occupational hazards?,c.	Biological hazards,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Which of the following is NOT considered one of the three occupational hazards?,d.	Chemical hazards,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Information about chemical or hazardous substances must be available to all employees.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Information about chemical or hazardous substances must be available to all employees.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,"Healthcare facilities are required by the ________________ to provide adequate ventilation systems, personal protective equipment and safe work operating procedures?",a.	Environmental Protection Agency,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,"Healthcare facilities are required by the ________________ to provide adequate ventilation systems, personal protective equipment and safe work operating procedures?",b.	U.S. Food and Drug Administration,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,"Healthcare facilities are required by the ________________ to provide adequate ventilation systems, personal protective equipment and safe work operating procedures?",c.	Occupational Safety and Health Administration,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,"Healthcare facilities are required by the ________________ to provide adequate ventilation systems, personal protective equipment and safe work operating procedures?",d. Centers for Medicare and Medicaid Services,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Time weighted average is the amount of a substance a person can be exposed to over an eight-hour day.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Time weighted average is the amount of a substance a person can be exposed to over an eight-hour day.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,The process of changing work or working conditions to reduce physical stress is,a.	called ergonomics,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,The process of changing work or working conditions to reduce physical stress is,b.	an employee injury reduction plan,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,The process of changing work or working conditions to reduce physical stress is,c.	the Occupational Safety and Health Administration Workers' Rights Program,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,The process of changing work or working conditions to reduce physical stress is,d.	the Occupational Safety and Health Administration Risk Management Program,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,The key to working safely is keeping the work area organized.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,The key to working safely is keeping the work area organized.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,When a technician cannot see what is in a sink or basin they should,a.	drain the sink or basin,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,When a technician cannot see what is in a sink or basin they should,b.	use a sponge forceps to grasp items,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,When a technician cannot see what is in a sink or basin they should,c.	have someone help determine what is in the sink or basin,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,When a technician cannot see what is in a sink or basin they should,d.	all the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Which of the following is NOT required for sharps safety?,a.	Dispose of all single use sharps in an appropriate container,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Which of the following is NOT required for sharps safety?,b.	Sharp ends should be pointed away from anyone's body during transport,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Which of the following is NOT required for sharps safety?,c.	Wash all disposable sharps before discarding them,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Which of the following is NOT required for sharps safety?,d.	All the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,The level of exposure to a harmful substance when an employer must take required precautions to protect the worker.,a.	Time weighted average,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,The level of exposure to a harmful substance when an employer must take required precautions to protect the worker.,b.	Short-term excursion limit,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,The level of exposure to a harmful substance when an employer must take required precautions to protect the worker.,c.	Permissible exposure limit,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,The level of exposure to a harmful substance when an employer must take required precautions to protect the worker.,d.	Action level,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Ergonomic injuries,a.	are not a concern for Central Service employees,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Ergonomic injuries,b.	are rare in today's work environment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Ergonomic injuries,c.	are a risk factor for persons who perform repetitive or physical work,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Ergonomic injuries,d.	happen only in the office setting,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Secondary containers of chemicals,a.	must be labeled with a copy of the original manufacturer's label or a generic label that identifies hazard warnings and directions,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Secondary containers of chemicals,b.	must be labeled with a permanent marker and must state the chemical's name and designated storage location,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Secondary containers of chemicals,c.	secondary containers of chemicals are not allowed in healthcare facilities,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Secondary containers of chemicals,d.	there are no restrictions for secondary container labels at this time,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Safety data sheets are provided by the,a.	Occupational Safety and Health Administration,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Safety data sheets are provided by the,b.	U.S. Food and Drug Administration,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Safety data sheets are provided by the,c.	Risk Management department,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,Safety data sheets are provided by the,d.	Product manufacturer,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,A molecular reaction that creates an uncontrolled release of energy is called,a.	combustion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,A molecular reaction that creates an uncontrolled release of energy is called,b.	polymerization,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,A molecular reaction that creates an uncontrolled release of energy is called,c.	vapor density,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8794,,Elearning-0000-166,SPD INTERNSHIP CHAPTER 22 - SAFETY AND RISK MANAGEMENT FOR CENTRAL SERVICE,,n13485,,choice,A molecular reaction that creates an uncontrolled release of energy is called,d.	fire,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following is an example of communication?,a.	Spoken word,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION- g13486,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following is an example of communication?,a.	Spoken word,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following is an example of communication?,b.	Written word,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following is an example of communication?,c.	Non-verbal expressions,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following is an example of communication?,d.	All the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Central Service technicians who do not think they are being treated appropriately by their employer should,a.	find another job,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Central Service technicians who do not think they are being treated appropriately by their employer should,b.	discuss the problem with their workplace peers,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Central Service technicians who do not think they are being treated appropriately by their employer should,c.	discuss the situation with their supervisor,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Central Service technicians who do not think they are being treated appropriately by their employer should,"d.	accept the situation as ""the way things are done""� at the facility",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,"Behavior relating to what is ""right""� and ""wrong""� relative to the standards of professional conduct are called",a.	ethical behavior,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,"Behavior relating to what is ""right""� and ""wrong""� relative to the standards of professional conduct are called",b.	moral behavior,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,"Behavior relating to what is ""right""� and ""wrong""� relative to the standards of professional conduct are called",c.	legal behavior,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,"Behavior relating to what is ""right""� and ""wrong""� relative to the standards of professional conduct are called",d.	personal behavior,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,A step in communication that occurs when a listener asks a question is called,a.	stereotyping,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,A step in communication that occurs when a listener asks a question is called,b.	feedback,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,A step in communication that occurs when a listener asks a question is called,c.	communication looping,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,A step in communication that occurs when a listener asks a question is called,d.	halo interpretation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,This process allows a person to understand someone else's needs,a.	Communication,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,This process allows a person to understand someone else's needs,b.	Human relations,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,This process allows a person to understand someone else's needs,c.	Feedback,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,This process allows a person to understand someone else's needs,d.	Moral behavior,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,"When speaking, one should",a.	be influenced by the listener's emotions,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,"When speaking, one should",b.	concentrate on the listener rather than oneself,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,"When speaking, one should",c.	concentrate on oneself rather than the listener,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,"When speaking, one should",d.	use technical jargon to impress the listener,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following basic listening tactics is most useful?,a.	Try to listen only for specific facts,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following basic listening tactics is most useful?,"b.	Ignore any non-verbal communication ""sent""� by the speaker",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following basic listening tactics is most useful?,c.	Focus on the delivery of the message rather than its content,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following basic listening tactics is most useful?,d.	None of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,The ability to use information gained from words or body language to interact with others,a.	Communication,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,The ability to use information gained from words or body language to interact with others,b.	Human relations,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,The ability to use information gained from words or body language to interact with others,c.	Teamwork,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,The ability to use information gained from words or body language to interact with others,d.	Mentoring,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following is the most important factor necessary for teamwork?,a.	Attitude,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following is the most important factor necessary for teamwork?,b.	Prompt,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following is the most important factor necessary for teamwork?,c.	Loyalty,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following is the most important factor necessary for teamwork?,d.	Cooperation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following statement is correct?,"a.	Informal work groups are ""bad""� for the organization",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following statement is correct?,b.	Informal work groups develop an informal communication system called the grapevine,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following statement is correct?,c.	A task group is an example of an informal group,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following statement is correct?,d.	Employees can only be members of one formal group at a time,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,A group of employees from different departments within the healthcare facility that work together to solve operating problems is called a,a.	decision-making team,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,A group of employees from different departments within the healthcare facility that work together to solve operating problems is called a,b.	multi-dimensional team,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,A group of employees from different departments within the healthcare facility that work together to solve operating problems is called a,c.	cross-functional team,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,A group of employees from different departments within the healthcare facility that work together to solve operating problems is called a,d.	management/sub-management team,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following is true about a valuing diversity effort?,"a.	It ""happens""� because top-level officials require it",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following is true about a valuing diversity effort?,b.	It occurs because a Central Service director desires it,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following is true about a valuing diversity effort?,"c.	It is a ""program""� in which a committee ""decides what to do""�",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Which of the following is true about a valuing diversity effort?,d.	None of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Coaching is an example of,a.	informal communication,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Coaching is an example of,b.	discipline,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Coaching is an example of,c.	formal communication,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Coaching is an example of,d.	Mentoring,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Knowing what is expected and consistently meeting those expectations is a part of,a.	effective communications,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Knowing what is expected and consistently meeting those expectations is a part of,b.	ethical behavior,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Knowing what is expected and consistently meeting those expectations is a part of,c.	job success,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,Knowing what is expected and consistently meeting those expectations is a part of,d.	professional behavior,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,When Central Service technicians have internet access at work,a.	it should be used for work-related purposes only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,When Central Service technicians have internet access at work,b.	it may be used for any purposes as long as it doesn't interfere with work,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,When Central Service technicians have internet access at work,c.	it should only be used during break time,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8784,,Elearning-0000-165,SPD INTERNSHIP CHAPTER 23 - SUCCESS THROUGH COMMUNICATION,,n13486,,choice,When Central Service technicians have internet access at work,d.	they should follow the facility's policy,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Which of the following is an open-ended question?,"a.	""How long have you worked here?""�",False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES- g13487,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Which of the following is an open-ended question?,"a.	""How long have you worked here?""�",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Which of the following is an open-ended question?,"b.	""Do you like your job?""�",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Which of the following is an open-ended question?,"c.	""What problems do you most frequently encounter on the job?""�",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Which of the following is an open-ended question?,"d.	""What is the name of Central Service director?""�",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Personal development improves employability skills.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Personal development improves employability skills.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,"When setting personal goals, set goals that are",a.	quickly attainable,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,"When setting personal goals, set goals that are",b.	attainable within five years then set new goals,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,"When setting personal goals, set goals that are","c.	attainable, then build on those successes",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,"When setting personal goals, set goals that are",d.	specific to the current position and education,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Professional development provides the information and experience needed for career progress.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Professional development provides the information and experience needed for career progress.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,A technician teaching others increases their own understanding of the standards.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,A technician teaching others increases their own understanding of the standards.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Planning and reviewing goals will identify activities to help meet those goals,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Planning and reviewing goals will identify activities to help meet those goals,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Resources found online have already been determined to be valid before they are posted online,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Resources found online have already been determined to be valid before they are posted online,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Steps toward attaining professional goals in Central Service include,a.	obtaining certification,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Steps toward attaining professional goals in Central Service include,b.	attending educational conferences,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Steps toward attaining professional goals in Central Service include,c.	participating in professional groups,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,Steps toward attaining professional goals in Central Service include,d.	all the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,One important step in preparing for an interview is,a.	reviewing the certification exam questions,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,One important step in preparing for an interview is,b.	developing a written response to application questions,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,One important step in preparing for an interview is,c.	anticipating possible interview questions,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,One important step in preparing for an interview is,d.	all the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,On the job relationships do NOT change when one team member has been promoted,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8779,,Elearning-0000-164,SPD INTERNSHIP CHAPTER 24 - PERSONAL AND PROFESSIONAL DEVELOPMENT FOR CENTRAL SERVICES,,n13487,,choice,On the job relationships do NOT change when one team member has been promoted,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9310,,Elearning-0000-559,FY2021 PHARMACY HEART FAILURE EDUCATION,,n13483,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 PHARMACY HEART FAILURE EDUCATION- g13483,False
9310,,Elearning-0000-559,FY2021 PHARMACY HEART FAILURE EDUCATION,,n13483,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9310,,Elearning-0000-559,FY2021 PHARMACY HEART FAILURE EDUCATION,,n13483,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9732,,Elearning-0000-942,2021 REHAB NSC NEUROSURGERY,,n13488,,choice,Bone flap will be placed in the abdomen following a craniectomy.   True or False?,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 REHAB NSC NEUROSURGERY- g13488,False
9732,,Elearning-0000-942,2021 REHAB NSC NEUROSURGERY,,n13488,,choice,Bone flap will be placed in the abdomen following a craniectomy.   True or False?,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9732,,Elearning-0000-942,2021 REHAB NSC NEUROSURGERY,,n13488,,choice,Bone flap will be placed in the abdomen following a craniectomy.   True or False?,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9732,,Elearning-0000-942,2021 REHAB NSC NEUROSURGERY,,n13488,,choice,"Seizures, CVA, and increased ICP can be complications of craniotomy or craniectomy. True or False",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9732,,Elearning-0000-942,2021 REHAB NSC NEUROSURGERY,,n13488,,choice,"Seizures, CVA, and increased ICP can be complications of craniotomy or craniectomy. True or False",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9732,,Elearning-0000-942,2021 REHAB NSC NEUROSURGERY,,n13488,,choice,Normal ICP is 15-25. True or False,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9732,,Elearning-0000-942,2021 REHAB NSC NEUROSURGERY,,n13488,,choice,Normal ICP is 15-25. True or False,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9732,,Elearning-0000-942,2021 REHAB NSC NEUROSURGERY,,n13488,,choice,"Pain, Hypoxia, and Increased BP can cause elevation of ICP.  True or False",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9732,,Elearning-0000-942,2021 REHAB NSC NEUROSURGERY,,n13488,,choice,"Pain, Hypoxia, and Increased BP can cause elevation of ICP.  True or False",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9732,,Elearning-0000-942,2021 REHAB NSC NEUROSURGERY,,n13488,,choice,EVD does not have to be clamped prior to mobilization of patient following craniotomy or craniectomy.  True or False,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9732,,Elearning-0000-942,2021 REHAB NSC NEUROSURGERY,,n13488,,choice,EVD does not have to be clamped prior to mobilization of patient following craniotomy or craniectomy.  True or False,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,The 4 Red Rules at NSH include all of following except,a.	2-Patient Identifiers,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021- g13491,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,The 4 Red Rules at NSH include all of following except,a.	2-Patient Identifiers,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,The 4 Red Rules at NSH include all of following except,b.	Specimen Packaging and Management/ Line Reconciliation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,The 4 Red Rules at NSH include all of following except,c.	Hand-off communication,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,The 4 Red Rules at NSH include all of following except,d.	Line Reconciliation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,The 4 Red Rules at NSH include all of following except,e.	Time-Out,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Red Rules are used at NSH to,a.	Ensure that staff are supported in speaking up when a critical rule is not followed,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Red Rules are used at NSH to,b.	Punish employees who not follow the policies and procedures as outlined,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Red Rules are used at NSH to,c.	Support staff for making safe choices,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Red Rules are used at NSH to,"d.	a, b, & C",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Red Rules are used at NSH to,e.	a & c,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,"When a Red Rule is violated, staff are expected to speak up and ""stop the line""� to ensure that patient safety is made a priority",a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,"When a Red Rule is violated, staff are expected to speak up and ""stop the line""� to ensure that patient safety is made a priority",b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Staff expectations in a Culture of Accountability include all of the following except:,a.	Implementing the chain-of-command when things are not proceeding as planned,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Staff expectations in a Culture of Accountability include all of the following except:,"b.	Completing Incident/ Verge report for all actual events as well as potential and ""near misses""� as well as concerns",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Staff expectations in a Culture of Accountability include all of the following except:,c.	Following policies and procedures,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Staff expectations in a Culture of Accountability include all of the following except:,d.	Focusing on what you are doing and not paying attention to those around you,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Staff expectations in a Culture of Accountability include all of the following except:,e.	Never signing for something that was not done,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,"When an error or deviation occurs, staff will be interviewed by their supervisor/ manager to understand the source of the errors in order to enhance our learning environment.",a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,"When an error or deviation occurs, staff will be interviewed by their supervisor/ manager to understand the source of the errors in order to enhance our learning environment.",b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Errors are evaluated under a culture of accountability.  An error that occurs as a result of a slip or lapse in practice would be considered a,a.	Human Error,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Errors are evaluated under a culture of accountability.  An error that occurs as a result of a slip or lapse in practice would be considered a,b.	At-Risk Behavior,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Errors are evaluated under a culture of accountability.  An error that occurs as a result of a slip or lapse in practice would be considered a,c.	Reckless Behavior,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Errors are evaluated under a culture of accountability.  An error that occurs when an employee believes the risk in not following policy is justified under the circumstances would be considered,a.	Human Error,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Errors are evaluated under a culture of accountability.  An error that occurs when an employee believes the risk in not following policy is justified under the circumstances would be considered,b.	At-Risk Behavior,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Errors are evaluated under a culture of accountability.  An error that occurs when an employee believes the risk in not following policy is justified under the circumstances would be considered,c.	Reckless Behavior,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Errors are evaluated under a culture of accountability.  An error that occurs as a result of an intentional violation of policy and /or practice would be considered a,a.	Human Error,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Errors are evaluated under a culture of accountability.  An error that occurs as a result of an intentional violation of policy and /or practice would be considered a,b.	At-Risk Behavior,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9654,,Elearning-0000-871,NORTHSIDE HOSPITAL RED RULES AND CULTURE OF ACCOUNTABILITY - 2021,,n13491,,choice,Errors are evaluated under a culture of accountability.  An error that occurs as a result of an intentional violation of policy and /or practice would be considered a,c.	Reckless Behavior,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9515,,Elearning-0000-745,C-394 BMT CTN 1803 NK CELL,,n13499,,choice,Patients must have:,a)	AML or MDS with high-risk of relapse,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is C-394 BMT CTN 1803 NK CELL- g13499,False
9515,,Elearning-0000-745,C-394 BMT CTN 1803 NK CELL,,n13499,,choice,Patients must have:,a)	AML or MDS with high-risk of relapse,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9515,,Elearning-0000-745,C-394 BMT CTN 1803 NK CELL,,n13499,,choice,Patients must have:,"b)	AML in CR, Cri, or MLFS",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9515,,Elearning-0000-745,C-394 BMT CTN 1803 NK CELL,,n13499,,choice,Patients must have:,c)	Relapsed/refractory AML,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9515,,Elearning-0000-745,C-394 BMT CTN 1803 NK CELL,,n13499,,choice,Patients must have:,d)	Relapsed/refractory NHL,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9515,,Elearning-0000-745,C-394 BMT CTN 1803 NK CELL,,n13499,,choice,Patients must have:,e)	Both A and B,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9515,,Elearning-0000-745,C-394 BMT CTN 1803 NK CELL,,n13499,,choice,Patients must be receiving a matched-related donor allo transplant only.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9515,,Elearning-0000-745,C-394 BMT CTN 1803 NK CELL,,n13499,,choice,Patients must be receiving a matched-related donor allo transplant only.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9515,,Elearning-0000-745,C-394 BMT CTN 1803 NK CELL,,n13499,,choice,K-NK002 will be given:,a)	On Day +1 after transplant,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9515,,Elearning-0000-745,C-394 BMT CTN 1803 NK CELL,,n13499,,choice,K-NK002 will be given:,b)	In 2 doses given 28-days apart,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9515,,Elearning-0000-745,C-394 BMT CTN 1803 NK CELL,,n13499,,choice,K-NK002 will be given:,"c)	In 3 doses given on Days -2, +7, and +28",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9515,,Elearning-0000-745,C-394 BMT CTN 1803 NK CELL,,n13499,,choice,K-NK002 will be given:,d)	During HD chemotherapy days prior to transplant,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9512,,Elearning-0000-742,C-429 ALLOVIR HC,,n13500,,choice,Patients must have:,a)	Had an allo transplant between 21 days and 1 year ago,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is C-429 ALLOVIR HC- g13500,False
9512,,Elearning-0000-742,C-429 ALLOVIR HC,,n13500,,choice,Patients must have:,a)	Had an allo transplant between 21 days and 1 year ago,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9512,,Elearning-0000-742,C-429 ALLOVIR HC,,n13500,,choice,Patients must have:,b)	Confirmed myeloid engraftment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9512,,Elearning-0000-742,C-429 ALLOVIR HC,,n13500,,choice,Patients must have:,c)	Diagnosed with hemorrhagic cystits,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9512,,Elearning-0000-742,C-429 ALLOVIR HC,,n13500,,choice,Patients must have:,d)	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9512,,Elearning-0000-742,C-429 ALLOVIR HC,,n13500,,choice,"Patients will receive Viralym-M or placebo in 2 separate infusion, 14 days apart.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9512,,Elearning-0000-742,C-429 ALLOVIR HC,,n13500,,choice,"Patients will receive Viralym-M or placebo in 2 separate infusion, 14 days apart.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9512,,Elearning-0000-742,C-429 ALLOVIR HC,,n13500,,choice,Patients who experience GVHD Grade >2 or worsening of GVHD (relative to baseline) at the time before the second infusion will not be permitted to receive the 2nd infusion.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9512,,Elearning-0000-742,C-429 ALLOVIR HC,,n13500,,choice,Patients who experience GVHD Grade >2 or worsening of GVHD (relative to baseline) at the time before the second infusion will not be permitted to receive the 2nd infusion.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8333,,Elearning-0000-121,TRAUMATIC HEMORRHAGE AND HEMORRHAGIC STROKE,,n13501,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Traumatic Hemorrhage and Hemorrhagic Stroke CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TRAUMATIC HEMORRHAGE AND HEMORRHAGIC STROKE- g13501,False
8333,,Elearning-0000-121,TRAUMATIC HEMORRHAGE AND HEMORRHAGIC STROKE,,n13501,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Traumatic Hemorrhage and Hemorrhagic Stroke CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8333,,Elearning-0000-121,TRAUMATIC HEMORRHAGE AND HEMORRHAGIC STROKE,,n13501,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Traumatic Hemorrhage and Hemorrhagic Stroke CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,"The purpose of Northside Hospital Fall and Injury Prevention Policy is to provide a safe environment of care, to prevent patient falls, and to manage falls that do occur.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is PCU FALL PREVENTION AND IBED AWARENESS- g13502,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,"The purpose of Northside Hospital Fall and Injury Prevention Policy is to provide a safe environment of care, to prevent patient falls, and to manage falls that do occur.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,"The purpose of Northside Hospital Fall and Injury Prevention Policy is to provide a safe environment of care, to prevent patient falls, and to manage falls that do occur.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,A patient is found on the floor by the bed. The patient has an abrasion to the leg. The Fall severity would be labeled as,a.	None,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,A patient is found on the floor by the bed. The patient has an abrasion to the leg. The Fall severity would be labeled as,b.	Minor,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,A patient is found on the floor by the bed. The patient has an abrasion to the leg. The Fall severity would be labeled as,c.	Moderate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,A patient is found on the floor by the bed. The patient has an abrasion to the leg. The Fall severity would be labeled as,d.	Major,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,A patient has a fall risk score of 30. The Fall Interventions would include:,a.	 Implementing the Universal Safety precautions,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,A patient has a fall risk score of 30. The Fall Interventions would include:,"b.	Yellow armband, yellow non-skid slippers, yellow falling star at door",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,A patient has a fall risk score of 30. The Fall Interventions would include:,c.	Mandatory Sitter at bedside,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,A patient has a fall risk score of 30. The Fall Interventions would include:,d.	A and B,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,A patient has a fall risk score of 30. The Fall Interventions would include:,"e.	A, B, and C",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,There are 3 Zones to set the bed alarm to specific need of a patient. The patient is at risk to fall. Which zone would you select for the patient?,a.	Zone 1,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,There are 3 Zones to set the bed alarm to specific need of a patient. The patient is at risk to fall. Which zone would you select for the patient?,b.	Zone 2,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,There are 3 Zones to set the bed alarm to specific need of a patient. The patient is at risk to fall. Which zone would you select for the patient?,c.	Zone 3,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,There are 3 Zones to set the bed alarm to specific need of a patient. The patient is at risk to fall. Which zone would you select for the patient?,d.	None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,"Before you set the bed with any parameters, you must zero the bed scale.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,"Before you set the bed with any parameters, you must zero the bed scale.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,The light on footboard is blinking amber. What does this indicate?,a.	The brake is not set,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,The light on footboard is blinking amber. What does this indicate?,b.	The bed alarm has not been activated,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,The light on footboard is blinking amber. What does this indicate?,c.	The parameters you have set have been compromised,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,The light on footboard is blinking amber. What does this indicate?,d.	A and B,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,Your patient had a fall. After you have cared for the patient you need to:,a.	Complete the HOSP Post Fall Guideline Orders in Cerner,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,Your patient had a fall. After you have cared for the patient you need to:,b.	Notify admitting MD and manager,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,Your patient had a fall. After you have cared for the patient you need to:,"c.	Complete Post Fall Evaluation Powerform in Cerner,  debriefing tool and an Incident report",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,Your patient had a fall. After you have cared for the patient you need to:,d.	All the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,The light on footboard is green. What does this indicate?,a.	The brake is on,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,The light on footboard is green. What does this indicate?,b.	The bed alarm is activated,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,The light on footboard is green. What does this indicate?,c.	The bed has been set to the parameters  specific to the patient and not compromised,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,The light on footboard is green. What does this indicate?,d.	B and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,The light at foot of bed is green: you know the bed exit alarm is activated.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,The light at foot of bed is green: you know the bed exit alarm is activated.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,Patient does not want the bed alarm on. What should you do?,a.	Provide education about the bed alarm,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,Patient does not want the bed alarm on. What should you do?,b.	Encourage the patient that you want to be there to assist them,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,Patient does not want the bed alarm on. What should you do?,c.	Tell them that they cannot have what they want,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,Patient does not want the bed alarm on. What should you do?,d.	A and B,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,Your patient is a Fall Risk. What is the appropriate zone for the patient?,a.	Zone 1,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,Your patient is a Fall Risk. What is the appropriate zone for the patient?,b.	Zone 2,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,Your patient is a Fall Risk. What is the appropriate zone for the patient?,c.	Zone 3,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,Your patient is a Fall Risk. What is the appropriate zone for the patient?,d.	Does not matter as long as the bed exit alarm is on.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,All Falls are to be reported into the Incident Reporting System,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,All Falls are to be reported into the Incident Reporting System,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,The bed should be set so that the Bed Brake alarms when off except:,a.	During transport,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,The bed should be set so that the Bed Brake alarms when off except:,b.	At HS,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,The bed should be set so that the Bed Brake alarms when off except:,c.	When patient in BR,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,The bed should be set so that the Bed Brake alarms when off except:,d.	None of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,PCU Goal is to have No Falls on the unit.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,PCU Goal is to have No Falls on the unit.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,After this CBL and Check-off you will be able to use the functions to full capacity on the Stryker iBed.,a. Yes,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
282,,SCORM-0000-92,PCU FALL PREVENTION AND IBED AWARENESS,,n13502,,choice,After this CBL and Check-off you will be able to use the functions to full capacity on the Stryker iBed.,b. No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,At the end of the MTP the Lead Nurse must complete and/ or participate in the following <b><u>except</u><b>,A. An Incident Report,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES- g13503,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,At the end of the MTP the Lead Nurse must complete and/ or participate in the following <b><u>except</u><b>,A. An Incident Report,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,At the end of the MTP the Lead Nurse must complete and/ or participate in the following <b><u>except</u><b>,B. Blood Transfusion Request Form,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,At the end of the MTP the Lead Nurse must complete and/ or participate in the following <b><u>except</u><b>,C. All three required documentations and submit to leadership in red MTP folder,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,At the end of the MTP the Lead Nurse must complete and/ or participate in the following <b><u>except</u><b>,D. MTP Debrief,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Who must be involved in the debriefing of the MTP?,"A. Surgeon, Anesthesiologist and Lead RN",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Who must be involved in the debriefing of the MTP?,B. Lead RN and Recorder,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Who must be involved in the debriefing of the MTP?,C. All who are involved in the MTP,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Who must be involved in the debriefing of the MTP?,"D. Anesthesiologist, Lead RN, and Scrub Tech",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Which form must be completed for each parcel pick up?,A Blood Product Utilization Form,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Which form must be completed for each parcel pick up?,B Incident Report,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Which form must be completed for each parcel pick up?,C Blood Product Issue Request Form,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Which form must be completed for each parcel pick up?,D MTP Debrief Quality Tool,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,The Recorder must document parcels administered to the patient on the ___________________?,A. Blood Product Utilization Form,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,The Recorder must document parcels administered to the patient on the ___________________?,B. Incident Report,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,The Recorder must document parcels administered to the patient on the ___________________?,C. Blood product Issue Request Form,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,The Recorder must document parcels administered to the patient on the ___________________?,D. MTP Debriefing Quality Tool,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,The Blood Product Utilization Form is part of the patient's Medical Record?,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,The Blood Product Utilization Form is part of the patient's Medical Record?,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Who initiates the MTP?,A. Anesthesiologist,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Who initiates the MTP?,B. Lead RN,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Who initiates the MTP?,C. Surgeon,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Who initiates the MTP?,D. A and or C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,"At the conclusion of an MTP, the MD/ Anesthesiologist will announce ""Stop MTP""� and the Lead Nurse will do all the following immediately <b><u>except</u></b>?",A. Catch up on charting,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,"At the conclusion of an MTP, the MD/ Anesthesiologist will announce ""Stop MTP""� and the Lead Nurse will do all the following immediately <b><u>except</u></b>?","B. Confirm ""We are Stopping MTP on Patient Name and MRN#""�",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,"At the conclusion of an MTP, the MD/ Anesthesiologist will announce ""Stop MTP""� and the Lead Nurse will do all the following immediately <b><u>except</u></b>?",C. Call Charge Nurse and communicate stop to MTP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,"At the conclusion of an MTP, the MD/ Anesthesiologist will announce ""Stop MTP""� and the Lead Nurse will do all the following immediately <b><u>except</u></b>?",D. Call Blood Bank and communicate stop to MTP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Which of the following are duties of the Runner ?,A. Provides Communication to and from the Blood Bank.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Which of the following are duties of the Runner ?,B. Picks up blood parcels (Provide Blood Product Issue Request for to Blood Bank),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Which of the following are duties of the Runner ?,"C. Returns to Blood Bank, once each parcel is delivered to the OR.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Which of the following are duties of the Runner ?,"D. Delivers Lab Specimens, e.g. Stat ABGs",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,Which of the following are duties of the Runner ?,E. All of the Above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,"If staffing allows for a <b>Runner #2, Runner #1 and #2</b> will share duties?",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,"If staffing allows for a <b>Runner #2, Runner #1 and #2</b> will share duties?",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,It is required to send the Blood Consent with the Blood Product Issue Request to Blood Bank when the Runner is picking up MTP parcels?,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9162,,Elearning-0000-424,FY2021 MASSIVE TRANSFUSION PROTOCOL (MTP): SURGICAL SERVICES,,n13503,,choice,It is required to send the Blood Consent with the Blood Product Issue Request to Blood Bank when the Runner is picking up MTP parcels?,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
2373,,ILT-0000-10920,INFUSION CENTER STAFF MEETING MARCH 2021,,n13504,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Infusion Center Staff meeting March 2021 CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is INFUSION CENTER STAFF MEETING MARCH 2021- g13504,False
2373,,ILT-0000-10920,INFUSION CENTER STAFF MEETING MARCH 2021,,n13504,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Infusion Center Staff meeting March 2021 CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
2373,,ILT-0000-10920,INFUSION CENTER STAFF MEETING MARCH 2021,,n13504,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Infusion Center Staff meeting March 2021 CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
4487,,ILT-0000-20384,TEST CBL ARCHIVE PROCESS,,n13506,,choice,"I acknowledge that I have read and understand the ""TEST CBL"".",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TEST CBL ARCHIVE PROCESS- g13506,False
4487,,ILT-0000-20384,TEST CBL ARCHIVE PROCESS,,n13506,,choice,"I acknowledge that I have read and understand the ""TEST CBL"".",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
4487,,ILT-0000-20384,TEST CBL ARCHIVE PROCESS,,n13506,,choice,"I acknowledge that I have read and understand the ""TEST CBL"".",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,"1.	If the newborn fails the first test, in what time frame can the test be repeated?",a.	3-4 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FCC NEWBORN CAR SEAT CHANGES 2021- g13507,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,"1.	If the newborn fails the first test, in what time frame can the test be repeated?",a.	3-4 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,"1.	If the newborn fails the first test, in what time frame can the test be repeated?",b.	Immediately,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,"1.	If the newborn fails the first test, in what time frame can the test be repeated?",c.	6-8 hours,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,"1.	If the newborn fails the first test, in what time frame can the test be repeated?",d.	30 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,2.	The car seat needs to be visualized and documented against for all newborns discharging from FCC.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,2.	The car seat needs to be visualized and documented against for all newborns discharging from FCC.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,3.	Parents should be educated about car seat safety and given the educational flyer on admission to FCC and throughout the stay until discharge.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,3.	Parents should be educated about car seat safety and given the educational flyer on admission to FCC and throughout the stay until discharge.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,4.	The Angle Tolerance test should be completed on the following newborns,a.	Less than 37 weeks gestation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,4.	The Angle Tolerance test should be completed on the following newborns,b.	Birthweight less than or equal to 2500 grams,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,4.	The Angle Tolerance test should be completed on the following newborns,c.	Down Syndrome,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,4.	The Angle Tolerance test should be completed on the following newborns,d.	Per provider order for hypotonic newborns,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,4.	The Angle Tolerance test should be completed on the following newborns,e.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,4.	The Angle Tolerance test should be completed on the following newborns,f.	A and B only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,"5.	The Angle Tolerance Test should be completed when the newborn is greater than 24 hours of age, regardless of delivery method.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,"5.	The Angle Tolerance Test should be completed when the newborn is greater than 24 hours of age, regardless of delivery method.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,"6.	If the discharging location is further than 90 minutes away from the hospital, the Angle Tolerance test must be completed for 120 minutes to ensure newborn stability.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9143,,Elearning-0000-407,FCC NEWBORN CAR SEAT CHANGES 2021,,n13507,,choice,"6.	If the discharging location is further than 90 minutes away from the hospital, the Angle Tolerance test must be completed for 120 minutes to ensure newborn stability.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9626,,Elearning-0000-846,FY2021 STERILITY VERIFICATION,,n13508,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 Sterility Verification"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 STERILITY VERIFICATION- g13508,False
9626,,Elearning-0000-846,FY2021 STERILITY VERIFICATION,,n13508,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 Sterility Verification"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9626,,Elearning-0000-846,FY2021 STERILITY VERIFICATION,,n13508,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 Sterility Verification"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
202,,SCORM-0000-28,DEVELOPING BEHAVIORAL HEALTH CHAMPIONS,,n13510,,choice,I have read and understood the content within the Developing Behavioral Health Champions CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is DEVELOPING BEHAVIORAL HEALTH CHAMPIONS- g13510,False
202,,SCORM-0000-28,DEVELOPING BEHAVIORAL HEALTH CHAMPIONS,,n13510,,choice,I have read and understood the content within the Developing Behavioral Health Champions CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
202,,SCORM-0000-28,DEVELOPING BEHAVIORAL HEALTH CHAMPIONS,,n13510,,choice,I have read and understood the content within the Developing Behavioral Health Champions CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9463,,Elearning-0000-698,5 CENTRAL CODE BLUE EDUCATION 2021,,n13512,,choice,I have read and understand the responsibilities during a CODE BLUE at Northside Hospital. I understand the content and will ask my leadership any questions that I may have.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 5 CENTRAL CODE BLUE EDUCATION 2021- g13512,False
9463,,Elearning-0000-698,5 CENTRAL CODE BLUE EDUCATION 2021,,n13512,,choice,I have read and understand the responsibilities during a CODE BLUE at Northside Hospital. I understand the content and will ask my leadership any questions that I may have.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9463,,Elearning-0000-698,5 CENTRAL CODE BLUE EDUCATION 2021,,n13512,,choice,I have read and understand the responsibilities during a CODE BLUE at Northside Hospital. I understand the content and will ask my leadership any questions that I may have.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,True/False: The Impella device does not require any anticoagulation,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 IMPELLA PHARMACY EDUCATION- g13513,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,True/False: The Impella device does not require any anticoagulation,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,True/False: The Impella device does not require any anticoagulation,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,The preferred method of monitoring anticoagulation status is:,a)	Anti-Xa,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,The preferred method of monitoring anticoagulation status is:,b)	PTT,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,The preferred method of monitoring anticoagulation status is:,c)	INR,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,The preferred method of monitoring anticoagulation status is:,d)	ACT,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,True/False: The purge solution must include a dextrose base solution,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,True/False: The purge solution must include a dextrose base solution,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,True/False: Providers may choose between two different ACT therapeutic ranges: 160 - 180 or 180 - 200.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,True/False: Providers may choose between two different ACT therapeutic ranges: 160 - 180 or 180 - 200.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,"True/False: Intravenous heparin infusion may be started, in addition to heparin purge solution, if post-insertion ACT falls below upper limit of therapeutic range.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,"True/False: Intravenous heparin infusion may be started, in addition to heparin purge solution, if post-insertion ACT falls below upper limit of therapeutic range.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,True/False: Impella Heparin dosing is recorded on the same flowsheet used for standard heparin infusions,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,True/False: Impella Heparin dosing is recorded on the same flowsheet used for standard heparin infusions,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,True/False: All heparin infusion calculations require an MD/PharmD double check,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9321,,Elearning-0000-569,FY2021 IMPELLA PHARMACY EDUCATION,,n13513,,choice,True/False: All heparin infusion calculations require an MD/PharmD double check,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21- g13515,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the examination of leads and significance.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the examination of leads and significance.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the examination of leads and significance.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the examination of leads and significance.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the examination of leads and significance.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between myocardial ischemia, injury and infarction.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between myocardial ischemia, injury and infarction.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between myocardial ischemia, injury and infarction.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between myocardial ischemia, injury and infarction.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between myocardial ischemia, injury and infarction.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to plot an axis on the 12 lead EKG & discuss conditions that cause axis deviation.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to plot an axis on the 12 lead EKG & discuss conditions that cause axis deviation.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to plot an axis on the 12 lead EKG & discuss conditions that cause axis deviation.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to plot an axis on the 12 lead EKG & discuss conditions that cause axis deviation.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to plot an axis on the 12 lead EKG & discuss conditions that cause axis deviation.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of right and left bundle branch blocks on 12 lead EKG.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of right and left bundle branch blocks on 12 lead EKG.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of right and left bundle branch blocks on 12 lead EKG.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of right and left bundle branch blocks on 12 lead EKG.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of right and left bundle branch blocks on 12 lead EKG.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify QT prolongation on 12-Lead EKG </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify QT prolongation on 12-Lead EKG </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify QT prolongation on 12-Lead EKG </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify QT prolongation on 12-Lead EKG </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify QT prolongation on 12-Lead EKG </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to identification of changes in the 12 Lead EKG associated with conditions that have potential life threatening implications.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to identification of changes in the 12 Lead EKG associated with conditions that have potential life threatening implications.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to identification of changes in the 12 Lead EKG associated with conditions that have potential life threatening implications.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to identification of changes in the 12 Lead EKG associated with conditions that have potential life threatening implications.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to identification of changes in the 12 Lead EKG associated with conditions that have potential life threatening implications.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in effectively communicating my findings to physicians to aid in the managing my patients medical conditions.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in effectively communicating my findings to physicians to aid in the managing my patients medical conditions.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in effectively communicating my findings to physicians to aid in the managing my patients medical conditions.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in effectively communicating my findings to physicians to aid in the managing my patients medical conditions.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in effectively communicating my findings to physicians to aid in the managing my patients medical conditions.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9921,,Questions-0000-55,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 3.29.21,,n13515,,choice,How would you improve this class?,"No recommendation for improvement (appropriate content, speaker, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
273,,SCORM-0000-83,NURSING AND PAIN MANAGEMENT,,n13522,,choice,I have read and understood the content within the Nursing and Pain Management CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NURSING AND PAIN MANAGEMENT- g13522,False
273,,SCORM-0000-83,NURSING AND PAIN MANAGEMENT,,n13522,,choice,I have read and understood the content within the Nursing and Pain Management CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
273,,SCORM-0000-83,NURSING AND PAIN MANAGEMENT,,n13522,,choice,I have read and understood the content within the Nursing and Pain Management CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
275,,SCORM-0000-85,ONCOLOGY FELLOWSHIP: KSU PRECEPTOR WELCOME,,n13523,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is ONCOLOGY FELLOWSHIP: KSU PRECEPTOR WELCOME- g13523,False
275,,SCORM-0000-85,ONCOLOGY FELLOWSHIP: KSU PRECEPTOR WELCOME,,n13523,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
275,,SCORM-0000-85,ONCOLOGY FELLOWSHIP: KSU PRECEPTOR WELCOME,,n13523,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
277,,SCORM-0000-87,ONCOLOGY FELLOWSHIP: PRECEPTOR TRAINING,,n13524,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is ONCOLOGY FELLOWSHIP: PRECEPTOR TRAINING- g13524,False
277,,SCORM-0000-87,ONCOLOGY FELLOWSHIP: PRECEPTOR TRAINING,,n13524,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
277,,SCORM-0000-87,ONCOLOGY FELLOWSHIP: PRECEPTOR TRAINING,,n13524,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
276,,SCORM-0000-86,ONCOLOGY FELLOWSHIP: MERCER PRECEPTOR WELCOME,,n13525,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is ONCOLOGY FELLOWSHIP: MERCER PRECEPTOR WELCOME- g13525,False
276,,SCORM-0000-86,ONCOLOGY FELLOWSHIP: MERCER PRECEPTOR WELCOME,,n13525,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
276,,SCORM-0000-86,ONCOLOGY FELLOWSHIP: MERCER PRECEPTOR WELCOME,,n13525,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9698,,Elearning-0000-911,CODE PINK: IT'S EVERYONE'S RESPONSIBILITY UPDATED,,n13530,,choice,"I acknowledge that I have read and understand CBL CODE PINK: IT'S EVERYONE'S RESPONSIBILITY UPDATED. I understand my role in CODE PINK and Infant safety. If I have any questions, I will see my supervisor to help me understand my role.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is CODE PINK: IT'S EVERYONE'S RESPONSIBILITY UPDATED- g13530,False
9698,,Elearning-0000-911,CODE PINK: IT'S EVERYONE'S RESPONSIBILITY UPDATED,,n13530,,choice,"I acknowledge that I have read and understand CBL CODE PINK: IT'S EVERYONE'S RESPONSIBILITY UPDATED. I understand my role in CODE PINK and Infant safety. If I have any questions, I will see my supervisor to help me understand my role.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9698,,Elearning-0000-911,CODE PINK: IT'S EVERYONE'S RESPONSIBILITY UPDATED,,n13530,,choice,"I acknowledge that I have read and understand CBL CODE PINK: IT'S EVERYONE'S RESPONSIBILITY UPDATED. I understand my role in CODE PINK and Infant safety. If I have any questions, I will see my supervisor to help me understand my role.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9597,,Elearning-0000-82,WSU CLINICAL EXCELLENCE _UNIT STAR AWARDS FY_21_Q2,,n13531,,choice,Please vote for one of the following staff members for the Clinical Excellence Award FY 21 Q 2,Megan Cooper,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is WSU CLINICAL EXCELLENCE _UNIT STAR AWARDS FY_21_Q2- g13531,False
9597,,Elearning-0000-82,WSU CLINICAL EXCELLENCE _UNIT STAR AWARDS FY_21_Q2,,n13531,,choice,Please vote for one of the following staff members for the Clinical Excellence Award FY 21 Q 2,Megan Cooper,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9597,,Elearning-0000-82,WSU CLINICAL EXCELLENCE _UNIT STAR AWARDS FY_21_Q2,,n13531,,choice,Please vote for one of the following staff members for the Clinical Excellence Award FY 21 Q 2,Josephine Roberson,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9597,,Elearning-0000-82,WSU CLINICAL EXCELLENCE _UNIT STAR AWARDS FY_21_Q2,,n13531,,choice,Please vote for one of the following staff members for the Unit star FY 21 Q 2,Angie Dixon,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9597,,Elearning-0000-82,WSU CLINICAL EXCELLENCE _UNIT STAR AWARDS FY_21_Q2,,n13531,,choice,Please vote for one of the following staff members for the Unit star FY 21 Q 2,Shameka Bostick,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21- g13533,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify issues of patient safety and error reduction in the delivery of healthcare to Infants.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify issues of patient safety and error reduction in the delivery of healthcare to Infants.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify issues of patient safety and error reduction in the delivery of healthcare to Infants.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify issues of patient safety and error reduction in the delivery of healthcare to Infants.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify issues of patient safety and error reduction in the delivery of healthcare to Infants.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of hypoglycemia.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of hypoglycemia.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of hypoglycemia.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of hypoglycemia.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of hypoglycemia.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe infants at risk for hypothermia.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe infants at risk for hypothermia.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe infants at risk for hypothermia.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe infants at risk for hypothermia.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe infants at risk for hypothermia.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state 3 precautions to minimize heat loss in the delivery room.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state 3 precautions to minimize heat loss in the delivery room.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state 3 precautions to minimize heat loss in the delivery room.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state 3 precautions to minimize heat loss in the delivery room.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state 3 precautions to minimize heat loss in the delivery room.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to distinguish between mild, moderate, and severe respiratory distress.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to distinguish between mild, moderate, and severe respiratory distress.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to distinguish between mild, moderate, and severe respiratory distress.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to distinguish between mild, moderate, and severe respiratory distress.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to distinguish between mild, moderate, and severe respiratory distress.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to interpret Blood Gases for respiratory and metabolic acidosis.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to interpret Blood Gases for respiratory and metabolic acidosis.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to interpret Blood Gases for respiratory and metabolic acidosis.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to interpret Blood Gases for respiratory and metabolic acidosis.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to interpret Blood Gases for respiratory and metabolic acidosis.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list the 3 major types of shock seen in infants.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list the 3 major types of shock seen in infants.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list the 3 major types of shock seen in infants.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list the 3 major types of shock seen in infants.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list the 3 major types of shock seen in infants.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify factors that can impair cardiac output.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify factors that can impair cardiac output.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify factors that can impair cardiac output.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify factors that can impair cardiac output.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify factors that can impair cardiac output.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define the term Shock.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define the term Shock.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define the term Shock.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define the term Shock.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define the term Shock.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the clinical signs of neonatal sepsis.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the clinical signs of neonatal sepsis.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the clinical signs of neonatal sepsis.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the clinical signs of neonatal sepsis.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the clinical signs of neonatal sepsis.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list perinatal and postnatal risk factors that predispose the infant to infection. Speaker - Coleen Poirier </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list perinatal and postnatal risk factors that predispose the infant to infection. Speaker - Coleen Poirier </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list perinatal and postnatal risk factors that predispose the infant to infection. Speaker - Coleen Poirier </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list perinatal and postnatal risk factors that predispose the infant to infection. Speaker - Coleen Poirier </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list perinatal and postnatal risk factors that predispose the infant to infection. Speaker - Coleen Poirier </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify methods to obtain lab specimens to rule out sepsis.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify methods to obtain lab specimens to rule out sepsis.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify methods to obtain lab specimens to rule out sepsis.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify methods to obtain lab specimens to rule out sepsis.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify methods to obtain lab specimens to rule out sepsis.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list 2 ways healthcare providers can support parents of sick infants.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list 2 ways healthcare providers can support parents of sick infants.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list 2 ways healthcare providers can support parents of sick infants.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list 2 ways healthcare providers can support parents of sick infants.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list 2 ways healthcare providers can support parents of sick infants.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize the importance of reducing errors to improve outcome.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize the importance of reducing errors to improve outcome.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize the importance of reducing errors to improve outcome.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize the importance of reducing errors to improve outcome.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize the importance of reducing errors to improve outcome.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence level for organizing the myriad of details and interventions necessary for stabilizing a sick infant. </OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence level for organizing the myriad of details and interventions necessary for stabilizing a sick infant. </OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence level for organizing the myriad of details and interventions necessary for stabilizing a sick infant. </OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence level for organizing the myriad of details and interventions necessary for stabilizing a sick infant. </OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence level for organizing the myriad of details and interventions necessary for stabilizing a sick infant. </OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kathy Cunningham</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kathy Cunningham</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kathy Cunningham</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kathy Cunningham</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kathy Cunningham</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,How would you improve this class?,"No Suggestions for improvement ( right content, speakers, location, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Carolyn Ford, RN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Carolyn Ford, RN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Carolyn Ford, RN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Carolyn Ford, RN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Carolyn Ford, RN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Coleen Poirier</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Coleen Poirier</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Coleen Poirier</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Coleen Poirier</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9867,,Questions-0000-157,STABLE PROGRAM (EVALUATION SURVEY) NSA  3.31.21,,n13533,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Coleen Poirier</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,"Duplicate Test. Existing test is NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)- g13535",False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to Identify key components of patient education for patients receiving oral anticancer agents.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to Identify key components of patient education for patients receiving oral anticancer agents.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to Identify key components of patient education for patients receiving oral anticancer agents.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to Identify key components of patient education for patients receiving oral anticancer agents.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to Identify key components of patient education for patients receiving oral anticancer agents.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9943,,Questions-0000-77,"NSF INFUSION CENTER JOURNAL CLUB - APRIL 1ST, 2021 (EVALUATION SURVEY)",,n13535,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"The parent provided car seat is appropriate to their infant's weight and height. Despite proper positioning,    there is still slack in the harness straps. (You can pinch the harness strap at the collarbone). Discharge is  tomorrow and they are unwilling to provide another car seat. You educate the parents (and document)      about the danger and liability in using the seat with slack in the harness straps. They sign the CSC statement of understanding saying ""We'll be careful""�. What do you do?",A)  Place blankets under and behind the infant to take up the slack in the harness straps then begin the car seat challenge.,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 SCN INFANT CAR SEAT- g13538,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"The parent provided car seat is appropriate to their infant's weight and height. Despite proper positioning,    there is still slack in the harness straps. (You can pinch the harness strap at the collarbone). Discharge is  tomorrow and they are unwilling to provide another car seat. You educate the parents (and document)      about the danger and liability in using the seat with slack in the harness straps. They sign the CSC statement of understanding saying ""We'll be careful""�. What do you do?",A)  Place blankets under and behind the infant to take up the slack in the harness straps then begin the car seat challenge.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"The parent provided car seat is appropriate to their infant's weight and height. Despite proper positioning,    there is still slack in the harness straps. (You can pinch the harness strap at the collarbone). Discharge is  tomorrow and they are unwilling to provide another car seat. You educate the parents (and document)      about the danger and liability in using the seat with slack in the harness straps. They sign the CSC statement of understanding saying ""We'll be careful""�. What do you do?",B) Contact Care Coordination for a DCFS referral as these parents are knowingly endangering their    infant.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"The parent provided car seat is appropriate to their infant's weight and height. Despite proper positioning,    there is still slack in the harness straps. (You can pinch the harness strap at the collarbone). Discharge is  tomorrow and they are unwilling to provide another car seat. You educate the parents (and document)      about the danger and liability in using the seat with slack in the harness straps. They sign the CSC statement of understanding saying ""We'll be careful""�. What do you do?",C) Have the parent initial both statements and then sign the Release of Liability for Child Safety Seat  (#NH0725) and proceed with the car seat challenge.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"The parent provided car seat is appropriate to their infant's weight and height. Despite proper positioning,    there is still slack in the harness straps. (You can pinch the harness strap at the collarbone). Discharge is  tomorrow and they are unwilling to provide another car seat. You educate the parents (and document)      about the danger and liability in using the seat with slack in the harness straps. They sign the CSC statement of understanding saying ""We'll be careful""�. What do you do?","D) Check the ""YES""� box for noncompliance and document that the parents verbalize understanding of the danger of the observed noncompliance with the manufacturer's instructions -slack in  the harness straps- in the comments section of the EMR and proceed with the car seat challenge.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,An infant previously receiving caffeine will have the car seat challenge deferred for at least,A)  7 days,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,An infant previously receiving caffeine will have the car seat challenge deferred for at least,B)  3 days,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,An infant previously receiving caffeine will have the car seat challenge deferred for at least,C) 5 days,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,An infant previously receiving caffeine will have the car seat challenge deferred for at least,D)  10 days,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,You are caring for an infant being discharged using medical equipment. How do you educate the caregiver to secure these items while traveling in a vehicle?,A)  Instruct them to wedge it with blankets,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,You are caring for an infant being discharged using medical equipment. How do you educate the caregiver to secure these items while traveling in a vehicle?,B)  Instruct them to seat belt it to an unoccupied seat,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,You are caring for an infant being discharged using medical equipment. How do you educate the caregiver to secure these items while traveling in a vehicle?,C)  Instruct them to wedge it with pillows or foam,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,You are caring for an infant being discharged using medical equipment. How do you educate the caregiver to secure these items while traveling in a vehicle?,D)  Any of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,The mom arrives on the day of discharge with a car seat she borrowed. She does not have the instruction manual and does not know how to adjust the harness straps. What do you do?,A)  Order a car seat from Central Distribution,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,The mom arrives on the day of discharge with a car seat she borrowed. She does not have the instruction manual and does not know how to adjust the harness straps. What do you do?,B)  Ask a staff member who has used a car seat to show mom how to adjust the harness straps,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,The mom arrives on the day of discharge with a car seat she borrowed. She does not have the instruction manual and does not know how to adjust the harness straps. What do you do?,C)  Look on the label or give the parent the list from the SCN Parent information folder for the manufacturer's toll free numbers and websites (or) to download/view the instruction manual,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,The mom arrives on the day of discharge with a car seat she borrowed. She does not have the instruction manual and does not know how to adjust the harness straps. What do you do?,D)  Ask a CPST to adjust the harness straps,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,You provided the parent with the car seat challenge education information. What else do you tell the parents about the car seat challenge?,A) Read the car seat instruction manual (or view the video on the car seat manufacturer's  website) prior to the challenge and practice adjusting the harness straps,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,You provided the parent with the car seat challenge education information. What else do you tell the parents about the car seat challenge?,"B) Bring the car seat, base and the instruction manual to the bedside when the infant is completing 4 or more PO feedings",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,You provided the parent with the car seat challenge education information. What else do you tell the parents about the car seat challenge?,C)	They will need to review and sign the car seat challenge statement and remain at the bedside for the first 15 minutes of the test in case repositioning is needed,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,You provided the parent with the car seat challenge education information. What else do you tell the parents about the car seat challenge?,D)  All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,When you sell a car seat or car bed from Central Distribution the parent must sign what  additional paperwork ?,A)  Agreement for purchase of child safety seat,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,When you sell a car seat or car bed from Central Distribution the parent must sign what  additional paperwork ?,B)  Medicaid reimbursement form,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,When you sell a car seat or car bed from Central Distribution the parent must sign what  additional paperwork ?,C) Release of liability for child safety seat,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,When you sell a car seat or car bed from Central Distribution the parent must sign what  additional paperwork ?,D)  B & C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"The shoulder harness straps are in the lowest position on the car seat. The infant is positioned with its back flat against the back of the car seat, yet the infants shoulders are still slightly ( �""�) below the lowest shoulder harness slot. The harness straps are snug (pass the ""pinch test""�). The parent has signed the CSC statement and is unwilling to bring   another car seat. What do you do?",A)  The straps are snug so there is not a compliance issue. Begin the car seat challenge,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"The shoulder harness straps are in the lowest position on the car seat. The infant is positioned with its back flat against the back of the car seat, yet the infants shoulders are still slightly ( �""�) below the lowest shoulder harness slot. The harness straps are snug (pass the ""pinch test""�). The parent has signed the CSC statement and is unwilling to bring   another car seat. What do you do?","B)  Check the manufacturer's instructions. If the harness height is allowed to be slightly above the shoulders, check the ""NO""� box for compliance issues and begin the car seat challenge but note that the harness height was allowed to be above the   shoulders in the comments box.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"The shoulder harness straps are in the lowest position on the car seat. The infant is positioned with its back flat against the back of the car seat, yet the infants shoulders are still slightly ( �""�) below the lowest shoulder harness slot. The harness straps are snug (pass the ""pinch test""�). The parent has signed the CSC statement and is unwilling to bring   another car seat. What do you do?","C)  Check the manufacturer's instructions. If the manufacturer does NOT allow  the shoulder harness to be above the  infants shoulders, check the ""YES""� box, describe the non-compliance issue (harness height above the infants shoulders),   indicate that the parents verbalized understanding of the danger of the misuse in the  comment box in the EMR and education record, then begin the car seat challenge",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"The shoulder harness straps are in the lowest position on the car seat. The infant is positioned with its back flat against the back of the car seat, yet the infants shoulders are still slightly ( �""�) below the lowest shoulder harness slot. The harness straps are snug (pass the ""pinch test""�). The parent has signed the CSC statement and is unwilling to bring   another car seat. What do you do?",D)  B & C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,What is the current AAP recommendation for how long an infant should ride rear-facing in a child safety seat?,A) The infant should ride rear-facing until it is both #20 lbs. and one year past the original due date,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,What is the current AAP recommendation for how long an infant should ride rear-facing in a child safety seat?,B) The infant should ride rear-facing until it is either 2 years old or #30 lbs.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,What is the current AAP recommendation for how long an infant should ride rear-facing in a child safety seat?,C) The infant should ride rear-facing until the harness straps are at the highest level on a rear-facing seat,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,What is the current AAP recommendation for how long an infant should ride rear-facing in a child safety seat?,D) The infant should ride rear facing until they reach the highest weight or height allowed by their child safety seat's manufacturer,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,It is the day of discharge. The parents did not bring the car seat base and are unable to go back home for the base. Can you do the car seat challenge without the base?,A) NO - if the car seat has a base you must do the test with the car seat in the base to verify the correct angle,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,It is the day of discharge. The parents did not bring the car seat base and are unable to go back home for the base. Can you do the car seat challenge without the base?,"B) YES - as long the car seat label indicates the car seat can be used without  the base, you are able to simulate the angle as recommended by the manufacturer, and you document that the base was not used in the comments box  in the EMR",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,The infant has a desaturation to 89% for 5 seconds after 40 minutes of the car seat challenge. How do you document this?,A) No documentation is needed at 40 minutes. Documentation is done at 0-30-60 & 90 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,The infant has a desaturation to 89% for 5 seconds after 40 minutes of the car seat challenge. How do you document this?,B) The desaturation did not last 10 seconds and therefore is not documented,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,The infant has a desaturation to 89% for 5 seconds after 40 minutes of the car seat challenge. How do you document this?,C)  Stop the car seat challenge and document it as failed,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,The infant has a desaturation to 89% for 5 seconds after 40 minutes of the car seat challenge. How do you document this?,"D)  Events outside the parameters during car seat challenge are documented in events box under ""Other""�  but this is not a failed car seat  challenge",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,The parent has brought a convertible seat for their infant's car seat challenge. What should you tell them?,A) Convertible seats are for toddlers. A car seat challenge can only be done in a rear-facing only car seat,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,The parent has brought a convertible seat for their infant's car seat challenge. What should you tell them?,B)  The car seat challenge can be done in a convertible seat if the infant fits and the angle of recline can be obtained.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,The parent has brought a convertible seat for their infant's car seat challenge. What should you tell them?,C)  The convertible seat does not have a level indicator so you are unable to do the car seat    challenge in a convertible seat,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,The parent has brought a convertible seat for their infant's car seat challenge. What should you tell them?,D)  A & C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"What are the ""fail""� criteria during the 90 - 120 minute car seat challenge?","A) A heart rate  < 80 for greater than 10 seconds, OR oxygen saturation < 88% for greater than 10 seconds; OR apnea for greater than 20 seconds",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"What are the ""fail""� criteria during the 90 - 120 minute car seat challenge?",B)  A heart rate < 80 OR an oxygen saturation < 90% regardless of the duration,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"What are the ""fail""� criteria during the 90 - 120 minute car seat challenge?","C)  Any oxygen saturation < 85%, regardless of duration",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"What are the ""fail""� criteria during the 90 - 120 minute car seat challenge?",D) Apnea for greater than 20 seconds OR oxygen saturation < 90% for greater than 10 seconds OR heart rate less than 80 for greater than 10 seconds,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,Where is the level indicator on the rear-facing car seat when used without the base?,"A) The level indicator is only on the base, not on the car seat",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,Where is the level indicator on the rear-facing car seat when used without the base?,B) The level indicator is on a sticker on the side of the car seat,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,Where is the level indicator on the rear-facing car seat when used without the base?,C) The level indicator is a line molded into the plastic on the side of the car seat,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,Where is the level indicator on the rear-facing car seat when used without the base?,D) B & C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"The infant had been completing 4-6 PO feedings but by the time the parent brings the car seat to the bedside,  the infant is no longer completing 4 PO feedings. When can you do the car seat challenge?",A. You must wait until the infant is completing 4-6 feedings again,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"The infant had been completing 4-6 PO feedings but by the time the parent brings the car seat to the bedside,  the infant is no longer completing 4 PO feedings. When can you do the car seat challenge?",B.  The provider must write for an order regarding timing of car seat challenge,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"The infant had been completing 4-6 PO feedings but by the time the parent brings the car seat to the bedside,  the infant is no longer completing 4 PO feedings. When can you do the car seat challenge?",C. Now since the infant had met requirements and should have had the car seat challenge done at that time,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"The infant had been completing 4-6 PO feedings but by the time the parent brings the car seat to the bedside,  the infant is no longer completing 4 PO feedings. When can you do the car seat challenge?",D. Once the infant is completing 3 PO feedings,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"The car seat challenge cannot be done if the infant is having ""events""�",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,"The car seat challenge cannot be done if the infant is having ""events""�",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,You must wait at least 24 hours after respiratory support is discontinued to do the car seat challenge.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9722,,Elearning-0000-933,2021 SCN INFANT CAR SEAT,,n13538,,choice,You must wait at least 24 hours after respiratory support is discontinued to do the car seat challenge.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9049,,Elearning-0000-321,NSH1224 AMENDMENT 7,,n13540,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSH1224 AMENDMENT 7- g13540,False
9049,,Elearning-0000-321,NSH1224 AMENDMENT 7,,n13540,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9049,,Elearning-0000-321,NSH1224 AMENDMENT 7,,n13540,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,The OB Hemorrhage Cart is a key component to achieving rapid access to medications and supplies needed during a postpartum hemorrhage,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is OB HEMORRHAGE CART- g13542,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,The OB Hemorrhage Cart is a key component to achieving rapid access to medications and supplies needed during a postpartum hemorrhage,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,The OB Hemorrhage Cart is a key component to achieving rapid access to medications and supplies needed during a postpartum hemorrhage,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,Hemorrhage carts will be located:,FCC,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,Hemorrhage carts will be located:,HRP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,Hemorrhage carts will be located:,L&D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,Hemorrhage carts will be located:,All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,The OB Hemorrhage Cart is secured by:,A zip tie,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,The OB Hemorrhage Cart is secured by:,2 Digital locks,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,The OB Hemorrhage Cart is secured by:,Red security seal,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,The OB Hemorrhage Cart is secured by:,B and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,The OB Hemorrhage Cart is secured by:,All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,Medications are stored in the OB Hemorrhage Cart,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,Medications are stored in the OB Hemorrhage Cart,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,What color seal should be placed over the lock bar on the cart to indicate it has been opened and cannot be used?,Green,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,What color seal should be placed over the lock bar on the cart to indicate it has been opened and cannot be used?,Red,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,What color seal should be placed over the lock bar on the cart to indicate it has been opened and cannot be used?,Yellow,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,How frequently should the cart thermometer be checked?,Once a day,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,How frequently should the cart thermometer be checked?,Every shift,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,How frequently should the cart thermometer be checked?,Once a week,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,"If a patient is transferred during use of a hemorrhage cart, the hemorrhage cart should be transferred with the patient.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9037,,Elearning-0000-310,OB HEMORRHAGE CART,,n13542,,choice,"If a patient is transferred during use of a hemorrhage cart, the hemorrhage cart should be transferred with the patient.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9090,,Elearning-0000-359,NSH1226 AMENDMENT 5,,n13541,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSH1226 AMENDMENT 5- g13541,False
9090,,Elearning-0000-359,NSH1226 AMENDMENT 5,,n13541,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9090,,Elearning-0000-359,NSH1226 AMENDMENT 5,,n13541,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is Northside's empiric treatment for CAP?,a.	Azithromycin 500mg IVPO q24hrs x 5 days,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 PHARMACY PNEUMONIA COMPETENCY- g13544,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is Northside's empiric treatment for CAP?,a.	Azithromycin 500mg IVPO q24hrs x 5 days,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is Northside's empiric treatment for CAP?,b.	Ceftriaxone 2g IV q24hrs,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is Northside's empiric treatment for CAP?,c.	Zosyn 4.5g IV q8h extended infusion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is Northside's empiric treatment for CAP?,d.	Ceftriaxone 2g IV q24h + Azithromycin 500mg IV/PO Q24hrs,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is the duration of therapy for HAP/VAP in a patient clinical improvement?,a.	It depends on the organism isolated,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is the duration of therapy for HAP/VAP in a patient clinical improvement?,b.	7 days of antibiotic treatment,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is the duration of therapy for HAP/VAP in a patient clinical improvement?,c.	10 days of antibiotic treatment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is the duration of therapy for HAP/VAP in a patient clinical improvement?,d.	14 days of antibiotic treatment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is Northside's empiric treatment for HAP/VAP?,a.	Cefepime 2g IV q8h,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is Northside's empiric treatment for HAP/VAP?,b.	Zosyn 4.5g IV q8h extended infusion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is Northside's empiric treatment for HAP/VAP?,c.	Meropenem 2g IV q8h,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is Northside's empiric treatment for HAP/VAP?,d.	Ceftazidime 2g IV q8h + Vancomycin pharmacy to dose,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,Which antibiotic has the highest Pseudomonas coverage per Northside's Antibiogram?,a.	Cefepime 2g IV q8h,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,Which antibiotic has the highest Pseudomonas coverage per Northside's Antibiogram?,b.	Meropenem 2g IV q8h,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,Which antibiotic has the highest Pseudomonas coverage per Northside's Antibiogram?,c.	Ceftazidime 2g IV q8h,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,Which antibiotic has the highest Pseudomonas coverage per Northside's Antibiogram?,d.	Levaquin 750mg IV q24h,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,Pharmacists should order MRSA nasal PCR when vancomycin is ordered for Pneumonia indication,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,Pharmacists should order MRSA nasal PCR when vancomycin is ordered for Pneumonia indication,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,Aztreonam does not have any gram positive coverage.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,Aztreonam does not have any gram positive coverage.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is Northside's Aspiration pneumonia empiric treatment,a.	Ceftriaxone 2g IV q24h,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is Northside's Aspiration pneumonia empiric treatment,b.	Unasyn 3g IV q24h if empyema/abscess suspected,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is Northside's Aspiration pneumonia empiric treatment,c.	Ceftriaxone 2g IV q24h + metronidazole 500mg IV q8h if empyema/abscess suspected,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,What is Northside's Aspiration pneumonia empiric treatment,"d.	A, B, and C are all possible choices for aspiration pneumonia",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,Patients with septic shock should not have antibiotics withheld based on a normal initial procalcitonin,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,Patients with septic shock should not have antibiotics withheld based on a normal initial procalcitonin,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,"Procalcitonin levels usually do not increase in response to infection with organisms that lack a cell wall (Mycoplasma, Chlamydia, Atypcial organisms)",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,"Procalcitonin levels usually do not increase in response to infection with organisms that lack a cell wall (Mycoplasma, Chlamydia, Atypcial organisms)",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,Antibiotics are strongly encouraged when Procalcitonin > 0.5ng/mL in LRTI infections.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,Antibiotics are strongly encouraged when Procalcitonin > 0.5ng/mL in LRTI infections.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,Nonbacterial causes of procalcitonin elevation include:,"a.	Severe trauma, cardiogenic shock, burns",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,Nonbacterial causes of procalcitonin elevation include:,b.	Intra-abdominal surgery,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,Nonbacterial causes of procalcitonin elevation include:,c.	Renal failure including ESRD/HD,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9751,,Elearning-0000-96,FY2021 PHARMACY PNEUMONIA COMPETENCY,,n13544,,choice,Nonbacterial causes of procalcitonin elevation include:,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
2449,,ILT-0000-11290,IP ONCOLOGY STAFF MEETING MARCH 2021,,n13545,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is IP ONCOLOGY STAFF MEETING MARCH 2021- g13545,False
2449,,ILT-0000-11290,IP ONCOLOGY STAFF MEETING MARCH 2021,,n13545,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
2449,,ILT-0000-11290,IP ONCOLOGY STAFF MEETING MARCH 2021,,n13545,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9718,,Elearning-0000-93,WOMEN'S SERVICES AD HOC MEDICATION ADMINISTRATION,,n13546,,choice,Nurses are allowed to use the emergency ad hoc administration tool for all medications,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is WOMEN'S SERVICES AD HOC MEDICATION ADMINISTRATION- g13546,False
9718,,Elearning-0000-93,WOMEN'S SERVICES AD HOC MEDICATION ADMINISTRATION,,n13546,,choice,Nurses are allowed to use the emergency ad hoc administration tool for all medications,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9718,,Elearning-0000-93,WOMEN'S SERVICES AD HOC MEDICATION ADMINISTRATION,,n13546,,choice,Nurses are allowed to use the emergency ad hoc administration tool for all medications,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9718,,Elearning-0000-93,WOMEN'S SERVICES AD HOC MEDICATION ADMINISTRATION,,n13546,,choice,Ad Hoc administration can be used for medications administered by anesthesia,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9718,,Elearning-0000-93,WOMEN'S SERVICES AD HOC MEDICATION ADMINISTRATION,,n13546,,choice,Ad Hoc administration can be used for medications administered by anesthesia,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9718,,Elearning-0000-93,WOMEN'S SERVICES AD HOC MEDICATION ADMINISTRATION,,n13546,,choice,How often will a report be run to determine if the ad hoc button is being used for unauthorized medications?,Every day,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9718,,Elearning-0000-93,WOMEN'S SERVICES AD HOC MEDICATION ADMINISTRATION,,n13546,,choice,How often will a report be run to determine if the ad hoc button is being used for unauthorized medications?,Every week,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9718,,Elearning-0000-93,WOMEN'S SERVICES AD HOC MEDICATION ADMINISTRATION,,n13546,,choice,How often will a report be run to determine if the ad hoc button is being used for unauthorized medications?,Every month,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9718,,Elearning-0000-93,WOMEN'S SERVICES AD HOC MEDICATION ADMINISTRATION,,n13546,,choice,Disciplinary actions will occur for staff members using the ad hoc administration tool for unapproved medications,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9718,,Elearning-0000-93,WOMEN'S SERVICES AD HOC MEDICATION ADMINISTRATION,,n13546,,choice,Disciplinary actions will occur for staff members using the ad hoc administration tool for unapproved medications,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9676,,Elearning-0000-891,HAPI PREVENTION EDUCATION - APRIL 2021 - PRESSURE INJURY STAGING,,n13548,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""HAPI Prevention Education - April 2021 - Pressure Injury Staging"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is HAPI PREVENTION EDUCATION - APRIL 2021 - PRESSURE INJURY STAGING- g13548,False
9676,,Elearning-0000-891,HAPI PREVENTION EDUCATION - APRIL 2021 - PRESSURE INJURY STAGING,,n13548,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""HAPI Prevention Education - April 2021 - Pressure Injury Staging"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9676,,Elearning-0000-891,HAPI PREVENTION EDUCATION - APRIL 2021 - PRESSURE INJURY STAGING,,n13548,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""HAPI Prevention Education - April 2021 - Pressure Injury Staging"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
249,,SCORM-0000-59,JADA INSERVICE VIDEO,,n13551,,choice,I have read and understood the content within the JADA Inservice Video.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is JADA INSERVICE VIDEO- g13551,False
249,,SCORM-0000-59,JADA INSERVICE VIDEO,,n13551,,choice,I have read and understood the content within the JADA Inservice Video.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
249,,SCORM-0000-59,JADA INSERVICE VIDEO,,n13551,,choice,I have read and understood the content within the JADA Inservice Video.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9623,,Elearning-0000-843,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NON-NURSING PT CONTACT,,n13695,,choice,"BEFAST means: Balance, Eyes, Face, Arms, Speech, Time.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NON-NURSING PT CONTACT- g13695,False
9623,,Elearning-0000-843,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NON-NURSING PT CONTACT,,n13695,,choice,"BEFAST means: Balance, Eyes, Face, Arms, Speech, Time.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9623,,Elearning-0000-843,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NON-NURSING PT CONTACT,,n13695,,choice,"BEFAST means: Balance, Eyes, Face, Arms, Speech, Time.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9623,,Elearning-0000-843,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NON-NURSING PT CONTACT,,n13695,,choice,It is important to know the last known well (LKW) of the patient.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9623,,Elearning-0000-843,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NON-NURSING PT CONTACT,,n13695,,choice,It is important to know the last known well (LKW) of the patient.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9623,,Elearning-0000-843,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NON-NURSING PT CONTACT,,n13695,,choice,"You can help to decrease your personal risk factors with diet, exercise, tobacco free life, and taking your prescribed medications.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9623,,Elearning-0000-843,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NON-NURSING PT CONTACT,,n13695,,choice,"You can help to decrease your personal risk factors with diet, exercise, tobacco free life, and taking your prescribed medications.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9624,,Elearning-0000-844,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NURSING,,n13555,,choice,"BEFAST means: Balance, Eyes, Face, Arms, Speech, Time.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NURSING- g13555,False
9624,,Elearning-0000-844,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NURSING,,n13555,,choice,"BEFAST means: Balance, Eyes, Face, Arms, Speech, Time.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9624,,Elearning-0000-844,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NURSING,,n13555,,choice,"BEFAST means: Balance, Eyes, Face, Arms, Speech, Time.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9624,,Elearning-0000-844,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NURSING,,n13555,,choice,"Primary RN responsibilities include: Determine, Last Known Well, Call telemetry, treat hypoglycemia, review medications, and labs, establish IV, remain with patient and work with rapid response for next steps.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9624,,Elearning-0000-844,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NURSING,,n13555,,choice,"Primary RN responsibilities include: Determine, Last Known Well, Call telemetry, treat hypoglycemia, review medications, and labs, establish IV, remain with patient and work with rapid response for next steps.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9624,,Elearning-0000-844,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NURSING,,n13555,,choice,SBAR should be used to communicate during a Stroke alert.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9624,,Elearning-0000-844,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NURSING,,n13555,,choice,SBAR should be used to communicate during a Stroke alert.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9624,,Elearning-0000-844,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NURSING,,n13555,,choice,There is a powerplan in Cerner that requires the ordering neurologist to sign off.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9624,,Elearning-0000-844,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NURSING,,n13555,,choice,There is a powerplan in Cerner that requires the ordering neurologist to sign off.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9624,,Elearning-0000-844,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NURSING,,n13555,,choice,The primary RN should assist with the NIHSS during Telestroke.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9624,,Elearning-0000-844,FY2021 NORTHSIDE HOSPITAL STROKE ALERT: NURSING,,n13555,,choice,The primary RN should assist with the NIHSS during Telestroke.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9637,,Elearning-0000-856,FY2021 NPSG MULTI-DRUG RESISTANT ORGANISMS (MDRO): PATIENT CARE,,n13557,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 NPSG MULTI-DRUG RESISTANT ORGANISMS (MDRO): PATIENT CARE CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 NPSG MULTI-DRUG RESISTANT ORGANISMS (MDRO): PATIENT CARE- g13557,False
9637,,Elearning-0000-856,FY2021 NPSG MULTI-DRUG RESISTANT ORGANISMS (MDRO): PATIENT CARE,,n13557,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 NPSG MULTI-DRUG RESISTANT ORGANISMS (MDRO): PATIENT CARE CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9637,,Elearning-0000-856,FY2021 NPSG MULTI-DRUG RESISTANT ORGANISMS (MDRO): PATIENT CARE,,n13557,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 NPSG MULTI-DRUG RESISTANT ORGANISMS (MDRO): PATIENT CARE CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9618,,Elearning-0000-839,FY2021 NPSG.07.05.01 - PREVENTION OF SURGICAL SITE INFECTIONS,,n13558,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 NPSG.07.05.01 - PREVENTION OF SURGICAL SITE INFECTIONS CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 NPSG.07.05.01 - PREVENTION OF SURGICAL SITE INFECTIONS- g13558,False
9618,,Elearning-0000-839,FY2021 NPSG.07.05.01 - PREVENTION OF SURGICAL SITE INFECTIONS,,n13558,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 NPSG.07.05.01 - PREVENTION OF SURGICAL SITE INFECTIONS CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9618,,Elearning-0000-839,FY2021 NPSG.07.05.01 - PREVENTION OF SURGICAL SITE INFECTIONS,,n13558,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 NPSG.07.05.01 - PREVENTION OF SURGICAL SITE INFECTIONS CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9638,,Elearning-0000-857,FY2021 NPSG.07.04.01 - PREVENTION OF CENTRAL LINE ASSOCIATED INFECTIONS,,n13560,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 NPSG.07.04.01 - PREVENTION OF CENTRAL LINE ASSOCIATED INFECTIONS CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 NPSG.07.04.01 - PREVENTION OF CENTRAL LINE ASSOCIATED INFECTIONS- g13560,False
9638,,Elearning-0000-857,FY2021 NPSG.07.04.01 - PREVENTION OF CENTRAL LINE ASSOCIATED INFECTIONS,,n13560,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 NPSG.07.04.01 - PREVENTION OF CENTRAL LINE ASSOCIATED INFECTIONS CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9638,,Elearning-0000-857,FY2021 NPSG.07.04.01 - PREVENTION OF CENTRAL LINE ASSOCIATED INFECTIONS,,n13560,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 NPSG.07.04.01 - PREVENTION OF CENTRAL LINE ASSOCIATED INFECTIONS CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9682,,Elearning-0000-897,FY2021 NPSG.07.01.01 - HAND HYGIENE PRINCIPLES,,n13559,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 NPSG.07.01.01 - HAND HYGIENE PRINCIPLES CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 NPSG.07.01.01 - HAND HYGIENE PRINCIPLES- g13559,False
9682,,Elearning-0000-897,FY2021 NPSG.07.01.01 - HAND HYGIENE PRINCIPLES,,n13559,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 NPSG.07.01.01 - HAND HYGIENE PRINCIPLES CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9682,,Elearning-0000-897,FY2021 NPSG.07.01.01 - HAND HYGIENE PRINCIPLES,,n13559,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 NPSG.07.01.01 - HAND HYGIENE PRINCIPLES CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9639,,Elearning-0000-858,FY2021 NPSG.07.06.01 - PREVENTION OF URINARY CATHETER ASSOCIATED INFECTIONS,,n13561,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 NPSG.07.06.01 - PREVENTION OF URINARY CATHETER ASSOCIATED INFECTIONS CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 NPSG.07.06.01 - PREVENTION OF URINARY CATHETER ASSOCIATED INFECTIONS- g13561,False
9639,,Elearning-0000-858,FY2021 NPSG.07.06.01 - PREVENTION OF URINARY CATHETER ASSOCIATED INFECTIONS,,n13561,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 NPSG.07.06.01 - PREVENTION OF URINARY CATHETER ASSOCIATED INFECTIONS CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9639,,Elearning-0000-858,FY2021 NPSG.07.06.01 - PREVENTION OF URINARY CATHETER ASSOCIATED INFECTIONS,,n13561,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 NPSG.07.06.01 - PREVENTION OF URINARY CATHETER ASSOCIATED INFECTIONS CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9639,,Elearning-0000-858,FY2021 NPSG.07.06.01 - PREVENTION OF URINARY CATHETER ASSOCIATED INFECTIONS,,n13561,,choice,What percentage of hospital-acquired UTIs are linked to indwelling urinary catheter use?,a.	30%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9639,,Elearning-0000-858,FY2021 NPSG.07.06.01 - PREVENTION OF URINARY CATHETER ASSOCIATED INFECTIONS,,n13561,,choice,What percentage of hospital-acquired UTIs are linked to indwelling urinary catheter use?,b.	50%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9639,,Elearning-0000-858,FY2021 NPSG.07.06.01 - PREVENTION OF URINARY CATHETER ASSOCIATED INFECTIONS,,n13561,,choice,What percentage of hospital-acquired UTIs are linked to indwelling urinary catheter use?,c.	60%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9639,,Elearning-0000-858,FY2021 NPSG.07.06.01 - PREVENTION OF URINARY CATHETER ASSOCIATED INFECTIONS,,n13561,,choice,What percentage of hospital-acquired UTIs are linked to indwelling urinary catheter use?,d.	80%,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9639,,Elearning-0000-858,FY2021 NPSG.07.06.01 - PREVENTION OF URINARY CATHETER ASSOCIATED INFECTIONS,,n13561,,choice,Complications of CAUTI include:,a.	Increased length of stay by 2-4 days,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9639,,Elearning-0000-858,FY2021 NPSG.07.06.01 - PREVENTION OF URINARY CATHETER ASSOCIATED INFECTIONS,,n13561,,choice,Complications of CAUTI include:,b.	Discomfort and pain to the patient,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9639,,Elearning-0000-858,FY2021 NPSG.07.06.01 - PREVENTION OF URINARY CATHETER ASSOCIATED INFECTIONS,,n13561,,choice,Complications of CAUTI include:,c.	Increased risk of mortality for the patient,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9639,,Elearning-0000-858,FY2021 NPSG.07.06.01 - PREVENTION OF URINARY CATHETER ASSOCIATED INFECTIONS,,n13561,,choice,Complications of CAUTI include:,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9308,,Elearning-0000-557,FY2021 UPDATED ELECTROLYTE REPLACEMENT ORDERS,,n13563,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the FY2021 Updated Electrolyte Replacement Orders CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 UPDATED ELECTROLYTE REPLACEMENT ORDERS- g13563,False
9308,,Elearning-0000-557,FY2021 UPDATED ELECTROLYTE REPLACEMENT ORDERS,,n13563,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the FY2021 Updated Electrolyte Replacement Orders CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9308,,Elearning-0000-557,FY2021 UPDATED ELECTROLYTE REPLACEMENT ORDERS,,n13563,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the FY2021 Updated Electrolyte Replacement Orders CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21- g13564,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9888,,Questions-0000-22,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 4-12-21,,n13564,,choice,How would you improve this class?,"No improvements needed (appropriate content, instructor, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,The application that MUST be utilized to help prevent the creation of duplicate medical records is:,a.	QuadraMed SmartID,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM- g13571,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,The application that MUST be utilized to help prevent the creation of duplicate medical records is:,a.	QuadraMed SmartID,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,The application that MUST be utilized to help prevent the creation of duplicate medical records is:,b.	Powerchart,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,The application that MUST be utilized to help prevent the creation of duplicate medical records is:,c.	WQM,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,The application that MUST be utilized to help prevent the creation of duplicate medical records is:,d.	One Chart,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,"If a duplicate MRN is discovered by Patient Access at the time of registration, the team member should contact Centralized Scheduling (404.851.6577) to have the patient rescheduled under the appropriate MRN.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,"If a duplicate MRN is discovered by Patient Access at the time of registration, the team member should contact Centralized Scheduling (404.851.6577) to have the patient rescheduled under the appropriate MRN.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,The email address used to report multiple MRNs is:,a.	DuplicateFINs@northside.com,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,The email address used to report multiple MRNs is:,b.	NSHDuplicateMRNs@northside.com,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,The email address used to report multiple MRNs is:,c.	DuplicateMRNNotifications@northside.com,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,The email address used to report multiple MRNs is:,d.	PrecertLeadership@northside.com,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,"Tara Daley needs to schedule an appointment at Hamilton Mill Imaging.  When you search for the patient, SmartID populates two green results: one affiliated to NSH Atlanta and the other affiliated to a physician practice.  Which medical record should you schedule the new appointment to according to the images below?",a.	MRN 958563,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,"Tara Daley needs to schedule an appointment at Hamilton Mill Imaging.  When you search for the patient, SmartID populates two green results: one affiliated to NSH Atlanta and the other affiliated to a physician practice.  Which medical record should you schedule the new appointment to according to the images below?",b.	MRN 2248562,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,"Tara Daley needs to schedule an appointment at Hamilton Mill Imaging.  When you search for the patient, SmartID populates two green results: one affiliated to NSH Atlanta and the other affiliated to a physician practice.  Which medical record should you schedule the new appointment to according to the images below?",c.	MRN 1015909,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,"Tara Daley needs to schedule an appointment at Hamilton Mill Imaging.  When you search for the patient, SmartID populates two green results: one affiliated to NSH Atlanta and the other affiliated to a physician practice.  Which medical record should you schedule the new appointment to according to the images below?",d.	Create New,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,"Submitting the duplicate MRN notification will result in the patient's entire medical history, such as documentation, financials, images, etc, being merged.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,"Submitting the duplicate MRN notification will result in the patient's entire medical history, such as documentation, financials, images, etc, being merged.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,"Ben Woods would like to schedule a CT scan at 1100 Forsyth.  When you search the system for him using name, DOB and gender, all of the results come back red.  What does this mean?",a. You entered incorrect search criteria,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,"Ben Woods would like to schedule a CT scan at 1100 Forsyth.  When you search the system for him using name, DOB and gender, all of the results come back red.  What does this mean?",b.	You need to create a new patient because he has never been to any of our facilities,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,"Ben Woods would like to schedule a CT scan at 1100 Forsyth.  When you search the system for him using name, DOB and gender, all of the results come back red.  What does this mean?",c.	These are all duplicate MRNs that need to be merged.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,"Ben Woods would like to schedule a CT scan at 1100 Forsyth.  When you search the system for him using name, DOB and gender, all of the results come back red.  What does this mean?",d.	Both a and c,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,"It is not necessary to follow-up on your merge request.  If you sent it, it will be done.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,"It is not necessary to follow-up on your merge request.  If you sent it, it will be done.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,While scheduling Miranda Pennyworth you notice that she has multiple MRNs.  How do you communicate that these duplicates exist?,a.	You complete the Duplicate MRN form or send an email to @Duplicate MRN Notifications,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,While scheduling Miranda Pennyworth you notice that she has multiple MRNs.  How do you communicate that these duplicates exist?,"b.	You notate Scheduling Comments with Duplicate MRN found, Merge Request Initiated",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,While scheduling Miranda Pennyworth you notice that she has multiple MRNs.  How do you communicate that these duplicates exist?,c.	You carbon copy the Supervisor of the site where the patient is scheduled on the Duplicate merge email,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,While scheduling Miranda Pennyworth you notice that she has multiple MRNs.  How do you communicate that these duplicates exist?,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,Philip Wesley is requesting to schedule at NSH Cherokee.  He has established history at NSH Atlanta and NSH Gwinnett when you search for him.  It is appropriate for you to schedule to this medical record.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9415,,Elearning-0000-654,DUPLICATE MRNS:  HOW TO IDENTIFY AND RESOLVE THEM,,n13571,,choice,Philip Wesley is requesting to schedule at NSH Cherokee.  He has established history at NSH Atlanta and NSH Gwinnett when you search for him.  It is appropriate for you to schedule to this medical record.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Modifier ML is affixed to a charge to communicate the absence of a physician's involvement during a patient encounter.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE- g13576,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Modifier ML is affixed to a charge to communicate the absence of a physician's involvement during a patient encounter.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Modifier ML is affixed to a charge to communicate the absence of a physician's involvement during a patient encounter.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Another name for a Mid-Level Provider is:,A) Medical Doctor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Another name for a Mid-Level Provider is:,B) Medical Assistant,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Another name for a Mid-Level Provider is:,C) Advanced Practice Provider,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Another name for a Mid-Level Provider is:,D) All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Another name for a Mid-Level Provider is:,E) C only,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,The ML modifier dictates how a claim is reimbursed by a payer.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,The ML modifier dictates how a claim is reimbursed by a payer.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Modifier ML is relied upon by the following departments:,A) Revenue Integrity and Compensation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Modifier ML is relied upon by the following departments:,B) Contracting and Productivity Management,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Modifier ML is relied upon by the following departments:,C) Professional Billing Services,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Modifier ML is relied upon by the following departments:,D) A and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Modifier ML is relied upon by the following departments:,E) All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Advance Practice Provider (APP) sees patient in conjunction with MD.  APP documents all elements of encounter with signature.  MD attests to a face to face encounter and documents substantive portion of the visit with signature.  Modifier ML should not be appended.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Advance Practice Provider (APP) sees patient in conjunction with MD.  APP documents all elements of encounter with signature.  MD attests to a face to face encounter and documents substantive portion of the visit with signature.  Modifier ML should not be appended.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,There are no RCx rules established for modifier ML to stop charges needing additional Charge Entry review before submission.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,There are no RCx rules established for modifier ML to stop charges needing additional Charge Entry review before submission.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Advanced Practice Provider (APP) sees patient alone and documents all elements of the encounter with signature.  The MD reviews the note and signs.  Modifier ML should not be appended.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Advanced Practice Provider (APP) sees patient alone and documents all elements of the encounter with signature.  The MD reviews the note and signs.  Modifier ML should not be appended.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,"If the Advanced Practice Provider (APP) is involved in the care of a patient, the APP is always entered as the Rendering and the MD as the Supervising.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,"If the Advanced Practice Provider (APP) is involved in the care of a patient, the APP is always entered as the Rendering and the MD as the Supervising.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,It is not necessary for the Physician (MD) to document their face to face services.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,It is not necessary for the Physician (MD) to document their face to face services.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Which credential(s) represent an Advance Practice Provider:,A) PA,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Which credential(s) represent an Advance Practice Provider:,B) MA,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Which credential(s) represent an Advance Practice Provider:,C) NP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Which credential(s) represent an Advance Practice Provider:,D) A or B,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9734,,Elearning-0000-944,REV INT - MODIFIER ML USE & CHARGE ENTRY GUIDE,,n13576,,choice,Which credential(s) represent an Advance Practice Provider:,E) A or C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,If Advance Directive Form has checked: I have not executed an Advance Directive and do not wish to discuss it further at this time. The nurse will do .....,Nothing needed to do at this time.,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is ADVANCE DIRECTIVE APRIL 2021- g13579,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,If Advance Directive Form has checked: I have not executed an Advance Directive and do not wish to discuss it further at this time. The nurse will do .....,Nothing needed to do at this time.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,If Advance Directive Form has checked: I have not executed an Advance Directive and do not wish to discuss it further at this time. The nurse will do .....,"Sign, date, and time to signify final review has been completed at the bottom of the form.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,If Advance Directive Form has checked: I have not executed an Advance Directive and do not wish to discuss it further at this time. The nurse will do .....,Ask the patient for a copy of their Advance Directive.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,If Advance Directive Form has checked: I have not executed an Advance Directive and do not wish to discuss it further at this time. The nurse will do .....,Call the family and as for copy of Advance Directive.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,If the patient has executed an Advance Directive and says they will provide a copy to Northside Hospital the nurse should make two attempts to get the copy from patient and/or family and document under communications. After two attempts have been documented the nurse will sign the bottom of the Advance Directive form in the chart that it is completed.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,If the patient has executed an Advance Directive and says they will provide a copy to Northside Hospital the nurse should make two attempts to get the copy from patient and/or family and document under communications. After two attempts have been documented the nurse will sign the bottom of the Advance Directive form in the chart that it is completed.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,"If the Advance Directive form is marked that an Advance Directive was provided on a previous admission to Northside Hospital the nurse is required to print a copy of this form, notify the physician that the copy is on the chart and document on the form that the physician was notified.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,"If the Advance Directive form is marked that an Advance Directive was provided on a previous admission to Northside Hospital the nurse is required to print a copy of this form, notify the physician that the copy is on the chart and document on the form that the physician was notified.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,The Advance Directive form in the chart should be reviewed by the nurse during chart check every shift for completion. The form is completed when you see a nurse signature at the bottom of the form.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,The Advance Directive form in the chart should be reviewed by the nurse during chart check every shift for completion. The form is completed when you see a nurse signature at the bottom of the form.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,If a patient is unable to answer any questions about their advance directives the nurse should:,Contact the legal family member if the patient has an advance directive.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,If a patient is unable to answer any questions about their advance directives the nurse should:,Chart unable to complete this information.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,"When a patient has an Advance Directive, the Advance Directive Acknowledgement form must be completed and on the chart along with a copy of the Advance Directive, in order for the Advance Directive Checklist to be complete.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,"When a patient has an Advance Directive, the Advance Directive Acknowledgement form must be completed and on the chart along with a copy of the Advance Directive, in order for the Advance Directive Checklist to be complete.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,Every patient should have an Advance Directive Checklist in the chart and completed.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9582,,Elearning-0000-806,ADVANCE DIRECTIVE APRIL 2021,,n13579,,choice,Every patient should have an Advance Directive Checklist in the chart and completed.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,The OB Hemorrhage Cart is a key component to achieving rapid access to medications supplies needed during a postpartum hemorrhage,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSC OB HEMORRHAGE CART 2021- g13580,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,The OB Hemorrhage Cart is a key component to achieving rapid access to medications supplies needed during a postpartum hemorrhage,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,The OB Hemorrhage Cart is a key component to achieving rapid access to medications supplies needed during a postpartum hemorrhage,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,The OB Hemorrhage Cart is secured by:,A zip tie,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,The OB Hemorrhage Cart is secured by:,2 Digital locks,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,The OB Hemorrhage Cart is secured by:,Red security seal,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,The OB Hemorrhage Cart is secured by:,B and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,The OB Hemorrhage Cart is secured by:,All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,Medications are stored in the OB Hemorrhage Cart,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,Medications are stored in the OB Hemorrhage Cart,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,What color seal should be placed over the lock bar on the cart to indicate is has been opened and cannot be used?,Red,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,What color seal should be placed over the lock bar on the cart to indicate is has been opened and cannot be used?,Yellow,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,What color seal should be placed over the lock bar on the cart to indicate is has been opened and cannot be used?,Green,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,How frequently should the cart thermometer be checked?,Once a day,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,How frequently should the cart thermometer be checked?,Every shift,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,How frequently should the cart thermometer be checked?,Once a week,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,"If a patient is transferred to a higher level of care during use of a hemorrhage cart, the hemorrhage cart should be transferred with the patient.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9038,,Elearning-0000-311,NSC OB HEMORRHAGE CART 2021,,n13580,,choice,"If a patient is transferred to a higher level of care during use of a hemorrhage cart, the hemorrhage cart should be transferred with the patient.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"You are caring for a nulliparous woman in labor that has been AROM 3 hours ago.  She has remained 4 cm during this time. There is a Cat I FHR tracing.  She has been augmented with Pitocin for 2 1/2 hours.  The provider mentioned at the nurse's station that if she does not have cervical change, that she will need a C/S.   Does the patient meet the criteria for having labor dystocia?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is LD FY 2021 NTSV INITIATIVE EDUCATION- g13584,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"You are caring for a nulliparous woman in labor that has been AROM 3 hours ago.  She has remained 4 cm during this time. There is a Cat I FHR tracing.  She has been augmented with Pitocin for 2 1/2 hours.  The provider mentioned at the nurse's station that if she does not have cervical change, that she will need a C/S.   Does the patient meet the criteria for having labor dystocia?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"You are caring for a nulliparous woman in labor that has been AROM 3 hours ago.  She has remained 4 cm during this time. There is a Cat I FHR tracing.  She has been augmented with Pitocin for 2 1/2 hours.  The provider mentioned at the nurse's station that if she does not have cervical change, that she will need a C/S.   Does the patient meet the criteria for having labor dystocia?",No,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"Your patient, J.F., G1 P0, has been admitted for elective induction of labor with Pitocin.   Her admitting cervical exam was 3/80/-1, soft and anterior.  Her membranes were ruptured 18 hours ago and she has been on Pitocin for over 24 hours.  There is a CAT I FHR tracing, and the patient remains afebrile. The provider has diagnosed her as a Failed Elective Induction.  Do you agree?",Yes,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"Your patient, J.F., G1 P0, has been admitted for elective induction of labor with Pitocin.   Her admitting cervical exam was 3/80/-1, soft and anterior.  Her membranes were ruptured 18 hours ago and she has been on Pitocin for over 24 hours.  There is a CAT I FHR tracing, and the patient remains afebrile. The provider has diagnosed her as a Failed Elective Induction.  Do you agree?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,Only mothers with Category III FHR tracings should have a C/S for Fetal Intolerance.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,Only mothers with Category III FHR tracings should have a C/S for Fetal Intolerance.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,What category is this FHR tracing?,Category I,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,What category is this FHR tracing?,Category II,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,What category is this FHR tracing?,Category III,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,What is the FHR variability in this tracing?,Absent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,What is the FHR variability in this tracing?,Minimal,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,What is the FHR variability in this tracing?,Moderate,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,What is the FHR variability in this tracing?,Marked,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"Patient is G1P0, C/C/+1 and is starting to push.  Her temperature is now 37.7 C. (99.9F). Based on the pattern, what conservative corrective measures will you perform?",No corrective measures necessary due to moderate FHRV,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"Patient is G1P0, C/C/+1 and is starting to push.  Her temperature is now 37.7 C. (99.9F). Based on the pattern, what conservative corrective measures will you perform?","Maternal position change, 300-500 ml IVF bolus, and push in the lateral position.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"Patient is G1P0, C/C/+1 and is starting to push.  Her temperature is now 37.7 C. (99.9F). Based on the pattern, what conservative corrective measures will you perform?",Administer terbutaline,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"Patient is G1P0, C/C/+1 and is starting to push.  Her temperature is now 37.7 C. (99.9F). Based on the pattern, what conservative corrective measures will you perform?",Call the provider,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"Patient is G1P0, C/C/+1 and is starting to push.  Her temperature is now 37.7 C. (99.9F). Based on the pattern, what conservative corrective measures will you perform?",Both B&C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"Patient is G1P0, C/C/+1 and is starting to push.  Her temperature is now 37.7 C. (99.9F). Based on the pattern, what conservative corrective measures will you perform?",Both B&D,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"Are there ""Clinically Significant decelerations""� = 50% of contractions?",Yes,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"Are there ""Clinically Significant decelerations""� = 50% of contractions?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"As long as the patient is progressing normally in the second stage, we can observe and continue to push.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"As long as the patient is progressing normally in the second stage, we can observe and continue to push.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"The patent is G2P1 admitted for early labor. Her SVE is 2-3/70/-2.  There is no known maternal or fetal risk factors noted upon admission.  Her last delivery was a NSVD. In the tracing below, is there moderate FHRV or accelerations?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"The patent is G2P1 admitted for early labor. Her SVE is 2-3/70/-2.  There is no known maternal or fetal risk factors noted upon admission.  Her last delivery was a NSVD. In the tracing below, is there moderate FHRV or accelerations?",No,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"In the tracing below, are there clinically significant decelerations with = 50% of contractions?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"In the tracing below, are there clinically significant decelerations with = 50% of contractions?",No,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,Would you perform and conservative corrective measures for this tracing?,"Yes, that is an appropriate action at this point.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,Would you perform and conservative corrective measures for this tracing?,"No, this is a category III tracing and she should be delivered as soon as possible.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"After performing conservative corrective measures, the pattern below persists for an hour. What should the plan of care be?",Observe for an additional hour since she is a multip,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"After performing conservative corrective measures, the pattern below persists for an hour. What should the plan of care be?",Observe for 30 additional minutes since there are no decels,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9222,,Elearning-0000-479,LD FY 2021 NTSV INITIATIVE EDUCATION,,n13584,,choice,"After performing conservative corrective measures, the pattern below persists for an hour. What should the plan of care be?",Move towards cesarean delivery,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9075,,Elearning-0000-345,NSH1287 AMENDMENT 11,,n13585,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSH1287 AMENDMENT 11- g13585,False
9075,,Elearning-0000-345,NSH1287 AMENDMENT 11,,n13585,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9075,,Elearning-0000-345,NSH1287 AMENDMENT 11,,n13585,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9667,,Elearning-0000-883,KRONOS TIME AND ATTENDANCE FOR NEW TIMEKEEPERS,,n13587,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""KRONOS Time and Attendance for New Timekeepers"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is KRONOS TIME AND ATTENDANCE FOR NEW TIMEKEEPERS- g13587,False
9667,,Elearning-0000-883,KRONOS TIME AND ATTENDANCE FOR NEW TIMEKEEPERS,,n13587,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""KRONOS Time and Attendance for New Timekeepers"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9667,,Elearning-0000-883,KRONOS TIME AND ATTENDANCE FOR NEW TIMEKEEPERS,,n13587,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""KRONOS Time and Attendance for New Timekeepers"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9349,,Elearning-0000-594,FY2020-2021 STERILIZER LOAD STICKER & PACKAGE LABELS,,n13589,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2020-2021 STERILIZER LOAD STICKER & PACKAGE LABELS- g13589,False
9349,,Elearning-0000-594,FY2020-2021 STERILIZER LOAD STICKER & PACKAGE LABELS,,n13589,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9349,,Elearning-0000-594,FY2020-2021 STERILIZER LOAD STICKER & PACKAGE LABELS,,n13589,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,"VS, Aldrete Score, and End Tidal CO2 must be assessed q5 minutes during the procedure and 30 minutes post sedation",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSC ICU PROCEDURAL MODERATE SEDATION- g13591,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,"VS, Aldrete Score, and End Tidal CO2 must be assessed q5 minutes during the procedure and 30 minutes post sedation",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,"VS, Aldrete Score, and End Tidal CO2 must be assessed q5 minutes during the procedure and 30 minutes post sedation",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,A large total dose is ordered initially to be given in smaller doses over the entire procedure,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,A large total dose is ordered initially to be given in smaller doses over the entire procedure,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,The RN may administer Propofol pushes when ordered in the procedural sedation power plan,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,The RN may administer Propofol pushes when ordered in the procedural sedation power plan,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,ICU Moderate Sedation Band is where procedural sedation is documented,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,ICU Moderate Sedation Band is where procedural sedation is documented,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,The recovery Aldrete score should be 9 or the patients baseline Aldrete score,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,The recovery Aldrete score should be 9 or the patients baseline Aldrete score,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,The RN must scan each individual dose of Fentanyl during the procedure,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,The RN must scan each individual dose of Fentanyl during the procedure,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,"When Propofol is documented in the MAR, ""performed by"" needs to remain the NAME OF the RN",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,"When Propofol is documented in the MAR, ""performed by"" needs to remain the NAME OF the RN",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,Only some procedures require universal protocol,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,Only some procedures require universal protocol,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,Procedural/Moderate sedation meds should be administered as soon as the powerplan is ordered,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,Procedural/Moderate sedation meds should be administered as soon as the powerplan is ordered,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,"when a patient is on a sedating IV continuous drip, the provider can give an order for the rate to be changed for the procedure",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,"when a patient is on a sedating IV continuous drip, the provider can give an order for the rate to be changed for the procedure",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,"The Aldrete scale is composed of Activity, Respiration, Circulation, Consciousness, and Oxygen Saturation",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,"The Aldrete scale is composed of Activity, Respiration, Circulation, Consciousness, and Oxygen Saturation",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,I have viewed the ICU Moderate Sedation Power Point and workflow video and understand the information presented to me.  I understand that I can go to a Clinician or Leadership team member with questions.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9270,,Elearning-0000-522,NSC ICU PROCEDURAL MODERATE SEDATION,,n13591,,choice,I have viewed the ICU Moderate Sedation Power Point and workflow video and understand the information presented to me.  I understand that I can go to a Clinician or Leadership team member with questions.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,Attempting less restrictive alternatives prior to applying restraints or placing a patient in seclusion is one strategy utilized at Northside Hospital to maintain the patient's rights and dignity?,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES- g13595,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,Attempting less restrictive alternatives prior to applying restraints or placing a patient in seclusion is one strategy utilized at Northside Hospital to maintain the patient's rights and dignity?,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,Attempting less restrictive alternatives prior to applying restraints or placing a patient in seclusion is one strategy utilized at Northside Hospital to maintain the patient's rights and dignity?,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,Mitten(s) are NOT a type of physical restraint,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,Mitten(s) are NOT a type of physical restraint,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,The use of restraints or seclusion is not associated with any potential physical or psychological risk?,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,The use of restraints or seclusion is not associated with any potential physical or psychological risk?,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,"Which situation is a Non-Violent, Non-Self-Destructive indication for restraint use?",a.	A patient with an emotional disorder poses a physical threat to other patients.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,"Which situation is a Non-Violent, Non-Self-Destructive indication for restraint use?",b.	A patient is pulling at his Foley catheter and demonstrates lack of understanding to comply with safety directions.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,"Which situation is a Non-Violent, Non-Self-Destructive indication for restraint use?",c.	A patient with an emotional disorder is attempting to cause physical harm to himself.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,"Which situation is a Non-Violent, Non-Self-Destructive indication for restraint use?",d.	A patient with a behavioral disorder poses a threat to the staff.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,Seclusion is defined as: A patient is involuntarily confined in a room or area from which the patient is physically prevented from leaving AND is alone.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,Seclusion is defined as: A patient is involuntarily confined in a room or area from which the patient is physically prevented from leaving AND is alone.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,"If restraints are removed and staff leave the room, a new order is required to reapply the restraints?",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,"If restraints are removed and staff leave the room, a new order is required to reapply the restraints?",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,"If a patient is temporarily released from restraints or seclusion for the purpose of caring for the patient's needs (i.e. toileting, feeding, bathing, and/or range of motion), a new restraint order is required to resume restraints or seclusion?",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,"If a patient is temporarily released from restraints or seclusion for the purpose of caring for the patient's needs (i.e. toileting, feeding, bathing, and/or range of motion), a new restraint order is required to resume restraints or seclusion?",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,"Which is NOT criteria for initiating Non-Violent, Non-Self-Destructive patient restraints?",a.	Patient is pulling at lines,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,"Which is NOT criteria for initiating Non-Violent, Non-Self-Destructive patient restraints?",b.	Patient is pulling at tubes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,"Which is NOT criteria for initiating Non-Violent, Non-Self-Destructive patient restraints?",c.	Patient wants to get out of bed unattended,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,"Which is NOT criteria for initiating Non-Violent, Non-Self-Destructive patient restraints?",d.	Patient demonstrates lack of understanding to comply with safety directions,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,You are applying soft limb restraints. Which finding indicates that you have NOT safely applied the restraints?,a.	Used the right-sized restraint,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,You are applying soft limb restraints. Which finding indicates that you have NOT safely applied the restraints?,b.	Applied the restraints according to manufacturer's directions,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,You are applying soft limb restraints. Which finding indicates that you have NOT safely applied the restraints?,c.	Secured the restraints to the siderails,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,You are applying soft limb restraints. Which finding indicates that you have NOT safely applied the restraints?,d.	Tied knots so they can be quickly released,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,"Which is NOT criteria for initiating Violent, Self-Destructive patient restraints or seclusion?",a.	Patient is an imminent risk of intentional harm to self,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,"Which is NOT criteria for initiating Violent, Self-Destructive patient restraints or seclusion?",b.	Patient is verbally abusive to staff,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9306,,Elearning-0000-555,FY21 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION FOR INPATIENT REHABILITATIVE SERVICES,,n13595,,choice,"Which is NOT criteria for initiating Violent, Self-Destructive patient restraints or seclusion?",c.	Patient is an imminent risk of intentional harm to others,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9118,,Elearning-0000-384,NSC FCC EXCLUSIVE BREASTFEEDING ROUNDING,,n13601,,choice,I acknowledge that I have read and understand the information provided in the NSC FCC Exclusive Breastfeeding Rounding CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSC FCC EXCLUSIVE BREASTFEEDING ROUNDING- g13601,False
9118,,Elearning-0000-384,NSC FCC EXCLUSIVE BREASTFEEDING ROUNDING,,n13601,,choice,I acknowledge that I have read and understand the information provided in the NSC FCC Exclusive Breastfeeding Rounding CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9118,,Elearning-0000-384,NSC FCC EXCLUSIVE BREASTFEEDING ROUNDING,,n13601,,choice,I acknowledge that I have read and understand the information provided in the NSC FCC Exclusive Breastfeeding Rounding CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,What is considered the normal range for the PR interval?,a.	0.12- 0.20 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL- g13602,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,What is considered the normal range for the PR interval?,a.	0.12- 0.20 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,What is considered the normal range for the PR interval?,b.	0.06- 0.10 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,What is considered the normal range for the PR interval?,c.	0.12- 0.20 seconds,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,What is considered the normal range for the PR interval?,d.	0.06- 0.10 seconds,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,The most appropriate treatment for Torsades de pointes is,"a.	BLS, epinephrine",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,The most appropriate treatment for Torsades de pointes is,b.	Transcutaneous pacing or atropine,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,The most appropriate treatment for Torsades de pointes is,"c.	BLS, defibrillation, epinephrine, amiodarone",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,The most appropriate treatment for Torsades de pointes is,"d.	Magnesium, overdrive pacing, isoproterenol",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,What is considered the normal range for the QT interval?,a.	0.36- 0.44 seconds,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,What is considered the normal range for the QT interval?,b.	0.20- 0.50 seconds,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,What is considered the normal range for the QT interval?,c.	0.50- 0.75 seconds,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,What is considered the normal range for the QT interval?,d.	0.12- 0.20 seconds,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,"According to Evidence-Based Practice for bedside cardiac monitoring , the primary arrhythmia monitoring lead is",a.	Lead II,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,"According to Evidence-Based Practice for bedside cardiac monitoring , the primary arrhythmia monitoring lead is",b.	Lead I,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,"According to Evidence-Based Practice for bedside cardiac monitoring , the primary arrhythmia monitoring lead is",c.	Lead VI,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,"According to Evidence-Based Practice for bedside cardiac monitoring , the primary arrhythmia monitoring lead is",d.	Lead aVF,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,A QRS complex represents,a.	Atrial depolarization,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,A QRS complex represents,b.	Atrial repolarization,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,A QRS complex represents,c.	Ventricular depolarization,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,A QRS complex represents,d.	Ventricular repolarization,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,"You have completed 2 minutes of CPR.  The ECG monitor displays the lead II rhythm shown below, and the patient has no pulse.  What best characterizes this patient's rhythm?",a.	Sinus bradycardia,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,"You have completed 2 minutes of CPR.  The ECG monitor displays the lead II rhythm shown below, and the patient has no pulse.  What best characterizes this patient's rhythm?",b.	Pulseless electrical activity,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,"You have completed 2 minutes of CPR.  The ECG monitor displays the lead II rhythm shown below, and the patient has no pulse.  What best characterizes this patient's rhythm?",c.	Second degree heart block type II,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,"You have completed 2 minutes of CPR.  The ECG monitor displays the lead II rhythm shown below, and the patient has no pulse.  What best characterizes this patient's rhythm?",d.	Third degree heart block,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,"A patient is admitted with a history of congestive heart failure.  The patient is experiencing shortness of breath, a blood pressure of 72/50 mmHg, and a heart rate of 190 beats per minute.  The patient's lead II ECG is displayed below.  What best characterizes the patient's rhythm?",a.	Unstable supraventricular tachycardia,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,"A patient is admitted with a history of congestive heart failure.  The patient is experiencing shortness of breath, a blood pressure of 72/50 mmHg, and a heart rate of 190 beats per minute.  The patient's lead II ECG is displayed below.  What best characterizes the patient's rhythm?",b.	Stable supraventricular tachycardia,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,"A patient is admitted with a history of congestive heart failure.  The patient is experiencing shortness of breath, a blood pressure of 72/50 mmHg, and a heart rate of 190 beats per minute.  The patient's lead II ECG is displayed below.  What best characterizes the patient's rhythm?",c.	Ventricular tachycardia,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,"A patient is admitted with a history of congestive heart failure.  The patient is experiencing shortness of breath, a blood pressure of 72/50 mmHg, and a heart rate of 190 beats per minute.  The patient's lead II ECG is displayed below.  What best characterizes the patient's rhythm?",d.	Sinus tachycardia,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,You are caring for a patient with a temporary Transvenous pacemaker.  What best characterizes the Lead II ECG displayed?,a.	Failure to fire,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,You are caring for a patient with a temporary Transvenous pacemaker.  What best characterizes the Lead II ECG displayed?,b.	Failure to capture,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,You are caring for a patient with a temporary Transvenous pacemaker.  What best characterizes the Lead II ECG displayed?,c.	Failure to sense,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,You are caring for a patient with a temporary Transvenous pacemaker.  What best characterizes the Lead II ECG displayed?,d.	Oversensing,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,A patient has no pulse and is a witnessed loss of consciousness.  The lead II ECG reveals this rhythm.  Which is the appropriate treatment for the rhythm displayed?,a.	Defibrillation,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,A patient has no pulse and is a witnessed loss of consciousness.  The lead II ECG reveals this rhythm.  Which is the appropriate treatment for the rhythm displayed?,b.	Synchronized cardioversion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,A patient has no pulse and is a witnessed loss of consciousness.  The lead II ECG reveals this rhythm.  Which is the appropriate treatment for the rhythm displayed?,c.	Administration of adenosine 12 mg IV push,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9927,,Questions-0000-61,FY2021 NSF ICU EKG INTERPRETATION ASSESSMENT CBL,,n13602,,choice,A patient has no pulse and is a witnessed loss of consciousness.  The lead II ECG reveals this rhythm.  Which is the appropriate treatment for the rhythm displayed?,d.	Administration of atropine 0.5mg IV push,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9365,,Elearning-0000-609,LD FY 2021 ORDER TYPES CLARIFICATION,,n13604,,choice,What types of orders should be placed on ALL patients at admission and do not require a provider to give the orders first?,Labor or Antepartum Order Sets,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is LD FY 2021 ORDER TYPES CLARIFICATION- g13604,False
9365,,Elearning-0000-609,LD FY 2021 ORDER TYPES CLARIFICATION,,n13604,,choice,What types of orders should be placed on ALL patients at admission and do not require a provider to give the orders first?,Labor or Antepartum Order Sets,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9365,,Elearning-0000-609,LD FY 2021 ORDER TYPES CLARIFICATION,,n13604,,choice,What types of orders should be placed on ALL patients at admission and do not require a provider to give the orders first?,Labor and Delivery Nurse Initiated Standing Orders,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9365,,Elearning-0000-609,LD FY 2021 ORDER TYPES CLARIFICATION,,n13604,,choice,What types of orders should be placed on ALL patients at admission and do not require a provider to give the orders first?,Hypertensive Regimen Orders,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9365,,Elearning-0000-609,LD FY 2021 ORDER TYPES CLARIFICATION,,n13604,,choice,What types of orders should be placed on ALL patients at admission and do not require a provider to give the orders first?,HIV communication orders,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9365,,Elearning-0000-609,LD FY 2021 ORDER TYPES CLARIFICATION,,n13604,,choice,"Your patient has a BP 167/92. Fifteen minutes later, you repeat her BP and the result is 174/98. You call the provider at home and she orders the Hydralazine regimen. What order type will you put for this order?",Verbal,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9365,,Elearning-0000-609,LD FY 2021 ORDER TYPES CLARIFICATION,,n13604,,choice,"Your patient has a BP 167/92. Fifteen minutes later, you repeat her BP and the result is 174/98. You call the provider at home and she orders the Hydralazine regimen. What order type will you put for this order?",Telephone,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9365,,Elearning-0000-609,LD FY 2021 ORDER TYPES CLARIFICATION,,n13604,,choice,"Your patient has a BP 167/92. Fifteen minutes later, you repeat her BP and the result is 174/98. You call the provider at home and she orders the Hydralazine regimen. What order type will you put for this order?",Protocol,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9365,,Elearning-0000-609,LD FY 2021 ORDER TYPES CLARIFICATION,,n13604,,choice,"Your patient has a BP 167/92. Fifteen minutes later, you repeat her BP and the result is 174/98. You call the provider at home and she orders the Hydralazine regimen. What order type will you put for this order?",Standing,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9365,,Elearning-0000-609,LD FY 2021 ORDER TYPES CLARIFICATION,,n13604,,choice,"Your patient is a walk in with no prenatal care and has the ""OB Labor Admission Acute NSH"" order set placed in Cerner. When you are drawing her bloodwork, you draw a Hepatitis B lab per the communication order in the order set. When you enter the order for ""Hepatitis B Surface Antigen,"" what order type will you place this under?",Telephone (because that's how the provider placed the initial communication order in the order set),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9365,,Elearning-0000-609,LD FY 2021 ORDER TYPES CLARIFICATION,,n13604,,choice,"Your patient is a walk in with no prenatal care and has the ""OB Labor Admission Acute NSH"" order set placed in Cerner. When you are drawing her bloodwork, you draw a Hepatitis B lab per the communication order in the order set. When you enter the order for ""Hepatitis B Surface Antigen,"" what order type will you place this under?",Protocol (because it's already been ordered by the provider and this order is completing the protocol),True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9365,,Elearning-0000-609,LD FY 2021 ORDER TYPES CLARIFICATION,,n13604,,choice,"Your patient is a walk in with no prenatal care and has the ""OB Labor Admission Acute NSH"" order set placed in Cerner. When you are drawing her bloodwork, you draw a Hepatitis B lab per the communication order in the order set. When you enter the order for ""Hepatitis B Surface Antigen,"" what order type will you place this under?",Standing (because the order is already standing and we are just activating it),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9365,,Elearning-0000-609,LD FY 2021 ORDER TYPES CLARIFICATION,,n13604,,choice,"Your patient is a walk in with no prenatal care and has the ""OB Labor Admission Acute NSH"" order set placed in Cerner. When you are drawing her bloodwork, you draw a Hepatitis B lab per the communication order in the order set. When you enter the order for ""Hepatitis B Surface Antigen,"" what order type will you place this under?",Verbal (because it's first on the list and any type is fine in this case),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,I have read and understood the content within the FCC Postpartum Hemorrhage Education CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FCC POSTPARTUM HEMORRHAGE CART EDUCATION- g13608,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,I have read and understood the content within the FCC Postpartum Hemorrhage Education CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,I have read and understood the content within the FCC Postpartum Hemorrhage Education CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,1.	The location where all of the carts will be include:,a)	1st floor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,1.	The location where all of the carts will be include:,b)	4th floor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,1.	The location where all of the carts will be include:,c)	5th floor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,1.	The location where all of the carts will be include:,d)	6th floor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,1.	The location where all of the carts will be include:,"e)	FCC, HRP, and L&D",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,2.	The Jada system and BT Balloon will be used in all of Women's Services:,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,2.	The Jada system and BT Balloon will be used in all of Women's Services:,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,3.	Bleach and hydrogen peroxide wipe can be used to clean the hemorrhage cart:,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,3.	Bleach and hydrogen peroxide wipe can be used to clean the hemorrhage cart:,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,4.	 The hemorrhage cart checklist should be complete how often by the supervisor or charge nurse:,a)	Once a day,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,4.	 The hemorrhage cart checklist should be complete how often by the supervisor or charge nurse:,b)	Every shift,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,4.	 The hemorrhage cart checklist should be complete how often by the supervisor or charge nurse:,c)	Once a month,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,4.	 The hemorrhage cart checklist should be complete how often by the supervisor or charge nurse:,d)	Once a week,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,5.	You can lock the QBL scale drawer open by:,a)	Pulling the red latch up,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,5.	You can lock the QBL scale drawer open by:,b)	Pushing the red latch down,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,5.	You can lock the QBL scale drawer open by:,c)	Leaving the red latch alone,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,6.	Drawer 2 contains which medical items:,a)	Refrigerated medications- Methergine and Hemabate,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,6.	Drawer 2 contains which medical items:,b)	IV start kits and needles,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,6.	Drawer 2 contains which medical items:,c)	IV tubing,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,6.	Drawer 2 contains which medical items:,"d)	Straight catheter, Foley catheter, and BT catheter",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,7.	Drawer 7 contains which medical items:,a)	IV tubing,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,7.	Drawer 7 contains which medical items:,"b)	Straight catheter, Foley catheter, and BT catheter",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,7.	Drawer 7 contains which medical items:,"c)	Blue Chux pads, Linens bags, biohazard bags, surgical gowns, and pads",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,7.	Drawer 7 contains which medical items:,d)	JADA system,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,"8.	Every OB hemorrhage Cart will have cart number that goes along with a binder, that's at sits on the top of the cart:",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,"8.	Every OB hemorrhage Cart will have cart number that goes along with a binder, that's at sits on the top of the cart:",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,9.	The QBL scale will measured in Kg but will need to be calculated in ____ for the QBL calculator:,a)	Pounds,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,9.	The QBL scale will measured in Kg but will need to be calculated in ____ for the QBL calculator:,b)	Grams,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,9.	The QBL scale will measured in Kg but will need to be calculated in ____ for the QBL calculator:,c)	Kilograms,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,9.	The QBL scale will measured in Kg but will need to be calculated in ____ for the QBL calculator:,d)	Liters,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,10.	All bloody items will be placed in the Joey Pouch for measurement and then placed in a linen bag or a biohazard bag:,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,10.	All bloody items will be placed in the Joey Pouch for measurement and then placed in a linen bag or a biohazard bag:,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,11.	Green used tape will be placed over the lock bar when returning the cart to Central Distribution:,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,11.	Green used tape will be placed over the lock bar when returning the cart to Central Distribution:,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,12.	FCC will be responsible for contacting Central Distribution to obtain a new cart for the unit:,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,12.	FCC will be responsible for contacting Central Distribution to obtain a new cart for the unit:,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,13.	Hemorrhage carts should be plugged into a regular outlet when not in use on the units:,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,13.	Hemorrhage carts should be plugged into a regular outlet when not in use on the units:,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,"14.	All carts will be secured with  red security seal tape, which indicates it's a new, unused cart:",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,"14.	All carts will be secured with  red security seal tape, which indicates it's a new, unused cart:",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,15.	If the  patient is transferred to another unit(mainly L&D) the cart will be transferred to L&D with the patient:,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,15.	If the  patient is transferred to another unit(mainly L&D) the cart will be transferred to L&D with the patient:,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,16.	A medication charge sheet will be placed in which drawer:,a)	Drawer 1,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,16.	A medication charge sheet will be placed in which drawer:,b)	Drawer 2,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,16.	A medication charge sheet will be placed in which drawer:,c)	Drawer 3,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
226,,SCORM-0000-32,FCC POSTPARTUM HEMORRHAGE CART EDUCATION,,n13608,,choice,16.	A medication charge sheet will be placed in which drawer:,d)	Drawer 4,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Immune-related endocrinopathies caused by checkpoint inhibitor immunotherapy typically present with nonspecific symptoms. These may include all of the follow except:,a.	Hypotension,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES- g13614,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Immune-related endocrinopathies caused by checkpoint inhibitor immunotherapy typically present with nonspecific symptoms. These may include all of the follow except:,a.	Hypotension,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Immune-related endocrinopathies caused by checkpoint inhibitor immunotherapy typically present with nonspecific symptoms. These may include all of the follow except:,b.	Excessive sweating,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Immune-related endocrinopathies caused by checkpoint inhibitor immunotherapy typically present with nonspecific symptoms. These may include all of the follow except:,c.	Fatigue,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Immune-related endocrinopathies caused by checkpoint inhibitor immunotherapy typically present with nonspecific symptoms. These may include all of the follow except:,d.	Hair Loss,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Immune-related endocrinopathies caused by checkpoint inhibitor immunotherapy typically present with nonspecific symptoms. These may include all of the follow except:,e.	Abnormal thyroid test,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,A patient with advanced renal cell carcinoma presents to your clinic for treatment today. The patient has been receiving nivolumab 240mg IV q 2 weeks for the past 20 weeks. You observe that the patient's AST/ALT have risen by more than 5 x ULN and you inform the provider. Which of the following are all appropriate for management of this potential immune-mediated adverse reaction to nivolumab?,a.	Discontinue nivolumab and consult Gastroenterology,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,A patient with advanced renal cell carcinoma presents to your clinic for treatment today. The patient has been receiving nivolumab 240mg IV q 2 weeks for the past 20 weeks. You observe that the patient's AST/ALT have risen by more than 5 x ULN and you inform the provider. Which of the following are all appropriate for management of this potential immune-mediated adverse reaction to nivolumab?,b.	Initiate high dose steroids followed by infliximab,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,A patient with advanced renal cell carcinoma presents to your clinic for treatment today. The patient has been receiving nivolumab 240mg IV q 2 weeks for the past 20 weeks. You observe that the patient's AST/ALT have risen by more than 5 x ULN and you inform the provider. Which of the following are all appropriate for management of this potential immune-mediated adverse reaction to nivolumab?,c.	Initiate prednisone 1-2mg/kg/day follow by corticosteroid taper and consider mycophenolate for persistent severe hepatitis despite high dose corticosteroids.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,A patient with advanced renal cell carcinoma presents to your clinic for treatment today. The patient has been receiving nivolumab 240mg IV q 2 weeks for the past 20 weeks. You observe that the patient's AST/ALT have risen by more than 5 x ULN and you inform the provider. Which of the following are all appropriate for management of this potential immune-mediated adverse reaction to nivolumab?,d.	A and C only,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,A patient with advanced renal cell carcinoma presents to your clinic for treatment today. The patient has been receiving nivolumab 240mg IV q 2 weeks for the past 20 weeks. You observe that the patient's AST/ALT have risen by more than 5 x ULN and you inform the provider. Which of the following are all appropriate for management of this potential immune-mediated adverse reaction to nivolumab?,e.	All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Diarrhea is a more common complaint with the use of CTLA-4 inhibitor versus an anti-PD1.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Diarrhea is a more common complaint with the use of CTLA-4 inhibitor versus an anti-PD1.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,How often should TSH and FT4 be monitored while a patient is receiving immunotherapy,a.	At baseline and then every 12 weeks during immunotherapy,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,How often should TSH and FT4 be monitored while a patient is receiving immunotherapy,b.	Prior to initiating immunotherapy only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,How often should TSH and FT4 be monitored while a patient is receiving immunotherapy,c.	At baseline and every 4-6 weeks for all immunotherapy,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,How often should TSH and FT4 be monitored while a patient is receiving immunotherapy,d.	At baseline and with each dose of ipilimumab,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Pneumonitis is an uncommon but potentially fatal complication of treatment with checkpoint inhibitor immunotherapy. Signs and symptoms of pneumonitis may include:,a.	Cough and SOB,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Pneumonitis is an uncommon but potentially fatal complication of treatment with checkpoint inhibitor immunotherapy. Signs and symptoms of pneumonitis may include:,b.	Radiographic changes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Pneumonitis is an uncommon but potentially fatal complication of treatment with checkpoint inhibitor immunotherapy. Signs and symptoms of pneumonitis may include:,c.	Chest pain,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Pneumonitis is an uncommon but potentially fatal complication of treatment with checkpoint inhibitor immunotherapy. Signs and symptoms of pneumonitis may include:,d.	Fever,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Pneumonitis is an uncommon but potentially fatal complication of treatment with checkpoint inhibitor immunotherapy. Signs and symptoms of pneumonitis may include:,e.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Most immune-related adverse events associated with checkpoint inhibitor immunotherapy occur immediately after the first dose.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Most immune-related adverse events associated with checkpoint inhibitor immunotherapy occur immediately after the first dose.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,"A 65 year old female patient with metastatic gastric cancer presents to your clinic for evaluation due to complaints of frequent diarrhea. After further questioning, she reports approximately 4 loose stools each day beginning three days ago. She is receiving treatment with pembrolizumab 200mg every 3 weeks with the last treatment date being one week ago. What is the most appropriate management of this Grade 2 irAE?",a.	Hold pembrolizumab and initiate IV methylprednisolone 1mg/kg/day,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,"A 65 year old female patient with metastatic gastric cancer presents to your clinic for evaluation due to complaints of frequent diarrhea. After further questioning, she reports approximately 4 loose stools each day beginning three days ago. She is receiving treatment with pembrolizumab 200mg every 3 weeks with the last treatment date being one week ago. What is the most appropriate management of this Grade 2 irAE?","b.	If there is no response after starting IV steroids in 2-3 days, may increase dose to 2mg/kg/day. Change to prednisone when appropriate",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,"A 65 year old female patient with metastatic gastric cancer presents to your clinic for evaluation due to complaints of frequent diarrhea. After further questioning, she reports approximately 4 loose stools each day beginning three days ago. She is receiving treatment with pembrolizumab 200mg every 3 weeks with the last treatment date being one week ago. What is the most appropriate management of this Grade 2 irAE?",c.	Treat with steroids until symptoms improve to Grade 1 or less. Permanently discontinue pembrolizumab.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,"A 65 year old female patient with metastatic gastric cancer presents to your clinic for evaluation due to complaints of frequent diarrhea. After further questioning, she reports approximately 4 loose stools each day beginning three days ago. She is receiving treatment with pembrolizumab 200mg every 3 weeks with the last treatment date being one week ago. What is the most appropriate management of this Grade 2 irAE?",d.	Never treat gastrointestinal adverse events with infliximab.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,"A 65 year old female patient with metastatic gastric cancer presents to your clinic for evaluation due to complaints of frequent diarrhea. After further questioning, she reports approximately 4 loose stools each day beginning three days ago. She is receiving treatment with pembrolizumab 200mg every 3 weeks with the last treatment date being one week ago. What is the most appropriate management of this Grade 2 irAE?",e.	A and B,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Ocular toxicity is the most common immune-related adverse event associated with checkpoint inhibitors.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Ocular toxicity is the most common immune-related adverse event associated with checkpoint inhibitors.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Successful management of immune checkpoint inhibitor toxicities require:,"a.	Excellent patient-provider communication, early diagnosis, and rapid use of corticosteroids.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Successful management of immune checkpoint inhibitor toxicities require:,b.	Premedication in the form of a corticosteroid prior to administration of any checkpoint inhibitor immunotherapy.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Successful management of immune checkpoint inhibitor toxicities require:,c.	Patients to report symptoms of potential toxicities once the patient does not show any improvement after 5 days of those specific symptoms,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Successful management of immune checkpoint inhibitor toxicities require:,d.	None of the above.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Adverse events from immunotherapy differ from conventional chemotherapy and can affect one or several different organ systems. This is due to the differences between immunotherapy and cytotoxic chemotherapy___________.,a.	Pharmacokinetics,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Adverse events from immunotherapy differ from conventional chemotherapy and can affect one or several different organ systems. This is due to the differences between immunotherapy and cytotoxic chemotherapy___________.,b.	Mechanism of Action,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Adverse events from immunotherapy differ from conventional chemotherapy and can affect one or several different organ systems. This is due to the differences between immunotherapy and cytotoxic chemotherapy___________.,c.	Dosing,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9736,,Elearning-0000-946,2021 MANAGEMENT OF IMMUNOTHERAPY RELATED TOXICITIES,,n13614,,choice,Adverse events from immunotherapy differ from conventional chemotherapy and can affect one or several different organ systems. This is due to the differences between immunotherapy and cytotoxic chemotherapy___________.,d.	Administration,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9642,,Elearning-0000-860,FY2021 SURGICAL SERVICES: PRESSURE INJURY PREVENTION,,n13615,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 SURGICAL SERVICES: PRESSURE INJURY PREVENTION"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 SURGICAL SERVICES: PRESSURE INJURY PREVENTION- g13615,False
9642,,Elearning-0000-860,FY2021 SURGICAL SERVICES: PRESSURE INJURY PREVENTION,,n13615,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 SURGICAL SERVICES: PRESSURE INJURY PREVENTION"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9642,,Elearning-0000-860,FY2021 SURGICAL SERVICES: PRESSURE INJURY PREVENTION,,n13615,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 SURGICAL SERVICES: PRESSURE INJURY PREVENTION"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9185,,Elearning-0000-445,FY2021 SURGICAL SERVICES MH FOR NON RN SURGICAL SERVICES,,n13619,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the FY2021 Surgical Services MH For Non RN Surgical Services  CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 SURGICAL SERVICES MH FOR NON RN SURGICAL SERVICES- g13619,False
9185,,Elearning-0000-445,FY2021 SURGICAL SERVICES MH FOR NON RN SURGICAL SERVICES,,n13619,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the FY2021 Surgical Services MH For Non RN Surgical Services  CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9185,,Elearning-0000-445,FY2021 SURGICAL SERVICES MH FOR NON RN SURGICAL SERVICES,,n13619,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the FY2021 Surgical Services MH For Non RN Surgical Services  CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21- g13620,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand the importance of creating a special and sacred experience for a bereaved family.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand the importance of creating a special and sacred experience for a bereaved family.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand the importance of creating a special and sacred experience for a bereaved family.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand the importance of creating a special and sacred experience for a bereaved family.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand the importance of creating a special and sacred experience for a bereaved family.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the importance of a caregiver's hands, as well as the work that they do.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the importance of a caregiver's hands, as well as the work that they do.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the importance of a caregiver's hands, as well as the work that they do.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the importance of a caregiver's hands, as well as the work that they do.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the importance of a caregiver's hands, as well as the work that they do.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list reasons why keepsakes and photography are an important part of the healing journey.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list reasons why keepsakes and photography are an important part of the healing journey.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list reasons why keepsakes and photography are an important part of the healing journey.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list reasons why keepsakes and photography are an important part of the healing journey.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list reasons why keepsakes and photography are an important part of the healing journey.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand policies and procedures regarding paperwork needed following a perinatal loss.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand policies and procedures regarding paperwork needed following a perinatal loss.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand policies and procedures regarding paperwork needed following a perinatal loss.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand policies and procedures regarding paperwork needed following a perinatal loss.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand policies and procedures regarding paperwork needed following a perinatal loss.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate ways to create an environment that is conducive to keepsake and photography collection.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate ways to create an environment that is conducive to keepsake and photography collection.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate ways to create an environment that is conducive to keepsake and photography collection.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate ways to create an environment that is conducive to keepsake and photography collection.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate ways to create an environment that is conducive to keepsake and photography collection.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate ways to create an environment that is conducive to keepsake and photography collection.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate ways to create an environment that is conducive to keepsake and photography collection.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate ways to create an environment that is conducive to keepsake and photography collection.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate ways to create an environment that is conducive to keepsake and photography collection.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate ways to create an environment that is conducive to keepsake and photography collection.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state reasons why bereavement photography is important to bereaved families and understand NSH policies and procedures related to bereavement photography.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state reasons why bereavement photography is important to bereaved families and understand NSH policies and procedures related to bereavement photography.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state reasons why bereavement photography is important to bereaved families and understand NSH policies and procedures related to bereavement photography.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state reasons why bereavement photography is important to bereaved families and understand NSH policies and procedures related to bereavement photography.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state reasons why bereavement photography is important to bereaved families and understand NSH policies and procedures related to bereavement photography.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand of the perspective of a bereaved parent.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand of the perspective of a bereaved parent.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand of the perspective of a bereaved parent.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand of the perspective of a bereaved parent.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand of the perspective of a bereaved parent.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the importance of working as a team in providing quality patient care.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the importance of working as a team in providing quality patient care.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the importance of working as a team in providing quality patient care.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the importance of working as a team in providing quality patient care.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the importance of working as a team in providing quality patient care.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge base related to perinatal bereavement care. </OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge base related to perinatal bereavement care. </OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge base related to perinatal bereavement care. </OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge base related to perinatal bereavement care. </OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge base related to perinatal bereavement care. </OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my comfort level when caring for families experiencing a perinatal loss.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my comfort level when caring for families experiencing a perinatal loss.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my comfort level when caring for families experiencing a perinatal loss.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my comfort level when caring for families experiencing a perinatal loss.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my comfort level when caring for families experiencing a perinatal loss.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Melissa Peterson</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Melissa Peterson</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Melissa Peterson</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Melissa Peterson</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Melissa Peterson</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Brigette Harbour, MSN, RN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Brigette Harbour, MSN, RN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Brigette Harbour, MSN, RN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Brigette Harbour, MSN, RN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Brigette Harbour, MSN, RN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Sandra Cramer</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Sandra Cramer</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Sandra Cramer</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Sandra Cramer</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Sandra Cramer</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper preparation of a baby for the morgue, as well as for retrieval of a baby for viewing.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper preparation of a baby for the morgue, as well as for retrieval of a baby for viewing.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper preparation of a baby for the morgue, as well as for retrieval of a baby for viewing.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper preparation of a baby for the morgue, as well as for retrieval of a baby for viewing.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9850,,Questions-0000-141,SACRED WORK: THE BEAUTY OF CARING FOR PERINATAL LOSS FAMILIES_ 2021 (EVALUATION SURVEY)  4.27.21,,n13620,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper preparation of a baby for the morgue, as well as for retrieval of a baby for viewing.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Patient MS was diagnosed with Chronic Lymphocytic Leukemia and is in to receive her 1st treatment of GAZYVA. How much of the 1000mg will she be given on days 1 & 2 respectively?,A.	200m & 800mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE- g13622,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Patient MS was diagnosed with Chronic Lymphocytic Leukemia and is in to receive her 1st treatment of GAZYVA. How much of the 1000mg will she be given on days 1 & 2 respectively?,A.	200m & 800mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Patient MS was diagnosed with Chronic Lymphocytic Leukemia and is in to receive her 1st treatment of GAZYVA. How much of the 1000mg will she be given on days 1 & 2 respectively?,B.	100mg & 900mg,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Patient MS was diagnosed with Chronic Lymphocytic Leukemia and is in to receive her 1st treatment of GAZYVA. How much of the 1000mg will she be given on days 1 & 2 respectively?,C.	600mg & 400mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Patient MS was diagnosed with Chronic Lymphocytic Leukemia and is in to receive her 1st treatment of GAZYVA. How much of the 1000mg will she be given on days 1 & 2 respectively?,D.	300mg & 700mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,YERVOY is available in MDV sizes of 50 mg and 200mg.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,YERVOY is available in MDV sizes of 50 mg and 200mg.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,All of the following medications are available as RTU (ready to use) except:,A.	Empliciti,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,All of the following medications are available as RTU (ready to use) except:,B.	Perjeta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,All of the following medications are available as RTU (ready to use) except:,C.	Bavencio,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,All of the following medications are available as RTU (ready to use) except:,D.	Darzalex,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,A loading dose is required by Herceptin Hylecta?,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,A loading dose is required by Herceptin Hylecta?,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Physician orders Cyramza 700 mg IV in NS 250ml for a patient.  How much fluid should the IA withdraw from the IV bag before adding the Cyramza?,A.	None,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Physician orders Cyramza 700 mg IV in NS 250ml for a patient.  How much fluid should the IA withdraw from the IV bag before adding the Cyramza?,B.	70mLs,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Physician orders Cyramza 700 mg IV in NS 250ml for a patient.  How much fluid should the IA withdraw from the IV bag before adding the Cyramza?,C.	45mLs,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Physician orders Cyramza 700 mg IV in NS 250ml for a patient.  How much fluid should the IA withdraw from the IV bag before adding the Cyramza?,D.	15mls,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Pharmacy received an order for Darzalex in D5W for IV infusion for a patient that is diabetic. Why does the Pharmacist need to call Physician to change order?,A.	Diabetic patients can NOT receive D5W infusion due to risk of high blood sugar after Infusion.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Pharmacy received an order for Darzalex in D5W for IV infusion for a patient that is diabetic. Why does the Pharmacist need to call Physician to change order?,B.	Darzalex can only be mixed with 0.9% NS.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Pharmacy received an order for Darzalex in D5W for IV infusion for a patient that is diabetic. Why does the Pharmacist need to call Physician to change order?,C.	Pharmacist does not have to call Physician for any of the above reasons.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Which is the following statements is NOT correct about Imfinzi ?,a.	It requires an in-line filter for Infusion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Which is the following statements is NOT correct about Imfinzi ?,b.	It is stable for 24 hours at room temperature after dilution,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Which is the following statements is NOT correct about Imfinzi ?,c.	Imfinzi vials should be kept refrigerated and in original package until dilution,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Which is the following statements is NOT correct about Imfinzi ?,d.	It comes in 2 vials sizes of 120 and 500 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Which checkpoint inhibitor is NOT an anti-PDL1 medication?,a.	Keytruda,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Which checkpoint inhibitor is NOT an anti-PDL1 medication?,b.	Imfinzi,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Which checkpoint inhibitor is NOT an anti-PDL1 medication?,c.	Bavencio,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Which checkpoint inhibitor is NOT an anti-PDL1 medication?,d.	Tecentriq,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Which checkpoint inhibitor does not require a filter?,a.	Keytruda,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Which checkpoint inhibitor does not require a filter?,b.	Opdivo,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Which checkpoint inhibitor does not require a filter?,c.	Tecentriq,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Which checkpoint inhibitor does not require a filter?,d.	Libtayo,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Adcetris is,a.	Available as SDV of 50mg lyophilized powder,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Adcetris is,b.	Indicated for Hodgkin's lymphoma,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Adcetris is,c.	Mixed in Normal Saline,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9737,,Elearning-0000-947,2021 IMMUNOTHERAPY FROM THE IA PERSPECTIVE,,n13622,,choice,Adcetris is,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,It is acceptable to return cold medication stock to the GCS annex on Fridays.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- g13623,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,It is acceptable to return cold medication stock to the GCS annex on Fridays.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,It is acceptable to return cold medication stock to the GCS annex on Fridays.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,Pharmacy technician should complete a full Nucleus inventory of all medications at minimum every ______.,a.	Day,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,Pharmacy technician should complete a full Nucleus inventory of all medications at minimum every ______.,b.	Other month,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,Pharmacy technician should complete a full Nucleus inventory of all medications at minimum every ______.,c.	Month,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,Pharmacy technician should complete a full Nucleus inventory of all medications at minimum every ______.,d.	Year,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,Which is not a benefit of managing inventory?,a.	Decreased inventory cost,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,Which is not a benefit of managing inventory?,b.	Minimizing drug waste,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,Which is not a benefit of managing inventory?,c.	Increased inventory turnover,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,Which is not a benefit of managing inventory?,d.	Increased quantity of expired drugs,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,"Drugs that will expire in _____ months or less with no current patient needs should be sent back to annex ( GCS) or redistributed ( ACC, NGDC, SHOA)",a.	3,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,"Drugs that will expire in _____ months or less with no current patient needs should be sent back to annex ( GCS) or redistributed ( ACC, NGDC, SHOA)",b.	2,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,"Drugs that will expire in _____ months or less with no current patient needs should be sent back to annex ( GCS) or redistributed ( ACC, NGDC, SHOA)",c.	6,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,"Drugs that will expire in _____ months or less with no current patient needs should be sent back to annex ( GCS) or redistributed ( ACC, NGDC, SHOA)",d.	4,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,Irinotecan 250mg dose is ordered.  Which is the optimal vial size combination to minimize waste?,a.	2 x 100mg + 2 x 40mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,Irinotecan 250mg dose is ordered.  Which is the optimal vial size combination to minimize waste?,b.	1 x 100mg + 4 x 40mg,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,The product expiration report may be used to identify expiring items within 3 months.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,The product expiration report may be used to identify expiring items within 3 months.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,"Medication should be ordered 5 days prior to treatment for GCS and 2 days prior to treatment for ACC, NGDC, and SHOA.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,"Medication should be ordered 5 days prior to treatment for GCS and 2 days prior to treatment for ACC, NGDC, and SHOA.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,Pharmacy staff should plan 3-4 additional days out for holiday closures and inclement weather and other shipping delays.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,Pharmacy staff should plan 3-4 additional days out for holiday closures and inclement weather and other shipping delays.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,Auto reorder is a useful tool for managing fast moving items.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,Auto reorder is a useful tool for managing fast moving items.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,"When restocking and dispensing medication, pharmacy technician should verify:",a.	NDC#,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,"When restocking and dispensing medication, pharmacy technician should verify:",b.	Lot #,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,"When restocking and dispensing medication, pharmacy technician should verify:",c.	Expiration date,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9726,,Elearning-0000-937,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,,n13623,,choice,"When restocking and dispensing medication, pharmacy technician should verify:",d.	All the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9309,,Elearning-0000-558,FY2021 SURGICAL SERVICES: ISOLATION - ANESTHESIA TECHS,,n13626,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 SURGICAL SERVICES ISOLATION - ANESTHESIA TECHS"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 SURGICAL SERVICES: ISOLATION - ANESTHESIA TECHS- g13626,False
9309,,Elearning-0000-558,FY2021 SURGICAL SERVICES: ISOLATION - ANESTHESIA TECHS,,n13626,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 SURGICAL SERVICES ISOLATION - ANESTHESIA TECHS"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9309,,Elearning-0000-558,FY2021 SURGICAL SERVICES: ISOLATION - ANESTHESIA TECHS,,n13626,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 SURGICAL SERVICES ISOLATION - ANESTHESIA TECHS"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9620,,Elearning-0000-840,"FY2021 SURGICAL SERVICES: TEMPERATURE, HUMIDITY AND AIRFLOW",,n13627,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 Surgical Services: Temperature, Humidity and Airflow"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,"Duplicate Test. Existing test is FY2021 SURGICAL SERVICES: TEMPERATURE, HUMIDITY AND AIRFLOW- g13627",False
9620,,Elearning-0000-840,"FY2021 SURGICAL SERVICES: TEMPERATURE, HUMIDITY AND AIRFLOW",,n13627,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 Surgical Services: Temperature, Humidity and Airflow"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9620,,Elearning-0000-840,"FY2021 SURGICAL SERVICES: TEMPERATURE, HUMIDITY AND AIRFLOW",,n13627,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 Surgical Services: Temperature, Humidity and Airflow"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21- g13629,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the role and importance of the mental health champion.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the role and importance of the mental health champion.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the role and importance of the mental health champion.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the role and importance of the mental health champion.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the role and importance of the mental health champion.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify 1013/2013 protocols and educate patients, families and others on the team of the importance of adhering to these protocols for patient safety and care.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify 1013/2013 protocols and educate patients, families and others on the team of the importance of adhering to these protocols for patient safety and care.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify 1013/2013 protocols and educate patients, families and others on the team of the importance of adhering to these protocols for patient safety and care.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify 1013/2013 protocols and educate patients, families and others on the team of the importance of adhering to these protocols for patient safety and care.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify 1013/2013 protocols and educate patients, families and others on the team of the importance of adhering to these protocols for patient safety and care.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to effectively communicate the importance of proper and compassionate care of patients/families who are high risk for self-harm or harm of others, exhibiting poor judgement and have behavioral concerns.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to effectively communicate the importance of proper and compassionate care of patients/families who are high risk for self-harm or harm of others, exhibiting poor judgement and have behavioral concerns.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to effectively communicate the importance of proper and compassionate care of patients/families who are high risk for self-harm or harm of others, exhibiting poor judgement and have behavioral concerns.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to effectively communicate the importance of proper and compassionate care of patients/families who are high risk for self-harm or harm of others, exhibiting poor judgement and have behavioral concerns.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to effectively communicate the importance of proper and compassionate care of patients/families who are high risk for self-harm or harm of others, exhibiting poor judgement and have behavioral concerns.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to educate patients, families and other members of the interdisciplinary team in working with patients who have mental health disorders and are in need of care.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to educate patients, families and other members of the interdisciplinary team in working with patients who have mental health disorders and are in need of care.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to educate patients, families and other members of the interdisciplinary team in working with patients who have mental health disorders and are in need of care.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to educate patients, families and other members of the interdisciplinary team in working with patients who have mental health disorders and are in need of care.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to educate patients, families and other members of the interdisciplinary team in working with patients who have mental health disorders and are in need of care.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to promoting comprehensive, integrated and responsive mental health and social care services to families of infants in the NICU nursery during times of stress.<OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to promoting comprehensive, integrated and responsive mental health and social care services to families of infants in the NICU nursery during times of stress.<OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to promoting comprehensive, integrated and responsive mental health and social care services to families of infants in the NICU nursery during times of stress.<OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to promoting comprehensive, integrated and responsive mental health and social care services to families of infants in the NICU nursery during times of stress.<OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to promoting comprehensive, integrated and responsive mental health and social care services to families of infants in the NICU nursery during times of stress.<OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence as it relates to being equipped for the role of the ""go-to""� person to support others in comfortably and effectively managing behavioral and mental health family needs and issues related to this population.<OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence as it relates to being equipped for the role of the ""go-to""� person to support others in comfortably and effectively managing behavioral and mental health family needs and issues related to this population.<OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence as it relates to being equipped for the role of the ""go-to""� person to support others in comfortably and effectively managing behavioral and mental health family needs and issues related to this population.<OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence as it relates to being equipped for the role of the ""go-to""� person to support others in comfortably and effectively managing behavioral and mental health family needs and issues related to this population.<OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence as it relates to being equipped for the role of the ""go-to""� person to support others in comfortably and effectively managing behavioral and mental health family needs and issues related to this population.<OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.<OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.<OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.<OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.<OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.<OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented for contact hours was free of commercial bias.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Stephanie Siegel, MSW</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Stephanie Siegel, MSW</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Stephanie Siegel, MSW</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Stephanie Siegel, MSW</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Stephanie Siegel, MSW</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lisa Mize, LCSW</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lisa Mize, LCSW</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lisa Mize, LCSW</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lisa Mize, LCSW</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lisa Mize, LCSW</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Amanda Thomas, LPC</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Amanda Thomas, LPC</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Amanda Thomas, LPC</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Amanda Thomas, LPC</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Amanda Thomas, LPC</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kristen Owens, LPC</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kristen Owens, LPC</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kristen Owens, LPC</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kristen Owens, LPC</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kristen Owens, LPC</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9851,,Questions-0000-142,SCN BEHAVIORAL HEALTH CHAMPION PROGRAM (EVALUATION SURVEY) 4.28.21,,n13629,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,"Duplicate Test. Existing test is RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021- g13640",False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss clinical research at Northside Hospital.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss clinical research at Northside Hospital.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss clinical research at Northside Hospital.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss clinical research at Northside Hospital.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss clinical research at Northside Hospital.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss clinical research, its components, types & importance.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss clinical research, its components, types & importance.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss clinical research, its components, types & importance.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss clinical research, its components, types & importance.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss clinical research, its components, types & importance.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe phases of investigational drug trials & medical devices approval process.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe phases of investigational drug trials & medical devices approval process.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe phases of investigational drug trials & medical devices approval process.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe phases of investigational drug trials & medical devices approval process.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe phases of investigational drug trials & medical devices approval process.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss governance of research and the Institutional Review board.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss governance of research and the Institutional Review board.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss governance of research and the Institutional Review board.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss governance of research and the Institutional Review board.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss governance of research and the Institutional Review board.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the Clinical Trial Management Research System.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the Clinical Trial Management Research System.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the Clinical Trial Management Research System.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the Clinical Trial Management Research System.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the Clinical Trial Management Research System.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the basic structure of research protocols.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the basic structure of research protocols.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the basic structure of research protocols.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the basic structure of research protocols.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the basic structure of research protocols.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the types of sponsors and protocol selection process.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the types of sponsors and protocol selection process.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the types of sponsors and protocol selection process.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the types of sponsors and protocol selection process.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the types of sponsors and protocol selection process.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe steps taken to implement a research protocol and staff roles.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe steps taken to implement a research protocol and staff roles.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe steps taken to implement a research protocol and staff roles.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe steps taken to implement a research protocol and staff roles.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe steps taken to implement a research protocol and staff roles.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the process utilized to conduct clinical trials and staff responsibilities.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the process utilized to conduct clinical trials and staff responsibilities.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the process utilized to conduct clinical trials and staff responsibilities.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the process utilized to conduct clinical trials and staff responsibilities.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the process utilized to conduct clinical trials and staff responsibilities.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe process to close protocols.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe process to close protocols.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe process to close protocols.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe process to close protocols.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe process to close protocols.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe expectations as it relates to role specific training.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe expectations as it relates to role specific training.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe expectations as it relates to role specific training.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe expectations as it relates to role specific training.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe expectations as it relates to role specific training.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has extended my knowledge of medical clinical research at Northside Hospital and filled a professional practice gap. </OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has extended my knowledge of medical clinical research at Northside Hospital and filled a professional practice gap. </OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has extended my knowledge of medical clinical research at Northside Hospital and filled a professional practice gap. </OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has extended my knowledge of medical clinical research at Northside Hospital and filled a professional practice gap. </OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has extended my knowledge of medical clinical research at Northside Hospital and filled a professional practice gap. </OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to discuss the structure of a research protocol.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to discuss the structure of a research protocol.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to discuss the structure of a research protocol.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to discuss the structure of a research protocol.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to discuss the structure of a research protocol.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to describe my role in protocol initiation & protocol closure.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to describe my role in protocol initiation & protocol closure.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to describe my role in protocol initiation & protocol closure.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to describe my role in protocol initiation & protocol closure.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to describe my role in protocol initiation & protocol closure.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Margaret Ferreira</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Margaret Ferreira</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Margaret Ferreira</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Margaret Ferreira</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Margaret Ferreira</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Andrea Patterson</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Andrea Patterson</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Andrea Patterson</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Andrea Patterson</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Andrea Patterson</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michael Bohannon</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michael Bohannon</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michael Bohannon</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michael Bohannon</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michael Bohannon</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Patrick Mikkelsen </ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Patrick Mikkelsen </ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Patrick Mikkelsen </ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Patrick Mikkelsen </ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Patrick Mikkelsen </ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Katherine Moore</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Katherine Moore</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Katherine Moore</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Katherine Moore</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Katherine Moore</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Hema Mody </ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Hema Mody </ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Hema Mody </ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Hema Mody </ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Hema Mody </ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Anila Lokhandwala</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Anila Lokhandwala</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Anila Lokhandwala</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Anila Lokhandwala</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Anila Lokhandwala</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9849,,Questions-0000-140,"RESEARCH 101 (EVALUATION SURVEY) NSA APRIL 29 & 30, 2021",,n13640,,choice,How would you improve this class?,"No improvement needed (appropriate content, handout, setting, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9330,,Elearning-0000-577,FY2021 5 C POST CARDIAC CATH DOCUMENTATION IN ONECHART,,n13650,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 5 C POST CARDIAC CATH DOCUMENTATION IN ONECHART- g13650,False
9330,,Elearning-0000-577,FY2021 5 C POST CARDIAC CATH DOCUMENTATION IN ONECHART,,n13650,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9330,,Elearning-0000-577,FY2021 5 C POST CARDIAC CATH DOCUMENTATION IN ONECHART,,n13650,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,Attempting less restrictive alternatives prior to applying restraints or placing a patient in seclusion is one strategy utilized at Northside Hospital to maintain the patient's rights and dignity?,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF- g13652,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,Attempting less restrictive alternatives prior to applying restraints or placing a patient in seclusion is one strategy utilized at Northside Hospital to maintain the patient's rights and dignity?,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,Attempting less restrictive alternatives prior to applying restraints or placing a patient in seclusion is one strategy utilized at Northside Hospital to maintain the patient's rights and dignity?,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,Mitten(s) are NOT a type of physical restraint,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,Mitten(s) are NOT a type of physical restraint,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,The use of restraints or seclusion is not associated with any potential physical or psychological risk?,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,The use of restraints or seclusion is not associated with any potential physical or psychological risk?,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,"Which situation is a Non-Violent, Non-Self-Destructive indication for restraint use?",a.	A patient with an emotional disorder poses a physical threat to other patients.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,"Which situation is a Non-Violent, Non-Self-Destructive indication for restraint use?",b.	A patient is pulling at his Foley catheter and demonstrates lack of understanding to comply with safety directions.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,"Which situation is a Non-Violent, Non-Self-Destructive indication for restraint use?",c.	A patient with an emotional disorder is attempting to cause physical harm to himself.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,"Which situation is a Non-Violent, Non-Self-Destructive indication for restraint use?",d.	A patient with a behavioral disorder poses a threat to the staff.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,Seclusion is defined as: A patient is involuntarily confined in a room or area from which the patient is physically prevented from leaving AND is alone.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,Seclusion is defined as: A patient is involuntarily confined in a room or area from which the patient is physically prevented from leaving AND is alone.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,"If restraints are removed and staff leave the room, a new order is required to reapply the restraints?",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,"If restraints are removed and staff leave the room, a new order is required to reapply the restraints?",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,"If a patient is temporarily released from restraints or seclusion for the purpose of caring for the patient's needs (i.e. toileting, feeding, bathing, and/or range of motion), a new restraint order is required to resume restraints or seclusion?",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,"If a patient is temporarily released from restraints or seclusion for the purpose of caring for the patient's needs (i.e. toileting, feeding, bathing, and/or range of motion), a new restraint order is required to resume restraints or seclusion?",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,"Which is NOT criteria for initiating Non-Violent, Non-Self-Destructive patient restraints?",a.	Patient is pulling at lines,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,"Which is NOT criteria for initiating Non-Violent, Non-Self-Destructive patient restraints?",b.	Patient is pulling at tubes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,"Which is NOT criteria for initiating Non-Violent, Non-Self-Destructive patient restraints?",c.	Patient wants to get out of bed unattended,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,"Which is NOT criteria for initiating Non-Violent, Non-Self-Destructive patient restraints?",d.	Patient demonstrates lack of understanding to comply with safety directions,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,You are applying soft limb restraints. Which finding indicates that you have NOT safely applied the restraints?,a.	Used the right-sized restraint,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,You are applying soft limb restraints. Which finding indicates that you have NOT safely applied the restraints?,b.	Applied the restraints according to manufacturer's directions,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,You are applying soft limb restraints. Which finding indicates that you have NOT safely applied the restraints?,c.	Secured the restraints to the siderails,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,You are applying soft limb restraints. Which finding indicates that you have NOT safely applied the restraints?,d.	Tied knots so they can be quickly released,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,"Which is NOT criteria for initiating Violent, Self-Destructive patient restraints or seclusion?",a.	Patient is an imminent risk of intentional harm to self,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,"Which is NOT criteria for initiating Violent, Self-Destructive patient restraints or seclusion?",b.	Patient is verbally abusive to staff,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9307,,Elearning-0000-556,FY2021 MANAGEMENT OF THE PATIENT AT RISK FOR RESTRAINT AND SECLUSION: ANCILLARY STAFF,,n13652,,choice,"Which is NOT criteria for initiating Violent, Self-Destructive patient restraints or seclusion?",c.	Patient is an imminent risk of intentional harm to others,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9483,,Elearning-0000-716,NSH 1282 JCAR017 EAP,,n13654,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSH 1282 JCAR017 EAP- g13654,False
9483,,Elearning-0000-716,NSH 1282 JCAR017 EAP,,n13654,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9483,,Elearning-0000-716,NSH 1282 JCAR017 EAP,,n13654,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9482,,Elearning-0000-715,NSH 1298 BB2121 EAP,,n13655,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSH 1298 BB2121 EAP- g13655,False
9482,,Elearning-0000-715,NSH 1298 BB2121 EAP,,n13655,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9482,,Elearning-0000-715,NSH 1298 BB2121 EAP,,n13655,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9219,,Elearning-0000-476,NSC L&D TEAM LEADER CLASS 2021,,n13656,,choice,I acknowledge that I have read and understand the information provided in the NSC L&D Team Leader Class 2021 CBL,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSC L&D TEAM LEADER CLASS 2021- g13656,False
9219,,Elearning-0000-476,NSC L&D TEAM LEADER CLASS 2021,,n13656,,choice,I acknowledge that I have read and understand the information provided in the NSC L&D Team Leader Class 2021 CBL,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9219,,Elearning-0000-476,NSC L&D TEAM LEADER CLASS 2021,,n13656,,choice,I acknowledge that I have read and understand the information provided in the NSC L&D Team Leader Class 2021 CBL,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,Which of the following is not true?,a. person dies by suicide every 12 minutes.,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS)- g13657,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,Which of the following is not true?,a. person dies by suicide every 12 minutes.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,Which of the following is not true?,"b. Over 40,000 people die by suicide each year.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,Which of the following is not true?,c. Highest risk age group is 30-45,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,Which of the following is not true?,d. 45% of people who died by suicide saw their primary care provider within a month of their death.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,What are the key contributing factors to suicide?,a. Psychological pain,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,What are the key contributing factors to suicide?,b. Wish to Escape,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,What are the key contributing factors to suicide?,c. Seeking a Solution,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,What are the key contributing factors to suicide?,d. Ambivalence,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,What are the key contributing factors to suicide?,e. All of the Above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,"True or False: The Columbia Protocol, also known as the Columbia Suicide-Severity Rating Scale, supports suicide risk assessment through a series of simple, plain-language questions that anyone can ask.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,"True or False: The Columbia Protocol, also known as the Columbia Suicide-Severity Rating Scale, supports suicide risk assessment through a series of simple, plain-language questions that anyone can ask.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,Which of the following is not a good example of how to ask someone if they are suicidal?,a. Have you wished you were dead or wished you could go to sleep and not wake up?,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,Which of the following is not a good example of how to ask someone if they are suicidal?,b. Have you been thinking about how you might kill yourself?,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,Which of the following is not a good example of how to ask someone if they are suicidal?,c. You aren't thinking of suicide are you?,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,Why should nurses ask about suicide risk?,a. Nurses spend more time with patients than other healthcare providers.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,Why should nurses ask about suicide risk?,b. Nurses see every patient.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,Why should nurses ask about suicide risk?,c. Nurses already screen for other safety/risk factors.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9457,,Elearning-0000-692,FY2021 - COLUMBIA SUICIDE SEVERITY RATING SCALE (CSSRS),,n13657,,choice,Why should nurses ask about suicide risk?,d. All of the above.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Which of the following is true in regards to intraosseous administration of medications?,a.	Most meds that can be given IV can also be given IO,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY- g13659,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Which of the following is true in regards to intraosseous administration of medications?,a.	Most meds that can be given IV can also be given IO,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Which of the following is true in regards to intraosseous administration of medications?,b.	The dose for most IO meds are twice (2x) the amount of IV doses,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Which of the following is true in regards to intraosseous administration of medications?,c.	Endotracheal route is preferred over IO route for med administration during codes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Which of the following is true in regards to intraosseous administration of medications?,d.	IO can only be considered peripheral access,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,PEA/asystolic arrests are associated with poor outcomes.  Which of the following strategies would be appropriate in managing a patient in PEA/asystole?,a.	Epinephrine 1mg IVP q3-5mins,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,PEA/asystolic arrests are associated with poor outcomes.  Which of the following strategies would be appropriate in managing a patient in PEA/asystole?,b.	Lidocaine 1-1.5mg/kg IVP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,PEA/asystolic arrests are associated with poor outcomes.  Which of the following strategies would be appropriate in managing a patient in PEA/asystole?,c.	Defibrillation after first round of chest compressions,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,PEA/asystolic arrests are associated with poor outcomes.  Which of the following strategies would be appropriate in managing a patient in PEA/asystole?,d.	Amiodarone 300mg IVP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,"Drawer 5 in the Adult Code Cart contains Respiratory Supplies, and Drawer 6 in the Adult Code Cart contains general miscellaneous supplies.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,"Drawer 5 in the Adult Code Cart contains Respiratory Supplies, and Drawer 6 in the Adult Code Cart contains general miscellaneous supplies.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,"You're working in main pharmacy and a code blue was called.  You arrive at the patient's room with an auxiliary box and it was a ""false alarm""� - patient had a pulse.  The team leader tells you that they already opened the code cart and obtained a dobutamine drip and hung it on the patient.  You -",a.	Suggest epinephrine 1mg IVP if the patient remains hypotensive,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,"You're working in main pharmacy and a code blue was called.  You arrive at the patient's room with an auxiliary box and it was a ""false alarm""� - patient had a pulse.  The team leader tells you that they already opened the code cart and obtained a dobutamine drip and hung it on the patient.  You -",b.	Check the patient's IV pole to see if a dobutamine drip is really hanging as it is not in the code cart,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,"You're working in main pharmacy and a code blue was called.  You arrive at the patient's room with an auxiliary box and it was a ""false alarm""� - patient had a pulse.  The team leader tells you that they already opened the code cart and obtained a dobutamine drip and hung it on the patient.  You -",c.	Breathe a sigh of relief that the code was not real and walk away,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,"You're working in main pharmacy and a code blue was called.  You arrive at the patient's room with an auxiliary box and it was a ""false alarm""� - patient had a pulse.  The team leader tells you that they already opened the code cart and obtained a dobutamine drip and hung it on the patient.  You -","d.	Suggest an amiodarone drip at 1mg/min for 6 hrs, then 0.5mg/min for 18 hrs thereafter",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Options for treating symptomatic bradycardia includes all of the following except:,a.	Atropine 1 mg IVP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Options for treating symptomatic bradycardia includes all of the following except:,b.	Dobutamine drip 5mcg/kg/min,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Options for treating symptomatic bradycardia includes all of the following except:,c.	Dopamine drip 5-20mcg/kg/min,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Options for treating symptomatic bradycardia includes all of the following except:,d.	Epinephrine 2-10mcg/min,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,There are no controlled medications in the adult code cart.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,There are no controlled medications in the adult code cart.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Which of the following drug-location pairs are matched incorrectly?,a.	Flumazenil 0.5mg/5mLvial - adult code cart 2nd drawer,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Which of the following drug-location pairs are matched incorrectly?,b.	Normal saline 1000mL IV bags - adult code cart 3rd drawer,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Which of the following drug-location pairs are matched incorrectly?,c.	Sodium bicarbonate 50mEq/50mL abbojects - adult code cart 1st drawer,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Which of the following drug-location pairs are matched incorrectly?,d.	Succinylcholine 100mg/ 5ml- pharmacy auxiliary box,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Which of the following medications would you never give via IV push?,a.	Epinephrine,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Which of the following medications would you never give via IV push?,b.	Sodium bicarbonate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Which of the following medications would you never give via IV push?,c.	Dopamine,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,Which of the following medications would you never give via IV push?,d.	Lidocaine,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,There are no medications for Rapid Sequence Intubation in the pharmacy auxiliary box.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,There are no medications for Rapid Sequence Intubation in the pharmacy auxiliary box.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,"A patient on the cardiac unit with episodes of non sustained ventricular tachycardia loses pulse and a code blue event is called on the unit. The patient's rhythm is quickly identified as ventricular tachycardia and the patient is successfully defibrillated, returning to NSR with a pulse. The physician requests an amiodarone bolus be given stat and a drip initiated. Which of the following is true?",a.	The pharmacist should remove the amiodarone bolus bag 1 from tray 1 of the adult code cart and prepare a 300mg bolus syringe for IV push.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,"A patient on the cardiac unit with episodes of non sustained ventricular tachycardia loses pulse and a code blue event is called on the unit. The patient's rhythm is quickly identified as ventricular tachycardia and the patient is successfully defibrillated, returning to NSR with a pulse. The physician requests an amiodarone bolus be given stat and a drip initiated. Which of the following is true?",b.	The pharmacist should remove the amiodarone bolus bag 2 from tray 1 of the adult code cart and prepare a 150mg bolus syringe for IV push.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,"A patient on the cardiac unit with episodes of non sustained ventricular tachycardia loses pulse and a code blue event is called on the unit. The patient's rhythm is quickly identified as ventricular tachycardia and the patient is successfully defibrillated, returning to NSR with a pulse. The physician requests an amiodarone bolus be given stat and a drip initiated. Which of the following is true?","c.	The pharmacist should disregard the bolus order and hand the nurse the premixed drip from drawer 1 of the code cart, instructing the RN to bolus from the bag.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9583,,Elearning-0000-807,FY2021 PHARMACY CODE BLUE AND EMERGENCY CART COMPETENCY,,n13659,,choice,"A patient on the cardiac unit with episodes of non sustained ventricular tachycardia loses pulse and a code blue event is called on the unit. The patient's rhythm is quickly identified as ventricular tachycardia and the patient is successfully defibrillated, returning to NSR with a pulse. The physician requests an amiodarone bolus be given stat and a drip initiated. Which of the following is true?","d.	The pharmacist should obtain a stat amiodarone 150mg/ 100ml IVPB which is not in the adult code cart to infuse over 10 minutes, (not IV push, as the patient now has a pulse), then proceed with the premixed drip at 1mg/ minute.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9679,,Elearning-0000-894,HAPI PREVENTION EDUCATION - MAY 2021 - BRADEN SCALE RISK FACTORS,,n13662,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""HAPI Prevention Education - May 2021 - Braden Scale Risk Factors"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is HAPI PREVENTION EDUCATION - MAY 2021 - BRADEN SCALE RISK FACTORS- g13662,False
9679,,Elearning-0000-894,HAPI PREVENTION EDUCATION - MAY 2021 - BRADEN SCALE RISK FACTORS,,n13662,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""HAPI Prevention Education - May 2021 - Braden Scale Risk Factors"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9679,,Elearning-0000-894,HAPI PREVENTION EDUCATION - MAY 2021 - BRADEN SCALE RISK FACTORS,,n13662,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""HAPI Prevention Education - May 2021 - Braden Scale Risk Factors"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9616,,Elearning-0000-837,FY2021 SURGICAL SERVICES: ESOPHAGECTOMY PATIENT CARE,,n13666,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 Surgical Services: Esophagectomy Patient Care"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 SURGICAL SERVICES: ESOPHAGECTOMY PATIENT CARE- g13666,False
9616,,Elearning-0000-837,FY2021 SURGICAL SERVICES: ESOPHAGECTOMY PATIENT CARE,,n13666,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 Surgical Services: Esophagectomy Patient Care"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9616,,Elearning-0000-837,FY2021 SURGICAL SERVICES: ESOPHAGECTOMY PATIENT CARE,,n13666,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 Surgical Services: Esophagectomy Patient Care"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
121,,SCORM-0000-201,TRALIANT_LMS_TEST_COURSE_072220_SCORM12,,n13668,,choice,I'm able to view this CBL successfully.,a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TRALIANT_LMS_TEST_COURSE_072220_SCORM12- g13668,False
121,,SCORM-0000-201,TRALIANT_LMS_TEST_COURSE_072220_SCORM12,,n13668,,choice,I'm able to view this CBL successfully.,a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
121,,SCORM-0000-201,TRALIANT_LMS_TEST_COURSE_072220_SCORM12,,n13668,,choice,I'm able to view this CBL successfully.,b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,"Duplicate Test. Existing test is NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)- g13669",False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss treatment-related toxicities experienced by patients receiving PARP inhibitor therapy.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss treatment-related toxicities experienced by patients receiving PARP inhibitor therapy.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss treatment-related toxicities experienced by patients receiving PARP inhibitor therapy.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss treatment-related toxicities experienced by patients receiving PARP inhibitor therapy.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss treatment-related toxicities experienced by patients receiving PARP inhibitor therapy.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9947,,Questions-0000-81,"NSF INFUSION CENTER JOURNAL CLUB - MAY 6TH, 2021 (EVALUATION SURVEY)",,n13669,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9653,,Elearning-0000-870,NURSE PRECEPTOR CLASS REGISTRATION PROCESS,,n13674,,choice,I have read the attached preceptor flyer.  I understand that I need to take my Net learning transcript and class date to my manager/manager designee to enroll in the Preceptor Development Part B classes.,Yes,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NURSE PRECEPTOR CLASS REGISTRATION PROCESS- g13674,False
9653,,Elearning-0000-870,NURSE PRECEPTOR CLASS REGISTRATION PROCESS,,n13674,,choice,I have read the attached preceptor flyer.  I understand that I need to take my Net learning transcript and class date to my manager/manager designee to enroll in the Preceptor Development Part B classes.,Yes,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9653,,Elearning-0000-870,NURSE PRECEPTOR CLASS REGISTRATION PROCESS,,n13674,,choice,I have read the attached preceptor flyer.  I understand that I need to take my Net learning transcript and class date to my manager/manager designee to enroll in the Preceptor Development Part B classes.,No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21- g13675,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN </ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN </ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN </ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN </ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN </ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9889,,Questions-0000-23,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-10-21,,n13675,,choice,How would you improve this class?,"No improvements needed (appropriate content, instructor, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21- g13679,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify which patient populations are most at risk for NEC.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify which patient populations are most at risk for NEC.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify which patient populations are most at risk for NEC.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify which patient populations are most at risk for NEC.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify which patient populations are most at risk for NEC.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe best practices for prevention of NEC.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe best practices for prevention of NEC.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe best practices for prevention of NEC.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe best practices for prevention of NEC.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe best practices for prevention of NEC.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my nursing knowledge as it relates to the Impact of human milk in preventing adverse conditions in preterm infants.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my nursing knowledge as it relates to the Impact of human milk in preventing adverse conditions in preterm infants.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my nursing knowledge as it relates to the Impact of human milk in preventing adverse conditions in preterm infants.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my nursing knowledge as it relates to the Impact of human milk in preventing adverse conditions in preterm infants.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my nursing knowledge as it relates to the Impact of human milk in preventing adverse conditions in preterm infants.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence in providing patients with education related to the use of donor milk for the preterm infant.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence in providing patients with education related to the use of donor milk for the preterm infant.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence in providing patients with education related to the use of donor milk for the preterm infant.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence in providing patients with education related to the use of donor milk for the preterm infant.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence in providing patients with education related to the use of donor milk for the preterm infant.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Katie Joyner, BSN, RNC-NIC</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Katie Joyner, BSN, RNC-NIC</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Katie Joyner, BSN, RNC-NIC</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Katie Joyner, BSN, RNC-NIC</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Katie Joyner, BSN, RNC-NIC</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,How would you improve this class?,"No improvements needed (appropriate content, instructor, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the benefits of human milk for the preterm baby.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the benefits of human milk for the preterm baby.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the benefits of human milk for the preterm baby.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the benefits of human milk for the preterm baby.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9896,,Questions-0000-30,BENEFITS OF HUMAN MILK & NEC PREVENTION (EVALUATION SURVEY) 5.11.21,,n13679,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the benefits of human milk for the preterm baby.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9622,,Elearning-0000-842,FY2021 CPG STROKE EDUCATION,,n13696,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 CPG Stroke Education"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 CPG STROKE EDUCATION- g13696,False
9622,,Elearning-0000-842,FY2021 CPG STROKE EDUCATION,,n13696,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 CPG Stroke Education"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9622,,Elearning-0000-842,FY2021 CPG STROKE EDUCATION,,n13696,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 CPG Stroke Education"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,All new Shiley Flex tubes come with a tapered percutaneous tip.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES- g13697,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,All new Shiley Flex tubes come with a tapered percutaneous tip.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,All new Shiley Flex tubes come with a tapered percutaneous tip.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,The Shiley Flex tube flange is rigid and will not conform to the patient's anatomy.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,The Shiley Flex tube flange is rigid and will not conform to the patient's anatomy.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,"The new Shiley Flex tubes have a built in 15 mm connector, so the inner cannula is not required for manual ventilation.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,"The new Shiley Flex tubes have a built in 15 mm connector, so the inner cannula is not required for manual ventilation.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,The inner cannulas for the Legacy Shiley and the new Shiley Flex tubes are not compatible and cannot be interchanged.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,The inner cannulas for the Legacy Shiley and the new Shiley Flex tubes are not compatible and cannot be interchanged.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,The Shiley Flex inner cannula does not need to be changed unless it is visibly soiled.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,The Shiley Flex inner cannula does not need to be changed unless it is visibly soiled.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,The recommended cuff pressure for the Shiley Flex taperguard cuff is,(A) 15 cmH2O,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,The recommended cuff pressure for the Shiley Flex taperguard cuff is,(B) 20 cmH2O,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,The recommended cuff pressure for the Shiley Flex taperguard cuff is,(C) 25 cmH2O,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,The recommended cuff pressure for the Shiley Flex taperguard cuff is,(D) 35 cmH2O,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,You do not need to place a laminated sign at the head of the patient's bed if a legacy Shiley trach tube is in use.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,You do not need to place a laminated sign at the head of the patient's bed if a legacy Shiley trach tube is in use.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,"Whenever a trach tube is downsized, the new obturator must be placed at the head of the bed and the old one discarded.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,"Whenever a trach tube is downsized, the new obturator must be placed at the head of the bed and the old one discarded.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,The transparent and flexible design of the Shiley Flex flange results in 80% less pressure injuries compared to the Shiley Legacy.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,The transparent and flexible design of the Shiley Flex flange results in 80% less pressure injuries compared to the Shiley Legacy.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,"If your product reference code is 8CN85H, your trach size is",(A) non-disposable 8.5 cuffed tracheostomy tube,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,"If your product reference code is 8CN85H, your trach size is",(B) disposable 8.5 cuffless tracheostomy tube,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,"If your product reference code is 8CN85H, your trach size is",(C) non-disposable 8 cuffed tracheostomy tube,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
92,,SCORM-0000-174,SHILEY FLEXIBLE ADULT TRACHEOSTOMY TUBES,,n13697,,choice,"If your product reference code is 8CN85H, your trach size is",(D) disposable 8 cuffed tracheostomy tube,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9707,,Elearning-0000-92,FY2021 AD HOC MEDICATION ADMINISTRATION FOR EMERGENT AND INTRAOPERATIVE USE,,n13699,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 AD HOC MEDICATION ADMINISTRATION FOR EMERGENT AND INTRAOPERATIVE USE- g13699,False
9707,,Elearning-0000-92,FY2021 AD HOC MEDICATION ADMINISTRATION FOR EMERGENT AND INTRAOPERATIVE USE,,n13699,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9707,,Elearning-0000-92,FY2021 AD HOC MEDICATION ADMINISTRATION FOR EMERGENT AND INTRAOPERATIVE USE,,n13699,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Why is the Distress Screening completed?,a)	We are told to do it,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER- g13700,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Why is the Distress Screening completed?,a)	We are told to do it,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Why is the Distress Screening completed?,"b)	To remain accredited with COC, providing a high standard of care",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Why is the Distress Screening completed?,"c)	To assess level of distress of patients, identify their needs and establish quality care and assistance",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Why is the Distress Screening completed?,d)	Both B and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,When would it be more appropriate to use a 2013 versus 1013?,"a)	The patient is incapacitated by alcohol, drugs or other substance on a re-occurring basis and present as a substantial risk of imminent harm to self and/or others if left untreated",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,When would it be more appropriate to use a 2013 versus 1013?,b)	The patient has mental illness and presents as a substantial risk of harm to self or others,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,When would it be more appropriate to use a 2013 versus 1013?,"c)	The patient has only mental illness and presents substantial risk of imminent harm to self or others with no primary diagnosis of alcoholism or other substance abuse nor dependency, he/she presents as a substantial risk of imminent harm to self or others.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,When would it be more appropriate to use a 2013 versus 1013?,d)	Patient is unable to care for his/her own physical health or safety as to create an imminently life-threatening crisis,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,If a patient score 4-7,"a)	Review and sign form, assess patient for any immediate needs/concerns",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,If a patient score 4-7,"b)	RN signs form, which is scanned into EMR",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,If a patient score 4-7,c)	Email distress screening tool to OCSW,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,If a patient score 4-7,d)	Notify patient that they will receive call from Social Worker,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,If a patient score 4-7,e)	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,"In handling a patient, who is expressing suicidal /homicidal ideation, but is on the phone, which of the following is not part of the protocol?",a)	Keep the patient on the phone,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,"In handling a patient, who is expressing suicidal /homicidal ideation, but is on the phone, which of the following is not part of the protocol?",b)	Notify the supervisor or another staff member to locate the patient's address,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,"In handling a patient, who is expressing suicidal /homicidal ideation, but is on the phone, which of the following is not part of the protocol?",c)	Call 911 to go to the patient's location,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,"In handling a patient, who is expressing suicidal /homicidal ideation, but is on the phone, which of the following is not part of the protocol?",d)	Do not document in patient's medical chart since the patient is not in the office.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,"In handling a patient, who is expressing suicidal /homicidal ideation, but is on the phone, which of the following is not part of the protocol?",e)	Submit an incident report,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Which of the following processes would be different in handling a  type 2 patients  versus  handling type  1 patients?,"a)	Follow the Chain of Command Communication for your area and notify OSW/Behavioral Health Services, notify MD if available",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Which of the following processes would be different in handling a  type 2 patients  versus  handling type  1 patients?,b)	Do not leave patient alone,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Which of the following processes would be different in handling a  type 2 patients  versus  handling type  1 patients?,"c)	Call 911 first, then call security, if available, to make aware of the situation.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Which of the following processes would be different in handling a  type 2 patients  versus  handling type  1 patients?,"d)	Document facts of the event in the patient ""�s medical chart and complete an incident report",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,"In handling type 1 patients, which of the following processes should be utilized?",a)	Follow the chain of command for your area and notify the OSW/Behavioral Health Services,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,"In handling type 1 patients, which of the following processes should be utilized?",b)	Call Security for your respective location; patient should not be left alone,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,"In handling type 1 patients, which of the following processes should be utilized?","c)	If OSW does not respond within a reasonable timeframe, call the Psych-Oncology Coordinator, respective Supervisor/ Lead OSW, or BHS, notify MD, if available.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,"In handling type 1 patients, which of the following processes should be utilized?",d)	Initiate a 1013 and transfer process with appropriate documentation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,"In handling type 1 patients, which of the following processes should be utilized?",e)	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Why is the Distress Screening completed?,a)	We are told to do it,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Why is the Distress Screening completed?,"b)	To remain accredited with COC, providing a high standard of care",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Why is the Distress Screening completed?,"c)	To assess level of distress of patients, identify their needs and establish quality care and assistance",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Why is the Distress Screening completed?,d)	Both B and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,If a patient scores 8-10,"a)	Review form with patient, assess for immediate needs/concerns, call/text OCSW/Behavioral Health for immediate assessment (in-person or telephone);",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,If a patient scores 8-10,b)	Input data into EMR,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,If a patient scores 8-10,c)	Email to OSW's email,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,If a patient scores 8-10,d)	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Patient scores 0-3,"a)	Review form with patient, assess for immediate needs/concerns",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Patient scores 0-3,"b)	Input form in EMR, making sure to input score and check box ""reviewed by RN""�",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Patient scores 0-3,c)	Educate patient on availability of psychosocial services. Handout accompanies distress tool,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,Patient scores 0-3,d)	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,When should patient be screen in order to remain in compliance with the distress screening guidelines?,a)	Give distress screen whenever you want,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,When should patient be screen in order to remain in compliance with the distress screening guidelines?,"b)	1st, 2nd or no later than 3rd visit",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,When should patient be screen in order to remain in compliance with the distress screening guidelines?,c)	Whenever there is a regimen change,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9492,,Elearning-0000-724,FY2021 DISTRESS SCREENING AND MANAGEMENT OF THE PATIENT NEEDING A 1013 ORDER,,n13700,,choice,When should patient be screen in order to remain in compliance with the distress screening guidelines?,d)	B & C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
102,,SCORM-0000-184,TIMELESS 101: INTRODUCTION,,n13703,,choice,I have read and understood the content within the Timeless 101: Introduction CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIMELESS 101: INTRODUCTION- g13703,False
102,,SCORM-0000-184,TIMELESS 101: INTRODUCTION,,n13703,,choice,I have read and understood the content within the Timeless 101: Introduction CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
102,,SCORM-0000-184,TIMELESS 101: INTRODUCTION,,n13703,,choice,I have read and understood the content within the Timeless 101: Introduction CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
103,,SCORM-0000-185,TIMELESS 102: LABEL PRINTING,,n13704,,choice,I have read and understood the content within the Timeless 102: Label Printing CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIMELESS 102: LABEL PRINTING- g13704,False
103,,SCORM-0000-185,TIMELESS 102: LABEL PRINTING,,n13704,,choice,I have read and understood the content within the Timeless 102: Label Printing CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
103,,SCORM-0000-185,TIMELESS 102: LABEL PRINTING,,n13704,,choice,I have read and understood the content within the Timeless 102: Label Printing CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
104,,SCORM-0000-186,TIMELESS 103: RECEIVE MILK/PRODUCTS,,n13705,,choice,I have read and understood the content within the Timeless 103: Receive Milk/Products CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIMELESS 103: RECEIVE MILK/PRODUCTS- g13705,False
104,,SCORM-0000-186,TIMELESS 103: RECEIVE MILK/PRODUCTS,,n13705,,choice,I have read and understood the content within the Timeless 103: Receive Milk/Products CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
104,,SCORM-0000-186,TIMELESS 103: RECEIVE MILK/PRODUCTS,,n13705,,choice,I have read and understood the content within the Timeless 103: Receive Milk/Products CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
105,,SCORM-0000-187,TIMELESS 104: SIMPLE PREPARE,,n13706,,choice,I have read and understood the content within the Timeless 104: Simple Prepare CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIMELESS 104: SIMPLE PREPARE- g13706,False
105,,SCORM-0000-187,TIMELESS 104: SIMPLE PREPARE,,n13706,,choice,I have read and understood the content within the Timeless 104: Simple Prepare CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
105,,SCORM-0000-187,TIMELESS 104: SIMPLE PREPARE,,n13706,,choice,I have read and understood the content within the Timeless 104: Simple Prepare CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
106,,SCORM-0000-188,TIMELESS 105: ADVANCED PREPARE INTRODUCTION,,n13707,,choice,I have read and understood the content within the Timeless 105: Advanced Prepare Introduction CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIMELESS 105: ADVANCED PREPARE INTRODUCTION- g13707,False
106,,SCORM-0000-188,TIMELESS 105: ADVANCED PREPARE INTRODUCTION,,n13707,,choice,I have read and understood the content within the Timeless 105: Advanced Prepare Introduction CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
106,,SCORM-0000-188,TIMELESS 105: ADVANCED PREPARE INTRODUCTION,,n13707,,choice,I have read and understood the content within the Timeless 105: Advanced Prepare Introduction CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
107,,SCORM-0000-189,TIMELESS 106: ADVANCED PREPARE,,n13708,,choice,I have read and understood the content within the Timeless 106: Advanced Prepare CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIMELESS 106: ADVANCED PREPARE- g13708,False
107,,SCORM-0000-189,TIMELESS 106: ADVANCED PREPARE,,n13708,,choice,I have read and understood the content within the Timeless 106: Advanced Prepare CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
107,,SCORM-0000-189,TIMELESS 106: ADVANCED PREPARE,,n13708,,choice,I have read and understood the content within the Timeless 106: Advanced Prepare CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
109,,SCORM-0000-190,TIMELESS 107: FEEDING,,n13709,,choice,I have read and understood the content within the Timeless 107: Feeding CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIMELESS 107: FEEDING- g13709,False
109,,SCORM-0000-190,TIMELESS 107: FEEDING,,n13709,,choice,I have read and understood the content within the Timeless 107: Feeding CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
109,,SCORM-0000-190,TIMELESS 107: FEEDING,,n13709,,choice,I have read and understood the content within the Timeless 107: Feeding CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
110,,SCORM-0000-191,TIMELESS 108: MOVE BOTTLES/PRODUCT,,n13711,,choice,I have read and understood the content within the Timeless 108: Move Bottles/Products CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIMELESS 108: MOVE BOTTLES/PRODUCT- g13711,False
110,,SCORM-0000-191,TIMELESS 108: MOVE BOTTLES/PRODUCT,,n13711,,choice,I have read and understood the content within the Timeless 108: Move Bottles/Products CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
110,,SCORM-0000-191,TIMELESS 108: MOVE BOTTLES/PRODUCT,,n13711,,choice,I have read and understood the content within the Timeless 108: Move Bottles/Products CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
117,,SCORM-0000-198,TIMELESS 115: PRODUCT MANAGEMENT,,n13712,,choice,I have read and understood the content within the Timeless 115: Product Management CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIMELESS 115: PRODUCT MANAGEMENT- g13712,False
117,,SCORM-0000-198,TIMELESS 115: PRODUCT MANAGEMENT,,n13712,,choice,I have read and understood the content within the Timeless 115: Product Management CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
117,,SCORM-0000-198,TIMELESS 115: PRODUCT MANAGEMENT,,n13712,,choice,I have read and understood the content within the Timeless 115: Product Management CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9328,,Elearning-0000-575,FY2021 PHARMACY BIOSIMILAR EDUCATION,,n13716,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 PHARMACY BIOSIMILAR EDUCATION- g13716,False
9328,,Elearning-0000-575,FY2021 PHARMACY BIOSIMILAR EDUCATION,,n13716,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9328,,Elearning-0000-575,FY2021 PHARMACY BIOSIMILAR EDUCATION,,n13716,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
111,,SCORM-0000-192,TIMELESS 109: MILK/PRODUCT DISPOSAL AND DISCHARGE,,n13713,,choice,I have read and understood the content within the Timeless 109: Milk/Product Disposal and Discharge CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIMELESS 109: MILK/PRODUCT DISPOSAL AND DISCHARGE- g13713,False
111,,SCORM-0000-192,TIMELESS 109: MILK/PRODUCT DISPOSAL AND DISCHARGE,,n13713,,choice,I have read and understood the content within the Timeless 109: Milk/Product Disposal and Discharge CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
111,,SCORM-0000-192,TIMELESS 109: MILK/PRODUCT DISPOSAL AND DISCHARGE,,n13713,,choice,I have read and understood the content within the Timeless 109: Milk/Product Disposal and Discharge CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
116,,SCORM-0000-197,TIMELESS 114: ADMIN MANAGEMENT,,n13714,,choice,I have read and understood the content within the Timeless 114: Admin Management CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIMELESS 114: ADMIN MANAGEMENT- g13714,False
116,,SCORM-0000-197,TIMELESS 114: ADMIN MANAGEMENT,,n13714,,choice,I have read and understood the content within the Timeless 114: Admin Management CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
116,,SCORM-0000-197,TIMELESS 114: ADMIN MANAGEMENT,,n13714,,choice,I have read and understood the content within the Timeless 114: Admin Management CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
115,,SCORM-0000-196,TIMELESS 113: MANAGE COMMUNITY ORDER,,n13715,,choice,I have read and understood the content within the Timeless 113: Manage Community Order CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIMELESS 113: MANAGE COMMUNITY ORDER- g13715,False
115,,SCORM-0000-196,TIMELESS 113: MANAGE COMMUNITY ORDER,,n13715,,choice,I have read and understood the content within the Timeless 113: Manage Community Order CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
115,,SCORM-0000-196,TIMELESS 113: MANAGE COMMUNITY ORDER,,n13715,,choice,I have read and understood the content within the Timeless 113: Manage Community Order CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
112,,SCORM-0000-193,TIMELESS 110: BAGS/BINS,,n13717,,choice,I have read and understood the content within the Timeless 110: Bags/Bins CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIMELESS 110: BAGS/BINS- g13717,False
112,,SCORM-0000-193,TIMELESS 110: BAGS/BINS,,n13717,,choice,I have read and understood the content within the Timeless 110: Bags/Bins CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
112,,SCORM-0000-193,TIMELESS 110: BAGS/BINS,,n13717,,choice,I have read and understood the content within the Timeless 110: Bags/Bins CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
113,,SCORM-0000-194,TIMELESS 111: MOTHER FEATURES,,n13718,,choice,I have read and understood the content within the Timeless 111: Mother's Features CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIMELESS 111: MOTHER FEATURES- g13718,False
113,,SCORM-0000-194,TIMELESS 111: MOTHER FEATURES,,n13718,,choice,I have read and understood the content within the Timeless 111: Mother's Features CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
113,,SCORM-0000-194,TIMELESS 111: MOTHER FEATURES,,n13718,,choice,I have read and understood the content within the Timeless 111: Mother's Features CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
114,,SCORM-0000-195,TIMELESS 112: FEED CONSENTS,,n13719,,choice,I have read and understood the content within the Timeless 112: Feed Consents CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIMELESS 112: FEED CONSENTS- g13719,False
114,,SCORM-0000-195,TIMELESS 112: FEED CONSENTS,,n13719,,choice,I have read and understood the content within the Timeless 112: Feed Consents CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
114,,SCORM-0000-195,TIMELESS 112: FEED CONSENTS,,n13719,,choice,I have read and understood the content within the Timeless 112: Feed Consents CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21- g13720,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify causes and pathophysiology of sepsis in the obstetric patient. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify causes and pathophysiology of sepsis in the obstetric patient. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify causes and pathophysiology of sepsis in the obstetric patient. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify causes and pathophysiology of sepsis in the obstetric patient. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify causes and pathophysiology of sepsis in the obstetric patient. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the physical assessment findings, common lab tests and best practice treatments for women with sepsis. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the physical assessment findings, common lab tests and best practice treatments for women with sepsis. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the physical assessment findings, common lab tests and best practice treatments for women with sepsis. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the physical assessment findings, common lab tests and best practice treatments for women with sepsis. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the physical assessment findings, common lab tests and best practice treatments for women with sepsis. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the causes and pathophysiology of cardiomyopathy.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the causes and pathophysiology of cardiomyopathy.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the causes and pathophysiology of cardiomyopathy.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the causes and pathophysiology of cardiomyopathy.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the causes and pathophysiology of cardiomyopathy.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the physical assessment including the radiographic and laboratory findings consistent with cardiomyopathy and describe treatment options. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the physical assessment including the radiographic and laboratory findings consistent with cardiomyopathy and describe treatment options. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the physical assessment including the radiographic and laboratory findings consistent with cardiomyopathy and describe treatment options. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the physical assessment including the radiographic and laboratory findings consistent with cardiomyopathy and describe treatment options. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the physical assessment including the radiographic and laboratory findings consistent with cardiomyopathy and describe treatment options. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify causes of hemorrhage in the obstetric patient and discuss recommendations for treatment. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify causes of hemorrhage in the obstetric patient and discuss recommendations for treatment. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify causes of hemorrhage in the obstetric patient and discuss recommendations for treatment. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify causes of hemorrhage in the obstetric patient and discuss recommendations for treatment. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify causes of hemorrhage in the obstetric patient and discuss recommendations for treatment. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe reasons for delays in the treatment of the hemorrhaging patient and nursing actions to reduce these delays.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe reasons for delays in the treatment of the hemorrhaging patient and nursing actions to reduce these delays.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe reasons for delays in the treatment of the hemorrhaging patient and nursing actions to reduce these delays.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe reasons for delays in the treatment of the hemorrhaging patient and nursing actions to reduce these delays.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe reasons for delays in the treatment of the hemorrhaging patient and nursing actions to reduce these delays.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss non-pharmacologic and pharmacologic methods for treating hemorrhage and prevent coagulopathies in the hemorrhaging woman.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss non-pharmacologic and pharmacologic methods for treating hemorrhage and prevent coagulopathies in the hemorrhaging woman.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss non-pharmacologic and pharmacologic methods for treating hemorrhage and prevent coagulopathies in the hemorrhaging woman.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss non-pharmacologic and pharmacologic methods for treating hemorrhage and prevent coagulopathies in the hemorrhaging woman.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss non-pharmacologic and pharmacologic methods for treating hemorrhage and prevent coagulopathies in the hemorrhaging woman.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathophysiology of hypertension in obstetrics and discuss best practice recommendations for treatment.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathophysiology of hypertension in obstetrics and discuss best practice recommendations for treatment.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathophysiology of hypertension in obstetrics and discuss best practice recommendations for treatment.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathophysiology of hypertension in obstetrics and discuss best practice recommendations for treatment.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathophysiology of hypertension in obstetrics and discuss best practice recommendations for treatment.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify treatment protocols and medications to treat hypertension in pregnancy.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify treatment protocols and medications to treat hypertension in pregnancy.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify treatment protocols and medications to treat hypertension in pregnancy.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify treatment protocols and medications to treat hypertension in pregnancy.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify treatment protocols and medications to treat hypertension in pregnancy.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss typical and atypical clinical presentations of hypertension in pregnancy.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss typical and atypical clinical presentations of hypertension in pregnancy.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss typical and atypical clinical presentations of hypertension in pregnancy.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss typical and atypical clinical presentations of hypertension in pregnancy.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss typical and atypical clinical presentations of hypertension in pregnancy.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss risk factors for pulmonary edema and its effects on the pregnant and postpartum woman.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss risk factors for pulmonary edema and its effects on the pregnant and postpartum woman.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss risk factors for pulmonary edema and its effects on the pregnant and postpartum woman.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss risk factors for pulmonary edema and its effects on the pregnant and postpartum woman.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss risk factors for pulmonary edema and its effects on the pregnant and postpartum woman.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify conditions that may lead to pulmonary edema.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify conditions that may lead to pulmonary edema.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify conditions that may lead to pulmonary edema.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify conditions that may lead to pulmonary edema.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify conditions that may lead to pulmonary edema.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how pulmonary edema leads to decreased perfusion in the pregnant patient and its potential effects on the mother and fetus. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how pulmonary edema leads to decreased perfusion in the pregnant patient and its potential effects on the mother and fetus. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how pulmonary edema leads to decreased perfusion in the pregnant patient and its potential effects on the mother and fetus. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how pulmonary edema leads to decreased perfusion in the pregnant patient and its potential effects on the mother and fetus. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how pulmonary edema leads to decreased perfusion in the pregnant patient and its potential effects on the mother and fetus. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.<OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.<OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.<OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.<OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.<OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge related to recognition and management of comorbid diseases during pregnancy.<OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge related to recognition and management of comorbid diseases during pregnancy.<OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge related to recognition and management of comorbid diseases during pregnancy.<OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge related to recognition and management of comorbid diseases during pregnancy.<OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge related to recognition and management of comorbid diseases during pregnancy.<OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ginny Wurttemberg, DNP, CNM, RN </ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ginny Wurttemberg, DNP, CNM, RN </ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ginny Wurttemberg, DNP, CNM, RN </ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ginny Wurttemberg, DNP, CNM, RN </ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ginny Wurttemberg, DNP, CNM, RN </ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lauren Schwartz, MSN, RN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lauren Schwartz, MSN, RN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lauren Schwartz, MSN, RN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lauren Schwartz, MSN, RN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lauren Schwartz, MSN, RN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9956,,Questions-0000-90,OBSTETRICAL COMPLICATIONS (EVALUATION SURVEY) ONLINE 5.5.21,,n13720,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,How often should DTR's be assessed and documented per policy?,a.	Every 30 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSC ICU MAG SULFATE POLICY- g13726,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,How often should DTR's be assessed and documented per policy?,a.	Every 30 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,How often should DTR's be assessed and documented per policy?,b.	Every hour,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,How often should DTR's be assessed and documented per policy?,c.	Every 2 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,How often should DTR's be assessed and documented per policy?,d.	Every 15 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,"2.	If the Magnesium level is greater than which of the following values, the physician should be notified and the therapy discontinued pending further orders?",a.	6.4 mg/dl,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,"2.	If the Magnesium level is greater than which of the following values, the physician should be notified and the therapy discontinued pending further orders?",b.	7.4 mg/dl,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,"2.	If the Magnesium level is greater than which of the following values, the physician should be notified and the therapy discontinued pending further orders?",c.	8.4 mg/dl,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,"2.	If the Magnesium level is greater than which of the following values, the physician should be notified and the therapy discontinued pending further orders?",d.	9.4 mg/dl,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,3.	How long do you have to communicate a critical value with the physician?,a.	5 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,3.	How long do you have to communicate a critical value with the physician?,b.	15 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,3.	How long do you have to communicate a critical value with the physician?,c.	1 hour,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,3.	How long do you have to communicate a critical value with the physician?,d.	30 minutes,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,4.	How often should urine output be assessed and documented per policy?,a.	Every hour,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,4.	How often should urine output be assessed and documented per policy?,b.	Every 2 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,4.	How often should urine output be assessed and documented per policy?,c.	Every 4 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,4.	How often should urine output be assessed and documented per policy?,d.	Every 8 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,"5.	During a loading dose of magnesium sulfate, how often should VS be assessed and documented?",a.	Every hour,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,"5.	During a loading dose of magnesium sulfate, how often should VS be assessed and documented?",b.	Every 5 min,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,"5.	During a loading dose of magnesium sulfate, how often should VS be assessed and documented?",c.	Every 15 min,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,"5.	During a loading dose of magnesium sulfate, how often should VS be assessed and documented?",d.	Every 30 min,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,". During magnesium maintenance infusion, VS should be assessed and documented every hour",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,". During magnesium maintenance infusion, VS should be assessed and documented every hour",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,Initiation and maintenance of magnesium sulfate does not require verification by 2 RN's.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,Initiation and maintenance of magnesium sulfate does not require verification by 2 RN's.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,8.	Which of the following is the antagonist of magnesium sulfate?,a.	Calcium Carbonate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,8.	Which of the following is the antagonist of magnesium sulfate?,b.	Calcium Gluconate,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,8.	Which of the following is the antagonist of magnesium sulfate?,c.	Sodium Chloride,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9204,,Elearning-0000-462,NSC ICU MAG SULFATE POLICY,,n13726,,choice,8.	Which of the following is the antagonist of magnesium sulfate?,d.	Magnesium Sulfate does not have an antagonist,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8529,,Elearning-0000-140,FY2021 PHARMACY SURGICAL EMERGENCIES COMPETENCY,,n13727,,choice,True or false- (Malignant Hyperthermia) MH and Local Anesthetic Toxicity (LAST) should be treated as an emergency,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 PHARMACY SURGICAL EMERGENCIES COMPETENCY- g13727,False
8529,,Elearning-0000-140,FY2021 PHARMACY SURGICAL EMERGENCIES COMPETENCY,,n13727,,choice,True or false- (Malignant Hyperthermia) MH and Local Anesthetic Toxicity (LAST) should be treated as an emergency,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8529,,Elearning-0000-140,FY2021 PHARMACY SURGICAL EMERGENCIES COMPETENCY,,n13727,,choice,True or false- (Malignant Hyperthermia) MH and Local Anesthetic Toxicity (LAST) should be treated as an emergency,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8529,,Elearning-0000-140,FY2021 PHARMACY SURGICAL EMERGENCIES COMPETENCY,,n13727,,choice,True or false- MH only occurs immediately after a triggering agent is administered.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8529,,Elearning-0000-140,FY2021 PHARMACY SURGICAL EMERGENCIES COMPETENCY,,n13727,,choice,True or false- MH only occurs immediately after a triggering agent is administered.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8529,,Elearning-0000-140,FY2021 PHARMACY SURGICAL EMERGENCIES COMPETENCY,,n13727,,choice,What medications can cause LAST?,A)      Exparel,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8529,,Elearning-0000-140,FY2021 PHARMACY SURGICAL EMERGENCIES COMPETENCY,,n13727,,choice,What medications can cause LAST?,B)      Bupivacaine,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8529,,Elearning-0000-140,FY2021 PHARMACY SURGICAL EMERGENCIES COMPETENCY,,n13727,,choice,What medications can cause LAST?,C)      Ropivacaine,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8529,,Elearning-0000-140,FY2021 PHARMACY SURGICAL EMERGENCIES COMPETENCY,,n13727,,choice,What medications can cause LAST?,D)      Lidocaine,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8529,,Elearning-0000-140,FY2021 PHARMACY SURGICAL EMERGENCIES COMPETENCY,,n13727,,choice,What medications can cause LAST?,E)      A&B only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8529,,Elearning-0000-140,FY2021 PHARMACY SURGICAL EMERGENCIES COMPETENCY,,n13727,,choice,What medications can cause LAST?,F)       All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9603,,Elearning-0000-825,DIALYSIS COMMUNICATION UPDATE  MAY 2021(2),,n13731,,choice,I have read and understand the CBL Dialysis Communication Update May 2021(2) and the subsequent expectations for compliance.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is DIALYSIS COMMUNICATION UPDATE  MAY 2021(2)- g13731,False
9603,,Elearning-0000-825,DIALYSIS COMMUNICATION UPDATE  MAY 2021(2),,n13731,,choice,I have read and understand the CBL Dialysis Communication Update May 2021(2) and the subsequent expectations for compliance.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9603,,Elearning-0000-825,DIALYSIS COMMUNICATION UPDATE  MAY 2021(2),,n13731,,choice,I have read and understand the CBL Dialysis Communication Update May 2021(2) and the subsequent expectations for compliance.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21- g13737,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN </ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN </ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN </ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN </ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN </ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9890,,Questions-0000-24,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 5-17-21,,n13737,,choice,How would you improve this class?,"No improvements needed (appropriate content, instructor, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,1.	Post-operative orders for patients that are S/P Esophagogastrectomy include,a.	Patients are NPO immediately post-op,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSC ICU ESOPHAGOGASTRECTOMY SURGERY- g13738,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,1.	Post-operative orders for patients that are S/P Esophagogastrectomy include,a.	Patients are NPO immediately post-op,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,1.	Post-operative orders for patients that are S/P Esophagogastrectomy include,"b.	Once cleared by the Surgeon, all medications will be given via the J-tube",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,1.	Post-operative orders for patients that are S/P Esophagogastrectomy include,c.	The provider will evaluate the patient for utilization of the J-tube about 48 hours post-operatively,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,1.	Post-operative orders for patients that are S/P Esophagogastrectomy include,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,"2.	Post-operatively, do not manipulate, move, or discontinue the patient's NG tube without permission from the Surgeon.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,"2.	Post-operatively, do not manipulate, move, or discontinue the patient's NG tube without permission from the Surgeon.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,3.	Medications may be given via the NG Tube post-operatively.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,3.	Medications may be given via the NG Tube post-operatively.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,4.	Notify the Thoracic Surgeon if there is no NG Tube output post-operatively,a.	In 4 hours,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,4.	Notify the Thoracic Surgeon if there is no NG Tube output post-operatively,b.	In 8 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,4.	Notify the Thoracic Surgeon if there is no NG Tube output post-operatively,c.	In 12 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,4.	Notify the Thoracic Surgeon if there is no NG Tube output post-operatively,d.	All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,5.	Decompression of the stomach post-esophagogastrectomy is essential because,a.	The surgery severs 2 of the 3 major arteries supplying the stomach.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,5.	Decompression of the stomach post-esophagogastrectomy is essential because,b.	Abdominal distention can cut off the existing blood supply and cause ischemia to occur.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,5.	Decompression of the stomach post-esophagogastrectomy is essential because,c.	The patient is high risk for aspiration.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,5.	Decompression of the stomach post-esophagogastrectomy is essential because,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,6.	You should report white milky-colored drainage from the JP chest drain to the Thoracic Surgeon immediately since this can be an indication of a Chyle leak related to lymphatic system injury.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,6.	You should report white milky-colored drainage from the JP chest drain to the Thoracic Surgeon immediately since this can be an indication of a Chyle leak related to lymphatic system injury.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,7.	I have read the CBL in its entirety and understand that I am responsible for this information.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,7.	I have read the CBL in its entirety and understand that I am responsible for this information.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,8.	I have listened to the video in its entirety and understand that I am responsible for this information.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,8.	I have listened to the video in its entirety and understand that I am responsible for this information.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,9.	Oral care is essential for these patients in order to prevent,a.	HAP,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,9.	Oral care is essential for these patients in order to prevent,b.	CAP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,9.	Oral care is essential for these patients in order to prevent,c.	VAP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,9.	Oral care is essential for these patients in order to prevent,d.	None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,10.	A potential complication for this surgery that has a high mortality rate is,a.	Pneumonia and ARDS,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,10.	A potential complication for this surgery that has a high mortality rate is,b.	Unresolved pain,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,10.	A potential complication for this surgery that has a high mortality rate is,c.	J tube complications,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9116,,Elearning-0000-382,NSC ICU ESOPHAGOGASTRECTOMY SURGERY,,n13738,,choice,10.	A potential complication for this surgery that has a high mortality rate is,d.	None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9072,,Elearning-0000-342,NSH1297 AMENDMENT 4,,n13742,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSH1297 AMENDMENT 4- g13742,False
9072,,Elearning-0000-342,NSH1297 AMENDMENT 4,,n13742,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9072,,Elearning-0000-342,NSH1297 AMENDMENT 4,,n13742,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9094,,Elearning-0000-362,NSH1208 AMENDMENT 3,,n13744,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSH1208 AMENDMENT 3- g13744,False
9094,,Elearning-0000-362,NSH1208 AMENDMENT 3,,n13744,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9094,,Elearning-0000-362,NSH1208 AMENDMENT 3,,n13744,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the definitions below is CORRECT?,a.	Neonate refers to a person from birth to 28 days of age,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY- g13745,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the definitions below is CORRECT?,a.	Neonate refers to a person from birth to 28 days of age,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the definitions below is CORRECT?,b.	Infant refers to a child who is >28 days to 1 year of age,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the definitions below is CORRECT?,c.	Pediatric refers to children from 1 year to 11 years,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the definitions below is CORRECT?,d.	Adolescent refers to a person who is 12-17 years,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the definitions below is CORRECT?,e.	Adult refers to a person who is 18 years or greater,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the definitions below is CORRECT?,f.	All of the above are correct,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the following statements is INCORRECT?,"a.	Neonatal code carts are located in Special Care Nursery, L&D, and FCC, and are used to resuscitate neonates and infants after birth until discharge.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the following statements is INCORRECT?,b.	Neonatal carts are located in ED and are used to Resuscitate Neonates and Infants up to 1 year of age.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the following statements is INCORRECT?,c.	Broselow carts are located in ED and Surgery and are used for resuscitation of children in those areas (Infants and pediatrics).,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the following statements is INCORRECT?,d.	Adult Code Carts contain a drawer (drawer 4) which contains medications and references for Infant and Pediatric Resuscitation.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,A five month old baby is brought into the Emergency Department with no respirations and no pulse. Which of the following is CORRECT related to resuscitation of this Infant?,a.	The ED will call the Neonatal evaluation team and use the Neonatal Code Cart and NRP algorithms for resuscitation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,A five month old baby is brought into the Emergency Department with no respirations and no pulse. Which of the following is CORRECT related to resuscitation of this Infant?,b.	The ED will use the Broselow Code Cart and PALS algorithms for resuscitation,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,A five month old baby is brought into the Emergency Department with no respirations and no pulse. Which of the following is CORRECT related to resuscitation of this Infant?,c.	The ED will use the Adult Code Cart and ACLS algorithms for resuscitation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,A five month old baby is brought into the Emergency Department with no respirations and no pulse. Which of the following is CORRECT related to resuscitation of this Infant?,d.	None of the above is correct,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,"Which is CORRECT regarding dosing references associated with Neonatal, Broselow, and Adult Code Carts?",a.	Neonatal Code Carts have reference binders on each cart with dosing sheets to calculate exact doses of medications based on weight or gestational age as applicable.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,"Which is CORRECT regarding dosing references associated with Neonatal, Broselow, and Adult Code Carts?","b.	Broselow Carts have color coded weight based PALS Pediatric Dosing Sheets in the medication drawer that correspond to drawer color and medication concentrations, and should be used to determine exact doses of medications based on weight.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,"Which is CORRECT regarding dosing references associated with Neonatal, Broselow, and Adult Code Carts?","c.	At Northside Hospital, the Broselow Tape in the Pediatric Medication Drawer should only be used to obtain an estimated weight range of a pediatric patient by measuring height / length if actual weight is not known.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,"Which is CORRECT regarding dosing references associated with Neonatal, Broselow, and Adult Code Carts?","d.	Adult Code Carts have weight based Pediatric Dosing Sheets located in the Pediatric Drawer (Drawer 4), which is identical to the Broselow Code Cart medication drawer.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,"Which is CORRECT regarding dosing references associated with Neonatal, Broselow, and Adult Code Carts?",e.	All of the above are correct.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,"True or false? The PALS dosing reference indicates initial dosing and rate for epinephrine and dopamine drips, and a weight based titration chart has been added for drip titration.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,"True or false? The PALS dosing reference indicates initial dosing and rate for epinephrine and dopamine drips, and a weight based titration chart has been added for drip titration.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the below is INCORRECT regarding the preferred way to administer 0.01mg/ kg epinephrine dose for PEA to a 9 kg infant in the ED:,a.	Use the PALS dosing sheet in the pediatric medication tray of the Broselow Code Cart to verify the correct exact dose in mg and mL based on the patient's weight,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the below is INCORRECT regarding the preferred way to administer 0.01mg/ kg epinephrine dose for PEA to a 9 kg infant in the ED:,"b.	Using the 1mg/ 10mL epinephrine Abboject in the pediatric medication drawer, withdraw 0.9ml (0.09mg) epinephrine into a syringe with appropriate markings of measurement using a transfer device (Rapidfill connector or stopcock)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the below is INCORRECT regarding the preferred way to administer 0.01mg/ kg epinephrine dose for PEA to a 9 kg infant in the ED:,"c.	Using the 1mg/ 10mL epinephrine Abboject in the pediatric medication drawer, inject  0.9ml (0.09mg) epinephrine dose into the infant's IV or IO access directly from the 1mg/ 10ml epinephrine Abboject syringe.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the following is CORRECT regarding Neonatal Resuscitation?,a.	Epinephrine is the primary pharmacologic treatment in NRP algorithm for neonatal resuscitation,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the following is CORRECT regarding Neonatal Resuscitation?,b.	Lidocaine and amiodarone are the primary treatment options for pulseless ventricular fibrillation and ventricular tachycardia in NRP the algorithm.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the following is CORRECT regarding Neonatal Resuscitation?,c.	The NRP algorithm includes defibrillation for pulseless ventricular fibrillation and ventricular tachycardia.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the following is INCORRECT regarding Infant and Pediatric Resuscitation using PALS?,a.	Epinephrine is the only pharmacologic treatment in the PALS algorithms for infant and pediatric resuscitation,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the following is INCORRECT regarding Infant and Pediatric Resuscitation using PALS?,b.	Epinephrine and Atropine are both options for symptomatic bradycardia in the PALS bradycardia algorithm.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the following is INCORRECT regarding Infant and Pediatric Resuscitation using PALS?,c.	Lidocaine and amiodarone are antiarrhythmic treatment options for pulseless ventricular fibrillation and ventricular tachycardia in the PALS Cardiac Arrest algorithm.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9159,,Elearning-0000-421,FY2021 PHARMACY NEONATAL INFANT PEDIATRIC RESUSCITATION COMPETENCY,,n13745,,choice,Which of the following is INCORRECT regarding Infant and Pediatric Resuscitation using PALS?,d.	The PALS algorithm includes defibrillation for pulseless ventricular fibrillation and ventricular tachycardia.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9446,,Elearning-0000-682,CONSTANT OBSERVER CASE STUDY CBL,,n13749,,choice,I have read the contents of this CBL in its entirety and I have filled out a Constant Observer Flowsheet and submitted it in Tara's mailbox.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is CONSTANT OBSERVER CASE STUDY CBL- g13749,False
9446,,Elearning-0000-682,CONSTANT OBSERVER CASE STUDY CBL,,n13749,,choice,I have read the contents of this CBL in its entirety and I have filled out a Constant Observer Flowsheet and submitted it in Tara's mailbox.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9446,,Elearning-0000-682,CONSTANT OBSERVER CASE STUDY CBL,,n13749,,choice,I have read the contents of this CBL in its entirety and I have filled out a Constant Observer Flowsheet and submitted it in Tara's mailbox.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9608,,Elearning-0000-83,WSU BHS COMPETENCY 2021,,n13753,,choice,"I have completed my updated Constant Observer Sheet using the Case Study provided in this CBL, filled out the top section of my Behavioral Health Annual Competency Form and signed the back, and placed these two forms in the Clinician's box.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is WSU BHS COMPETENCY 2021- g13753,False
9608,,Elearning-0000-83,WSU BHS COMPETENCY 2021,,n13753,,choice,"I have completed my updated Constant Observer Sheet using the Case Study provided in this CBL, filled out the top section of my Behavioral Health Annual Competency Form and signed the back, and placed these two forms in the Clinician's box.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9608,,Elearning-0000-83,WSU BHS COMPETENCY 2021,,n13753,,choice,"I have completed my updated Constant Observer Sheet using the Case Study provided in this CBL, filled out the top section of my Behavioral Health Annual Competency Form and signed the back, and placed these two forms in the Clinician's box.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,1.	Radiation Oncology price estimates consist of what two types of estimates?,a.	Profee and Technical,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021- g13754,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,1.	Radiation Oncology price estimates consist of what two types of estimates?,a.	Profee and Technical,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,1.	Radiation Oncology price estimates consist of what two types of estimates?,b.	Technical only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,1.	Radiation Oncology price estimates consist of what two types of estimates?,c.	Profee only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,2. The Oncology Financial Resource Specialist should create a _____________ and ______________ estimate for employed physicians.,a.	Professional and Contracted,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,2. The Oncology Financial Resource Specialist should create a _____________ and ______________ estimate for employed physicians.,b.	Professional and Technical,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,2. The Oncology Financial Resource Specialist should create a _____________ and ______________ estimate for employed physicians.,c.	Technical and Commercial,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,3.	The Oncology Financial Resource Specialist should create a _____________ ________ only for contracted physicians.,a.	Technical estimate,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,3.	The Oncology Financial Resource Specialist should create a _____________ ________ only for contracted physicians.,b.	Insurance estimate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,3.	The Oncology Financial Resource Specialist should create a _____________ ________ only for contracted physicians.,c.	Contracted estimate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"4.	If the patient has a Profee and a technical estimate, which should be generated first?",a.	Either one - it does not matter which order they are created in,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"4.	If the patient has a Profee and a technical estimate, which should be generated first?",b.	Technical,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"4.	If the patient has a Profee and a technical estimate, which should be generated first?",c.	Profee,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,5.	The Oncology Financial Resource Specialist should review previous accounts for outstanding balances and bad debt. This should be included in the FET as it is the total patient financial responsibility.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,5.	The Oncology Financial Resource Specialist should review previous accounts for outstanding balances and bad debt. This should be included in the FET as it is the total patient financial responsibility.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"6.	When creating the technical estimate, it is not necessary to deduct the Profee estimate from the remaining insurance benefits.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"6.	When creating the technical estimate, it is not necessary to deduct the Profee estimate from the remaining insurance benefits.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,7.	What is the first step in preparation for creating a Radiation Oncology price estimate?,a.	Access STAR ILE and locate Modality Treatment Plan,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,7.	What is the first step in preparation for creating a Radiation Oncology price estimate?,b.	Access STAR to obtain insurance benefits,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,7.	What is the first step in preparation for creating a Radiation Oncology price estimate?,c.	Log into the FET Tool,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,8.	What is the name of the tool used by the Oncology Financial Resource Specialist to calculate the technical fees listed on the Modality Treatment Plan?,a.	Estimation Workbook,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,8.	What is the name of the tool used by the Oncology Financial Resource Specialist to calculate the technical fees listed on the Modality Treatment Plan?,b.	FET,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,8.	What is the name of the tool used by the Oncology Financial Resource Specialist to calculate the technical fees listed on the Modality Treatment Plan?,c.	Technical Workbook,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,9. A standard note code must be added to each account to notate the financial outcome.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,9. A standard note code must be added to each account to notate the financial outcome.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,10. A financial clearance/ non-clearance email will be sent to the appropriate email distribution list after the Oncology Financial Resource Specialist works each account.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,10. A financial clearance/ non-clearance email will be sent to the appropriate email distribution list after the Oncology Financial Resource Specialist works each account.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,11.	The Modality Treatment plan specifies the quantities of CPT codes and differentiates which codes are Profee versus technical.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,11.	The Modality Treatment plan specifies the quantities of CPT codes and differentiates which codes are Profee versus technical.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"12.	When creating the technical estimate, the Oncology Financial Resource Specialist will refer to the standard processes and procedures via the Financial Estimation Tool.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"12.	When creating the technical estimate, the Oncology Financial Resource Specialist will refer to the standard processes and procedures via the Financial Estimation Tool.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,13.	Each treatment plan has either 3 days or 5 days listed at the top. What does the Oncology Financial Resource Specialist use this for?,a.	This does not indicate anything,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,13.	Each treatment plan has either 3 days or 5 days listed at the top. What does the Oncology Financial Resource Specialist use this for?,b.	The number of treatments,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,13.	Each treatment plan has either 3 days or 5 days listed at the top. What does the Oncology Financial Resource Specialist use this for?,c.	The number of business days to financially clear the patient,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"14. If an ABN is located in STAR, the Oncology Financial Resource Specialist should create a self-pay estimate for the applicable non-covered CPT codes?",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"14. If an ABN is located in STAR, the Oncology Financial Resource Specialist should create a self-pay estimate for the applicable non-covered CPT codes?",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"15.	 Once the Oncology Financial Resource Specialist completes the ABN, the completed document should be scanned into what ILE folder?",a.	PFS: Primary Insurance,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"15.	 Once the Oncology Financial Resource Specialist completes the ABN, the completed document should be scanned into what ILE folder?",b.	PFS: Insurance Information,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"15.	 Once the Oncology Financial Resource Specialist completes the ABN, the completed document should be scanned into what ILE folder?",c.	PFS: ABN,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,16.	The Intake team will write ________________ across the top of the treatment plan when a patient's care must begin immediately.,a.	Hurry Up,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,16.	The Intake team will write ________________ across the top of the treatment plan when a patient's care must begin immediately.,b.	Emergency,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,16.	The Intake team will write ________________ across the top of the treatment plan when a patient's care must begin immediately.,c.	ASAP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"17.	 If an emergency patient is unable to make a suitable payment arrangement or qualify for financial assistance, their appointment ______ _______ be postponed.",a.	Will,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"17.	 If an emergency patient is unable to make a suitable payment arrangement or qualify for financial assistance, their appointment ______ _______ be postponed.",b.	Will not,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"17.	 If an emergency patient is unable to make a suitable payment arrangement or qualify for financial assistance, their appointment ______ _______ be postponed.",c.	May be,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,18.	 The Oncology Financial Resource Specialist fills out the Patient Tracker on each patient worked.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,18.	 The Oncology Financial Resource Specialist fills out the Patient Tracker on each patient worked.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"19. If a non-emergency patient cannot make a suitable payment arrangement or qualify for financial assistance, the treatment is  ____________________",a.	Postponed/rescheduled,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"19. If a non-emergency patient cannot make a suitable payment arrangement or qualify for financial assistance, the treatment is  ____________________",b.	Continued,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"19. If a non-emergency patient cannot make a suitable payment arrangement or qualify for financial assistance, the treatment is  ____________________",c.	Cancelled,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,20.	Generic Treatment Plans will be created for patients that do not have an estimated amount due for radiation oncology treatment but may have _______________,a.	Outstanding balances and/or bad debt,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,20.	Generic Treatment Plans will be created for patients that do not have an estimated amount due for radiation oncology treatment but may have _______________,b.	A regularly scheduled appointment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,20.	Generic Treatment Plans will be created for patients that do not have an estimated amount due for radiation oncology treatment but may have _______________,c.	Paperwork that needs to be updated,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,21. The Radiation Oncology Estimation Workbook is located in what folder?,a.	Patient Access All - Radiation Oncology Estimator Worksheet,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,21. The Radiation Oncology Estimation Workbook is located in what folder?,b.	Patient Access All - Rad Onc Profee Worksheet,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,21. The Radiation Oncology Estimation Workbook is located in what folder?,c.	Patient Access All - Profee Workbook,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"22.	When saving an estimate letter in the Radiation Oncology Estimation Workbook, the following process is followed:","a.	While on the letter tab, hit the save button",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"22.	When saving an estimate letter in the Radiation Oncology Estimation Workbook, the following process is followed:","b.	While on the letter tab, do ""file, save as""� and save letter to desktop",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"22.	When saving an estimate letter in the Radiation Oncology Estimation Workbook, the following process is followed:",c.	Return to the patient tab and hit the gray save button at the top,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"23.	 By selecting the gray ""SAVE""    button on the Patient Form tab of the Radiation Oncology Estimation Workbook, the estimate letter is:",a.	Automatically saved to the Galen folder,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"23.	 By selecting the gray ""SAVE""    button on the Patient Form tab of the Radiation Oncology Estimation Workbook, the estimate letter is:",b.	Automatically saved to the desktop,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"23.	 By selecting the gray ""SAVE""    button on the Patient Form tab of the Radiation Oncology Estimation Workbook, the estimate letter is:",c.	Automatically sent to the patient,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"24.	 Once the Profee estimate letter is saved on the Galen drive, the Oncology Financial Resource Specialist should access the Galen drive and","a.	Open the excel workbook, access the estimate letter and change to a PDF format",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"24.	 Once the Profee estimate letter is saved on the Galen drive, the Oncology Financial Resource Specialist should access the Galen drive and",b.	Open the excel workbook and delete the estimate letter,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"24.	 Once the Profee estimate letter is saved on the Galen drive, the Oncology Financial Resource Specialist should access the Galen drive and",c.	Do nothing.  Galen does not need the letter,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,25.	 Profee and technical payments are applied to the same outlet in Wells Fargo.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,25.	 Profee and technical payments are applied to the same outlet in Wells Fargo.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,26.	 What two steps have to be done in order to create the Profee Financial Estimate letter once the Oncology Financial Resource Specialist accesses the Radiation Oncology Estimation Workbook?,a.	Fill in the insurance benefits on the Patient Form and review the Detailed Bill Estimate tab,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,26.	 What two steps have to be done in order to create the Profee Financial Estimate letter once the Oncology Financial Resource Specialist accesses the Radiation Oncology Estimation Workbook?,b.	Fill in the insurance benefits on the Patient Form tab and save to the desktop,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,26.	 What two steps have to be done in order to create the Profee Financial Estimate letter once the Oncology Financial Resource Specialist accesses the Radiation Oncology Estimation Workbook?,c.	Fill in the insurance benefits on the Patient Form tab and compare the Treatment Plan CPT Codes and Quantities to the ones listed on the Template List tab and update as needed,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"27.	 If an Oncology Financial Resource Specialist is unable to reach a patient to provide an estimate prior to treatment, the patient is considered financially cleared.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,"27.	 If an Oncology Financial Resource Specialist is unable to reach a patient to provide an estimate prior to treatment, the patient is considered financially cleared.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,28.	 When should the Oncology Financial Resource Specialist run eligibility through RevRunner (if applicable) to see if the patient has met more of their deductible or out of pocket prior to creating the estimate letter?,a.	Only if benefits were verified by the Intake Team within the past two weeks,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,28.	 When should the Oncology Financial Resource Specialist run eligibility through RevRunner (if applicable) to see if the patient has met more of their deductible or out of pocket prior to creating the estimate letter?,b.	Only if benefits were verified by the Intake Team within the past week,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,28.	 When should the Oncology Financial Resource Specialist run eligibility through RevRunner (if applicable) to see if the patient has met more of their deductible or out of pocket prior to creating the estimate letter?,c.	Prior to every estimate,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,29.	 The Oncology Financial Resource Specialist should scan both the profee and technical estimate letters to what folder in ILE?,a.	PFS:  POS COLLECTIONS DOCUMENTS,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,29.	 The Oncology Financial Resource Specialist should scan both the profee and technical estimate letters to what folder in ILE?,b.	PFS:  PRICE ESTIMATE LETTERS,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,29.	 The Oncology Financial Resource Specialist should scan both the profee and technical estimate letters to what folder in ILE?,c.	PFS:  COLLECTIONS LETTERS,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,30.	  If a patient pays more than the required 1/3 down deposit the Oncology Financial Resource Specialist should use what form located on the Revenue Cycle Website?,a.	Generic FET Letter,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,30.	  If a patient pays more than the required 1/3 down deposit the Oncology Financial Resource Specialist should use what form located on the Revenue Cycle Website?,b.	Copay FET Letter,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8952,,Elearning-0000-233,RADIATION ONCOLOGY TRAINING FOR PROFESSIONAL AND TECHNICAL PRICE ESTIMATES_2021,,n13754,,choice,30.	  If a patient pays more than the required 1/3 down deposit the Oncology Financial Resource Specialist should use what form located on the Revenue Cycle Website?,c.	1/3 Down/Copay Only FET Letter,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,Vasopressors increase vasoconstriction which can increase perfusion to distal tissue like the skin,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION- g13755,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,Vasopressors increase vasoconstriction which can increase perfusion to distal tissue like the skin,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,Vasopressors increase vasoconstriction which can increase perfusion to distal tissue like the skin,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,What is the most common mistake made in regards to not completing titrations correctly (may result in putting patients at higher risk for skin breakdown)?,1. Titrating gtts every time a MAP is outside of ordered range,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,What is the most common mistake made in regards to not completing titrations correctly (may result in putting patients at higher risk for skin breakdown)?,2.  2 consecutive MAPs> ordered upper parameter without decreasing the vasopressor gtt,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,What is the most common mistake made in regards to not completing titrations correctly (may result in putting patients at higher risk for skin breakdown)?,"3,  Titrating gtt when MAP is within ordered range",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,What is the most common mistake made in regards to not completing titrations correctly (may result in putting patients at higher risk for skin breakdown)?,4.  All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,"MAP ordered range is to maintain MAP 65-80, patient has a MAP of 64 followed by a MAP of 65, what should you do? (best answer)",1.  Titrate the vasopressor up by the ordered dose,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,"MAP ordered range is to maintain MAP 65-80, patient has a MAP of 64 followed by a MAP of 65, what should you do? (best answer)",2.  Titrate vasopressor down by ordered dose,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,"MAP ordered range is to maintain MAP 65-80, patient has a MAP of 64 followed by a MAP of 65, what should you do? (best answer)","3.  Continue to monitor VS every 15 minutes until 2 consecutive MAP's are out of range, then titrate according to order",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,"MAP ordered range is to maintain MAP 65-80, patient has a MAP of 64 followed by a MAP of 65, what should you do? (best answer)",4.  None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,"To aggressively wean vasopressor gtts, what is the recommended MAP range?",1.  MAP 65-70 for the majority of patients,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,"To aggressively wean vasopressor gtts, what is the recommended MAP range?","2.  MAP 70-80, higher is better",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,"To aggressively wean vasopressor gtts, what is the recommended MAP range?",3.  MAP 60-50,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,"To aggressively wean vasopressor gtts, what is the recommended MAP range?",4. MAP 75-85,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,It is best to complete all titrations through the MAR,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,It is best to complete all titrations through the MAR,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,"At the beginning of every shift, the oncoming RN should enter gtt rates in iVIEW gtt section during handoff for verification of line reconciliation and to ensure baseline rate for all gtt titrations for the shift",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,"At the beginning of every shift, the oncoming RN should enter gtt rates in iVIEW gtt section during handoff for verification of line reconciliation and to ensure baseline rate for all gtt titrations for the shift",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,If a patient has 2 VS sources (Cuff pressure and Aline)- both sources must be documented in the EMR every 15 minutes for the duration of all vasoactive gtts.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,If a patient has 2 VS sources (Cuff pressure and Aline)- both sources must be documented in the EMR every 15 minutes for the duration of all vasoactive gtts.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,Communications orders should only be used for 1 time events,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,Communications orders should only be used for 1 time events,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,"It is ok to titrate vasoactive gtts when VS are within ordered range (example:  MAP is 75, order is to maintain MAP of 60-80)",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,"It is ok to titrate vasoactive gtts when VS are within ordered range (example:  MAP is 75, order is to maintain MAP of 60-80)",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,"I have read and understand the content of the CBL entitled FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION, understand that I am responsible for the content contained herein, and proper vasoactive gtt titrations following provider orders.  I will seek assistance or further education as needed.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9315,,Elearning-0000-563,FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION,,n13755,,choice,"I have read and understand the content of the CBL entitled FY2021 NSF ICU VASOACTIVE GTT TITRATION EDUCATION, understand that I am responsible for the content contained herein, and proper vasoactive gtt titrations following provider orders.  I will seek assistance or further education as needed.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"According to ISMP, heparin, argatroban, and all IV anticoagulants are:",a.	High-alert medications,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY- g13756,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"According to ISMP, heparin, argatroban, and all IV anticoagulants are:",a.	High-alert medications,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"According to ISMP, heparin, argatroban, and all IV anticoagulants are:",b.	Low-alert medications,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"According to ISMP, heparin, argatroban, and all IV anticoagulants are:",c.	Highly addictive medications,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"According to ISMP, heparin, argatroban, and all IV anticoagulants are:",d.	None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,Potential adverse effects of heparin include:,a.	Systemic bleeding,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,Potential adverse effects of heparin include:,b.	Heparin-induced thrombocytopenia,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,Potential adverse effects of heparin include:,c.	Heparin-induced osteopenia,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,Potential adverse effects of heparin include:,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,Heparin is indicated for:,a.	Prophylaxis for DVT/PE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,Heparin is indicated for:,b.	Treatment of DVT/PE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,Heparin is indicated for:,c.	Acute Coronary Syndrome,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,Heparin is indicated for:,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"You are caring for an elderly patient (85 years old) who is on a heparin drip at 850 units per hour.  The admitting diagnosis is rule out DVT in left lower extremity.  The patient's home medications include aspirin and Plavix.  BP with routine vitals is 190/95 mmHg.  The patient is awake, but their mental status has noticeably declined since the last assessment and they are requesting something for a severe headache.  The patient's 6 hour anti-Xa result was just received from the lab and is > 2.  Which of the following statements are true:",a.	The patient has an increased risk of bleeding due to their anti-Xa and concurrent anti-platelet therapy.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"You are caring for an elderly patient (85 years old) who is on a heparin drip at 850 units per hour.  The admitting diagnosis is rule out DVT in left lower extremity.  The patient's home medications include aspirin and Plavix.  BP with routine vitals is 190/95 mmHg.  The patient is awake, but their mental status has noticeably declined since the last assessment and they are requesting something for a severe headache.  The patient's 6 hour anti-Xa result was just received from the lab and is > 2.  Which of the following statements are true:",b.	The heparin drip should be held and the physician contacted for orders.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"You are caring for an elderly patient (85 years old) who is on a heparin drip at 850 units per hour.  The admitting diagnosis is rule out DVT in left lower extremity.  The patient's home medications include aspirin and Plavix.  BP with routine vitals is 190/95 mmHg.  The patient is awake, but their mental status has noticeably declined since the last assessment and they are requesting something for a severe headache.  The patient's 6 hour anti-Xa result was just received from the lab and is > 2.  Which of the following statements are true:",c.	The headache and elevated BP could be an indication of an impending serious adverse drug event,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"You are caring for an elderly patient (85 years old) who is on a heparin drip at 850 units per hour.  The admitting diagnosis is rule out DVT in left lower extremity.  The patient's home medications include aspirin and Plavix.  BP with routine vitals is 190/95 mmHg.  The patient is awake, but their mental status has noticeably declined since the last assessment and they are requesting something for a severe headache.  The patient's 6 hour anti-Xa result was just received from the lab and is > 2.  Which of the following statements are true:",d.	All of the above are true.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,CC is a 62 year old male admitted to the medical unit with a deep vein thrombosis in his left lower leg.  His admitting physician initiates the weight-based heparin order set based on the following parameters:  80 units/kg bolus followed by 18 units/kg/hour infusion.  CC weighs 77kg.  His baseline PTT is 27.  CC's initial bolus dose will be:,a.	6160 units,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,CC is a 62 year old male admitted to the medical unit with a deep vein thrombosis in his left lower leg.  His admitting physician initiates the weight-based heparin order set based on the following parameters:  80 units/kg bolus followed by 18 units/kg/hour infusion.  CC weighs 77kg.  His baseline PTT is 27.  CC's initial bolus dose will be:,b.	6000 units,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,CC is a 62 year old male admitted to the medical unit with a deep vein thrombosis in his left lower leg.  His admitting physician initiates the weight-based heparin order set based on the following parameters:  80 units/kg bolus followed by 18 units/kg/hour infusion.  CC weighs 77kg.  His baseline PTT is 27.  CC's initial bolus dose will be:,c.	5000 units,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,CC is a 62 year old male admitted to the medical unit with a deep vein thrombosis in his left lower leg.  His admitting physician initiates the weight-based heparin order set based on the following parameters:  80 units/kg bolus followed by 18 units/kg/hour infusion.  CC weighs 77kg.  His baseline PTT is 27.  CC's initial bolus dose will be:,"d.	10,000 units",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"The pharmacy dispensed heparin 10,000 units/ 10 ml vial for administration of the bolus.  The correct volume to be administered is:",a.	2 ml,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"The pharmacy dispensed heparin 10,000 units/ 10 ml vial for administration of the bolus.  The correct volume to be administered is:",b.	4 ml,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"The pharmacy dispensed heparin 10,000 units/ 10 ml vial for administration of the bolus.  The correct volume to be administered is:",c.	6 ml,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"The pharmacy dispensed heparin 10,000 units/ 10 ml vial for administration of the bolus.  The correct volume to be administered is:",d.	8 ml,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"The orders specify the patient will receive 18 units/kg/hour via continuous infusion.  Again, the patient's dosing weight is 77.9 kg.  How many units per hour will CC receive?  Units/hour = (units/kg/hour) x (patient's weight) = units/hour (DO NOT ROUND).",a.	1400 units/hour,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"The orders specify the patient will receive 18 units/kg/hour via continuous infusion.  Again, the patient's dosing weight is 77.9 kg.  How many units per hour will CC receive?  Units/hour = (units/kg/hour) x (patient's weight) = units/hour (DO NOT ROUND).",b.	1402.2 units/hour,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"The orders specify the patient will receive 18 units/kg/hour via continuous infusion.  Again, the patient's dosing weight is 77.9 kg.  How many units per hour will CC receive?  Units/hour = (units/kg/hour) x (patient's weight) = units/hour (DO NOT ROUND).",c.	1387 units/hour,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"The orders specify the patient will receive 18 units/kg/hour via continuous infusion.  Again, the patient's dosing weight is 77.9 kg.  How many units per hour will CC receive?  Units/hour = (units/kg/hour) x (patient's weight) = units/hour (DO NOT ROUND).",d.	1500 units/hour,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"In order to deliver 1402.2 units/hour of heparin, the infusion pump should be set to deliver how many ml/hour?  The heparin drip dispensed from pharmacy is 25,000 units in 500 mL with a concentration of 50 units/mL. Round to the nearest 0.1mL per pump capabilities.",a.	28 ml/hour,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"In order to deliver 1402.2 units/hour of heparin, the infusion pump should be set to deliver how many ml/hour?  The heparin drip dispensed from pharmacy is 25,000 units in 500 mL with a concentration of 50 units/mL. Round to the nearest 0.1mL per pump capabilities.",b.	28.1 ml/hour,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"In order to deliver 1402.2 units/hour of heparin, the infusion pump should be set to deliver how many ml/hour?  The heparin drip dispensed from pharmacy is 25,000 units in 500 mL with a concentration of 50 units/mL. Round to the nearest 0.1mL per pump capabilities.",c.	27 ml/hour,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"In order to deliver 1402.2 units/hour of heparin, the infusion pump should be set to deliver how many ml/hour?  The heparin drip dispensed from pharmacy is 25,000 units in 500 mL with a concentration of 50 units/mL. Round to the nearest 0.1mL per pump capabilities.",d.	30 ml/hour,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"Prior to administration of a heparin bolus dose, the nurse should",a.	Verify the bolus dose calculations with a pharmacist or physician,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"Prior to administration of a heparin bolus dose, the nurse should","b.	Read the medication label three times (drug name, concentration, and vial size)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"Prior to administration of a heparin bolus dose, the nurse should","c.	Confirm the amount in the syringe (both the dose in units, and volume in ml) with a second RN",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"Prior to administration of a heparin bolus dose, the nurse should",d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,Argatroban can be used in patients with Heparin-Induced Thrombocytopenia (HIT),TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,Argatroban can be used in patients with Heparin-Induced Thrombocytopenia (HIT),FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,11.	AA is a 55 year old female on a heparin infusion who develops severe thrombocytopenia with concern for HIT.  Her discontinues heparin and orders an argatroban infusion to begin 2 hours later. Her baseline anticoagulation labs are within normal limits and she has normal liver function. CC weighs 68.5kg and her initial argatroban infusion dose is 2 mcg/kg/min.  What is her initial infusion rate in mcg/hr (do not round)? Argatroban infusion rate ______ mcg/kg/min x ______kg x 60 = rate in mcg/hr,a.	8000 mcg/hr,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,11.	AA is a 55 year old female on a heparin infusion who develops severe thrombocytopenia with concern for HIT.  Her discontinues heparin and orders an argatroban infusion to begin 2 hours later. Her baseline anticoagulation labs are within normal limits and she has normal liver function. CC weighs 68.5kg and her initial argatroban infusion dose is 2 mcg/kg/min.  What is her initial infusion rate in mcg/hr (do not round)? Argatroban infusion rate ______ mcg/kg/min x ______kg x 60 = rate in mcg/hr,b.	9000 mcg/hr,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,11.	AA is a 55 year old female on a heparin infusion who develops severe thrombocytopenia with concern for HIT.  Her discontinues heparin and orders an argatroban infusion to begin 2 hours later. Her baseline anticoagulation labs are within normal limits and she has normal liver function. CC weighs 68.5kg and her initial argatroban infusion dose is 2 mcg/kg/min.  What is her initial infusion rate in mcg/hr (do not round)? Argatroban infusion rate ______ mcg/kg/min x ______kg x 60 = rate in mcg/hr,c.	8220 mcg/hr,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,11.	AA is a 55 year old female on a heparin infusion who develops severe thrombocytopenia with concern for HIT.  Her discontinues heparin and orders an argatroban infusion to begin 2 hours later. Her baseline anticoagulation labs are within normal limits and she has normal liver function. CC weighs 68.5kg and her initial argatroban infusion dose is 2 mcg/kg/min.  What is her initial infusion rate in mcg/hr (do not round)? Argatroban infusion rate ______ mcg/kg/min x ______kg x 60 = rate in mcg/hr,d.	8550 mcg/hr,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"In order to deliver 8220 mcg/hr of argatroban, the infusion pump should be set to deliver how many mL/hour?  The argatroban drip dispensed from pharmacy is 250mg in 250 mL with a concentration of 1000 mcg/mL. Round to the nearest 0.1mL per pump capabilities.",a.	9 mL/hr,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"In order to deliver 8220 mcg/hr of argatroban, the infusion pump should be set to deliver how many mL/hour?  The argatroban drip dispensed from pharmacy is 250mg in 250 mL with a concentration of 1000 mcg/mL. Round to the nearest 0.1mL per pump capabilities.",b.	8.5 mL/hr,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"In order to deliver 8220 mcg/hr of argatroban, the infusion pump should be set to deliver how many mL/hour?  The argatroban drip dispensed from pharmacy is 250mg in 250 mL with a concentration of 1000 mcg/mL. Round to the nearest 0.1mL per pump capabilities.",c.	8.3 mL/hr,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"In order to deliver 8220 mcg/hr of argatroban, the infusion pump should be set to deliver how many mL/hour?  The argatroban drip dispensed from pharmacy is 250mg in 250 mL with a concentration of 1000 mcg/mL. Round to the nearest 0.1mL per pump capabilities.",d.	8.2 mL.hr,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,The initials of the nurse performing calculations and the pharmacist (or physician) performing the independent double check must be recorded on the heparin or argatroban flow sheet.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,The initials of the nurse performing calculations and the pharmacist (or physician) performing the independent double check must be recorded on the heparin or argatroban flow sheet.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"Pump settings must be verified and documented at all of the following except""�",a.	Infusion initiation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"Pump settings must be verified and documented at all of the following except""�",b.	Bag changes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"Pump settings must be verified and documented at all of the following except""�",c.	Tubing changes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"Pump settings must be verified and documented at all of the following except""�",d.	Rate changes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"Pump settings must be verified and documented at all of the following except""�",e.	Shift changes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"Pump settings must be verified and documented at all of the following except""�",f.	Therapeutic Anti-Xa/PTT values,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"If titration via the nomogram for heparin or argatroban cause the rate to decrease to 0 ml/hour, which of the following is the correct action?",a.	Contact the physician for additional instructions/orders,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"If titration via the nomogram for heparin or argatroban cause the rate to decrease to 0 ml/hour, which of the following is the correct action?",b.	Stop the infusion and recheck level in 6 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"If titration via the nomogram for heparin or argatroban cause the rate to decrease to 0 ml/hour, which of the following is the correct action?",c.	Decrease the rate by  � and contact the physician,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,"If titration via the nomogram for heparin or argatroban cause the rate to decrease to 0 ml/hour, which of the following is the correct action?",d.	Continue the current rate and recheck level in 6 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,A patient on a heparin or argatroban infusion is found to have an error in their dosing weight of 10kg. Which of the following is the correct action?,"a.	Take no action, no change is required to the infusion rate",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,A patient on a heparin or argatroban infusion is found to have an error in their dosing weight of 10kg. Which of the following is the correct action?,b.	Document the correct dosing weight in the EMR and notify pharmacy,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,A patient on a heparin or argatroban infusion is found to have an error in their dosing weight of 10kg. Which of the following is the correct action?,"c.	Print a new flowsheet, write the correct dosing weight and re-calculate the infusion rate",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,A patient on a heparin or argatroban infusion is found to have an error in their dosing weight of 10kg. Which of the following is the correct action?,d.	Cross out the incorrect weight on the current flowsheet and write the correct weight.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,A patient on a heparin or argatroban infusion is found to have an error in their dosing weight of 10kg. Which of the following is the correct action?,e.	B and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9324,,Elearning-0000-571,FY2021 HEPARIN AND ARGATROBAN INFUSION EDUCATION: NURSING AND PHARMACY,,n13756,,choice,A patient on a heparin or argatroban infusion is found to have an error in their dosing weight of 10kg. Which of the following is the correct action?,f.	B and D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"According to current Northside policy, which age group requires all medication orders to be double checked?",A.	< 1 year old,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY- g13757,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"According to current Northside policy, which age group requires all medication orders to be double checked?",A.	< 1 year old,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"According to current Northside policy, which age group requires all medication orders to be double checked?",B.	11 years and younger,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"According to current Northside policy, which age group requires all medication orders to be double checked?",C.	12 years and younger,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"According to current Northside policy, which age group requires all medication orders to be double checked?",D.	18 years and younger,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,What is the most common source of pediatric patient harm during medical treatment?,A.	Procedural technique errors,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,What is the most common source of pediatric patient harm during medical treatment?,B.	Delays in therapeutic management,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,What is the most common source of pediatric patient harm during medical treatment?,C.	Medication errors,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,What is the most common source of pediatric patient harm during medical treatment?,D.	Lack of clinical guidelines,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which pediatric patient group is NOT identified as being at the highest risk of experiencing a medication error?,A. Surgery patients,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which pediatric patient group is NOT identified as being at the highest risk of experiencing a medication error?,B. ED patients,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which pediatric patient group is NOT identified as being at the highest risk of experiencing a medication error?,C. ICU patients,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which pediatric patient group is NOT identified as being at the highest risk of experiencing a medication error?,D. < 2 years old,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"In one study, pediatric patients were at risk of a potentially dangerous prescribing error that was _____ times greater than adult patients.",A.	2,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"In one study, pediatric patients were at risk of a potentially dangerous prescribing error that was _____ times greater than adult patients.",B.	3,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"In one study, pediatric patients were at risk of a potentially dangerous prescribing error that was _____ times greater than adult patients.",C.	4,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"In one study, pediatric patients were at risk of a potentially dangerous prescribing error that was _____ times greater than adult patients.",D.	5,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which of the following is true about independent double checks?,"A.	When done appropriately, double checks can decrease errors by 80%",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which of the following is true about independent double checks?,B.	Every situation requires two pharmacists to perform a double check,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which of the following is true about independent double checks?,C.	Only high risk medications require a double check,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which of the following is true about independent double checks?,D.	The first practitioner should not communicate their findings to the 2nd practitioner,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which of the following contributes to concerns of providing pediatric patients with medications in liquid form?,A.	Some medications are not commercially available as a liquid,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which of the following contributes to concerns of providing pediatric patients with medications in liquid form?,B.	Some commercially available products have unfavorable excipients,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which of the following contributes to concerns of providing pediatric patients with medications in liquid form?,C.	Some commercially available products are too concentrated for smaller patients and infants,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which of the following contributes to concerns of providing pediatric patients with medications in liquid form?,D.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"Based on multiple studies, pediatric patients in the emergency department are at particularly high risk of errors related to:",A.	Acetaminophen,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"Based on multiple studies, pediatric patients in the emergency department are at particularly high risk of errors related to:","B.	Adrenals, corticosteroids",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"Based on multiple studies, pediatric patients in the emergency department are at particularly high risk of errors related to:",C.	Insulin,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"Based on multiple studies, pediatric patients in the emergency department are at particularly high risk of errors related to:",D.	Opioids,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which of the following factors is thought to contribute to the medication error in the Emily Jerry case?,A.	Adult and pediatric medications stored together,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which of the following factors is thought to contribute to the medication error in the Emily Jerry case?,B.	Crowded pharmacy,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which of the following factors is thought to contribute to the medication error in the Emily Jerry case?,C.	Staff distracted by their cell phone,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which of the following factors is thought to contribute to the medication error in the Emily Jerry case?,D.	New electronic medical record implementation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which medication does Northside NICU further dilute to improve measurability?,A.	Carvedilol,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which medication does Northside NICU further dilute to improve measurability?,B.	Omeprazole,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which medication does Northside NICU further dilute to improve measurability?,C.	Baclofen,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,Which medication does Northside NICU further dilute to improve measurability?,D.	Propranolol,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"What patient areas are excluded from the ""Pediatric Patient Alert""�?",A.	NICU and Well Baby Nursery,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"What patient areas are excluded from the ""Pediatric Patient Alert""�?",B.	Main OR,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"What patient areas are excluded from the ""Pediatric Patient Alert""�?",C.	Labor and Delivery,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9006,,Elearning-0000-282,FY2021 PHARMACY NEONATAL AND PEDIATRIC MEDICATION COMPETENCY,,n13757,,choice,"What patient areas are excluded from the ""Pediatric Patient Alert""�?",D.	Emergency Department,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9021,,Elearning-0000-296,ON-Q PUMP EDUCATION WSU FY21,,n13763,,choice,I have read and understand the FY21 On-Q Pump Education CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is ON-Q PUMP EDUCATION WSU FY21- g13763,False
9021,,Elearning-0000-296,ON-Q PUMP EDUCATION WSU FY21,,n13763,,choice,I have read and understand the FY21 On-Q Pump Education CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9021,,Elearning-0000-296,ON-Q PUMP EDUCATION WSU FY21,,n13763,,choice,I have read and understand the FY21 On-Q Pump Education CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9549,,Elearning-0000-776,NSC ICU BBRAUN 400 ES PUMP UPDATE,,n13764,,choice,"I have read the CBL in it's entirety.  I understand that if I have questions, I can contact a leadership team member.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSC ICU BBRAUN 400 ES PUMP UPDATE- g13764,False
9549,,Elearning-0000-776,NSC ICU BBRAUN 400 ES PUMP UPDATE,,n13764,,choice,"I have read the CBL in it's entirety.  I understand that if I have questions, I can contact a leadership team member.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9549,,Elearning-0000-776,NSC ICU BBRAUN 400 ES PUMP UPDATE,,n13764,,choice,"I have read the CBL in it's entirety.  I understand that if I have questions, I can contact a leadership team member.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8902,,Elearning-0000-188,NSC ICU SEPSIS BOLUS FROM THE ED TO ICU,,n13765,,choice,"1.	Per the new workflow, when a patient arrives from the ED to the ICU with a sepsis bolus infusing""�",a.	The ICU nurse will see a task on Care Compass. b.	The task serves as a reminder to follow through with the new workflow c.	Do not complete the task until the infusion is complete and the end time is documented in the MAR.  d.	All of the above.,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSC ICU SEPSIS BOLUS FROM THE ED TO ICU- g13765,False
8902,,Elearning-0000-188,NSC ICU SEPSIS BOLUS FROM THE ED TO ICU,,n13765,,choice,"1.	Per the new workflow, when a patient arrives from the ED to the ICU with a sepsis bolus infusing""�",a.	The ICU nurse will see a task on Care Compass. b.	The task serves as a reminder to follow through with the new workflow c.	Do not complete the task until the infusion is complete and the end time is documented in the MAR.  d.	All of the above.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8902,,Elearning-0000-188,NSC ICU SEPSIS BOLUS FROM THE ED TO ICU,,n13765,,choice,"1.	Per the new workflow, when a patient arrives from the ED to the ICU with a sepsis bolus infusing""�",b.	The task serves as a reminder to follow through with the new workflow,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8902,,Elearning-0000-188,NSC ICU SEPSIS BOLUS FROM THE ED TO ICU,,n13765,,choice,"1.	Per the new workflow, when a patient arrives from the ED to the ICU with a sepsis bolus infusing""�",c.	Do not complete the task until the infusion is complete and the end time is documented in the MAR.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8902,,Elearning-0000-188,NSC ICU SEPSIS BOLUS FROM THE ED TO ICU,,n13765,,choice,"1.	Per the new workflow, when a patient arrives from the ED to the ICU with a sepsis bolus infusing""�",d.	All of the above.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8902,,Elearning-0000-188,NSC ICU SEPSIS BOLUS FROM THE ED TO ICU,,n13765,,choice,"2.	Select the correct order of actions:  When the sepsis bolus that was begun in the ED is complete, to end the infusion""� a.	Go to the MAR and find your sepsis bolus order b.	Select the Infuse square and document the infused volume in the ""infuse volume (mL)""� box c.	Click Apply d.	Click on the blue ""Pending""� box e.	Ensure that the ""to""� time is updated for the end-time of the infusion bag","i.	a, b, c, d, e",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8902,,Elearning-0000-188,NSC ICU SEPSIS BOLUS FROM THE ED TO ICU,,n13765,,choice,"2.	Select the correct order of actions:  When the sepsis bolus that was begun in the ED is complete, to end the infusion""� a.	Go to the MAR and find your sepsis bolus order b.	Select the Infuse square and document the infused volume in the ""infuse volume (mL)""� box c.	Click Apply d.	Click on the blue ""Pending""� box e.	Ensure that the ""to""� time is updated for the end-time of the infusion bag","ii.	a, d, b, e, c",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8902,,Elearning-0000-188,NSC ICU SEPSIS BOLUS FROM THE ED TO ICU,,n13765,,choice,"2.	Select the correct order of actions:  When the sepsis bolus that was begun in the ED is complete, to end the infusion""� a.	Go to the MAR and find your sepsis bolus order b.	Select the Infuse square and document the infused volume in the ""infuse volume (mL)""� box c.	Click Apply d.	Click on the blue ""Pending""� box e.	Ensure that the ""to""� time is updated for the end-time of the infusion bag","iii.	a, c, b, d, e",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8902,,Elearning-0000-188,NSC ICU SEPSIS BOLUS FROM THE ED TO ICU,,n13765,,choice,"2.	Select the correct order of actions:  When the sepsis bolus that was begun in the ED is complete, to end the infusion""� a.	Go to the MAR and find your sepsis bolus order b.	Select the Infuse square and document the infused volume in the ""infuse volume (mL)""� box c.	Click Apply d.	Click on the blue ""Pending""� box e.	Ensure that the ""to""� time is updated for the end-time of the infusion bag","iv.	a, e, d, b, c",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8902,,Elearning-0000-188,NSC ICU SEPSIS BOLUS FROM THE ED TO ICU,,n13765,,choice,"3.	If the volume infused by the ED is not documented in I & O, document the volume of the sepsis bolus from the ED in either""�",a.	Pre-Arrival IV fluid amount,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8902,,Elearning-0000-188,NSC ICU SEPSIS BOLUS FROM THE ED TO ICU,,n13765,,choice,"3.	If the volume infused by the ED is not documented in I & O, document the volume of the sepsis bolus from the ED in either""�",b.	Sepsis Bolus Continuous infusion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8902,,Elearning-0000-188,NSC ICU SEPSIS BOLUS FROM THE ED TO ICU,,n13765,,choice,"3.	If the volume infused by the ED is not documented in I & O, document the volume of the sepsis bolus from the ED in either""�",c.	A and b,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8902,,Elearning-0000-188,NSC ICU SEPSIS BOLUS FROM THE ED TO ICU,,n13765,,choice,"3.	If the volume infused by the ED is not documented in I & O, document the volume of the sepsis bolus from the ED in either""�",d.	None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8902,,Elearning-0000-188,NSC ICU SEPSIS BOLUS FROM THE ED TO ICU,,n13765,,choice,"4.	If a patient requires subsequent infusions to complete the total sepsis bolus dose, return to the normal process-start the bag in MAW and document the end time in Infusion Billing and the infused volume in I & O.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8902,,Elearning-0000-188,NSC ICU SEPSIS BOLUS FROM THE ED TO ICU,,n13765,,choice,"4.	If a patient requires subsequent infusions to complete the total sepsis bolus dose, return to the normal process-start the bag in MAW and document the end time in Infusion Billing and the infused volume in I & O.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,1.	The new standard maximum drip rate for Fentanyl is,a.	450 mcg/hr.,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021- g13766,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,1.	The new standard maximum drip rate for Fentanyl is,a.	450 mcg/hr.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,1.	The new standard maximum drip rate for Fentanyl is,b.	250 mcg/hr.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,1.	The new standard maximum drip rate for Fentanyl is,c.	500 mcg/hr.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,1.	The new standard maximum drip rate for Fentanyl is,d.	None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,2.	Providers may modify drip max to allow for higher maximum to meet individual patient needs on either analgesic or sedative continuous infusions.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,2.	Providers may modify drip max to allow for higher maximum to meet individual patient needs on either analgesic or sedative continuous infusions.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,3.	You should contact the patient's provider if the patient is not at PAYEN or RASS goal and is at/approaching maximum rate to discuss changing maximum or adding other therapy.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,3.	You should contact the patient's provider if the patient is not at PAYEN or RASS goal and is at/approaching maximum rate to discuss changing maximum or adding other therapy.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,4.	The new standard maximum drip rate for Midazolam is,a.	250mcg/hr.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,4.	The new standard maximum drip rate for Midazolam is,b.	20mg/hr.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,4.	The new standard maximum drip rate for Midazolam is,c.	10mg/hr.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,4.	The new standard maximum drip rate for Midazolam is,d.	None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,"5.	For patients that are on analgesic and sedative infusions, a Ketamine loading dose may not be required.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,"5.	For patients that are on analgesic and sedative infusions, a Ketamine loading dose may not be required.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,6.	All Ketamine drips will be linked to an order for Midazolam for emergence reactions.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,6.	All Ketamine drips will be linked to an order for Midazolam for emergence reactions.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,"7.	Per the new orders, a physician may not choose between",a.	Fixed rate infusion of Ketamine,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,"7.	Per the new orders, a physician may not choose between",b.	Titratable infusion of Ketamine,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,"7.	Per the new orders, a physician may not choose between",c.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,"8.	If titratable ketamine infusion is ordered, stop titrating all previously ordered infusions for that same indication.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,"8.	If titratable ketamine infusion is ordered, stop titrating all previously ordered infusions for that same indication.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,9.	Psychotomimetic effects induced by the emergence from Ketamine (e.g. downward titration of a ketamine infusion) include,a.	Hallucinations,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,9.	Psychotomimetic effects induced by the emergence from Ketamine (e.g. downward titration of a ketamine infusion) include,"b.	Confusion, delirium",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,9.	Psychotomimetic effects induced by the emergence from Ketamine (e.g. downward titration of a ketamine infusion) include,"c.	Combativeness, irrational behavior",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,9.	Psychotomimetic effects induced by the emergence from Ketamine (e.g. downward titration of a ketamine infusion) include,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,"10.	I have read the information on ICU Sedative and Analgesic Drip Updates in its entirety.  I understand that if I have questions, I can ask an ICU leadership team member.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9250,,Elearning-0000-504,NSC ICU KETAMINE INFUSIONS AND NEW SEDATIVE ANALGESIA DRIP MAXES 2021,,n13766,,choice,"10.	I have read the information on ICU Sedative and Analgesic Drip Updates in its entirety.  I understand that if I have questions, I can ask an ICU leadership team member.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the maximum amount of time a Bronchoscope should soak?,a.	2 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is DELAYED REPROCESSING- g13768,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the maximum amount of time a Bronchoscope should soak?,a.	2 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the maximum amount of time a Bronchoscope should soak?,b.	1 hour,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the maximum amount of time a Bronchoscope should soak?,c.	24 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the maximum amount of time a Bronchoscope should soak?,d.	30 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the purpose of writing the time of pre-cleaning on the top of the dirty scope bag?,a.	To help document the time it took to finished the procedure,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the purpose of writing the time of pre-cleaning on the top of the dirty scope bag?,b.	To document the time it took to do the pre-cleaning,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the purpose of writing the time of pre-cleaning on the top of the dirty scope bag?,c.	There is no point to put the time on the bag.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the purpose of writing the time of pre-cleaning on the top of the dirty scope bag?,d.	To help ensure the scope is reprocessed with the 60 minute window per the FDA in order the minimize risk of infection for patients?,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the minimum amount of time an ERCP scope should be soaked?,a.	 2 hours,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the minimum amount of time an ERCP scope should be soaked?,b.	10 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the minimum amount of time an ERCP scope should be soaked?,c.	1 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the minimum amount of time an ERCP scope should be soaked?,d.	24 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the maximum of amount time any scope should be soaked?,a.	2 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the maximum of amount time any scope should be soaked?,b.	10 hours,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the maximum of amount time any scope should be soaked?,c.	1 hour,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the maximum of amount time any scope should be soaked?,d.	24 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What does intercept foam do?,a.	Intercept foam cleans the scope,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What does intercept foam do?,b.	Intercept foam kill the bacteria?,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What does intercept foam do?,c.	Intercept foam replaces the pre-cleaning process?,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What does intercept foam do?,d.	Intercept foam used according to the IFU's protects the inside and outside of the scope from the formation of Biofilm up to 72 hours.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the correct product to soak the scope in for delayed reprocessing?,a.	Water,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the correct product to soak the scope in for delayed reprocessing?,b.	Cidex,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the correct product to soak the scope in for delayed reprocessing?,c.	Cotton Candy,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9427,,Elearning-0000-665,DELAYED REPROCESSING,,n13768,,choice,What is the correct product to soak the scope in for delayed reprocessing?,d.	Diluted Enzol,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Acute Coronary Syndrome include all the following except:,a.	STEMI,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 ACUTE CORONARY SYNDROME- g13770,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Acute Coronary Syndrome include all the following except:,a.	STEMI,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Acute Coronary Syndrome include all the following except:,b.	Aortic Dissection,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Acute Coronary Syndrome include all the following except:,c.	NSTEMI,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Acute Coronary Syndrome include all the following except:,d.	Unstable Angina,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,True/False: In hospital STEMI results in improved outcomes vs outpatient STEMI's.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,True/False: In hospital STEMI results in improved outcomes vs outpatient STEMI's.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Which of the following best describes the most common pathophysiologic mechanism present during ST segment elevation myocardial infarction?,a.	Coronary plaque erosion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Which of the following best describes the most common pathophysiologic mechanism present during ST segment elevation myocardial infarction?,b.	Coronary plaque rupture (plaque rupture and plaque erosion can result in thrombosis. STEMI is most often from coronary thrombosis after plaque rupture and less often from fixed obstruction),True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Which of the following best describes the most common pathophysiologic mechanism present during ST segment elevation myocardial infarction?,c.	Coronary plaque progression causing progressive stenosis,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Which of the following best describes the most common pathophysiologic mechanism present during ST segment elevation myocardial infarction?,d.	Coronary Vasospasm,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,"Your patient presents with nagging epigastric pain that has worsened over the day without relieve from Tums.  Your patient is female, no other symptoms reported and has diabetes.  What is the most important next steps?",a.	Start an IV,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,"Your patient presents with nagging epigastric pain that has worsened over the day without relieve from Tums.  Your patient is female, no other symptoms reported and has diabetes.  What is the most important next steps?",b.	Call the physician,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,"Your patient presents with nagging epigastric pain that has worsened over the day without relieve from Tums.  Your patient is female, no other symptoms reported and has diabetes.  What is the most important next steps?",c. 	Obtain a 12 lead ECG,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,"Your patient presents with nagging epigastric pain that has worsened over the day without relieve from Tums.  Your patient is female, no other symptoms reported and has diabetes.  What is the most important next steps?",d.	Obtain Vital Signs,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,True/False: A New left bundle branch block (LBBB) may be considered a STEMI,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,True/False: A New left bundle branch block (LBBB) may be considered a STEMI,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,NSTEMI may present with ST depression including T wave inversion which means?,a.	Partial occlusion of major coronary artery,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,NSTEMI may present with ST depression including T wave inversion which means?,b.	Complete occlusion of major coronary artery,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,NSTEMI may present with ST depression including T wave inversion which means?,c.	Sustained Coronary Spasms,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,NSTEMI may present with ST depression including T wave inversion which means?,d.	Normal coronary artery flow,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Your patient is showing ECG changes in Leads V3 - V6.  Which walls of the heart are being affected?,a.	Septal Wall,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Your patient is showing ECG changes in Leads V3 - V6.  Which walls of the heart are being affected?,b.	Inferior Wall,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Your patient is showing ECG changes in Leads V3 - V6.  Which walls of the heart are being affected?,c.	Anterior Wall,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Your patient is showing ECG changes in Leads V3 - V6.  Which walls of the heart are being affected?,d.	Anterior/Lateral Wall,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,A patient presents to the ED and is a confirmed STEMI.  What is the standard time for FMC to Balloon?,a.	120 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,A patient presents to the ED and is a confirmed STEMI.  What is the standard time for FMC to Balloon?,b.	60 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,A patient presents to the ED and is a confirmed STEMI.  What is the standard time for FMC to Balloon?,c.	90 minutes,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,A patient presents to the ED and is a confirmed STEMI.  What is the standard time for FMC to Balloon?,d.	75 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,True/False: A patient comes to the ED with chest pain but the 12 ECG does not show a STEMI.  This is conclusive that there is no further evaluation needed.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,True/False: A patient comes to the ED with chest pain but the 12 ECG does not show a STEMI.  This is conclusive that there is no further evaluation needed.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Based on American Heart Get with the Guidelines - CAD; patient who have had a STEMI with PCI should go home with:,a.	Heart Failure Clinic Referral,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Based on American Heart Get with the Guidelines - CAD; patient who have had a STEMI with PCI should go home with:,b.	Cardiac Rehab Referral,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Based on American Heart Get with the Guidelines - CAD; patient who have had a STEMI with PCI should go home with:,c.	Coumadin Clinic Referral,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9744,,Elearning-0000-953,FY2021 ACUTE CORONARY SYNDROME,,n13770,,choice,Based on American Heart Get with the Guidelines - CAD; patient who have had a STEMI with PCI should go home with:,d.	Cardiology Referral,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,Which two leads would reveal an anterior wall MI?,a.	V1 and V2,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI- g13775,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,Which two leads would reveal an anterior wall MI?,a.	V1 and V2,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,Which two leads would reveal an anterior wall MI?,"b.	Leads I, II and AVF",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,Which two leads would reveal an anterior wall MI?,c.	V3 and V4,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,Which two leads would reveal an anterior wall MI?,d.	V5 and V6,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,Any metformin containing medication must be held only for 3 days post procedure.,a. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,Any metformin containing medication must be held only for 3 days post procedure.,b. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,"The sheath has just been pulled and your patient has become very diaphoretic, BP and HR has dropped.  What is the most likely cause:",a.	Vasovagal,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,"The sheath has just been pulled and your patient has become very diaphoretic, BP and HR has dropped.  What is the most likely cause:",b.	Retroperitoneal bleed,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,"The sheath has just been pulled and your patient has become very diaphoretic, BP and HR has dropped.  What is the most likely cause:",c.	Dehydration,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,"The sheath has just been pulled and your patient has become very diaphoretic, BP and HR has dropped.  What is the most likely cause:",d.	Ventricular arrhythmia,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,When should ACE inhibitors be prescribed for PCI patients:,"a.	Indefinitely with heart failure, LV dysfunction with LVEF <40%, hypertension, or diabetes",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,When should ACE inhibitors be prescribed for PCI patients:,"b.	Absence of LV dysfunction, hypertension or diabetes",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,When should ACE inhibitors be prescribed for PCI patients:,c.	HF with LVEF of >40%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,When should ACE inhibitors be prescribed for PCI patients:,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,Reversal for heparin,a.	Platelet infusion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,Reversal for heparin,b.	Protamine,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,Reversal for heparin,c.	No available reversal agent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,Reversal for heparin,d.	Naloxone,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,Reopro (abciximab) can be administered up to 8 hours post PCI procedure.,a. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,Reopro (abciximab) can be administered up to 8 hours post PCI procedure.,b. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,Heparin is compatible with amiodarone and can be infused through the same IV line.,a. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,Heparin is compatible with amiodarone and can be infused through the same IV line.,b. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,The patient has unrelieved Chest Pain post PCI despite analgesia; the nurse should:,a.	Continue to monitor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,The patient has unrelieved Chest Pain post PCI despite analgesia; the nurse should:,b.	Get a 12-lead ECG,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,The patient has unrelieved Chest Pain post PCI despite analgesia; the nurse should:,c.	Perform more frequent VS,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,The patient has unrelieved Chest Pain post PCI despite analgesia; the nurse should:,d.	Notify the Medical Team,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,A pseudoaneurysm is typically associated with Inadequate compression after sheath removal and hemostasis,a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,A pseudoaneurysm is typically associated with Inadequate compression after sheath removal and hemostasis,b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,"Upon Discharge, it is important that the patient receive the following information",a. Test result,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,"Upon Discharge, it is important that the patient receive the following information",b. Follow up appointment(s),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,"Upon Discharge, it is important that the patient receive the following information",c. Aware of smoking risk,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9700,,Elearning-0000-913,CARE OF THE PATIENT PRE AND POST CARDIAC CATHETERIZATION AND PCI,,n13775,,choice,"Upon Discharge, it is important that the patient receive the following information",d. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,"Duplicate Test. Existing test is NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)- g13779",False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the effects of intermittent fasting on health, aging, and disease.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the effects of intermittent fasting on health, aging, and disease.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the effects of intermittent fasting on health, aging, and disease.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the effects of intermittent fasting on health, aging, and disease.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the effects of intermittent fasting on health, aging, and disease.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9946,,Questions-0000-80,"NSF INFUSION CENTER JOURNAL CLUB - JUNE 3RD, 2021 (EVALUATION SURVEY)",,n13779,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9613,,Elearning-0000-834,FY2021 TELEMETRY AND ALARMS FOR NURSING AND MONITOR TECHS,,n13780,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 TELEMETRY AND ALARMS FOR NURSING AND MONITOR TECHS"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 TELEMETRY AND ALARMS FOR NURSING AND MONITOR TECHS- g13780,False
9613,,Elearning-0000-834,FY2021 TELEMETRY AND ALARMS FOR NURSING AND MONITOR TECHS,,n13780,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 TELEMETRY AND ALARMS FOR NURSING AND MONITOR TECHS"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9613,,Elearning-0000-834,FY2021 TELEMETRY AND ALARMS FOR NURSING AND MONITOR TECHS,,n13780,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 TELEMETRY AND ALARMS FOR NURSING AND MONITOR TECHS"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9671,,Elearning-0000-887,FY2021 TELEMETRY AND ALARMS FOR THE ICU NURSE,,n13781,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 TELEMETRY AND ALARMS FOR THE ICU NURSE"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 TELEMETRY AND ALARMS FOR THE ICU NURSE- g13781,False
9671,,Elearning-0000-887,FY2021 TELEMETRY AND ALARMS FOR THE ICU NURSE,,n13781,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 TELEMETRY AND ALARMS FOR THE ICU NURSE"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9671,,Elearning-0000-887,FY2021 TELEMETRY AND ALARMS FOR THE ICU NURSE,,n13781,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 TELEMETRY AND ALARMS FOR THE ICU NURSE"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21- g13782,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN_K</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN_K</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN_K</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN_K</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN_K</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9951,,Questions-0000-85,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-9-21,,n13782,,choice,How would you improve this class?,"Nothing: (appropriate content, speaker, setting, setting.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,"True/False - Complex Regional Pain Syndrome (CRPS) is a form of chronic pain that usually affects an arm or a leg. It typically happens after an injury, surgery, stroke, or hear attack.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING- g13783,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,"True/False - Complex Regional Pain Syndrome (CRPS) is a form of chronic pain that usually affects an arm or a leg. It typically happens after an injury, surgery, stroke, or hear attack.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,"True/False - Complex Regional Pain Syndrome (CRPS) is a form of chronic pain that usually affects an arm or a leg. It typically happens after an injury, surgery, stroke, or hear attack.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,CRPS is classified into two categories: CRPS-I and CRPS-II. The main difference between the two categories is:,a.	CRPS I occurs after an illness or injury that directly damaged the nerves in the affected limb,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,CRPS is classified into two categories: CRPS-I and CRPS-II. The main difference between the two categories is:,b.	CRPS II occurs after an illness or injury that directly damaged the nerves in the affected limb,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,CRPS is classified into two categories: CRPS-I and CRPS-II. The main difference between the two categories is:,c.	CRPS I only occurs at birth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,CRPS is classified into two categories: CRPS-I and CRPS-II. The main difference between the two categories is:,d.	CRPS II only occurs later in life,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,True/False - Every patient with CRPS presents with the same symptoms and follows the same treatment plan.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,True/False - Every patient with CRPS presents with the same symptoms and follows the same treatment plan.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,"True/False - Prior to surgery, the surgeon should discuss the pain management plan with the patient and document in the H&P.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,"True/False - Prior to surgery, the surgeon should discuss the pain management plan with the patient and document in the H&P.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,Treatment options for CRPS include:,"a.	Medications (e.g. NSAIDS, oioids, corticosteroids, antidepressants, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,Treatment options for CRPS include:,b.	Heat therapy,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,Treatment options for CRPS include:,c.	Cold therapy,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,Treatment options for CRPS include:,d.	Physical therapy,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,Treatment options for CRPS include:,e.	There are no treatment options for CRPS,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,Treatment options for CRPS include:,f.	All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,Treatment options for CRPS include:,"g.	A, B, D only",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9449,,Elearning-0000-685,FY2021 COMPLEX REGIONAL PAIN SYNDROME: NURSING,,n13783,,choice,Treatment options for CRPS include:,"h.	A, B, C, D only",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9414,,Elearning-0000-653,FY2021 ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13786,,choice,ECMO is a new support system and has only been around for 10 years.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION- g13786,False
9414,,Elearning-0000-653,FY2021 ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13786,,choice,ECMO is a new support system and has only been around for 10 years.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9414,,Elearning-0000-653,FY2021 ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13786,,choice,ECMO is a new support system and has only been around for 10 years.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9414,,Elearning-0000-653,FY2021 ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13786,,choice,Venovenous (VV) ECMO only supports the heart.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9414,,Elearning-0000-653,FY2021 ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13786,,choice,Venovenous (VV) ECMO only supports the heart.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9414,,Elearning-0000-653,FY2021 ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13786,,choice,"There are many different indications for ECMO, including but not limited to: Flu, Covid-19, Asthma, Heart Attack, Cardiogenic Shock, and Septic Shock",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9414,,Elearning-0000-653,FY2021 ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13786,,choice,"There are many different indications for ECMO, including but not limited to: Flu, Covid-19, Asthma, Heart Attack, Cardiogenic Shock, and Septic Shock",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,"Two random controlled trials have been utilized to justify the efficacy of ECMO in the adult respiratory population, those are called the CESAR and EOLIA Trials.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 ECMO RESPIRATORY CARE SPECIFIC- g13788,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,"Two random controlled trials have been utilized to justify the efficacy of ECMO in the adult respiratory population, those are called the CESAR and EOLIA Trials.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,"Two random controlled trials have been utilized to justify the efficacy of ECMO in the adult respiratory population, those are called the CESAR and EOLIA Trials.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,"A patient with a PaO2 of 160, Murray score of 2, and peep of 5 would make a good candidate for ECMO.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,"A patient with a PaO2 of 160, Murray score of 2, and peep of 5 would make a good candidate for ECMO.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,There are no absolute contraindications to ECLS.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,There are no absolute contraindications to ECLS.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,The basic goal(s) of VV ECMO management include:,"Using High peep, High Oxygen, and the use of iNO",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,The basic goal(s) of VV ECMO management include:,"Decrease further lung damage, Reduce oxygen toxicity, and provide lung rest",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,The basic goal(s) of VV ECMO management include:,Use very high ECMO flows to support the work of the heart,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,Optimal ventilator while on VV ECMO are:,"Rate=15, PIP=30, PEEP=10, FiO2=40%",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,Optimal ventilator while on VV ECMO are:,"Rate=25, PIP=25, Peep=20, FiO2=30%",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,Optimal ventilator while on VV ECMO are:,"Rate=10, PIP=15, Peep=15, FiO2=21%",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,Optimal ventilator while on VV ECMO are:,"Rate=10, PIP=10, Peep=10, Fio2=40%",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,A SaO2 of 85% and a PaO2 of 50 is acceptable on VV ECMO.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,A SaO2 of 85% and a PaO2 of 50 is acceptable on VV ECMO.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,"Depending on the patient's condition, the patient will not always be on ""rest vent settings""� while on VA ECMO.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,"Depending on the patient's condition, the patient will not always be on ""rest vent settings""� while on VA ECMO.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,"While on ECMO, CO2 removal is controlled by the ECMO blood flow.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,"While on ECMO, CO2 removal is controlled by the ECMO blood flow.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,"While on ECMO, Oxygenation is controlled by the ECMO Sweep gas.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,"While on ECMO, Oxygenation is controlled by the ECMO Sweep gas.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,Routine ventilator changes are not made unless ECMO and Critical Care Physicians are notified.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9412,,Elearning-0000-651,FY2021 ECMO RESPIRATORY CARE SPECIFIC,,n13788,,choice,Routine ventilator changes are not made unless ECMO and Critical Care Physicians are notified.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,I have read and understood the content within the Philips Monitor IntelliVue Education CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is PHILIPS MONITOR INTELLIVUE EDUCATION- g13787,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,I have read and understood the content within the Philips Monitor IntelliVue Education CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,I have read and understood the content within the Philips Monitor IntelliVue Education CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,The X3 (small brain) on the back of the monitors can be undocked to utilize as a handheld monitor.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,The X3 (small brain) on the back of the monitors can be undocked to utilize as a handheld monitor.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,Sheila is performing a CSAT and gets a phone call from Admission team. She can barely hear what the nurse is saying on the phone. Sheila should turn the volume down on the Philips Monitor.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,Sheila is performing a CSAT and gets a phone call from Admission team. She can barely hear what the nurse is saying on the phone. Sheila should turn the volume down on the Philips Monitor.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,"Baby Girl Williams has a heart rate of 77. The Philips Monitor starts alarming and Vanessa, the anchor, silences the alarm. The monitor will alarm again in ______ minute(s) if the event continues.",1,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,"Baby Girl Williams has a heart rate of 77. The Philips Monitor starts alarming and Vanessa, the anchor, silences the alarm. The monitor will alarm again in ______ minute(s) if the event continues.",2,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,"Baby Girl Williams has a heart rate of 77. The Philips Monitor starts alarming and Vanessa, the anchor, silences the alarm. The monitor will alarm again in ______ minute(s) if the event continues.",3,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,"Baby Girl Williams has a heart rate of 77. The Philips Monitor starts alarming and Vanessa, the anchor, silences the alarm. The monitor will alarm again in ______ minute(s) if the event continues.",5,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,The Philips Monitor defaults as Profile ______ .,Neo,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,The Philips Monitor defaults as Profile ______ .,Car,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,The Philips Monitor defaults as Profile ______ .,Pedi,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,The Philips Monitor defaults as Profile ______ .,CCHD,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,"Sarah, 5WA Anchor, has just completed the CSAT on Baby Boy Brown, but has not documented vitals in Cerner. Monique, 5WB Anchor, asks for the Philips Monitor to complete a CSAT on a baby. What should Sarah do?","Click ""Stop Car""� and allow Monique to utilize the Philips Monitor.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,"Sarah, 5WA Anchor, has just completed the CSAT on Baby Boy Brown, but has not documented vitals in Cerner. Monique, 5WB Anchor, asks for the Philips Monitor to complete a CSAT on a baby. What should Sarah do?","Click ""End Case""�, obtain vitals, and allow Monique to utilize the Philips Monitor.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,"Sarah, 5WA Anchor, has just completed the CSAT on Baby Boy Brown, but has not documented vitals in Cerner. Monique, 5WB Anchor, asks for the Philips Monitor to complete a CSAT on a baby. What should Sarah do?","Obtain vitals, click ""End Case""�, and allow Monique to utilize the Philips Monitor.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,"Sarah, 5WA Anchor, has just completed the CSAT on Baby Boy Brown, but has not documented vitals in Cerner. Monique, 5WB Anchor, asks for the Philips Monitor to complete a CSAT on a baby. What should Sarah do?",Allow Monique to utilize the Philips Monitor and obtain vitals afterwards.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,Anchor Nurse Tiffany wants to see all vitals (normal and abnormal) that has occurred the past 30 minutes. What Smart Key should Tiffany utilize to access this feature?,Main Setup,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,Anchor Nurse Tiffany wants to see all vitals (normal and abnormal) that has occurred the past 30 minutes. What Smart Key should Tiffany utilize to access this feature?,Vitals Trend,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,Anchor Nurse Tiffany wants to see all vitals (normal and abnormal) that has occurred the past 30 minutes. What Smart Key should Tiffany utilize to access this feature?,Event Review,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,Anchor Nurse Tiffany wants to see all vitals (normal and abnormal) that has occurred the past 30 minutes. What Smart Key should Tiffany utilize to access this feature?,Profiles,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,Anchor Nurse Carmen wants to see only abnormal vitals (life-threatening and non-life-threatening) that has occurred the past 30 minutes. What Smart Key should Tiffany utilize to access this feature?,Main Setup,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,Anchor Nurse Carmen wants to see only abnormal vitals (life-threatening and non-life-threatening) that has occurred the past 30 minutes. What Smart Key should Tiffany utilize to access this feature?,Vitals Trend,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,Anchor Nurse Carmen wants to see only abnormal vitals (life-threatening and non-life-threatening) that has occurred the past 30 minutes. What Smart Key should Tiffany utilize to access this feature?,Event Review,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,Anchor Nurse Carmen wants to see only abnormal vitals (life-threatening and non-life-threatening) that has occurred the past 30 minutes. What Smart Key should Tiffany utilize to access this feature?,Profiles,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,"The Smart Key ""Start Car""� defaults as ______ minutes duration.",30,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,"The Smart Key ""Start Car""� defaults as ______ minutes duration.",60,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,"The Smart Key ""Start Car""� defaults as ______ minutes duration.",90,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,"The Smart Key ""Start Car""� defaults as ______ minutes duration.",120,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,"Anchor Nurse Maria is getting ready to begin a CSAT. What is the FIRST thing she should do before initiating the ""Start Car""� Smart Key?",Ensure that the Profile is set to Profile Car.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,"Anchor Nurse Maria is getting ready to begin a CSAT. What is the FIRST thing she should do before initiating the ""Start Car""� Smart Key?",Ensure that the alarm volume has been reduced to 3.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,"Anchor Nurse Maria is getting ready to begin a CSAT. What is the FIRST thing she should do before initiating the ""Start Car""� Smart Key?",Ensure that the Profile is set to Profile Neo.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,"Anchor Nurse Maria is getting ready to begin a CSAT. What is the FIRST thing she should do before initiating the ""Start Car""� Smart Key?",Ensure that the timer is set to 60 minutes.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,What is the indicator for each alarm?,Yellow (inoperable); red (life-threatening events); blue (non-life-threatening events),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,What is the indicator for each alarm?,Yellow (non-life-threatening events); red (life-threatening events); blue (inoperable),True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,What is the indicator for each alarm?,Yellow (life-threatening events); red (non-life-threatening events); blue (inoperable),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
284,,SCORM-0000-94,PHILIPS MONITOR INTELLIVUE EDUCATION,,n13787,,choice,What is the indicator for each alarm?,Yellow (non-life-threatening events); red (inoperable); blue (life-threatening events),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9413,,Elearning-0000-652,FY2021 ICU ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13789,,choice,ECMO is a new support system and has only been around for 10 years.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 ICU ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION- g13789,False
9413,,Elearning-0000-652,FY2021 ICU ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13789,,choice,ECMO is a new support system and has only been around for 10 years.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9413,,Elearning-0000-652,FY2021 ICU ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13789,,choice,ECMO is a new support system and has only been around for 10 years.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9413,,Elearning-0000-652,FY2021 ICU ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13789,,choice,Venovenous (VV) ECMO only supports the heart.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9413,,Elearning-0000-652,FY2021 ICU ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13789,,choice,Venovenous (VV) ECMO only supports the heart.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9413,,Elearning-0000-652,FY2021 ICU ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13789,,choice,"There are many different indications for ECMO, including but not limited to: Flu, Covid-19, Asthma, Heart Attack, Cardiogenic Shock, and Septic Shock",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9413,,Elearning-0000-652,FY2021 ICU ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13789,,choice,"There are many different indications for ECMO, including but not limited to: Flu, Covid-19, Asthma, Heart Attack, Cardiogenic Shock, and Septic Shock",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9413,,Elearning-0000-652,FY2021 ICU ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13789,,choice,The ICU nurse will be responsible for documenting the head to toe assessment as well as documenting on the ECMO flowsheet.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9413,,Elearning-0000-652,FY2021 ICU ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13789,,choice,The ICU nurse will be responsible for documenting the head to toe assessment as well as documenting on the ECMO flowsheet.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9413,,Elearning-0000-652,FY2021 ICU ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13789,,choice,There will always be an ECMO designee at the bedside and an ECMO physician in close proximity to the patient.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9413,,Elearning-0000-652,FY2021 ICU ECMO: EXTRACORPOREAL MEMBRANE OXYGENATION,,n13789,,choice,There will always be an ECMO designee at the bedside and an ECMO physician in close proximity to the patient.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21- g13847,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9901,,Questions-0000-35,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 5-28-21,,n13847,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9513,,Elearning-0000-743,C-401 VERSION 3.0,,n13792,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is C-401 VERSION 3.0- g13792,False
9513,,Elearning-0000-743,C-401 VERSION 3.0,,n13792,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9513,,Elearning-0000-743,C-401 VERSION 3.0,,n13792,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,"Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21- g13795",False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9914,,Questions-0000-48,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 5-28-21",,n13795,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21- g13793,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9908,,Questions-0000-42,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 5-28-21,,n13793,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9660,,Elearning-0000-877,FY2021 MOCK SURVEY FINDINGS - PCT.CCA.UCS,,n13797,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 MOCK SURVEY FINDINGS - PCT.CCA.UCS"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 MOCK SURVEY FINDINGS - PCT.CCA.UCS- g13797,False
9660,,Elearning-0000-877,FY2021 MOCK SURVEY FINDINGS - PCT.CCA.UCS,,n13797,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 MOCK SURVEY FINDINGS - PCT.CCA.UCS"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9660,,Elearning-0000-877,FY2021 MOCK SURVEY FINDINGS - PCT.CCA.UCS,,n13797,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 MOCK SURVEY FINDINGS - PCT.CCA.UCS"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8907,,Elearning-0000-192,TIPS FOR HIGH QUALITY HAND-OFFS,,n13799,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIPS FOR HIGH QUALITY HAND-OFFS- g13799,False
8907,,Elearning-0000-192,TIPS FOR HIGH QUALITY HAND-OFFS,,n13799,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8907,,Elearning-0000-192,TIPS FOR HIGH QUALITY HAND-OFFS,,n13799,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is MIND THE GAP (EVALUATION SURVEY) 6-8-21- g13803,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the difference between gap identification and needs assessment.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the difference between gap identification and needs assessment.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the difference between gap identification and needs assessment.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the difference between gap identification and needs assessment.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the difference between gap identification and needs assessment.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the differences between a knowledge gap vs a skills gap vs a practice gap.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the differences between a knowledge gap vs a skills gap vs a practice gap.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the differences between a knowledge gap vs a skills gap vs a practice gap.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the differences between a knowledge gap vs a skills gap vs a practice gap.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the differences between a knowledge gap vs a skills gap vs a practice gap.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe tools and strategies that can be utilized for gap identification and validation.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe tools and strategies that can be utilized for gap identification and validation.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe tools and strategies that can be utilized for gap identification and validation.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe tools and strategies that can be utilized for gap identification and validation.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe tools and strategies that can be utilized for gap identification and validation.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence as it relates to incorporating gap identification and gap validation strategies/tools into my education design process.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence as it relates to incorporating gap identification and gap validation strategies/tools into my education design process.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence as it relates to incorporating gap identification and gap validation strategies/tools into my education design process.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence as it relates to incorporating gap identification and gap validation strategies/tools into my education design process.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence as it relates to incorporating gap identification and gap validation strategies/tools into my education design process.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Pamela Noonan, MS, BSN, NPD-BC</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Pamela Noonan, MS, BSN, NPD-BC</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Pamela Noonan, MS, BSN, NPD-BC</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Pamela Noonan, MS, BSN, NPD-BC</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Pamela Noonan, MS, BSN, NPD-BC</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Pamela Noonan, MS, BSN, NPD-BC</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Natasha Melbourne, MSN, RN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Natasha Melbourne, MSN, RN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Natasha Melbourne, MSN, RN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Natasha Melbourne, MSN, RN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Natasha Melbourne, MSN, RN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Natasha Melbourne, MSN, RN</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9940,,Questions-0000-74,MIND THE GAP (EVALUATION SURVEY) 6-8-21,,n13803,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21- g13805,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Bailey Ray, RN, BSN, OCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Bailey Ray, RN, BSN, OCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Bailey Ray, RN, BSN, OCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Bailey Ray, RN, BSN, OCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Bailey Ray, RN, BSN, OCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9806,,Questions-0000-101,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 06-9-21,,n13805,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
95,,SCORM-0000-177,SUCCESSFACTORS SYSTEM TRAINING 2021,,n13807,,choice,I have read and understood the content within the SuccessFactors System Training 2021 CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SUCCESSFACTORS SYSTEM TRAINING 2021- g13807,False
95,,SCORM-0000-177,SUCCESSFACTORS SYSTEM TRAINING 2021,,n13807,,choice,I have read and understood the content within the SuccessFactors System Training 2021 CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
95,,SCORM-0000-177,SUCCESSFACTORS SYSTEM TRAINING 2021,,n13807,,choice,I have read and understood the content within the SuccessFactors System Training 2021 CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,"1.	Post-Intensive Care Syndrome is a constellation of new or worsening impairments in cognition, physical ability and/or psychological well-being for individuals who have survived critical illness requiring intensive care. a.	TRUE  b.	FALSE",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is PICS FOR ACUTE CARE REHAB- g13808,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,"1.	Post-Intensive Care Syndrome is a constellation of new or worsening impairments in cognition, physical ability and/or psychological well-being for individuals who have survived critical illness requiring intensive care. a.	TRUE  b.	FALSE",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,"1.	Post-Intensive Care Syndrome is a constellation of new or worsening impairments in cognition, physical ability and/or psychological well-being for individuals who have survived critical illness requiring intensive care. a.	TRUE  b.	FALSE",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,2.	The following illnesses and conditions that require ICU care can lead to PICS: a.	Cancer b.	Stroke  c.	Sepsis d.	Respiratory Distress/ARDS e.	COVID-19 f.	All of the above,a.	Cancer,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,2.	The following illnesses and conditions that require ICU care can lead to PICS: a.	Cancer b.	Stroke  c.	Sepsis d.	Respiratory Distress/ARDS e.	COVID-19 f.	All of the above,b.	Stroke,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,2.	The following illnesses and conditions that require ICU care can lead to PICS: a.	Cancer b.	Stroke  c.	Sepsis d.	Respiratory Distress/ARDS e.	COVID-19 f.	All of the above,c.	Sepsis,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,2.	The following illnesses and conditions that require ICU care can lead to PICS: a.	Cancer b.	Stroke  c.	Sepsis d.	Respiratory Distress/ARDS e.	COVID-19 f.	All of the above,d.	Respiratory Distress/ARDS,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,2.	The following illnesses and conditions that require ICU care can lead to PICS: a.	Cancer b.	Stroke  c.	Sepsis d.	Respiratory Distress/ARDS e.	COVID-19 f.	All of the above,e.	COVID-19,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,2.	The following illnesses and conditions that require ICU care can lead to PICS: a.	Cancer b.	Stroke  c.	Sepsis d.	Respiratory Distress/ARDS e.	COVID-19 f.	All of the above,f.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,"3.	Patients who develop PICS can have cognitive impairment, physical impairments, and psychiatric illness that can last for years after their hospitalization. a.	TRUE  b.	FALSE",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,"3.	Patients who develop PICS can have cognitive impairment, physical impairments, and psychiatric illness that can last for years after their hospitalization. a.	TRUE  b.	FALSE",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,"4.	When a Speech Pathologist evaluates a PICS patient, they only need to address dysphagia, and not cognition and/or dysphonia. a.	TRUE b.	FALSE",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,"4.	When a Speech Pathologist evaluates a PICS patient, they only need to address dysphagia, and not cognition and/or dysphonia. a.	TRUE b.	FALSE",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,"5.	When an Occupational and/or Physical Therapist evaluates a PICS patient, they are treating: a.	Pain b.	Respiratory, Core, and Limb Muscle Strength c.	Activity Limitations d.	None of the above e.	A,B, and C",a.	Pain,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,"5.	When an Occupational and/or Physical Therapist evaluates a PICS patient, they are treating: a.	Pain b.	Respiratory, Core, and Limb Muscle Strength c.	Activity Limitations d.	None of the above e.	A,B, and C","b.	Respiratory, Core, and Limb Muscle Strength",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,"5.	When an Occupational and/or Physical Therapist evaluates a PICS patient, they are treating: a.	Pain b.	Respiratory, Core, and Limb Muscle Strength c.	Activity Limitations d.	None of the above e.	A,B, and C",c.	Activity Limitations,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,"5.	When an Occupational and/or Physical Therapist evaluates a PICS patient, they are treating: a.	Pain b.	Respiratory, Core, and Limb Muscle Strength c.	Activity Limitations d.	None of the above e.	A,B, and C",d.	None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,"5.	When an Occupational and/or Physical Therapist evaluates a PICS patient, they are treating: a.	Pain b.	Respiratory, Core, and Limb Muscle Strength c.	Activity Limitations d.	None of the above e.	A,B, and C","e.	A,B, and C",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,"6.	Northside Hospital has a PICS Clinic: a.	at all Out-Patient locations b.	where therapists have received specific education regarding PICS, and follow discipline specific guidelines c.	where all PICS patients are screened for behavioral health needs, and are referred as indicated d.	all of the above",a.	at all Out-Patient locations,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,"6.	Northside Hospital has a PICS Clinic: a.	at all Out-Patient locations b.	where therapists have received specific education regarding PICS, and follow discipline specific guidelines c.	where all PICS patients are screened for behavioral health needs, and are referred as indicated d.	all of the above","b.	where therapists have received specific education regarding PICS, and follow discipline specific guidelines",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,"6.	Northside Hospital has a PICS Clinic: a.	at all Out-Patient locations b.	where therapists have received specific education regarding PICS, and follow discipline specific guidelines c.	where all PICS patients are screened for behavioral health needs, and are referred as indicated d.	all of the above","c.	where all PICS patients are screened for behavioral health needs, and are referred as indicated",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8983,,Elearning-0000-261,PICS FOR ACUTE CARE REHAB,,n13808,,choice,"6.	Northside Hospital has a PICS Clinic: a.	at all Out-Patient locations b.	where therapists have received specific education regarding PICS, and follow discipline specific guidelines c.	where all PICS patients are screened for behavioral health needs, and are referred as indicated d.	all of the above",d.	all of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9493,,Elearning-0000-725,C-459 BMT CTN 1903,,n13810,,choice,Patients must be:,a)	Eligible for high dose chemotherapy and autologous stem cell transplant.,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is C-459 BMT CTN 1903- g13810,False
9493,,Elearning-0000-725,C-459 BMT CTN 1903,,n13810,,choice,Patients must be:,a)	Eligible for high dose chemotherapy and autologous stem cell transplant.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9493,,Elearning-0000-725,C-459 BMT CTN 1903,,n13810,,choice,Patients must be:,b)	HIV+ but with the viral load below the limit of detection by standard commercial assay.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9493,,Elearning-0000-725,C-459 BMT CTN 1903,,n13810,,choice,Patients must be:,c)	Diagnosed with relapsed/refractory DLBCL having received 2-3 prior regimens.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9493,,Elearning-0000-725,C-459 BMT CTN 1903,,n13810,,choice,Patients must be:,d)	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9493,,Elearning-0000-725,C-459 BMT CTN 1903,,n13810,,choice,Patients will receive the HST-NEETs on Day +1 (the day after autologous stem cell transplant).,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9493,,Elearning-0000-725,C-459 BMT CTN 1903,,n13810,,choice,Patients will receive the HST-NEETs on Day +1 (the day after autologous stem cell transplant).,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9493,,Elearning-0000-725,C-459 BMT CTN 1903,,n13810,,choice,A universal donor will be used for HST-NEET manufacturing that will occur 1 week prior to autologous stem cell transplant.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9493,,Elearning-0000-725,C-459 BMT CTN 1903,,n13810,,choice,A universal donor will be used for HST-NEET manufacturing that will occur 1 week prior to autologous stem cell transplant.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,I acknowledge that I have read and understood the FY2021 Interdisciplinary Plan of Care for Dialysis Patients: Nursing CBL in its entirety.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING- g13813,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,I acknowledge that I have read and understood the FY2021 Interdisciplinary Plan of Care for Dialysis Patients: Nursing CBL in its entirety.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,I acknowledge that I have read and understood the FY2021 Interdisciplinary Plan of Care for Dialysis Patients: Nursing CBL in its entirety.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,What is the purpose of a persistent note (yellow highlighted text) in the IPOC?,a.	Persistent notes have no real purpose. You can choose to use them if you want.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,What is the purpose of a persistent note (yellow highlighted text) in the IPOC?,b.	Persistent notes provide important information such as guidance in selecting appropriate goals/outcomes and interventions based on a patient's individual needs and condition,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,What is the purpose of a persistent note (yellow highlighted text) in the IPOC?,c.	Persistent notes are reminders on issues to follow up with the MD,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,Where do you find the reference document with the list of applicable IPOCS,a.	OneChart Central: Job Aids: Clinical Care tab and Women's Health tab,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,Where do you find the reference document with the list of applicable IPOCS,b.	Pdrive: IPOCs,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,Where do you find the reference document with the list of applicable IPOCS,c.	Under Orders in OneChart,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,You can add Patient Specific Goals and Patient Specific Interventions to any IPOC if the built in elements do not meet the patient's needs.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,You can add Patient Specific Goals and Patient Specific Interventions to any IPOC if the built in elements do not meet the patient's needs.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,The following IPOCs are appropriate for patients with Renal Dysfunction / Dialysis,a.	Fluid Volume Excess Prevention and Management,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,The following IPOCs are appropriate for patients with Renal Dysfunction / Dialysis,b.	Nutritional Deficit,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,The following IPOCs are appropriate for patients with Renal Dysfunction / Dialysis,c.	Fluid Volume Deficit,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,The following IPOCs are appropriate for patients with Renal Dysfunction / Dialysis,d.	Infection Prevention and Management: CLABSI phase,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,The following IPOCs are appropriate for patients with Renal Dysfunction / Dialysis,e.	Any of the above may be appropriate according to patient condition and need,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,"What should you do with ""Suggested Plans""� before the end of your shift?","a.	Nothing, they are just suggestions",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,"What should you do with ""Suggested Plans""� before the end of your shift?","b.	""Accept/Initiate""� plans that are appropriate and ""reject""� plans that are not appropriate, based on patient condition and need",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9481,,Elearning-0000-714,FY2021 INTERDISCIPLINARY PLAN OF CARE FOR DIALYSIS PATIENTS: NURSING,,n13813,,choice,"What should you do with ""Suggested Plans""� before the end of your shift?","c.	""Accept""� all plans",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21- g13844,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify issues of patient safety and error reduction in the delivery of healthcare to Infants.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify issues of patient safety and error reduction in the delivery of healthcare to Infants.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify issues of patient safety and error reduction in the delivery of healthcare to Infants.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify issues of patient safety and error reduction in the delivery of healthcare to Infants.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify issues of patient safety and error reduction in the delivery of healthcare to Infants.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of hypoglycemia .</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of hypoglycemia .</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of hypoglycemia .</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of hypoglycemia .</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of hypoglycemia .</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe infants at risk for hypothermia.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe infants at risk for hypothermia.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe infants at risk for hypothermia.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe infants at risk for hypothermia.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe infants at risk for hypothermia.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state 3 precautions to minimize heat loss in the delivery room.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state 3 precautions to minimize heat loss in the delivery room.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state 3 precautions to minimize heat loss in the delivery room.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state 3 precautions to minimize heat loss in the delivery room.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state 3 precautions to minimize heat loss in the delivery room.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to distinguish between mild, moderate, and severe respiratory distress.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to distinguish between mild, moderate, and severe respiratory distress.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to distinguish between mild, moderate, and severe respiratory distress.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to distinguish between mild, moderate, and severe respiratory distress.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to distinguish between mild, moderate, and severe respiratory distress.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to interpret Blood Gases for respiratory and metabolic acidosis.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to interpret Blood Gases for respiratory and metabolic acidosis.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to interpret Blood Gases for respiratory and metabolic acidosis.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to interpret Blood Gases for respiratory and metabolic acidosis.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to interpret Blood Gases for respiratory and metabolic acidosis.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list the 3 major types of shock seen in infants.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list the 3 major types of shock seen in infants.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list the 3 major types of shock seen in infants.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list the 3 major types of shock seen in infants.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list the 3 major types of shock seen in infants.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify factors that can impair cardiac output.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify factors that can impair cardiac output.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify factors that can impair cardiac output.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify factors that can impair cardiac output.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify factors that can impair cardiac output.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define the term Shock.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define the term Shock.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define the term Shock.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define the term Shock.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to define the term Shock.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the clinical signs of neonatal sepsis.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the clinical signs of neonatal sepsis.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the clinical signs of neonatal sepsis.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the clinical signs of neonatal sepsis.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the clinical signs of neonatal sepsis.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list perinatal and postnatal risk factors that predispose the infant to infection.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list perinatal and postnatal risk factors that predispose the infant to infection.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list perinatal and postnatal risk factors that predispose the infant to infection.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list perinatal and postnatal risk factors that predispose the infant to infection.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list perinatal and postnatal risk factors that predispose the infant to infection.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify methods to obtain lab specimens to rule out sepsis.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify methods to obtain lab specimens to rule out sepsis.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify methods to obtain lab specimens to rule out sepsis.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify methods to obtain lab specimens to rule out sepsis.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify methods to obtain lab specimens to rule out sepsis.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list 2 ways healthcare providers can support parents of sick infants.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list 2 ways healthcare providers can support parents of sick infants.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list 2 ways healthcare providers can support parents of sick infants.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list 2 ways healthcare providers can support parents of sick infants.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to list 2 ways healthcare providers can support parents of sick infants.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize the importance of reducing errors to improve outcome.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize the importance of reducing errors to improve outcome.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize the importance of reducing errors to improve outcome.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize the importance of reducing errors to improve outcome.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize the importance of reducing errors to improve outcome.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence level for organizing the myriad of details and interventions necessary for stabilizing a sick infant. </OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence level for organizing the myriad of details and interventions necessary for stabilizing a sick infant. </OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence level for organizing the myriad of details and interventions necessary for stabilizing a sick infant. </OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence level for organizing the myriad of details and interventions necessary for stabilizing a sick infant. </OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence level for organizing the myriad of details and interventions necessary for stabilizing a sick infant. </OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Erica Miller</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Erica Miller</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Erica Miller</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Erica Miller</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Erica Miller</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Leann Vanlandingham  </ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Leann Vanlandingham  </ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Leann Vanlandingham  </ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Leann Vanlandingham  </ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Leann Vanlandingham  </ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dana Gopal </ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dana Gopal </ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dana Gopal </ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dana Gopal </ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dana Gopal </ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Maggie Jones</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Maggie Jones</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Maggie Jones</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Maggie Jones</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Maggie Jones</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9869,,Questions-0000-159,STABLE PROGRAM (EVALUATION SURVEY) NSF 6.07.21,,n13844,,choice,How would you improve this class?,"No Suggestions for improvement ( right content, speakers, location, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,Multiple patient deaths and injuries have occurred due to lack of line reconciliation being done.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 LINE RECONCILIATION- g13846,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,Multiple patient deaths and injuries have occurred due to lack of line reconciliation being done.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,Multiple patient deaths and injuries have occurred due to lack of line reconciliation being done.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,The following lines should be reconciled at the change of shift:,Tube feedings,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,The following lines should be reconciled at the change of shift:,Urinary Catheters,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,The following lines should be reconciled at the change of shift:,JP drains,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,The following lines should be reconciled at the change of shift:,All the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,When checking an IV line during shift change and you find there is not sticker for tubing change you should:,Ask the last shift nurse to label it.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,When checking an IV line during shift change and you find there is not sticker for tubing change you should:,Discard the entire IV set-up.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,When checking an IV line during shift change and you find there is not sticker for tubing change you should:,Assume it was from the admission date.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,When checking an IV line during shift change and you find there is not sticker for tubing change you should:,Nothing,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,Line Reconciliation process should be done the following times:,"Hand-off communication, patient returns from procedure",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,Line Reconciliation process should be done the following times:,"Prior to initiating any new infusion, before patient returns from procedure",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,Line Reconciliation process should be done the following times:,"When assuming care of a patient, within one hour of transferring to the unit.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,Line reconciliation should be documented in cerner only one time a shift.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,Line reconciliation should be documented in cerner only one time a shift.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,Patients with suction hook-up in room should have line reconciliation done.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9210,,Elearning-0000-468,FY2021 LINE RECONCILIATION,,n13846,,choice,Patients with suction hook-up in room should have line reconciliation done.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,"After sheath is removed and patient establishes hemostasis, Vital signs should be done:","every 15 minutes x 4, every 30 minutes x 4, then every hour x 4",False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT- g13848,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,"After sheath is removed and patient establishes hemostasis, Vital signs should be done:","every 15 minutes x 4, every 30 minutes x 4, then every hour x 4",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,"After sheath is removed and patient establishes hemostasis, Vital signs should be done:","every 5 minutes x 4, every 15 minutes x 4, then every hour x 4",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,"After sheath is removed and patient establishes hemostasis, Vital signs should be done:","every 15 minutes x 4, every 30 minutes x 2, then every hour x 4",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,"After sheath is removed and patient establishes hemostasis, Vital signs should be done:",Vital signs are done in Cath lab.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,"After a cardiac catheter is completed the nurse should assess for pain, pallor, pulse, paresthesia, and paralysis.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,"After a cardiac catheter is completed the nurse should assess for pain, pallor, pulse, paresthesia, and paralysis.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,Documentation for a patient returning from a Cardiac Catheter should be included in Cerner under:,Patient Assessment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,Documentation for a patient returning from a Cardiac Catheter should be included in Cerner under:,Adult Systems Assessment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,Documentation for a patient returning from a Cardiac Catheter should be included in Cerner under:,Cardiovascular Post-Procedure Monitoring,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,Documentation for a patient returning from a Cardiac Catheter should be included in Cerner under:,Adult Education,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,Patients post-cardiac catheter should position head of bed at 40 degrees.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,Patients post-cardiac catheter should position head of bed at 40 degrees.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,Complications associated with Femoral Access post catheter procedure include all except:,"Neural damage, Death",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,Complications associated with Femoral Access post catheter procedure include all except:,"Thrombosis, Free bleeding",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,Complications associated with Femoral Access post catheter procedure include all except:,"Hematoma, Venous thrombosis",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,Complications associated with Femoral Access post catheter procedure include all except:,"itching to skin, hypothermia",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,If complications occur after a cardiac catheter it is best to call rapid response team.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,If complications occur after a cardiac catheter it is best to call rapid response team.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,Complications that can occur after a radial post catheter procedure can include:,itching,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,Complications that can occur after a radial post catheter procedure can include:,Bleeding and spasms,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,Complications that can occur after a radial post catheter procedure can include:,Retroperitoneal hemorrage,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,"I understand my responsibilities as a nurse to monitor a cardiac catheter patient as instructed in this training, that charting will be in real time and completed with all details under the Cardiovascular Post-Procedure Monitoring tab in Cerner. I also understand the complications that can occur for both a",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8360,,Elearning-0000-1234,FY2021 POST CARDIAC CATHETERIZATION MANAGEMENT,,n13848,,choice,"I understand my responsibilities as a nurse to monitor a cardiac catheter patient as instructed in this training, that charting will be in real time and completed with all details under the Cardiovascular Post-Procedure Monitoring tab in Cerner. I also understand the complications that can occur for both a",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"1.	If a code purple is announced you should""�",a.	Remain at nurses station,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is WSU EMERGENCY CODES _UCS- g13850,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"1.	If a code purple is announced you should""�",a.	Remain at nurses station,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"1.	If a code purple is announced you should""�",b.	Answer call lights and phones,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"1.	If a code purple is announced you should""�",c.	Direct traffic,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"1.	If a code purple is announced you should""�",d.	All the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,2.	If you should happen to see a patient matching the description called over the intercom and/or wearing a purple armband is observed call security and keep patient in sight,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,2.	If you should happen to see a patient matching the description called over the intercom and/or wearing a purple armband is observed call security and keep patient in sight,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"3.	If a Bomb threat (code orange) is called in via the phone you should""�",a.	Attempt to keep caller talking and try to get as much as information as possible,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"3.	If a Bomb threat (code orange) is called in via the phone you should""�",b.	Complete bomb threat checklist located in Lucidoc,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"3.	If a Bomb threat (code orange) is called in via the phone you should""�",c.	Alert nearby employee and have them contact security,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"3.	If a Bomb threat (code orange) is called in via the phone you should""�",d.	All the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"4.	If a Bomb threat (code orange) is a written message you should, handle the message as little as possible, notify security and place message in a clean plastic bag",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"4.	If a Bomb threat (code orange) is a written message you should, handle the message as little as possible, notify security and place message in a clean plastic bag",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"5.	If a code Brown is activated you can expect to""�",a.	Evacuate horizontally from one smoke compartment to another and place the patient's medical records in a pillow case to move with the patient,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"5.	If a code Brown is activated you can expect to""�",b.	To find a person wandering the halls,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"5.	If a code Brown is activated you can expect to""�",c.	Get under the desk,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"5.	If a code Brown is activated you can expect to""�",d.	Scream for help,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"6.	For a code Grey, you would do all EXCEPT""�",a.	Remain at nurses station,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"6.	For a code Grey, you would do all EXCEPT""�",b.	Answer call lights and phones,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"6.	For a code Grey, you would do all EXCEPT""�",c.	Direct traffic,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"6.	For a code Grey, you would do all EXCEPT""�",d.	Take shelter under desks,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"6.	For a code Grey, you would do all EXCEPT""�",e.	Scream for help,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"7.	If you notice discolored water or low water pressure (code dry) you should notify""�",a.	Biomed,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"7.	If you notice discolored water or low water pressure (code dry) you should notify""�",b.	Engineering,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"7.	If you notice discolored water or low water pressure (code dry) you should notify""�",c.	MD,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"7.	If you notice discolored water or low water pressure (code dry) you should notify""�",d.	No one,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,8.	It is important to obtain the name and number of a caller reporting a victim contaminated with hazardous material (code yellow) before transferring the caller to the ED in case of disconnection,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,8.	It is important to obtain the name and number of a caller reporting a victim contaminated with hazardous material (code yellow) before transferring the caller to the ED in case of disconnection,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,9.	During a Code Blue (Cardiopulmonary Arrest)  the UCS should,a.	Call 8911,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,9.	During a Code Blue (Cardiopulmonary Arrest)  the UCS should,b.	Remain at nurses station,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,9.	During a Code Blue (Cardiopulmonary Arrest)  the UCS should,c.	Answer call lights and phones,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,9.	During a Code Blue (Cardiopulmonary Arrest)  the UCS should,"d.	Make calls as directed by RN and/or charge nurse, call MD as directed",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,9.	During a Code Blue (Cardiopulmonary Arrest)  the UCS should,e.	All the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"10.	During a code pink, stop any visitor or employee that passes through with any item large enough to fit an infant in. Say ""we have an infant alert and I notice you have an object that could conceal an infant, I apologize for the delay but would you mind opening the (item) so that we can clear you to leave the hospital?""� If no infant seen thank them, apologize for any delay and ask them to wait for security to avoid being stopped again. If they refuse to let you look in object notify security immediately. Alert other employees to help you. A staff member may follow them at a safe distance. Do not attempt to detain them",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"10.	During a code pink, stop any visitor or employee that passes through with any item large enough to fit an infant in. Say ""we have an infant alert and I notice you have an object that could conceal an infant, I apologize for the delay but would you mind opening the (item) so that we can clear you to leave the hospital?""� If no infant seen thank them, apologize for any delay and ask them to wait for security to avoid being stopped again. If they refuse to let you look in object notify security immediately. Alert other employees to help you. A staff member may follow them at a safe distance. Do not attempt to detain them",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"11.	If there is an active shooter (code silver) in the hospital you should""�",a.	Try to remain calm,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"11.	If there is an active shooter (code silver) in the hospital you should""�",b.	Try not to provoke the threat,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"11.	If there is an active shooter (code silver) in the hospital you should""�","c.	Shelter in place by barricading a room, turn off lights, close blinds, and silence cell phones",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"11.	If there is an active shooter (code silver) in the hospital you should""�",d.	You should only make the personal choice to attempt to negotiate with or overpower the shooter if it is a last resort and there is no possibility of escape,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"11.	If there is an active shooter (code silver) in the hospital you should""�",e.	All the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"12.	You should remain at the nurses station, answer call lights and phones, and direction traffic during a code red",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9575,,Elearning-0000-80,WSU EMERGENCY CODES _UCS,,n13850,,choice,"12.	You should remain at the nurses station, answer call lights and phones, and direction traffic during a code red",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21- g13854,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9909,,Questions-0000-43,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-11-21,,n13854,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,"Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21- g13853",False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9915,,Questions-0000-49,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-11-21",,n13853,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21- g13852,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, RN-C, BSN, CCRN</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9902,,Questions-0000-36,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-11-21,,n13852,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
243,,SCORM-0000-49,FY2021 SURGICAL SERVICES: LUMBAR DRAIN MANAGEMENT FOR PACU,,n13856,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 Surgical Services: Lumbar Drain Management for PACU CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 SURGICAL SERVICES: LUMBAR DRAIN MANAGEMENT FOR PACU- g13856,False
243,,SCORM-0000-49,FY2021 SURGICAL SERVICES: LUMBAR DRAIN MANAGEMENT FOR PACU,,n13856,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 Surgical Services: Lumbar Drain Management for PACU CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
243,,SCORM-0000-49,FY2021 SURGICAL SERVICES: LUMBAR DRAIN MANAGEMENT FOR PACU,,n13856,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the FY2021 Surgical Services: Lumbar Drain Management for PACU CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9634,,Elearning-0000-853,2021 PULMONARY HYPERTENSION FOR RT CBL,,n13857,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the 2021 Pulmonary Hypertension for RT CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 PULMONARY HYPERTENSION FOR RT CBL- g13857,False
9634,,Elearning-0000-853,2021 PULMONARY HYPERTENSION FOR RT CBL,,n13857,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the 2021 Pulmonary Hypertension for RT CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9634,,Elearning-0000-853,2021 PULMONARY HYPERTENSION FOR RT CBL,,n13857,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the 2021 Pulmonary Hypertension for RT CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9643,,Elearning-0000-861,2021 PNEUMONIA DSC FOR RT CBL,,n13858,,choice,What are the 4 indicators we are measuring for Pneumonia DSC?,"1. Nursing documentation of SMI, progressive mobility, antibiotic stewardship, pneumonia vaccination",False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 PNEUMONIA DSC FOR RT CBL- g13858,False
9643,,Elearning-0000-861,2021 PNEUMONIA DSC FOR RT CBL,,n13858,,choice,What are the 4 indicators we are measuring for Pneumonia DSC?,"1. Nursing documentation of SMI, progressive mobility, antibiotic stewardship, pneumonia vaccination",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9643,,Elearning-0000-861,2021 PNEUMONIA DSC FOR RT CBL,,n13858,,choice,What are the 4 indicators we are measuring for Pneumonia DSC?,"2. Oral care, progressive mobility, diet reconciliation, oxygen weaning",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9643,,Elearning-0000-861,2021 PNEUMONIA DSC FOR RT CBL,,n13858,,choice,What are the 4 indicators we are measuring for Pneumonia DSC?,"3. Oxygen weaning, nursing documentation of SMI, progressive mobility, diet reconciliation",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9643,,Elearning-0000-861,2021 PNEUMONIA DSC FOR RT CBL,,n13858,,choice,What are the 4 indicators we are measuring for Pneumonia DSC?,"4. Hand hygiene, oxygen weaning, oral care, progressive mobility",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9662,,Elearning-0000-879,2021 LUNG CANCER DSC FOR RT CBL,,n13859,,choice,What are 4 of the indicators we are measuring?,"1. Oral Care Provided; toothbrush BID, PT consult, Pain Goal met, Nodal Stations and Length of stay.",False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 LUNG CANCER DSC FOR RT CBL- g13859,False
9662,,Elearning-0000-879,2021 LUNG CANCER DSC FOR RT CBL,,n13859,,choice,What are 4 of the indicators we are measuring?,"1. Oral Care Provided; toothbrush BID, PT consult, Pain Goal met, Nodal Stations and Length of stay.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9662,,Elearning-0000-879,2021 LUNG CANCER DSC FOR RT CBL,,n13859,,choice,What are 4 of the indicators we are measuring?,"2. Patient Education, SLP consult, Documentation of Nodal Stations and Length of stay.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9662,,Elearning-0000-879,2021 LUNG CANCER DSC FOR RT CBL,,n13859,,choice,What are 4 of the indicators we are measuring?,"3. Ambulation initiation by nursing, Nursing documentation of Incentive Spirometry, Prehab Referrals, and Speech Therapy optimization of safe swallow function.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9662,,Elearning-0000-879,2021 LUNG CANCER DSC FOR RT CBL,,n13859,,choice,What are 4 of the indicators we are measuring?,"4. Patients up out of bed on day of surgery, Oral Care Provided; toothbrush BID, OT consult, Length of stay.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9110,,Elearning-0000-377,NSC HEMORRHAGE CART,,n13860,,choice,The OB Hemorrhage Cart is a key component to achieving rapid access to medications supplies needed during a postpartum hemorrhage,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSC HEMORRHAGE CART- g13860,False
9110,,Elearning-0000-377,NSC HEMORRHAGE CART,,n13860,,choice,The OB Hemorrhage Cart is a key component to achieving rapid access to medications supplies needed during a postpartum hemorrhage,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9110,,Elearning-0000-377,NSC HEMORRHAGE CART,,n13860,,choice,The OB Hemorrhage Cart is a key component to achieving rapid access to medications supplies needed during a postpartum hemorrhage,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9110,,Elearning-0000-377,NSC HEMORRHAGE CART,,n13860,,choice,The OB Hemorrhage Cart is secured by:,A zip tie,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9110,,Elearning-0000-377,NSC HEMORRHAGE CART,,n13860,,choice,The OB Hemorrhage Cart is secured by:,2 Digital locks,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9110,,Elearning-0000-377,NSC HEMORRHAGE CART,,n13860,,choice,The OB Hemorrhage Cart is secured by:,Red security seal,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9110,,Elearning-0000-377,NSC HEMORRHAGE CART,,n13860,,choice,The OB Hemorrhage Cart is secured by:,B and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9110,,Elearning-0000-377,NSC HEMORRHAGE CART,,n13860,,choice,The OB Hemorrhage Cart is secured by:,All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9110,,Elearning-0000-377,NSC HEMORRHAGE CART,,n13860,,choice,Medications are stored in the OB Hemorrhage Cart,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9110,,Elearning-0000-377,NSC HEMORRHAGE CART,,n13860,,choice,Medications are stored in the OB Hemorrhage Cart,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9110,,Elearning-0000-377,NSC HEMORRHAGE CART,,n13860,,choice,What color seal should be placed over the lock bar on the cart to indicate is has been opened and cannot be used?,Red,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9110,,Elearning-0000-377,NSC HEMORRHAGE CART,,n13860,,choice,What color seal should be placed over the lock bar on the cart to indicate is has been opened and cannot be used?,Yellow,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9110,,Elearning-0000-377,NSC HEMORRHAGE CART,,n13860,,choice,What color seal should be placed over the lock bar on the cart to indicate is has been opened and cannot be used?,Green,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9110,,Elearning-0000-377,NSC HEMORRHAGE CART,,n13860,,choice,How frequently should the cart thermometer be checked?,Once a day,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9110,,Elearning-0000-377,NSC HEMORRHAGE CART,,n13860,,choice,How frequently should the cart thermometer be checked?,Every shift,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9110,,Elearning-0000-377,NSC HEMORRHAGE CART,,n13860,,choice,How frequently should the cart thermometer be checked?,Once a week,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9625,,Elearning-0000-845,2021 STROKE FOR RT CBL,,n13866,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""2021 STROKE FOR RT CBL"" content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 STROKE FOR RT CBL- g13866,False
9625,,Elearning-0000-845,2021 STROKE FOR RT CBL,,n13866,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""2021 STROKE FOR RT CBL"" content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9625,,Elearning-0000-845,2021 STROKE FOR RT CBL,,n13866,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""2021 STROKE FOR RT CBL"" content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9695,,Elearning-0000-909,2021 COPD FOR RT CBL,,n13865,,choice,What are the 4 indicators we are measuring for COPD DSC?,"1. Smoking cessation, mobility, incentive spirometry, COPD action plan documentation",False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 COPD FOR RT CBL- g13865,False
9695,,Elearning-0000-909,2021 COPD FOR RT CBL,,n13865,,choice,What are the 4 indicators we are measuring for COPD DSC?,"1. Smoking cessation, mobility, incentive spirometry, COPD action plan documentation",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9695,,Elearning-0000-909,2021 COPD FOR RT CBL,,n13865,,choice,What are the 4 indicators we are measuring for COPD DSC?,"2. COPD action plan documentation, CUN7 (follow up visit with PCP/pulmonologist within 7 days), speech therapy consult, RT discharge topic education",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9695,,Elearning-0000-909,2021 COPD FOR RT CBL,,n13865,,choice,What are the 4 indicators we are measuring for COPD DSC?,"3. RT discharge topic education, pneumonia vaccine, mobility, smoking cessation",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9695,,Elearning-0000-909,2021 COPD FOR RT CBL,,n13865,,choice,What are the 4 indicators we are measuring for COPD DSC?,"4. Physical therapy consult, mobility, CUN7 (follow up visit with PCP/pulmonologist within 7 days), RT discharge topic education",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8404,,Elearning-0000-1274,REV INT - INTRO TO PRO FEE CARDIOLOGY CODING,,n13867,,choice,I have reviewed the Revenue Integrity Intro to Pro Fee Cardiology Coding CBL and acknowledge that I am responsible for understanding the content therein.  I also understand that I should stop in the face of uncertainty and ask for clarification.  I know where and how to get my questions answered about this topic.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is REV INT - INTRO TO PRO FEE CARDIOLOGY CODING- g13867,False
8404,,Elearning-0000-1274,REV INT - INTRO TO PRO FEE CARDIOLOGY CODING,,n13867,,choice,I have reviewed the Revenue Integrity Intro to Pro Fee Cardiology Coding CBL and acknowledge that I am responsible for understanding the content therein.  I also understand that I should stop in the face of uncertainty and ask for clarification.  I know where and how to get my questions answered about this topic.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8404,,Elearning-0000-1274,REV INT - INTRO TO PRO FEE CARDIOLOGY CODING,,n13867,,choice,I have reviewed the Revenue Integrity Intro to Pro Fee Cardiology Coding CBL and acknowledge that I am responsible for understanding the content therein.  I also understand that I should stop in the face of uncertainty and ask for clarification.  I know where and how to get my questions answered about this topic.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"<b>CASE STUDY</b><br> Mr. Jones is a 68 year-old male admitted for a left total hip replacement.  He has a history of Type 2 Diabetes, Hypertension and Gout.  The discharge plan is to go home with his care partner. The patient has just returned from the PACU and is experiencing mild pain and some nausea but vital signs are stable.<br><br>  Using C.H.A.D.S., you have addressed the following areas of the POC.  What would be an appropriate plan(s) for Change in condition?<br><br>  <b>Change in Condition - ________________________</b><br> <b>High-Risk Comorbidities - </b>Therapeutic Regimen Management (r/t DM and HTN)<br> <b>Admission Diagnosis -</b> Knowledge Deficit<br> <b>Discharge Planning - </b>Knowledge Deficit<br> <b>Safety - </b>At Risk to Fall<br><br>",a.	Urinary Dysfunction,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING- g13868,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"<b>CASE STUDY</b><br> Mr. Jones is a 68 year-old male admitted for a left total hip replacement.  He has a history of Type 2 Diabetes, Hypertension and Gout.  The discharge plan is to go home with his care partner. The patient has just returned from the PACU and is experiencing mild pain and some nausea but vital signs are stable.<br><br>  Using C.H.A.D.S., you have addressed the following areas of the POC.  What would be an appropriate plan(s) for Change in condition?<br><br>  <b>Change in Condition - ________________________</b><br> <b>High-Risk Comorbidities - </b>Therapeutic Regimen Management (r/t DM and HTN)<br> <b>Admission Diagnosis -</b> Knowledge Deficit<br> <b>Discharge Planning - </b>Knowledge Deficit<br> <b>Safety - </b>At Risk to Fall<br><br>",a.	Urinary Dysfunction,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"<b>CASE STUDY</b><br> Mr. Jones is a 68 year-old male admitted for a left total hip replacement.  He has a history of Type 2 Diabetes, Hypertension and Gout.  The discharge plan is to go home with his care partner. The patient has just returned from the PACU and is experiencing mild pain and some nausea but vital signs are stable.<br><br>  Using C.H.A.D.S., you have addressed the following areas of the POC.  What would be an appropriate plan(s) for Change in condition?<br><br>  <b>Change in Condition - ________________________</b><br> <b>High-Risk Comorbidities - </b>Therapeutic Regimen Management (r/t DM and HTN)<br> <b>Admission Diagnosis -</b> Knowledge Deficit<br> <b>Discharge Planning - </b>Knowledge Deficit<br> <b>Safety - </b>At Risk to Fall<br><br>","b.	No new IPOC needed as Knowledge Deficit addresses change in condition, admission diagnosis and discharge planning",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"<b>CASE STUDY</b><br> Mr. Jones is a 68 year-old male admitted for a left total hip replacement.  He has a history of Type 2 Diabetes, Hypertension and Gout.  The discharge plan is to go home with his care partner. The patient has just returned from the PACU and is experiencing mild pain and some nausea but vital signs are stable.<br><br>  Using C.H.A.D.S., you have addressed the following areas of the POC.  What would be an appropriate plan(s) for Change in condition?<br><br>  <b>Change in Condition - ________________________</b><br> <b>High-Risk Comorbidities - </b>Therapeutic Regimen Management (r/t DM and HTN)<br> <b>Admission Diagnosis -</b> Knowledge Deficit<br> <b>Discharge Planning - </b>Knowledge Deficit<br> <b>Safety - </b>At Risk to Fall<br><br>",c.	Nausea Management and/or Pain Management Acute,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"<b>CASE STUDY</b><br> Mr. Jones is a 68 year-old male admitted for a left total hip replacement.  He has a history of Type 2 Diabetes, Hypertension and Gout.  The discharge plan is to go home with his care partner. The patient has just returned from the PACU and is experiencing mild pain and some nausea but vital signs are stable.<br><br>  Using C.H.A.D.S., you have addressed the following areas of the POC.  What would be an appropriate plan(s) for Change in condition?<br><br>  <b>Change in Condition - ________________________</b><br> <b>High-Risk Comorbidities - </b>Therapeutic Regimen Management (r/t DM and HTN)<br> <b>Admission Diagnosis -</b> Knowledge Deficit<br> <b>Discharge Planning - </b>Knowledge Deficit<br> <b>Safety - </b>At Risk to Fall<br><br>",d.	Change in condition is not important,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"A ""High-Risk Comorbidity""� is a condition that, if left untreated during the hospital stay, would be problematic for the patient.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"A ""High-Risk Comorbidity""� is a condition that, if left untreated during the hospital stay, would be problematic for the patient.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"When establishing target dates for IPOC outcomes, which of the following statements about is true?",a.	All outcome target dates should be set for the anticipated date of discharge,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"When establishing target dates for IPOC outcomes, which of the following statements about is true?","b.	When setting target dates, nursing should consider the patient condition and expected progress toward discharge so that (s)he can set a reasonable time-frame for each outcome",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"When establishing target dates for IPOC outcomes, which of the following statements about is true?",c.	All target dates should be about 24-48 hours from the time they are initiated,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"When establishing target dates for IPOC outcomes, which of the following statements about is true?",d.	The target dates are unimportant and thus all target dates should be set for the same date and time,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,How often should the IPOC be updated/evaluated?,a.	Every 4 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,How often should the IPOC be updated/evaluated?,b.	At least once per shift,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,How often should the IPOC be updated/evaluated?,c.	Only when something changes with the patient,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,How often should the IPOC be updated/evaluated?,d.	Just before discharge,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"What should you do with ""Suggested Plans""� before the end of your shift?","a.	Nothing, they are just suggestions",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"What should you do with ""Suggested Plans""� before the end of your shift?","b.	""Accept""� plans that are appropriate and ""reject""� plans that are not",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"What should you do with ""Suggested Plans""� before the end of your shift?","c.	""Accept""� all suggested plans",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"What should you do with ""Suggested Plans""� before the end of your shift?",d.	Reject all plans as the system is suggesting them unnecessarily,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"Each patient should have an <b>individualized</b> plan of care based upon patient history, reason for admission, provider orders, nursing assessment, and Peratrend or other early warning system.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,"Each patient should have an <b>individualized</b> plan of care based upon patient history, reason for admission, provider orders, nursing assessment, and Peratrend or other early warning system.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,How can the IPOC be individualized for a particular patient?,a.	No IPOC can be individualized because they are standardized bundles of care that cannot be altered.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,How can the IPOC be individualized for a particular patient?,b.	By applying target dates to outcomes/goals in consideration of patient needs and condition.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,How can the IPOC be individualized for a particular patient?,c.	By adding built-in components that are not default preselects but are appropriate to patient need and condition.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,How can the IPOC be individualized for a particular patient?,d.	By adding patient specific outcomes or patient specific interventions.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
240,,SCORM-0000-46,FY2021 INTERDISCIPLINARY PLAN OF CARE: NURSING,,n13868,,choice,How can the IPOC be individualized for a particular patient?,"e.	b, c, and d are all ways that an IPOC can be individualized for a particular patient",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9602,,Elearning-0000-824,FORSYTH FCC ECD,,n13871,,choice,The new ECD changes are only in the maternal chart. The newborn changes will happen at a later date.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FORSYTH FCC ECD- g13871,False
9602,,Elearning-0000-824,FORSYTH FCC ECD,,n13871,,choice,The new ECD changes are only in the maternal chart. The newborn changes will happen at a later date.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9602,,Elearning-0000-824,FORSYTH FCC ECD,,n13871,,choice,The new ECD changes are only in the maternal chart. The newborn changes will happen at a later date.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9602,,Elearning-0000-824,FORSYTH FCC ECD,,n13871,,choice,The ECD changes will help streamline charting.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9602,,Elearning-0000-824,FORSYTH FCC ECD,,n13871,,choice,The ECD changes will help streamline charting.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9602,,Elearning-0000-824,FORSYTH FCC ECD,,n13871,,choice,I have read and understood the content of this module.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9602,,Elearning-0000-824,FORSYTH FCC ECD,,n13871,,choice,I have read and understood the content of this module.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
242,,SCORM-0000-48,FY2021 SURGICAL SERVICES: END OF CASE SURGICAL DEBRIEF,,n13872,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the SURGICAL SERVICES: FY2021 END OF CASE SURGICAL DEBRIEF CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 SURGICAL SERVICES: END OF CASE SURGICAL DEBRIEF- g13872,False
242,,SCORM-0000-48,FY2021 SURGICAL SERVICES: END OF CASE SURGICAL DEBRIEF,,n13872,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the SURGICAL SERVICES: FY2021 END OF CASE SURGICAL DEBRIEF CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
242,,SCORM-0000-48,FY2021 SURGICAL SERVICES: END OF CASE SURGICAL DEBRIEF,,n13872,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the SURGICAL SERVICES: FY2021 END OF CASE SURGICAL DEBRIEF CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8975,,Elearning-0000-254,POSITIONING AND ZFLO IN THE NICU,,n13873,,choice,What are the benefits of positioning?,a. Promotes improved rest and neurobehavioral organization.,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is POSITIONING AND ZFLO IN THE NICU- g13873,False
8975,,Elearning-0000-254,POSITIONING AND ZFLO IN THE NICU,,n13873,,choice,What are the benefits of positioning?,a. Promotes improved rest and neurobehavioral organization.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8975,,Elearning-0000-254,POSITIONING AND ZFLO IN THE NICU,,n13873,,choice,What are the benefits of positioning?,b. Guides normal fetal neuromotor and musculoskeletal development.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8975,,Elearning-0000-254,POSITIONING AND ZFLO IN THE NICU,,n13873,,choice,What are the benefits of positioning?,c. Protects skin integrity.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8975,,Elearning-0000-254,POSITIONING AND ZFLO IN THE NICU,,n13873,,choice,What are the benefits of positioning?,d. Assist in thermoregulation.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8975,,Elearning-0000-254,POSITIONING AND ZFLO IN THE NICU,,n13873,,choice,What are the benefits of positioning?,e. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8975,,Elearning-0000-254,POSITIONING AND ZFLO IN THE NICU,,n13873,,choice,All infants admitted to the NICU under 33 weeks are positioned in a Z-Flo.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8975,,Elearning-0000-254,POSITIONING AND ZFLO IN THE NICU,,n13873,,choice,All infants admitted to the NICU under 33 weeks are positioned in a Z-Flo.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8975,,Elearning-0000-254,POSITIONING AND ZFLO IN THE NICU,,n13873,,choice,"In all positions, the infant should be in a midline flexed position with containment.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8975,,Elearning-0000-254,POSITIONING AND ZFLO IN THE NICU,,n13873,,choice,"In all positions, the infant should be in a midline flexed position with containment.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8975,,Elearning-0000-254,POSITIONING AND ZFLO IN THE NICU,,n13873,,choice,"I acknowledge that I have read and understand the information provided in the ""Positioning and Zflo in the NICU"" CBL.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8975,,Elearning-0000-254,POSITIONING AND ZFLO IN THE NICU,,n13873,,choice,"I acknowledge that I have read and understand the information provided in the ""Positioning and Zflo in the NICU"" CBL.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,True or False?  KINDER1 falls screening is used for both adult and pediatric patients.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is ED KINDER1 FALLS SCREENING- g13875,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,True or False?  KINDER1 falls screening is used for both adult and pediatric patients.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,True or False?  KINDER1 falls screening is used for both adult and pediatric patients.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,Which of the following patients are at risk to fall?,a.	A 30-year-old who came to the ED because of a fall,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,Which of the following patients are at risk to fall?,b.	An intoxicated patient,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,Which of the following patients are at risk to fall?,c.	A 10-month old infant who cannot walk,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,Which of the following patients are at risk to fall?,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,True or False?  Patients identified as at risk to fall do not need to have a safety plan documented.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,True or False?  Patients identified as at risk to fall do not need to have a safety plan documented.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,"A patient was identified as NOT at risk to fall in triage.  Later in their ED visit, the patient falls while using the restroom.  What should the ED nurse do?","a.	Assist the patient to bed, notify the provider, and address immediate medical needs",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,"A patient was identified as NOT at risk to fall in triage.  Later in their ED visit, the patient falls while using the restroom.  What should the ED nurse do?",b.	Complete a new KINDER1 falls screening via Ad Hoc Forms and implement a safety plan,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,"A patient was identified as NOT at risk to fall in triage.  Later in their ED visit, the patient falls while using the restroom.  What should the ED nurse do?",c.	Complete an incident report,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,"A patient was identified as NOT at risk to fall in triage.  Later in their ED visit, the patient falls while using the restroom.  What should the ED nurse do?",d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,Which falls scale will be used for Admission Holds in the ED?,a.	KINDER1,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,Which falls scale will be used for Admission Holds in the ED?,b.	Morse Fall Scale,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,Which falls scale will be used for Admission Holds in the ED?,c.	Falls Risk Assessment Tool,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9693,,Elearning-0000-907,ED KINDER1 FALLS SCREENING,,n13875,,choice,Which falls scale will be used for Admission Holds in the ED?,d.	None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9627,,Elearning-0000-847,"FY2021 SURGICAL SERVICES: CULTURE OF SAFETY, ACCOUNTABILITY, AND PROFESSIONALISM",,n13876,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 Surgical Services: Culture of Safety, Accountability and Professionalism"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,"Duplicate Test. Existing test is FY2021 SURGICAL SERVICES: CULTURE OF SAFETY, ACCOUNTABILITY, AND PROFESSIONALISM- g13876",False
9627,,Elearning-0000-847,"FY2021 SURGICAL SERVICES: CULTURE OF SAFETY, ACCOUNTABILITY, AND PROFESSIONALISM",,n13876,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 Surgical Services: Culture of Safety, Accountability and Professionalism"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9627,,Elearning-0000-847,"FY2021 SURGICAL SERVICES: CULTURE OF SAFETY, ACCOUNTABILITY, AND PROFESSIONALISM",,n13876,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""FY2021 Surgical Services: Culture of Safety, Accountability and Professionalism"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,True or False?  It is appropriate to get an approximate weight to save on time when giving Alteplase?,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is ALTEPLASE EDUCATION FOR CRITICAL CARE- g13877,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,True or False?  It is appropriate to get an approximate weight to save on time when giving Alteplase?,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,True or False?  It is appropriate to get an approximate weight to save on time when giving Alteplase?,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,Alteplase bolus should be 10% of total calculated dose and should be administered over:,A) 10 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,Alteplase bolus should be 10% of total calculated dose and should be administered over:,B) 2 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,Alteplase bolus should be 10% of total calculated dose and should be administered over:,C) 1 minute,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,Alteplase bolus should be 10% of total calculated dose and should be administered over:,D) 1 hour,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,"True or False? <br><br> You receive a patient while Alteplase is infusing.<br><br> The transferring nurse and receiving nurse perform a bedside NIHSS together and the transferring nurse should report the last completed vitals, cardiac rhythm, NIHSS and bleeding/angioedema assessment as documented on the flowsheet and the next time the ordered assessments are due.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,"True or False? <br><br> You receive a patient while Alteplase is infusing.<br><br> The transferring nurse and receiving nurse perform a bedside NIHSS together and the transferring nurse should report the last completed vitals, cardiac rhythm, NIHSS and bleeding/angioedema assessment as documented on the flowsheet and the next time the ordered assessments are due.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,"Patients who receive Alteplase must have vitals, cardiac rhythm, NIHSS and bleeding/angioedema assessment documented:<br><ul> <li>Every 15 minutes for 2 hours, then""�</li> <li>Every 30 minutes for 6 hours, then""�</li> <li>Every hour for __ hours.</li> </ul>",A. 10 hrs,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,"Patients who receive Alteplase must have vitals, cardiac rhythm, NIHSS and bleeding/angioedema assessment documented:<br><ul> <li>Every 15 minutes for 2 hours, then""�</li> <li>Every 30 minutes for 6 hours, then""�</li> <li>Every hour for __ hours.</li> </ul>",B. 24 hrs,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,"Patients who receive Alteplase must have vitals, cardiac rhythm, NIHSS and bleeding/angioedema assessment documented:<br><ul> <li>Every 15 minutes for 2 hours, then""�</li> <li>Every 30 minutes for 6 hours, then""�</li> <li>Every hour for __ hours.</li> </ul>",C. 16 hrs,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,Your patient has been receiving Alteplase for 30 minutes when his B/P goes up to 191/115. What is your next step?,A. Turn off Alteplase infusion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,Your patient has been receiving Alteplase for 30 minutes when his B/P goes up to 191/115. What is your next step?,B. Give prn Labetalol as per the Alteplase order set,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,Your patient has been receiving Alteplase for 30 minutes when his B/P goes up to 191/115. What is your next step?,C. Do a stat EKG,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,<u><b>Alteplase Dosing</b></u><br><br> Total Dose formula:	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:   Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Total Dose is:</b>,A) 56.4 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,<u><b>Alteplase Dosing</b></u><br><br> Total Dose formula:	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:   Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Total Dose is:</b>,B)  50 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,<u><b>Alteplase Dosing</b></u><br><br> Total Dose formula:	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:   Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Total Dose is:</b>,C)  63 mg,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,<u><b>Alteplase Dosing</b></u><br><br> Total Dose formula:	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:   Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Discard amount is:</b>,A) 56.4 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,<u><b>Alteplase Dosing</b></u><br><br> Total Dose formula:	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:   Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Discard amount is:</b>,B) 50 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,<u><b>Alteplase Dosing</b></u><br><br> Total Dose formula:	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:   Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Discard amount is:</b>,C) 37 mg,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,<u><b>Alteplase Dosing</b></u><br><br> Total Dose formula:	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:   Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Bolus dose is:</b>,A)  6.3 mg,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,<u><b>Alteplase Dosing</b></u><br><br> Total Dose formula:	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:   Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Bolus dose is:</b>,B)  5 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,<u><b>Alteplase Dosing</b></u><br><br> Total Dose formula:	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:   Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Bolus dose is:</b>,C) 5.6 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,<u><b>Alteplase Dosing</b></u><br><br> Total Dose formula:	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:   Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Infusion dose is:</b>,A) 6.3 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,<u><b>Alteplase Dosing</b></u><br><br> Total Dose formula:	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:   Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Infusion dose is:</b>,B) 56.7 mg,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9709,,Elearning-0000-921,ALTEPLASE EDUCATION FOR CRITICAL CARE,,n13877,,choice,<u><b>Alteplase Dosing</b></u><br><br> Total Dose formula:	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:   Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Infusion dose is:</b>,C) 53.8 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,True or False?  It is appropriate to get an approximate weight to save on time when giving Alteplase?,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is ALTEPLASE EDUCATION FOR RRT- g13878,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,True or False?  It is appropriate to get an approximate weight to save on time when giving Alteplase?,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,True or False?  It is appropriate to get an approximate weight to save on time when giving Alteplase?,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,Alteplase bolus should be 10% of total calculated dose and should be administered over:,A) 10 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,Alteplase bolus should be 10% of total calculated dose and should be administered over:,B) 2 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,Alteplase bolus should be 10% of total calculated dose and should be administered over:,C) 1 minute,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,Alteplase bolus should be 10% of total calculated dose and should be administered over:,C) 1 hour,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,"True or False? <br> You receive a patient while Alteplase is infusing.  The transferring nurse and receiving nurse perform a bedside NIHSS together and the transferring nurse should report the last completed vitals, cardiac rhythm, NIHSS and bleeding/angioedema assessment as documented on the flowsheet and the next time the ordered assessments are due.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,"True or False? <br> You receive a patient while Alteplase is infusing.  The transferring nurse and receiving nurse perform a bedside NIHSS together and the transferring nurse should report the last completed vitals, cardiac rhythm, NIHSS and bleeding/angioedema assessment as documented on the flowsheet and the next time the ordered assessments are due.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,"Patients who receive Alteplase must have vitals, cardiac rhythm, NIHSS and bleeding/angioedema assessment documented:<br> <ul> <li>Every 15 minutes for 2 hours, then""�</li> <li>Every 30 minutes for 6 hours, then""�</li> <li>Every hour for __ hours.</li> </ul>",A. 10 hrs,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,"Patients who receive Alteplase must have vitals, cardiac rhythm, NIHSS and bleeding/angioedema assessment documented:<br> <ul> <li>Every 15 minutes for 2 hours, then""�</li> <li>Every 30 minutes for 6 hours, then""�</li> <li>Every hour for __ hours.</li> </ul>",B. 24 hrs,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,"Patients who receive Alteplase must have vitals, cardiac rhythm, NIHSS and bleeding/angioedema assessment documented:<br> <ul> <li>Every 15 minutes for 2 hours, then""�</li> <li>Every 30 minutes for 6 hours, then""�</li> <li>Every hour for __ hours.</li> </ul>",C. 16 hrs,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,Your patient has been receiving Alteplase for 30 minutes when his B/P goes up to 191/115. What is your next step?,A. Turn off Alteplase infusion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,Your patient has been receiving Alteplase for 30 minutes when his B/P goes up to 191/115. What is your next step?,B. Give prn Labetalol as per the Alteplase order set,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,Your patient has been receiving Alteplase for 30 minutes when his B/P goes up to 191/115. What is your next step?,C. Do a stat EKG,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,<b>Alteplase Dosing</b><br><br> Total Dose formula: 	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:    Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Total Dose is:</b>,A) 56.4 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,<b>Alteplase Dosing</b><br><br> Total Dose formula: 	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:    Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Total Dose is:</b>,B)  50 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,<b>Alteplase Dosing</b><br><br> Total Dose formula: 	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:    Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Total Dose is:</b>,C)  63 mg,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,<b>Alteplase Dosing</b><br><br> Total Dose formula: 	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:    Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Discard amount is:</b>,A) 56.4 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,<b>Alteplase Dosing</b><br><br> Total Dose formula: 	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:    Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Discard amount is:</b>,B) 50 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,<b>Alteplase Dosing</b><br><br> Total Dose formula: 	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:    Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Discard amount is:</b>,C) 37 mg,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,<b>Alteplase Dosing</b><br><br> Total Dose formula: 	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:    Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Bolus dose is:</b>,A)  6.3 mg,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,<b>Alteplase Dosing</b><br><br> Total Dose formula: 	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:    Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Bolus dose is:</b>,B)  5 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,<b>Alteplase Dosing</b><br><br> Total Dose formula: 	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:    Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Bolus dose is:</b>,C) 5.6 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,<b>Alteplase Dosing</b><br><br> Total Dose formula: 	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:    Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Infusion dose is:</b>,A) 6.3 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,<b>Alteplase Dosing</b><br><br> Total Dose formula: 	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:    Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Infusion dose is:</b>,B) 56.7 mg,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9708,,Elearning-0000-920,ALTEPLASE EDUCATION FOR RRT,,n13878,,choice,<b>Alteplase Dosing</b><br><br> Total Dose formula: 	   0.9 mg/kg x _____kg = ____mg (max dose 90mg).<br> Bolus dose formula: 	   Total dose x 0.1 = ____ mg<br> Infusion dose formula:    Total dose - bolus dose = ____ mg / 1 mg/mL / 1 hour = infusion rate = ____mL/hr<br> Amount to discard formula:   100mg - Total dose = ____ mg (discard prior to administration)<br> Patient Weight = 70kg<br><br> <b>Infusion dose is:</b>,C) 53.8 mg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9655,,Elearning-0000-872,NSH 1304 KARMMA-7,,n13879,,choice,Patients must have:,a)	Relapsed/refractory Multiple Myeloma,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSH 1304 KARMMA-7- g13879,False
9655,,Elearning-0000-872,NSH 1304 KARMMA-7,,n13879,,choice,Patients must have:,a)	Relapsed/refractory Multiple Myeloma,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9655,,Elearning-0000-872,NSH 1304 KARMMA-7,,n13879,,choice,Patients must have:,b)	Relapsed/refractory AML,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9655,,Elearning-0000-872,NSH 1304 KARMMA-7,,n13879,,choice,Patients must have:,c)	Relapsed/refractory NHL,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9655,,Elearning-0000-872,NSH 1304 KARMMA-7,,n13879,,choice,Patients must have:,d)	None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9655,,Elearning-0000-872,NSH 1304 KARMMA-7,,n13879,,choice,Patients will be randomized to receive either bb2121 CAR-T cells or a standard of care combination therapy.,a)	True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9655,,Elearning-0000-872,NSH 1304 KARMMA-7,,n13879,,choice,Patients will be randomized to receive either bb2121 CAR-T cells or a standard of care combination therapy.,b)	False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9655,,Elearning-0000-872,NSH 1304 KARMMA-7,,n13879,,choice,Patients must have achieved a minimal response or better to at least 1 prior regimen to be eligible.,a) True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9655,,Elearning-0000-872,NSH 1304 KARMMA-7,,n13879,,choice,Patients must have achieved a minimal response or better to at least 1 prior regimen to be eligible.,b) False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,State and federal law require hospitals to provide appropriate medical screening exams and stabilizing treatment to any patient who comes to the hospital requesting examination or treatment?,a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF- g13880,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,State and federal law require hospitals to provide appropriate medical screening exams and stabilizing treatment to any patient who comes to the hospital requesting examination or treatment?,a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,State and federal law require hospitals to provide appropriate medical screening exams and stabilizing treatment to any patient who comes to the hospital requesting examination or treatment?,b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,Who may perform a screening examination?,a. Physician Assistant,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,Who may perform a screening examination?,b. Certified Nurse Midwife,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,Who may perform a screening examination?,c. Advanced Practice RN,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,Who may perform a screening examination?,d. MD,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,Who may perform a screening examination?,e. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,"Northside hospital personnel should <u>not</u> advise parents to go to ""Children's Hospital""� before the screening exam is completed?",a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,"Northside hospital personnel should <u>not</u> advise parents to go to ""Children's Hospital""� before the screening exam is completed?",b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,Triage assessment by a RN is considered a medical screening exam?,a. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,Triage assessment by a RN is considered a medical screening exam?,b. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,Concerns regarding possible violations of the EMTALA policy should be referred to the,a. ED Supervisor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,Concerns regarding possible violations of the EMTALA policy should be referred to the,b. House Coordinator/ PSC,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,Concerns regarding possible violations of the EMTALA policy should be referred to the,c. Risk Management,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,Concerns regarding possible violations of the EMTALA policy should be referred to the,d. either b or c,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,"Requests to transfer patients <u>from other facilities, including</u> other Northside facilities, will be referred to the  ________________  who is responsible for determining whether the Hospital has sufficient capacity to treat the patient at the time the transfer is requested.",a. ED Supervisor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,"Requests to transfer patients <u>from other facilities, including</u> other Northside facilities, will be referred to the  ________________  who is responsible for determining whether the Hospital has sufficient capacity to treat the patient at the time the transfer is requested.",b. House Coordinator/ PSC/ Transfer Line for Gwinnett,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,"Requests to transfer patients <u>from other facilities, including</u> other Northside facilities, will be referred to the  ________________  who is responsible for determining whether the Hospital has sufficient capacity to treat the patient at the time the transfer is requested.",c. ED Physician,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,"Requests to transfer patients <u>from other facilities, including</u> other Northside facilities, will be referred to the  ________________  who is responsible for determining whether the Hospital has sufficient capacity to treat the patient at the time the transfer is requested.",d. Risk Management,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,"Patients  who leave from the ED or L&D prior to the medical screening being completed should be provided the form called ""Leaving Against Medical Advice""� to sign after review the content.",a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9691,,Elearning-0000-905,EMTALA ANNUAL EDUCATION FOR THE ED AND L&D STAFF,,n13880,,choice,"Patients  who leave from the ED or L&D prior to the medical screening being completed should be provided the form called ""Leaving Against Medical Advice""� to sign after review the content.",b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21- g13938,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Bailey Ray, RN, BSN, OCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Bailey Ray, RN, BSN, OCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Bailey Ray, RN, BSN, OCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Bailey Ray, RN, BSN, OCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Bailey Ray, RN, BSN, OCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9808,,Questions-0000-103,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSC 07-9-21,,n13938,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is MIND THE GAP (EVALUATION SURVEY) 6-17-21- g13884,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the difference between gap identification and needs assessment.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the difference between gap identification and needs assessment.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the difference between gap identification and needs assessment.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the difference between gap identification and needs assessment.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state the difference between gap identification and needs assessment.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the differences between a knowledge gap vs a skills gap vs a practice gap.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the differences between a knowledge gap vs a skills gap vs a practice gap.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the differences between a knowledge gap vs a skills gap vs a practice gap.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the differences between a knowledge gap vs a skills gap vs a practice gap.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the differences between a knowledge gap vs a skills gap vs a practice gap.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe tools and strategies that can be utilized for gap identification and validation.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe tools and strategies that can be utilized for gap identification and validation.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe tools and strategies that can be utilized for gap identification and validation.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe tools and strategies that can be utilized for gap identification and validation.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe tools and strategies that can be utilized for gap identification and validation.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence as it relates to incorporating gap identification and gap validation strategies/tools into my education design process.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence as it relates to incorporating gap identification and gap validation strategies/tools into my education design process.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence as it relates to incorporating gap identification and gap validation strategies/tools into my education design process.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence as it relates to incorporating gap identification and gap validation strategies/tools into my education design process.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence as it relates to incorporating gap identification and gap validation strategies/tools into my education design process.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Pamela Noonan, MS, BSN, NPD-BC</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Pamela Noonan, MS, BSN, NPD-BC</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Pamela Noonan, MS, BSN, NPD-BC</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Pamela Noonan, MS, BSN, NPD-BC</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Pamela Noonan, MS, BSN, NPD-BC</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Pamela Noonan, MS, BSN, NPD-BC</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Natasha Melbourne, MSN, RN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Natasha Melbourne, MSN, RN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Natasha Melbourne, MSN, RN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Natasha Melbourne, MSN, RN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Natasha Melbourne, MSN, RN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Natasha Melbourne, MSN, RN</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9939,,Questions-0000-73,MIND THE GAP (EVALUATION SURVEY) 6-17-21,,n13884,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21- g13885,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Patricia Thompson, MSN, RN, OCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Patricia Thompson, MSN, RN, OCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Patricia Thompson, MSN, RN, OCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Patricia Thompson, MSN, RN, OCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Patricia Thompson, MSN, RN, OCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Laura Stanley, BSN, RN, BMTCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Laura Stanley, BSN, RN, BMTCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Laura Stanley, BSN, RN, BMTCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Laura Stanley, BSN, RN, BMTCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Laura Stanley, BSN, RN, BMTCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9809,,Questions-0000-104,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSF 06-22-21,,n13885,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21- g13888,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN_K</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN_K</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN_K</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN_K</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN_K</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9950,,Questions-0000-84,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 6-23-21,,n13888,,choice,How would you improve this class?,"Nothing: (appropriate content, speaker, setting, setting.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9358,,Elearning-0000-602,CONTINUOUS READINESS: FIRE SAFETY EDUCATION,,n13891,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Continuous Readiness: Fire Safety Education CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is CONTINUOUS READINESS: FIRE SAFETY EDUCATION- g13891,False
9358,,Elearning-0000-602,CONTINUOUS READINESS: FIRE SAFETY EDUCATION,,n13891,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Continuous Readiness: Fire Safety Education CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9358,,Elearning-0000-602,CONTINUOUS READINESS: FIRE SAFETY EDUCATION,,n13891,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Continuous Readiness: Fire Safety Education CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,A Bronch Wash is any volume less than 20ml,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 ANNUAL BRONCH TEST- g13892,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,A Bronch Wash is any volume less than 20ml,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,A Bronch Wash is any volume less than 20ml,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,A Bronchial Alveolar Lavage is any volume 20ml or greater,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,A Bronchial Alveolar Lavage is any volume 20ml or greater,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,What do you need to be aware of before giving Phenylephrine,1. It can decrease blood pressure,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,What do you need to be aware of before giving Phenylephrine,2. It can increase blood pressure,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,What do you need to be aware of before giving Phenylephrine,3. It can cause a fast/irregular heartbeat,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,What do you need to be aware of before giving Phenylephrine,4. It can increase the blood pressure and cause a fast/irregular heartbeat.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,Correct mixture for Phenylephrine is,1. 10ml mixed with 1ml of 0.9% Sodium Chloride,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,Correct mixture for Phenylephrine is,2. 1ml mixed with 9ml of 0.9% Sodium Chloride,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,Correct mixture for Phenylephrine is,3. 1ml mixed with 9ml of 0.9% Sodium Bicarb,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,What is the best way to achieve hemostasis in the lung,1. CPAP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,What is the best way to achieve hemostasis in the lung,2. Iced normal saline lavage,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,What is the best way to achieve hemostasis in the lung,3. Hold pressure with the bronchoscope,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,"When prepping nares for a bronchoscopy, what% viscous lidocaine should be used",1. 10%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,"When prepping nares for a bronchoscopy, what% viscous lidocaine should be used",2. 1%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,"When prepping nares for a bronchoscopy, what% viscous lidocaine should be used",3. 5%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,"When prepping nares for a bronchoscopy, what% viscous lidocaine should be used",4. 2%,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,"When prepping a patient for a bronchoscopy, with platelets less than 50, you should prep the mouth instead of the nares",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,"When prepping a patient for a bronchoscopy, with platelets less than 50, you should prep the mouth instead of the nares",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,Cytology brushings are fixed on slides and sprayed with what fixative spray?,1. Formaldehyde,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,Cytology brushings are fixed on slides and sprayed with what fixative spray?,2. Alcohol,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,Cytology brushings are fixed on slides and sprayed with what fixative spray?,3. Peroxide,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,Cytology brushings are fixed on slides and sprayed with what fixative spray?,4. Hairspray,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,You should always wear gloves when touching a bronchoscope?,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,You should always wear gloves when touching a bronchoscope?,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,The Medication sheet should be:,1. Signed and dated only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,The Medication sheet should be:,2. Noted and timed only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,The Medication sheet should be:,"3. Signed, dated, timed, and noted",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,The Medication sheet should be:,4. None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,The bedside pre-clean of the bronchoscope can be done after you take the samples to the lab,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,The bedside pre-clean of the bronchoscope can be done after you take the samples to the lab,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,The enzymatic sponge is utilized during the bedside pre-clean,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,The enzymatic sponge is utilized during the bedside pre-clean,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,You should transport a bronchoscope in a closed bin,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,You should transport a bronchoscope in a closed bin,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,It is ok if a clean bronchoscope touches another clean bronchoscope while stored in gi lab,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,It is ok if a clean bronchoscope touches another clean bronchoscope while stored in gi lab,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,Physicians are responsible for placing bronch orders in to cerner,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9569,,Elearning-0000-794,2021 ANNUAL BRONCH TEST,,n13892,,choice,Physicians are responsible for placing bronch orders in to cerner,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9472,,Elearning-0000-706,CHEROKEE PNUEMONIA DSC FOR RT 2021,,n13894,,choice,What are the 4 indicators we are measuring for Pneumonia DSC?,"1. Nursing documentation of SMI, progressive mobility, antibiotic stewardship, pneumonia vaccination",False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is CHEROKEE PNUEMONIA DSC FOR RT 2021- g13894,False
9472,,Elearning-0000-706,CHEROKEE PNUEMONIA DSC FOR RT 2021,,n13894,,choice,What are the 4 indicators we are measuring for Pneumonia DSC?,"1. Nursing documentation of SMI, progressive mobility, antibiotic stewardship, pneumonia vaccination",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9472,,Elearning-0000-706,CHEROKEE PNUEMONIA DSC FOR RT 2021,,n13894,,choice,What are the 4 indicators we are measuring for Pneumonia DSC?,"2. Oral care, progressive mobility, diet reconciliation, oxygen weaning",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9472,,Elearning-0000-706,CHEROKEE PNUEMONIA DSC FOR RT 2021,,n13894,,choice,What are the 4 indicators we are measuring for Pneumonia DSC?,"3. Oxygen weaning, nursing documentation of SMI, progressive mobility, % of follow up appointment within 7days of discharge with PCP or Pulmonologist",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9472,,Elearning-0000-706,CHEROKEE PNUEMONIA DSC FOR RT 2021,,n13894,,choice,What are the 4 indicators we are measuring for Pneumonia DSC?,"4. Hand hygiene, oxygen weaning, oral care, progressive mobility",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9647,,Elearning-0000-865,POLICY & PROCEDURE UPDATES FOR ONCOLOGY NURSING,,n13896,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""Policy & Procedure Updates for Oncology Nursing"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is POLICY & PROCEDURE UPDATES FOR ONCOLOGY NURSING- g13896,False
9647,,Elearning-0000-865,POLICY & PROCEDURE UPDATES FOR ONCOLOGY NURSING,,n13896,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""Policy & Procedure Updates for Oncology Nursing"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9647,,Elearning-0000-865,POLICY & PROCEDURE UPDATES FOR ONCOLOGY NURSING,,n13896,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""Policy & Procedure Updates for Oncology Nursing"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
260,,SCORM-0000-70,NEUROSURGERY SPINE LECTURE - 6TH FLOOR NSC,,n13897,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Neurosurgery Spine Lecture - 6th Floor NSC CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NEUROSURGERY SPINE LECTURE - 6TH FLOOR NSC- g13897,False
260,,SCORM-0000-70,NEUROSURGERY SPINE LECTURE - 6TH FLOOR NSC,,n13897,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Neurosurgery Spine Lecture - 6th Floor NSC CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
260,,SCORM-0000-70,NEUROSURGERY SPINE LECTURE - 6TH FLOOR NSC,,n13897,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Neurosurgery Spine Lecture - 6th Floor NSC CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"NSH K-5 Policy provides guidelines for the handling of hazardous drugs (HDs) in conformance with USP, OSHA, NIOSH and EPA standards to protect NSH staff from unintended HD exposure.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION- g13899,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"NSH K-5 Policy provides guidelines for the handling of hazardous drugs (HDs) in conformance with USP, OSHA, NIOSH and EPA standards to protect NSH staff from unintended HD exposure.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"NSH K-5 Policy provides guidelines for the handling of hazardous drugs (HDs) in conformance with USP, OSHA, NIOSH and EPA standards to protect NSH staff from unintended HD exposure.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which one of the following hazardous medication list grouping is incorrect?,a.	Group 2 - Hazardous agents (primarily reproductive risk),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which one of the following hazardous medication list grouping is incorrect?,b.	Group 1 - Hazardous agents (cytotoxic antineoplastic/reproductive risks),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which one of the following hazardous medication list grouping is incorrect?,c.	Group 2A - Non-hazardous antineoplastic agents,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which one of the following hazardous medication list grouping is incorrect?,d.	Appendix D - Excluded drugs based on NSH risk assessment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"New Hazardous Drug Alerts fire in PowerChart and PharmNet for all Group 1 and 2 HDs with NON-PARENTERAL routes, when ordered, to ensure that safe handling procedures and appropriate patient monitoring is in place.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"New Hazardous Drug Alerts fire in PowerChart and PharmNet for all Group 1 and 2 HDs with NON-PARENTERAL routes, when ordered, to ensure that safe handling procedures and appropriate patient monitoring is in place.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"All sterile compounding areas and devices where hazardous drugs are handled must following the following cleaning steps per pharmacy policies, cleaning logs, and standard operating procedures using approved products:",a.	Decontamination,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"All sterile compounding areas and devices where hazardous drugs are handled must following the following cleaning steps per pharmacy policies, cleaning logs, and standard operating procedures using approved products:",b.	Cleaning,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"All sterile compounding areas and devices where hazardous drugs are handled must following the following cleaning steps per pharmacy policies, cleaning logs, and standard operating procedures using approved products:",c.	Disinfection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"All sterile compounding areas and devices where hazardous drugs are handled must following the following cleaning steps per pharmacy policies, cleaning logs, and standard operating procedures using approved products:",d.	Deactivate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"All sterile compounding areas and devices where hazardous drugs are handled must following the following cleaning steps per pharmacy policies, cleaning logs, and standard operating procedures using approved products:",e.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"For hazardous medications (group 1 or 2), any manipulations of tablets/capsules such as splitting or crushing will be performed inside a BSC or CACI and dispensed in final dosage form for administration",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"For hazardous medications (group 1 or 2), any manipulations of tablets/capsules such as splitting or crushing will be performed inside a BSC or CACI and dispensed in final dosage form for administration",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,a.	Protective Gown,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,b.	Eye/Face protection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,c.	Respiratory protection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,d.	Footwear,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,e.	Gloves,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,f.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,The spill response team is activated for any spills that is not contained by the following:,a.	Two Spill Kits,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,The spill response team is activated for any spills that is not contained by the following:,b.	Single Spill Kit,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,The spill response team is activated for any spills that is not contained by the following:,c.	Three Spill Kits,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,The spill response team is activated for any spills that is not contained by the following:,d.	Any spill in patient care area,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,The spill response team is activated for any spills that is not contained by the following:,e.	Any spill in pharmacy area,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Gloves used in the preparation of HDs must be:,a.	Disposable,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Gloves used in the preparation of HDs must be:,b.	Powdered to facilitate removal,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Gloves used in the preparation of HDs must be:,c.	Specified as ASTM-tested chemotherapy gloves,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Gloves used in the preparation of HDs must be:,d.	A and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"When reconstituting and withdrawing chemotherapy medications from vials, aerosol droplets may be generated. This can be minimized or eliminated by using:",a.	Filter needles,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"When reconstituting and withdrawing chemotherapy medications from vials, aerosol droplets may be generated. This can be minimized or eliminated by using:",b.	Leur-Lock syringes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"When reconstituting and withdrawing chemotherapy medications from vials, aerosol droplets may be generated. This can be minimized or eliminated by using:",c.	Closed-system transfer devices (CSTDs),True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"When reconstituting and withdrawing chemotherapy medications from vials, aerosol droplets may be generated. This can be minimized or eliminated by using:",d.	None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Gowns and gloves worn while working in the HD preparation area can be worn while working in other medication preparation areas.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Gowns and gloves worn while working in the HD preparation area can be worn while working in other medication preparation areas.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which of the following types of containment primary engineering controls (C-PECs) can be used for preparing sterile HDs?,a.	Biological safety cabinet (BSC),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which of the following types of containment primary engineering controls (C-PECs) can be used for preparing sterile HDs?,b.	Horizontal laminar air flow workbench,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which of the following types of containment primary engineering controls (C-PECs) can be used for preparing sterile HDs?,c.	Compounding aseptic containment isolator (CACI),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which of the following types of containment primary engineering controls (C-PECs) can be used for preparing sterile HDs?,d.	A and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Spill kits:,a.	May be obtained from Central Supply when needed,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Spill kits:,b.	Are kept wherever HDs and chemotherapy agents are handled,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Spill kits:,c.	Contain supplies needed to clean a HD spill,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Spill kits:,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"Hazardous drugs (Group 1 and 2) that require manipulation or compounding may be stored in areas with non-hazardous drugs; however, they must be stored above other drugs on higher medication shelves.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"Hazardous drugs (Group 1 and 2) that require manipulation or compounding may be stored in areas with non-hazardous drugs; however, they must be stored above other drugs on higher medication shelves.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"Group 1 HDs in final dosage forms (tablets, capsules, pre-filled syringes) may not be stored in patient medication drawers with non-hazardous drugs or in unit-based automated dispensing cabinets.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"Group 1 HDs in final dosage forms (tablets, capsules, pre-filled syringes) may not be stored in patient medication drawers with non-hazardous drugs or in unit-based automated dispensing cabinets.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"With the exception of hormonal agents, an Informed Consent for Drug Therapy is required for the initiation of any Group 1 or 2 HD prescribed for an oncology indication. The consent must be fully completed, with all applicable sections addressed.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,"With the exception of hormonal agents, an Informed Consent for Drug Therapy is required for the initiation of any Group 1 or 2 HD prescribed for an oncology indication. The consent must be fully completed, with all applicable sections addressed.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,How often do you have to change the gown during hazardous drug compounding?,a.	At least every 12 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,How often do you have to change the gown during hazardous drug compounding?,b.	At least every 24 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,How often do you have to change the gown during hazardous drug compounding?,c.	At least every 3 hours,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,How often do you have to change the gown during hazardous drug compounding?,d.	 At shift change,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Cytotoxic chemotherapy dispensed in a syringe must not take up more than 80% of the total volume of the syringe.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Cytotoxic chemotherapy dispensed in a syringe must not take up more than 80% of the total volume of the syringe.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which statement is true?,a.	Cytotoxic chemotherapy doses maybe rounded down or up to the nearest vials size within < 5% of the calculated dose,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which statement is true?,b.	Cytotoxic chemotherapy doses maybe rounded down to the nearest vials size within < 5% of the calculated dose,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which statement is true?,c.	Monoclonal antibodies and other biologic agents may be dose rounded down or up to the nearest vial size within = 10% of the calculated dose.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which statement is true?,d.	Monoclonal antibodies and other biologic agents may be dose rounded down or up to the nearest vial size within = 5% of the calculated dose.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which statement is true?,e.	a & c,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which statement is true?,f.	b & c,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,PA or NP may sign C1D1 chemotherapy orders.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,PA or NP may sign C1D1 chemotherapy orders.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which statement is false?,a. Verbal and telephone orders to initiate chemotherapy will not be accepted,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which statement is false?,b. A physician must sign C1D1 chemotherapy orders,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which statement is false?,c. Pregnancy screening is required at baseline and then at least once a week while the patient is on therapy,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,Which statement is false?,d. Treating physicians are responsible for monitoring cumulative anthracycline doses,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,How often do you have to change the outer gloves during hazardous drug sterile compounding?,a.	At least every 8 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,How often do you have to change the outer gloves during hazardous drug sterile compounding?,b.	At least every 3  hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,How often do you have to change the outer gloves during hazardous drug sterile compounding?,c.	At least every 30 minutes,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,How often do you have to change the outer gloves during hazardous drug sterile compounding?,At shift change,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,When wearing double gloves:,a.	The gown cuffs should be tucked over both gloves,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,When wearing double gloves:,b.	The gown cuffs should be tucked under both gloves,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,When wearing double gloves:,c.	The inner glove should be worn under the cuff and the outer glove should be worn over the gown cuff,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9251,,Elearning-0000-505,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION,,n13899,,choice,When wearing double gloves:,d.	It makes no difference if gown cuffs are worn over or under the gloves,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8388,,Elearning-0000-126,TELESTROKE EDUCATION TRAINING FOR RRT AND HC,,n13901,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Telestroke Education Training For RRT and HC CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TELESTROKE EDUCATION TRAINING FOR RRT AND HC- g13901,False
8388,,Elearning-0000-126,TELESTROKE EDUCATION TRAINING FOR RRT AND HC,,n13901,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Telestroke Education Training For RRT and HC CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8388,,Elearning-0000-126,TELESTROKE EDUCATION TRAINING FOR RRT AND HC,,n13901,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Telestroke Education Training For RRT and HC CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,"Ms. Jones is a 19 year old G1PO patient that delivered a 36 week baby girl by C section. The patient had a c section related to severe preeclampsia. The patient was on magnesium sulfate for 24 hours after delivery. She is prescribed labetalol 300 mg PO TID. Her blood pressures have ranged 130s-150s/70s-90s since admission.   At 48 hours postpartum, the patient's blood pressure is 176/97.  What is your next nursing action?",Repeat BP in 5 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS- g13906,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,"Ms. Jones is a 19 year old G1PO patient that delivered a 36 week baby girl by C section. The patient had a c section related to severe preeclampsia. The patient was on magnesium sulfate for 24 hours after delivery. She is prescribed labetalol 300 mg PO TID. Her blood pressures have ranged 130s-150s/70s-90s since admission.   At 48 hours postpartum, the patient's blood pressure is 176/97.  What is your next nursing action?",Repeat BP in 5 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,"Ms. Jones is a 19 year old G1PO patient that delivered a 36 week baby girl by C section. The patient had a c section related to severe preeclampsia. The patient was on magnesium sulfate for 24 hours after delivery. She is prescribed labetalol 300 mg PO TID. Her blood pressures have ranged 130s-150s/70s-90s since admission.   At 48 hours postpartum, the patient's blood pressure is 176/97.  What is your next nursing action?",Repeat BP in 15 minutes,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,"Ms. Jones is a 19 year old G1PO patient that delivered a 36 week baby girl by C section. The patient had a c section related to severe preeclampsia. The patient was on magnesium sulfate for 24 hours after delivery. She is prescribed labetalol 300 mg PO TID. Her blood pressures have ranged 130s-150s/70s-90s since admission.   At 48 hours postpartum, the patient's blood pressure is 176/97.  What is your next nursing action?",Administer an extra dose of labetalol 300 mg PO,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,"Ms. Jones is a 19 year old G1PO patient that delivered a 36 week baby girl by C section. The patient had a c section related to severe preeclampsia. The patient was on magnesium sulfate for 24 hours after delivery. She is prescribed labetalol 300 mg PO TID. Her blood pressures have ranged 130s-150s/70s-90s since admission.   At 48 hours postpartum, the patient's blood pressure is 176/97.  What is your next nursing action?",Notify the provider,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,The patient's blood pressure 15 minutes later is 159/110 and she is now complaining of a headache.  What is your next nursing action?,Wait 30 minutes and recheck the blood pressure again to make sure it was a valid blood pressure reading,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,The patient's blood pressure 15 minutes later is 159/110 and she is now complaining of a headache.  What is your next nursing action?,Call the provider to determine what regimen to initiate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,The patient's blood pressure 15 minutes later is 159/110 and she is now complaining of a headache.  What is your next nursing action?,Review the admission orders to determine which regimen was selected in the communication order,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,"The patient has a communication order to initiate the IV hydralazine regimen for severe, sustained hypertension.  What is your next nursing action?",Place an order for the hydralazine regimen via the OB Hypertension Acute NSH orders as a standing order,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,"The patient has a communication order to initiate the IV hydralazine regimen for severe, sustained hypertension.  What is your next nursing action?",Place an order for the hydralazine OB regimen via the Hypertension Acute NSH orders as a protocol order,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,"The patient has a communication order to initiate the IV hydralazine regimen for severe, sustained hypertension.  What is your next nursing action?",Place an order for the hydralazine regimen via the OB Hypertension Acute NSH orders as a telephone order,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,"Hydralazine 10 mg x 1 dose is administered and the patient achieves a target blood pressure of 148/99.  You begin monitoring her blood pressure q 10 min per the orders.  30 minutes after her last dose of hydralazine, the patient's BP is 168/90.  What is your next nursing action?",Repeat the BP in 15 minutes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,"Hydralazine 10 mg x 1 dose is administered and the patient achieves a target blood pressure of 148/99.  You begin monitoring her blood pressure q 10 min per the orders.  30 minutes after her last dose of hydralazine, the patient's BP is 168/90.  What is your next nursing action?",Call the provider to obtain a new order for treatment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,"Hydralazine 10 mg x 1 dose is administered and the patient achieves a target blood pressure of 148/99.  You begin monitoring her blood pressure q 10 min per the orders.  30 minutes after her last dose of hydralazine, the patient's BP is 168/90.  What is your next nursing action?",Administer the second dose of hydralazine 10 mg IV per the regimen,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,"Hydralazine 10 mg x 1 dose is administered and the patient achieves a target blood pressure of 148/99.  You begin monitoring her blood pressure q 10 min per the orders.  30 minutes after her last dose of hydralazine, the patient's BP is 168/90.  What is your next nursing action?",Administer labetalol 20 mg IV,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,"The second dose of hydralazine 10mg IV is not effective.  You continue to the next dose in the hydralazine regimen and administer labetalol 20 mg IV.  The patient achieves a target blood pressure and maintains target range for the following 4 hours.  During hourly blood pressure monitoring, her blood pressure elevates to 174/90.  What is your next nursing action?",Repeat BP in 15 minutes,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,"The second dose of hydralazine 10mg IV is not effective.  You continue to the next dose in the hydralazine regimen and administer labetalol 20 mg IV.  The patient achieves a target blood pressure and maintains target range for the following 4 hours.  During hourly blood pressure monitoring, her blood pressure elevates to 174/90.  What is your next nursing action?","Administer Hydralazine 10 mg IV, and notify provider",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,"The second dose of hydralazine 10mg IV is not effective.  You continue to the next dose in the hydralazine regimen and administer labetalol 20 mg IV.  The patient achieves a target blood pressure and maintains target range for the following 4 hours.  During hourly blood pressure monitoring, her blood pressure elevates to 174/90.  What is your next nursing action?","Administer Labetalol 20 mg IV, and notify provider",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,"The second dose of hydralazine 10mg IV is not effective.  You continue to the next dose in the hydralazine regimen and administer labetalol 20 mg IV.  The patient achieves a target blood pressure and maintains target range for the following 4 hours.  During hourly blood pressure monitoring, her blood pressure elevates to 174/90.  What is your next nursing action?","Administer Labetalol 40 mg IV, and notify provider",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,15 minutes later the patient's blood pressure is 168/105.  What is your next nursing action?,"Administer Hydralazine 10 mg IV, and notify provider",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,15 minutes later the patient's blood pressure is 168/105.  What is your next nursing action?,"Administer Labetalol 20 mg IV, and notify provider",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,15 minutes later the patient's blood pressure is 168/105.  What is your next nursing action?,"Administer Labetalol 40 mg IV, and notify provider",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9477,,Elearning-0000-710,CHANGES TO OB ANTIHYPERTENSIVE MEDICATION ORDERS,,n13906,,choice,15 minutes later the patient's blood pressure is 168/105.  What is your next nursing action?,Call the provider to obtain a new order for treatment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,"If a patient is not experiencing pain when you assess for it, you should still document at least once per shift that the patient is not experiencing pain.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is PAIN MANAGEMENT - CARDIAC MED/SURG- g13907,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,"If a patient is not experiencing pain when you assess for it, you should still document at least once per shift that the patient is not experiencing pain.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,"If a patient is not experiencing pain when you assess for it, you should still document at least once per shift that the patient is not experiencing pain.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,Within what time frame do you need to reassess a patient's pain after treatment?,a.  3 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,Within what time frame do you need to reassess a patient's pain after treatment?,b. 1 hour,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,Within what time frame do you need to reassess a patient's pain after treatment?,c. 2 hours,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,Within what time frame do you need to reassess a patient's pain after treatment?,d. 4 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,"When assessing pain you always need to be sure to document Pain rating (0-10), Pain goal, Site, Characteristics, Duration, Sedation, and Interventions.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,"When assessing pain you always need to be sure to document Pain rating (0-10), Pain goal, Site, Characteristics, Duration, Sedation, and Interventions.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,"You need to document all non-pharmacological pain management interventions provided, and reassessment of those interventions as well.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,"You need to document all non-pharmacological pain management interventions provided, and reassessment of those interventions as well.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What are non-pharmacological pain management interventions?,a. Ice,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What are non-pharmacological pain management interventions?,b. Heat,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What are non-pharmacological pain management interventions?,c. Massage,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What are non-pharmacological pain management interventions?,d. Repositioning,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What are non-pharmacological pain management interventions?,"e. a, b, c, d",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What pain score range is mild pain?,a. 1-4,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What pain score range is mild pain?,b. 1-3,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What pain score range is mild pain?,c. 1-2,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What pain score range is mild pain?,d. 1-5,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What pain score range is moderate pain?,a. 2-6,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What pain score range is moderate pain?,b. 3-6,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What pain score range is moderate pain?,c. 4-6,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What pain score range is moderate pain?,d. 4-5,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What pain score range is severe pain?,a. 7-10,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What pain score range is severe pain?,b. 6-10,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What pain score range is severe pain?,c. 5-10,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,What pain score range is severe pain?,d. 8-10,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,"Pain treatment should be based off of the patient's pain score dosing range, and you should always check orders to ensure that the treatment aligns with the patients pain score.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,"Pain treatment should be based off of the patient's pain score dosing range, and you should always check orders to ensure that the treatment aligns with the patients pain score.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,Pain should be included in the patients IPOC when they are experiencing pain.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,Pain should be included in the patients IPOC when they are experiencing pain.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,The Patient Preference Pain Management Standing order should be utilized when the patient requests pain medication which is in a lower category than what they score their pain as. The medication must be on the patient's medication list.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9645,,Elearning-0000-863,PAIN MANAGEMENT - CARDIAC MED/SURG,,n13907,,choice,The Patient Preference Pain Management Standing order should be utilized when the patient requests pain medication which is in a lower category than what they score their pain as. The medication must be on the patient's medication list.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"75 year-old male on Rivaroxaban 15mg daily for atrial fibrillation (CHA2DS2VASc=6) presents to the ED with dizziness, hypotension (BP 80/50), and black tarry stools. Hgb=7, Hct=22.1, plt=193, SCr=2.46 (baseline 1.7). His last dose of Rivaroxaban was 6 hours ago.  The ED provider asks for your recommendation on reversal of Rivaroxaban. Using the NSH reference guide, what will you recommend?","a.	Patient is not having a major, life-threatening bleed; Hold Rivaroxaban, provide supportive care and control bleeding site until the drug is out his system.",False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT- g13918,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"75 year-old male on Rivaroxaban 15mg daily for atrial fibrillation (CHA2DS2VASc=6) presents to the ED with dizziness, hypotension (BP 80/50), and black tarry stools. Hgb=7, Hct=22.1, plt=193, SCr=2.46 (baseline 1.7). His last dose of Rivaroxaban was 6 hours ago.  The ED provider asks for your recommendation on reversal of Rivaroxaban. Using the NSH reference guide, what will you recommend?","a.	Patient is not having a major, life-threatening bleed; Hold Rivaroxaban, provide supportive care and control bleeding site until the drug is out his system.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"75 year-old male on Rivaroxaban 15mg daily for atrial fibrillation (CHA2DS2VASc=6) presents to the ED with dizziness, hypotension (BP 80/50), and black tarry stools. Hgb=7, Hct=22.1, plt=193, SCr=2.46 (baseline 1.7). His last dose of Rivaroxaban was 6 hours ago.  The ED provider asks for your recommendation on reversal of Rivaroxaban. Using the NSH reference guide, what will you recommend?","b.	Patient is having a major, life-threatening bleed; administer high dose andexanet alfa: 800mg IV bolus followed by continuous infusion of 8mg/min for up to 120 minutes",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"75 year-old male on Rivaroxaban 15mg daily for atrial fibrillation (CHA2DS2VASc=6) presents to the ED with dizziness, hypotension (BP 80/50), and black tarry stools. Hgb=7, Hct=22.1, plt=193, SCr=2.46 (baseline 1.7). His last dose of Rivaroxaban was 6 hours ago.  The ED provider asks for your recommendation on reversal of Rivaroxaban. Using the NSH reference guide, what will you recommend?","c.	Patient is having a major, life-threatening bleed; administer low dose andexanet alfa: 400mg IV bolus followed by continuous infusion of 4mg/min for up to 120 minutes",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"75 year-old male on Rivaroxaban 15mg daily for atrial fibrillation (CHA2DS2VASc=6) presents to the ED with dizziness, hypotension (BP 80/50), and black tarry stools. Hgb=7, Hct=22.1, plt=193, SCr=2.46 (baseline 1.7). His last dose of Rivaroxaban was 6 hours ago.  The ED provider asks for your recommendation on reversal of Rivaroxaban. Using the NSH reference guide, what will you recommend?","d.	Patient is having a major, life-threatening bleed; administer idarucizumab 5g IV as 2 consecutive doses of 2.5mg each",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"Due to their high risk for thrombotic events, anticoagulant reversal agents should only be used to treat major, life-threatening bleeding events. Which of the following are considered a major, life-threatening bleed?","a.	Bleeding at a critical site such as intracranial hemorrhage, CNS bleeds (intraocular, spinal), thoracic, intra-abdominal (not including intraluminal GI bleeding)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"Due to their high risk for thrombotic events, anticoagulant reversal agents should only be used to treat major, life-threatening bleeding events. Which of the following are considered a major, life-threatening bleed?","b.	Bleeding that results in hemodynamic instability such as hypotension (SBP <90 mmHg or a drop in SBP >40 mmHg from baseline), tachycardia, or makers of poor organ perfusion (ex. UOP < 0.5mL/kg/hr)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"Due to their high risk for thrombotic events, anticoagulant reversal agents should only be used to treat major, life-threatening bleeding events. Which of the following are considered a major, life-threatening bleed?",c.	Overt bleeding resulting in hemoglobin drop of 2 g/dL or more from baseline,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"Due to their high risk for thrombotic events, anticoagulant reversal agents should only be used to treat major, life-threatening bleeding events. Which of the following are considered a major, life-threatening bleed?",d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"83 year-old patient on Apixaban 5mg BID for atrial fibrillation presents to the ED with bright red blood per rectum x 2 days. Blood pressure is 110/70 (normal for her baseline), Hbg=10, Hct=28, plt=145, SCr=0.8 (baseline 0.9). Her lase dose of Apixaban was 10 hours ago. The ED provider asks for your recommendation on reversal of Apixaban. Using the NSH reference guide, what will you recommend?","a.	Patient is not having a major, life-threatening bleed; Hold Apixaban, provide supportive care and control bleeding site until the drug is out her system.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"83 year-old patient on Apixaban 5mg BID for atrial fibrillation presents to the ED with bright red blood per rectum x 2 days. Blood pressure is 110/70 (normal for her baseline), Hbg=10, Hct=28, plt=145, SCr=0.8 (baseline 0.9). Her lase dose of Apixaban was 10 hours ago. The ED provider asks for your recommendation on reversal of Apixaban. Using the NSH reference guide, what will you recommend?","b.	Patient is having a major, life-threatening bleed; administer high dose andexanet alfa: 800mg IV bolus followed by continuous infusion of 8mg/min for up to 120 minutes",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"83 year-old patient on Apixaban 5mg BID for atrial fibrillation presents to the ED with bright red blood per rectum x 2 days. Blood pressure is 110/70 (normal for her baseline), Hbg=10, Hct=28, plt=145, SCr=0.8 (baseline 0.9). Her lase dose of Apixaban was 10 hours ago. The ED provider asks for your recommendation on reversal of Apixaban. Using the NSH reference guide, what will you recommend?","c.	Patient is having a major, life-threatening bleed; administer low dose andexanet alfa: 400mg IV bolus followed by continuous infusion of 4mg/min for up to 120 minutes",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"83 year-old patient on Apixaban 5mg BID for atrial fibrillation presents to the ED with bright red blood per rectum x 2 days. Blood pressure is 110/70 (normal for her baseline), Hbg=10, Hct=28, plt=145, SCr=0.8 (baseline 0.9). Her lase dose of Apixaban was 10 hours ago. The ED provider asks for your recommendation on reversal of Apixaban. Using the NSH reference guide, what will you recommend?","d.	Patient is having a major, life-threatening bleed; administer idarucizumab 5g IV as 2 consecutive doses of 2.5mg each",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"83 year-old female on Apixaban 5mg BID for atrial fibrillation presents to the ED with bright red blood per rectum x 2 days. Blood pressure is 80/50 (baseline 110/80), Hbg=7 (baseline 10), Hct=28, plt=145, SCr=0.8 (baseline 0.9). Her lase dose of Apixaban was 10 hours ago. The ED provider asks for your recommendation on reversal of Apixaban. Using the NSH reference guide, what will you recommend?","a.	Patient is not having a major, life-threatening bleed; Hold Apixaban, provide supportive care and control bleeding site until the drug is out her system.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"83 year-old female on Apixaban 5mg BID for atrial fibrillation presents to the ED with bright red blood per rectum x 2 days. Blood pressure is 80/50 (baseline 110/80), Hbg=7 (baseline 10), Hct=28, plt=145, SCr=0.8 (baseline 0.9). Her lase dose of Apixaban was 10 hours ago. The ED provider asks for your recommendation on reversal of Apixaban. Using the NSH reference guide, what will you recommend?","b.	Patient is having a major, life-threatening bleed; administer high dose andexanet alfa: 800mg IV bolus followed by continuous infusion of 8mg/min for up to 120 minutes",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"83 year-old female on Apixaban 5mg BID for atrial fibrillation presents to the ED with bright red blood per rectum x 2 days. Blood pressure is 80/50 (baseline 110/80), Hbg=7 (baseline 10), Hct=28, plt=145, SCr=0.8 (baseline 0.9). Her lase dose of Apixaban was 10 hours ago. The ED provider asks for your recommendation on reversal of Apixaban. Using the NSH reference guide, what will you recommend?","c.	Patient is having a major, life-threatening bleed; administer low dose andexanet alfa: 400mg IV bolus followed by continuous infusion of 4mg/min for up to 120 minutes",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"83 year-old female on Apixaban 5mg BID for atrial fibrillation presents to the ED with bright red blood per rectum x 2 days. Blood pressure is 80/50 (baseline 110/80), Hbg=7 (baseline 10), Hct=28, plt=145, SCr=0.8 (baseline 0.9). Her lase dose of Apixaban was 10 hours ago. The ED provider asks for your recommendation on reversal of Apixaban. Using the NSH reference guide, what will you recommend?","d.	Patient is having a major, life-threatening bleed; administer idarucizumab 5g IV as 2 consecutive doses of 2.5mg each",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"67 year-old male on Edoxaban 60mg daily for atrial fibrillation presents to the ED after a ground level fall in which he hit his head. Per the patient's wife, his mental status is altered from baseline and she is concerned he has a concussion. CT of the head reveals severe intracranial hemorrhage. The ED providers asks for your recommendation on reversal of Edoxaban, using the NSH reference guide, what will you recommend?","a.	Patient is not having a major, life-threatening bleed; Hold Edoxaban, provide supportive care and control bleeding site until the drug is out his system.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"67 year-old male on Edoxaban 60mg daily for atrial fibrillation presents to the ED after a ground level fall in which he hit his head. Per the patient's wife, his mental status is altered from baseline and she is concerned he has a concussion. CT of the head reveals severe intracranial hemorrhage. The ED providers asks for your recommendation on reversal of Edoxaban, using the NSH reference guide, what will you recommend?","b.	Patient is having a major, life-threatening bleed; administer high dose andexanet alfa: 800mg IV bolus followed by continuous infusion of 8mg/min for up to 120 minutes",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"67 year-old male on Edoxaban 60mg daily for atrial fibrillation presents to the ED after a ground level fall in which he hit his head. Per the patient's wife, his mental status is altered from baseline and she is concerned he has a concussion. CT of the head reveals severe intracranial hemorrhage. The ED providers asks for your recommendation on reversal of Edoxaban, using the NSH reference guide, what will you recommend?","c.	Patient is having a major, life-threatening bleed; administer low dose andexanet alfa: 400mg IV bolus followed by continuous infusion of 4mg/min for up to 120 minutes",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"67 year-old male on Edoxaban 60mg daily for atrial fibrillation presents to the ED after a ground level fall in which he hit his head. Per the patient's wife, his mental status is altered from baseline and she is concerned he has a concussion. CT of the head reveals severe intracranial hemorrhage. The ED providers asks for your recommendation on reversal of Edoxaban, using the NSH reference guide, what will you recommend?","d.	Patient is having a major, life-threatening bleed; however, andexanet alfa is not indicated for reversal of Edoxaban. Administer 4PCC (Kcentra) 50units/kg.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,What factors should be considered in the perioperative management of anticoagulant therapy?,"a.	Drug specific details including dose, elimination half-life, and method of drug elimination/excretion",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,What factors should be considered in the perioperative management of anticoagulant therapy?,b.	Procedure specific risk for major bleeding,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,What factors should be considered in the perioperative management of anticoagulant therapy?,c.	Patient risk factors for perioperative thrombotic events,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,What factors should be considered in the perioperative management of anticoagulant therapy?,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"A 70 year-old female who takes Apixaban 5mg BID for atrial fibrillation is scheduled for a knee replacement in the coming weeks due to chronic osteoarthritis. You are working in surgery pharmacy and the surgeon calls to ask for your recommendation on the perioperative management of her Apixaban. The surgeon is concerned for bleeding during the procedure but is also hesitant to hold anticoagulation very long due to recent history (<3 months ago) of a stroke while taking a different anticoagulant. Using labs from the most recent pre-op blood work, you calculate the patient's estimated creatinine clearance to be 65mL/min Using the NSH reference guide, what will you recommend?",a.	Hold Apixaban for 1 to 2 days prior to procedure,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"A 70 year-old female who takes Apixaban 5mg BID for atrial fibrillation is scheduled for a knee replacement in the coming weeks due to chronic osteoarthritis. You are working in surgery pharmacy and the surgeon calls to ask for your recommendation on the perioperative management of her Apixaban. The surgeon is concerned for bleeding during the procedure but is also hesitant to hold anticoagulation very long due to recent history (<3 months ago) of a stroke while taking a different anticoagulant. Using labs from the most recent pre-op blood work, you calculate the patient's estimated creatinine clearance to be 65mL/min Using the NSH reference guide, what will you recommend?",b.	Hold Apixaban for 2 to 3 days prior to procedure,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"A 70 year-old female who takes Apixaban 5mg BID for atrial fibrillation is scheduled for a knee replacement in the coming weeks due to chronic osteoarthritis. You are working in surgery pharmacy and the surgeon calls to ask for your recommendation on the perioperative management of her Apixaban. The surgeon is concerned for bleeding during the procedure but is also hesitant to hold anticoagulation very long due to recent history (<3 months ago) of a stroke while taking a different anticoagulant. Using labs from the most recent pre-op blood work, you calculate the patient's estimated creatinine clearance to be 65mL/min Using the NSH reference guide, what will you recommend?",c.	Consider using prophylactic doses of unfractionated heparin or enoxaparin while apixban is being held,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"A 70 year-old female who takes Apixaban 5mg BID for atrial fibrillation is scheduled for a knee replacement in the coming weeks due to chronic osteoarthritis. You are working in surgery pharmacy and the surgeon calls to ask for your recommendation on the perioperative management of her Apixaban. The surgeon is concerned for bleeding during the procedure but is also hesitant to hold anticoagulation very long due to recent history (<3 months ago) of a stroke while taking a different anticoagulant. Using labs from the most recent pre-op blood work, you calculate the patient's estimated creatinine clearance to be 65mL/min Using the NSH reference guide, what will you recommend?",d.	Both A and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"A 70 year-old female who takes Apixaban 5mg BID for atrial fibrillation is scheduled for a knee replacement in the coming weeks due to chronic osteoarthritis. You are working in surgery pharmacy and the surgeon calls to ask for your recommendation on the perioperative management of her Apixaban. The surgeon is concerned for bleeding during the procedure but is also hesitant to hold anticoagulation very long due to recent history (<3 months ago) of a stroke while taking a different anticoagulant. Using labs from the most recent pre-op blood work, you calculate the patient's estimated creatinine clearance to be 65mL/min Using the NSH reference guide, what will you recommend?",e.	Both B and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"68 year-old male is taking warfarin 5mg daily and aspirin 81mg daily for prophylaxis due to a mechanical mitral valve. The physician asks for your recommendation on how long to hold warfarin and aspirin prior to squamous cell skin cancer excision. Using the NSH reference guide, what will you recommend?","a.	This is a low bleed risk procedure; hold warfarin for 5 days or until INR <2 and it is not required to hold aspirin. The patient has a high risk for perioperative VTE, consider prophylactic heparin or enoxaparin while warfarin is being held.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"68 year-old male is taking warfarin 5mg daily and aspirin 81mg daily for prophylaxis due to a mechanical mitral valve. The physician asks for your recommendation on how long to hold warfarin and aspirin prior to squamous cell skin cancer excision. Using the NSH reference guide, what will you recommend?","b.	This is a minimal bleed risk procedure that may not require holding warfarin or aspirin. The patient has a high risk for perioperative VTE, and if the provider does wish to hold anticoagulation, consider prophylactic heparin or enoxaparin while warfarin is being held.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"68 year-old male is taking warfarin 5mg daily and aspirin 81mg daily for prophylaxis due to a mechanical mitral valve. The physician asks for your recommendation on how long to hold warfarin and aspirin prior to squamous cell skin cancer excision. Using the NSH reference guide, what will you recommend?",c.	This is a low bleed risk procedure; hold warfarin for 5 days or until INR < 2 and it is not required to hold aspirin. There is no need to consider prophylactic anticoagulants while warfarin is being held.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"68 year-old male is taking warfarin 5mg daily and aspirin 81mg daily for prophylaxis due to a mechanical mitral valve. The physician asks for your recommendation on how long to hold warfarin and aspirin prior to squamous cell skin cancer excision. Using the NSH reference guide, what will you recommend?",d.	This is a minimal bleed risk procedure; hold warfarin for 2-3 days and it is not required to hold aspirin.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"A 72 year old male presents to the ED after a fall. The patient is determined to have a severe hip fracture and the ortho surgeon consulted would like to perform emergent hip replacement surgery. The patient is taking Clopidogrel 75mg daily for a history of NSTEMI that occurred 12 months ago. The last dose of clopidogrel was taken 10 hours ago. The surgeon asks how long they should delay surgery to allow for recovery of platelet function. Using the NSH reference guide, what will you recommend?","a.	This is a high bleed risk procedure, delay surgery for 5 days from the last dose of clopidogrel to allow for recovery of platelet function.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"A 72 year old male presents to the ED after a fall. The patient is determined to have a severe hip fracture and the ortho surgeon consulted would like to perform emergent hip replacement surgery. The patient is taking Clopidogrel 75mg daily for a history of NSTEMI that occurred 12 months ago. The last dose of clopidogrel was taken 10 hours ago. The surgeon asks how long they should delay surgery to allow for recovery of platelet function. Using the NSH reference guide, what will you recommend?","b.	The patient may be taken to surgery right away, it is not recommended to delay urgent or emergent surgery due to antiplatelet use alone.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"A 72 year old male presents to the ED after a fall. The patient is determined to have a severe hip fracture and the ortho surgeon consulted would like to perform emergent hip replacement surgery. The patient is taking Clopidogrel 75mg daily for a history of NSTEMI that occurred 12 months ago. The last dose of clopidogrel was taken 10 hours ago. The surgeon asks how long they should delay surgery to allow for recovery of platelet function. Using the NSH reference guide, what will you recommend?","c.	This is a high bleed risk procedure, delay surgery for 7 days from the last dose of clopidogrel to allow for recovery of platelet function.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"A 72 year old male presents to the ED after a fall. The patient is determined to have a severe hip fracture and the ortho surgeon consulted would like to perform emergent hip replacement surgery. The patient is taking Clopidogrel 75mg daily for a history of NSTEMI that occurred 12 months ago. The last dose of clopidogrel was taken 10 hours ago. The surgeon asks how long they should delay surgery to allow for recovery of platelet function. Using the NSH reference guide, what will you recommend?",d.	This is a low bleed risk procedure and it is not required to hold antiplatelet agents.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"A patient who takes Rivaroxaban 10mg daily for secondary DVT prophylaxis status post an unprovoked DVT 13 months ago is scheduled to undergo a total abdominal hysterectomy. You are asked how long it is recommended to hold Rivaroxaban prior to surgery. CrCl= 45mL/min. Using the NSH reference guide, what will you recommend?","a.	Hold Rivaroxaban for 3 days prior to surgery, consider using prophylactic heparin or enoxaparin while Rivaroxaban is being held.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"A patient who takes Rivaroxaban 10mg daily for secondary DVT prophylaxis status post an unprovoked DVT 13 months ago is scheduled to undergo a total abdominal hysterectomy. You are asked how long it is recommended to hold Rivaroxaban prior to surgery. CrCl= 45mL/min. Using the NSH reference guide, what will you recommend?","b.	Hold Rivaroxaban for 2 days prior to surgery, patient has a low risk for perioperative VTE and prophylactic heparin or enoxaparin may not be needed while Rivaroxaban is being held.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"A patient who takes Rivaroxaban 10mg daily for secondary DVT prophylaxis status post an unprovoked DVT 13 months ago is scheduled to undergo a total abdominal hysterectomy. You are asked how long it is recommended to hold Rivaroxaban prior to surgery. CrCl= 45mL/min. Using the NSH reference guide, what will you recommend?",c.	Hold Rivaroxaban for 2 days prior to surgery and consider using prophylactic heparin or enoxaparin while Rivaroxaban is being held.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"A patient who takes Rivaroxaban 10mg daily for secondary DVT prophylaxis status post an unprovoked DVT 13 months ago is scheduled to undergo a total abdominal hysterectomy. You are asked how long it is recommended to hold Rivaroxaban prior to surgery. CrCl= 45mL/min. Using the NSH reference guide, what will you recommend?","d.	Hold Rivaroxaban for 1 day prior to surgery, patient has a low risk for perioperative VTE and prophylactic heparin or enoxaparin may not be needed while Rivaroxaban is being held.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,A patient who is takes Enoxaparin for treatment of a PE is scheduled to undergo initial placement of a nephrostomy tube. You are asked how long to hold Enoxaparin prior to the procedure and how long after the procedure to resume the medication. All labs are WNL.,a.	Do not hold,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,A patient who is takes Enoxaparin for treatment of a PE is scheduled to undergo initial placement of a nephrostomy tube. You are asked how long to hold Enoxaparin prior to the procedure and how long after the procedure to resume the medication. All labs are WNL.,b.	Hold 12 hours/Resume in 6 hr,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,A patient who is takes Enoxaparin for treatment of a PE is scheduled to undergo initial placement of a nephrostomy tube. You are asked how long to hold Enoxaparin prior to the procedure and how long after the procedure to resume the medication. All labs are WNL.,c.	Hold 24 hours/Resume in 6 hr,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,A patient who is takes Enoxaparin for treatment of a PE is scheduled to undergo initial placement of a nephrostomy tube. You are asked how long to hold Enoxaparin prior to the procedure and how long after the procedure to resume the medication. All labs are WNL.,d.	Hold 24 hours/Resume in 48 hr,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,T/F Anesthesia should always be contacted when anticoagulant or antiplatelet agents and an epidural or intrathecal are ordered concurrently.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,T/F Anesthesia should always be contacted when anticoagulant or antiplatelet agents and an epidural or intrathecal are ordered concurrently.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"The minimum time between the last dose of Heparin 5,000 units SQ every 12 hours and the placement of an epidural catheter is ________.",a.	8 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"The minimum time between the last dose of Heparin 5,000 units SQ every 12 hours and the placement of an epidural catheter is ________.",b.	12 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"The minimum time between the last dose of Heparin 5,000 units SQ every 12 hours and the placement of an epidural catheter is ________.",c.	6 hours,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"The minimum time between the last dose of Heparin 5,000 units SQ every 12 hours and the placement of an epidural catheter is ________.",d.	24 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"The minimum time between the removal of an epidural catheter and the first dose of Heparin 5,000 units SQ every 12 hours is  ________.",a.	6 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"The minimum time between the removal of an epidural catheter and the first dose of Heparin 5,000 units SQ every 12 hours is  ________.",b.	12 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"The minimum time between the removal of an epidural catheter and the first dose of Heparin 5,000 units SQ every 12 hours is  ________.",c.	1 hour,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,"The minimum time between the removal of an epidural catheter and the first dose of Heparin 5,000 units SQ every 12 hours is  ________.",d.	8 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,The first dose of enoxaparin 40mg daily may be given _________.,a.	&#8805 12 hours after removal of epidural catheter.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,The first dose of enoxaparin 40mg daily may be given _________.,b..	&#8805   4 hours after removal of epidural catheter.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,The first dose of enoxaparin 40mg daily may be given _________.,c.	&#8805   4 hours after removal of AND &#8805 12 hours after initial placement of epidural catheter; whichever is longer,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,The first dose of enoxaparin 40mg daily may be given _________.,d.	&#8805 12 hours after removal of AND &#8805  24 hours after initial placement of epidural catheter; whichever is longer,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,The minimum time between the last dose of enoxaparin 1mg/kg BID and the placement of an epidural catheter is ______.,a.	12 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,The minimum time between the last dose of enoxaparin 1mg/kg BID and the placement of an epidural catheter is ______.,b.	24 hours,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,The minimum time between the last dose of enoxaparin 1mg/kg BID and the placement of an epidural catheter is ______.,c.	8 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9302,,Elearning-0000-551,FY2021 PHARMACY ANTICOAGULATION REVERSAL AND PERIPROCEDURAL MANAGEMENT,,n13918,,choice,The minimum time between the last dose of enoxaparin 1mg/kg BID and the placement of an epidural catheter is ______.,d.	6 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9593,,Elearning-0000-816,HAPI PREVENTION EDUCATION - JULY 2021 - PRESSURE INJURY PREVENTION OFFLOADING,,n13909,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""HAPI Prevention - July 2021 - Pressure Injury Prevention Offloading"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is HAPI PREVENTION EDUCATION - JULY 2021 - PRESSURE INJURY PREVENTION OFFLOADING- g13909,False
9593,,Elearning-0000-816,HAPI PREVENTION EDUCATION - JULY 2021 - PRESSURE INJURY PREVENTION OFFLOADING,,n13909,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""HAPI Prevention - July 2021 - Pressure Injury Prevention Offloading"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9593,,Elearning-0000-816,HAPI PREVENTION EDUCATION - JULY 2021 - PRESSURE INJURY PREVENTION OFFLOADING,,n13909,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""HAPI Prevention - July 2021 - Pressure Injury Prevention Offloading"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9644,,Elearning-0000-862,PEOPLEFLUENT FOR HIRING MANAGERS CBL,,n13910,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""PeopleFluent For Hiring Managers CBL"" content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is PEOPLEFLUENT FOR HIRING MANAGERS CBL- g13910,False
9644,,Elearning-0000-862,PEOPLEFLUENT FOR HIRING MANAGERS CBL,,n13910,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""PeopleFluent For Hiring Managers CBL"" content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9644,,Elearning-0000-862,PEOPLEFLUENT FOR HIRING MANAGERS CBL,,n13910,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""PeopleFluent For Hiring Managers CBL"" content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9683,,Elearning-0000-898,GI LAB NSF: STERILE SUPPLY STORAGE,,n13915,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""GI LAB NSF: STERILE SUPPLY STORAGE"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is GI LAB NSF: STERILE SUPPLY STORAGE- g13915,False
9683,,Elearning-0000-898,GI LAB NSF: STERILE SUPPLY STORAGE,,n13915,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""GI LAB NSF: STERILE SUPPLY STORAGE"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9683,,Elearning-0000-898,GI LAB NSF: STERILE SUPPLY STORAGE,,n13915,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""GI LAB NSF: STERILE SUPPLY STORAGE"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21- g13914,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9903,,Questions-0000-37,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 6-25-21,,n13914,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,"Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21- g13913",False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9916,,Questions-0000-50,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 6-25-21",,n13913,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21- g13912,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN, CCRN -K</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9910,,Questions-0000-44,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 6-25-21,,n13912,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,When can you drawn an ABG per RT Protocol?,A. Any patient who is in distress or has had a change in status,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 RESPIRATORY ABG COMPETENCY CBL- g13916,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,When can you drawn an ABG per RT Protocol?,A. Any patient who is in distress or has had a change in status,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,When can you drawn an ABG per RT Protocol?,B. Any patient suddenly requiring greater than or equal to 50% FIO2,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,When can you drawn an ABG per RT Protocol?,C. Any patient with an exacerbation of their medical condition where their acid/base balance is questioned,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,When can you drawn an ABG per RT Protocol?,D. Any patient in which oximetry results are questionable,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,When can you drawn an ABG per RT Protocol?,E. ABGs may be obtained on a PRN basis based on the clinical presentation of the patient on the ventilator,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,When can you drawn an ABG per RT Protocol?,"F. A, B, and C Only",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,When can you drawn an ABG per RT Protocol?,G. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is not true about AM ABGs in the ICU?,ABGs in the ICU are always a Complete Panel unless ordered otherwise,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is not true about AM ABGs in the ICU?,Am ABGs in the ICU are only done if there is an active order in Cerner,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is not true about AM ABGs in the ICU?,Am ABGs are done daily on all Vented patients,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"You must take an ABG machine to the bedside, but in the event you cannot, what process is most appropriate?","A. Pt sticker can be taken to the lab after verifying the Pt's name, FIN number, and DOB on the Patient's arm band",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"You must take an ABG machine to the bedside, but in the event you cannot, what process is most appropriate?",B. Pt sticker can be taken to the lab after verifying Pt's correct room number,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"You must take an ABG machine to the bedside, but in the event you cannot, what process is most appropriate?",C. Pt sticker can be taken to the lab after verifying one patient identifier,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"When running a sample, what are the reasons you might see question marks instead of results on the results page?",A. Expired sample,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"When running a sample, what are the reasons you might see question marks instead of results on the results page?",B. Analyze time is before the draw time,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"When running a sample, what are the reasons you might see question marks instead of results on the results page?",C. Wrong patient sticker,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"When running a sample, what are the reasons you might see question marks instead of results on the results page?",D. No order entered in Cerner,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"When running a sample, what are the reasons you might see question marks instead of results on the results page?","E. A, B, C",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"When running a sample, what are the reasons you might see question marks instead of results on the results page?",F. A  and B,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"When running a sample, what are the reasons you might see question marks instead of results on the results page?",G. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"If the patients armband or sticker doesn't scan, you will have to manually enter ""AC""� followed by the patients FIN number. If entered correctly what should happen next?",A. Therapist will also manually enter Pt's full name and DOB,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"If the patients armband or sticker doesn't scan, you will have to manually enter ""AC""� followed by the patients FIN number. If entered correctly what should happen next?",B. A gray demographics box will appear for the therapist to confirm correct Pt information was entered,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"If the patients armband or sticker doesn't scan, you will have to manually enter ""AC""� followed by the patients FIN number. If entered correctly what should happen next?",C. None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is true?,A. You do not have to have an ABG to wean,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is true?,B. Use both SpO2 and EtCO2 to wean as long at they are correlating with previous gasses,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is true?,C. None are true,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is true?,D. A and B are true,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is true regarding notification of critical ABG results?,A. Therapist must document under critical notification tab in Cerner,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is true regarding notification of critical ABG results?,B. Therapist must document last name and credential. For example: Dr. Boyce,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is true regarding notification of critical ABG results?,"C. Therapist must document first initial, last name, and credential. For example: P. Boyce MD",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is true regarding notification of critical ABG results?,D. Results can be given to a licensed health care professional,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is true regarding notification of critical ABG results?,E. A and D are true,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is true regarding notification of critical ABG results?,F. C and D are true,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"If collateral circulation cannot be verified as a positive Allen's Test on either hand, you can do a brachial stick per protocol?",A. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"If collateral circulation cannot be verified as a positive Allen's Test on either hand, you can do a brachial stick per protocol?",B. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,What is not considered a MANDATORY field when running an ABG?,"A. Correct Patient Name, Fin #, and DOB",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,What is not considered a MANDATORY field when running an ABG?,B. Draw time,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,What is not considered a MANDATORY field when running an ABG?,C. Ordering MD,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,What is not considered a MANDATORY field when running an ABG?,D. Sample type,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,What is not considered a MANDATORY field when running an ABG?,E. Oxygen device,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"Verification of orders, correct patient identification, proper technique in obtaining and prepping the blood sample, confirmation of demographic information, pertinent date entry, and reporting of critical values are all integral parts of the quality assurance process in ABG analysis.",A. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,"Verification of orders, correct patient identification, proper technique in obtaining and prepping the blood sample, confirmation of demographic information, pertinent date entry, and reporting of critical values are all integral parts of the quality assurance process in ABG analysis.",B. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,The image shows the correct charging of additional test when running a complete panel?,A. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,The image shows the correct charging of additional test when running a complete panel?,B. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is true regarding Red Rule violations when scanning the wrong patient information?,A. Red Rules are not reported if the Therapist self reports,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is true regarding Red Rule violations when scanning the wrong patient information?,B. Red Rules are not reported if the Nurse hands you the incorrect sticker during a CODE/Rapid Response,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is true regarding Red Rule violations when scanning the wrong patient information?,C. Red Rules are not reported if we catch the mistake immediately after the sample is approved,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9713,,Elearning-0000-925,2021 RESPIRATORY ABG COMPETENCY CBL,,n13916,,choice,Which statement is true regarding Red Rule violations when scanning the wrong patient information?,D. All Red Rules are reported. It is your responsibility to report results on the correct patient,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9581,,Elearning-0000-805,HEART FAILURE DISEASE MANAGAMENT CLINIC CHEROKEE,,n13917,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Heart Failure Disease Managament Clinic Cherokee CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is HEART FAILURE DISEASE MANAGAMENT CLINIC CHEROKEE- g13917,False
9581,,Elearning-0000-805,HEART FAILURE DISEASE MANAGAMENT CLINIC CHEROKEE,,n13917,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Heart Failure Disease Managament Clinic Cherokee CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9581,,Elearning-0000-805,HEART FAILURE DISEASE MANAGAMENT CLINIC CHEROKEE,,n13917,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Heart Failure Disease Managament Clinic Cherokee CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21- g13920,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN CCRN-K </ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN CCRN-K </ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN CCRN-K </ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN CCRN-K </ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN CCRN-K </ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9891,,Questions-0000-25,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 6-28-21,,n13920,,choice,How would you improve this class?,"No improvements needed (appropriate content, instructor, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21- g13924,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss crash dynamics related to injury prevention.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss crash dynamics related to injury prevention.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss crash dynamics related to injury prevention.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss crash dynamics related to injury prevention.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss crash dynamics related to injury prevention.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize Georgia's and AAP's recommendations for child safety seat use.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize Georgia's and AAP's recommendations for child safety seat use.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize Georgia's and AAP's recommendations for child safety seat use.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize Georgia's and AAP's recommendations for child safety seat use.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize Georgia's and AAP's recommendations for child safety seat use.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand rationale for rear facing car seats.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand rationale for rear facing car seats.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand rationale for rear facing car seats.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand rationale for rear facing car seats.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand rationale for rear facing car seats.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize car safety recommendations for growing infants and children.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize car safety recommendations for growing infants and children.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize car safety recommendations for growing infants and children.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize car safety recommendations for growing infants and children.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize car safety recommendations for growing infants and children.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify infants at risk for airway obstruction.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify infants at risk for airway obstruction.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify infants at risk for airway obstruction.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify infants at risk for airway obstruction.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify infants at risk for airway obstruction.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe safe travel options for infants who fail the car seat challenge/angle tolerance test.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe safe travel options for infants who fail the car seat challenge/angle tolerance test.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe safe travel options for infants who fail the car seat challenge/angle tolerance test.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe safe travel options for infants who fail the car seat challenge/angle tolerance test.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe safe travel options for infants who fail the car seat challenge/angle tolerance test.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to utilize the recall list to identify if a car seat has a recall.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to utilize the recall list to identify if a car seat has a recall.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to utilize the recall list to identify if a car seat has a recall.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to utilize the recall list to identify if a car seat has a recall.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to utilize the recall list to identify if a car seat has a recall.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the dangers of air bags and car seats.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the dangers of air bags and car seats.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the dangers of air bags and car seats.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the dangers of air bags and car seats.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the dangers of air bags and car seats.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe car seat cleaning practices.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe car seat cleaning practices.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe car seat cleaning practices.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe car seat cleaning practices.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe car seat cleaning practices.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to State corrections needed when viewing pictures of children in car seats at car seat check events.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to State corrections needed when viewing pictures of children in car seats at car seat check events.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to State corrections needed when viewing pictures of children in car seats at car seat check events.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to State corrections needed when viewing pictures of children in car seats at car seat check events.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to State corrections needed when viewing pictures of children in car seats at car seat check events.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify simulated car seat misuses and discuss corrective actions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify simulated car seat misuses and discuss corrective actions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify simulated car seat misuses and discuss corrective actions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify simulated car seat misuses and discuss corrective actions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify simulated car seat misuses and discuss corrective actions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine qualities and qualifications for becoming CPST.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine qualities and qualifications for becoming CPST.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine qualities and qualifications for becoming CPST.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine qualities and qualifications for becoming CPST.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine qualities and qualifications for becoming CPST.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve parent education.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve parent education.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve parent education.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve parent education.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve parent education.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Alex McKeithan</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Alex McKeithan</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Alex McKeithan</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Alex McKeithan</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Alex McKeithan</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kathy Cunningham</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kathy Cunningham</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kathy Cunningham</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kathy Cunningham</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kathy Cunningham</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9932,,Questions-0000-66,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 6.30.21,,n13924,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"NSH K-5 Policy provides guidelines for the handling of hazardous drugs (HDs) in conformance with USP, OSHA, NIOSH and EPA standards to protect NSH staff from unintended HD exposure.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS- g13923,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"NSH K-5 Policy provides guidelines for the handling of hazardous drugs (HDs) in conformance with USP, OSHA, NIOSH and EPA standards to protect NSH staff from unintended HD exposure.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"NSH K-5 Policy provides guidelines for the handling of hazardous drugs (HDs) in conformance with USP, OSHA, NIOSH and EPA standards to protect NSH staff from unintended HD exposure.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Which one of the following hazardous medication list grouping is incorrect?,a.	Group 2 - Hazardous agents (primarily reproductive risk),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Which one of the following hazardous medication list grouping is incorrect?,b.	Group 1 - Hazardous agents (cytotoxic antineoplastic/reproductive risks),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Which one of the following hazardous medication list grouping is incorrect?,c.	Group 2A - Non-hazardous antineoplastic agents,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Which one of the following hazardous medication list grouping is incorrect?,d.	Appendix D - Excluded drugs based on NSH risk assessment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"New Hazardous Drug Alerts fire in PowerChart and PharmNet for all Group 1 and 2 HDs with NON-PARENTERAL routes, when ordered, to ensure that safe handling procedures and appropriate patient monitoring is in place.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"New Hazardous Drug Alerts fire in PowerChart and PharmNet for all Group 1 and 2 HDs with NON-PARENTERAL routes, when ordered, to ensure that safe handling procedures and appropriate patient monitoring is in place.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"All sterile compounding areas and devices where hazardous drugs are handled must following the following cleaning steps per pharmacy policies, cleaning logs, and standard operating procedures using approved products:",a.	Decontamination,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"All sterile compounding areas and devices where hazardous drugs are handled must following the following cleaning steps per pharmacy policies, cleaning logs, and standard operating procedures using approved products:",b.	Cleaning,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"All sterile compounding areas and devices where hazardous drugs are handled must following the following cleaning steps per pharmacy policies, cleaning logs, and standard operating procedures using approved products:",c.	Disinfection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"All sterile compounding areas and devices where hazardous drugs are handled must following the following cleaning steps per pharmacy policies, cleaning logs, and standard operating procedures using approved products:",d.	Deactivate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"All sterile compounding areas and devices where hazardous drugs are handled must following the following cleaning steps per pharmacy policies, cleaning logs, and standard operating procedures using approved products:",e.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"For hazardous medications (group 1 or 2), any manipulations of tablets/capsules such as splitting or crushing will be performed inside a BSC or CACI and dispensed in final dosage form for administration",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"For hazardous medications (group 1 or 2), any manipulations of tablets/capsules such as splitting or crushing will be performed inside a BSC or CACI and dispensed in final dosage form for administration",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,a.	Protective Gown,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,b.	Eye/Face protection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,c.	Respiratory protection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,d.	Footwear,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,e.	Gloves,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,f.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,The spill response team is activated for any spills that is not contained by the following:,a.	Two Spill Kits,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,The spill response team is activated for any spills that is not contained by the following:,b.	Single Spill Kit,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,The spill response team is activated for any spills that is not contained by the following:,c.	Three Spill Kits,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,The spill response team is activated for any spills that is not contained by the following:,d.	Any spill in patient care area,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,The spill response team is activated for any spills that is not contained by the following:,e.	Any spill in pharmacy area,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Gloves used in the preparation of HDs must be:,a.	Disposable,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Gloves used in the preparation of HDs must be:,b.	Powdered to facilitate removal,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Gloves used in the preparation of HDs must be:,c.	Specified as ASTM-tested chemotherapy gloves,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Gloves used in the preparation of HDs must be:,d.	A and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"When reconstituting and withdrawing chemotherapy medications from vials, aerosol droplets may be generated. This can be minimized or eliminated by using:",a.	Filter needles,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"When reconstituting and withdrawing chemotherapy medications from vials, aerosol droplets may be generated. This can be minimized or eliminated by using:",b.	Leur-Lock syringes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"When reconstituting and withdrawing chemotherapy medications from vials, aerosol droplets may be generated. This can be minimized or eliminated by using:",c.	Closed-system transfer devices (CSTDs),True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"When reconstituting and withdrawing chemotherapy medications from vials, aerosol droplets may be generated. This can be minimized or eliminated by using:",d.	None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,When wearing double gloves:,a.	The gown cuffs should be tucked over both gloves,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,When wearing double gloves:,b.	The gown cuffs should be tucked under both gloves,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,When wearing double gloves:,c.	The inner glove should be worn under the cuff and the outer glove should be worn over the gown cuff,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,When wearing double gloves:,d.	It makes no difference if gown cuffs are worn over or under the gloves,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Gowns and gloves worn while working in the HD preparation area can be worn while working in other medication preparation areas.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Gowns and gloves worn while working in the HD preparation area can be worn while working in other medication preparation areas.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Which of the following types of containment primary engineering controls (C-PECs) can be used for preparing sterile HDs?,a.	Biological safety cabinet (BSC),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Which of the following types of containment primary engineering controls (C-PECs) can be used for preparing sterile HDs?,b.	Horizontal laminar air flow workbench,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Which of the following types of containment primary engineering controls (C-PECs) can be used for preparing sterile HDs?,c.	Compounding aseptic containment isolator (CACI),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Which of the following types of containment primary engineering controls (C-PECs) can be used for preparing sterile HDs?,d.	A and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Spill kits:,a.	May be obtained from Central Supply when needed,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Spill kits:,b.	Are kept wherever HDs and chemotherapy agents are handled,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Spill kits:,c.	Contain supplies needed to clean a HD spill,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Spill kits:,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"Hazardous drugs (Group 1 and 2) that require manipulation or compounding may be stored in areas with non-hazardous drugs; however, they must be stored above other drugs on higher medication shelves.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"Hazardous drugs (Group 1 and 2) that require manipulation or compounding may be stored in areas with non-hazardous drugs; however, they must be stored above other drugs on higher medication shelves.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"Group 1 HDs in final dosage forms (tablets, capsules, pre-filled syringes) may not be stored in patient medication drawers with non-hazardous drugs or in unit-based automated dispensing cabinets.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,"Group 1 HDs in final dosage forms (tablets, capsules, pre-filled syringes) may not be stored in patient medication drawers with non-hazardous drugs or in unit-based automated dispensing cabinets.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,How often do you have to change the gown during hazardous drug compounding?,a.	At least every 12 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,How often do you have to change the gown during hazardous drug compounding?,b.	At least every 24 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,How often do you have to change the gown during hazardous drug compounding?,c.	At least every 3 hours,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,How often do you have to change the gown during hazardous drug compounding?,d.	At least every 8 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,How often do you have to change the outer gloves during hazardous drug sterile compounding?,a.	At least every 8 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,How often do you have to change the outer gloves during hazardous drug sterile compounding?,b.	At least every 3  hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,How often do you have to change the outer gloves during hazardous drug sterile compounding?,c.	At least every 30 minutes,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,How often do you have to change the outer gloves during hazardous drug sterile compounding?,d.	 At shift change,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Cytotoxic chemotherapy dispensed in a syringe must not take up more than 80% of the total volume of the syringe.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Cytotoxic chemotherapy dispensed in a syringe must not take up more than 80% of the total volume of the syringe.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Which statement is true?,a.	Cytotoxic chemotherapy doses maybe rounded down or up to the nearest vials size within < 5% of the calculated dose,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Which statement is true?,b.	Cytotoxic chemotherapy doses maybe rounded down to the nearest vials size within < 5% of the calculated dose,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Which statement is true?,c.	Monoclonal antibodies and other biologic agents may be dose rounded down or up to the nearest vial size within = 10% of the calculated dose.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Which statement is true?,d.	Monoclonal antibodies and other biologic agents may be dose rounded down or up to the nearest vial size within = 5% of the calculated dose.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Which statement is true?,e.	a & c,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9252,,Elearning-0000-506,FY2021 PHARMACY HAZARDOUS DRUGS / CHEMOTHERAPEUTICS (K-5) POLICY EDUCATION TECHNICIANS,,n13923,,choice,Which statement is true?,f.	b & c,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9325,,Elearning-0000-572,FY2021 PHARMACY ECMO EDUCATION,,n13925,,choice,Which of the following are true statements,a.	Veno-venous ECMO provides respiratory support for critically ill patients,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 PHARMACY ECMO EDUCATION- g13925,False
9325,,Elearning-0000-572,FY2021 PHARMACY ECMO EDUCATION,,n13925,,choice,Which of the following are true statements,a.	Veno-venous ECMO provides respiratory support for critically ill patients,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9325,,Elearning-0000-572,FY2021 PHARMACY ECMO EDUCATION,,n13925,,choice,Which of the following are true statements,b.	Veno-arterial ECMO provides both cardiac and respiratory support for critically ill patients,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9325,,Elearning-0000-572,FY2021 PHARMACY ECMO EDUCATION,,n13925,,choice,Which of the following are true statements,c.	ECMO is NOT a cure for respiratory or cardiac failure but can be used as short term therapy until organ function is recovered,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9325,,Elearning-0000-572,FY2021 PHARMACY ECMO EDUCATION,,n13925,,choice,Which of the following are true statements,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9325,,Elearning-0000-572,FY2021 PHARMACY ECMO EDUCATION,,n13925,,choice,True or False: ECMO cannot be used in patients that have an absolute contraindication to anticoagulation,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9325,,Elearning-0000-572,FY2021 PHARMACY ECMO EDUCATION,,n13925,,choice,True or False: ECMO cannot be used in patients that have an absolute contraindication to anticoagulation,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9325,,Elearning-0000-572,FY2021 PHARMACY ECMO EDUCATION,,n13925,,choice,Heparin is the preferred anticoagulant in ECMO. Which of the following statements is TRUE about heparin orders for ECMO:,a.	All ECMO heparin drips are monitoring with ACT,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9325,,Elearning-0000-572,FY2021 PHARMACY ECMO EDUCATION,,n13925,,choice,Heparin is the preferred anticoagulant in ECMO. Which of the following statements is TRUE about heparin orders for ECMO:,b.	Heparin drips should be dosed using actual body weight with no weight cap,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9325,,Elearning-0000-572,FY2021 PHARMACY ECMO EDUCATION,,n13925,,choice,Heparin is the preferred anticoagulant in ECMO. Which of the following statements is TRUE about heparin orders for ECMO:,c.	ECMO heparin drips should be titrated using the ECMO specific nomogram and all dose changes should be recorded on the ECMO heparin flowsheet,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9325,,Elearning-0000-572,FY2021 PHARMACY ECMO EDUCATION,,n13925,,choice,Heparin is the preferred anticoagulant in ECMO. Which of the following statements is TRUE about heparin orders for ECMO:,d.	No double check is required for ECMO heparin drips due to the frequency of lab checks,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9325,,Elearning-0000-572,FY2021 PHARMACY ECMO EDUCATION,,n13925,,choice,"True or False: ECMO orders include concentrated options of sedation, analgesic, neuromuscular blocker, and vasopressor drips, when available, to limit fluid volumes",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9325,,Elearning-0000-572,FY2021 PHARMACY ECMO EDUCATION,,n13925,,choice,"True or False: ECMO orders include concentrated options of sedation, analgesic, neuromuscular blocker, and vasopressor drips, when available, to limit fluid volumes",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Normal Axillary Temp in the newborn should be between 36.1 degrees Celcius and 36.4 Celcious?,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021- g13927,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Normal Axillary Temp in the newborn should be between 36.1 degrees Celcius and 36.4 Celcious?,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Normal Axillary Temp in the newborn should be between 36.1 degrees Celcius and 36.4 Celcious?,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Conduction is the method of heat loss when what occurs?,a. Airflow carrying heat to or away from an object occurs,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Conduction is the method of heat loss when what occurs?,b.  Heat exchange between objects in direct contact with each other,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Conduction is the method of heat loss when what occurs?,c.  Radiant energy exchange between tow objects not in contact with each other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Conduction is the method of heat loss when what occurs?,"d.  Thermal energy turns liquid into vapor, removing energy (heat) away from the object",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Three characteristics that put newborns at a greater risk for heat loss is:,"a.  a smaller surface area to body mass ratio, decreased subcutaneous fat and greater body water content",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Three characteristics that put newborns at a greater risk for heat loss is:,"b. having greater body water content, larger surface area to body mass ratio and ability to shiver",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Three characteristics that put newborns at a greater risk for heat loss is:,"c.  having greater body water content, larger surface area to body mass ratio and not able to shiver",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Three characteristics that put newborns at a greater risk for heat loss is:,"d. decreased subcutaneous fat, peripheral cyanosis and skin that is mature leading to increased evaporative water and heat losses",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Signs and symptoms of hypothermia include:,"a. acryocyanosis, cool mottled or pale skin",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Signs and symptoms of hypothermia include:,"b. hypoglycemia, poor feeder, week or feeble cry",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Signs and symptoms of hypothermia include:,"c. decreased activity, lethergy, hypotonia",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Signs and symptoms of hypothermia include:,"d. bradycardia, tachypnea, respirtory distress, poor weight gain",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Signs and symptoms of hypothermia include:,e. all of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,True or False if left untreated hypothermia may lead to life theatening complications,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,True or False if left untreated hypothermia may lead to life theatening complications,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Care activities to help prevent hypothermia include which of the following?,"a. Skin to skin, increase room temperature, and dress in clothes and place hat on infant",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Care activities to help prevent hypothermia include which of the following?,b. place infant under radiant warmer with temp probe and set on manual,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Care activities to help prevent hypothermia include which of the following?,"c. place infant under radiant warmer with temp probe and set on ""baby""",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Care activities to help prevent hypothermia include which of the following?,d. a and c,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Care activities to help prevent hypothermia include which of the following?,e. all of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Signs and symptoms of hyperthermia in the newborn include:,"a. tachycardia, tachypnea, apnea",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Signs and symptoms of hyperthermia in the newborn include:,"b.lethargy, hypotonia,and irritibility",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Signs and symptoms of hyperthermia in the newborn include:,"c. poor feeding, weak cry and warm extremities",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Signs and symptoms of hyperthermia in the newborn include:,"d. a, b and c",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Signs and symptoms of hyperthermia in the newborn include:,e. non of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,You are getting VS on Baby North who just came to the floor. Baby North's temp is 36.3 C. What is the first step you should do?,a. take infant to nursery and place under radiant warmer with temp probe set to baby,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,You are getting VS on Baby North who just came to the floor. Baby North's temp is 36.3 C. What is the first step you should do?,"b. place skin to skin with mother, S. O. or other family member",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,You are getting VS on Baby North who just came to the floor. Baby North's temp is 36.3 C. What is the first step you should do?,c. use heel warmers to warm infant 36.3 is too cold,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,You are getting VS on Baby North who just came to the floor. Baby North's temp is 36.3 C. What is the first step you should do?,d. do nothing this is an acceptable temperature.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,When should you recheck Baby North's Temperature after initiating the first intervention?,a. in 1 hour,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,When should you recheck Baby North's Temperature after initiating the first intervention?,b. it does not need to be rechecked as it was within normal range,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,When should you recheck Baby North's Temperature after initiating the first intervention?,c. 30 minutes,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,When should you recheck Baby North's Temperature after initiating the first intervention?,d. with the next set of VS in 4 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,When you recheck Baby North's temperature (1st 30 min check) it is not rising. Your next step is to :,"a. place infant on radiant warmer with skin probe set at 36.5 in ""baby"" mode",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,When you recheck Baby North's temperature (1st 30 min check) it is not rising. Your next step is to :,b. do nothing temp is WNL,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,When you recheck Baby North's temperature (1st 30 min check) it is not rising. Your next step is to :,c. call SCN/TCN to transfer infant,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,When you recheck Baby North's temperature (1st 30 min check) it is not rising. Your next step is to :,d. call the provider,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,When you recheck Baby North's temperature (1st 30 min check) it is not rising. Your next step is to :,e. warm blankets in microwave and swaddle infant,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Baby North needed to go to the nursery to be placed on a radiant warmer for rewarming protocol.  Baby North has now had two consecutive temperatures 30 mins apart and each was 36.8  and 36.9 so she may return to her mother.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,Baby North needed to go to the nursery to be placed on a radiant warmer for rewarming protocol.  Baby North has now had two consecutive temperatures 30 mins apart and each was 36.8  and 36.9 so she may return to her mother.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,"Baby North has been returned to her mother in an open crib swaddled in blankets, diaper, clothes and hat.  How often should her temperature be rechecked?",a. Her temperature was normal and does not need rechecking,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,"Baby North has been returned to her mother in an open crib swaddled in blankets, diaper, clothes and hat.  How often should her temperature be rechecked?",b. Every 30 mins times 4,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,"Baby North has been returned to her mother in an open crib swaddled in blankets, diaper, clothes and hat.  How often should her temperature be rechecked?",c. Recheck temperature every hour times 2,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,"Baby North has been returned to her mother in an open crib swaddled in blankets, diaper, clothes and hat.  How often should her temperature be rechecked?",d. Recheck temperature every 30 mins time 2 then every hour times 4 then may return to every 4 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,"Policies frequently change and are updated.  If I am in doubt of what, how and or when procedures or processes should be done I should always look at the policy in Lucidoc and review and follow my policy.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9117,,Elearning-0000-383,NSC FCC NEWBORN THERMOREGULATION COMPETENCY 2021,,n13927,,choice,"Policies frequently change and are updated.  If I am in doubt of what, how and or when procedures or processes should be done I should always look at the policy in Lucidoc and review and follow my policy.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21- g13926,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state elements of the universal characteristics of the preceptor role.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state elements of the universal characteristics of the preceptor role.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state elements of the universal characteristics of the preceptor role.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state elements of the universal characteristics of the preceptor role.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state elements of the universal characteristics of the preceptor role.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state opportunities for self-improvement related to people skills, self-knowledge, technical and teaching skills</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state opportunities for self-improvement related to people skills, self-knowledge, technical and teaching skills</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state opportunities for self-improvement related to people skills, self-knowledge, technical and teaching skills</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state opportunities for self-improvement related to people skills, self-knowledge, technical and teaching skills</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state opportunities for self-improvement related to people skills, self-knowledge, technical and teaching skills</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify adult learning principles.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify adult learning principles.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify adult learning principles.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify adult learning principles.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify adult learning principles.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine how people learn and how to balance comfort with discomfort.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine how people learn and how to balance comfort with discomfort.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine how people learn and how to balance comfort with discomfort.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine how people learn and how to balance comfort with discomfort.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine how people learn and how to balance comfort with discomfort.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe current models for quick assessment of learner knowledge and use of daily objectives.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe current models for quick assessment of learner knowledge and use of daily objectives.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe current models for quick assessment of learner knowledge and use of daily objectives.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe current models for quick assessment of learner knowledge and use of daily objectives.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe current models for quick assessment of learner knowledge and use of daily objectives.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the benefits of debriefing and determine how and when to fit it in during the daily work assignment.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the benefits of debriefing and determine how and when to fit it in during the daily work assignment.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the benefits of debriefing and determine how and when to fit it in during the daily work assignment.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the benefits of debriefing and determine how and when to fit it in during the daily work assignment.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the benefits of debriefing and determine how and when to fit it in during the daily work assignment.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to my role as a preceptor in the Surgical Services Department.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to my role as a preceptor in the Surgical Services Department.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to my role as a preceptor in the Surgical Services Department.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to my role as a preceptor in the Surgical Services Department.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to my role as a preceptor in the Surgical Services Department.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to function in the role of Surgical Services Preceptor.OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to function in the role of Surgical Services Preceptor.OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to function in the role of Surgical Services Preceptor.OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to function in the role of Surgical Services Preceptor.OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to function in the role of Surgical Services Preceptor.OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Vanessa Jones</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Vanessa Jones</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Vanessa Jones</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Vanessa Jones</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Vanessa Jones</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Scarborough, BSN, RN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Scarborough, BSN, RN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Scarborough, BSN, RN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Scarborough, BSN, RN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Scarborough, BSN, RN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9871,,Questions-0000-160,SURGICAL SERVICES PRECEPTOR LIVE (EVALUATION SURVEY) NSF 6.30.21,,n13926,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,A device that is intended to be used on patient's mucous membranes is classified as:,A.  Non-critical,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY21 ANNUAL HLD UPDATE- g13929,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,A device that is intended to be used on patient's mucous membranes is classified as:,A.  Non-critical,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,A device that is intended to be used on patient's mucous membranes is classified as:,B.  Semi-critical,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,A device that is intended to be used on patient's mucous membranes is classified as:,C.  Critical,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,What is the minimum reprocessing requirement for devices used in semi-critical applications?,A.  High level disinfection,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,What is the minimum reprocessing requirement for devices used in semi-critical applications?,B.  Low level disinfection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,What is the minimum reprocessing requirement for devices used in semi-critical applications?,C.  Sterilization,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,Warnings/precautions regarding high level disinfectant chemicals common to all include:,"A.  Avoidance of contact with eyes, skin, clothing, food, fumes/vapors",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,Warnings/precautions regarding high level disinfectant chemicals common to all include:,B.  Provision of adequate ventilation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,Warnings/precautions regarding high level disinfectant chemicals common to all include:,C.  Attention to device rinsing per manufacturer's IFU,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,Warnings/precautions regarding high level disinfectant chemicals common to all include:,D.  Do not use on flexible endoscopes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,Warnings/precautions regarding high level disinfectant chemicals common to all include:,"E.  A, B, C",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,Warnings/precautions regarding high level disinfectant chemicals common to all include:,F.  All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,"When considering the choice of the ideal high level disinfectant, one quality that does not make the list is:",A.  Act slowly,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,"When considering the choice of the ideal high level disinfectant, one quality that does not make the list is:",B.  Cost effective,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,"When considering the choice of the ideal high level disinfectant, one quality that does not make the list is:",C.  Be odorless and non-staining,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,What must be done prior to high level disinfection in order for it to be effective?,A.  Allow instruments to air dry,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,What must be done prior to high level disinfection in order for it to be effective?,B.  Clean instruments according to IFU to remove fluids or debris,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,What must be done prior to high level disinfection in order for it to be effective?,C.  Wipe instruments with a paper towel,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,How often must reusable high level disinfectant chemicals be tested using product specific indicators (test strips/discs)?,A.  Daily,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,How often must reusable high level disinfectant chemicals be tested using product specific indicators (test strips/discs)?,B.  Monthly,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9567,,Elearning-0000-792,FY21 ANNUAL HLD UPDATE,,n13929,,choice,How often must reusable high level disinfectant chemicals be tested using product specific indicators (test strips/discs)?,C.  Prior to each use,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,"Duplicate Test. Existing test is NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)- g13932",False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the effects of intermittent fasting on health, aging, and disease.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the effects of intermittent fasting on health, aging, and disease.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the effects of intermittent fasting on health, aging, and disease.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the effects of intermittent fasting on health, aging, and disease.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the effects of intermittent fasting on health, aging, and disease.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9945,,Questions-0000-79,"NSF INFUSION CENTER JOURNAL CLUB - JULY 1ST, 2021 (EVALUATION SURVEY)",,n13932,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21- g13933,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss crash dynamics related to injury prevention.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss crash dynamics related to injury prevention.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss crash dynamics related to injury prevention.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss crash dynamics related to injury prevention.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss crash dynamics related to injury prevention.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize Georgia's and AAP's recommendations for child safety seat use.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize Georgia's and AAP's recommendations for child safety seat use.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize Georgia's and AAP's recommendations for child safety seat use.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize Georgia's and AAP's recommendations for child safety seat use.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize Georgia's and AAP's recommendations for child safety seat use.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand rationale for rear facing car seats.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand rationale for rear facing car seats.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand rationale for rear facing car seats.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand rationale for rear facing car seats.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand rationale for rear facing car seats.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize car safety recommendations for growing infants and children.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize car safety recommendations for growing infants and children.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize car safety recommendations for growing infants and children.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize car safety recommendations for growing infants and children.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize car safety recommendations for growing infants and children.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify infants at risk for airway obstruction.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify infants at risk for airway obstruction.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify infants at risk for airway obstruction.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify infants at risk for airway obstruction.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify infants at risk for airway obstruction.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe safe travel options for infants who fail the car seat challenge/angle tolerance test.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe safe travel options for infants who fail the car seat challenge/angle tolerance test.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe safe travel options for infants who fail the car seat challenge/angle tolerance test.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe safe travel options for infants who fail the car seat challenge/angle tolerance test.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe safe travel options for infants who fail the car seat challenge/angle tolerance test.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to utilize the recall list to identify if a car seat has a recall.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to utilize the recall list to identify if a car seat has a recall.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to utilize the recall list to identify if a car seat has a recall.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to utilize the recall list to identify if a car seat has a recall.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to utilize the recall list to identify if a car seat has a recall.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the dangers of air bags and car seats.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the dangers of air bags and car seats.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the dangers of air bags and car seats.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the dangers of air bags and car seats.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the dangers of air bags and car seats.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe car seat cleaning practices.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe car seat cleaning practices.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe car seat cleaning practices.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe car seat cleaning practices.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe car seat cleaning practices.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to State corrections needed when viewing pictures of children in car seats at car seat check events.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to State corrections needed when viewing pictures of children in car seats at car seat check events.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to State corrections needed when viewing pictures of children in car seats at car seat check events.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to State corrections needed when viewing pictures of children in car seats at car seat check events.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to State corrections needed when viewing pictures of children in car seats at car seat check events.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify simulated car seat misuses and discuss corrective actions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify simulated car seat misuses and discuss corrective actions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify simulated car seat misuses and discuss corrective actions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify simulated car seat misuses and discuss corrective actions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify simulated car seat misuses and discuss corrective actions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine qualities and qualifications for becoming CPST.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine qualities and qualifications for becoming CPST.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine qualities and qualifications for becoming CPST.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine qualities and qualifications for becoming CPST.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to determine qualities and qualifications for becoming CPST.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve parent education.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve parent education.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve parent education.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve parent education.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve parent education.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Allison Craig</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Allison Craig</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Allison Craig</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Allison Craig</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Allison Craig</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kathy Cunningham</ol>,Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kathy Cunningham</ol>,Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kathy Cunningham</ol>,Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kathy Cunningham</ol>,Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kathy Cunningham</ol>,Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9933,,Questions-0000-67,KEEPING KIDS SAFE (EVALUATION SURVEY) NSA 7.7.21,,n13933,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21- g13936,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, BSN, RN-C, CCRN, PCCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, BSN, RN-C, CCRN, PCCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, BSN, RN-C, CCRN, PCCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, BSN, RN-C, CCRN, PCCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, BSN, RN-C, CCRN, PCCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9953,,Questions-0000-87,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-7-21,,n13936,,choice,How would you improve this class?,"Nothing: (appropriate content, speaker, setting, setting.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21- g13937,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the examination of leads and significance.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the examination of leads and significance.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the examination of leads and significance.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the examination of leads and significance.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the examination of leads and significance.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between myocardial ischemia, injury and infarction.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between myocardial ischemia, injury and infarction.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between myocardial ischemia, injury and infarction.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between myocardial ischemia, injury and infarction.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between myocardial ischemia, injury and infarction.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to plot an axis on the 12 lead EKG & discuss conditions that cause axis deviation.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to plot an axis on the 12 lead EKG & discuss conditions that cause axis deviation.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to plot an axis on the 12 lead EKG & discuss conditions that cause axis deviation.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to plot an axis on the 12 lead EKG & discuss conditions that cause axis deviation.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to plot an axis on the 12 lead EKG & discuss conditions that cause axis deviation.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of right and left bundle branch blocks on 12 lead EKG.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of right and left bundle branch blocks on 12 lead EKG.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of right and left bundle branch blocks on 12 lead EKG.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of right and left bundle branch blocks on 12 lead EKG.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of right and left bundle branch blocks on 12 lead EKG.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify QT prolongation on 12-Lead EKG </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify QT prolongation on 12-Lead EKG </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify QT prolongation on 12-Lead EKG </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify QT prolongation on 12-Lead EKG </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify QT prolongation on 12-Lead EKG </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to identification of changes in the 12 Lead EKG associated with conditions that have potential life threatening implications.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to identification of changes in the 12 Lead EKG associated with conditions that have potential life threatening implications.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to identification of changes in the 12 Lead EKG associated with conditions that have potential life threatening implications.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to identification of changes in the 12 Lead EKG associated with conditions that have potential life threatening implications.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to identification of changes in the 12 Lead EKG associated with conditions that have potential life threatening implications.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in effectively communicating my findings to physicians to aid in the managing my patients medical conditions.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in effectively communicating my findings to physicians to aid in the managing my patients medical conditions.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in effectively communicating my findings to physicians to aid in the managing my patients medical conditions.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in effectively communicating my findings to physicians to aid in the managing my patients medical conditions.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in effectively communicating my findings to physicians to aid in the managing my patients medical conditions.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9922,,Questions-0000-56,FUNDAMENTALS OF 12 LEAD EKG ( EVALUATION SURVEY) 7.8.21,,n13937,,choice,How would you improve this class?,"No recommendation for improvement (appropriate content, speaker, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21- g13941,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9912,,Questions-0000-46,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-9-21,,n13941,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,"Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21- g13940",False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9918,,Questions-0000-52,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-9-21",,n13940,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21- g13939,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9905,,Questions-0000-39,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-9-21,,n13939,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9316,,Elearning-0000-564,FY2021 NSF ICU POST CATH DOCUMENTATION EDUCATION,,n13942,,choice,I have read and understand the education surrounding post cath assessment and re assessment.  I attest to demonstrate assessment and documentation of assessment per provider orders,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 NSF ICU POST CATH DOCUMENTATION EDUCATION- g13942,False
9316,,Elearning-0000-564,FY2021 NSF ICU POST CATH DOCUMENTATION EDUCATION,,n13942,,choice,I have read and understand the education surrounding post cath assessment and re assessment.  I attest to demonstrate assessment and documentation of assessment per provider orders,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9316,,Elearning-0000-564,FY2021 NSF ICU POST CATH DOCUMENTATION EDUCATION,,n13942,,choice,I have read and understand the education surrounding post cath assessment and re assessment.  I attest to demonstrate assessment and documentation of assessment per provider orders,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
225,,SCORM-0000-31,ETIME TIMEKEEPER TRAINING,,n13943,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the eTime Timekeeper Training CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is ETIME TIMEKEEPER TRAINING- g13943,False
225,,SCORM-0000-31,ETIME TIMEKEEPER TRAINING,,n13943,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the eTime Timekeeper Training CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
225,,SCORM-0000-31,ETIME TIMEKEEPER TRAINING,,n13943,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the eTime Timekeeper Training CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Number 1 root cause for Sentinel Events is,A.  Poor Communication,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION- g13945,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Number 1 root cause for Sentinel Events is,A.  Poor Communication,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Number 1 root cause for Sentinel Events is,B. Inexperience of Staff,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Number 1 root cause for Sentinel Events is,C. Distractions,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Number 1 root cause for Sentinel Events is,D. Fatigue,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Successful HOC occurs when there is,A.  Active Listening and Interactive Communication between both parties,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Successful HOC occurs when there is,B.  Time allotted for Questions and Verbal Verification of Received Information,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Successful HOC occurs when there is,C. Limit to Interruptions during HOC,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Successful HOC occurs when there is,D. All the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,True or False HOC should only be completed during permanent relief?,A. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,True or False HOC should only be completed during permanent relief?,B. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,All individuals are responsible for  HOC during relief <b><u>EXCEPT</u></b>,A. Scrub Tech to Scrub Tech,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,All individuals are responsible for  HOC during relief <b><u>EXCEPT</u></b>,B. Support Tech to Primary RN,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,All individuals are responsible for  HOC during relief <b><u>EXCEPT</u></b>,C. Primary Nurse to Relief Nurse,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,All individuals are responsible for  HOC during relief <b><u>EXCEPT</u></b>,D. All the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,When <b><u>MUST</u></b> a nurse document HOC?,A. Breaks,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,When <b><u>MUST</u></b> a nurse document HOC?,B. Meals Breaks,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,When <b><u>MUST</u></b> a nurse document HOC?,C. Permanent Relief,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,When <b><u>MUST</u></b> a nurse document HOC?,D. All the Above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Some of the elements that must be covered in HOC include?,"A. Time Out (patient name, date of birth, procedure, allergies)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Some of the elements that must be covered in HOC include?,B. Medications on the field and amount administered to patient,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Some of the elements that must be covered in HOC include?,C. Specimen Status,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Some of the elements that must be covered in HOC include?,D. All the Above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Who is responsible for the patients care and well being after HOC?,A. Surgeon,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Who is responsible for the patients care and well being after HOC?,B. Reporting RN and reporting Surgical Technologist,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Who is responsible for the patients care and well being after HOC?,C. Receiving RN and receiving Surgical Technologist,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,Who is responsible for the patients care and well being after HOC?,D. First Assist,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,The use of a HOC checklist as a memory aid serves what purpose(s)?,A. Ensures that critical information necessary for patient care is not omitted,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,The use of a HOC checklist as a memory aid serves what purpose(s)?,B. Provides a consistent order in which information should be communicated from care provider to care provider,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,The use of a HOC checklist as a memory aid serves what purpose(s)?,C. Provides a visual guide for individuals to use during HOC,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
241,,SCORM-0000-47,FY2021 SURGICAL SERVICES INTRAOPERATIVE  RN HAND-OFF COMMUNICATION,,n13945,,choice,The use of a HOC checklist as a memory aid serves what purpose(s)?,D. All the Above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9686,,Elearning-0000-900,SCN FEEDING WORKFLOW UPDATE,,n13948,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""SCN Feeding Workflow Update"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SCN FEEDING WORKFLOW UPDATE- g13948,False
9686,,Elearning-0000-900,SCN FEEDING WORKFLOW UPDATE,,n13948,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""SCN Feeding Workflow Update"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9686,,Elearning-0000-900,SCN FEEDING WORKFLOW UPDATE,,n13948,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""SCN Feeding Workflow Update"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
125,,SCORM-0000-205,WAVE ONBOARDING REPORT TUTORIAL,,n13949,,choice,I have read and understood the content within the WAVE Onboarding Report Tutorial CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is WAVE ONBOARDING REPORT TUTORIAL- g13949,False
125,,SCORM-0000-205,WAVE ONBOARDING REPORT TUTORIAL,,n13949,,choice,I have read and understood the content within the WAVE Onboarding Report Tutorial CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
125,,SCORM-0000-205,WAVE ONBOARDING REPORT TUTORIAL,,n13949,,choice,I have read and understood the content within the WAVE Onboarding Report Tutorial CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9329,,Elearning-0000-576,FY2021 BBRAUN ONGUARD CLOSED SYSTEM TRANSFER DEVICE (CSTD),,n13950,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the FY2021 BBRAUN ONGUARD CLOSED SYSTEM TRANSFER DEVICE (CSTD) CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 BBRAUN ONGUARD CLOSED SYSTEM TRANSFER DEVICE (CSTD)- g13950,False
9329,,Elearning-0000-576,FY2021 BBRAUN ONGUARD CLOSED SYSTEM TRANSFER DEVICE (CSTD),,n13950,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the FY2021 BBRAUN ONGUARD CLOSED SYSTEM TRANSFER DEVICE (CSTD) CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9329,,Elearning-0000-576,FY2021 BBRAUN ONGUARD CLOSED SYSTEM TRANSFER DEVICE (CSTD),,n13950,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the FY2021 BBRAUN ONGUARD CLOSED SYSTEM TRANSFER DEVICE (CSTD) CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9130,,Elearning-0000-395,ONS CONGRESS 2021 REFLECTIONS,,n13953,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the ONS CONGRESS 2021 REFLECTIONS CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is ONS CONGRESS 2021 REFLECTIONS- g13953,False
9130,,Elearning-0000-395,ONS CONGRESS 2021 REFLECTIONS,,n13953,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the ONS CONGRESS 2021 REFLECTIONS CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9130,,Elearning-0000-395,ONS CONGRESS 2021 REFLECTIONS,,n13953,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the ONS CONGRESS 2021 REFLECTIONS CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Which of the following are components of the Thoracic Surgery protocol?<br> A. Institute SMI and IPPB on all patients with a unit dose of Albuterol (2.5mg) and Ipratroprium Bromide (0.5mg) at a frequency of every 8 hours for 24 hours. B. IPPB PIP of 15cmH20. C. Patient assessment including pre and post vital signs (heart and respiratory rate, breath sounds, sputum production, Sp02 and level of consciousness) D. After 24 hours, if the bronchodilator is not indicated, it may be changed to PRN.",1. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 RESPIRATORY ICU COMPETENCY- g13954,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Which of the following are components of the Thoracic Surgery protocol?<br> A. Institute SMI and IPPB on all patients with a unit dose of Albuterol (2.5mg) and Ipratroprium Bromide (0.5mg) at a frequency of every 8 hours for 24 hours. B. IPPB PIP of 15cmH20. C. Patient assessment including pre and post vital signs (heart and respiratory rate, breath sounds, sputum production, Sp02 and level of consciousness) D. After 24 hours, if the bronchodilator is not indicated, it may be changed to PRN.",1. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Which of the following are components of the Thoracic Surgery protocol?<br> A. Institute SMI and IPPB on all patients with a unit dose of Albuterol (2.5mg) and Ipratroprium Bromide (0.5mg) at a frequency of every 8 hours for 24 hours. B. IPPB PIP of 15cmH20. C. Patient assessment including pre and post vital signs (heart and respiratory rate, breath sounds, sputum production, Sp02 and level of consciousness) D. After 24 hours, if the bronchodilator is not indicated, it may be changed to PRN.",2. A and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Which of the following are components of the Thoracic Surgery protocol?<br> A. Institute SMI and IPPB on all patients with a unit dose of Albuterol (2.5mg) and Ipratroprium Bromide (0.5mg) at a frequency of every 8 hours for 24 hours. B. IPPB PIP of 15cmH20. C. Patient assessment including pre and post vital signs (heart and respiratory rate, breath sounds, sputum production, Sp02 and level of consciousness) D. After 24 hours, if the bronchodilator is not indicated, it may be changed to PRN.","3. A, C, D",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Contraindications for IPPB therapy include presence of ICP > 20, recent facial/oral surgery or trauma, esophageal surgery, untreated pneumothorax, hemodynamic instability, acute sinusitis and acute hemoptysis or nausea.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Contraindications for IPPB therapy include presence of ICP > 20, recent facial/oral surgery or trauma, esophageal surgery, untreated pneumothorax, hemodynamic instability, acute sinusitis and acute hemoptysis or nausea.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Which statement about ASV mode is FALSE?<br> A. Institute SMI and IPPB on all patients with a unit dose of Albuterol (2.5mg) and Ipratroprium Bromide (0.5mg) at a frequency of every 8 hours for 24 hours. B. IPPB PIP of 15cmH20. C. Patient assessment including pre and post vital signs (heart and respiratory rate, breath sounds, sputum production, Sp02 and level of consciousness) D. After 24 hours, if the bronchodilator is not indicated, it may be changed to PRN.",1. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Which statement about ASV mode is FALSE?<br> A. Institute SMI and IPPB on all patients with a unit dose of Albuterol (2.5mg) and Ipratroprium Bromide (0.5mg) at a frequency of every 8 hours for 24 hours. B. IPPB PIP of 15cmH20. C. Patient assessment including pre and post vital signs (heart and respiratory rate, breath sounds, sputum production, Sp02 and level of consciousness) D. After 24 hours, if the bronchodilator is not indicated, it may be changed to PRN.",2. A and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Which statement about ASV mode is FALSE?<br> A. Institute SMI and IPPB on all patients with a unit dose of Albuterol (2.5mg) and Ipratroprium Bromide (0.5mg) at a frequency of every 8 hours for 24 hours. B. IPPB PIP of 15cmH20. C. Patient assessment including pre and post vital signs (heart and respiratory rate, breath sounds, sputum production, Sp02 and level of consciousness) D. After 24 hours, if the bronchodilator is not indicated, it may be changed to PRN.","3. A, C, D",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Contraindications for IPPB therapy include presence of ICP > 20, recent facial/oral surgery or trauma, esophageal surgery, untreated pneumothorax, hemodynamic instability, acute sinusitis and acute hemoptysis or nausea.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Contraindications for IPPB therapy include presence of ICP > 20, recent facial/oral surgery or trauma, esophageal surgery, untreated pneumothorax, hemodynamic instability, acute sinusitis and acute hemoptysis or nausea.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Which statement about ASV mode is FALSE?,1. ASV maintains an operator-preset minimum minute ventilation independent of the patient's activity.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Which statement about ASV mode is FALSE?,"2. On the G5, the maximum pressure set by ASV is always 10 cmH2O below the maximum pressure limit, thus the maximum pressure and the ASV limit co-vary.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Which statement about ASV mode is FALSE?,"3. The lowest Minute Volume % to be used in ASV mode is 100%.  Per protocol, the RT may set the MV% to 80% without a Physican's order for patients with a diagnosis of COPD.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Which statement about ASV mode is FALSE?,"4. When started, the device delivers 3 test breaths in synchronized intermittent mandatory pressure ventilation mode.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"In ASV mode, adjustment to which of the following settings will affect delivered Vt and MV. A. Patient Height B. Gender C. % Minute Volume D. PEEP E. Trigger F. ETS (Expiratory Trigger Sensitivity)","1. A, B, C, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"In ASV mode, adjustment to which of the following settings will affect delivered Vt and MV. A. Patient Height B. Gender C. % Minute Volume D. PEEP E. Trigger F. ETS (Expiratory Trigger Sensitivity)",2. A and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"In ASV mode, adjustment to which of the following settings will affect delivered Vt and MV. A. Patient Height B. Gender C. % Minute Volume D. PEEP E. Trigger F. ETS (Expiratory Trigger Sensitivity)","3. B, C, F",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"In ASV mode, adjustment to which of the following settings will affect delivered Vt and MV. A. Patient Height B. Gender C. % Minute Volume D. PEEP E. Trigger F. ETS (Expiratory Trigger Sensitivity)","4. A, B, C",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"In ASV mode, adjustment to which of the following settings will affect delivered Vt and MV. A. Patient Height B. Gender C. % Minute Volume D. PEEP E. Trigger F. ETS (Expiratory Trigger Sensitivity)",5. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Pinsp is a direct correlation to the Pressure Support level the patient is requiring in ASV, and should be documented every vent check under invasive ventilation - Pinsp.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Pinsp is a direct correlation to the Pressure Support level the patient is requiring in ASV, and should be documented every vent check under invasive ventilation - Pinsp.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,APV-CMV functions similar to the conventional pressure-controlled modes with the exception that a target volume may be delivered.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,APV-CMV functions similar to the conventional pressure-controlled modes with the exception that a target volume may be delivered.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Your patient remains intubated in APV-CMV mode after surgery: Vt 500mL, RR 14, PEEP 5. Fi02 50%. Exh Vt 515mL, Total RR 16, Sp02 99%. No pressors, no sedation.  All pain medications are PRN.   Patient is awake and follows commands. AM ABG results:  7.47 / 30 / 105 / 25 / 1.8.  EtC02 31.   What is the next appropriate course of action?<br> A. Report the ABG to the physician and make changes only if ordered. B. Decrease the set rate to 12bpm.  C. Decrease Fi02  D. Decrease the Vt to 450mL. E. Start the SBT using either ASV 100%MV or CPAP/PS, notify the physician and RN and document in the EMR",1. A only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Your patient remains intubated in APV-CMV mode after surgery: Vt 500mL, RR 14, PEEP 5. Fi02 50%. Exh Vt 515mL, Total RR 16, Sp02 99%. No pressors, no sedation.  All pain medications are PRN.   Patient is awake and follows commands. AM ABG results:  7.47 / 30 / 105 / 25 / 1.8.  EtC02 31.   What is the next appropriate course of action?<br> A. Report the ABG to the physician and make changes only if ordered. B. Decrease the set rate to 12bpm.  C. Decrease Fi02  D. Decrease the Vt to 450mL. E. Start the SBT using either ASV 100%MV or CPAP/PS, notify the physician and RN and document in the EMR",2. C and D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Your patient remains intubated in APV-CMV mode after surgery: Vt 500mL, RR 14, PEEP 5. Fi02 50%. Exh Vt 515mL, Total RR 16, Sp02 99%. No pressors, no sedation.  All pain medications are PRN.   Patient is awake and follows commands. AM ABG results:  7.47 / 30 / 105 / 25 / 1.8.  EtC02 31.   What is the next appropriate course of action?<br> A. Report the ABG to the physician and make changes only if ordered. B. Decrease the set rate to 12bpm.  C. Decrease Fi02  D. Decrease the Vt to 450mL. E. Start the SBT using either ASV 100%MV or CPAP/PS, notify the physician and RN and document in the EMR","3. B, C, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Your patient remains intubated in APV-CMV mode after surgery: Vt 500mL, RR 14, PEEP 5. Fi02 50%. Exh Vt 515mL, Total RR 16, Sp02 99%. No pressors, no sedation.  All pain medications are PRN.   Patient is awake and follows commands. AM ABG results:  7.47 / 30 / 105 / 25 / 1.8.  EtC02 31.   What is the next appropriate course of action?<br> A. Report the ABG to the physician and make changes only if ordered. B. Decrease the set rate to 12bpm.  C. Decrease Fi02  D. Decrease the Vt to 450mL. E. Start the SBT using either ASV 100%MV or CPAP/PS, notify the physician and RN and document in the EMR",4. C and E,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Per the Mechanical Ventilator protocol, select the appropriate Vt for a male patient with ARDS - Height 5'8""�",A. 255mL - 395mL,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Per the Mechanical Ventilator protocol, select the appropriate Vt for a male patient with ARDS - Height 5'8""�",B. 280mL - 420mL,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Per the Mechanical Ventilator protocol, select the appropriate Vt for a male patient with ARDS - Height 5'8""�",C. 300mL - 440mL,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Per the Mechanical Ventilator protocol, select the appropriate Vt for a male patient with ARDS - Height 5'8""�",D. 320mL - 460mL,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,68 y/old male is intubated for hypoxic respiratory failure secondary to COVID PNA.  The Pa02 is 52mmHg on a Fi02 of 85%.   CXR shows dense bilateral infiltrates  Select the following strategies you might include in the management of this ventilated patient.<br> A. Use the P/V tool to screen for a recruitment maneuver and to set optimal PEEP B. Increase Fi02  C. Change modes from APV-CMV to ASV for improved ventilator synchrony D. Adjust Vt to achieve 4-6mL/kg IBW E. Consider Prone position or Nitric oxide,1. A and B,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,68 y/old male is intubated for hypoxic respiratory failure secondary to COVID PNA.  The Pa02 is 52mmHg on a Fi02 of 85%.   CXR shows dense bilateral infiltrates  Select the following strategies you might include in the management of this ventilated patient.<br> A. Use the P/V tool to screen for a recruitment maneuver and to set optimal PEEP B. Increase Fi02  C. Change modes from APV-CMV to ASV for improved ventilator synchrony D. Adjust Vt to achieve 4-6mL/kg IBW E. Consider Prone position or Nitric oxide,"2. B, C, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,68 y/old male is intubated for hypoxic respiratory failure secondary to COVID PNA.  The Pa02 is 52mmHg on a Fi02 of 85%.   CXR shows dense bilateral infiltrates  Select the following strategies you might include in the management of this ventilated patient.<br> A. Use the P/V tool to screen for a recruitment maneuver and to set optimal PEEP B. Increase Fi02  C. Change modes from APV-CMV to ASV for improved ventilator synchrony D. Adjust Vt to achieve 4-6mL/kg IBW E. Consider Prone position or Nitric oxide,3. B and D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,68 y/old male is intubated for hypoxic respiratory failure secondary to COVID PNA.  The Pa02 is 52mmHg on a Fi02 of 85%.   CXR shows dense bilateral infiltrates  Select the following strategies you might include in the management of this ventilated patient.<br> A. Use the P/V tool to screen for a recruitment maneuver and to set optimal PEEP B. Increase Fi02  C. Change modes from APV-CMV to ASV for improved ventilator synchrony D. Adjust Vt to achieve 4-6mL/kg IBW E. Consider Prone position or Nitric oxide,"4. A, B, D, E",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,68 y/old male is intubated for hypoxic respiratory failure secondary to COVID PNA.  The Pa02 is 52mmHg on a Fi02 of 85%.   CXR shows dense bilateral infiltrates  Select the following strategies you might include in the management of this ventilated patient.<br> A. Use the P/V tool to screen for a recruitment maneuver and to set optimal PEEP B. Increase Fi02  C. Change modes from APV-CMV to ASV for improved ventilator synchrony D. Adjust Vt to achieve 4-6mL/kg IBW E. Consider Prone position or Nitric oxide,"5. C, D, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,68 y/old male is intubated for hypoxic respiratory failure secondary to COVID PNA.  The Pa02 is 52mmHg on a Fi02 of 85%.   CXR shows dense bilateral infiltrates  Select the following strategies you might include in the management of this ventilated patient.<br> A. Use the P/V tool to screen for a recruitment maneuver and to set optimal PEEP B. Increase Fi02  C. Change modes from APV-CMV to ASV for improved ventilator synchrony D. Adjust Vt to achieve 4-6mL/kg IBW E. Consider Prone position or Nitric oxide,6. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"In P-CMV mode, what factor may affect the delivered Vt? A. Changes in the respiratory system compliance B. Administration of bronchodilators C. Patient's respiratory activity D. Changes to the pressure control level",1. A and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"In P-CMV mode, what factor may affect the delivered Vt? A. Changes in the respiratory system compliance B. Administration of bronchodilators C. Patient's respiratory activity D. Changes to the pressure control level",2. A and D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"In P-CMV mode, what factor may affect the delivered Vt? A. Changes in the respiratory system compliance B. Administration of bronchodilators C. Patient's respiratory activity D. Changes to the pressure control level","3. A, B, C",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"In P-CMV mode, what factor may affect the delivered Vt? A. Changes in the respiratory system compliance B. Administration of bronchodilators C. Patient's respiratory activity D. Changes to the pressure control level",4. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Which of these statements regarding Spontaneous mode is FALSE?,"a. When pressure support is set to zero, the mode functions like  a conventional CPAP system.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Which of these statements regarding Spontaneous mode is FALSE?,b. The patient determines the breath timing and may be either flow or  pressure triggered.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Which of these statements regarding Spontaneous mode is FALSE?,"c. The settings in this mode include: Psupport, P-ramp, ETS, PEEP,  Fi02 and Trigger.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Which of these statements regarding Spontaneous mode is FALSE?,"d. If the back up mode is selected, the vent will transition from SPONT to APV-CMV mode when the apnea alarm is triggered.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"The vent weaning readiness criteria includes a PEEP =  8 cmH20, Fi02 = 50%, spontaneous respirations and a patient that follows commands.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"The vent weaning readiness criteria includes a PEEP =  8 cmH20, Fi02 = 50%, spontaneous respirations and a patient that follows commands.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Which statement regarding the Spontaneous Breathing Trial is FALSE?,A. The SBT should not exceed 120 minutes unless ordered by MD or midlevel.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Which statement regarding the Spontaneous Breathing Trial is FALSE?,"B. If at any time the patient because unstable or has an increased RR > 35bpm, the mode should be changed to achieve the pre-trial minute volume.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Which statement regarding the Spontaneous Breathing Trial is FALSE?,C. ASV at 100%MV or CPAP/PS mode may be used.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Which statement regarding the Spontaneous Breathing Trial is FALSE?,"D. ASV at 100%MV may be used and the Pinsp should be < 15cmH20 to be considered in a ""weaning""� mode.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Which statement regarding the Spontaneous Breathing Trial is FALSE?,"E. If the patient is on pressors, the RT and RN must confirm that the physician is aware of the type and dose of pressors before a weaning trial is conducted.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,The red alarm cable connected should be documented with every Q4h vent check while confirmation of the audible and visual alarms should be documented with every vent check.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,The red alarm cable connected should be documented with every Q4h vent check while confirmation of the audible and visual alarms should be documented with every vent check.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Oral care and tube movement  is performed Q2 and is a shared responsibility between Nursing and Respiratory Therapy.   Night shift should consult the RN prior to performing mouth care/tube movement to ensure undisturbed sleep time.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Oral care and tube movement  is performed Q2 and is a shared responsibility between Nursing and Respiratory Therapy.   Night shift should consult the RN prior to performing mouth care/tube movement to ensure undisturbed sleep time.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Hollister tube holders should be labeled with the date and time of application to ensure they are changed Q72h and PRN.Skin assessment co-signature is required on ALL tube holder changes.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Hollister tube holders should be labeled with the date and time of application to ensure they are changed Q72h and PRN.Skin assessment co-signature is required on ALL tube holder changes.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Physician orders are needed for which of the following?<br> A. BiPAP use B. Brachial ABG C. Use of a bite block D. Changing vent modes to start the SBT E. Extubation,1. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Physician orders are needed for which of the following?<br> A. BiPAP use B. Brachial ABG C. Use of a bite block D. Changing vent modes to start the SBT E. Extubation,"2. A, C, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Physician orders are needed for which of the following?<br> A. BiPAP use B. Brachial ABG C. Use of a bite block D. Changing vent modes to start the SBT E. Extubation,3. B and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Physician orders are needed for which of the following?<br> A. BiPAP use B. Brachial ABG C. Use of a bite block D. Changing vent modes to start the SBT E. Extubation,"4. A, B, C, E",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"When patients are placed in the prone position, which of the following tube holders are acceptable?",A. Hollister,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"When patients are placed in the prone position, which of the following tube holders are acceptable?",B. Silk tape then Stabiltube,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"When patients are placed in the prone position, which of the following tube holders are acceptable?",C. Hollister with Physician's order,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"When patients are placed in the prone position, which of the following tube holders are acceptable?",D.  B and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"ETS (expiratory trigger sensitivity), represents the percent of peak inspiratory flow at which the ventilator cycles from inspiration to exhalation.  The normal default ETS is 25%.  An intubated patient with COPD or air trapping would benefit from an increase of ETS to 40%.  What effect does this have on the I:E ratio?","A. Increased I-time, decreased E-time",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"ETS (expiratory trigger sensitivity), represents the percent of peak inspiratory flow at which the ventilator cycles from inspiration to exhalation.  The normal default ETS is 25%.  An intubated patient with COPD or air trapping would benefit from an increase of ETS to 40%.  What effect does this have on the I:E ratio?","B. Decreased I-time, increased E-time",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"ETS (expiratory trigger sensitivity), represents the percent of peak inspiratory flow at which the ventilator cycles from inspiration to exhalation.  The normal default ETS is 25%.  An intubated patient with COPD or air trapping would benefit from an increase of ETS to 40%.  What effect does this have on the I:E ratio?","C. Decreased I-time, decreased E-time",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"ETS (expiratory trigger sensitivity), represents the percent of peak inspiratory flow at which the ventilator cycles from inspiration to exhalation.  The normal default ETS is 25%.  An intubated patient with COPD or air trapping would benefit from an increase of ETS to 40%.  What effect does this have on the I:E ratio?",D. None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"In regards to Heliox via the Hamilton G5, which of these statements is FALSE?",A. Only the G5 can utilize Heliox.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"In regards to Heliox via the Hamilton G5, which of these statements is FALSE?",B. The G5 flow sensor must be recalibrated with Heliox prior to starting the therapy.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"In regards to Heliox via the Hamilton G5, which of these statements is FALSE?",C. The circuit must first be changed from a single limb with a HME to a heated wire circuit prior to starting Heliox therapy,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"An ARDS patient is intubated in APV-CMV mode: Vt 380mL, Rate 22bpm, PEEP<br> 10cmH20, Fi02 85%.  Sp02 90%.<br> ABG results:  pH 7.32, PaC02 49, Pa02 57.8, HC03 26, BE +2.5.<br> What is the P/F ratio?",A. 68,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"An ARDS patient is intubated in APV-CMV mode: Vt 380mL, Rate 22bpm, PEEP<br> 10cmH20, Fi02 85%.  Sp02 90%.<br> ABG results:  pH 7.32, PaC02 49, Pa02 57.8, HC03 26, BE +2.5.<br> What is the P/F ratio?",B.  70,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"An ARDS patient is intubated in APV-CMV mode: Vt 380mL, Rate 22bpm, PEEP<br> 10cmH20, Fi02 85%.  Sp02 90%.<br> ABG results:  pH 7.32, PaC02 49, Pa02 57.8, HC03 26, BE +2.5.<br> What is the P/F ratio?",C.  66,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"An ARDS patient is intubated in APV-CMV mode: Vt 380mL, Rate 22bpm, PEEP<br> 10cmH20, Fi02 85%.  Sp02 90%.<br> ABG results:  pH 7.32, PaC02 49, Pa02 57.8, HC03 26, BE +2.5.<br> What is the P/F ratio?",D.  49,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Complications of inverse I:E ratio include, but are not limited to, excessive gas trapping, adverse hemodynamic effects, and the need for sedation",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Complications of inverse I:E ratio include, but are not limited to, excessive gas trapping, adverse hemodynamic effects, and the need for sedation",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Performing an Inspiratory hold on the Hamilton ventilator allows for the measurement of which parameter?,A. Peak airway pressure,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Performing an Inspiratory hold on the Hamilton ventilator allows for the measurement of which parameter?,B. Optimal PEEP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Performing an Inspiratory hold on the Hamilton ventilator allows for the measurement of which parameter?,C. Dynamic lung compliance,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Performing an Inspiratory hold on the Hamilton ventilator allows for the measurement of which parameter?,D. Plateau pressure,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,The Hamilton ventilator will display which of the following calculations and measurements?,A. Lung compliance,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,The Hamilton ventilator will display which of the following calculations and measurements?,B. AutoPEEP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,The Hamilton ventilator will display which of the following calculations and measurements?,C. Rapid shallow breathing index,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,The Hamilton ventilator will display which of the following calculations and measurements?,D. Airway resistance,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,The Hamilton ventilator will display which of the following calculations and measurements?,"E. A, C, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,The Hamilton ventilator will display which of the following calculations and measurements?,F. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Hamilton C2-C3 in NIV-ST mode<br>   Your patient is currently on a Vision BiPAP.  Ordered settings: IPAP 15, EPAP 8, Rate 14, Fi02 50%.  You need to transport the patient using a Hamilton C2.  Which picture shows the correct settings for the Hamilton device?",A.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Hamilton C2-C3 in NIV-ST mode<br>   Your patient is currently on a Vision BiPAP.  Ordered settings: IPAP 15, EPAP 8, Rate 14, Fi02 50%.  You need to transport the patient using a Hamilton C2.  Which picture shows the correct settings for the Hamilton device?",B.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Hamilton C2-C3 in NIV-ST mode<br>   Your patient is currently on a Vision BiPAP.  Ordered settings: IPAP 15, EPAP 8, Rate 14, Fi02 50%.  You need to transport the patient using a Hamilton C2.  Which picture shows the correct settings for the Hamilton device?",C.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,BiPAP is contraindicated in which of the following cases:<br> A.  Actively vomiting B.  Inability to protect the airway; severely obtunded C.  Hypercapnia with spontaneous respiratory effort D.  Trauma or burns involving the face E.   Apnea or respiratory arrest,"1. A, D, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,BiPAP is contraindicated in which of the following cases:<br> A.  Actively vomiting B.  Inability to protect the airway; severely obtunded C.  Hypercapnia with spontaneous respiratory effort D.  Trauma or burns involving the face E.   Apnea or respiratory arrest,"2. B, C, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,BiPAP is contraindicated in which of the following cases:<br> A.  Actively vomiting B.  Inability to protect the airway; severely obtunded C.  Hypercapnia with spontaneous respiratory effort D.  Trauma or burns involving the face E.   Apnea or respiratory arrest,"3. A, B, D, E",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,BiPAP is contraindicated in which of the following cases:<br> A.  Actively vomiting B.  Inability to protect the airway; severely obtunded C.  Hypercapnia with spontaneous respiratory effort D.  Trauma or burns involving the face E.   Apnea or respiratory arrest,4. A and E,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,BiPAP is contraindicated in which of the following cases:<br> A.  Actively vomiting B.  Inability to protect the airway; severely obtunded C.  Hypercapnia with spontaneous respiratory effort D.  Trauma or burns involving the face E.   Apnea or respiratory arrest,5. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Vision BiPAP settings:  IPAP 12,  EPAP 6, RR 12, Fi02 50%, Sp02 95%.  Exh Vt 300mL, total RR 22. ABG 7.28 / 72 / 63 / 31 / 4.9 Which statement regarding changes to the settings is TRUE?<br>  A. Increasing the EPAP will improve both ventilation and oxygenation. B. Increasing EPAP alone may improve oxygenation but will adversely affect ventilation. C. An increase in EPAP must be accompanied by an increase in IPAP for ventilation to remain constant or improve. D. Increasing the set rate to 20 will improve ventilation. E. Increasing IPAP will improve ventilation.","1. A, B, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Vision BiPAP settings:  IPAP 12,  EPAP 6, RR 12, Fi02 50%, Sp02 95%.  Exh Vt 300mL, total RR 22. ABG 7.28 / 72 / 63 / 31 / 4.9 Which statement regarding changes to the settings is TRUE?<br>  A. Increasing the EPAP will improve both ventilation and oxygenation. B. Increasing EPAP alone may improve oxygenation but will adversely affect ventilation. C. An increase in EPAP must be accompanied by an increase in IPAP for ventilation to remain constant or improve. D. Increasing the set rate to 20 will improve ventilation. E. Increasing IPAP will improve ventilation.","2.   B, C and E",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Vision BiPAP settings:  IPAP 12,  EPAP 6, RR 12, Fi02 50%, Sp02 95%.  Exh Vt 300mL, total RR 22. ABG 7.28 / 72 / 63 / 31 / 4.9 Which statement regarding changes to the settings is TRUE?<br>  A. Increasing the EPAP will improve both ventilation and oxygenation. B. Increasing EPAP alone may improve oxygenation but will adversely affect ventilation. C. An increase in EPAP must be accompanied by an increase in IPAP for ventilation to remain constant or improve. D. Increasing the set rate to 20 will improve ventilation. E. Increasing IPAP will improve ventilation.","3. C, D, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Vision BiPAP settings:  IPAP 12,  EPAP 6, RR 12, Fi02 50%, Sp02 95%.  Exh Vt 300mL, total RR 22. ABG 7.28 / 72 / 63 / 31 / 4.9 Which statement regarding changes to the settings is TRUE?<br>  A. Increasing the EPAP will improve both ventilation and oxygenation. B. Increasing EPAP alone may improve oxygenation but will adversely affect ventilation. C. An increase in EPAP must be accompanied by an increase in IPAP for ventilation to remain constant or improve. D. Increasing the set rate to 20 will improve ventilation. E. Increasing IPAP will improve ventilation.",4. All statements are true,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"If a patient is trached and needs to be on BIPAP, which mode is to be used on the G5/C2/C3 or transport vent?",a.   NIV-ST,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"If a patient is trached and needs to be on BIPAP, which mode is to be used on the G5/C2/C3 or transport vent?",b.   Spontaneous,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"If a patient is trached and needs to be on BIPAP, which mode is to be used on the G5/C2/C3 or transport vent?",c.   NIV,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"If a patient is trached and needs to be on BIPAP, which mode is to be used on the G5/C2/C3 or transport vent?",d.   NIPPV,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Per protocol, what are the initial HFO settings?","a.  Hz 5, Power 8 - adjusting for adequate chest wiggle, Ti 50%, Fi02 same as conventional vent, MAP set to same as conventional vent, Bias Flow 35 lpm",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Per protocol, what are the initial HFO settings?","b.  Hz 5, Power 5 - adjusting for adequate chest wiggle, Ti 33%, Fi02 100%, MAP set to 5cmH20 above mean pressure on conventional vent, Bias Flow 35 lpm",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Per protocol, what are the initial HFO settings?","c.  Hz 3, Power 5 - adjusting for adequate chest wiggle, Ti 40%, Fi02 same as conventional vent, MAP set to same as conventional vent, Bias Flow 25 lpm",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Per protocol, what are the initial HFO settings?","d.  Hz 5, Power 8 - adjusting for adequate chest wiggle, Ti 33%, Fi02 100%, MAP set to 5cmH20  below mean pressure on conventional vent, Bias Flow 45 lpm",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Contraindications for the HFO recruitment maneuver include:<br> A.  Pneumothorax with active air leak B.  Hemodynamic instability:  Mean arterial pressure < 60mmHg C.  Greater than 12 hours since start of HFO D.  Fi02 less than 75%,1.  All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Contraindications for the HFO recruitment maneuver include:<br> A.  Pneumothorax with active air leak B.  Hemodynamic instability:  Mean arterial pressure < 60mmHg C.  Greater than 12 hours since start of HFO D.  Fi02 less than 75%,2.  A and B,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Contraindications for the HFO recruitment maneuver include:<br> A.  Pneumothorax with active air leak B.  Hemodynamic instability:  Mean arterial pressure < 60mmHg C.  Greater than 12 hours since start of HFO D.  Fi02 less than 75%,"3.  A, B, C",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Contraindications for the HFO recruitment maneuver include:<br> A.  Pneumothorax with active air leak B.  Hemodynamic instability:  Mean arterial pressure < 60mmHg C.  Greater than 12 hours since start of HFO D.  Fi02 less than 75%,4.  B and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"On the Sensormedics Oscillator, what parameter could be changed to improve ventilation?",a.   Frequency,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"On the Sensormedics Oscillator, what parameter could be changed to improve ventilation?",b.   Cuff Leak,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"On the Sensormedics Oscillator, what parameter could be changed to improve ventilation?",c.    I Time,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"On the Sensormedics Oscillator, what parameter could be changed to improve ventilation?",d. Amplitude,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"On the Sensormedics Oscillator, what parameter could be changed to improve ventilation?",e. A and B only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"On the Sensormedics Oscillator, what parameter could be changed to improve ventilation?","f. A, B, C, D",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"On the Sensormedics Oscillator, what parameters could be changed to improve oxygenation?",a.   MAP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"On the Sensormedics Oscillator, what parameters could be changed to improve oxygenation?",b.   FiO2,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"On the Sensormedics Oscillator, what parameters could be changed to improve oxygenation?",c. Amplitude,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"On the Sensormedics Oscillator, what parameters could be changed to improve oxygenation?",d. A and B only,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"On the Sensormedics Oscillator, what parameters could be changed to improve oxygenation?","e. A, B, C",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Per protocol, which changes could correct the following ABG using the HFO 3100B? pH 7.24 - PaC02 68 - Pa02 80 - HCO3 29 - BE 3.9<br> A. Increase Hz, Decrease Power B. Increase Power, Increase Hz C. Decreased Hz, Increase Power D. Cuff leak","1.  A, D, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Per protocol, which changes could correct the following ABG using the HFO 3100B? pH 7.24 - PaC02 68 - Pa02 80 - HCO3 29 - BE 3.9<br> A. Increase Hz, Decrease Power B. Increase Power, Increase Hz C. Decreased Hz, Increase Power D. Cuff leak",2.  B and D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Per protocol, which changes could correct the following ABG using the HFO 3100B? pH 7.24 - PaC02 68 - Pa02 80 - HCO3 29 - BE 3.9<br> A. Increase Hz, Decrease Power B. Increase Power, Increase Hz C. Decreased Hz, Increase Power D. Cuff leak",3.  C and D,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Consider transition to conventional ventilation when the Fi02 is </= 50% and the mPaw is < 25cmH20, or you are not able to ventilate the patient despite all the appropriate changes.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Consider transition to conventional ventilation when the Fi02 is </= 50% and the mPaw is < 25cmH20, or you are not able to ventilate the patient despite all the appropriate changes.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Under the Respiratory Protocol for Nitric Oxide:  What  level should the patient  initially be started on?,a.  5 PPM,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Under the Respiratory Protocol for Nitric Oxide:  What  level should the patient  initially be started on?,b.  10 PPM,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Under the Respiratory Protocol for Nitric Oxide:  What  level should the patient  initially be started on?,c.  Therapist discretion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Under the Respiratory Protocol for Nitric Oxide:  What  level should the patient  initially be started on?,d.  20 PPM,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Under the Respiratory Protocol for Nitric Oxide: What is the highest level a patient should be on?,a. 20ppm,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Under the Respiratory Protocol for Nitric Oxide: What is the highest level a patient should be on?,b. 30ppm,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Under the Respiratory Protocol for Nitric Oxide: What is the highest level a patient should be on?,c. 40ppm,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Under the Respiratory Protocol for Nitric Oxide: What is the highest level a patient should be on?,d. 60ppm,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,When should you consider changing the Nitric oxide filter and sample line?,A. When you see fluid in the sample line,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,When should you consider changing the Nitric oxide filter and sample line?,B. When the measured Nitric oxide and Fi02 is inaccurate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,When should you consider changing the Nitric oxide filter and sample line?,"C. After medications like Tobramycin, Mucomyst or Colistin are nebulized inline",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,When should you consider changing the Nitric oxide filter and sample line?,D. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,A hydrogen peroxide wipe is used to clean which pieces of equipment?<br> A. ALL Hamilton devices  B. McGrath intubation handles C. EMMA capnography devices D. Personal stethoscopes E. A Vision BiPAP used for a patient with C. diff,1. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,A hydrogen peroxide wipe is used to clean which pieces of equipment?<br> A. ALL Hamilton devices  B. McGrath intubation handles C. EMMA capnography devices D. Personal stethoscopes E. A Vision BiPAP used for a patient with C. diff,"2. A, B, D",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,A hydrogen peroxide wipe is used to clean which pieces of equipment?<br> A. ALL Hamilton devices  B. McGrath intubation handles C. EMMA capnography devices D. Personal stethoscopes E. A Vision BiPAP used for a patient with C. diff,3. A and B only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,A hydrogen peroxide wipe is used to clean which pieces of equipment?<br> A. ALL Hamilton devices  B. McGrath intubation handles C. EMMA capnography devices D. Personal stethoscopes E. A Vision BiPAP used for a patient with C. diff,"4. A, C, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Components of the Fresh Trach protocol include?,A. Signage on the door with the date and time the 48 hour observation ends,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Components of the Fresh Trach protocol include?,B.  ETC02 Q4  and breath sounds documentation with any patient repositioning during the first 48 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Components of the Fresh Trach protocol include?,C.  Same size trach and one size smaller at bedside,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Components of the Fresh Trach protocol include?,D.  Obturator at the HOB,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Components of the Fresh Trach protocol include?,E.  Airway box at bedside,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Components of the Fresh Trach protocol include?,F.  Ambu bag and mask at bedside,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Components of the Fresh Trach protocol include?,G.  All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"For a trach patient with a cuffless tube, what supplies do you need at bedside?<br> A. Obturator B. Same size trach tube, both cuffed and cuffless C. A cuffed tube one size smaller D. A cuffless tube one size smaller E. Ambu bag and mask","1. A, B, C, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"For a trach patient with a cuffless tube, what supplies do you need at bedside?<br> A. Obturator B. Same size trach tube, both cuffed and cuffless C. A cuffed tube one size smaller D. A cuffless tube one size smaller E. Ambu bag and mask","2. B, C, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"For a trach patient with a cuffless tube, what supplies do you need at bedside?<br> A. Obturator B. Same size trach tube, both cuffed and cuffless C. A cuffed tube one size smaller D. A cuffless tube one size smaller E. Ambu bag and mask",3. A and E,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"For a trach patient with a cuffless tube, what supplies do you need at bedside?<br> A. Obturator B. Same size trach tube, both cuffed and cuffless C. A cuffed tube one size smaller D. A cuffless tube one size smaller E. Ambu bag and mask",4. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"The radiant infant warmer with supplies is located across from ED Room 11, just in front of the ambulance entrance to the ED.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"The radiant infant warmer with supplies is located across from ED Room 11, just in front of the ambulance entrance to the ED.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,There are two supply rooms for respiratory equipment in the ED:  One supply room across from Care Team 3 and the other is the respiratory equipment room housing the ABG analyzer and C2.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,There are two supply rooms for respiratory equipment in the ED:  One supply room across from Care Team 3 and the other is the respiratory equipment room housing the ABG analyzer and C2.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"49 F, 5'5""�, with a history of chronic renal failure, CHF, pulmonary edema, morbid obesity, and HTN is admitted to the ICU after having missed her dialysis treatment.  She arrives on the unit wearing a NRB mask at 15lpm, Sp02 92%.  She presents with crackles throughout, labored breathing in a tripod position.  CXR shows pulmonary edema.  ABG results on current settings: 7.29/54/69/29/3.1.  HR 100.  B/P 115/69.  The decision is made to intubate and sedate.  Per protocol, what initial mode and settings would be most appropriate?","A. ASV 140%, PEEP 10, Fi02 100%.  Target 8lpm.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"49 F, 5'5""�, with a history of chronic renal failure, CHF, pulmonary edema, morbid obesity, and HTN is admitted to the ICU after having missed her dialysis treatment.  She arrives on the unit wearing a NRB mask at 15lpm, Sp02 92%.  She presents with crackles throughout, labored breathing in a tripod position.  CXR shows pulmonary edema.  ABG results on current settings: 7.29/54/69/29/3.1.  HR 100.  B/P 115/69.  The decision is made to intubate and sedate.  Per protocol, what initial mode and settings would be most appropriate?","B. P-CMV, PC 20cmH20, RR 16, PEEP 8, Fi02 85%, exh Vt 570mL",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"49 F, 5'5""�, with a history of chronic renal failure, CHF, pulmonary edema, morbid obesity, and HTN is admitted to the ICU after having missed her dialysis treatment.  She arrives on the unit wearing a NRB mask at 15lpm, Sp02 92%.  She presents with crackles throughout, labored breathing in a tripod position.  CXR shows pulmonary edema.  ABG results on current settings: 7.29/54/69/29/3.1.  HR 100.  B/P 115/69.  The decision is made to intubate and sedate.  Per protocol, what initial mode and settings would be most appropriate?","C. APV-CMV Vt 400, RR 20, PEEP 10, Fi02 100%",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Spontaneous Breathing Trial Reason Not Done includes which of the following?<br> A. ICP > 20 B. Patient on Dopamine > 5 mcg/kg/min C. Patient on Norepinephrine > 2 mcg/kg/min D. Patient on Neosynephrine > 100 mcg/min E. Patient on Vasopressin - any dose,"1. B, C, D, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Spontaneous Breathing Trial Reason Not Done includes which of the following?<br> A. ICP > 20 B. Patient on Dopamine > 5 mcg/kg/min C. Patient on Norepinephrine > 2 mcg/kg/min D. Patient on Neosynephrine > 100 mcg/min E. Patient on Vasopressin - any dose,"2. A, B, C, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Spontaneous Breathing Trial Reason Not Done includes which of the following?<br> A. ICP > 20 B. Patient on Dopamine > 5 mcg/kg/min C. Patient on Norepinephrine > 2 mcg/kg/min D. Patient on Neosynephrine > 100 mcg/min E. Patient on Vasopressin - any dose,3. C and E,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Spontaneous Breathing Trial Reason Not Done includes which of the following?<br> A. ICP > 20 B. Patient on Dopamine > 5 mcg/kg/min C. Patient on Norepinephrine > 2 mcg/kg/min D. Patient on Neosynephrine > 100 mcg/min E. Patient on Vasopressin - any dose,4. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"It is day 3 after trach tube placement in the OR.  There is no skin barrier in place, sutures remain intact, and you notice skin breakdown below the flange.  Which statements regarding skin breakdown are TRUE?<br> A. Trach sutures may be removed prior to 5 days when new skin breakdown occurs.  Notify the physician once sutures are removed, place a skin barrier and write a Progress note.  B. An incident report must be logged, a physician promptly notified and Progress Note written.  C. Notify the RN to consult wound care and document the skin breakdown in Cerner. D. If ointment is at bedside, RT may scan the medication before applying it when scheduled trach care is done.",1. All statements are true,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"It is day 3 after trach tube placement in the OR.  There is no skin barrier in place, sutures remain intact, and you notice skin breakdown below the flange.  Which statements regarding skin breakdown are TRUE?<br> A. Trach sutures may be removed prior to 5 days when new skin breakdown occurs.  Notify the physician once sutures are removed, place a skin barrier and write a Progress note.  B. An incident report must be logged, a physician promptly notified and Progress Note written.  C. Notify the RN to consult wound care and document the skin breakdown in Cerner. D. If ointment is at bedside, RT may scan the medication before applying it when scheduled trach care is done.",2. A and D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"It is day 3 after trach tube placement in the OR.  There is no skin barrier in place, sutures remain intact, and you notice skin breakdown below the flange.  Which statements regarding skin breakdown are TRUE?<br> A. Trach sutures may be removed prior to 5 days when new skin breakdown occurs.  Notify the physician once sutures are removed, place a skin barrier and write a Progress note.  B. An incident report must be logged, a physician promptly notified and Progress Note written.  C. Notify the RN to consult wound care and document the skin breakdown in Cerner. D. If ointment is at bedside, RT may scan the medication before applying it when scheduled trach care is done.",3. B and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"It is day 3 after trach tube placement in the OR.  There is no skin barrier in place, sutures remain intact, and you notice skin breakdown below the flange.  Which statements regarding skin breakdown are TRUE?<br> A. Trach sutures may be removed prior to 5 days when new skin breakdown occurs.  Notify the physician once sutures are removed, place a skin barrier and write a Progress note.  B. An incident report must be logged, a physician promptly notified and Progress Note written.  C. Notify the RN to consult wound care and document the skin breakdown in Cerner. D. If ointment is at bedside, RT may scan the medication before applying it when scheduled trach care is done.",4. B and D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Progress note topics include which of the following?<br> A. Fi02 increase > 10% B. SBT start and stop time with mode and settings, including the reason why SBT is stopped C. Clinical changes requiring additional support, like the initiation of BiPAP or Optiflow D. All intubations and extubations E. Changes of airway type, vent mode or PEEP F. Codes and Rapid Response G. ICU shift summaries H. RT evaluation and treat consults","1. B, D, E, G",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Progress note topics include which of the following?<br> A. Fi02 increase > 10% B. SBT start and stop time with mode and settings, including the reason why SBT is stopped C. Clinical changes requiring additional support, like the initiation of BiPAP or Optiflow D. All intubations and extubations E. Changes of airway type, vent mode or PEEP F. Codes and Rapid Response G. ICU shift summaries H. RT evaluation and treat consults","2. A, D, G, H",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Progress note topics include which of the following?<br> A. Fi02 increase > 10% B. SBT start and stop time with mode and settings, including the reason why SBT is stopped C. Clinical changes requiring additional support, like the initiation of BiPAP or Optiflow D. All intubations and extubations E. Changes of airway type, vent mode or PEEP F. Codes and Rapid Response G. ICU shift summaries H. RT evaluation and treat consults","3. B, C, F, G,",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Progress note topics include which of the following?<br> A. Fi02 increase > 10% B. SBT start and stop time with mode and settings, including the reason why SBT is stopped C. Clinical changes requiring additional support, like the initiation of BiPAP or Optiflow D. All intubations and extubations E. Changes of airway type, vent mode or PEEP F. Codes and Rapid Response G. ICU shift summaries H. RT evaluation and treat consults",4. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Laryngectomy patients<br> What is the appropriate way to ventilate with a bag/mask for a laryngectomy patient without an artificial airway?,1. Cover the laryngectomy stoma with your hand or gauze and bag through the mouth with the AMBU bag.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Laryngectomy patients<br> What is the appropriate way to ventilate with a bag/mask for a laryngectomy patient without an artificial airway?,2. Use an adult AMBU bag and a pediatric mask over the laryngectomy stoma to provide ventilation.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Laryngectomy patients<br> What is the appropriate way to ventilate with a bag/mask for a laryngectomy patient without an artificial airway?,3. Intubate through the mouth with an ETT and provide ventilation with the AMBU bag.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Laryngectomy patients<br> What is the appropriate way to ventilate with a bag/mask for a laryngectomy patient without an artificial airway?,4. Do not use an AMBU bag for laryngectomy patients.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Nitric with C2/C3<br> C2/C3 with Nitric oxide: use heated wire circuit<br>  Visual content only - Reviewed.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Nitric with C2/C3<br> C2/C3 with Nitric oxide: use heated wire circuit<br>  Visual content only - Reviewed.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Nitric with Transport Vent<br> Transport vent with Nitric oxide : Use heated wire circuit, bypass heater   Visual content only - Reviewed.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Nitric with Transport Vent<br> Transport vent with Nitric oxide : Use heated wire circuit, bypass heater   Visual content only - Reviewed.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Heliox<br> Heliox tank, regulator, hose for G5 connection<br>  Visual content only - Reviewed.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Heliox<br> Heliox tank, regulator, hose for G5 connection<br>  Visual content only - Reviewed.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Heliox<br> G5 with Heliox: connection (we have 3 G5)  Visual content only - Reviewed.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Heliox<br> G5 with Heliox: connection (we have 3 G5)  Visual content only - Reviewed.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Heliox with G-5<br> G5 screenshots: select gas source then calibrate on Heliox  Visual conten only - Reviewed.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Heliox with G-5<br> G5 screenshots: select gas source then calibrate on Heliox  Visual conten only - Reviewed.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Prone positioning: Silk tape, then Stabiltube. Hollister only per MD order. Skin assessment co-signature is required on ALL tube holder changes.  Visual content only - Reviewed.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Prone positioning: Silk tape, then Stabiltube. Hollister only per MD order. Skin assessment co-signature is required on ALL tube holder changes.  Visual content only - Reviewed.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Skin Co-Signature for ETT's<br> (When The Tube holder is changed)  Visual content only - Reviewed.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,Skin Co-Signature for ETT's<br> (When The Tube holder is changed)  Visual content only - Reviewed.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Heliox<br> The Heliox mask, attach the Aerogen spacer and nebulizer using elbow  Visual content only - Reviewed.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9730,,Elearning-0000-940,2021 RESPIRATORY ICU COMPETENCY,,n13954,,choice,"Heliox<br> The Heliox mask, attach the Aerogen spacer and nebulizer using elbow  Visual content only - Reviewed.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9681,,Elearning-0000-896,HAND OFF COMMUNICATION PERIOPERATIVE COMMUNICATION,,n13956,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""Hand Off Communication Perioperative Communication"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is HAND OFF COMMUNICATION PERIOPERATIVE COMMUNICATION- g13956,False
9681,,Elearning-0000-896,HAND OFF COMMUNICATION PERIOPERATIVE COMMUNICATION,,n13956,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""Hand Off Communication Perioperative Communication"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9681,,Elearning-0000-896,HAND OFF COMMUNICATION PERIOPERATIVE COMMUNICATION,,n13956,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""Hand Off Communication Perioperative Communication"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"NSH K-5 Policy provides guidelines for the handling of hazardous drugs (HDs) in conformance with USP, OSHA, NIOSH and EPA standards to protect NSH staff from unintended HD exposure.",a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION- g13959,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"NSH K-5 Policy provides guidelines for the handling of hazardous drugs (HDs) in conformance with USP, OSHA, NIOSH and EPA standards to protect NSH staff from unintended HD exposure.",a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"NSH K-5 Policy provides guidelines for the handling of hazardous drugs (HDs) in conformance with USP, OSHA, NIOSH and EPA standards to protect NSH staff from unintended HD exposure.",b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which one of the following hazardous medication list grouping is incorrect?,a.	Group 2 - Hazardous agents (primarily reproductive risk),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which one of the following hazardous medication list grouping is incorrect?,b.	Group 1 - Hazardous agents (cytotoxic antineoplastic/reproductive risks),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which one of the following hazardous medication list grouping is incorrect?,c.	Group 2A - Non-hazardous antineoplastic agents,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which one of the following hazardous medication list grouping is incorrect?,d.	Appendix D - Excluded drugs based on NSH risk assessment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"All sterile compounding areas and devices where hazardous drugs are handled must following the following cleaning steps per pharmacy policies, cleaning logs, and standard operating procedures using approved products:",a.	Decontamination,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"All sterile compounding areas and devices where hazardous drugs are handled must following the following cleaning steps per pharmacy policies, cleaning logs, and standard operating procedures using approved products:",b.	Cleaning,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"All sterile compounding areas and devices where hazardous drugs are handled must following the following cleaning steps per pharmacy policies, cleaning logs, and standard operating procedures using approved products:",c.	Disinfection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"All sterile compounding areas and devices where hazardous drugs are handled must following the following cleaning steps per pharmacy policies, cleaning logs, and standard operating procedures using approved products:",d.	Deactivate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"All sterile compounding areas and devices where hazardous drugs are handled must following the following cleaning steps per pharmacy policies, cleaning logs, and standard operating procedures using approved products:",e.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,a.	Protective Gown,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,b.	Eye/Face protection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,c.	Respiratory protection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,d.	Footwear,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,e.	Gloves,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,The following Personal Protective Equipment is utilized for handling various dosage forms of hazardous drugs:,f.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,The spill response team is activated for any spills that is not contained by the following:,a.	Two Spill Kits,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,The spill response team is activated for any spills that is not contained by the following:,b.	Single Spill Kit,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,The spill response team is activated for any spills that is not contained by the following:,c.	Three Spill Kits,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,The spill response team is activated for any spills that is not contained by the following:,d.	Any spill in patient care area,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,The spill response team is activated for any spills that is not contained by the following:,e.	Any spill in pharmacy area,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Gloves used in the preparation of HDs must be:,a.	Disposable,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Gloves used in the preparation of HDs must be:,b.	Powdered to facilitate removal,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Gloves used in the preparation of HDs must be:,c.	Specified as ASTM-tested chemotherapy gloves,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Gloves used in the preparation of HDs must be:,d.	A and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"When reconstituting and withdrawing chemotherapy medications from vials, aerosol droplets may be generated. This can be minimized or eliminated by using:",a.	Filter needles,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"When reconstituting and withdrawing chemotherapy medications from vials, aerosol droplets may be generated. This can be minimized or eliminated by using:",b.	Leur-Lock syringes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"When reconstituting and withdrawing chemotherapy medications from vials, aerosol droplets may be generated. This can be minimized or eliminated by using:",c.	Closed-system transfer devices (CSTDs),True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"When reconstituting and withdrawing chemotherapy medications from vials, aerosol droplets may be generated. This can be minimized or eliminated by using:",d.	None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,When wearing double gloves:,a.	The gown cuffs should be tucked over both gloves,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,When wearing double gloves:,b.	The gown cuffs should be tucked under both gloves,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,When wearing double gloves:,c.	The inner glove should be worn under the cuff and the outer glove should be worn over the gown cuff,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,When wearing double gloves:,d.	It makes no difference if gown cuffs are worn over or under the gloves,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Gowns and gloves worn while working in the HD preparation area can be worn while working in other medication preparation areas.,a.	True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Gowns and gloves worn while working in the HD preparation area can be worn while working in other medication preparation areas.,b.	False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which of the following types of containment primary engineering controls (C-PECs) can be used for preparing sterile HDs?,a.	Biological safety cabinet (BSC),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which of the following types of containment primary engineering controls (C-PECs) can be used for preparing sterile HDs?,b.	Horizontal laminar air flow workbench,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which of the following types of containment primary engineering controls (C-PECs) can be used for preparing sterile HDs?,c.	Compounding aseptic containment isolator (CACI),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which of the following types of containment primary engineering controls (C-PECs) can be used for preparing sterile HDs?,d.	A and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Spill kits:,a.	May be obtained from Central Supply when needed,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Spill kits:,b.	Are kept wherever HDs and chemotherapy agents are handled,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Spill kits:,c.	Contain supplies needed to clean a HD spill,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Spill kits:,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"Hazardous drugs (Group 1 and 2) that require manipulation or compounding may be stored in areas with non-hazardous drugs; however, they must be stored above other drugs on higher medication shelves.",a.	True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"Hazardous drugs (Group 1 and 2) that require manipulation or compounding may be stored in areas with non-hazardous drugs; however, they must be stored above other drugs on higher medication shelves.",b.	False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"Group 1 HDs in final dosage forms (tablets, capsules, pre-filled syringes) may not be stored in patient medication drawers with non-hazardous drugs or in unit-based automated dispensing cabinets.",a.	True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"Group 1 HDs in final dosage forms (tablets, capsules, pre-filled syringes) may not be stored in patient medication drawers with non-hazardous drugs or in unit-based automated dispensing cabinets.",b.	False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"With the exception of hormonal agents, an Informed Consent for Drug Therapy is required for the initiation of any Group 1 or 2 HD prescribed for an oncology indication. The consent must be fully completed, with all applicable sections addressed.",a. True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,"With the exception of hormonal agents, an Informed Consent for Drug Therapy is required for the initiation of any Group 1 or 2 HD prescribed for an oncology indication. The consent must be fully completed, with all applicable sections addressed.",b. False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,How often do you have to change the gown during hazardous drug compounding?,a.	At least every 12 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,How often do you have to change the gown during hazardous drug compounding?,b.	At least every 24 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,How often do you have to change the gown during hazardous drug compounding?,c.	At least every 3 hours,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,How often do you have to change the gown during hazardous drug compounding?,d.	At least every 8 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,How often do you have to change the outer gloves during hazardous drug sterile compounding?,a.	At least every 8 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,How often do you have to change the outer gloves during hazardous drug sterile compounding?,b.	At least every 3  hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,How often do you have to change the outer gloves during hazardous drug sterile compounding?,c.	At least every 30 minutes,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,How often do you have to change the outer gloves during hazardous drug sterile compounding?,d.	 At shift change,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Cytotoxic chemotherapy dispensed in a syringe must not take up more than 80% of the total volume of the syringe.,a.	True,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Cytotoxic chemotherapy dispensed in a syringe must not take up more than 80% of the total volume of the syringe.,b.	False,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which statement is true?,a.	Cytotoxic chemotherapy doses maybe rounded down or up to the nearest vials size within < 5% of the calculated dose,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which statement is true?,b.	Cytotoxic chemotherapy doses maybe rounded down to the nearest vials size within < 5% of the calculated dose,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which statement is true?,c.	Monoclonal antibodies and other biologic agents may be dose rounded down or up to the nearest vial size within = 10% of the calculated dose.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which statement is true?,d.	Monoclonal antibodies and other biologic agents may be dose rounded down or up to the nearest vial size within = 5% of the calculated dose.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which statement is true?,e.	a & c,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which statement is true?,f.	b & c,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,PA or NP may sign C1D1 chemotherapy orders.,a. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,PA or NP may sign C1D1 chemotherapy orders.,b. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which statement is false?,a. Verbal and telephone orders to initiate chemotherapy will not be accepted,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which statement is false?,b. A physician must sign C1D1 chemotherapy orders,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which statement is false?,c. Pregnancy screening is required at baseline and then at least once a week while the patient is on therapy,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9675,,Elearning-0000-890,HAZARDOUS DRUGS (K-5) POLICY OBIC PHARMACY EDUCATION,,n13959,,choice,Which statement is false?,d. Treating physicians are responsible for monitoring cumulative anthracycline doses,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,All fresh trachs performed by Atlanta Head and Neck Associates (AHNA) will use the fresh trach protocol without any changes.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is ATLANTA HEAD AND NECK ASSOCIATES- g13960,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,All fresh trachs performed by Atlanta Head and Neck Associates (AHNA) will use the fresh trach protocol without any changes.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,All fresh trachs performed by Atlanta Head and Neck Associates (AHNA) will use the fresh trach protocol without any changes.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,What will dictate the care of the fresh trachs done by AHNA?,a.	The surgeons will write specific orders that may change from patient-to-patient.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,What will dictate the care of the fresh trachs done by AHNA?,"b.	The nurse, the doctor and the RT must communicate to develop an appropriate plan of care.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,What will dictate the care of the fresh trachs done by AHNA?,c.	Patients that do not have specific orders from the surgeon will follow the Fresh Trach Protocol with additional instructions.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,What will dictate the care of the fresh trachs done by AHNA?,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,What considerations should be taken for patients with a reconstructive flap?,a.	No trach ties or elastic bands can be used around the neck.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,What considerations should be taken for patients with a reconstructive flap?,b.	Suctioning is done Q2 hours.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,What considerations should be taken for patients with a reconstructive flap?,c.	The patients MUST have a humidification device as mucus plugging is common.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,What considerations should be taken for patients with a reconstructive flap?,"d.	A ""Head and Neck Flap""� sign should be present at the HOB until the patient leaves the ICU.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,What considerations should be taken for patients with a reconstructive flap?,e.	A and B only.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,What considerations should be taken for patients with a reconstructive flap?,f.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,How is humidification secured for patients with a reconstructive flap?,a.	Safety pins attach the trach collar to tape on the patient's chest.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,How is humidification secured for patients with a reconstructive flap?,b.	The green elastic strap goes behind the patient's neck to secure the trach collar.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,How is humidification secured for patients with a reconstructive flap?,"c.	If tape will not stick to the patient's chest, a towel may go behind the patient's neck and the safety pins should secure the trach collar to the towel",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,How is humidification secured for patients with a reconstructive flap?,d.	No humidification is needed for patients with reconstructive neck flaps.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,How is humidification secured for patients with a reconstructive flap?,e.	A and C only,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,How is humidification secured for patients with a reconstructive flap?,f.	All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,Can the RT remove sutures after 5 day for AHNA trach patients?,a.	NO. The sutures can only be removed by the surgeon.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9558,,Elearning-0000-784,ATLANTA HEAD AND NECK ASSOCIATES,,n13960,,choice,Can the RT remove sutures after 5 day for AHNA trach patients?,b.	YES. The RT can remove the sutures after seeking physician approval.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"Per protocol, you can obtain ABGs when a patient is on _____ or greater FiO2 and then contact the physician with the results.",a.	30%,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY- g13964,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"Per protocol, you can obtain ABGs when a patient is on _____ or greater FiO2 and then contact the physician with the results.",a.	30%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"Per protocol, you can obtain ABGs when a patient is on _____ or greater FiO2 and then contact the physician with the results.",b.	40%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"Per protocol, you can obtain ABGs when a patient is on _____ or greater FiO2 and then contact the physician with the results.",c.	50%,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which probe goes with the Capnography monitor?,a.	Adult Respiratory Sensor with SpO2 and RR,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which probe goes with the Capnography monitor?,b.	Neonatal-Adult SpO2 Sensor,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which statement about CPAP documentation is False?,a. the patient does not have to sign a release of liability to use their home CPAP,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which statement about CPAP documentation is False?,b. Home CPAP units will be checked Qshift,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which statement about CPAP documentation is False?,c. CPAP documentation includes the documentation of skin integrity,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,How often do you change an inner cannula?,A. BID and as needed,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,How often do you change an inner cannula?,B. Q24 on dayshift and as needed,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,How often do you change an inner cannula?,C. Q24 on nightshift and as needed,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,How often do you change an inner cannula?,D. Not during the 48 hour fresh trach protocol,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Home oxygen assessment includes documenting under respiratory assessment tab during which of the following:,"a.	If room air Sp02 at rest is < 89%, place patient on oxygen to get their Sp02 > or = 89%. If able to ambulate, see what 02 is needed to keep Sp02 > 88% on exertion)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Home oxygen assessment includes documenting under respiratory assessment tab during which of the following:,"b.	If room air Sp02 is > or = to 89% at rest, you need to do a room air Sp02 with exertion",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Home oxygen assessment includes documenting under respiratory assessment tab during which of the following:,"c.	If exertional Sp02 is lower than < 89%, you need to document how much 02 is needed to keep Sp02 > 89%. Please relay to RN and Case Management",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Home oxygen assessment includes documenting under respiratory assessment tab during which of the following:,d.	None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Home oxygen assessment includes documenting under respiratory assessment tab during which of the following:,e.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"BioMed work order, found on the Intranet under Requests, should include which of the following information?  A. Facility B. Tag C. Patient name and DOB D. Problem  E. Location /Room","A.	A, B, and E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"BioMed work order, found on the Intranet under Requests, should include which of the following information?  A. Facility B. Tag C. Patient name and DOB D. Problem  E. Location /Room",B.	D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"BioMed work order, found on the Intranet under Requests, should include which of the following information?  A. Facility B. Tag C. Patient name and DOB D. Problem  E. Location /Room","C.	A, B, C, D, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"BioMed work order, found on the Intranet under Requests, should include which of the following information?  A. Facility B. Tag C. Patient name and DOB D. Problem  E. Location /Room","D.	A, B, D, E",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which of the following is not a component of the fresh trach protocol?,a.	Signage on the door with the date and time the 48 hour observations ends,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which of the following is not a component of the fresh trach protocol?,b.	Same size trach and one size smaller,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which of the following is not a component of the fresh trach protocol?,c.	Speaking Valve in Room,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which of the following is not a component of the fresh trach protocol?,d.	Obturator at the HOB,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which of the following is not a component of the fresh trach protocol?,e.	Airway box at bedside,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which of the following is not a component of the fresh trach protocol?,f.	Ambu bag at bedside,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Any Trach patient outside the ICU needs to be placed on Remote monitoring.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Any Trach patient outside the ICU needs to be placed on Remote monitoring.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,The Respiratory Therapist will attend the transport of a patient when: a.	The fiO2> 50% b.	The patient has a tracheostomy tube and is on Oxygen c.	The patient is intubated and mechanically ventilated d.	On high flow nasal cannula,i.	A and B,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,The Respiratory Therapist will attend the transport of a patient when: a.	The fiO2> 50% b.	The patient has a tracheostomy tube and is on Oxygen c.	The patient is intubated and mechanically ventilated d.	On high flow nasal cannula,ii.	C only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,The Respiratory Therapist will attend the transport of a patient when: a.	The fiO2> 50% b.	The patient has a tracheostomy tube and is on Oxygen c.	The patient is intubated and mechanically ventilated d.	On high flow nasal cannula,iii.	A and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,The Respiratory Therapist will attend the transport of a patient when: a.	The fiO2> 50% b.	The patient has a tracheostomy tube and is on Oxygen c.	The patient is intubated and mechanically ventilated d.	On high flow nasal cannula,"iv.	A, B, C and D",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,When should you consider weaning your patient off of optiflow?,a.	At the earliest appropriate time,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,When should you consider weaning your patient off of optiflow?,b.	When the fio2 is less than or equal to 50%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,When should you consider weaning your patient off of optiflow?,c.	Per physician order,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,When should you consider weaning your patient off of optiflow?,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"According to the bronchodilator protocol, a patient's home nebulizer or medication regimen can be changed without a MD order",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"According to the bronchodilator protocol, a patient's home nebulizer or medication regimen can be changed without a MD order",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"If an order reads, ""CPAP per RT protocol""�, you should set up: a.	The Remstar, Lumis or Airsense10 in the Auto mode  b.	Fixed CPAP of 15CM c.	If O2 is needed you can bleed in up to 4 L/min d.	If O2 is needed you can bleed in up to 15 L/min",i.	A. only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"If an order reads, ""CPAP per RT protocol""�, you should set up: a.	The Remstar, Lumis or Airsense10 in the Auto mode  b.	Fixed CPAP of 15CM c.	If O2 is needed you can bleed in up to 4 L/min d.	If O2 is needed you can bleed in up to 15 L/min",ii.	B. only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"If an order reads, ""CPAP per RT protocol""�, you should set up: a.	The Remstar, Lumis or Airsense10 in the Auto mode  b.	Fixed CPAP of 15CM c.	If O2 is needed you can bleed in up to 4 L/min d.	If O2 is needed you can bleed in up to 15 L/min",iii.	A and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"If an order reads, ""CPAP per RT protocol""�, you should set up: a.	The Remstar, Lumis or Airsense10 in the Auto mode  b.	Fixed CPAP of 15CM c.	If O2 is needed you can bleed in up to 4 L/min d.	If O2 is needed you can bleed in up to 15 L/min",iv.	A and D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,When a Trach patient on the floor is de-cannulated you must:,a.	Stay in the room with the patient for 24 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,When a Trach patient on the floor is de-cannulated you must:,b.	Place on a remote pulse ox for 24 hours per policy,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,When a Trach patient on the floor is de-cannulated you must:,c.	Place on a remote Capnography for 24 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,When a Trach patient on the floor is de-cannulated you must:,d.	B or C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,When a Trach patient on the floor is de-cannulated you must:,e.	A and B,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"Per CPAP/BiPAP protocol, the physician will be contacted when:",a.	Heart rate increases or decreases to >20 from the pre therapy heart rate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"Per CPAP/BiPAP protocol, the physician will be contacted when:",b.	Therapist is unable to achieve an adequate mask seal,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"Per CPAP/BiPAP protocol, the physician will be contacted when:",c.	Tach dysrhythmias or Brach arrhythmias Occur,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"Per CPAP/BiPAP protocol, the physician will be contacted when:",d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"When using the C1 or C3 in Non-invasive mode, it is important to set the following:",a.	I-time lower than I time Max and ETS at least 50% to help compensate for leaks in the mask,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"When using the C1 or C3 in Non-invasive mode, it is important to set the following:",b.	I-time needs to be higher than I time Max and ETS at 25%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,On the code sheet you should ALWAYS make sure the airway/Etco2 section is filled out correctly before signing the sheet,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,On the code sheet you should ALWAYS make sure the airway/Etco2 section is filled out correctly before signing the sheet,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"What should you do when a patient is not compliant with CPAP, home or Hospital unit?","a.	It's okay, they have the right to refuse treatment",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"What should you do when a patient is not compliant with CPAP, home or Hospital unit?","b.	Notify the physician, place them on a capnography remote monitor and educate on why it is needed.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"What should you do when a patient is not compliant with CPAP, home or Hospital unit?",c.	Place them on 3L nc,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which are the indicators for continuous pulse oximetry? a.	All Post-operative patients on a PCA pump or epidural. b.	Tracheostomy patients located outside ICU and those recently decannulated <24 hrs. c.	Floor patient with a PaO2 <65,i.	A and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which are the indicators for continuous pulse oximetry? a.	All Post-operative patients on a PCA pump or epidural. b.	Tracheostomy patients located outside ICU and those recently decannulated <24 hrs. c.	Floor patient with a PaO2 <65,ii.	B and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which are the indicators for continuous pulse oximetry? a.	All Post-operative patients on a PCA pump or epidural. b.	Tracheostomy patients located outside ICU and those recently decannulated <24 hrs. c.	Floor patient with a PaO2 <65,"iii.	A, B, C",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which are the indicators for continuous pulse oximetry? a.	All Post-operative patients on a PCA pump or epidural. b.	Tracheostomy patients located outside ICU and those recently decannulated <24 hrs. c.	Floor patient with a PaO2 <65,iv.	B only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"Remote monitors placed per protocol may be discontinued one hour after the PCA/Epidural has been discontinued, BIPAP/CPAP usage has been discontinued, or a repeat ABG results in a PaO2 > 65mmHg.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"Remote monitors placed per protocol may be discontinued one hour after the PCA/Epidural has been discontinued, BIPAP/CPAP usage has been discontinued, or a repeat ABG results in a PaO2 > 65mmHg.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"Patients on CPAP, home or Hospital Unit that require more than 40% / 5lpm FiO2 bled into the unit to maintain SpO2 within the oxygen policy guidelines will need to be placed on:",a.	Remote capnography,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"Patients on CPAP, home or Hospital Unit that require more than 40% / 5lpm FiO2 bled into the unit to maintain SpO2 within the oxygen policy guidelines will need to be placed on:",b.	Remote Pulse Oximeter,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"Per Bronchodilator Therapy, the therapist can order the following medications: a.	Albuterol b.	Levalbuterol (Xopenex) c.	Ipratropium (Atrovent) d.	Brovana e.	Pulmicort",i.	A and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"Per Bronchodilator Therapy, the therapist can order the following medications: a.	Albuterol b.	Levalbuterol (Xopenex) c.	Ipratropium (Atrovent) d.	Brovana e.	Pulmicort","ii.	A, B, and C",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"Per Bronchodilator Therapy, the therapist can order the following medications: a.	Albuterol b.	Levalbuterol (Xopenex) c.	Ipratropium (Atrovent) d.	Brovana e.	Pulmicort","iii.	A,D,E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"Per Bronchodilator Therapy, the therapist can order the following medications: a.	Albuterol b.	Levalbuterol (Xopenex) c.	Ipratropium (Atrovent) d.	Brovana e.	Pulmicort",iv.	All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,A patient may be on the floor with a cuffed Trach.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,A patient may be on the floor with a cuffed Trach.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which of the following patient type needs to be monitored by remote pulse oximetry,a.	Patients with a PaO2 65 or less,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which of the following patient type needs to be monitored by remote pulse oximetry,b.	Patients on comfort care,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Which of the following patient type needs to be monitored by remote pulse oximetry,c.	Any patient requiring more than 6l of oxygen to maintain their SpO2 greater than 92%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Patients on high flow device requiring an FiO2of 50% or greater to maintain a SpO2 of 92% or patients that have had a FiO2 increase of 10% or greater over 1-2 hours should have a pulmonary or critical care consult for management and to determine appropriate  hospital unit placement.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,Patients on high flow device requiring an FiO2of 50% or greater to maintain a SpO2 of 92% or patients that have had a FiO2 increase of 10% or greater over 1-2 hours should have a pulmonary or critical care consult for management and to determine appropriate  hospital unit placement.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"If the therapist receives an order for a Bipap device from a provider other than Critical Care, they will stabilize the patient then:",a.	Personally contact the critical care doc on call to notify them of the patient,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,"If the therapist receives an order for a Bipap device from a provider other than Critical Care, they will stabilize the patient then:",b.	Communicate with the ordering physician that Critical Care must be consulted for further evaluation,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,When setting up a MetaNeb treatment on a patient which of the following is not set:,a.	Oscillations,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,When setting up a MetaNeb treatment on a patient which of the following is not set:,b.	Pressure,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9739,,Elearning-0000-949,2021 CHEROKEE RESPIRATORY ADULT FLOOR COMPETENCY,,n13964,,choice,When setting up a MetaNeb treatment on a patient which of the following is not set:,c.	Resistance,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
274,,SCORM-0000-84,OCCUPATIONAL THERAPY AND HEART FAILURE,,n13963,,choice,I have read and understood the content within the Occupational Therapy and Heart Failure CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is OCCUPATIONAL THERAPY AND HEART FAILURE- g13963,False
274,,SCORM-0000-84,OCCUPATIONAL THERAPY AND HEART FAILURE,,n13963,,choice,I have read and understood the content within the Occupational Therapy and Heart Failure CBL.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
274,,SCORM-0000-84,OCCUPATIONAL THERAPY AND HEART FAILURE,,n13963,,choice,I have read and understood the content within the Occupational Therapy and Heart Failure CBL.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9611,,Elearning-0000-832,TIMELESS 116: MOTHERS KIOSK,,n13968,,choice,I acknowledge that I have read and understand the Timeless 116: Mothers Kiosk CBL in its entirety.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is TIMELESS 116: MOTHERS KIOSK- g13968,False
9611,,Elearning-0000-832,TIMELESS 116: MOTHERS KIOSK,,n13968,,choice,I acknowledge that I have read and understand the Timeless 116: Mothers Kiosk CBL in its entirety.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9611,,Elearning-0000-832,TIMELESS 116: MOTHERS KIOSK,,n13968,,choice,I acknowledge that I have read and understand the Timeless 116: Mothers Kiosk CBL in its entirety.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21- g13969,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN CCRN-K </ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN CCRN-K </ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN CCRN-K </ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN CCRN-K </ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN CCRN-K </ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9892,,Questions-0000-26,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-12-21,,n13969,,choice,How would you improve this class?,"No improvements needed (appropriate content, instructor, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21- g13971,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe internal structures and function of the heart along with cardiac conduction.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe internal structures and function of the heart along with cardiac conduction.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe internal structures and function of the heart along with cardiac conduction.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe internal structures and function of the heart along with cardiac conduction.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe internal structures and function of the heart along with cardiac conduction.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe specialized properties of cardiac cells.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe specialized properties of cardiac cells.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe specialized properties of cardiac cells.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe specialized properties of cardiac cells.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe specialized properties of cardiac cells.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe normal ECG measurements.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe normal ECG measurements.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe normal ECG measurements.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe normal ECG measurements.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe normal ECG measurements.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe flow of electricity through the heart based on lead placement.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe flow of electricity through the heart based on lead placement.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe flow of electricity through the heart based on lead placement.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe flow of electricity through the heart based on lead placement.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe flow of electricity through the heart based on lead placement.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state how to calculate heart rate using estimation and exact method given a 6 second strip. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state how to calculate heart rate using estimation and exact method given a 6 second strip. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state how to calculate heart rate using estimation and exact method given a 6 second strip. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state how to calculate heart rate using estimation and exact method given a 6 second strip. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state how to calculate heart rate using estimation and exact method given a 6 second strip. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to explore ECG graph paper and its use systematic approach to ECG rhythm interpretation.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to explore ECG graph paper and its use systematic approach to ECG rhythm interpretation.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to explore ECG graph paper and its use systematic approach to ECG rhythm interpretation.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to explore ECG graph paper and its use systematic approach to ECG rhythm interpretation.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to explore ECG graph paper and its use systematic approach to ECG rhythm interpretation.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state ECG characteristics for Normal Sinus Rhythm.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state ECG characteristics for Normal Sinus Rhythm.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state ECG characteristics for Normal Sinus Rhythm.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state ECG characteristics for Normal Sinus Rhythm.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state ECG characteristics for Normal Sinus Rhythm.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe and identify dysrhythmias originating from selected areas of the cardiac conduction system (SA node, atria, ventricle, AV node, etc.) to include ECG criteria for each along with principles of management. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe and identify dysrhythmias originating from selected areas of the cardiac conduction system (SA node, atria, ventricle, AV node, etc.) to include ECG criteria for each along with principles of management. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe and identify dysrhythmias originating from selected areas of the cardiac conduction system (SA node, atria, ventricle, AV node, etc.) to include ECG criteria for each along with principles of management. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe and identify dysrhythmias originating from selected areas of the cardiac conduction system (SA node, atria, ventricle, AV node, etc.) to include ECG criteria for each along with principles of management. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe and identify dysrhythmias originating from selected areas of the cardiac conduction system (SA node, atria, ventricle, AV node, etc.) to include ECG criteria for each along with principles of management. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe and identify different types of heart blocks to include ECG criteria for each and principles of management.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe and identify different types of heart blocks to include ECG criteria for each and principles of management.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe and identify different types of heart blocks to include ECG criteria for each and principles of management.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe and identify different types of heart blocks to include ECG criteria for each and principles of management.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe and identify different types of heart blocks to include ECG criteria for each and principles of management.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe and identify ECG criteria for asystole and PEA.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe and identify ECG criteria for asystole and PEA.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe and identify ECG criteria for asystole and PEA.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe and identify ECG criteria for asystole and PEA.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe and identify ECG criteria for asystole and PEA.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge/skills of life threating EKG rhythm recognition along with principles of management..</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge/skills of life threating EKG rhythm recognition along with principles of management..</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge/skills of life threating EKG rhythm recognition along with principles of management..</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge/skills of life threating EKG rhythm recognition along with principles of management..</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge/skills of life threating EKG rhythm recognition along with principles of management..</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered will assist me in passing the ACLS megacode & test.<OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered will assist me in passing the ACLS megacode & test.<OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered will assist me in passing the ACLS megacode & test.<OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered will assist me in passing the ACLS megacode & test.<OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered will assist me in passing the ACLS megacode & test.<OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN </ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN </ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN </ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN </ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN </ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9938,,Questions-0000-72,LIFE THREATENING EKG RECOGNITION (EVALUATION SURVEY) ONLINE 7.14.21,,n13971,,choice,How would you improve this class?,"No improvements needed (appropriate content, instructor, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,"If patient is complaining of pain and burning at the IV site, the nurse should consider extravasation and stop infusion and assess site immediately.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION- g13972,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,"If patient is complaining of pain and burning at the IV site, the nurse should consider extravasation and stop infusion and assess site immediately.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,"If patient is complaining of pain and burning at the IV site, the nurse should consider extravasation and stop infusion and assess site immediately.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,"If IV access has visible blood return, the nurse should consider IV is patent and there is no need to flush IV access.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,"If IV access has visible blood return, the nurse should consider IV is patent and there is no need to flush IV access.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,It is possible that Vesicant drugs could leak at the insertion site causing extravasation without the vein wall being punctured.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,It is possible that Vesicant drugs could leak at the insertion site causing extravasation without the vein wall being punctured.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,"A cold or warm compress should be applied on extravasation site for 20minutes, 4 times per day for the first 48hrs.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,"A cold or warm compress should be applied on extravasation site for 20minutes, 4 times per day for the first 48hrs.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,"When administering Amiodarone, an inline filter should always be used.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,"When administering Amiodarone, an inline filter should always be used.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Which of the following are early signs/symptoms of extravasation?,a.	Local blistering,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Which of the following are early signs/symptoms of extravasation?,b.	Loss of blood return,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Which of the following are early signs/symptoms of extravasation?,c.	Mild burning and discomfort  on IV site,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Which of the following are early signs/symptoms of extravasation?,d.	Increased pain,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Which of the following are early signs/symptoms of extravasation?,e.	Ulceration,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Which of the following are early signs/symptoms of extravasation?,f.	Increased swelling,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Which of the following are early signs/symptoms of extravasation?,"g.	B,C",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,What is the ideal time to administer extravasation antidotes to get the maximum effects?,a.	Within 4hrs of extravasation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,What is the ideal time to administer extravasation antidotes to get the maximum effects?,b.	Within one hour,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,What is the ideal time to administer extravasation antidotes to get the maximum effects?,c.	It can be administered any time,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,What is the ideal time to administer extravasation antidotes to get the maximum effects?,d.	Within 24hrs,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,What is the correct sequence of events that should happen at the first suspicion of an extravasation? 1. Remove IV access 2.stop infusion 3.attempt to aspirate drug from the IV device 4. Disconnect IV tubing,"a.	2,3,1,4",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,What is the correct sequence of events that should happen at the first suspicion of an extravasation? 1. Remove IV access 2.stop infusion 3.attempt to aspirate drug from the IV device 4. Disconnect IV tubing,"b.	2,1,3,4",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,What is the correct sequence of events that should happen at the first suspicion of an extravasation? 1. Remove IV access 2.stop infusion 3.attempt to aspirate drug from the IV device 4. Disconnect IV tubing,"c.	2,4,3,1",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,What is the correct sequence of events that should happen at the first suspicion of an extravasation? 1. Remove IV access 2.stop infusion 3.attempt to aspirate drug from the IV device 4. Disconnect IV tubing,"d.	1,2,3,4",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Which medication requires a warm compress?,a.	Amiodarone,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Which medication requires a warm compress?,b.	Dobutamine,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Which medication requires a warm compress?,c.	TPN,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Which medication requires a warm compress?,d.	Potassium Chloride,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Hyalurondase should be administered,a.	In a series of five 0.2ml injection in a clock wise manner around the circumference of the extravasation.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Hyalurondase should be administered,b.	Using a new 25 gauge needle for each injection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Hyalurondase should be administered,c.	A total dose of 1ml dose subcutaneously,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Hyalurondase should be administered,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Phentolamine should be administered,a.	In a series of ten injections in a clock wise manner around the circumference of the extravasation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Phentolamine should be administered,b.	Total dose should not exceed 0.2mg/kg or 5mg.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Phentolamine should be administered,c.	Using a 25 gauge needle for each injection subcutaneously,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,Phentolamine should be administered,d.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,How often should the RN assess and document IV access while infusing Vesicant drugs,a.	Once per shift and as needed,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,How often should the RN assess and document IV access while infusing Vesicant drugs,b.	Twice a shift,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,How often should the RN assess and document IV access while infusing Vesicant drugs,c.	A minimum of every 2hrs,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9689,,Elearning-0000-903,EXTRAVASATION MANAGEMENT OF NON-CHOMOTHERAPY MEDICATION,,n13972,,choice,How often should the RN assess and document IV access while infusing Vesicant drugs,d.	Once per shift,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Which of the following are components of the Thoracic Surgery protocol?<br> A. Institute SMI and IPPB on all patients with a unit dose of Albuterol (2.5mg) and Ipratroprium Bromide (0.5mg) at a frequency of every 8 hours for 24 hours.<br> B. IPPB PIP of 15cmH20.<br> C. Patient assessment including pre and post vital signs (heart and respiratory rate, breath sounds, sputum production, Sp02 and level of consciousness)<br> D. After 24 hours, if the bronchodilator is not indicated, it may be changed to PRN.",1. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 RESPIRATORY ADULT ICU COMPETENCY- g13985,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Which of the following are components of the Thoracic Surgery protocol?<br> A. Institute SMI and IPPB on all patients with a unit dose of Albuterol (2.5mg) and Ipratroprium Bromide (0.5mg) at a frequency of every 8 hours for 24 hours.<br> B. IPPB PIP of 15cmH20.<br> C. Patient assessment including pre and post vital signs (heart and respiratory rate, breath sounds, sputum production, Sp02 and level of consciousness)<br> D. After 24 hours, if the bronchodilator is not indicated, it may be changed to PRN.",1. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Which of the following are components of the Thoracic Surgery protocol?<br> A. Institute SMI and IPPB on all patients with a unit dose of Albuterol (2.5mg) and Ipratroprium Bromide (0.5mg) at a frequency of every 8 hours for 24 hours.<br> B. IPPB PIP of 15cmH20.<br> C. Patient assessment including pre and post vital signs (heart and respiratory rate, breath sounds, sputum production, Sp02 and level of consciousness)<br> D. After 24 hours, if the bronchodilator is not indicated, it may be changed to PRN.",2. A and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Which of the following are components of the Thoracic Surgery protocol?<br> A. Institute SMI and IPPB on all patients with a unit dose of Albuterol (2.5mg) and Ipratroprium Bromide (0.5mg) at a frequency of every 8 hours for 24 hours.<br> B. IPPB PIP of 15cmH20.<br> C. Patient assessment including pre and post vital signs (heart and respiratory rate, breath sounds, sputum production, Sp02 and level of consciousness)<br> D. After 24 hours, if the bronchodilator is not indicated, it may be changed to PRN.","3. A, C, D",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Contraindications for IPPB therapy include presence of ICP > 20, recent facial/oral surgery or trauma, esophageal surgery, untreated pneumothorax, hemodynamic instability, acute sinusitis and acute hemoptysis or nausea.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Contraindications for IPPB therapy include presence of ICP > 20, recent facial/oral surgery or trauma, esophageal surgery, untreated pneumothorax, hemodynamic instability, acute sinusitis and acute hemoptysis or nausea.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Which statement about ASV mode is FALSE?,1. ASV maintains an operator-preset minimum minute ventilation independent of the patient's activity.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Which statement about ASV mode is FALSE?,"2. On the G5, the maximum pressure set by ASV is always 10 cmH2O below the maximum pressure limit, thus the maximum pressure and the ASV limit co-vary.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Which statement about ASV mode is FALSE?,"3. The lowest Minute Volume % to be used in ASV mode is 100%.  Per protocol, the RT may set the MV% to 80% without a Physican's order for patients with a diagnosis of COPD.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Which statement about ASV mode is FALSE?,"4. When started, the device delivers 3 test breaths in synchronized intermittent mandatory pressure ventilation mode.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"In ASV mode, adjustment to which of the following settings will affect delivered Vt and MV.<br> A. Patient Height<br> B. Gender<br> C. % Minute Volume<br> D. PEEP<br> E. Trigger<br> F. ETS (Expiratory Trigger Sensitivity)","1. A, B, C, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"In ASV mode, adjustment to which of the following settings will affect delivered Vt and MV.<br> A. Patient Height<br> B. Gender<br> C. % Minute Volume<br> D. PEEP<br> E. Trigger<br> F. ETS (Expiratory Trigger Sensitivity)",2. A and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"In ASV mode, adjustment to which of the following settings will affect delivered Vt and MV.<br> A. Patient Height<br> B. Gender<br> C. % Minute Volume<br> D. PEEP<br> E. Trigger<br> F. ETS (Expiratory Trigger Sensitivity)","3. B, C, F",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"In ASV mode, adjustment to which of the following settings will affect delivered Vt and MV.<br> A. Patient Height<br> B. Gender<br> C. % Minute Volume<br> D. PEEP<br> E. Trigger<br> F. ETS (Expiratory Trigger Sensitivity)","4. A, B, C",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"In ASV mode, adjustment to which of the following settings will affect delivered Vt and MV.<br> A. Patient Height<br> B. Gender<br> C. % Minute Volume<br> D. PEEP<br> E. Trigger<br> F. ETS (Expiratory Trigger Sensitivity)",5. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Pinsp is a direct correlation to the Pressure Support level the patient is requiring in ASV, and should be documented every vent check under invasive ventilation - Pinsp.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Pinsp is a direct correlation to the Pressure Support level the patient is requiring in ASV, and should be documented every vent check under invasive ventilation - Pinsp.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,APV-CMV functions similar to the conventional pressure-controlled modes with the exception that a target volume may be delivered.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,APV-CMV functions similar to the conventional pressure-controlled modes with the exception that a target volume may be delivered.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Your patient remains intubated in APV-CMV mode after surgery: Vt 500mL, RR 14,<br> PEEP 5. Fi02 50%. Exh Vt 515mL, Total RR 16, Sp02 99%. No pressors, no sedation.<br> All pain medications are PRN.   Patient is awake and follows commands.<br> AM ABG results:  7.47 / 30 / 105 / 25 / 1.8.  EtC02 31.<br> What is the next appropriate course of action?<br>  A. Report the ABG to the physician and make changes only if ordered.<br> B. Decrease the set rate to 12bpm.<br>  C. Decrease Fi02<br>  D. Decrease the Vt to 450mL.<br> E. Start the SBT using either ASV 100%MV or CPAP/PS, notify the physician and RN and document in the EMR   .",1. A only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Your patient remains intubated in APV-CMV mode after surgery: Vt 500mL, RR 14,<br> PEEP 5. Fi02 50%. Exh Vt 515mL, Total RR 16, Sp02 99%. No pressors, no sedation.<br> All pain medications are PRN.   Patient is awake and follows commands.<br> AM ABG results:  7.47 / 30 / 105 / 25 / 1.8.  EtC02 31.<br> What is the next appropriate course of action?<br>  A. Report the ABG to the physician and make changes only if ordered.<br> B. Decrease the set rate to 12bpm.<br>  C. Decrease Fi02<br>  D. Decrease the Vt to 450mL.<br> E. Start the SBT using either ASV 100%MV or CPAP/PS, notify the physician and RN and document in the EMR   .",2. C and D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Your patient remains intubated in APV-CMV mode after surgery: Vt 500mL, RR 14,<br> PEEP 5. Fi02 50%. Exh Vt 515mL, Total RR 16, Sp02 99%. No pressors, no sedation.<br> All pain medications are PRN.   Patient is awake and follows commands.<br> AM ABG results:  7.47 / 30 / 105 / 25 / 1.8.  EtC02 31.<br> What is the next appropriate course of action?<br>  A. Report the ABG to the physician and make changes only if ordered.<br> B. Decrease the set rate to 12bpm.<br>  C. Decrease Fi02<br>  D. Decrease the Vt to 450mL.<br> E. Start the SBT using either ASV 100%MV or CPAP/PS, notify the physician and RN and document in the EMR   .","3. B, C, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Your patient remains intubated in APV-CMV mode after surgery: Vt 500mL, RR 14,<br> PEEP 5. Fi02 50%. Exh Vt 515mL, Total RR 16, Sp02 99%. No pressors, no sedation.<br> All pain medications are PRN.   Patient is awake and follows commands.<br> AM ABG results:  7.47 / 30 / 105 / 25 / 1.8.  EtC02 31.<br> What is the next appropriate course of action?<br>  A. Report the ABG to the physician and make changes only if ordered.<br> B. Decrease the set rate to 12bpm.<br>  C. Decrease Fi02<br>  D. Decrease the Vt to 450mL.<br> E. Start the SBT using either ASV 100%MV or CPAP/PS, notify the physician and RN and document in the EMR   .",4. C and E,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Per the Mechanical Ventilator protocol, select the appropriate Vt for a male patient with ARDS - Height 5'8""�",A. 255mL - 395mL,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Per the Mechanical Ventilator protocol, select the appropriate Vt for a male patient with ARDS - Height 5'8""�",B. 280mL - 420mL,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Per the Mechanical Ventilator protocol, select the appropriate Vt for a male patient with ARDS - Height 5'8""�",C. 300mL - 440mL,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Per the Mechanical Ventilator protocol, select the appropriate Vt for a male patient with ARDS - Height 5'8""�",D. 320mL - 460mL,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,68 y/old male is intubated for hypoxic respiratory failure secondary to COVID PNA.<br> The Pa02 is 52mmHg on a Fi02 of 85%<br>  CXR shows dense bilateral infiltrates.<br> Select the following strategies you might include in the management of this ventilated patient.<br>  A. Use the P/V tool to screen for a recruitment maneuver and to set optimal PEEP<br> B. Increase Fi02<br>  C. Change modes from APV-CMV to ASV for improved ventilator synchrony<br> D. Adjust Vt to achieve 4-6mL/kg IBW<br> E. Consider Prone position or Nitric oxide,1. A and B,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,68 y/old male is intubated for hypoxic respiratory failure secondary to COVID PNA.<br> The Pa02 is 52mmHg on a Fi02 of 85%<br>  CXR shows dense bilateral infiltrates.<br> Select the following strategies you might include in the management of this ventilated patient.<br>  A. Use the P/V tool to screen for a recruitment maneuver and to set optimal PEEP<br> B. Increase Fi02<br>  C. Change modes from APV-CMV to ASV for improved ventilator synchrony<br> D. Adjust Vt to achieve 4-6mL/kg IBW<br> E. Consider Prone position or Nitric oxide,"2. B, C, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,68 y/old male is intubated for hypoxic respiratory failure secondary to COVID PNA.<br> The Pa02 is 52mmHg on a Fi02 of 85%<br>  CXR shows dense bilateral infiltrates.<br> Select the following strategies you might include in the management of this ventilated patient.<br>  A. Use the P/V tool to screen for a recruitment maneuver and to set optimal PEEP<br> B. Increase Fi02<br>  C. Change modes from APV-CMV to ASV for improved ventilator synchrony<br> D. Adjust Vt to achieve 4-6mL/kg IBW<br> E. Consider Prone position or Nitric oxide,3. B and D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,68 y/old male is intubated for hypoxic respiratory failure secondary to COVID PNA.<br> The Pa02 is 52mmHg on a Fi02 of 85%<br>  CXR shows dense bilateral infiltrates.<br> Select the following strategies you might include in the management of this ventilated patient.<br>  A. Use the P/V tool to screen for a recruitment maneuver and to set optimal PEEP<br> B. Increase Fi02<br>  C. Change modes from APV-CMV to ASV for improved ventilator synchrony<br> D. Adjust Vt to achieve 4-6mL/kg IBW<br> E. Consider Prone position or Nitric oxide,"4. A, B, D, E",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,68 y/old male is intubated for hypoxic respiratory failure secondary to COVID PNA.<br> The Pa02 is 52mmHg on a Fi02 of 85%<br>  CXR shows dense bilateral infiltrates.<br> Select the following strategies you might include in the management of this ventilated patient.<br>  A. Use the P/V tool to screen for a recruitment maneuver and to set optimal PEEP<br> B. Increase Fi02<br>  C. Change modes from APV-CMV to ASV for improved ventilator synchrony<br> D. Adjust Vt to achieve 4-6mL/kg IBW<br> E. Consider Prone position or Nitric oxide,"5. C, D, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,68 y/old male is intubated for hypoxic respiratory failure secondary to COVID PNA.<br> The Pa02 is 52mmHg on a Fi02 of 85%<br>  CXR shows dense bilateral infiltrates.<br> Select the following strategies you might include in the management of this ventilated patient.<br>  A. Use the P/V tool to screen for a recruitment maneuver and to set optimal PEEP<br> B. Increase Fi02<br>  C. Change modes from APV-CMV to ASV for improved ventilator synchrony<br> D. Adjust Vt to achieve 4-6mL/kg IBW<br> E. Consider Prone position or Nitric oxide,6. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"In P-CMV mode, what factor may affect the delivered Vt?<br> A. Changes in the respiratory system compliance<br> B. Administration of bronchodilators<br> C. Patient's respiratory activity<br> D. Changes to the pressure control level",1. A and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"In P-CMV mode, what factor may affect the delivered Vt?<br> A. Changes in the respiratory system compliance<br> B. Administration of bronchodilators<br> C. Patient's respiratory activity<br> D. Changes to the pressure control level",2. A and D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"In P-CMV mode, what factor may affect the delivered Vt?<br> A. Changes in the respiratory system compliance<br> B. Administration of bronchodilators<br> C. Patient's respiratory activity<br> D. Changes to the pressure control level","3. A, B, C",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"In P-CMV mode, what factor may affect the delivered Vt?<br> A. Changes in the respiratory system compliance<br> B. Administration of bronchodilators<br> C. Patient's respiratory activity<br> D. Changes to the pressure control level",4. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Which of these statements regarding Spontaneous mode is FALSE?,"a. When pressure support is set to zero, the mode functions like  a conventional CPAP system.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Which of these statements regarding Spontaneous mode is FALSE?,b. The patient determines the breath timing and may be either flow or  pressure triggered.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Which of these statements regarding Spontaneous mode is FALSE?,"c. The settings in this mode include: Psupport, P-ramp, ETS, PEEP,  Fi02 and Trigger.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Which of these statements regarding Spontaneous mode is FALSE?,"d. If the back up mode is selected, the vent will transition from SPONT to APV-CMV mode when the apnea alarm is triggered.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"The vent weaning readiness criteria includes a PEEP = 8 cmH20, Fi02 = 50%, effective cough, manageable secretions, the patient is awake and alert.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"The vent weaning readiness criteria includes a PEEP = 8 cmH20, Fi02 = 50%, effective cough, manageable secretions, the patient is awake and alert.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Which statement regarding the Spontaneous Breathing Trial is FALSE?,A. The SBT should not exceed 120 minutes unless ordered by MD or midlevel.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Which statement regarding the Spontaneous Breathing Trial is FALSE?,"B. If at any time the patient because unstable or has an increased RR > 35bpm, the mode should be changed to achieve the pre-trial minute volume.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Which statement regarding the Spontaneous Breathing Trial is FALSE?,C. ASV at 100%MV or CPAP/PS mode may be used.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Which statement regarding the Spontaneous Breathing Trial is FALSE?,"D. ASV at 100%MV may be used and the Pinsp should be < 15cmH20 to be considered in a ""weaning""� mode.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Which statement regarding the Spontaneous Breathing Trial is FALSE?,"E. If the patient is on pressors, the RT and RN must confirm that the physician is aware of the type and dose of pressors before a weaning trial is conducted.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,The connection of the red alarm cable should be documented with every Q4h vent check as well as the audible and visual alarms.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,The connection of the red alarm cable should be documented with every Q4h vent check as well as the audible and visual alarms.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Oral care and tube movement  is performed Q2 and is a shared responsibility between Nursing and Respiratory Therapy.   Night shift should consult the RN prior to performing mouth care/tube movement to ensure undisturbed sleep time.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Oral care and tube movement  is performed Q2 and is a shared responsibility between Nursing and Respiratory Therapy.   Night shift should consult the RN prior to performing mouth care/tube movement to ensure undisturbed sleep time.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Hollister tube holders should be labeled with the date and time of application to ensure they are changed Q72h and PRN.Skin assessment co-signature is required on ALL tube holder changes.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Hollister tube holders should be labeled with the date and time of application to ensure they are changed Q72h and PRN.Skin assessment co-signature is required on ALL tube holder changes.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Physician orders are needed for which of the following?<br> A. BiPAP use<br> B. Brachial ABG<br> C. Use of a bite block<br> D. Changing vent modes to start the SBT<br> E. Extubation,1. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Physician orders are needed for which of the following?<br> A. BiPAP use<br> B. Brachial ABG<br> C. Use of a bite block<br> D. Changing vent modes to start the SBT<br> E. Extubation,"2. A, C, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Physician orders are needed for which of the following?<br> A. BiPAP use<br> B. Brachial ABG<br> C. Use of a bite block<br> D. Changing vent modes to start the SBT<br> E. Extubation,3. B and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Physician orders are needed for which of the following?<br> A. BiPAP use<br> B. Brachial ABG<br> C. Use of a bite block<br> D. Changing vent modes to start the SBT<br> E. Extubation,"4. A, B, C, E",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"When patients are placed in the prone position, which of the following tube holders are acceptable?",A. Hollister,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"When patients are placed in the prone position, which of the following tube holders are acceptable?",B. Silk tape then Stabiltube,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"When patients are placed in the prone position, which of the following tube holders are acceptable?",C. Hollister with Physician's order,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"When patients are placed in the prone position, which of the following tube holders are acceptable?",D.  B and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"ETS (expiratory trigger sensitivity), represents the percent of peak inspiratory flow at which the ventilator cycles from inspiration to exhalation.  The normal default ETS is 25%.  An intubated patient with COPD or air trapping would benefit from an increase of ETS to 40%.  What effect does this have on the I:E ratio?","A. Increased I-time, decreased E-time",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"ETS (expiratory trigger sensitivity), represents the percent of peak inspiratory flow at which the ventilator cycles from inspiration to exhalation.  The normal default ETS is 25%.  An intubated patient with COPD or air trapping would benefit from an increase of ETS to 40%.  What effect does this have on the I:E ratio?","B. Decreased I-time, increased E-time",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"ETS (expiratory trigger sensitivity), represents the percent of peak inspiratory flow at which the ventilator cycles from inspiration to exhalation.  The normal default ETS is 25%.  An intubated patient with COPD or air trapping would benefit from an increase of ETS to 40%.  What effect does this have on the I:E ratio?","C. Decreased I-time, decreased E-time",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"ETS (expiratory trigger sensitivity), represents the percent of peak inspiratory flow at which the ventilator cycles from inspiration to exhalation.  The normal default ETS is 25%.  An intubated patient with COPD or air trapping would benefit from an increase of ETS to 40%.  What effect does this have on the I:E ratio?",D. None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"In regards to Heliox via the Hamilton G5, which of these statements is FALSE?",A. Only the G5 can utilize Heliox.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"In regards to Heliox via the Hamilton G5, which of these statements is FALSE?",B. The G5 flow sensor must be recalibrated with Heliox prior to starting the therapy.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"In regards to Heliox via the Hamilton G5, which of these statements is FALSE?",C. The circuit must first be changed from a single limb with a  HME to a heated wire circuit prior to starting Heliox therapy.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"An ARDS patient is intubated in APV-CMV mode: Vt 380mL, Rate 22bpm, PEEP 10cmH20, Fi02 85%.  Sp02 90%. <br>  ABG results:  pH 7.32, PaC02 49, Pa02 57.8, HC03 26, BE +2.5.<br> What is the P/F ratio?",A.  68,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"An ARDS patient is intubated in APV-CMV mode: Vt 380mL, Rate 22bpm, PEEP 10cmH20, Fi02 85%.  Sp02 90%. <br>  ABG results:  pH 7.32, PaC02 49, Pa02 57.8, HC03 26, BE +2.5.<br> What is the P/F ratio?",B.  70,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"An ARDS patient is intubated in APV-CMV mode: Vt 380mL, Rate 22bpm, PEEP 10cmH20, Fi02 85%.  Sp02 90%. <br>  ABG results:  pH 7.32, PaC02 49, Pa02 57.8, HC03 26, BE +2.5.<br> What is the P/F ratio?",C.  66,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"An ARDS patient is intubated in APV-CMV mode: Vt 380mL, Rate 22bpm, PEEP 10cmH20, Fi02 85%.  Sp02 90%. <br>  ABG results:  pH 7.32, PaC02 49, Pa02 57.8, HC03 26, BE +2.5.<br> What is the P/F ratio?",D.  49,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Complications of inverse I:E ratio include, but are not limited to, excessive gas trapping, adverse hemodynamic effects, and the need for sedation",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Complications of inverse I:E ratio include, but are not limited to, excessive gas trapping, adverse hemodynamic effects, and the need for sedation",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Performing an Inspiratory hold on the Hamilton ventilator allows for the measurement of which parameter?,A. Peak airway pressure,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Performing an Inspiratory hold on the Hamilton ventilator allows for the measurement of which parameter?,B. Optimal PEEP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Performing an Inspiratory hold on the Hamilton ventilator allows for the measurement of which parameter?,C. Dynamic lung compliance,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Performing an Inspiratory hold on the Hamilton ventilator allows for the measurement of which parameter?,D. Plateau pressure,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,The Hamilton ventilator will display which of the following calculations and measurements?,A. Lung compliance,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,The Hamilton ventilator will display which of the following calculations and measurements?,B. AutoPEEP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,The Hamilton ventilator will display which of the following calculations and measurements?,C. Rapid shallow breathing index,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,The Hamilton ventilator will display which of the following calculations and measurements?,D. Airway resistance,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,The Hamilton ventilator will display which of the following calculations and measurements?,"E. A, C, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,The Hamilton ventilator will display which of the following calculations and measurements?,F. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,BiPAP is contraindicated in which of the following cases:<br>  A.  Actively vomiting<br> B.  Inability to protect the airway; severely obtunded<br> C.  Hypercapnia with spontaneous respiratory effort<br> D.  Trauma or burns involving the face<br> E.   Apnea or respiratory arrest,"1. A, D, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,BiPAP is contraindicated in which of the following cases:<br>  A.  Actively vomiting<br> B.  Inability to protect the airway; severely obtunded<br> C.  Hypercapnia with spontaneous respiratory effort<br> D.  Trauma or burns involving the face<br> E.   Apnea or respiratory arrest,"2. B, C, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,BiPAP is contraindicated in which of the following cases:<br>  A.  Actively vomiting<br> B.  Inability to protect the airway; severely obtunded<br> C.  Hypercapnia with spontaneous respiratory effort<br> D.  Trauma or burns involving the face<br> E.   Apnea or respiratory arrest,"3. A, B, D, E",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,BiPAP is contraindicated in which of the following cases:<br>  A.  Actively vomiting<br> B.  Inability to protect the airway; severely obtunded<br> C.  Hypercapnia with spontaneous respiratory effort<br> D.  Trauma or burns involving the face<br> E.   Apnea or respiratory arrest,4. A and E,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,BiPAP is contraindicated in which of the following cases:<br>  A.  Actively vomiting<br> B.  Inability to protect the airway; severely obtunded<br> C.  Hypercapnia with spontaneous respiratory effort<br> D.  Trauma or burns involving the face<br> E.   Apnea or respiratory arrest,5. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Vision BiPAP settings:  IPAP 12,  EPAP 6, RR 12, Fi02 50%, Sp02 95%.  Exh Vt 300mL, total RR 22<br> ABG 7.28 / 72 / 63 / 31 / 4.9<br> Which statement regarding changes to the settings is TRUE?<br>  A. Increasing the EPAP will improve both ventilation and oxygenation.<br> B. Increasing EPAP alone may improve oxygenation but will adversely affect ventilation.<br> C. An increase in EPAP must be accompanied by an increase in IPAP for ventilation to remain constant or improve.<br> D. Increasing the set rate to 20 will improve ventilation.<br> E. Increasing IPAP will improve ventilation.","1. A, B, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Vision BiPAP settings:  IPAP 12,  EPAP 6, RR 12, Fi02 50%, Sp02 95%.  Exh Vt 300mL, total RR 22<br> ABG 7.28 / 72 / 63 / 31 / 4.9<br> Which statement regarding changes to the settings is TRUE?<br>  A. Increasing the EPAP will improve both ventilation and oxygenation.<br> B. Increasing EPAP alone may improve oxygenation but will adversely affect ventilation.<br> C. An increase in EPAP must be accompanied by an increase in IPAP for ventilation to remain constant or improve.<br> D. Increasing the set rate to 20 will improve ventilation.<br> E. Increasing IPAP will improve ventilation.","2.   B, C and E",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Vision BiPAP settings:  IPAP 12,  EPAP 6, RR 12, Fi02 50%, Sp02 95%.  Exh Vt 300mL, total RR 22<br> ABG 7.28 / 72 / 63 / 31 / 4.9<br> Which statement regarding changes to the settings is TRUE?<br>  A. Increasing the EPAP will improve both ventilation and oxygenation.<br> B. Increasing EPAP alone may improve oxygenation but will adversely affect ventilation.<br> C. An increase in EPAP must be accompanied by an increase in IPAP for ventilation to remain constant or improve.<br> D. Increasing the set rate to 20 will improve ventilation.<br> E. Increasing IPAP will improve ventilation.","3. C, D, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Vision BiPAP settings:  IPAP 12,  EPAP 6, RR 12, Fi02 50%, Sp02 95%.  Exh Vt 300mL, total RR 22<br> ABG 7.28 / 72 / 63 / 31 / 4.9<br> Which statement regarding changes to the settings is TRUE?<br>  A. Increasing the EPAP will improve both ventilation and oxygenation.<br> B. Increasing EPAP alone may improve oxygenation but will adversely affect ventilation.<br> C. An increase in EPAP must be accompanied by an increase in IPAP for ventilation to remain constant or improve.<br> D. Increasing the set rate to 20 will improve ventilation.<br> E. Increasing IPAP will improve ventilation.",4. All statements are true,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"If a patient is trached and needs to be on BIPAP, which mode is to be used on the G5/C2/C3 or transport vent?",a.   NIV-ST,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"If a patient is trached and needs to be on BIPAP, which mode is to be used on the G5/C2/C3 or transport vent?",b.   Spontaneous,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"If a patient is trached and needs to be on BIPAP, which mode is to be used on the G5/C2/C3 or transport vent?",c.   NIV,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"If a patient is trached and needs to be on BIPAP, which mode is to be used on the G5/C2/C3 or transport vent?",d.   NIPPV,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Per protocol, what are the initial HFO settings?","a.  Hz 5, Power 8 - adjusting for adequate chest wiggle, Ti 50%, Fi02 same as conventional vent, MAP set to same as conventional vent, Bias Flow 35 lpm",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Per protocol, what are the initial HFO settings?","b.  Hz 5, Power 5 - adjusting for adequate chest wiggle, Ti 33%, Fi02 100%, MAP set to 5cmH20 above mean pressure on conventional vent, Bias Flow 35 lpm",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Per protocol, what are the initial HFO settings?","c.  Hz 3, Power 5 - adjusting for adequate chest wiggle, Ti 40%, Fi02 same as conventional vent, MAP set to same as conventional vent, Bias Flow 25 lpm",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Per protocol, what are the initial HFO settings?","d.  Hz 5, Power 8 - adjusting for adequate chest wiggle, Ti 33%, Fi02 100%, MAP set to 5cmH20  below mean pressure on conventional vent, Bias Flow 45 lpm",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Contraindications for the HFO recruitment maneuver include:<br> A.  Pneumothorax with active air leak<br> B.  Hemodynamic instability:  Mean arterial pressure < 60mmHg<br> C.  Greater than 12 hours since start of HFO<br> D.  Fi02 less than 75%,1.  All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Contraindications for the HFO recruitment maneuver include:<br> A.  Pneumothorax with active air leak<br> B.  Hemodynamic instability:  Mean arterial pressure < 60mmHg<br> C.  Greater than 12 hours since start of HFO<br> D.  Fi02 less than 75%,2.  A and B,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Contraindications for the HFO recruitment maneuver include:<br> A.  Pneumothorax with active air leak<br> B.  Hemodynamic instability:  Mean arterial pressure < 60mmHg<br> C.  Greater than 12 hours since start of HFO<br> D.  Fi02 less than 75%,"3.  A, B, C",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Contraindications for the HFO recruitment maneuver include:<br> A.  Pneumothorax with active air leak<br> B.  Hemodynamic instability:  Mean arterial pressure < 60mmHg<br> C.  Greater than 12 hours since start of HFO<br> D.  Fi02 less than 75%,4.  B and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"On the Sensormedics Oscillator, what parameter could be changed to improve ventilation?",a.   Frequency,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"On the Sensormedics Oscillator, what parameter could be changed to improve ventilation?",b.   Cuff Leak,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"On the Sensormedics Oscillator, what parameter could be changed to improve ventilation?",c.    I Time,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"On the Sensormedics Oscillator, what parameter could be changed to improve ventilation?",d. Amplitude,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"On the Sensormedics Oscillator, what parameter could be changed to improve ventilation?",e. A and B only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"On the Sensormedics Oscillator, what parameter could be changed to improve ventilation?","f. A, B, C, D",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"On the Sensormedics Oscillator, what parameters could be changed to improve oxygenation?",a. MAP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"On the Sensormedics Oscillator, what parameters could be changed to improve oxygenation?",b.   FiO2,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"On the Sensormedics Oscillator, what parameters could be changed to improve oxygenation?",c. Amplitude,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"On the Sensormedics Oscillator, what parameters could be changed to improve oxygenation?",d. A and B only,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"On the Sensormedics Oscillator, what parameters could be changed to improve oxygenation?","e. A, B, C",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Per protocol, which changes could correct the following ABG using the HFO 3100B?<br>  pH 7.24<br> - PaC02 68 - Pa02 80<br> - HCO3 29<br> - BE 3.9<br>  A. Increase Hz, Decrease Power<br> B. Increase Power, Increase Hz<br> C. Decreased Hz, Increase Power<br> D. Cuff leak","1.  A, D, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Per protocol, which changes could correct the following ABG using the HFO 3100B?<br>  pH 7.24<br> - PaC02 68 - Pa02 80<br> - HCO3 29<br> - BE 3.9<br>  A. Increase Hz, Decrease Power<br> B. Increase Power, Increase Hz<br> C. Decreased Hz, Increase Power<br> D. Cuff leak",2.  B and D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Per protocol, which changes could correct the following ABG using the HFO 3100B?<br>  pH 7.24<br> - PaC02 68 - Pa02 80<br> - HCO3 29<br> - BE 3.9<br>  A. Increase Hz, Decrease Power<br> B. Increase Power, Increase Hz<br> C. Decreased Hz, Increase Power<br> D. Cuff leak",3.  C and D,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Consider transition to conventional ventilation when the Fi02 is </= 50% and the mPaw is < 25cmH20, or you are not able to ventilate the patient despite all the appropriate changes.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Consider transition to conventional ventilation when the Fi02 is </= 50% and the mPaw is < 25cmH20, or you are not able to ventilate the patient despite all the appropriate changes.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Under the Respiratory Protocol for Nitric Oxide:  What  level should the patient  initially be started on?,a.  5 PPM,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Under the Respiratory Protocol for Nitric Oxide:  What  level should the patient  initially be started on?,b.  10 PPM,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Under the Respiratory Protocol for Nitric Oxide:  What  level should the patient  initially be started on?,c.  Therapist discretion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Under the Respiratory Protocol for Nitric Oxide:  What  level should the patient  initially be started on?,d.  20 PPM,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Under the Respiratory Protocol for Nitric Oxide: What is the highest level a patient should be on?,a. 20ppm,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Under the Respiratory Protocol for Nitric Oxide: What is the highest level a patient should be on?,b. 30ppm,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Under the Respiratory Protocol for Nitric Oxide: What is the highest level a patient should be on?,c. 40ppm,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Under the Respiratory Protocol for Nitric Oxide: What is the highest level a patient should be on?,d. 60ppm,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Hamilton C2-C3 in NIV-ST mode<br> Your patient is currently on a Vision BiPAP.  Ordered settings: IPAP 15, EPAP 8, Rate 14, Fi02 50%.  You need to transport the patient using a Hamilton C2.  Which picture shows the correct settings for the Hamilton device?",A.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Hamilton C2-C3 in NIV-ST mode<br> Your patient is currently on a Vision BiPAP.  Ordered settings: IPAP 15, EPAP 8, Rate 14, Fi02 50%.  You need to transport the patient using a Hamilton C2.  Which picture shows the correct settings for the Hamilton device?",B.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Hamilton C2-C3 in NIV-ST mode<br> Your patient is currently on a Vision BiPAP.  Ordered settings: IPAP 15, EPAP 8, Rate 14, Fi02 50%.  You need to transport the patient using a Hamilton C2.  Which picture shows the correct settings for the Hamilton device?",C.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,When should you consider changing the Nitric oxide filter and sample line?,A. When you see fluid in the sample line,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,When should you consider changing the Nitric oxide filter and sample line?,B. When the measured Nitric oxide and Fi02 is inaccurate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,When should you consider changing the Nitric oxide filter and sample line?,"C. After medications like Tobramycin, Mucomyst or Colistin are nebulized inline",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,When should you consider changing the Nitric oxide filter and sample line?,D. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,A hydrogen peroxide wipe is used to clean which pieces of equipment?<br> A. ALL Hamilton devices<br>  B. McGrath intubation handles<br> C. EMMA capnography devices<br> D. Personal stethoscopes<br> E. A Vision BiPAP used for a patient with C. diff,1. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,A hydrogen peroxide wipe is used to clean which pieces of equipment?<br> A. ALL Hamilton devices<br>  B. McGrath intubation handles<br> C. EMMA capnography devices<br> D. Personal stethoscopes<br> E. A Vision BiPAP used for a patient with C. diff,"2. A, B, D",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,A hydrogen peroxide wipe is used to clean which pieces of equipment?<br> A. ALL Hamilton devices<br>  B. McGrath intubation handles<br> C. EMMA capnography devices<br> D. Personal stethoscopes<br> E. A Vision BiPAP used for a patient with C. diff,3. A and B only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,A hydrogen peroxide wipe is used to clean which pieces of equipment?<br> A. ALL Hamilton devices<br>  B. McGrath intubation handles<br> C. EMMA capnography devices<br> D. Personal stethoscopes<br> E. A Vision BiPAP used for a patient with C. diff,"4. A, C, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Components of the Fresh Trach protocol include?,A. Signage on the door with the date and time the 48 hour observation ends,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Components of the Fresh Trach protocol include?,B.  ETC02 Q4  and breath sounds documentation with any patient repositioning during the first 48 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Components of the Fresh Trach protocol include?,C.  Same size trach and one size smaller at bedside,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Components of the Fresh Trach protocol include?,D.  Obturator at the HOB,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Components of the Fresh Trach protocol include?,E.  Airway box at bedside,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Components of the Fresh Trach protocol include?,F.  Ambu bag and mask at bedside,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Components of the Fresh Trach protocol include?,G.  All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"For a trach patient with a cuffless tube, what supplies do you need at bedside?<br>  A. Obturator<br> B. Same size trach tube, both cuffed and cuffless<br> C. A cuffed tube one size smaller<br> D. A cuffless tube one size smaller<br> E. Ambu bag and mask","1. A, B, C, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"For a trach patient with a cuffless tube, what supplies do you need at bedside?<br>  A. Obturator<br> B. Same size trach tube, both cuffed and cuffless<br> C. A cuffed tube one size smaller<br> D. A cuffless tube one size smaller<br> E. Ambu bag and mask","2. B, C, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"For a trach patient with a cuffless tube, what supplies do you need at bedside?<br>  A. Obturator<br> B. Same size trach tube, both cuffed and cuffless<br> C. A cuffed tube one size smaller<br> D. A cuffless tube one size smaller<br> E. Ambu bag and mask",3. A and E,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"For a trach patient with a cuffless tube, what supplies do you need at bedside?<br>  A. Obturator<br> B. Same size trach tube, both cuffed and cuffless<br> C. A cuffed tube one size smaller<br> D. A cuffless tube one size smaller<br> E. Ambu bag and mask",4. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"The radiant infant warmer with supplies is located across from ED Room 11, just in front of the ambulance entrance to the ED.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"The radiant infant warmer with supplies is located across from ED Room 11, just in front of the ambulance entrance to the ED.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,There are two supply rooms for respiratory equipment in the ED:  One supply room across from Care Team 3 and the other is the respiratory equipment room housing the ABG analyzer and C2.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,There are two supply rooms for respiratory equipment in the ED:  One supply room across from Care Team 3 and the other is the respiratory equipment room housing the ABG analyzer and C2.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"49 F, 5'5""�, with a history of chronic renal failure, CHF, pulmonary edema, morbid obesity, and HTN is admitted to the ICU after having missed her dialysis treatment.  She arrives on the unit wearing a NRB mask at 15lpm, Sp02 92%.  She presents with crackles throughout, labored breathing in a tripod position.  CXR shows pulmonary edema.  ABG results on current settings: 7.29/54/69/29/3.1.  HR 100.  B/P 115/69.  The decision is made to intubate and sedate.  Per protocol, what initial mode and settings would be most appropriate?","A. APV-CMV Vt 500, RR 18, PEEP 12, Fi02 75%",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"49 F, 5'5""�, with a history of chronic renal failure, CHF, pulmonary edema, morbid obesity, and HTN is admitted to the ICU after having missed her dialysis treatment.  She arrives on the unit wearing a NRB mask at 15lpm, Sp02 92%.  She presents with crackles throughout, labored breathing in a tripod position.  CXR shows pulmonary edema.  ABG results on current settings: 7.29/54/69/29/3.1.  HR 100.  B/P 115/69.  The decision is made to intubate and sedate.  Per protocol, what initial mode and settings would be most appropriate?","B. ASV 140%, PEEP 10, Fi02 100%.  Target 8lpm.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"49 F, 5'5""�, with a history of chronic renal failure, CHF, pulmonary edema, morbid obesity, and HTN is admitted to the ICU after having missed her dialysis treatment.  She arrives on the unit wearing a NRB mask at 15lpm, Sp02 92%.  She presents with crackles throughout, labored breathing in a tripod position.  CXR shows pulmonary edema.  ABG results on current settings: 7.29/54/69/29/3.1.  HR 100.  B/P 115/69.  The decision is made to intubate and sedate.  Per protocol, what initial mode and settings would be most appropriate?","C. P-CMV, PC 20cmH20, RR 16, PEEP 8, Fi02 85%, exh Vt 570mL",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"49 F, 5'5""�, with a history of chronic renal failure, CHF, pulmonary edema, morbid obesity, and HTN is admitted to the ICU after having missed her dialysis treatment.  She arrives on the unit wearing a NRB mask at 15lpm, Sp02 92%.  She presents with crackles throughout, labored breathing in a tripod position.  CXR shows pulmonary edema.  ABG results on current settings: 7.29/54/69/29/3.1.  HR 100.  B/P 115/69.  The decision is made to intubate and sedate.  Per protocol, what initial mode and settings would be most appropriate?","D. APV-CMV Vt 400, RR 20, PEEP 10, Fi02 100%",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Spontaneous Breathing Trial Reason Not Done includes which of the following?<br>  A. ICP > 20<br> B. Patient on Dopamine > 5 mcg/kg/min<br> C. Patient on Norepinephrine > 2 mcg/kg/min<br> D. Patient on Neosynephrine > 100 mcg/min<br> E. Patient on Vasopressin - any dose,"1. B, C, D, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Spontaneous Breathing Trial Reason Not Done includes which of the following?<br>  A. ICP > 20<br> B. Patient on Dopamine > 5 mcg/kg/min<br> C. Patient on Norepinephrine > 2 mcg/kg/min<br> D. Patient on Neosynephrine > 100 mcg/min<br> E. Patient on Vasopressin - any dose,"2. A, B, C, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Spontaneous Breathing Trial Reason Not Done includes which of the following?<br>  A. ICP > 20<br> B. Patient on Dopamine > 5 mcg/kg/min<br> C. Patient on Norepinephrine > 2 mcg/kg/min<br> D. Patient on Neosynephrine > 100 mcg/min<br> E. Patient on Vasopressin - any dose,3. C and E,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Spontaneous Breathing Trial Reason Not Done includes which of the following?<br>  A. ICP > 20<br> B. Patient on Dopamine > 5 mcg/kg/min<br> C. Patient on Norepinephrine > 2 mcg/kg/min<br> D. Patient on Neosynephrine > 100 mcg/min<br> E. Patient on Vasopressin - any dose,4. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"It is day 3 after trach tube placement in the OR.  There is no skin barrier in place, sutures remain intact, and you notice skin breakdown below the flange.<br>  Which statements regarding skin breakdown are TRUE?<br>  A. Trach sutures may be removed prior to 5 days when new skin breakdown occurs.  Notify the physician once sutures are removed, place a skin barrier and write a Progress note.<br>  B. An incident report must be logged, a physician promptly notified and Progress Note written.<br>  C. Notify the RN to consult wound care and document the skin breakdown in Cerner.<br> D. If ointment is at bedside, RT may scan the medication before applying it when scheduled trach care is done.",1. All statements are true,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"It is day 3 after trach tube placement in the OR.  There is no skin barrier in place, sutures remain intact, and you notice skin breakdown below the flange.<br>  Which statements regarding skin breakdown are TRUE?<br>  A. Trach sutures may be removed prior to 5 days when new skin breakdown occurs.  Notify the physician once sutures are removed, place a skin barrier and write a Progress note.<br>  B. An incident report must be logged, a physician promptly notified and Progress Note written.<br>  C. Notify the RN to consult wound care and document the skin breakdown in Cerner.<br> D. If ointment is at bedside, RT may scan the medication before applying it when scheduled trach care is done.",2. A and D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"It is day 3 after trach tube placement in the OR.  There is no skin barrier in place, sutures remain intact, and you notice skin breakdown below the flange.<br>  Which statements regarding skin breakdown are TRUE?<br>  A. Trach sutures may be removed prior to 5 days when new skin breakdown occurs.  Notify the physician once sutures are removed, place a skin barrier and write a Progress note.<br>  B. An incident report must be logged, a physician promptly notified and Progress Note written.<br>  C. Notify the RN to consult wound care and document the skin breakdown in Cerner.<br> D. If ointment is at bedside, RT may scan the medication before applying it when scheduled trach care is done.",3. B and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"It is day 3 after trach tube placement in the OR.  There is no skin barrier in place, sutures remain intact, and you notice skin breakdown below the flange.<br>  Which statements regarding skin breakdown are TRUE?<br>  A. Trach sutures may be removed prior to 5 days when new skin breakdown occurs.  Notify the physician once sutures are removed, place a skin barrier and write a Progress note.<br>  B. An incident report must be logged, a physician promptly notified and Progress Note written.<br>  C. Notify the RN to consult wound care and document the skin breakdown in Cerner.<br> D. If ointment is at bedside, RT may scan the medication before applying it when scheduled trach care is done.",4. B and D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Progress note topics include which of the following?<br>   A. Fi02 increase > 10%<br> B. SBT start and stop time with mode and settings, including the reason why SBT is stopped<br> C. Clinical changes requiring additional support, like the initiation of BiPAP or Optiflow<br> D. All intubations and extubations<br> E. Changes of airway type, vent mode or PEEP<br> F. Codes and Rapid Response<br> G. ICU shift summaries<br> H. RT evaluation and treat consults","1. B, D, E, G",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Progress note topics include which of the following?<br>   A. Fi02 increase > 10%<br> B. SBT start and stop time with mode and settings, including the reason why SBT is stopped<br> C. Clinical changes requiring additional support, like the initiation of BiPAP or Optiflow<br> D. All intubations and extubations<br> E. Changes of airway type, vent mode or PEEP<br> F. Codes and Rapid Response<br> G. ICU shift summaries<br> H. RT evaluation and treat consults","2. A, D, G, H",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Progress note topics include which of the following?<br>   A. Fi02 increase > 10%<br> B. SBT start and stop time with mode and settings, including the reason why SBT is stopped<br> C. Clinical changes requiring additional support, like the initiation of BiPAP or Optiflow<br> D. All intubations and extubations<br> E. Changes of airway type, vent mode or PEEP<br> F. Codes and Rapid Response<br> G. ICU shift summaries<br> H. RT evaluation and treat consults","3. B, C, F, G,",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Progress note topics include which of the following?<br>   A. Fi02 increase > 10%<br> B. SBT start and stop time with mode and settings, including the reason why SBT is stopped<br> C. Clinical changes requiring additional support, like the initiation of BiPAP or Optiflow<br> D. All intubations and extubations<br> E. Changes of airway type, vent mode or PEEP<br> F. Codes and Rapid Response<br> G. ICU shift summaries<br> H. RT evaluation and treat consults",4. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Laryngectomy patients<br>  What is the appropriate way to ventilate with a bag/mask for a laryngectomy patient without an artificial airway?,1. Cover the laryngectomy stoma with your hand or gauze and bag through the mouth with the AMBU bag.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Laryngectomy patients<br>  What is the appropriate way to ventilate with a bag/mask for a laryngectomy patient without an artificial airway?,2. Use an adult AMBU bag and a pediatric mask over the laryngectomy stoma to provide ventilation.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Laryngectomy patients<br>  What is the appropriate way to ventilate with a bag/mask for a laryngectomy patient without an artificial airway?,3. Intubate through the mouth with an ETT and provide ventilation with the AMBU bag.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Laryngectomy patients<br>  What is the appropriate way to ventilate with a bag/mask for a laryngectomy patient without an artificial airway?,4. Do not use an AMBU bag for laryngectomy patients.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Nitric with C2/C3<br> C2/C3 with Nitric oxide: use heated wire circuit<br>  Acknowledge this slide was reviewed.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Nitric with C2/C3<br> C2/C3 with Nitric oxide: use heated wire circuit<br>  Acknowledge this slide was reviewed.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Nitric with Transport Vent<br> Transport vent with Nitric oxide : Use heated wire circuit, bypass heater<br>  Acknowledge slide was reviewed.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Nitric with Transport Vent<br> Transport vent with Nitric oxide : Use heated wire circuit, bypass heater<br>  Acknowledge slide was reviewed.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Heliox<br> The Heliox mask; attach the Aerogen spacer and nebulizer using elbow<br>  Acknowledge slide was reviewed.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Heliox<br> The Heliox mask; attach the Aerogen spacer and nebulizer using elbow<br>  Acknowledge slide was reviewed.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Heliox<br> Heliox tank, regulator, hose for G5 connection<br>  Acknowledge slide was reviewed.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Heliox<br> Heliox tank, regulator, hose for G5 connection<br>  Acknowledge slide was reviewed.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Heliox<br> G5 with Heliox: connection (we have 3 G5)<br>  Acknowledge slide was reviewed.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Heliox<br> G5 with Heliox: connection (we have 3 G5)<br>  Acknowledge slide was reviewed.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Heliox with G-5<br> G5 screenshots: select gas source then calibrate on Heliox<br> You must calibrate the flowsensor with the Heliox***<br>  Acknowledge slide was reviewed.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Heliox with G-5<br> G5 screenshots: select gas source then calibrate on Heliox<br> You must calibrate the flowsensor with the Heliox***<br>  Acknowledge slide was reviewed.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Prone positioning: Silk tape, then Stabiltube. Hollister only per MD order. Skin assessment co-signature is required on ALL tube holder changes.<br>  Acknowledge slide was reviewed.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,"Prone positioning: Silk tape, then Stabiltube. Hollister only per MD order. Skin assessment co-signature is required on ALL tube holder changes.<br>  Acknowledge slide was reviewed.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Skin Co-Signature for ETT's <br> (When The Tube holder is changed)<br>  Acknowledge slide was reviewed.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9727,,Elearning-0000-938,2021 RESPIRATORY ADULT ICU COMPETENCY,,n13985,,choice,Skin Co-Signature for ETT's <br> (When The Tube holder is changed)<br>  Acknowledge slide was reviewed.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21- g13988,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe normal vs abnormal cardiac findings in pregnancy.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe normal vs abnormal cardiac findings in pregnancy.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe normal vs abnormal cardiac findings in pregnancy.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe normal vs abnormal cardiac findings in pregnancy.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe normal vs abnormal cardiac findings in pregnancy.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize pulmonary changes of pregnancy.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize pulmonary changes of pregnancy.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize pulmonary changes of pregnancy.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize pulmonary changes of pregnancy.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize pulmonary changes of pregnancy.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe neurologic alterations of pregnancy.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe neurologic alterations of pregnancy.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe neurologic alterations of pregnancy.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe neurologic alterations of pregnancy.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe neurologic alterations of pregnancy.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss hematologic changes of pregnancy.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss hematologic changes of pregnancy.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss hematologic changes of pregnancy.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss hematologic changes of pregnancy.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss hematologic changes of pregnancy.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss lab changes and recognize expected laboratory variations in pregnancy.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss lab changes and recognize expected laboratory variations in pregnancy.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss lab changes and recognize expected laboratory variations in pregnancy.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss lab changes and recognize expected laboratory variations in pregnancy.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss lab changes and recognize expected laboratory variations in pregnancy.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how normal physiologic changes of pregnancy impact clinical presentation.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how normal physiologic changes of pregnancy impact clinical presentation.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how normal physiologic changes of pregnancy impact clinical presentation.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how normal physiologic changes of pregnancy impact clinical presentation.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how normal physiologic changes of pregnancy impact clinical presentation.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the 4Ps of Labor (Power, Passenger, Passage, Psyche).</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the 4Ps of Labor (Power, Passenger, Passage, Psyche).</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the 4Ps of Labor (Power, Passenger, Passage, Psyche).</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the 4Ps of Labor (Power, Passenger, Passage, Psyche).</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the 4Ps of Labor (Power, Passenger, Passage, Psyche).</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss why changing positions enhances labor and describe actions for labor nurses to take to improve vaginal birth.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss why changing positions enhances labor and describe actions for labor nurses to take to improve vaginal birth.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss why changing positions enhances labor and describe actions for labor nurses to take to improve vaginal birth.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss why changing positions enhances labor and describe actions for labor nurses to take to improve vaginal birth.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss why changing positions enhances labor and describe actions for labor nurses to take to improve vaginal birth.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss non-pharmacologic pain relief methods in labor.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss non-pharmacologic pain relief methods in labor.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss non-pharmacologic pain relief methods in labor.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss non-pharmacologic pain relief methods in labor.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss non-pharmacologic pain relief methods in labor.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss fetal monitoring and labor progression for nullipars.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss fetal monitoring and labor progression for nullipars.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss fetal monitoring and labor progression for nullipars.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss fetal monitoring and labor progression for nullipars.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss fetal monitoring and labor progression for nullipars.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the normal physiologic changes of pregnancy.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the normal physiologic changes of pregnancy.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the normal physiologic changes of pregnancy.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the normal physiologic changes of pregnancy.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the normal physiologic changes of pregnancy.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence as it relates recognizing normal changes vs abnormal changes in pregnancy & postpartum.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence as it relates recognizing normal changes vs abnormal changes in pregnancy & postpartum.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence as it relates recognizing normal changes vs abnormal changes in pregnancy & postpartum.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence as it relates recognizing normal changes vs abnormal changes in pregnancy & postpartum.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence as it relates recognizing normal changes vs abnormal changes in pregnancy & postpartum.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ginny Wurttemberg, DNP, RNC</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ginny Wurttemberg, DNP, RNC</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ginny Wurttemberg, DNP, RNC</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ginny Wurttemberg, DNP, RNC</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ginny Wurttemberg, DNP, RNC</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lauren Schwartz, MSN, RN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lauren Schwartz, MSN, RN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lauren Schwartz, MSN, RN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lauren Schwartz, MSN, RN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Lauren Schwartz, MSN, RN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9886,,Questions-0000-20,BACK TO BASICS: IMPROVING VAGINAL BIRTH ONLINE (EVALUATION SURVEY) 7-20-21,,n13988,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21- g13989,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, BSN, RN-C, CCRN, PCCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, BSN, RN-C, CCRN, PCCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, BSN, RN-C, CCRN, PCCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, BSN, RN-C, CCRN, PCCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, BSN, RN-C, CCRN, PCCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9952,,Questions-0000-86,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 7-20-21,,n13989,,choice,How would you improve this class?,"Nothing: (appropriate content, speaker, setting, setting.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21- g13990,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify key differences in how chemotherapy, biotherapy, immunotherapy and targeted therapy work to treat cancer.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the concept of ""targeted therapy""� and identify specific mechanisms of action for commonly prescribed drugs.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the mechanisms of action for commonly prescribed agents.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify common side effects associated with commonly prescribed agents.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to state key principles associated with safe handling and administration of hazardous medications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate the skills associated with safe handling and administration of chemotherapy and biotherapy agents.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my confidence in performing skills related to safe administration and handling of chemotherapy and biotherapy medications for oncology indications.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Punita Panchal, BSN, RN, BMTCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Punita Panchal, BSN, RN, BMTCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Punita Panchal, BSN, RN, BMTCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Punita Panchal, BSN, RN, BMTCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Punita Panchal, BSN, RN, BMTCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Christina Happeny, BSN, RN, OCN </ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Christina Happeny, BSN, RN, OCN </ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Christina Happeny, BSN, RN, OCN </ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Christina Happeny, BSN, RN, OCN </ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Christina Happeny, BSN, RN, OCN </ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9807,,Questions-0000-102,PRINCIPLES OF CHEMOTHERAPY & BIOTHERAPY (EVALUATION SURVEY) NSA 07-20-21,,n13990,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"When a rapid response is called, you should ALWAYS inform your Charge RT/ 5335 and the nurse taking care of the patient.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 RESPIRATORY ADULT FLOOR COMPETENCY- g13997,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"When a rapid response is called, you should ALWAYS inform your Charge RT/ 5335 and the nurse taking care of the patient.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"When a rapid response is called, you should ALWAYS inform your Charge RT/ 5335 and the nurse taking care of the patient.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,On the code sheet you should ALWAYS make sure the Airway and ETC02 section is filled out correctly before signing the sheet.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,On the code sheet you should ALWAYS make sure the Airway and ETC02 section is filled out correctly before signing the sheet.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,You are called to the PACU to set up a CPAP on a gastric sleeve patient.  You first confirm the MD order and it states CPAP per RT Protocol.  You would then place the patient on which of the following settings?,1.  5 cm,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,You are called to the PACU to set up a CPAP on a gastric sleeve patient.  You first confirm the MD order and it states CPAP per RT Protocol.  You would then place the patient on which of the following settings?,2. 10 cm,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,You are called to the PACU to set up a CPAP on a gastric sleeve patient.  You first confirm the MD order and it states CPAP per RT Protocol.  You would then place the patient on which of the following settings?,3. 15 cm,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,You are called to the PACU to set up a CPAP on a gastric sleeve patient.  You first confirm the MD order and it states CPAP per RT Protocol.  You would then place the patient on which of the following settings?,4. Auto set mode with high pressure limit of 10cm.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"What do you do when a patient has a history of OSA but is not complaint with CPAP, Home or Hospital unit?",1. Do nothing.  The patient has the right to refuse treatment.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"What do you do when a patient has a history of OSA but is not complaint with CPAP, Home or Hospital unit?",2. Notify the Physician and place them on a Capnography Remote Monitor. Document in the EMR and write a Progress Note.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"What do you do when a patient has a history of OSA but is not complaint with CPAP, Home or Hospital unit?",3.  Place them on 3 l/m nasal oxygen,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"What do you do when a patient has a history of OSA but is not complaint with CPAP, Home or Hospital unit?",4.  Place them on an Optiflow at 50 l/min & 50% Fio2,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Patients on CPAP, home unit or hospital unit that require more than 40% / >5 lpm bled into the unit to maintain SpO2 within the oxygen policy guidelines will need to be placed on:",1. Remote Capnography,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Patients on CPAP, home unit or hospital unit that require more than 40% / >5 lpm bled into the unit to maintain SpO2 within the oxygen policy guidelines will need to be placed on:",2. Remote Pulse Ox,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,When do you need to call the MD for a CPAP order?<br> A.   When the patient is requiring 50% FIO2.<br>  B.   When the patient states they are on specific CPAP pressures at home but did not bring their CPAP device<br>  C.   When the patients Sats are < 88% in PACU.,1. A & B,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,When do you need to call the MD for a CPAP order?<br> A.   When the patient is requiring 50% FIO2.<br>  B.   When the patient states they are on specific CPAP pressures at home but did not bring their CPAP device<br>  C.   When the patients Sats are < 88% in PACU.,2. B & C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,When do you need to call the MD for a CPAP order?<br> A.   When the patient is requiring 50% FIO2.<br>  B.   When the patient states they are on specific CPAP pressures at home but did not bring their CPAP device<br>  C.   When the patients Sats are < 88% in PACU.,3. B only,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,When do you need to call the MD for a CPAP order?<br> A.   When the patient is requiring 50% FIO2.<br>  B.   When the patient states they are on specific CPAP pressures at home but did not bring their CPAP device<br>  C.   When the patients Sats are < 88% in PACU.,4. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"If an order reads ""Respiratory CPAP (Hospital Owned Device) Therapy Protocol""�, you should set up:","A. Air-sense or Lumis in autoset mode with a minimum pressure of 4cmH20, max of 18cmH20",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"If an order reads ""Respiratory CPAP (Hospital Owned Device) Therapy Protocol""�, you should set up:",B. Fixed CPAP of 15cmH20,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"If an order reads ""Respiratory CPAP (Hospital Owned Device) Therapy Protocol""�, you should set up:",C. Up to 15lpm of 02 bled inline,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"If an order reads ""Respiratory CPAP (Hospital Owned Device) Therapy Protocol""�, you should set up:",D. Up to 4lpm of 02 bled inline,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"If an order reads ""Respiratory CPAP (Hospital Owned Device) Therapy Protocol""�, you should set up:",E. A and D,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"When using the Hamilton C-2/C-3 for BiPAP, it is important  to set the following :","1. I- time lower than I- time Max and ETS to 50% to compensate for mask leaks, promoting synchrony and patient comfort",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"When using the Hamilton C-2/C-3 for BiPAP, it is important  to set the following :",2.  I time needs to be higher than I time Max & ETS at 25%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Per the Oxygen Administration Protocol, you can obtain ABGs when a patient is on 40% or greater FiO2 without a physician order:",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Per the Oxygen Administration Protocol, you can obtain ABGs when a patient is on 40% or greater FiO2 without a physician order:",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,All post-op thoracic patients for the first 24 hours will receive:,1. SMI/Accupap(+10cm)/albuterol and ipratropium bromide Q8,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,All post-op thoracic patients for the first 24 hours will receive:,2. Accupap only Q8,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,All post-op thoracic patients for the first 24 hours will receive:,3. SMI only Q8,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,All post-op thoracic patients for the first 24 hours will receive:,4. Aerosol treatments with Duoneb and Mucomyst Q8,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Home oxygen assessment includes documenting under home O2 assessment tab which of the following:,"a.  If room air sat at rest is < 89, place patient on oxygen to get their sat  >or = 89.  If able to ambulate, see what o2 is needed to keep > 88 on exertion(pt at home might need higher o2 when ambulating)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Home oxygen assessment includes documenting under home O2 assessment tab which of the following:,"b.  If room air sat is > or = to  89% at rest, you need to do a room air sat with  exertion",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Home oxygen assessment includes documenting under home O2 assessment tab which of the following:,c.  If exertional sat is lower than <89% you need to document how much o2 is needed to keep sat > 89%. Please relay to RN and Case Management,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Home oxygen assessment includes documenting under home O2 assessment tab which of the following:,d.  All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Home oxygen assessment includes documenting under home O2 assessment tab which of the following:,e.  None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Any trach outside the ICU needs to be on a remote pulse oximeter:,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Any trach outside the ICU needs to be on a remote pulse oximeter:,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,What is the Jackson size of this trach?,1) 8.5,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,What is the Jackson size of this trach?,2) 7.5,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,What is the Jackson size of this trach?,3) 8,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,What is the Jackson size of this trach?,4) 85,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,When a trach patient on the floor is de-cannulated you must :,1.   Stay in room with the patient for 24 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,When a trach patient on the floor is de-cannulated you must :,2.   Keep the patient on a remote pulse ox for 24 hours per policy,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,When a trach patient on the floor is de-cannulated you must :,3.  Place on a remote capnography for 24 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,The remote therapist will assess monitored patients and document results twice per shift.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,The remote therapist will assess monitored patients and document results twice per shift.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,You have a patient that does not use home O2 at baseline and was placed on a remote monitor for low PaO2 10 days ago.<br> The patient has been on room air for 48 hours and the patient has not had any desat episodes for 24 hours.  What is your next plan of action?,1. Place the patient on a remote Capnography.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,You have a patient that does not use home O2 at baseline and was placed on a remote monitor for low PaO2 10 days ago.<br> The patient has been on room air for 48 hours and the patient has not had any desat episodes for 24 hours.  What is your next plan of action?,2. Call the physician to have the remote monitor d/c'd.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,You have a patient that does not use home O2 at baseline and was placed on a remote monitor for low PaO2 10 days ago.<br> The patient has been on room air for 48 hours and the patient has not had any desat episodes for 24 hours.  What is your next plan of action?,3. Continue to use the remote pulse ox until the patient is discharged.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,You have a patient that does not use home O2 at baseline and was placed on a remote monitor for low PaO2 10 days ago.<br> The patient has been on room air for 48 hours and the patient has not had any desat episodes for 24 hours.  What is your next plan of action?,4. Place the patient on a nasal cannula.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which of these statements is TRUE regarding the Remote monitors?,A.  The Capnography monitor attaches to the probe with blue end,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which of these statements is TRUE regarding the Remote monitors?,B.  The Remote Pulse-ox monitor attaches to the probe with the white end,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which of these statements is TRUE regarding the Remote monitors?,C.  The sensor with Sp02 and RR attaches to the Remote Pulse-ox monitor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which of these statements is TRUE regarding the Remote monitors?,D.  All statements are true,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"According to the bronchodilator protocol, a patient's home nebulizer or medication regimen can be changed without a MD order.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"According to the bronchodilator protocol, a patient's home nebulizer or medication regimen can be changed without a MD order.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which Statement regarding the Bronchodilator Therapy Protocol is FALSE?,"1.  If the frequency is increased or the patient calls more often for a treatment than ordered, the Physician or Mid-level must be contacted by phone to notify them of changes in the patient status.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which Statement regarding the Bronchodilator Therapy Protocol is FALSE?,2.  Budesonide (Pulmicort) ordered by the physician or mid-level cannot be discontinued or made PRN by the RT.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which Statement regarding the Bronchodilator Therapy Protocol is FALSE?,"3.  If a physician or midlevel enters an order for concurrent therapy with Brovana , Pulmicort, Albuterol and Atrovent, they may be administered per RT discretion or patient preference.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which Statement regarding the Bronchodilator Therapy Protocol is FALSE?,"4.  If the physician does not specify the medications and only writes for Respiratory to Evaluate and Treat, the RT may order albuterol 2.5mg at the following frequencies:  Q4, Q6, BID, TID, QID, Q4 w/a or Q6 w/a.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"If a patient is requiring Q4 hour treatments initially, nebulizer treatments are to be given via?",1. Regular nebulizer,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"If a patient is requiring Q4 hour treatments initially, nebulizer treatments are to be given via?",2. Pep Device,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"If a patient is requiring Q4 hour treatments initially, nebulizer treatments are to be given via?",3. Aerogen,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"If a patient is requiring Q4 hour treatments initially, nebulizer treatments are to be given via?",4. None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Levalbuterol (Xopenex) 1.25mg may be substituted for albuterol if the physician indicates that or if the patient has an adverse reaction to albuterol.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Levalbuterol (Xopenex) 1.25mg may be substituted for albuterol if the physician indicates that or if the patient has an adverse reaction to albuterol.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Per the Bronchodilator protocol, when can Respiratory Therapy order Ipratropium (Atrovent 0.5mg)?<br>  A. It may be added to albuterol/Levabuterol therapy at the same frequency if the patient is on home ipratropium therapy<br> B. If the physician does not specify the medications and only writes for Respiratory to Evaluate and Treat for Bronchodilator therapy and the patient has a diagnosis of COPD<br> C. When the patient is in persistent respiratory distress after initial bronchodilator treatment requiring treatments more often than every six hours<br> D. RT cannot order Atrovent 0.5mg.",1. B and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Per the Bronchodilator protocol, when can Respiratory Therapy order Ipratropium (Atrovent 0.5mg)?<br>  A. It may be added to albuterol/Levabuterol therapy at the same frequency if the patient is on home ipratropium therapy<br> B. If the physician does not specify the medications and only writes for Respiratory to Evaluate and Treat for Bronchodilator therapy and the patient has a diagnosis of COPD<br> C. When the patient is in persistent respiratory distress after initial bronchodilator treatment requiring treatments more often than every six hours<br> D. RT cannot order Atrovent 0.5mg.","2. A, B, C",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Per the Bronchodilator protocol, when can Respiratory Therapy order Ipratropium (Atrovent 0.5mg)?<br>  A. It may be added to albuterol/Levabuterol therapy at the same frequency if the patient is on home ipratropium therapy<br> B. If the physician does not specify the medications and only writes for Respiratory to Evaluate and Treat for Bronchodilator therapy and the patient has a diagnosis of COPD<br> C. When the patient is in persistent respiratory distress after initial bronchodilator treatment requiring treatments more often than every six hours<br> D. RT cannot order Atrovent 0.5mg.",3. A and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Per the Bronchodilator protocol, when can Respiratory Therapy order Ipratropium (Atrovent 0.5mg)?<br>  A. It may be added to albuterol/Levabuterol therapy at the same frequency if the patient is on home ipratropium therapy<br> B. If the physician does not specify the medications and only writes for Respiratory to Evaluate and Treat for Bronchodilator therapy and the patient has a diagnosis of COPD<br> C. When the patient is in persistent respiratory distress after initial bronchodilator treatment requiring treatments more often than every six hours<br> D. RT cannot order Atrovent 0.5mg.",4. B only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Inhaled Pentamidine, an antiprotozoal agent, is indicated for:",1. Treatment of bronchospasms,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Inhaled Pentamidine, an antiprotozoal agent, is indicated for:",2. Bacterial Pneumonia in cystic fibrosis patients,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Inhaled Pentamidine, an antiprotozoal agent, is indicated for:",3. Prevention of PJP/pneumocystis,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Inhaled Pentamidine, an antiprotozoal agent, is indicated for:",4. Treatment of RSV,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Ribavirin is approved  for the treatment of:,1.  RSV,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Ribavirin is approved  for the treatment of:,2.  Pneumocystis,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Ribavirin is approved  for the treatment of:,3.  Pseudomonas,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,How often are the Parts to the Aerogen Pump/nebulizer to be replaced?,1. After each treatment,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,How often are the Parts to the Aerogen Pump/nebulizer to be replaced?,2. Q12,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,How often are the Parts to the Aerogen Pump/nebulizer to be replaced?,3. You don't need to clean,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,How often are the Parts to the Aerogen Pump/nebulizer to be replaced?,4. Between patients only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Where do the parts of the Ribavirin treatment go after each use?,1.  In the black chemo bucket in patient room,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Where do the parts of the Ribavirin treatment go after each use?,2.  In the trash can,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Where do the parts of the Ribavirin treatment go after each use?,3.  Its reused for 24 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Where do the parts of the Ribavirin treatment go after each use?,4.  Blue trash bin,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"The SMI policy:<br> A.  Instruct patient on use and purpose of incentive spirometer.       Mark goal and 50% with yellow sticker /Place name on unit<br>  B.   Perform Smi: if patient reaches > 75% of their goal, turn over to nursing       and inform them. Inform patient they are to do exercise q2 wa on own.       Perform SMI daily as long as the patient is in the 50-75% range<br>  C.   If patient is less than 50% of predicted value, initiate IPPB with SMI BID  or       with scheduled treatment until they can achieve greater than 50% of their        goal for 2 consecutive visits<br>   D.   Document Education/Document Goal/Document number of attempts",1.   all of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"The SMI policy:<br> A.  Instruct patient on use and purpose of incentive spirometer.       Mark goal and 50% with yellow sticker /Place name on unit<br>  B.   Perform Smi: if patient reaches > 75% of their goal, turn over to nursing       and inform them. Inform patient they are to do exercise q2 wa on own.       Perform SMI daily as long as the patient is in the 50-75% range<br>  C.   If patient is less than 50% of predicted value, initiate IPPB with SMI BID  or       with scheduled treatment until they can achieve greater than 50% of their        goal for 2 consecutive visits<br>   D.   Document Education/Document Goal/Document number of attempts","2.   A, C, & D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"The SMI policy:<br> A.  Instruct patient on use and purpose of incentive spirometer.       Mark goal and 50% with yellow sticker /Place name on unit<br>  B.   Perform Smi: if patient reaches > 75% of their goal, turn over to nursing       and inform them. Inform patient they are to do exercise q2 wa on own.       Perform SMI daily as long as the patient is in the 50-75% range<br>  C.   If patient is less than 50% of predicted value, initiate IPPB with SMI BID  or       with scheduled treatment until they can achieve greater than 50% of their        goal for 2 consecutive visits<br>   D.   Document Education/Document Goal/Document number of attempts","3.   A, B, & D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"The SMI policy:<br> A.  Instruct patient on use and purpose of incentive spirometer.       Mark goal and 50% with yellow sticker /Place name on unit<br>  B.   Perform Smi: if patient reaches > 75% of their goal, turn over to nursing       and inform them. Inform patient they are to do exercise q2 wa on own.       Perform SMI daily as long as the patient is in the 50-75% range<br>  C.   If patient is less than 50% of predicted value, initiate IPPB with SMI BID  or       with scheduled treatment until they can achieve greater than 50% of their        goal for 2 consecutive visits<br>   D.   Document Education/Document Goal/Document number of attempts","4.   B, C, & D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"When giving an aerosol treatment with Heliox, you should:<br>  A.   Use an 80:20 tank<br> B.   Use the 80:20 regulator(in wire cart in department)<br> C.   Use the heliox adaptable mask with the aerogen nebulizer<br> D.   If oxygen is needed , you can use a nasal cannula under the        mask or you can attach o2 tubing under the aerogen spacer        up to 6 l/min",1.    All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"When giving an aerosol treatment with Heliox, you should:<br>  A.   Use an 80:20 tank<br> B.   Use the 80:20 regulator(in wire cart in department)<br> C.   Use the heliox adaptable mask with the aerogen nebulizer<br> D.   If oxygen is needed , you can use a nasal cannula under the        mask or you can attach o2 tubing under the aerogen spacer        up to 6 l/min",2.    Only A & B,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"When giving an aerosol treatment with Heliox, you should:<br>  A.   Use an 80:20 tank<br> B.   Use the 80:20 regulator(in wire cart in department)<br> C.   Use the heliox adaptable mask with the aerogen nebulizer<br> D.   If oxygen is needed , you can use a nasal cannula under the        mask or you can attach o2 tubing under the aerogen spacer        up to 6 l/min","3.    Only A, B, & C",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Heliox:,"1. The mixture generates less resistance than atmospheric air when passing  through the airways of the lungs, and thus requires less effort by a patient",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Heliox:,2.    Heliox is a breathing gas composed of a mixture of helium (He) and           oxygen (O2),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Heliox:,"3. Heliox is mainly used in conditions of large airway narrowing (upper airway  obstruction from tumors or foreign bodies and vocal cord dysfunction). There is also some use of heliox in conditions of the medium airways (croup, asthma and chronic obstructive pulmonary disease",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Heliox:,4. All are true statements,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Heliox:,5. Only 3 is a true statement,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Empty inhalers and leftover Ribavirin medication will be disposed of in the black trash bin.<br>  Partial doses of Albuterol/Xopenex/Atrovent/Pulmicort/Mucomyst may be disposed of In the Blue trash bin,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Empty inhalers and leftover Ribavirin medication will be disposed of in the black trash bin.<br>  Partial doses of Albuterol/Xopenex/Atrovent/Pulmicort/Mucomyst may be disposed of In the Blue trash bin,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which statement about CPAP documentation is FALSE?,A. A hospital owned CPAP device will be checked Q12 and with any change in settings or status of the patient,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which statement about CPAP documentation is FALSE?,B. Home CPAP units will be checked Qshift.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which statement about CPAP documentation is FALSE?,C. CPAP documentation includes skin integrity and the use of any skin barrier,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"When using a BiPAP, Physician will be notified when:",A. Heart rate increases or decreases to > 20% from pre therapy heart rate.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"When using a BiPAP, Physician will be notified when:",B. Therapist is unable to achieve an adequate mask seal.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"When using a BiPAP, Physician will be notified when:",C. Tachydysrhythmias or Brachyarrhythmias occur.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"When using a BiPAP, Physician will be notified when:",D. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which are components of the fresh trach protocol?,A. Sign on the door with the date and time the 48 hour observation ends.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which are components of the fresh trach protocol?,B. ETC02 and breath sounds documentation with any patient repositioning.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which are components of the fresh trach protocol?,C. Same size trach and one size smaller.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which are components of the fresh trach protocol?,D. Obturator at the HOB.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which are components of the fresh trach protocol?,E. Airway box at bedside.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which are components of the fresh trach protocol?,F. Ambu bag/mask at bedside.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which are components of the fresh trach protocol?,G. Respiratory at the bedside for all repositioning.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which are components of the fresh trach protocol?,H. All of the above.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,How often do you change an inner cannula?<br>  A. Qshift on nightshift and as needed<br> B. BID and as needed<br> C. Q24 on dayshift and as needed<br> D. Not during the 48 hour fresh trach protocol,1. C and D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,How often do you change an inner cannula?<br>  A. Qshift on nightshift and as needed<br> B. BID and as needed<br> C. Q24 on dayshift and as needed<br> D. Not during the 48 hour fresh trach protocol,2. A and D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,How often do you change an inner cannula?<br>  A. Qshift on nightshift and as needed<br> B. BID and as needed<br> C. Q24 on dayshift and as needed<br> D. Not during the 48 hour fresh trach protocol,3. B only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,How often do you change an inner cannula?<br>  A. Qshift on nightshift and as needed<br> B. BID and as needed<br> C. Q24 on dayshift and as needed<br> D. Not during the 48 hour fresh trach protocol,4. C only,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"A BioMed work order, found on the Intranet under requests, should include which of the following information?<br>  A. Facility<br> B. Tag<br> C. Patient name and DOB<br> D. Problem<br>  E. Location /Room","1. A, B, C ,D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"A BioMed work order, found on the Intranet under requests, should include which of the following information?<br>  A. Facility<br> B. Tag<br> C. Patient name and DOB<br> D. Problem<br>  E. Location /Room","2. A, B, D, E",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"A BioMed work order, found on the Intranet under requests, should include which of the following information?<br>  A. Facility<br> B. Tag<br> C. Patient name and DOB<br> D. Problem<br>  E. Location /Room","3. B, D, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"A BioMed work order, found on the Intranet under requests, should include which of the following information?<br>  A. Facility<br> B. Tag<br> C. Patient name and DOB<br> D. Problem<br>  E. Location /Room",4. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which of the following items will you find on the P-drive?<br>  A. How to change a CPAP from variable to fixed.<br> B. Equipment manuals<br> C. Release of liability forms<br> D. Hand hygiene results<br> E. EMMA / Code blue statistics,1. B and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which of the following items will you find on the P-drive?<br>  A. How to change a CPAP from variable to fixed.<br> B. Equipment manuals<br> C. Release of liability forms<br> D. Hand hygiene results<br> E. EMMA / Code blue statistics,"2. A, B, C",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which of the following items will you find on the P-drive?<br>  A. How to change a CPAP from variable to fixed.<br> B. Equipment manuals<br> C. Release of liability forms<br> D. Hand hygiene results<br> E. EMMA / Code blue statistics,"3. A, D, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which of the following items will you find on the P-drive?<br>  A. How to change a CPAP from variable to fixed.<br> B. Equipment manuals<br> C. Release of liability forms<br> D. Hand hygiene results<br> E. EMMA / Code blue statistics,"4. A, B, C, D, E",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Lucidoc, found on the Northside Intranet, contains which of the following?<br>  A. Interdisciplinary Professional Practice (IPP) System-wide<br> B. Human Resources Policies<br> C. Respiratory Therapy Protocols<br> D. Centricity Web<br> E. Corporate Compliance","1. A, C, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Lucidoc, found on the Northside Intranet, contains which of the following?<br>  A. Interdisciplinary Professional Practice (IPP) System-wide<br> B. Human Resources Policies<br> C. Respiratory Therapy Protocols<br> D. Centricity Web<br> E. Corporate Compliance","2. A, B, C, E",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Lucidoc, found on the Northside Intranet, contains which of the following?<br>  A. Interdisciplinary Professional Practice (IPP) System-wide<br> B. Human Resources Policies<br> C. Respiratory Therapy Protocols<br> D. Centricity Web<br> E. Corporate Compliance",3. B and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Lucidoc, found on the Northside Intranet, contains which of the following?<br>  A. Interdisciplinary Professional Practice (IPP) System-wide<br> B. Human Resources Policies<br> C. Respiratory Therapy Protocols<br> D. Centricity Web<br> E. Corporate Compliance",4. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"To place a Remote Pulse ox monitor in standby, you disconnect the pulse ox sensor from the cable then press DISMISS from the drop down menu and silence the alarm.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"To place a Remote Pulse ox monitor in standby, you disconnect the pulse ox sensor from the cable then press DISMISS from the drop down menu and silence the alarm.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Which of the following items are located in every code cart drawer labelled Miscellaneous?<br>  A. 14 Fr suction kit with gloves,<br> B. Suction canister with lid<br> C. Suction tubing both long and short<br> D. Yankauer<br> E. Wall suction regulator","1. B, C, D, E",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Which of the following items are located in every code cart drawer labelled Miscellaneous?<br>  A. 14 Fr suction kit with gloves,<br> B. Suction canister with lid<br> C. Suction tubing both long and short<br> D. Yankauer<br> E. Wall suction regulator","2. A, B, C, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Which of the following items are located in every code cart drawer labelled Miscellaneous?<br>  A. 14 Fr suction kit with gloves,<br> B. Suction canister with lid<br> C. Suction tubing both long and short<br> D. Yankauer<br> E. Wall suction regulator",3. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,"Which of the following items are located in every code cart drawer labelled Miscellaneous?<br>  A. 14 Fr suction kit with gloves,<br> B. Suction canister with lid<br> C. Suction tubing both long and short<br> D. Yankauer<br> E. Wall suction regulator",4. None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,All of the following are contraindications of using MetaNeb EXCEPT:,A.   Head or neck injury that has not been stabilized,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,All of the following are contraindications of using MetaNeb EXCEPT:,B.   Active pulmonary hemorrhaging,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,All of the following are contraindications of using MetaNeb EXCEPT:,"C.   Presence of ICP >20, recent facial/oral surgery or trauma",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,All of the following are contraindications of using MetaNeb EXCEPT:,D.   Esophageal surgery and/or gastric sleeve surgery,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,All of the following are contraindications of using MetaNeb EXCEPT:,E.    Neuromuscular disorders,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,All of the following are contraindications of using MetaNeb EXCEPT:,F.    COPD,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,All of the following are contraindications of using MetaNeb EXCEPT:,G.   Post-Op Management of Atelectasis,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,All of the following are contraindications of using MetaNeb EXCEPT:,H. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,All of the following are contraindications of using MetaNeb EXCEPT:,"I.  E, F and G",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which statement regarding the delivery of IPV therapy is FALSE?,1.   The RT must remain with the patient while therapy is in progress.  Therapy must    be stopped before RT can leave the room.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which statement regarding the delivery of IPV therapy is FALSE?,2. Alternate between CPEP and CHFO modes every 2.5 minutes until the treatment is complete and the nebulizer is empty.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which statement regarding the delivery of IPV therapy is FALSE?,"3. IPV facilitates the mobilization of secretions, lung expansion therapy,  and the treatment and prevention of pulmonary atelectasis",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Which statement regarding the delivery of IPV therapy is FALSE?,"4. If the physician does not order medications for nebulization, RT will order Duoneb Q6 and document in the EMR",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Respiratory Therapy is NOT responsible for bringing the code cart to any Code Blue in the 980/960 buildings.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Respiratory Therapy is NOT responsible for bringing the code cart to any Code Blue in the 980/960 buildings.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,FYI'S: Please read. It's good information  Acknowledge slide review.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,FYI'S: Please read. It's good information  Acknowledge slide review.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Home O2 Assessment<br>  Acknowledge slide review.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Home O2 Assessment<br>  Acknowledge slide review.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Smoking Cessation<br>  Acknowledge slide review.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Smoking Cessation<br>  Acknowledge slide review.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Learner Assessment<br>  Acknowledge slide review.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Learner Assessment<br>  Acknowledge slide review.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Provider Notification<br>  Acknowledge slide review.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Provider Notification<br>  Acknowledge slide review.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,RT Handoff Notifications,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,RT Handoff Notifications,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Code Blue and Rapid Response<br>  Acknowledge slide review.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Code Blue and Rapid Response<br>  Acknowledge slide review.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,MetaNeb<br>  Acknowledge slide review.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,MetaNeb<br>  Acknowledge slide review.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Cough Assist<br>  Acknowledge slide review.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9728,,Elearning-0000-939,2021 RESPIRATORY ADULT FLOOR COMPETENCY,,n13997,,choice,Cough Assist<br>  Acknowledge slide review.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21- g13996,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9904,,Questions-0000-38,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 7-23-21,,n13996,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,"Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21- g13998",False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9917,,Questions-0000-51,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 7-23-21",,n13998,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21- g13995,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9911,,Questions-0000-45,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 7-23-21,,n13995,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8931,,Elearning-0000-214,RESPIRATORY PERIPHERAL ARTERIAL SAMPLING CBL 2021 FORSYTH,,n14002,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the RESPIRATORY PERIPHERAL ARTERIAL SAMPLING CBL 2021 FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is RESPIRATORY PERIPHERAL ARTERIAL SAMPLING CBL 2021 FORSYTH- g14002,False
8931,,Elearning-0000-214,RESPIRATORY PERIPHERAL ARTERIAL SAMPLING CBL 2021 FORSYTH,,n14002,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the RESPIRATORY PERIPHERAL ARTERIAL SAMPLING CBL 2021 FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8931,,Elearning-0000-214,RESPIRATORY PERIPHERAL ARTERIAL SAMPLING CBL 2021 FORSYTH,,n14002,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the RESPIRATORY PERIPHERAL ARTERIAL SAMPLING CBL 2021 FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9745,,Elearning-0000-954,2021 ABG CBL FORSYTH,,n14003,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the 2021 ABG CBL FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 ABG CBL FORSYTH- g14003,False
9745,,Elearning-0000-954,2021 ABG CBL FORSYTH,,n14003,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the 2021 ABG CBL FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9745,,Elearning-0000-954,2021 ABG CBL FORSYTH,,n14003,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the 2021 ABG CBL FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,All intubated babies must have two healthcare providers at the bedside for repositioning to reduce unplanned extubations.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 NICU COMPETENCY EXAM_ NSF- g14004,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,All intubated babies must have two healthcare providers at the bedside for repositioning to reduce unplanned extubations.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,All intubated babies must have two healthcare providers at the bedside for repositioning to reduce unplanned extubations.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What is the primary role of the second person that is needed for repositioning an intubated baby?,A. To give the other person some company,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What is the primary role of the second person that is needed for repositioning an intubated baby?,B. To offer encouragement to the primary caregiver,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What is the primary role of the second person that is needed for repositioning an intubated baby?,"C. To maintain the airway before, during, and after patient repositioning",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When should the bedside bag & mask and/or the t-piece resuscitator circuit be replaced?,A. When damaged or visibly soiled,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When should the bedside bag & mask and/or the t-piece resuscitator circuit be replaced?,B. After it is used to deliver PPV,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When should the bedside bag & mask and/or the t-piece resuscitator circuit be replaced?,C. When admitting a new patient,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When should the bedside bag & mask and/or the t-piece resuscitator circuit be replaced?,D. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"When changing or setting-up the bedside bag and mask and/or t-piece resuscitator, the storage bag should be labeled with the date the equipment was set up.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"When changing or setting-up the bedside bag and mask and/or t-piece resuscitator, the storage bag should be labeled with the date the equipment was set up.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When should the closed suction setup for ET tubes be replaced?,A. Every night,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When should the closed suction setup for ET tubes be replaced?,B. When visibly soiled or damaged,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When should the closed suction setup for ET tubes be replaced?,C. Weekly on Sunday nights,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When should the closed suction setup for ET tubes be replaced?,D. None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When should the closed suction setup for ET tubes be replaced?,E. B & C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Effective hand hygiene is the single most important intervention in decreasing the incidence of infection and disease.  When should proper hand hygiene be performed?,A. Entering the unit before shift report.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Effective hand hygiene is the single most important intervention in decreasing the incidence of infection and disease.  When should proper hand hygiene be performed?,B. Before and after patient contact.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Effective hand hygiene is the single most important intervention in decreasing the incidence of infection and disease.  When should proper hand hygiene be performed?,C. Before putting on gloves and after removal of gloves.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Effective hand hygiene is the single most important intervention in decreasing the incidence of infection and disease.  When should proper hand hygiene be performed?,D. Before touching anything in the infant's bed space.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Effective hand hygiene is the single most important intervention in decreasing the incidence of infection and disease.  When should proper hand hygiene be performed?,E. When moving from a contaminated body site to a clean site during care.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Effective hand hygiene is the single most important intervention in decreasing the incidence of infection and disease.  When should proper hand hygiene be performed?,F. All of the above.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which of the following does maintaining NCPAP promote?,A.  FRC,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which of the following does maintaining NCPAP promote?,B.  Endogenous surfactant production,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which of the following does maintaining NCPAP promote?,C.  Oxygenation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which of the following does maintaining NCPAP promote?,D.  All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,ALL babies < 30 weeks should have CPAP placed on them immediately in the delivery room.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,ALL babies < 30 weeks should have CPAP placed on them immediately in the delivery room.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Any interruption of CPAP when admitting a patient to SCN should be avoided.  Which of the following may be caused by interruption of CPAP?,A.  Over distention,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Any interruption of CPAP when admitting a patient to SCN should be avoided.  Which of the following may be caused by interruption of CPAP?,B.  Decreased oxygenation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Any interruption of CPAP when admitting a patient to SCN should be avoided.  Which of the following may be caused by interruption of CPAP?,C.  Atelectasis or loss of FRC,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Any interruption of CPAP when admitting a patient to SCN should be avoided.  Which of the following may be caused by interruption of CPAP?,D.  B and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,The initial blood gas for an infant/neonate that is admitted on CPAP should be obtained:,A. Immediately upon admission to the unit,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,The initial blood gas for an infant/neonate that is admitted on CPAP should be obtained:,B. After lines are placed by the physician,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,The initial blood gas for an infant/neonate that is admitted on CPAP should be obtained:,"C. After 1 hour of continuous, uninterrupted time on CPAP",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,The initial blood gas for an infant/neonate that is admitted on CPAP should be obtained:,"D. After length, head, and chest are measured",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Any nasal redness, bruising, or skin breakdown due to nasal prong therapy requires the MD and RN to be notified and results charted.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Any nasal redness, bruising, or skin breakdown due to nasal prong therapy requires the MD and RN to be notified and results charted.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How do you determine the correct size nasal prongs for CPAP or NIPPV?,A. Use the INCA Nasal Sizing Gauge,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How do you determine the correct size nasal prongs for CPAP or NIPPV?,B. Use the prong size that fill the nares without dilating or causing blanching,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How do you determine the correct size nasal prongs for CPAP or NIPPV?,C. Doesn't matter because the Cannulaide provides a seal,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How do you determine the correct size nasal prongs for CPAP or NIPPV?,D. A & B,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How do you determine the correct size nasal prongs for CPAP or NIPPV?,E. None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Normal saline should only be used to clear the in-line suction catheter and NOT instilled down the endotracheal tube as a lavage, UNLESS ordered by a physician.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Normal saline should only be used to clear the in-line suction catheter and NOT instilled down the endotracheal tube as a lavage, UNLESS ordered by a physician.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Prior to being placed on a patient, the device check and breathing circuit check must be performed on the Drager VN 500.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Prior to being placed on a patient, the device check and breathing circuit check must be performed on the Drager VN 500.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which statement best describes the Volume Guarantee mode?,"A.  Set volume, variable pressure",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which statement best describes the Volume Guarantee mode?,"B.  Set pressure, variable volume",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which statement best describes the Volume Guarantee mode?,"C.  Set volume, set pressure",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Your 1000g patient has an arterial PCO2 of 69 and is on the following settings:<br>  PC-AC/VG = 7.0mL, PMAX = 25, PEEP = 5, Ti = 0.4s, Back-up Rate=30, total rate of 60.<br> Based on the ventilator weaning guidelines, what actions should be taken?",A. Increase VG to blow-off CO2,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Your 1000g patient has an arterial PCO2 of 69 and is on the following settings:<br>  PC-AC/VG = 7.0mL, PMAX = 25, PEEP = 5, Ti = 0.4s, Back-up Rate=30, total rate of 60.<br> Based on the ventilator weaning guidelines, what actions should be taken?",B. Call MD for high PCO2,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Your 1000g patient has an arterial PCO2 of 69 and is on the following settings:<br>  PC-AC/VG = 7.0mL, PMAX = 25, PEEP = 5, Ti = 0.4s, Back-up Rate=30, total rate of 60.<br> Based on the ventilator weaning guidelines, what actions should be taken?",C. Call MD due to max VG,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Your 1000g patient has an arterial PCO2 of 69 and is on the following settings:<br>  PC-AC/VG = 7.0mL, PMAX = 25, PEEP = 5, Ti = 0.4s, Back-up Rate=30, total rate of 60.<br> Based on the ventilator weaning guidelines, what actions should be taken?",D. None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"In the PC-SIMV/VG mode, only the set breaths are full ventilator breaths.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"In the PC-SIMV/VG mode, only the set breaths are full ventilator breaths.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,The vent settings are:<br> PC-AC/VG = 3.0mL 	PMAX= 25	 PEEP = 5.Rate = 30 	Set Ti = 0.5 seconds<br>  Your patient requires a PIP of 22 to deliver this volume. How will the delivered PIP change if your patient becomes more compliant?,A.  Delivered PIP will increase,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,The vent settings are:<br> PC-AC/VG = 3.0mL 	PMAX= 25	 PEEP = 5.Rate = 30 	Set Ti = 0.5 seconds<br>  Your patient requires a PIP of 22 to deliver this volume. How will the delivered PIP change if your patient becomes more compliant?,B.  Delivered PIP will decrease.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,The vent settings are:<br> PC-AC/VG = 3.0mL 	PMAX= 25	 PEEP = 5.Rate = 30 	Set Ti = 0.5 seconds<br>  Your patient requires a PIP of 22 to deliver this volume. How will the delivered PIP change if your patient becomes more compliant?,C.  No change,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Where should the initial flow trigger be set for patients on the Drager VN-500?,A.  0.2 for initial setting,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Where should the initial flow trigger be set for patients on the Drager VN-500?,B.  High enough to stop the patient from being tachypneic,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Where should the initial flow trigger be set for patients on the Drager VN-500?,"C.  Adjusted to prevent auto-cycling, but allow for easy patient triggering",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Where should the initial flow trigger be set for patients on the Drager VN-500?,D.  A and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Your 1000 gram infant is on PC-SIMV with the following settings:<br> P Insp = 22	PEEP = 5 cmH2O	Rate = 30 breaths/min<br>  Ti = 0.4 seconds	Measured Vte = 12 cc	PCO2 on ABG = 40.<br>  What change would you make to the ventilator settings?,A.  Increase the rate to 34,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Your 1000 gram infant is on PC-SIMV with the following settings:<br> P Insp = 22	PEEP = 5 cmH2O	Rate = 30 breaths/min<br>  Ti = 0.4 seconds	Measured Vte = 12 cc	PCO2 on ABG = 40.<br>  What change would you make to the ventilator settings?,B.  Wean P Insp to maintain VT  5 to 7 cc per kg,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Your 1000 gram infant is on PC-SIMV with the following settings:<br> P Insp = 22	PEEP = 5 cmH2O	Rate = 30 breaths/min<br>  Ti = 0.4 seconds	Measured Vte = 12 cc	PCO2 on ABG = 40.<br>  What change would you make to the ventilator settings?,C.  Extubate to Bubble CPAP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Your 1000 gram infant is on PC-SIMV with the following settings:<br> P Insp = 22	PEEP = 5 cmH2O	Rate = 30 breaths/min<br>  Ti = 0.4 seconds	Measured Vte = 12 cc	PCO2 on ABG = 40.<br>  What change would you make to the ventilator settings?,D.  Decrease rate to 25,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,The Ventilator Performance Check and Circuit Calibration on the 3100A  needs to be performed:,A. Every 500 hours of use,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,The Ventilator Performance Check and Circuit Calibration on the 3100A  needs to be performed:,B. After each patient use,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,The Ventilator Performance Check and Circuit Calibration on the 3100A  needs to be performed:,C. Before setting up for use on a new patient,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"If the PCO2 on the blood gas for a baby on HFOV is too high, you can increase ventilation on the HFOV by:",A. Decreasing the Hz/Frequency,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"If the PCO2 on the blood gas for a baby on HFOV is too high, you can increase ventilation on the HFOV by:",B. Increasing the Amps/Power,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"If the PCO2 on the blood gas for a baby on HFOV is too high, you can increase ventilation on the HFOV by:",C. Increasing the Hz/Frequency,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"If the PCO2 on the blood gas for a baby on HFOV is too high, you can increase ventilation on the HFOV by:",D. Increasing the MAP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"If the PCO2 on the blood gas for a baby on HFOV is too high, you can increase ventilation on the HFOV by:",E. A & B,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"If the PCO2 on the blood gas for a baby on HFOV is too high, you can increase ventilation on the HFOV by:",F. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How do you assess adequate lung inflation for babies on HFOV?,A.  Auscultate for bilateral and equal breath sounds,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How do you assess adequate lung inflation for babies on HFOV?,B.  Assess the amount of chest wiggle,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How do you assess adequate lung inflation for babies on HFOV?,C.  Lung expansion on chest X-ray (diaphragm sits between 8 to 10 ribs),True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How do you assess the baby for proper Power/Amplitude on 3100A?,A. Chest wiggle to mid-thigh,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How do you assess the baby for proper Power/Amplitude on 3100A?,B. Chest wiggle to umbilicus,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How do you assess the baby for proper Power/Amplitude on 3100A?,C. Auscultate for oscillations equally throughout all lobes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How do you assess the baby for proper Power/Amplitude on 3100A?,D. Chest X-ray,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When would you call the doctor for a baby with a chest x-ray that shows the lungs as under or over inflated?,A.   When the lung expansion is = 10 ribs.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When would you call the doctor for a baby with a chest x-ray that shows the lungs as under or over inflated?,B.   When the lung expansion is < 8 ribs.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When would you call the doctor for a baby with a chest x-ray that shows the lungs as under or over inflated?,C.   When the MAP is > 30.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When would you call the doctor for a baby with a chest x-ray that shows the lungs as under or over inflated?,D.   All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When would you call the doctor for a baby with a chest x-ray that shows the lungs as under or over inflated?,E.   Just A & B,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"According to the Ventilator Weaning Guidelines, when should the therapist increase ventilator support?",A. When PCO2 is > 65,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"According to the Ventilator Weaning Guidelines, when should the therapist increase ventilator support?",B. When ordered by the MD,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"According to the Ventilator Weaning Guidelines, when should the therapist increase ventilator support?","C. When an ETCO2 or TcCO2 tracing, that has been correlated to a blood gas, trends higher than a stable level",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"According to the Ventilator Weaning Guidelines, when should the therapist increase ventilator support?",D. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"A 32 week, 1 day old patient is on BCPAP of +9 cmH2O.  The baby has an increased work of breathing with FiO2 of 75% with SpO2 of 88%.  The RT notifies the physician and is ordered to intubate and give surfactant.  Which of the following is the most likely effect of surfactant administration?",A. Decrease alveolar surface tension,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"A 32 week, 1 day old patient is on BCPAP of +9 cmH2O.  The baby has an increased work of breathing with FiO2 of 75% with SpO2 of 88%.  The RT notifies the physician and is ordered to intubate and give surfactant.  Which of the following is the most likely effect of surfactant administration?",B. Maintain bronchiolar patency,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"A 32 week, 1 day old patient is on BCPAP of +9 cmH2O.  The baby has an increased work of breathing with FiO2 of 75% with SpO2 of 88%.  The RT notifies the physician and is ordered to intubate and give surfactant.  Which of the following is the most likely effect of surfactant administration?",C. Preferentially improve the surface tension of collapsed alveoli,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"A 32 week, 1 day old patient is on BCPAP of +9 cmH2O.  The baby has an increased work of breathing with FiO2 of 75% with SpO2 of 88%.  The RT notifies the physician and is ordered to intubate and give surfactant.  Which of the following is the most likely effect of surfactant administration?",D. Increase the pressure needed to keep alveoli open,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"The dose number of Curosurf (1st, 2nd, or 3rd dose) should be noted in the comments field of OneChart MAR and Respiratory Therapy iView.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"The dose number of Curosurf (1st, 2nd, or 3rd dose) should be noted in the comments field of OneChart MAR and Respiratory Therapy iView.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What supplies are needed for drawing a blood sample from a Peripheral Arterial Line (PAL)?,"A. Sterile gloves, clean chux or 4 x 4 gauze, unvented syringe for waste, vented syringe for blood sampling, 4 Site scrubs, heparin flush syringe and Curos green cap.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What supplies are needed for drawing a blood sample from a Peripheral Arterial Line (PAL)?,"B. Gloves, clean chux or 4 x 4 gauze, vented syringe for waste, vented syringe for blood sampling, 4 Site scrubs, heparin flush syringe and Curos green cap.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What supplies are needed for drawing a blood sample from a Peripheral Arterial Line (PAL)?,"C. Gloves, clean chux only, vented syringe for waste, vented syringe for blood sampling, 2 Site scrubs, heparin flush syringe and Curos green cap.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What supplies are needed for drawing a blood sample from a Peripheral Arterial Line (PAL)?,"D. Gloves, 4 x 4 gauze, unvented syringe for waste, unvented syringe for blood sampling, 4 Site scrubs, heparin flush syringe and Curos green cap.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How much heparin is required to flush an umbilical artery catheter in the SCN?,A. 1cc over 30 - 60 seconds,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How much heparin is required to flush an umbilical artery catheter in the SCN?,B. 0.3 - 0.5cc over 30 - 60 seconds,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How much heparin is required to flush an umbilical artery catheter in the SCN?,C. 0.5cc rapidly,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How much heparin is required to flush an umbilical artery catheter in the SCN?,D. Until the line is clear,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"There must be a new MD order to use the RAM prongs on a HFNC, BCPAP or NIPPV patient, even if the baby was already on RAM prongs during previous therapies.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"There must be a new MD order to use the RAM prongs on a HFNC, BCPAP or NIPPV patient, even if the baby was already on RAM prongs during previous therapies.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"When RAM prongs are ordered to be used with HFNC, the prongs used should not occlude the nares.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"When RAM prongs are ordered to be used with HFNC, the prongs used should not occlude the nares.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When does an Oxygen Index need to be calculated?,A. With every ABG for patients receiving inhaled nitric oxide therapy,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When does an Oxygen Index need to be calculated?,B. With every patient on HFOV,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When does an Oxygen Index need to be calculated?,C. Only when the patient is on 100% oxygen,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When does an Oxygen Index need to be calculated?,D. If ordered by the physician,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,When does an Oxygen Index need to be calculated?,E. A & D,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Calculate the Oxygen Index for a 38 week newborn with confirmed pulmonary hypertension via echocardiogram on Inhaled Nitric Oxide based on the following parameters:,br> MAP = 25	FiO2 = 75%	PaO2 = 50",A. 60,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Calculate the Oxygen Index for a 38 week newborn with confirmed pulmonary hypertension via echocardiogram on Inhaled Nitric Oxide based on the following parameters:,br> MAP = 25	FiO2 = 75%	PaO2 = 50",B. 55,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Calculate the Oxygen Index for a 38 week newborn with confirmed pulmonary hypertension via echocardiogram on Inhaled Nitric Oxide based on the following parameters:,br> MAP = 25	FiO2 = 75%	PaO2 = 50",C. 37.5,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What oxygen index requires a call to the MD?,A. OI > 20 for babies = 34 weeks,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What oxygen index requires a call to the MD?,B.  OI > 10 for babies 26 - 33 6/7 weeks,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What oxygen index requires a call to the MD?,C. None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What oxygen index requires a call to the MD?,D. A & B,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which statement best describes the indication for use of inhaled nitric oxide?,A. Hypoxic Respiratory Failure associated with clinical or echocardiographic evidence of pulmonary hypertension,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which statement best describes the indication for use of inhaled nitric oxide?,B. Meconium Aspiration Syndrome requiring FiO2 > 50%,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which statement best describes the indication for use of inhaled nitric oxide?,C. Pulmonary Interstitial Ephysema requiring HFOV,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which of the following shows the correct placement and adaptors for the nitric injector module on a 3100 A/B HFOV?,A.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which of the following shows the correct placement and adaptors for the nitric injector module on a 3100 A/B HFOV?,B.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which of the following shows the correct placement and adaptors for the nitric injector module on a 3100 A/B HFOV?,C.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which of the following shows the correct placement of the nitric sample line on HFOV? (sample line has a yellow tag),A.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which of the following shows the correct placement of the nitric sample line on HFOV? (sample line has a yellow tag),B.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which of the following shows the correct placement of the nitric sample line on HFOV? (sample line has a yellow tag),C.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which of the following shows correct placement of the nitric injector module on the Drager VN-500?,A.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which of the following shows correct placement of the nitric injector module on the Drager VN-500?,B.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which of the following shows correct placement of the nitric injector module on the Drager VN-500?,C.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which of the following shows correct placement of the nitric sampling line for the Drager?,A.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which of the following shows correct placement of the nitric sampling line for the Drager?,B.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,Which of the following shows correct placement of the nitric sampling line for the Drager?,C.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How often should the orange resus bags be checked for inventory?,A)	Once per shift by the Resus RT,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How often should the orange resus bags be checked for inventory?,B)	Once per day by the charge therapist,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How often should the orange resus bags be checked for inventory?,"C)	After each use, if an item is used",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How often should the orange resus bags be checked for inventory?,D)	A & C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,All unplanned extubations need to be followed up with an incident report.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,All unplanned extubations need to be followed up with an incident report.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What is the proper starting temperature for the TC probe when placing on a neonate?,A)	41 �C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What is the proper starting temperature for the TC probe when placing on a neonate?,B)	37 �C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What is the proper starting temperature for the TC probe when placing on a neonate?,C)	39 �C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What is the proper starting temperature for the TC probe when placing on a neonate?,D)	42 �C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What is the maximum temperature for the TC probe on a term neonate?,A)	42 �C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What is the maximum temperature for the TC probe on a term neonate?,B)	41 �C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What is the maximum temperature for the TC probe on a term neonate?,C)	40 �C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What is the maximum temperature for the TC probe on a term neonate?,D)	39 �C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Unless the physician orders to NOT use a TC monitor, EVERY baby on HFOV must have a TC monitor.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Unless the physician orders to NOT use a TC monitor, EVERY baby on HFOV must have a TC monitor.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"If condensation persistently develops in the respiratory circuit, what are the proper steps to be taken?","A.  If the baby is in an open crib or radiant warmer, remove the unheated portion of the inspiratory limb.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"If condensation persistently develops in the respiratory circuit, what are the proper steps to be taken?","B.  If the baby is in a Caleo isolette, remove the unheated portion of the inspiratory limb if the air temperature of the Caleo is < 34 �C.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"If condensation persistently develops in the respiratory circuit, what are the proper steps to be taken?",C.  Make sure temp probes are pushed all the way into the ports.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"If condensation persistently develops in the respiratory circuit, what are the proper steps to be taken?","D.  If flow is < 5 Lpm, set heater to Non-Invasive.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"If condensation persistently develops in the respiratory circuit, what are the proper steps to be taken?",E.  All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"According to NRP, what is the single most effective way to reverse bradycardia?",A.	Chest Compressions,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"According to NRP, what is the single most effective way to reverse bradycardia?",B.	Blow-by Therapy,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"According to NRP, what is the single most effective way to reverse bradycardia?",C.	Effective PPV confirmed by MRSOPA,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"According to NRP, what is the single most effective way to reverse bradycardia?",D.	CPAP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How often should the Cannulaide be checked on patients who are on BCPAP and NIPPV?,A. Once per day.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How often should the Cannulaide be checked on patients who are on BCPAP and NIPPV?,B. Every 6 hours.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How often should the Cannulaide be checked on patients who are on BCPAP and NIPPV?,C. Every 3 to 4 hours.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,How often should the Cannulaide be checked on patients who are on BCPAP and NIPPV?,D. Once a shift.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What is the correct mode to use when placing a patient on Non Invasive Positive Pressure Ventilation on the Drager VN-500 and what color should be displayed on the monitor?,A. P-CMV and orange,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What is the correct mode to use when placing a patient on Non Invasive Positive Pressure Ventilation on the Drager VN-500 and what color should be displayed on the monitor?,B. P-CPAP and green,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What is the correct mode to use when placing a patient on Non Invasive Positive Pressure Ventilation on the Drager VN-500 and what color should be displayed on the monitor?,C. P-SIMV and yellow,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,What is the correct mode to use when placing a patient on Non Invasive Positive Pressure Ventilation on the Drager VN-500 and what color should be displayed on the monitor?,D. P-AC and blue,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Any unopened and unused vials of surfactant should be returned to pharmacy, whereas any used or unused portion of an opened vial or syringe should be discarded appropriately, per policy.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9733,,Elearning-0000-943,2021 NICU COMPETENCY EXAM_ NSF,,n14004,,choice,"Any unopened and unused vials of surfactant should be returned to pharmacy, whereas any used or unused portion of an opened vial or syringe should be discarded appropriately, per policy.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8914,,Elearning-0000-199,SCN HAND HYGIENE  2021 FINAL_RRT FORSYTH,,n14007,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the SCN HAND HYGIENE  2021 FINAL_RRT FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is SCN HAND HYGIENE  2021 FINAL_RRT FORSYTH- g14007,False
8914,,Elearning-0000-199,SCN HAND HYGIENE  2021 FINAL_RRT FORSYTH,,n14007,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the SCN HAND HYGIENE  2021 FINAL_RRT FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8914,,Elearning-0000-199,SCN HAND HYGIENE  2021 FINAL_RRT FORSYTH,,n14007,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the SCN HAND HYGIENE  2021 FINAL_RRT FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A Covid negative patient is very lethargic and has an ABG result: 7.20/93/150/42.0/100% on 8L HFNC. You place them on BiPAP on AVAPS with settings of target Vt 450, Pmax 15, Pmin 8, EPAP 5 Rate 8, FiO2 50%. An ABG repeated after 1 hour is 7.25/89/130/42/99%. What adjustments could you make?",A.	Increase target Vt,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH- g14009,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A Covid negative patient is very lethargic and has an ABG result: 7.20/93/150/42.0/100% on 8L HFNC. You place them on BiPAP on AVAPS with settings of target Vt 450, Pmax 15, Pmin 8, EPAP 5 Rate 8, FiO2 50%. An ABG repeated after 1 hour is 7.25/89/130/42/99%. What adjustments could you make?",A.	Increase target Vt,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A Covid negative patient is very lethargic and has an ABG result: 7.20/93/150/42.0/100% on 8L HFNC. You place them on BiPAP on AVAPS with settings of target Vt 450, Pmax 15, Pmin 8, EPAP 5 Rate 8, FiO2 50%. An ABG repeated after 1 hour is 7.25/89/130/42/99%. What adjustments could you make?",B.	Increase Pmax and Pmin,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A Covid negative patient is very lethargic and has an ABG result: 7.20/93/150/42.0/100% on 8L HFNC. You place them on BiPAP on AVAPS with settings of target Vt 450, Pmax 15, Pmin 8, EPAP 5 Rate 8, FiO2 50%. An ABG repeated after 1 hour is 7.25/89/130/42/99%. What adjustments could you make?",C.	Increase EPAP,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A Covid negative patient is very lethargic and has an ABG result: 7.20/93/150/42.0/100% on 8L HFNC. You place them on BiPAP on AVAPS with settings of target Vt 450, Pmax 15, Pmin 8, EPAP 5 Rate 8, FiO2 50%. An ABG repeated after 1 hour is 7.25/89/130/42/99%. What adjustments could you make?",D.	Decrease Rate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A Covid negative patient is very lethargic and has an ABG result: 7.20/93/150/42.0/100% on 8L HFNC. You place them on BiPAP on AVAPS with settings of target Vt 450, Pmax 15, Pmin 8, EPAP 5 Rate 8, FiO2 50%. An ABG repeated after 1 hour is 7.25/89/130/42/99%. What adjustments could you make?",E.	Decrease FiO2,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A Covid negative patient is very lethargic and has an ABG result: 7.20/93/150/42.0/100% on 8L HFNC. You place them on BiPAP on AVAPS with settings of target Vt 450, Pmax 15, Pmin 8, EPAP 5 Rate 8, FiO2 50%. An ABG repeated after 1 hour is 7.25/89/130/42/99%. What adjustments could you make?",F.	Increase Rate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A Covid negative patient is very lethargic and has an ABG result: 7.20/93/150/42.0/100% on 8L HFNC. You place them on BiPAP on AVAPS with settings of target Vt 450, Pmax 15, Pmin 8, EPAP 5 Rate 8, FiO2 50%. An ABG repeated after 1 hour is 7.25/89/130/42/99%. What adjustments could you make?","G.	A, B, E, F",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A Covid negative patient is very lethargic and has an ABG result: 7.20/93/150/42.0/100% on 8L HFNC. You place them on BiPAP on AVAPS with settings of target Vt 450, Pmax 15, Pmin 8, EPAP 5 Rate 8, FiO2 50%. An ABG repeated after 1 hour is 7.25/89/130/42/99%. What adjustments could you make?",H.	Only A & B,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A Covid negative patient is very lethargic and has an ABG result: 7.20/93/150/42.0/100% on 8L HFNC. You place them on BiPAP on AVAPS with settings of target Vt 450, Pmax 15, Pmin 8, EPAP 5 Rate 8, FiO2 50%. An ABG repeated after 1 hour is 7.25/89/130/42/99%. What adjustments could you make?",I.	All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,A patient with a PCA pump needs remote monitoring. He has a history of OSA and he is wearing his home CPAP. Which device would be most appropriate?,A.	Capnostream EtCO2 remote monitor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,A patient with a PCA pump needs remote monitoring. He has a history of OSA and he is wearing his home CPAP. Which device would be most appropriate?,B.	NellCor  remote monitored pulse oximeter,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,A patient with a PCA pump needs remote monitoring. He has a history of OSA and he is wearing his home CPAP. Which device would be most appropriate?,C.	Nellcor N65 pulse oximeter,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,A patient with a PCA pump needs remote monitoring. He has a history of OSA and he is wearing his home CPAP. Which device would be most appropriate?,D.	Floor Dynamap monitor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,A patient with a trach transfers from ICU to your floor. What do you need to do?,"A.	Verify equipment such as oxygen, humidity therapy, & suction are set up",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,A patient with a trach transfers from ICU to your floor. What do you need to do?,"B.	Verify ambu-bag and extra trachs are at bedside including one of equal size, and one size smaller than the patient's trach size.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,A patient with a trach transfers from ICU to your floor. What do you need to do?,C.	Set up remote pulse ox on patient and enter patient data and orders into all computer systems,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,A patient with a trach transfers from ICU to your floor. What do you need to do?,D.	Assess patient and document assessment and recommendations in computer system,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,A patient with a trach transfers from ICU to your floor. What do you need to do?,E.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following are FALSE concerning Tracheostomy patients during transports?,A.	Respiratory Therapist must accompany the patient during the entire transport (must stay with patient).,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following are FALSE concerning Tracheostomy patients during transports?,"B.	A bag valve mask, obturator or spare tracheostomy must also accompany the patient during transport in the event the airway is displaced.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following are FALSE concerning Tracheostomy patients during transports?,"C.	If a patient is having an MRI or CT performed, the Respiratory Therapist must stay in the MRI or CT room and be able to access the patient in the event of an emergency at all times.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following are FALSE concerning Tracheostomy patients during transports?,"D.	Respiratory Therapist must accompany the patient during transport, and may leave patient (if stable) in area where procedure is to be performed",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Patient has a history of COPD is admitted with Pneumonia. Home meds on MED REC form completed by the nurse include ProAir 2puffs PRN, 0.5mg Pulmicort and 15mcg Brovana BID, 0.5mg Albuterol Q4, and Advair 250/50. What changes would you recommend to the physician?",A.	None. These are home meds and we don't recommend changing home meds.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Patient has a history of COPD is admitted with Pneumonia. Home meds on MED REC form completed by the nurse include ProAir 2puffs PRN, 0.5mg Pulmicort and 15mcg Brovana BID, 0.5mg Albuterol Q4, and Advair 250/50. What changes would you recommend to the physician?",B.	Keep meds as listed but add 0.5mg Atrovent Q4 and Spiriva 1 puff daily,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Patient has a history of COPD is admitted with Pneumonia. Home meds on MED REC form completed by the nurse include ProAir 2puffs PRN, 0.5mg Pulmicort and 15mcg Brovana BID, 0.5mg Albuterol Q4, and Advair 250/50. What changes would you recommend to the physician?",C.	Change Albuterol to Xopenex per interchange policy & add Spiriva 1 puff daily,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Patient has a history of COPD is admitted with Pneumonia. Home meds on MED REC form completed by the nurse include ProAir 2puffs PRN, 0.5mg Pulmicort and 15mcg Brovana BID, 0.5mg Albuterol Q4, and Advair 250/50. What changes would you recommend to the physician?","D.	Recommend discontinuing one of the duplications of inhaled corticosteroid and long-acting beta agonist medications, consider adding 0.5mg Atrovent Q4.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,A patient admitted with pneumonia has Incentive Spirometry ordered Q2w/a. Predicted Goal is 2750 but patient is only achieving 1300ml at start of therapy.  What is the percentage the patient is achieving and what changes would you make per protocol?,"A.	75%: Change SMI to PRN for nursing to follow, notify RN & Document in EMR",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,A patient admitted with pneumonia has Incentive Spirometry ordered Q2w/a. Predicted Goal is 2750 but patient is only achieving 1300ml at start of therapy.  What is the percentage the patient is achieving and what changes would you make per protocol?,"B.	50% - 75%: Continue SMI for now, start IPPB in 3 days; Document in EMR",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,A patient admitted with pneumonia has Incentive Spirometry ordered Q2w/a. Predicted Goal is 2750 but patient is only achieving 1300ml at start of therapy.  What is the percentage the patient is achieving and what changes would you make per protocol?,C.	50%-75%: Start IBBP therapy and discontinue SMI; Document in EMR,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,A patient admitted with pneumonia has Incentive Spirometry ordered Q2w/a. Predicted Goal is 2750 but patient is only achieving 1300ml at start of therapy.  What is the percentage the patient is achieving and what changes would you make per protocol?,D.	<50%: Start IBBP and continue use of SMI BID or after each IPPB treatment to measure volume improvement until patient can achieve goal >50% for 2 consecutive visits;  Document both in EMR,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,A patient admitted with pneumonia has Incentive Spirometry ordered Q2w/a. Predicted Goal is 2750 but patient is only achieving 1300ml at start of therapy.  What is the percentage the patient is achieving and what changes would you make per protocol?,"E.	<50%: continue SMI, reassess in 72 hours for need for IPPB; Document in EMR",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Patient's SMI Goal is 2500 per the nomogram based on height, age, and gender. What do you put on the yellow SMI sticker and where do you place the sticker?",A.	Write Goal and start date. Place sticker in chart,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Patient's SMI Goal is 2500 per the nomogram based on height, age, and gender. What do you put on the yellow SMI sticker and where do you place the sticker?",B.	Write Goal and volume <50%. Place sticker on nebulizer,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Patient's SMI Goal is 2500 per the nomogram based on height, age, and gender. What do you put on the yellow SMI sticker and where do you place the sticker?",C.	Write Goal and volume <50%. Place sticker just above goal line on SMI,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Patient's SMI Goal is 2500 per the nomogram based on height, age, and gender. What do you put on the yellow SMI sticker and where do you place the sticker?",D.	What yellow sticker?,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,The proper steps for setting a patient up with Remote monitoring include:,A.	Selecting the correct monitor and accessory equipment; putting in a remote monitoring order with start date and time,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,The proper steps for setting a patient up with Remote monitoring include:,B.	Use the pink probe with the Pulse oximeter and the white probe with the Capnostream,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,The proper steps for setting a patient up with Remote monitoring include:,"C.	Placing the patient data in Bernoulli using 2 patient identifiers, start date & time and notify Telemetry at 43588",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,The proper steps for setting a patient up with Remote monitoring include:,D.	Chart appropriately in EMR,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,The proper steps for setting a patient up with Remote monitoring include:,"E.	Completing Log Book in dept. to include patient name, account number, CB#, pager assigned, and device selected.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,The proper steps for setting a patient up with Remote monitoring include:,F.	Patients on >5L O2 are placed on Capnostream EtCO2 monitoring,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,The proper steps for setting a patient up with Remote monitoring include:,"G.	A, C, D, E",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,The proper steps for setting a patient up with Remote monitoring include:,"H.	A, B, E, F",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient is on 5TC post thoracotomy with orders for Respiratory Therapy. The patient appears without distress, has chest tube present and it is functioning. His only complaint is mild pain at the incision site. What are the appropriate actions?",A.	Start Albuterol nebs Q8 and AccuPAP for 24 hours then d/c therapy,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient is on 5TC post thoracotomy with orders for Respiratory Therapy. The patient appears without distress, has chest tube present and it is functioning. His only complaint is mild pain at the incision site. What are the appropriate actions?","B.	Start SMI and 10cmH2O of IPPB therapy with 2.5mg Albuterol and 0.5mg Atrovent Q8 for 24 hours, then reassess.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient is on 5TC post thoracotomy with orders for Respiratory Therapy. The patient appears without distress, has chest tube present and it is functioning. His only complaint is mild pain at the incision site. What are the appropriate actions?",C.	Enter start date and goal in SMI order's comment section,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient is on 5TC post thoracotomy with orders for Respiratory Therapy. The patient appears without distress, has chest tube present and it is functioning. His only complaint is mild pain at the incision site. What are the appropriate actions?",D.	We don't do respiratory protocol on 5TC patients,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient is on 5TC post thoracotomy with orders for Respiratory Therapy. The patient appears without distress, has chest tube present and it is functioning. His only complaint is mild pain at the incision site. What are the appropriate actions?",E.	Place correct orders in EMR and document assessment and therapy in EMR,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient is on 5TC post thoracotomy with orders for Respiratory Therapy. The patient appears without distress, has chest tube present and it is functioning. His only complaint is mild pain at the incision site. What are the appropriate actions?","F.	B, C, E",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient is on 5TC post thoracotomy with orders for Respiratory Therapy. The patient appears without distress, has chest tube present and it is functioning. His only complaint is mild pain at the incision site. What are the appropriate actions?",G.	A & E,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You have a Covid positive patient on 10L HFNC who needs to go on Optiflow. Which settings would you recommend?,A.	Set flow at 60Lpm and 100% FiO2 and wean flow first by 5 liters until below 30Lpm before weaning oxygen,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You have a Covid positive patient on 10L HFNC who needs to go on Optiflow. Which settings would you recommend?,B.	Set flow at 30Lpm and 50% FiO2; wean FiO2 before flow; follow MD recommendations for titration. Try to get patient in negative pressure room & place STOP sign AGP sign outside patient room.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You have a Covid positive patient on 10L HFNC who needs to go on Optiflow. Which settings would you recommend?,C.	Set flow at 40Lpm and 100% FiO2 and wean flow first by 5% until below 30L before weaning FiO2,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You have a Covid positive patient on 10L HFNC who needs to go on Optiflow. Which settings would you recommend?,D.	All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Where is correct placement of the Aerogen  or Aerosol nebulizer on the BiPAP/CPAP device?,A.	Proximal to the machine but after the 1st filter on the machine,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Where is correct placement of the Aerogen  or Aerosol nebulizer on the BiPAP/CPAP device?,B.	Proximal to the patient but before the 2nd filter on the mask,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Where is correct placement of the Aerogen  or Aerosol nebulizer on the BiPAP/CPAP device?,"C.	Distal from the patient, proximal from the machine, but before the 1st filter",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Where is correct placement of the Aerogen  or Aerosol nebulizer on the BiPAP/CPAP device?,"D.	Proximal to the patient, between the 2nd filter and the mask or on the exhalation port.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which statements are correct?,"A.	All vents in storage areas need to be clean, plugged in, & bagged with disposable supplies packaged with vent.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which statements are correct?,"B.	Any equipment that is SET-UP READY for USE, must be stickered with date of setup and RT initials. Set up is good for 2 weeks.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which statements are correct?,C.	Equipment cleaning and set-up is everyone's responsibility,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which statements are correct?,D.	All equipment must be set up and ready to go at all times,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which statements are correct?,"E.	A, B, C",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which statements are correct?,F.	All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Per the PDP for Oxygen Therapy, an ABG may be obtained by the RT per policy when:",A.	Any patient who requires high flow oxygen > or = to 50%. The attending physician will be notified of the results immediately.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Per the PDP for Oxygen Therapy, an ABG may be obtained by the RT per policy when:",B.	Any patient with an exacerbation of their pulmonary condition in which their Acid/Base or PCO2 status is questionable.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Per the PDP for Oxygen Therapy, an ABG may be obtained by the RT per policy when:",C.	Any patient in which oximetry results are questionable,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Per the PDP for Oxygen Therapy, an ABG may be obtained by the RT per policy when:",D.	All of the Above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"If an order reads, ""CPAP per RT Protocol""� you should set up:",A.	Air-sense10 or ResMed S9 in auto mode,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"If an order reads, ""CPAP per RT Protocol""� you should set up:","B.	If O2 is needed, you can bleed in up to 15 L/min",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"If an order reads, ""CPAP per RT Protocol""� you should set up:","C.	If O2 is needed, you can bleed in up to 4 L/min",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"If an order reads, ""CPAP per RT Protocol""� you should set up:",D.	V-60 only if auto CPAP device not available; start with 5 cmH2O. This level may be increased in 2 cmH2O increments Q10minutes to a maximum of 18cmH2O.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"If an order reads, ""CPAP per RT Protocol""� you should set up:","E.	A, B, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"If an order reads, ""CPAP per RT Protocol""� you should set up:","F.	A, C, D",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Home Oxygen Assessment documentation includes which of the following:,"A.	If room air SpO2 at rest is < 89, place patient on oxygen to get SpO2 >= 89%. If able to ambulate, monitor oxygen amount needed to keep SpO2 >88% on exertion",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Home Oxygen Assessment documentation includes which of the following:,"B.	If room air SpO2 is >=89% at rest, do a room air SpO2 with exertion",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Home Oxygen Assessment documentation includes which of the following:,"C.	If exertional SpO2 is <89%, document how much oxygen is needed to keep SpO2 > 89%.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Home Oxygen Assessment documentation includes which of the following:,D.	A & B,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Home Oxygen Assessment documentation includes which of the following:,E.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Per CPAP/BiPAP protocol, the physician will be contacted when:",A.	HR increases or decreases 20% from pre-therapy HR,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Per CPAP/BiPAP protocol, the physician will be contacted when:",B.	Therapist is unable to achieve an adequate mask seal,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Per CPAP/BiPAP protocol, the physician will be contacted when:",C.	No improvement within 1 hour after post ABG,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Per CPAP/BiPAP protocol, the physician will be contacted when:",D.	A & C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"Per CPAP/BiPAP protocol, the physician will be contacted when:",E.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which are the components of the fresh trach protocol?,A.	Signage on the door with the date and time the 48 hour observation ends,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which are the components of the fresh trach protocol?,B.	EtCO2 documented Q4,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which are the components of the fresh trach protocol?,"C.	Ambu-bag & mask, same size trach, and one size smaller at bedside, Obturator at HOB",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which are the components of the fresh trach protocol?,D.	Respiratory therapist to be at the bedside for all patient turns/movement,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which are the components of the fresh trach protocol?,E.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You have an order for an ABG. What is the process for analyzing this test?,A.	Verify order in EMR FIRST! Use 2 patient identifiers (compare sticker to EMR chart),False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You have an order for an ABG. What is the process for analyzing this test?,"B.	Run sample in analyzer, input data at analyzer including correct panel type",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You have an order for an ABG. What is the process for analyzing this test?,C.	Always pick Complete Panel regardless of order,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You have an order for an ABG. What is the process for analyzing this test?,"D.	Address any critical comments with appropriate documentation, then approve sample,",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You have an order for an ABG. What is the process for analyzing this test?,"E.	Verify results appear in EMR, complete ABG (Adhoc) collection form & chart Therapist time.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You have an order for an ABG. What is the process for analyzing this test?,"F.	A, B, D, E",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You have an order for an ABG. What is the process for analyzing this test?,"G.	A, B, C, D",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You have an ABG with critical results. Which of the following statements is FALSE.,A.	You have 30 minutes to contact a licensed provider or MD to report critical values,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You have an ABG with critical results. Which of the following statements is FALSE.,B.	You have 60 minutes to contact a licensed provider or MD to report critical values,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You have an ABG with critical results. Which of the following statements is FALSE.,"C.	You must document in analyzer who you contacted and include first name or initial, full last name, AND credential.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You have an ABG with critical results. Which of the following statements is FALSE.,D.	Critical results can only be called to a licensed medical provider.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You analyze an ionized calcium sample. Which Adhoc form do you use in Cerner to charge?,A.	ABG form,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You analyze an ionized calcium sample. Which Adhoc form do you use in Cerner to charge?,B.	Non-ABG Lab Testing form,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You analyze an ionized calcium sample. Which Adhoc form do you use in Cerner to charge?,C.	Blood Gas Sample Collection form,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You analyze an ionized calcium sample. Which Adhoc form do you use in Cerner to charge?,D.	ABG-SCN (RT) form,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You decide to change a patient's albuterol treatments frequency per RT protocol. Which steps are correct for changing medication orders in Cerner?,A.	Modify the Aerosol Treatment order under Respiratory Orders to change the frequency,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You decide to change a patient's albuterol treatments frequency per RT protocol. Which steps are correct for changing medication orders in Cerner?,B.	Cancel & Reorder the Aerosol Treatment order under Respiratory Orders to change frequency,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You decide to change a patient's albuterol treatments frequency per RT protocol. Which steps are correct for changing medication orders in Cerner?,C.	Modify the Albuterol order under Medications Orders to change the frequency,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,You decide to change a patient's albuterol treatments frequency per RT protocol. Which steps are correct for changing medication orders in Cerner?,D.	Cancel & Reorder the Albuterol order under Medication Orders to change the frequency,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Your (non-Covid) patient is wearing BiPAP regularly. Which of the following statements are true regarding skin integrity?,A.	Skin integrity will be assessed with each device check,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Your (non-Covid) patient is wearing BiPAP regularly. Which of the following statements are true regarding skin integrity?,"B.	A skin barrier device, such as Protecta-Gel should be used, especially if irritation or redness present, and MD is notified.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Your (non-Covid) patient is wearing BiPAP regularly. Which of the following statements are true regarding skin integrity?,"C.	If skin breakdown occurs, a wound consult must be placed and an incident report must be filed",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Your (non-Covid) patient is wearing BiPAP regularly. Which of the following statements are true regarding skin integrity?,"D.	Use alternative interface such as ""under-the-nose""� mask",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Your (non-Covid) patient is wearing BiPAP regularly. Which of the following statements are true regarding skin integrity?,E.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient goes from 2L NC to 6L NC during your shift. His SpO2 on 6L is 91%. His WOB is unlabored at rest, but he is SOB with activity. He does not wear home oxygen. What steps should you take?","A.	Increase oxygen, notify RN, document Progress note in EMR",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient goes from 2L NC to 6L NC during your shift. His SpO2 on 6L is 91%. His WOB is unlabored at rest, but he is SOB with activity. He does not wear home oxygen. What steps should you take?","B.	Change to High-Flow NC, titrate to increase SpO2 >= 92%",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient goes from 2L NC to 6L NC during your shift. His SpO2 on 6L is 91%. His WOB is unlabored at rest, but he is SOB with activity. He does not wear home oxygen. What steps should you take?",C.	Order and Draw ABG per O2 protocol & notify MD of results,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient goes from 2L NC to 6L NC during your shift. His SpO2 on 6L is 91%. His WOB is unlabored at rest, but he is SOB with activity. He does not wear home oxygen. What steps should you take?","D.	Leave oxygen at 6L, SpO2 of 91% is acceptable at rest",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient goes from 2L NC to 6L NC during your shift. His SpO2 on 6L is 91%. His WOB is unlabored at rest, but he is SOB with activity. He does not wear home oxygen. What steps should you take?","E.	A, B, C",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient goes from 2L NC to 6L NC during your shift. His SpO2 on 6L is 91%. His WOB is unlabored at rest, but he is SOB with activity. He does not wear home oxygen. What steps should you take?",F.	A & B only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient goes from 2L NC to 6L NC during your shift. His SpO2 on 6L is 91%. His WOB is unlabored at rest, but he is SOB with activity. He does not wear home oxygen. What steps should you take?",G.	D only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient is on Capnography monitoring per MD orders. His IPI is alarming at 3. HR is 80, SpO2 is 92%, RR is 6, EtCO2 is 19. What should you do?",A.	Assess patient in person,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient is on Capnography monitoring per MD orders. His IPI is alarming at 3. HR is 80, SpO2 is 92%, RR is 6, EtCO2 is 19. What should you do?",B.	Decrease IPI Alarm to OFF,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient is on Capnography monitoring per MD orders. His IPI is alarming at 3. HR is 80, SpO2 is 92%, RR is 6, EtCO2 is 19. What should you do?",C.	Verify Capnostream Nasal cannula is on patient and both prongs are in nares,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient is on Capnography monitoring per MD orders. His IPI is alarming at 3. HR is 80, SpO2 is 92%, RR is 6, EtCO2 is 19. What should you do?",D.	Verify RR actual vs monitor reading,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient is on Capnography monitoring per MD orders. His IPI is alarming at 3. HR is 80, SpO2 is 92%, RR is 6, EtCO2 is 19. What should you do?","E.	If patient is on oxygen too, verify flow is < 6L",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient is on Capnography monitoring per MD orders. His IPI is alarming at 3. HR is 80, SpO2 is 92%, RR is 6, EtCO2 is 19. What should you do?","F.	A, C, D, E",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"A patient is on Capnography monitoring per MD orders. His IPI is alarming at 3. HR is 80, SpO2 is 92%, RR is 6, EtCO2 is 19. What should you do?",G.	All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following statements is FALSE?,A.	Notes or comments should be placed in a Progress Note in Cerner,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following statements is FALSE?,B.	Right-click any charting field and place a comment if necessary,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following statements is FALSE?,C.	Chart education on every patient on therapy at least once a shift,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following statements is FALSE?,D.	Smoking cessation education is charted in Social Habits Education section,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which Statements are FALSE about oxygen weaning/titration as NSH?,"A.	Once a shift, weaning or titration of oxygen should be attempted for any patient wearing low flow (<7L) oxygen, who does NOT wear oxygen at home, unless they meet certain criteria.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which Statements are FALSE about oxygen weaning/titration as NSH?,"B.	If a patient does not qualify for oxygen titration, the RT must select a reason for why patient was not weaned from the REASON NOT TITRATED field in EMR",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which Statements are FALSE about oxygen weaning/titration as NSH?,"C.	AMI, Comfort Care, Pt at home level, & SpO2 less than 90% are some of the choices for REASON NOT TITRATED. OTHER is another choice, that opens a free text window, where RT can chart why oxygen weaning not indicated.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which Statements are FALSE about oxygen weaning/titration as NSH?,D.	 Oxygen titration must also be documented on ventilated patients Q shift,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following statements are true regarding skin integrity and airway status for a tracheostomy patient?,"A.	Skin integrity and airway status will be assessed with each device check, or therapy administered or minimum Qshift.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following statements are true regarding skin integrity and airway status for a tracheostomy patient?,"B.	A skin barrier device, such as Cavilon swabs, Drawtex drain pads,  Mepilex, or Duoderm,  will be used, especially if irritation or redness present, and MD is notified.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following statements are true regarding skin integrity and airway status for a tracheostomy patient?,"C.	If skin breakdown occurs, a wound consult must be placed and an incident report must be filed",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following statements are true regarding skin integrity and airway status for a tracheostomy patient?,D.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"When a patient brings in a home CPAP/BiPAP, the RT must do the following:",A.	Place a Biomed work order for device inspection,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"When a patient brings in a home CPAP/BiPAP, the RT must do the following:",B.	Have patient sign release of liability form and place in Chart under Consents,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"When a patient brings in a home CPAP/BiPAP, the RT must do the following:",C.	Verify or place appropriate orders and protocols,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"When a patient brings in a home CPAP/BiPAP, the RT must do the following:",D.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"During a Code Blue, the RT must call out the EtCO2 Q2 minutes. This is because:",A.	An EtCO2 measurement verifies airway placement in the lungs,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"During a Code Blue, the RT must call out the EtCO2 Q2 minutes. This is because:",B.	An EtCO2 < 10mmHg indicates poor circulation and reduces the likelihood of ROSC,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"During a Code Blue, the RT must call out the EtCO2 Q2 minutes. This is because:",C.	Adequacy of Chest compressions can be seen by a EtCO2 > 10-15 mmHg,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"During a Code Blue, the RT must call out the EtCO2 Q2 minutes. This is because:",D.	A sudden rise in EtCO2 could indicated ROSC and a pulse check should be done,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,"During a Code Blue, the RT must call out the EtCO2 Q2 minutes. This is because:",E.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following statements are true about remote monitoring?,A.	All patients who need monitoring go on a pulse ox with a pink wrap probe and then get put Bernoulli.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following statements are true about remote monitoring?,"B.	If the patient is on the dynamap on the floor, they don't need to go on remote monitoring",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following statements are true about remote monitoring?,C.	Only PCA patients go on Remote Monitoring and only for 24 hours,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following statements are true about remote monitoring?,"D.	The criteria for EtCO2 monitoring is located on the badge cards and includes high risk factors such as COPD, BMI >35, age >80, Sepsis, Respiratory distress (RR <10 or >30);",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following statements are true about remote monitoring?,"E.	Patients with PaO2 on ABG <65 mmHg will go on remote pulse ox with RR, per Oxygen PDP",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following statements are true about remote monitoring?,F.	D & E,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9804,,Questions-0000-10,2021 RESPIRATORY ADULT EXAM LEVEL I FORSYTH,,n14009,,choice,Which of the following statements are true about remote monitoring?,G.	All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8144,,Elearning-0000-104,2021 VENTILATOR MODES FOR RT FORSYTH,,n14008,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the 2021 VENTILATOR MODES FOR RT FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 VENTILATOR MODES FOR RT FORSYTH- g14008,False
8144,,Elearning-0000-104,2021 VENTILATOR MODES FOR RT FORSYTH,,n14008,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the 2021 VENTILATOR MODES FOR RT FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8144,,Elearning-0000-104,2021 VENTILATOR MODES FOR RT FORSYTH,,n14008,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the 2021 VENTILATOR MODES FOR RT FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9560,,Elearning-0000-786,ASV-1.1 FOR  RT FORSYTH,,n14011,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the ASV-1.1 for RT FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is ASV-1.1 FOR  RT FORSYTH- g14011,False
9560,,Elearning-0000-786,ASV-1.1 FOR  RT FORSYTH,,n14011,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the ASV-1.1 for RT FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9560,,Elearning-0000-786,ASV-1.1 FOR  RT FORSYTH,,n14011,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the ASV-1.1 for RT FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9189,,Elearning-0000-449,METANEB-IPV FORSYTH,,n14012,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the MetaNeb-IPV FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is METANEB-IPV FORSYTH- g14012,False
9189,,Elearning-0000-449,METANEB-IPV FORSYTH,,n14012,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the MetaNeb-IPV FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9189,,Elearning-0000-449,METANEB-IPV FORSYTH,,n14012,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the MetaNeb-IPV FORSYTH CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8634,,Elearning-0000-150,CONTINUOUS READINESS SUPPLY STORAGE,,n14014,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the CONTINUOUS READINESS SUPPLY STORAGE CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is CONTINUOUS READINESS SUPPLY STORAGE- g14014,False
8634,,Elearning-0000-150,CONTINUOUS READINESS SUPPLY STORAGE,,n14014,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the CONTINUOUS READINESS SUPPLY STORAGE CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8634,,Elearning-0000-150,CONTINUOUS READINESS SUPPLY STORAGE,,n14014,,choice,"For questions about these statements, contact your manager.<br><br>  I have reviewed the CONTINUOUS READINESS SUPPLY STORAGE CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21- g14015,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, BSN, RN-C, CCRN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, BSN, RN-C, CCRN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, BSN, RN-C, CCRN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, BSN, RN-C, CCRN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Mary King, BSN, RN-C, CCRN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9893,,Questions-0000-27,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 7-26-21,,n14015,,choice,How would you improve this class?,"No improvements needed (appropriate content, instructor, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9552,,Elearning-0000-779,LARYNGECTOMY,,n14023,,choice,"If a patient has a laryngectomy, the patient can be intubated through the mouth if mechanical ventilation is needed.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is LARYNGECTOMY- g14023,False
9552,,Elearning-0000-779,LARYNGECTOMY,,n14023,,choice,"If a patient has a laryngectomy, the patient can be intubated through the mouth if mechanical ventilation is needed.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9552,,Elearning-0000-779,LARYNGECTOMY,,n14023,,choice,"If a patient has a laryngectomy, the patient can be intubated through the mouth if mechanical ventilation is needed.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9552,,Elearning-0000-779,LARYNGECTOMY,,n14023,,choice,Which statements are true for laryngectomy patients:<br> 1)	The patient should have an ETT placed through the neck stoma during a respiratory emergency.<br> 2)	The upper airway maintains communication with the lower airway and the patient may be intubated through the mouth if necessary.<br> 3)	A speaking valve should NEVER be used for a laryngectomy patient.<br> 4)	Bagging can only be performed through the neck with a pediatric mask,a)	All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9552,,Elearning-0000-779,LARYNGECTOMY,,n14023,,choice,Which statements are true for laryngectomy patients:<br> 1)	The patient should have an ETT placed through the neck stoma during a respiratory emergency.<br> 2)	The upper airway maintains communication with the lower airway and the patient may be intubated through the mouth if necessary.<br> 3)	A speaking valve should NEVER be used for a laryngectomy patient.<br> 4)	Bagging can only be performed through the neck with a pediatric mask,"b)	1, 3, 4",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9552,,Elearning-0000-779,LARYNGECTOMY,,n14023,,choice,Which statements are true for laryngectomy patients:<br> 1)	The patient should have an ETT placed through the neck stoma during a respiratory emergency.<br> 2)	The upper airway maintains communication with the lower airway and the patient may be intubated through the mouth if necessary.<br> 3)	A speaking valve should NEVER be used for a laryngectomy patient.<br> 4)	Bagging can only be performed through the neck with a pediatric mask,"c)	2, 3, 4",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9552,,Elearning-0000-779,LARYNGECTOMY,,n14023,,choice,Which statements are true for laryngectomy patients:<br> 1)	The patient should have an ETT placed through the neck stoma during a respiratory emergency.<br> 2)	The upper airway maintains communication with the lower airway and the patient may be intubated through the mouth if necessary.<br> 3)	A speaking valve should NEVER be used for a laryngectomy patient.<br> 4)	Bagging can only be performed through the neck with a pediatric mask,"d)	1, 3",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9552,,Elearning-0000-779,LARYNGECTOMY,,n14023,,choice,"If the patient has a laryngectomy, what should be at the HOB?",a)	Fresh Trach sign,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9552,,Elearning-0000-779,LARYNGECTOMY,,n14023,,choice,"If the patient has a laryngectomy, what should be at the HOB?","b)	""I am a neck breather""� sign",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9552,,Elearning-0000-779,LARYNGECTOMY,,n14023,,choice,"If the patient has a laryngectomy, what should be at the HOB?",c)	Nothing needed at the HOB,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9552,,Elearning-0000-779,LARYNGECTOMY,,n14023,,choice,"If mechanical ventilation is necessary, an ETT should be placed through the stoma such that the balloon is nearly visible under the skin.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9552,,Elearning-0000-779,LARYNGECTOMY,,n14023,,choice,"If mechanical ventilation is necessary, an ETT should be placed through the stoma such that the balloon is nearly visible under the skin.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9552,,Elearning-0000-779,LARYNGECTOMY,,n14023,,choice,What should be used to clean around the patient's laryngectomy stoma?,a)	Hydrogen peroxide,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9552,,Elearning-0000-779,LARYNGECTOMY,,n14023,,choice,What should be used to clean around the patient's laryngectomy stoma?,b)	Sterile saline,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9552,,Elearning-0000-779,LARYNGECTOMY,,n14023,,choice,What should be used to clean around the patient's laryngectomy stoma?,c)	Tap water,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9253,,Elearning-0000-507,JULY 2021 POLICY & PROCEDURE ONCOLOGY NURSING UPDATE FOR ACC & GCS,,n14024,,choice,"For questions about these statements, contact your manager or clinical specialist.<br><br>  I have reviewed the JULY 2021 POLICY & PROCEDURE ONCOLOGY NURSING UPDATE for ACC & GCS CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is JULY 2021 POLICY & PROCEDURE ONCOLOGY NURSING UPDATE FOR ACC & GCS- g14024,False
9253,,Elearning-0000-507,JULY 2021 POLICY & PROCEDURE ONCOLOGY NURSING UPDATE FOR ACC & GCS,,n14024,,choice,"For questions about these statements, contact your manager or clinical specialist.<br><br>  I have reviewed the JULY 2021 POLICY & PROCEDURE ONCOLOGY NURSING UPDATE for ACC & GCS CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9253,,Elearning-0000-507,JULY 2021 POLICY & PROCEDURE ONCOLOGY NURSING UPDATE FOR ACC & GCS,,n14024,,choice,"For questions about these statements, contact your manager or clinical specialist.<br><br>  I have reviewed the JULY 2021 POLICY & PROCEDURE ONCOLOGY NURSING UPDATE for ACC & GCS CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21- g14025,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to Identify areas of FHR interpretation that have consensus among individuals who interpret FHR tracings.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to Identify areas of FHR interpretation that have consensus among individuals who interpret FHR tracings.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to Identify areas of FHR interpretation that have consensus among individuals who interpret FHR tracings.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to Identify areas of FHR interpretation that have consensus among individuals who interpret FHR tracings.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to Identify areas of FHR interpretation that have consensus among individuals who interpret FHR tracings.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to outline a standardized approach to intervening for abnormal FHR patterns.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to outline a standardized approach to intervening for abnormal FHR patterns.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to outline a standardized approach to intervening for abnormal FHR patterns.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to outline a standardized approach to intervening for abnormal FHR patterns.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to outline a standardized approach to intervening for abnormal FHR patterns.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to associate clinical manifestations in conjunction with FHR patterns that hold increased clinical significance based upon the most common acute FHR emergencies.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to associate clinical manifestations in conjunction with FHR patterns that hold increased clinical significance based upon the most common acute FHR emergencies.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to associate clinical manifestations in conjunction with FHR patterns that hold increased clinical significance based upon the most common acute FHR emergencies.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to associate clinical manifestations in conjunction with FHR patterns that hold increased clinical significance based upon the most common acute FHR emergencies.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to associate clinical manifestations in conjunction with FHR patterns that hold increased clinical significance based upon the most common acute FHR emergencies.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to summarize key strategies that confirm that the electronic signal is of fetal origin on the fetal heart rate tracing.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to summarize key strategies that confirm that the electronic signal is of fetal origin on the fetal heart rate tracing.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to summarize key strategies that confirm that the electronic signal is of fetal origin on the fetal heart rate tracing.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to summarize key strategies that confirm that the electronic signal is of fetal origin on the fetal heart rate tracing.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to summarize key strategies that confirm that the electronic signal is of fetal origin on the fetal heart rate tracing.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe specific features of uterine contractions that determine uteroplacental perfusion and fetal oxygenation.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe specific features of uterine contractions that determine uteroplacental perfusion and fetal oxygenation.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe specific features of uterine contractions that determine uteroplacental perfusion and fetal oxygenation.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe specific features of uterine contractions that determine uteroplacental perfusion and fetal oxygenation.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe specific features of uterine contractions that determine uteroplacental perfusion and fetal oxygenation.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the relevance of the 30-minute rule in the setting of variant FHR patterns.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the relevance of the 30-minute rule in the setting of variant FHR patterns.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the relevance of the 30-minute rule in the setting of variant FHR patterns.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the relevance of the 30-minute rule in the setting of variant FHR patterns.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the relevance of the 30-minute rule in the setting of variant FHR patterns.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>I will change my practice as a result of this activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>I will change my practice as a result of this activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>I will change my practice as a result of this activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>I will change my practice as a result of this activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>I will change my practice as a result of this activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ginny Wurttemberg, MSN, RN </ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ginny Wurttemberg, MSN, RN </ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ginny Wurttemberg, MSN, RN </ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ginny Wurttemberg, MSN, RN </ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Ginny Wurttemberg, MSN, RN </ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kristen Foshee, RNC-OB, CBC </ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kristen Foshee, RNC-OB, CBC </ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kristen Foshee, RNC-OB, CBC </ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kristen Foshee, RNC-OB, CBC </ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Kristen Foshee, RNC-OB, CBC </ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9884,,Questions-0000-18,ADVANCED ELECTRONIC FETAL MONITORING (EFM) (EVALUATION SURVEY)  7.29.21,,n14025,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, setting, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21- g14027,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the elements of coaching in the new age of leadership.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the elements of coaching in the new age of leadership.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the elements of coaching in the new age of leadership.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the elements of coaching in the new age of leadership.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the elements of coaching in the new age of leadership.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the components of coaching.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the components of coaching.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the components of coaching.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the components of coaching.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to articulate the components of coaching.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the value of coaching as a fundamental part of the management process.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the value of coaching as a fundamental part of the management process.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the value of coaching as a fundamental part of the management process.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the value of coaching as a fundamental part of the management process.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the value of coaching as a fundamental part of the management process.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the value of coaching as a fundamental part of the management process.<OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the value of coaching as a fundamental part of the management process.<OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the value of coaching as a fundamental part of the management process.<OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the value of coaching as a fundamental part of the management process.<OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge as it relates to the value of coaching as a fundamental part of the management process.<OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence in my ability to apply coaching fundamentals to the exercise of leadership at every level of surgical services. </OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence in my ability to apply coaching fundamentals to the exercise of leadership at every level of surgical services. </OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence in my ability to apply coaching fundamentals to the exercise of leadership at every level of surgical services. </OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence in my ability to apply coaching fundamentals to the exercise of leadership at every level of surgical services. </OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of confidence in my ability to apply coaching fundamentals to the exercise of leadership at every level of surgical services. </OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rebecca Roe, MSN-Ed, RN CNOR</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rebecca Roe, MSN-Ed, RN CNOR</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rebecca Roe, MSN-Ed, RN CNOR</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rebecca Roe, MSN-Ed, RN CNOR</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rebecca Roe, MSN-Ed, RN CNOR</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Amy Fischer, BSN, RN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Amy Fischer, BSN, RN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Amy Fischer, BSN, RN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Amy Fischer, BSN, RN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Amy Fischer, BSN, RN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9873,,Questions-0000-162,THE LEADER AS COACH (EVALUATION SURVEY) 8.2.21,,n14027,,choice,How would you improve this class?,"No improvements needed (appropriate content, instructor, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,"Duplicate Test. Existing test is NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)- g14028",False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to screen patients for the use of CBD-containing products and advise them regarding potential adverse effects.  </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to screen patients for the use of CBD-containing products and advise them regarding potential adverse effects.  </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to screen patients for the use of CBD-containing products and advise them regarding potential adverse effects.  </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to screen patients for the use of CBD-containing products and advise them regarding potential adverse effects.  </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to screen patients for the use of CBD-containing products and advise them regarding potential adverse effects.  </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my level of knowledge as it relates to current cancer research.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my clinical decision-making confidence as it relates to the care of cancer patients.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online training platform was appropriate for the activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Rosemary McCabe, BSN, RN, OCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of  Michelle Homsy, BSN, RN, OCN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9944,,Questions-0000-78,"NSF INFUSION CENTER JOURNAL CLUB - AUGUST  4TH, 2021 (EVALUATION SURVEY)",,n14028,,choice,How would you improve this class?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
8993,,Elearning-0000-270,PHILIPS MONITOR INTELLIVUE EDUCATION MX400,,n14029,,choice,"I acknowledge that I have read this CBL in its entirety, and I understand how to properly navigate functionality on the Philips Monitor IntellliVue MX400.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is PHILIPS MONITOR INTELLIVUE EDUCATION MX400- g14029,False
8993,,Elearning-0000-270,PHILIPS MONITOR INTELLIVUE EDUCATION MX400,,n14029,,choice,"I acknowledge that I have read this CBL in its entirety, and I understand how to properly navigate functionality on the Philips Monitor IntellliVue MX400.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
8993,,Elearning-0000-270,PHILIPS MONITOR INTELLIVUE EDUCATION MX400,,n14029,,choice,"I acknowledge that I have read this CBL in its entirety, and I understand how to properly navigate functionality on the Philips Monitor IntellliVue MX400.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9586,,Elearning-0000-81,WSU CLINICAL EXCELLENCE _UNIT STAR AWARDS FY_21_Q3,,n14030,,choice,"Please vote for one of the following staff members for the Clinical Excellence Award FY 21 Q 3,  Ni Aung or Jummy Kareem",Ni Aung,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is WSU CLINICAL EXCELLENCE _UNIT STAR AWARDS FY_21_Q3- g14030,False
9586,,Elearning-0000-81,WSU CLINICAL EXCELLENCE _UNIT STAR AWARDS FY_21_Q3,,n14030,,choice,"Please vote for one of the following staff members for the Clinical Excellence Award FY 21 Q 3,  Ni Aung or Jummy Kareem",Ni Aung,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9586,,Elearning-0000-81,WSU CLINICAL EXCELLENCE _UNIT STAR AWARDS FY_21_Q3,,n14030,,choice,"Please vote for one of the following staff members for the Clinical Excellence Award FY 21 Q 3,  Ni Aung or Jummy Kareem",Jummy Kareem,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9586,,Elearning-0000-81,WSU CLINICAL EXCELLENCE _UNIT STAR AWARDS FY_21_Q3,,n14030,,choice,"Please vote for one of the following staff members for the Unit star FY 21 Q 3,  Angie Dixon or Sabrena Sanders",Angie Dixon,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9586,,Elearning-0000-81,WSU CLINICAL EXCELLENCE _UNIT STAR AWARDS FY_21_Q3,,n14030,,choice,"Please vote for one of the following staff members for the Unit star FY 21 Q 3,  Angie Dixon or Sabrena Sanders",Sabrena Sanders,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,The OB Hemorrhage Cart is a key component to achieving rapid access to medications supplies needed during a postpartum hemorrhage.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FY2021 OB HEMORRHAGE CART - NSF- g14032,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,The OB Hemorrhage Cart is a key component to achieving rapid access to medications supplies needed during a postpartum hemorrhage.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,The OB Hemorrhage Cart is a key component to achieving rapid access to medications supplies needed during a postpartum hemorrhage.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,Hemorrhage carts will be located,FCC,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,Hemorrhage carts will be located,L&D,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,Hemorrhage carts will be located,L&D only,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,Hemorrhage carts will be located,Both A&B,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,The OB Hemorrhage Cart is secured by:,A zip tie,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,The OB Hemorrhage Cart is secured by:,2 Digital locks,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,The OB Hemorrhage Cart is secured by:,Red security seal,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,The OB Hemorrhage Cart is secured by:,B and C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,The OB Hemorrhage Cart is secured by:,All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,Medications are stored in the OB Hemorrhage Cart,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,Medications are stored in the OB Hemorrhage Cart,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,What color seal should be placed over the lock bar on the cart to indicate is has been opened and cannot be used?,Red,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,What color seal should be placed over the lock bar on the cart to indicate is has been opened and cannot be used?,Yellow,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,What color seal should be placed over the lock bar on the cart to indicate is has been opened and cannot be used?,Green,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,How frequently should the cart thermometer be checked?,Once a day,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,How frequently should the cart thermometer be checked?,Every shift,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,How frequently should the cart thermometer be checked?,Once a week,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,"If a patient is transferred during use of a hemorrhage cart, the hemorrhage cart should be transferred with the patient.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9651,,Elearning-0000-869,FY2021 OB HEMORRHAGE CART - NSF,,n14032,,choice,"If a patient is transferred during use of a hemorrhage cart, the hemorrhage cart should be transferred with the patient.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9601,,Elearning-0000-823,HAND HYGIENE ATTESTATION 2021,,n14039,,choice,I have reviewed the hospital Hand Hygiene Policy and this CBL. I attest that I will speak up if I witness any break in proper Hand Hygiene.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is HAND HYGIENE ATTESTATION 2021- g14039,False
9601,,Elearning-0000-823,HAND HYGIENE ATTESTATION 2021,,n14039,,choice,I have reviewed the hospital Hand Hygiene Policy and this CBL. I attest that I will speak up if I witness any break in proper Hand Hygiene.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9601,,Elearning-0000-823,HAND HYGIENE ATTESTATION 2021,,n14039,,choice,I have reviewed the hospital Hand Hygiene Policy and this CBL. I attest that I will speak up if I witness any break in proper Hand Hygiene.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Rituxan Hycela � is available in:,a. 11..7 ml vial,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 NOVEL SUBCUTANEOUS BIOLOGICS- g14042,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Rituxan Hycela � is available in:,a. 11..7 ml vial,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Rituxan Hycela � is available in:,b. 13.4 ml vial,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Rituxan Hycela � is available in:,c. 15.5 ml vial,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Rituxan Hycela � is available in:,d. a and b,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,A loading dose is required for Herceptin Hylecta �,a. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,A loading dose is required for Herceptin Hylecta �,b. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Which of the following is correct about Darzalex Faspro �?,"a. Contains 1800 mg Darzalex/30,000units Hyaluronic acid in 15 ml.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Which of the following is correct about Darzalex Faspro �?,b. Administration requires an infusion pump.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Which of the following is correct about Darzalex Faspro �?,c. Requires successful completion of a Darzalex � IV dose prior to administration of Darzalex Faspro �.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Which of the following is correct about Darzalex Faspro �?,d-	Requires premeds be given at least one hour before dose.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Which technique is used to increase bioavailability of a subcutaneous combination of biological drug with enzyme rHuPH20 in oncology treatment?,"a. The two components are administered sequentially through the same needle, with rHuPH20 introduced first, followed by the immunoglobulin.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Which technique is used to increase bioavailability of a subcutaneous combination of biological drug with enzyme rHuPH20 in oncology treatment?,b. rHuPH20 is co-formulated with the subcutaneous active biotherapeutic.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Which technique is used to increase bioavailability of a subcutaneous combination of biological drug with enzyme rHuPH20 in oncology treatment?,c. CADD pump administration allows for continuous SC administration,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Fixed dosing for subcutaneous mABs is considered a drawback although it is more efficient and more convenient,a. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Fixed dosing for subcutaneous mABs is considered a drawback although it is more efficient and more convenient,b. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Herceptin Hylecta � is injected SC over:,a. 2-5 min,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Herceptin Hylecta � is injected SC over:,b. 5 min,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Herceptin Hylecta � is injected SC over:,c. 10-15 min,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Herceptin Hylecta � is injected SC over:,d. 20-30 min,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,"Although the pharmacokinetic profiles of IV and SC formulations are different, SC formulations are preferred by patients and healthcare providers for the following reasons:",a. Cost savings opportunities,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,"Although the pharmacokinetic profiles of IV and SC formulations are different, SC formulations are preferred by patients and healthcare providers for the following reasons:",b. Shorter administration time,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,"Although the pharmacokinetic profiles of IV and SC formulations are different, SC formulations are preferred by patients and healthcare providers for the following reasons:",c. Decreased patient discomfort,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,"Although the pharmacokinetic profiles of IV and SC formulations are different, SC formulations are preferred by patients and healthcare providers for the following reasons:",d. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Rituxan Hycela using the new subcutaneous novel administration technique:,a. Requires administration of a BSA- adjusted intravenous Rituxan � dose prior to Rituxan Hycela �.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Rituxan Hycela using the new subcutaneous novel administration technique:,b. Requires a 1400mg loading dose for follicular lymphoma.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Rituxan Hycela using the new subcutaneous novel administration technique:,c. Has flat 1600mg dose for all indications,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Rituxan Hycela using the new subcutaneous novel administration technique:,d. Is interchangeable with Rituxan IV,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Phesgo 600mg x 2 is interchangeable with Phesgo 1200mg. Either may be used for loading dose.,a. True,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Phesgo 600mg x 2 is interchangeable with Phesgo 1200mg. Either may be used for loading dose.,b. False,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Subcutaneous biologics are administered at home for all of the following diseases except:,a. Rheumatoid Arthritis,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Subcutaneous biologics are administered at home for all of the following diseases except:,b. Multiple Sclerosis,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Subcutaneous biologics are administered at home for all of the following diseases except:,c. Cancer,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9657,,Elearning-0000-874,2021 NOVEL SUBCUTANEOUS BIOLOGICS,,n14042,,choice,Subcutaneous biologics are administered at home for all of the following diseases except:,d. Diabetes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,The magnitude of increase in red blood cell concentration is primarily controlled by the length of time erythropoietin concentrations are maintained.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is RPH UPDATE ON RBCGFS 2021- g14043,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,The magnitude of increase in red blood cell concentration is primarily controlled by the length of time erythropoietin concentrations are maintained.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,The magnitude of increase in red blood cell concentration is primarily controlled by the length of time erythropoietin concentrations are maintained.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,All are appropriate uses of ESAs except,a. Anemia of chronic kidney disease,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,All are appropriate uses of ESAs except,b. Myelodysplastic syndrome,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,All are appropriate uses of ESAs except,c. Zidovudine treated HIV+ patients,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,All are appropriate uses of ESAs except,d. Acute renal failure,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,"Typically, increases in hemoglobin, red blood cells and hematocrit are not seen for 2-6 weeks after beginning therapy.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,"Typically, increases in hemoglobin, red blood cells and hematocrit are not seen for 2-6 weeks after beginning therapy.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,ESAs should only be initiated when hemoglobin levels fall below 10g/dl for,a. CKD patients on hemodialysis,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,ESAs should only be initiated when hemoglobin levels fall below 10g/dl for,b. CKD patients not on hemodialysis,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,ESAs should only be initiated when hemoglobin levels fall below 10g/dl for,c. Chemotherapy induced anemia,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,ESAs should only be initiated when hemoglobin levels fall below 10g/dl for,d. B and C,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,ESAs should only be initiated when hemoglobin levels fall below 10g/dl for,"e. A, B and C",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,Greater biological response to ESAs is not observed at doses exceeding,a. 120 units/kg three times weekly,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,Greater biological response to ESAs is not observed at doses exceeding,b. 200 units/kg three times weekly,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,Greater biological response to ESAs is not observed at doses exceeding,c. 300 units/kg three times weekly,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,Greater biological response to ESAs is not observed at doses exceeding,d. 500 units/kg three times weekly,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,"In almost all published studies, subcutaneous administration of ESAs in chronic kidney disease is associated with a 25-50% EPO dose reduction compared to IV administration.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,"In almost all published studies, subcutaneous administration of ESAs in chronic kidney disease is associated with a 25-50% EPO dose reduction compared to IV administration.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,ESAs have been shown to improve quality of life in patients with chemotherapy induced anemia.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,ESAs have been shown to improve quality of life in patients with chemotherapy induced anemia.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,Administration of iron helps to,a. Achieve and maintain goal hemoglobin levels,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,Administration of iron helps to,b. Prevent iron deficiencies,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,Administration of iron helps to,c. Minimize the dose of ESA needed,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,Administration of iron helps to,d. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,When would it be appropriate to recommend holding the dose of ESA in a CKD patient not on hemodialysis?,a. Hemoglobin > 12 g/dL,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,When would it be appropriate to recommend holding the dose of ESA in a CKD patient not on hemodialysis?,b. Hemoglobin >11 g/dL,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,When would it be appropriate to recommend holding the dose of ESA in a CKD patient not on hemodialysis?,c. Hemoglobin >10 g/dL,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,When would it be appropriate to recommend holding the dose of ESA in a CKD patient not on hemodialysis?,d. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,Systemic reactions may occur during or following intravenous iron administration and include all of the following except:,"a. fever, chills",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,Systemic reactions may occur during or following intravenous iron administration and include all of the following except:,"b. backache, myalgia",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,Systemic reactions may occur during or following intravenous iron administration and include all of the following except:,"c. sweating, excessive lacrimation",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9629,,Elearning-0000-849,RPH UPDATE ON RBCGFS 2021,,n14043,,choice,Systemic reactions may occur during or following intravenous iron administration and include all of the following except:,"d. dizziness, syncope",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Jones has been taking Xeloda for 3 months and her prescription says 4 tablets in the morning and 3 tablets in the evening. During your call she tells you that she has been taking 2 tablets every 12 hours because it doesn't make her feel well. <br><br> What do you do?,A. Ask her about her side effects and tell her to continue the way she is taking them.,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- g14044,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Jones has been taking Xeloda for 3 months and her prescription says 4 tablets in the morning and 3 tablets in the evening. During your call she tells you that she has been taking 2 tablets every 12 hours because it doesn't make her feel well. <br><br> What do you do?,A. Ask her about her side effects and tell her to continue the way she is taking them.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Jones has been taking Xeloda for 3 months and her prescription says 4 tablets in the morning and 3 tablets in the evening. During your call she tells you that she has been taking 2 tablets every 12 hours because it doesn't make her feel well. <br><br> What do you do?,B. Tell her that she must stop immediately and make an appointment to see the MD.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Jones has been taking Xeloda for 3 months and her prescription says 4 tablets in the morning and 3 tablets in the evening. During your call she tells you that she has been taking 2 tablets every 12 hours because it doesn't make her feel well. <br><br> What do you do?,C. Document your call in EMR and notify the Physician/RN directly.  Instruct the patient to contact the office to discuss dose change with the Physician.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Jones has been taking Xeloda for 3 months and her prescription says 4 tablets in the morning and 3 tablets in the evening. During your call she tells you that she has been taking 2 tablets every 12 hours because it doesn't make her feel well. <br><br> What do you do?,D. Do nothing because some medication is better than her not taking it at all.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Mr Depp does not pick up the phone and you would like to leave a message. What information can you leave on the voicemail?,"A. Patient name, patient's DOB, doctor's name, and medication",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Mr Depp does not pick up the phone and you would like to leave a message. What information can you leave on the voicemail?,"B. Patient name, your name, your title, patient's medication, patient's medical record number, and doctor's name, and office location",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Mr Depp does not pick up the phone and you would like to leave a message. What information can you leave on the voicemail?,"C. Patient name, your name, your title, and clinic's name",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Mr Depp does not pick up the phone and you would like to leave a message. What information can you leave on the voicemail?,"D. Doctor's name, office location, patient's name, patient's DOB, date of therapy, and name of medication",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Cruise has been on vacation and missed her first day of Gleevec therapy. She asks you if she can take 2 the following day like she used to do with her birth control. What would you recommend?,"A. Yes, you can double your dose any time you miss a dose as long as you don't take more than 2 days together.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Cruise has been on vacation and missed her first day of Gleevec therapy. She asks you if she can take 2 the following day like she used to do with her birth control. What would you recommend?,"B. No, you should never double the dose of your medication. Skip the missed dose if it's too close to your next dose or take the missed dose as soon as you remember if it's not too close to your next dose.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Cruise has been on vacation and missed her first day of Gleevec therapy. She asks you if she can take 2 the following day like she used to do with her birth control. What would you recommend?,"C. Yes, you can take as many doses as needed to get back on schedule.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Cruise has been on vacation and missed her first day of Gleevec therapy. She asks you if she can take 2 the following day like she used to do with her birth control. What would you recommend?,"D. No, don't double the dose. Skip a day as a wash out and start your therapy again from day 1.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Jackson has just started taking Alecensa and has told you that it's too expensive so she picked up her refill but plans on taking it every other day to make it last longer. <br><br> What do you recommend?,A. Counsel her on the side effects of therapy and let her know to call the office with any questions and document your call in EMR.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Jackson has just started taking Alecensa and has told you that it's too expensive so she picked up her refill but plans on taking it every other day to make it last longer. <br><br> What do you recommend?,B. Remind the patient that the medication is most effective when it is taken as prescribed by the physician. Notify the physician and nursing staff she is having financial barriers to therapy and look into potential solutions or financial assistance and document your call in EMR.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Jackson has just started taking Alecensa and has told you that it's too expensive so she picked up her refill but plans on taking it every other day to make it last longer. <br><br> What do you recommend?,"C. Let her know that instead of taking her medication every other day, she can open the capsules and only take half so that it will last her the duration of therapy.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Jackson has just started taking Alecensa and has told you that it's too expensive so she picked up her refill but plans on taking it every other day to make it last longer. <br><br> What do you recommend?,D. Document her change in therapy in the EMR but don't say anything to the physician or nursing staff.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Mr Brown tells you that the physician has changed his therapy and he no longer needs his Cabometyx. He tells you that he met another patient in his support group that is taking the same medication and wants to give him the remaining pills.<br><br> What do you recommend?,"A. Advise him that medications should never be shared and he should call the local drug take back center, take it to a local medication drop off unit in the community, or contact the pharmacy for instructions on proper disposal.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Mr Brown tells you that the physician has changed his therapy and he no longer needs his Cabometyx. He tells you that he met another patient in his support group that is taking the same medication and wants to give him the remaining pills.<br><br> What do you recommend?,B. Tell him it's all right as long as you can call the other patient to verify the dose of his therapy.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Mr Brown tells you that the physician has changed his therapy and he no longer needs his Cabometyx. He tells you that he met another patient in his support group that is taking the same medication and wants to give him the remaining pills.<br><br> What do you recommend?,C. Instruct him to bring the medication back to the office and you will dispose of it for him.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Mr Brown tells you that the physician has changed his therapy and he no longer needs his Cabometyx. He tells you that he met another patient in his support group that is taking the same medication and wants to give him the remaining pills.<br><br> What do you recommend?,"D. Tell him he can choose any of the above options, depending on what suits him the best.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Price is currently taking Revlimid and wants to make an appointment with you to counsel her on her medication. <br><br> Which response <u>would not</u> be appropriate?,A. Make an appointment with her to discuss her medication and counsel her.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Price is currently taking Revlimid and wants to make an appointment with you to counsel her on her medication. <br><br> Which response <u>would not</u> be appropriate?,B. Refer her to the retail pharmacy because only certain pharmacists are authorized to counsel a patient on Revlimid due to the REMS program.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Price is currently taking Revlimid and wants to make an appointment with you to counsel her on her medication. <br><br> Which response <u>would not</u> be appropriate?,C. Tell her that you cannot speak to her currently but you can set up a date/time to counsel her over the phone.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,Ms Price is currently taking Revlimid and wants to make an appointment with you to counsel her on her medication. <br><br> Which response <u>would not</u> be appropriate?,D. Tell her you have a few minutes and can discuss her Revlimid now.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,"Choose the best type of questions to use when counseling a patient from the questions below.<br><br>  I. ""Are you having any problems with your medication?""�<br> II. ""What did your provider tell you to expect while on therapy?""�<br> III. ""What side effects will you be looking out for while on this medication?""�<br> IV. ""Do you have any questions?""�<br><br>","A.	I, II, IV",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,"Choose the best type of questions to use when counseling a patient from the questions below.<br><br>  I. ""Are you having any problems with your medication?""�<br> II. ""What did your provider tell you to expect while on therapy?""�<br> III. ""What side effects will you be looking out for while on this medication?""�<br> IV. ""Do you have any questions?""�<br><br>","B.	I, II, III, IV",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,"Choose the best type of questions to use when counseling a patient from the questions below.<br><br>  I. ""Are you having any problems with your medication?""�<br> II. ""What did your provider tell you to expect while on therapy?""�<br> III. ""What side effects will you be looking out for while on this medication?""�<br> IV. ""Do you have any questions?""�<br><br>","C.	III, IV",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,"Choose the best type of questions to use when counseling a patient from the questions below.<br><br>  I. ""Are you having any problems with your medication?""�<br> II. ""What did your provider tell you to expect while on therapy?""�<br> III. ""What side effects will you be looking out for while on this medication?""�<br> IV. ""Do you have any questions?""�<br><br>","D.	II, III",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,What is the pharmacist's role in oral medication adherence?,A. Building a strong pharmacist-patient relationship.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,What is the pharmacist's role in oral medication adherence?,"B. Recognizing barriers to therapy such as drug cost, inability to swallow pills, etc.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,What is the pharmacist's role in oral medication adherence?,C. Increased potential for drug toxicity,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,What is the pharmacist's role in oral medication adherence?,D. A & B,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,What is the pharmacist's role in oral medication adherence?,E. All of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,"Prior to calling a patient, make sure to do the following:","A.  Review patient's past and current course of therapy, identify correct treatment plan, appropriate dose, and need for dose adjustments",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,"Prior to calling a patient, make sure to do the following:",B. Document the topics that you would like to discuss with the patient,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,"Prior to calling a patient, make sure to do the following:",C. Familiarize yourself with patient's medication,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,"Prior to calling a patient, make sure to do the following:",D. A &C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,"Prior to calling a patient, make sure to do the following:",E. None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,"True or False: All Adverse events, lack of compliance, or any other issue should be communicated to the physician and/or nursing staff and documented in the EMR.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9631,,Elearning-0000-850,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,,n14044,,choice,"True or False: All Adverse events, lack of compliance, or any other issue should be communicated to the physician and/or nursing staff and documented in the EMR.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21- g14046,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the cardiac anatomy and physiology. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proper application of ECG leads.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review Northside Hospitals' Telemetry Monitoring Policies and Procedures.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to review selected-cardiac dysrhythmias and appropriate nursing interventions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Bundle Branch Blocks and appropriate nursing interventions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe signs and symptoms of Acute MI and Nursing Interventions.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe Life Threatening Dysthymias and Nursing Interventions. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge in caring for patients on telemetry cardiac monitoring.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN_K</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN_K</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN_K</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN_K</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, BSN, RN, CCRN_K</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9955,,Questions-0000-89,NURSING IMPLICATIONS FOR THE PATIENT ON TELEMETRY MONITORING (EVALUATION SURVEY) ONLINE 8-4-21,,n14046,,choice,How would you improve this class?,"Nothing: (appropriate content, speaker, setting, setting.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
228,,SCORM-0000-34,FIRE SAFETY ORIENTATION UPDATED (2021),,n14047,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""Fire Safety Orientation (2021)"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FIRE SAFETY ORIENTATION UPDATED (2021)- g14047,False
228,,SCORM-0000-34,FIRE SAFETY ORIENTATION UPDATED (2021),,n14047,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""Fire Safety Orientation (2021)"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
228,,SCORM-0000-34,FIRE SAFETY ORIENTATION UPDATED (2021),,n14047,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""Fire Safety Orientation (2021)"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
228,,SCORM-0000-34,FIRE SAFETY ORIENTATION UPDATED (2021),,n14047,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""Fire Safety Orientation Updated (2021)"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
228,,SCORM-0000-34,FIRE SAFETY ORIENTATION UPDATED (2021),,n14047,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the ""Fire Safety Orientation Updated (2021)"" CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9392,,Elearning-0000-633,FCC CHEROKEE ONSTAGE BEHAVIORS-MAKING A GREAT FIRST IMPRESSION 2021,,n14049,,choice,True or False?  When you come to work you are onstage?,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is FCC CHEROKEE ONSTAGE BEHAVIORS-MAKING A GREAT FIRST IMPRESSION 2021- g14049,False
9392,,Elearning-0000-633,FCC CHEROKEE ONSTAGE BEHAVIORS-MAKING A GREAT FIRST IMPRESSION 2021,,n14049,,choice,True or False?  When you come to work you are onstage?,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9392,,Elearning-0000-633,FCC CHEROKEE ONSTAGE BEHAVIORS-MAKING A GREAT FIRST IMPRESSION 2021,,n14049,,choice,True or False?  When you come to work you are onstage?,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9392,,Elearning-0000-633,FCC CHEROKEE ONSTAGE BEHAVIORS-MAKING A GREAT FIRST IMPRESSION 2021,,n14049,,choice,Good customer service is taking the extra step to help without being asked. It's all about attitude and skills. It includes:,a. Legendary attention to detail,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9392,,Elearning-0000-633,FCC CHEROKEE ONSTAGE BEHAVIORS-MAKING A GREAT FIRST IMPRESSION 2021,,n14049,,choice,Good customer service is taking the extra step to help without being asked. It's all about attitude and skills. It includes:,b. Exceeding people's expectations,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9392,,Elearning-0000-633,FCC CHEROKEE ONSTAGE BEHAVIORS-MAKING A GREAT FIRST IMPRESSION 2021,,n14049,,choice,Good customer service is taking the extra step to help without being asked. It's all about attitude and skills. It includes:,c. Being customer/patient centered,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9392,,Elearning-0000-633,FCC CHEROKEE ONSTAGE BEHAVIORS-MAKING A GREAT FIRST IMPRESSION 2021,,n14049,,choice,Good customer service is taking the extra step to help without being asked. It's all about attitude and skills. It includes:,d. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9392,,Elearning-0000-633,FCC CHEROKEE ONSTAGE BEHAVIORS-MAKING A GREAT FIRST IMPRESSION 2021,,n14049,,choice,When looking for solutions focus on short term solution instead of long term solutions,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9392,,Elearning-0000-633,FCC CHEROKEE ONSTAGE BEHAVIORS-MAKING A GREAT FIRST IMPRESSION 2021,,n14049,,choice,When looking for solutions focus on short term solution instead of long term solutions,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9392,,Elearning-0000-633,FCC CHEROKEE ONSTAGE BEHAVIORS-MAKING A GREAT FIRST IMPRESSION 2021,,n14049,,choice,True or False? Never let backstage come onstage,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9392,,Elearning-0000-633,FCC CHEROKEE ONSTAGE BEHAVIORS-MAKING A GREAT FIRST IMPRESSION 2021,,n14049,,choice,True or False? Never let backstage come onstage,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9392,,Elearning-0000-633,FCC CHEROKEE ONSTAGE BEHAVIORS-MAKING A GREAT FIRST IMPRESSION 2021,,n14049,,choice,People make judgements in the first ___________ seconds! You only have one Chance to make aGREAT first impression!,a. 90 seconds,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9392,,Elearning-0000-633,FCC CHEROKEE ONSTAGE BEHAVIORS-MAKING A GREAT FIRST IMPRESSION 2021,,n14049,,choice,People make judgements in the first ___________ seconds! You only have one Chance to make aGREAT first impression!,b. 30 seconds,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9392,,Elearning-0000-633,FCC CHEROKEE ONSTAGE BEHAVIORS-MAKING A GREAT FIRST IMPRESSION 2021,,n14049,,choice,People make judgements in the first ___________ seconds! You only have one Chance to make aGREAT first impression!,c. 60 seconds,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9392,,Elearning-0000-633,FCC CHEROKEE ONSTAGE BEHAVIORS-MAKING A GREAT FIRST IMPRESSION 2021,,n14049,,choice,People make judgements in the first ___________ seconds! You only have one Chance to make aGREAT first impression!,d. 15 seconds,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Chapter 5:  Regulations and Standards<br> Agency which may intervene in a matter of worker protection even if there are no specific regulations covering the situation.,a.	Occupational Safety and Health Administration,True,100,FAIL DUPLICATE TEST: 200,"Duplicate Test. Existing test is SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15- g14050",False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Chapter 5:  Regulations and Standards<br> Agency which may intervene in a matter of worker protection even if there are no specific regulations covering the situation.,a.	Occupational Safety and Health Administration,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Chapter 5:  Regulations and Standards<br> Agency which may intervene in a matter of worker protection even if there are no specific regulations covering the situation.,b.	Environmental Protection Agency,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Chapter 5:  Regulations and Standards<br> Agency which may intervene in a matter of worker protection even if there are no specific regulations covering the situation.,c.	U.S. Food and Drug Administration,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Chapter 5:  Regulations and Standards<br> Agency which may intervene in a matter of worker protection even if there are no specific regulations covering the situation.,d.	Association of perioperative Registered Nurses,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Regulations under the Clean Air Act are administered by the,a.	Occupational Safety and Health Administration,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Regulations under the Clean Air Act are administered by the,b.	U.S. Food and Drug Administration,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Regulations under the Clean Air Act are administered by the,c.	Environmental Protection Agency,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Regulations under the Clean Air Act are administered by the,d.	Association of periOperative Registered Nurses,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The agency which imposes very strict labeling requirements on manufacturers of disinfectants used by Central Service departments.,a.	Occupational Safety and Health Administration,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The agency which imposes very strict labeling requirements on manufacturers of disinfectants used by Central Service departments.,b.	U.S. Food and Drug Administration,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The agency which imposes very strict labeling requirements on manufacturers of disinfectants used by Central Service departments.,c.	Environmental Protection Agency,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The agency which imposes very strict labeling requirements on manufacturers of disinfectants used by Central Service departments.,d.	Association for the Advancement of Medical Instrumentation,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Healthcare regulations and standards establish,a.	minimal levels of quality and safety,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Healthcare regulations and standards establish,b.	equal pay practices,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Healthcare regulations and standards establish,c.	productivity time lines,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Healthcare regulations and standards establish,d.	all of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Chemical indicators are classified as,a.	FDA Class I medical devices,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Chemical indicators are classified as,b.	FDA Class II medical devices,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Chemical indicators are classified as,c.	FDA Class III medical devices,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Chemical indicators are classified as,"d.	None, not regulatory by FDA",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Heart valves and pacemakers are example of,a.	FDA Class I medical devices,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Heart valves and pacemakers are example of,b.	FDA Class II medical devices,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Heart valves and pacemakers are example of,c.	FDA Class III medical devices,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Heart valves and pacemakers are example of,"d.	None, not regulatory by FDA",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,"Under current regulations, who is required to report suspected medical device related deaths to the U.S. Food and Drug Administration?",a.	Device manufacturer,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,"Under current regulations, who is required to report suspected medical device related deaths to the U.S. Food and Drug Administration?",b.	Hospitals,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,"Under current regulations, who is required to report suspected medical device related deaths to the U.S. Food and Drug Administration?",c.	All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,"Under current regulations, who is required to report suspected medical device related deaths to the U.S. Food and Drug Administration?",d.	None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Standards and regulations help set levels of ___________________________ in our departments.,a.	quality,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Standards and regulations help set levels of ___________________________ in our departments.,b.	safety,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Standards and regulations help set levels of ___________________________ in our departments.,c.	efficiency,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Standards and regulations help set levels of ___________________________ in our departments.,d.	both quality and safety,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Medical device reporting is regulated by the,a.	National Fire Protection Associated,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Medical device reporting is regulated by the,b.	Environmental Protection Agency,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Medical device reporting is regulated by the,c.	World Health Organization,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Medical device reporting is regulated by the,d.	U.S. Food and Drug Administration,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The Department of Transportation enforces statutes relating to the,a.	transportation of clean and soiled instruments between facilities,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The Department of Transportation enforces statutes relating to the,b.	transportation of medical supplies for emergency use,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The Department of Transportation enforces statutes relating to the,c.	transportation of equipment for the decontamination area,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The Department of Transportation enforces statutes relating to the,d.	transportation of instrumentation across state lines,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,"Sometimes state or local regulations differ from Federal regulations and when that happens, the most stringent regulations apply.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,"Sometimes state or local regulations differ from Federal regulations and when that happens, the most stringent regulations apply.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,It is optional to allow the Occupational Safety and Health Administration's regulation for wearing personal protective equipment in the Central Service decontamination area.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,It is optional to allow the Occupational Safety and Health Administration's regulation for wearing personal protective equipment in the Central Service decontamination area.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Third-party reprocessors are regulated by the U.S. Food and Drug Administration.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Third-party reprocessors are regulated by the U.S. Food and Drug Administration.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Recommendations regarding sterilization practices are provided by the Association for the Advancement of Medical Instrumentation.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Recommendations regarding sterilization practices are provided by the Association for the Advancement of Medical Instrumentation.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The Occupational Safety and Health Administration is a voluntary association dedicated to infection control and prevention.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The Occupational Safety and Health Administration is a voluntary association dedicated to infection control and prevention.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Failure to receive accreditation from The Joint Commission can result in the loss of Medicare and Medicaid payments.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Failure to receive accreditation from The Joint Commission can result in the loss of Medicare and Medicaid payments.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The Society of Gastroenterology Nurses and Associates is a source for information about the proper processing of flexible endoscopes.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The Society of Gastroenterology Nurses and Associates is a source for information about the proper processing of flexible endoscopes.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Class III medical devices are identified as high risk.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Class III medical devices are identified as high risk.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Reuse of single use medical devices is less regulated now than it was in the 1990's.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Reuse of single use medical devices is less regulated now than it was in the 1990's.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The U.S. Food and Drug Administration recalls may be either mandatory or voluntary.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The U.S. Food and Drug Administration recalls may be either mandatory or voluntary.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,"Chapter 14:  High-Temperature Sterilization<br>  When loading a steam sterilizer, basins should be",a.	placed in an uptight position,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,"Chapter 14:  High-Temperature Sterilization<br>  When loading a steam sterilizer, basins should be",b.	loaded first,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,"Chapter 14:  High-Temperature Sterilization<br>  When loading a steam sterilizer, basins should be",c.	placed on edge,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,"Chapter 14:  High-Temperature Sterilization<br>  When loading a steam sterilizer, basins should be",d.	placed in a wire basket,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The higher bioburden on an object,a.	the more difficult it will be to sterilize,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The higher bioburden on an object,b.	the less time it will take to sterilize it,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The higher bioburden on an object,c.	the more biological tests will be needed in the load,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The higher bioburden on an object,d.	the longer it will take to cool after sterilization,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,"When combining loads, hard goods should be placed on the top shelves to allow for more efficient removal of the condensate.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,"When combining loads, hard goods should be placed on the top shelves to allow for more efficient removal of the condensate.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The steam sterilization process can be affected by the design of the medical device being sterilized.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The steam sterilization process can be affected by the design of the medical device being sterilized.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Central Service technicians need to understand the anatomy of a steam sterilizer to,a.	know how to properly clean the chamber,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Central Service technicians need to understand the anatomy of a steam sterilizer to,b.	understand how the sterilizer operates,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Central Service technicians need to understand the anatomy of a steam sterilizer to,c.	understand how to test the thermostatic trap,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Central Service technicians need to understand the anatomy of a steam sterilizer to,d.	know how to properly maintain the jacket,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The weakest part of a steam sterilizer is the,a.	jacket,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The weakest part of a steam sterilizer is the,b.	gasket,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The weakest part of a steam sterilizer is the,c.	door,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The weakest part of a steam sterilizer is the,d.	thermostatic valve,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Three of the main phases of a terminal steam sterilizer cycle are,"a.	gravity, exposure and exhaust",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Three of the main phases of a terminal steam sterilizer cycle are,"b.	pre-vacuum, exposure and exhaust",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Three of the main phases of a terminal steam sterilizer cycle are,"c.	exposure, exhaust and dry",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Three of the main phases of a terminal steam sterilizer cycle are,"d.	conditioning, exposure and exhaust",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The most common reason for steam sterilization failure is,a.	lack of steam contact with the instrument,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The most common reason for steam sterilization failure is,b.	insufficient temperature,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The most common reason for steam sterilization failure is,c.	inadequate exposure time,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The most common reason for steam sterilization failure is,d.	drying issues,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The coolest place in a steam sterilizer is the,a.	gasket,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The coolest place in a steam sterilizer is the,b.	thermostatic trap,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The coolest place in a steam sterilizer is the,c.	jacket,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,The coolest place in a steam sterilizer is the,d.	chamber,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Steam flush pressure pulse sterilizers are a type of gravity sterilizers,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Steam flush pressure pulse sterilizers are a type of gravity sterilizers,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Factors that can cause sterilant contact failure with the instrument are,"a.	cleaning, loosely packed load",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Factors that can cause sterilant contact failure with the instrument are,"b.	conditioning, size and weight of the instrument",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Factors that can cause sterilant contact failure with the instrument are,"c.	solid bottom containers, exposure time",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Factors that can cause sterilant contact failure with the instrument are,"d.	crowded loads, clogged drain strainer",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,One of the most frequent causes of a clogged drain screen is,a.	tape,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,One of the most frequent causes of a clogged drain screen is,b.	wrapper particles,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,One of the most frequent causes of a clogged drain screen is,c.	poor stream quality,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,One of the most frequent causes of a clogged drain screen is,d.	malfunctioning baffle plate,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,After sterilization the load contents may take two hours or more to cool.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,After sterilization the load contents may take two hours or more to cool.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Peel pouches should be placed ________________________________________ for sterilization.,"a.	on edge, paper to plastic",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Peel pouches should be placed ________________________________________ for sterilization.,"b.	on edge, plastic to plastic",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Peel pouches should be placed ________________________________________ for sterilization.,c.	placed flat with the plastic side up,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Peel pouches should be placed ________________________________________ for sterilization.,d.	placed flat with the paper side up,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Items with a standard steam sterilization cycle recommended by the manufacturer can be damaged if run in an extended cycle.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Items with a standard steam sterilization cycle recommended by the manufacturer can be damaged if run in an extended cycle.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,How frequently should a sterilizer's strainer be removed and cleaned?,a.	daily,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,How frequently should a sterilizer's strainer be removed and cleaned?,b.	after each use,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,How frequently should a sterilizer's strainer be removed and cleaned?,c.	once weekly,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,How frequently should a sterilizer's strainer be removed and cleaned?,d.	only when the machine's operating control gauge indicates cleaning is necessary,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Immediate use steam sterilization is the process to sterilize trays for future use.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Immediate use steam sterilization is the process to sterilize trays for future use.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Wood products should be sterilized in an extended steam cycle.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Wood products should be sterilized in an extended steam cycle.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,When water is seen on the outside of a pack after sterilization the pack is considered safe to use if all other packs in the load are dry.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,When water is seen on the outside of a pack after sterilization the pack is considered safe to use if all other packs in the load are dry.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Packs that are improperly packaged or loaded on the sterilizer cart frequently become wet packs.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Packs that are improperly packaged or loaded on the sterilizer cart frequently become wet packs.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Chapter 15:  Low-Temperature Sterilization<br> Woven reusable fabrics are the packaging of choice for ozone sterilization.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Chapter 15:  Low-Temperature Sterilization<br> Woven reusable fabrics are the packaging of choice for ozone sterilization.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Ethylene kills microorganisms by a process called oxidation.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Ethylene kills microorganisms by a process called oxidation.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,"Ethylene oxide, hydrogen peroxide and ozone sterilization process must all be monitored using chemical, physical and biological monitors.",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,"Ethylene oxide, hydrogen peroxide and ozone sterilization process must all be monitored using chemical, physical and biological monitors.",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,"Ethylene oxide, hydrogen peroxide and ozone sterilization can all use the same packaging materials.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,"Ethylene oxide, hydrogen peroxide and ozone sterilization can all use the same packaging materials.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Lumens should be moist when using hydrogen peroxide as a sterilizing agent.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Lumens should be moist when using hydrogen peroxide as a sterilizing agent.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Ethylene oxide is a toxic gas.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Ethylene oxide is a toxic gas.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Cellulose-containing packaging materials are not compatible with hydrogen peroxide sterilization.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Cellulose-containing packaging materials are not compatible with hydrogen peroxide sterilization.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Information about a device's compatibility with a specific sterilization process should be obtained from the device's manufacturer.,TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Information about a device's compatibility with a specific sterilization process should be obtained from the device's manufacturer.,FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,An extended aeration cycle is required for items sterilized in ozone sterilization processes.,TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,An extended aeration cycle is required for items sterilized in ozone sterilization processes.,FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Permissible exposure levels for low-temperature sterilization methods are established by the,a.	U.S. Food and Drug Administration,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Permissible exposure levels for low-temperature sterilization methods are established by the,b.	Centers for Disease Control,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Permissible exposure levels for low-temperature sterilization methods are established by the,c.	Occupational Safety and Health Administration,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9863,,Questions-0000-153,"SPD INTERNSHIP: TEST 4 CHAPTERS 5, 14, 15",,n14050,,choice,Permissible exposure levels for low-temperature sterilization methods are established by the,d.	Environmental Protection Agency,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,How does the newborn appear on the Circumcision Dashboard?,"A. The Admission Team documents ""Yes""� in the Birth Information Powerform to the parents having plans for their newborn to be circumcised.",False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is CERNER CIRCUMCISION DASHBOARD- g14051,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,How does the newborn appear on the Circumcision Dashboard?,"A. The Admission Team documents ""Yes""� in the Birth Information Powerform to the parents having plans for their newborn to be circumcised.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,How does the newborn appear on the Circumcision Dashboard?,"B. The Anchor Nurse documents in Circumcision in iView ""Yes""� to the parents having plans for their newborn to be circumcised.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,How does the newborn appear on the Circumcision Dashboard?,C. All baby boys will automatically appear on the Circumcision Dashboard.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,How does the newborn appear on the Circumcision Dashboard?,D. Answers A or B are both correct.,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,"True or False: A newborn has all 8 green check marks on the circumcision dashboard, so the Anchor Nurse can assume the newborn is eligible for circumcision.",TRUE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,"True or False: A newborn has all 8 green check marks on the circumcision dashboard, so the Anchor Nurse can assume the newborn is eligible for circumcision.",FALSE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,When should the Pre-Circumcision Checklist be reviewed and/or documented in by the Anchor Nurse?,A. Before the Time-Out Procedure,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,When should the Pre-Circumcision Checklist be reviewed and/or documented in by the Anchor Nurse?,B. Each Shift,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,When should the Pre-Circumcision Checklist be reviewed and/or documented in by the Anchor Nurse?,C. As the different requirements are met,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,When should the Pre-Circumcision Checklist be reviewed and/or documented in by the Anchor Nurse?,D. If newborn's medical status changes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,When should the Pre-Circumcision Checklist be reviewed and/or documented in by the Anchor Nurse?,E. All the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,"It was documented in the Pre-Circumcision Checklist that the newborn was feeding well. Two shifts have since passed, and the newborn is no longer feeding well. The Pediatrician is notified, and writes a ""Hold Circ""� order. The OB Provider then calls saying that they see the newborn has the 8 required green checks to be eligible for circumcision. What should the Anchor Nurse do?",A. Allow the OB Provider to come circumcise the newborn.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,"It was documented in the Pre-Circumcision Checklist that the newborn was feeding well. Two shifts have since passed, and the newborn is no longer feeding well. The Pediatrician is notified, and writes a ""Hold Circ""� order. The OB Provider then calls saying that they see the newborn has the 8 required green checks to be eligible for circumcision. What should the Anchor Nurse do?","B. Inform the Provider that the newborn has a ""Hold Circ""� order because they are no longer feeding well, and cannot be circumcised at this time.",True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,"It was documented in the Pre-Circumcision Checklist that the newborn was feeding well. Two shifts have since passed, and the newborn is no longer feeding well. The Pediatrician is notified, and writes a ""Hold Circ""� order. The OB Provider then calls saying that they see the newborn has the 8 required green checks to be eligible for circumcision. What should the Anchor Nurse do?",C. None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,Which of the following is true?,A. It is the responsibility of the Mother Baby Nurse to fill out the Pre-Circumcision Checklist.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,Which of the following is true?,B. It is the responsibility of the Anchor Nurse to fill out the Pre-Circumcision Checklist.,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,Which of the following is true?,"C. The Mother Baby Nurse is responsible for obtaining signed consent for circumcision procedure and notifying the Anchor Nurse informed consent has been obtained, informing the Anchor Nurse when newborn has their first void and updating the Anchor Nurse with any changes in newborn status.",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9479,,Elearning-0000-712,CERNER CIRCUMCISION DASHBOARD,,n14051,,choice,Which of the following is true?,D. B&C,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,The main factors managed by multilayer sacral foam dressings to <u>prevent</u> against pressure injuries include all of the following except:,a. Friction,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE- g14052,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,The main factors managed by multilayer sacral foam dressings to <u>prevent</u> against pressure injuries include all of the following except:,a. Friction,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,The main factors managed by multilayer sacral foam dressings to <u>prevent</u> against pressure injuries include all of the following except:,b. Shear,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,The main factors managed by multilayer sacral foam dressings to <u>prevent</u> against pressure injuries include all of the following except:,c. Pressure,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,The main factors managed by multilayer sacral foam dressings to <u>prevent</u> against pressure injuries include all of the following except:,d. Moisture,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,Essential steps of skin care to help assist with pressure injury prevention include all of the following except?,a. Moisturize skin daily and right after bathing,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,Essential steps of skin care to help assist with pressure injury prevention include all of the following except?,b. Some protectants may be for prevention while others may be for treatment,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,Essential steps of skin care to help assist with pressure injury prevention include all of the following except?,c. Avoid rigorous scrubbing or rubbing of skin,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,Essential steps of skin care to help assist with pressure injury prevention include all of the following except?,d. Barriers can protect the skin from excessive moisture,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,Essential steps of skin care to help assist with pressure injury prevention include all of the following except?,e. Use cleansing products that are alkaline in nature,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,Skin protectants and liquid cyanoacrylates protect against?,a. Adhesive,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,Skin protectants and liquid cyanoacrylates protect against?,b. Friction,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,Skin protectants and liquid cyanoacrylates protect against?,c. Moisture and incontinence,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,Skin protectants and liquid cyanoacrylates protect against?,d. All of the above,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,Skin protectants and liquid cyanoacrylates protect against?,e. None of the above,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,The Skin Champion Nurse is assessing a patient whose pressure injury is medical device related. Which of the following statements is false?,a. Thorough skin inspection under and around a device is important to preventing these injuries,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,The Skin Champion Nurse is assessing a patient whose pressure injury is medical device related. Which of the following statements is false?,b. These pressure injuries cannot be staged,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,The Skin Champion Nurse is assessing a patient whose pressure injury is medical device related. Which of the following statements is false?,c. Devices should be assessed for proper fit,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,The Skin Champion Nurse is assessing a patient whose pressure injury is medical device related. Which of the following statements is false?,d. Respiratory devices are common sources of injury,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,The Skin Champion Nurse is applying a multilayer sacral foam dressing for prevention of pressure injuries. Which is NOT a consideration they should think about?,a. The dressing can stay on for as long as it lasts without the skin being assessed,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,The Skin Champion Nurse is applying a multilayer sacral foam dressing for prevention of pressure injuries. Which is NOT a consideration they should think about?,b. The cost associated with the dressing,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,The Skin Champion Nurse is applying a multilayer sacral foam dressing for prevention of pressure injuries. Which is NOT a consideration they should think about?,c. The size and appropriateness of the dressing,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9678,,Elearning-0000-893,HAPI PREVENTION EDUCATION - AUGUST 2021 - PRESSURE INJURY PREVENTION - DEFENSE,,n14052,,choice,The Skin Champion Nurse is applying a multilayer sacral foam dressing for prevention of pressure injuries. Which is NOT a consideration they should think about?,d. The ability of the dressing to manage microclimate and friction,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21- g14055,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9906,,Questions-0000-40,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- BMT ONLY 2.3) 8-6-21,,n14055,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21- g14054,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasopressors.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasopressors.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for sedatives, hypnotics, paralytics and narcotics.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9913,,Questions-0000-47,DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY- ED & ICU ONLY 5.5) 8-6-21,,n14054,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,"Duplicate Test. Existing test is DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21- g14053",False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for Diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for diuretics, anti-arrhythmics and inotropes.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the mechanism of action, indications and normal dosing for vasodilators.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe titration, side effects, monitoring parameters and nursing precautions for vasodilators. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to providing care for patients on continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence as it relates to monitoring and titrating medications administered via continuous IV drips.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for the activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Michele Aldoretta, MSN, RN, CCRN</ol>",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,How would you improve this class (check all that apply)?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,How would you improve this class (check all that apply)?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,How would you improve this class (check all that apply)?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,How would you improve this class (check all that apply)?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,How would you improve this class (check all that apply)?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,How would you improve this class (check all that apply)?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9919,,Questions-0000-53,"DRIP MANAGEMENT FOR SPECIALTY AREAS (EVALUATION SURVEY-PCU, PCCU, PTCU & NPCU ONLY 3.1 ) 8-6-21",,n14053,,choice,How would you improve this class (check all that apply)?,"Nothing: (appropriate speakers, content, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9692,,Elearning-0000-906,2021 EMOTIONAL SUPPORT FOR STAFF CBL,,n14058,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the 2021 Emotional Support  For Staff CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is 2021 EMOTIONAL SUPPORT FOR STAFF CBL- g14058,False
9692,,Elearning-0000-906,2021 EMOTIONAL SUPPORT FOR STAFF CBL,,n14058,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the 2021 Emotional Support  For Staff CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9692,,Elearning-0000-906,2021 EMOTIONAL SUPPORT FOR STAFF CBL,,n14058,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the 2021 Emotional Support  For Staff CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9699,,Elearning-0000-912,CLEANLINESS IN THE MRI ROOM,,n14059,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the Cleanliness in the MRI Room CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is CLEANLINESS IN THE MRI ROOM- g14059,False
9699,,Elearning-0000-912,CLEANLINESS IN THE MRI ROOM,,n14059,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the Cleanliness in the MRI Room CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,FAIL DUPLICATE TEST: 200,Duplicate test,False
9699,,Elearning-0000-912,CLEANLINESS IN THE MRI ROOM,,n14059,,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the Cleanliness in the MRI Room CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate Test. Existing test is BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21- g14063,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,Please list the location for this activity.,Atlanta,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,Please list the location for this activity.,Forsyth,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,Please list the location for this activity.,Cherokee,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,Please list the location for this activity.,Other,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the internal structures and functions of the heart. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to understand lead placement and its importance in EKG interpretation.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to verbalize an organized approach to the assessment of EKG rhythm strip tracings.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of normal sinus rhythm. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the SA node and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the atria and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the AV node and nursing implications </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics of dysrhythmias originating in the ventricles and nursing implications.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the defining characteristics for conduction defects and nursing implications. </ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify pacemaker rhythms on EKG strips.<ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of electrocardiogram monitoring, interpretation and ways to initiate the appropriate nursing and medical response for patients experiencing dysrhythmias.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.<OL>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Strongly Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Agree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,No Opinion,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,<OL><B>SETTING</B></OL> <OL>Facility or online platform was appropriate for this activity</ol>,Strongly Disagree,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN CCRN-K </ol>",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN CCRN-K </ol>",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN CCRN-K </ol>",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN CCRN-K </ol>",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Dina McDonald, RN, BSN CCRN-K </ol>",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"Overall, this activity was:",Excellent,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"Overall, this activity was:",Very Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"Overall, this activity was:",Good,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"Overall, this activity was:",Fair,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"Overall, this activity was:",Poor,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",Yes,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",No,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",N/A,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,How would you improve this class?,Reduce content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,How would you improve this class?,Increase content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,How would you improve this class?,Update content covered in class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,How would you improve this class?,Improve the instructional methods,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,How would you improve this class?,Make course activities more stimulating,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,How would you improve this class?,Slow the pace of the class,False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
9894,,Questions-0000-28,BASIC DYSRHYTHMIA INTERPRETATION REFRESHER ( EVALUATION SURVEY) 8-9-21,,n14063,,choice,How would you improve this class?,"No improvements needed (appropriate content, instructor, facility, etc.)",False,0,FAIL DUPLICATE TEST: 200,Duplicate test,False
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,It is acceptable to return cold medication stock to the GCS annex on Fridays.,TRUE,False,0,SUCCESS: 200,"New Test with ID 1426 has been created. New Question with ID 10666 has been created (Test ID 1426). New Answer with ID 37259 has been created (Test ID 1426, Question ID 10666).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,It is acceptable to return cold medication stock to the GCS annex on Fridays.,FALSE,True,100,SUCCESS: 200,"New Answer with ID 37260 has been created (Test ID 1426, Question ID 10666).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,Pharmacy technician should complete a full Nucleus inventory of all medications at minimum every ______.,a.	Day,False,0,SUCCESS: 200,"New Question with ID 10667 has been created (Test ID 1426). New Answer with ID 37261 has been created (Test ID 1426, Question ID 10667).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,Pharmacy technician should complete a full Nucleus inventory of all medications at minimum every ______.,b.	Other month,False,0,SUCCESS: 200,"New Answer with ID 37262 has been created (Test ID 1426, Question ID 10667).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,Pharmacy technician should complete a full Nucleus inventory of all medications at minimum every ______.,c.	Month,True,100,SUCCESS: 200,"New Answer with ID 37263 has been created (Test ID 1426, Question ID 10667).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,Pharmacy technician should complete a full Nucleus inventory of all medications at minimum every ______.,d.	Year,False,0,SUCCESS: 200,"New Answer with ID 37264 has been created (Test ID 1426, Question ID 10667).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,Which is not a benefit of managing inventory?,a.	Decreased inventory cost,False,0,SUCCESS: 200,"New Question with ID 10668 has been created (Test ID 1426). New Answer with ID 37265 has been created (Test ID 1426, Question ID 10668).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,Which is not a benefit of managing inventory?,b.	Minimizing drug waste,False,0,SUCCESS: 200,"New Answer with ID 37266 has been created (Test ID 1426, Question ID 10668).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,Which is not a benefit of managing inventory?,c.	Increased inventory turnover,False,0,SUCCESS: 200,"New Answer with ID 37267 has been created (Test ID 1426, Question ID 10668).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,Which is not a benefit of managing inventory?,d.	Increased quantity of expired drugs,True,100,SUCCESS: 200,"New Answer with ID 37268 has been created (Test ID 1426, Question ID 10668).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,"Drugs that will expire in _____ months or less with no current patient needs should be sent back to annex ( GCS) or redistributed ( ACC, NGDC, SHOA)",a.	3,True,100,SUCCESS: 200,"New Question with ID 10669 has been created (Test ID 1426). New Answer with ID 37269 has been created (Test ID 1426, Question ID 10669).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,"Drugs that will expire in _____ months or less with no current patient needs should be sent back to annex ( GCS) or redistributed ( ACC, NGDC, SHOA)",b.	2,False,0,SUCCESS: 200,"New Answer with ID 37270 has been created (Test ID 1426, Question ID 10669).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,"Drugs that will expire in _____ months or less with no current patient needs should be sent back to annex ( GCS) or redistributed ( ACC, NGDC, SHOA)",c.	6,False,0,SUCCESS: 200,"New Answer with ID 37271 has been created (Test ID 1426, Question ID 10669).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,"Drugs that will expire in _____ months or less with no current patient needs should be sent back to annex ( GCS) or redistributed ( ACC, NGDC, SHOA)",d.	4,False,0,SUCCESS: 200,"New Answer with ID 37272 has been created (Test ID 1426, Question ID 10669).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,Irinotecan 250mg dose is ordered.  Which is the optimal vial size combination to minimize waste?,a.	2 x 100mg + 2 x 40mg,False,0,SUCCESS: 200,"New Question with ID 10670 has been created (Test ID 1426). New Answer with ID 37273 has been created (Test ID 1426, Question ID 10670).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,Irinotecan 250mg dose is ordered.  Which is the optimal vial size combination to minimize waste?,b.	1 x 100mg + 4 x 40mg,True,100,SUCCESS: 200,"New Answer with ID 37274 has been created (Test ID 1426, Question ID 10670).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,The product expiration report may be used to identify expiring items within 3 months.,TRUE,True,100,SUCCESS: 200,"New Question with ID 10671 has been created (Test ID 1426). New Answer with ID 37275 has been created (Test ID 1426, Question ID 10671).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,The product expiration report may be used to identify expiring items within 3 months.,FALSE,False,0,SUCCESS: 200,"New Answer with ID 37276 has been created (Test ID 1426, Question ID 10671).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,"Medication should be ordered 5 days prior to treatment for GCS and 2 days prior to treatment for ACC, NGDC, and SHOA.",TRUE,False,0,SUCCESS: 200,"New Question with ID 10672 has been created (Test ID 1426). New Answer with ID 37277 has been created (Test ID 1426, Question ID 10672).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,"Medication should be ordered 5 days prior to treatment for GCS and 2 days prior to treatment for ACC, NGDC, and SHOA.",FALSE,True,100,SUCCESS: 200,"New Answer with ID 37278 has been created (Test ID 1426, Question ID 10672).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,Pharmacy staff should plan 3-4 additional days out for holiday closures and inclement weather and other shipping delays.,TRUE,True,100,SUCCESS: 200,"New Question with ID 10673 has been created (Test ID 1426). New Answer with ID 37279 has been created (Test ID 1426, Question ID 10673).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,Pharmacy staff should plan 3-4 additional days out for holiday closures and inclement weather and other shipping delays.,FALSE,False,0,SUCCESS: 200,"New Answer with ID 37280 has been created (Test ID 1426, Question ID 10673).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,Auto reorder is a useful tool for managing fast moving items.,TRUE,True,100,SUCCESS: 200,"New Question with ID 10674 has been created (Test ID 1426). New Answer with ID 37281 has been created (Test ID 1426, Question ID 10674).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,Auto reorder is a useful tool for managing fast moving items.,FALSE,False,0,SUCCESS: 200,"New Answer with ID 37282 has been created (Test ID 1426, Question ID 10674).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,"When restocking and dispensing medication, pharmacy technician should verify:",a.	NDC#,False,0,SUCCESS: 200,"New Question with ID 10675 has been created (Test ID 1426). New Answer with ID 37283 has been created (Test ID 1426, Question ID 10675).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,"When restocking and dispensing medication, pharmacy technician should verify:",b.	Lot #,False,0,SUCCESS: 200,"New Answer with ID 37284 has been created (Test ID 1426, Question ID 10675).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,"When restocking and dispensing medication, pharmacy technician should verify:",c.	Expiration date,False,0,SUCCESS: 200,"New Answer with ID 37285 has been created (Test ID 1426, Question ID 10675).",True
10080,Elearning-0000-1851,Elearning-0000-1851,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE,n13623,2021 RX TECH INVENTORY MANAGEMENT AND AVOIDABLE WASTE- n13623,choice,"When restocking and dispensing medication, pharmacy technician should verify:",d.	All the above,True,100,SUCCESS: 200,"New Answer with ID 37286 has been created (Test ID 1426, Question ID 10675).",True
9996,Elearning-0000-1767,Elearning-0000-1767,2021 PULMONARY HYPERTENSION FOR RT CBL,2021 PULMONARY HYPERTENSION FOR RT CBL,n13857,2021 PULMONARY HYPERTENSION FOR RT CBL- n13857,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the 2021 Pulmonary Hypertension for RT CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",TRUE,True,100,SUCCESS: 200,"New Test with ID 1427 has been created. New Question with ID 10676 has been created (Test ID 1427). New Answer with ID 37287 has been created (Test ID 1427, Question ID 10676).",True
9996,Elearning-0000-1767,Elearning-0000-1767,2021 PULMONARY HYPERTENSION FOR RT CBL,2021 PULMONARY HYPERTENSION FOR RT CBL,n13857,2021 PULMONARY HYPERTENSION FOR RT CBL- n13857,choice,"For questions about these statements, contact your manager or clinician.<br><br> I have reviewed the 2021 Pulmonary Hypertension for RT CBL content.<br> I understand that I am responsible for the information.<br> I know where and how to get my questions answered about this topic.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br>",FALSE,False,0,SUCCESS: 200,"New Answer with ID 37288 has been created (Test ID 1427, Question ID 10676).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The normal oxygen saturation for a healthy adult is about:,97 % - 98 %,True,100,SUCCESS: 200,"New Test with ID 1428 has been created. New Question with ID 10677 has been created (Test ID 1428). New Answer with ID 37289 has been created (Test ID 1428, Question ID 10677).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The normal oxygen saturation for a healthy adult is about:,92 % - 96 %,False,0,SUCCESS: 200,"New Answer with ID 37290 has been created (Test ID 1428, Question ID 10677).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The normal oxygen saturation for a healthy adult is about:,91 % - 93 %,False,0,SUCCESS: 200,"New Answer with ID 37291 has been created (Test ID 1428, Question ID 10677).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The normal oxygen saturation for a healthy adult is about:,88 % - 90 %,False,0,SUCCESS: 200,"New Answer with ID 37292 has been created (Test ID 1428, Question ID 10677).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"The physician orders the opiate Fentanyl (Sublimaze) 25 mcg and Midazolam (Versed) 2 mg to be given IV. You draw up and administer the drugs as prescribed. All of the following statements are true about Benzodiazipines (Valium, Versed) EXC EPT:",They are used to relieve pain.,True,100,SUCCESS: 200,"New Question with ID 10678 has been created (Test ID 1428). New Answer with ID 37293 has been created (Test ID 1428, Question ID 10678).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"The physician orders the opiate Fentanyl (Sublimaze) 25 mcg and Midazolam (Versed) 2 mg to be given IV. You draw up and administer the drugs as prescribed. All of the following statements are true about Benzodiazipines (Valium, Versed) EXC EPT:",They generally relieve nervousness or tension.,False,0,SUCCESS: 200,"New Answer with ID 37294 has been created (Test ID 1428, Question ID 10678).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"The physician orders the opiate Fentanyl (Sublimaze) 25 mcg and Midazolam (Versed) 2 mg to be given IV. You draw up and administer the drugs as prescribed. All of the following statements are true about Benzodiazipines (Valium, Versed) EXC EPT:",The dosage is usually lower when given with an opioid.,False,0,SUCCESS: 200,"New Answer with ID 37295 has been created (Test ID 1428, Question ID 10678).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"The physician orders the opiate Fentanyl (Sublimaze) 25 mcg and Midazolam (Versed) 2 mg to be given IV. You draw up and administer the drugs as prescribed. All of the following statements are true about Benzodiazipines (Valium, Versed) EXC EPT:",They may cause respiratory depression.,False,0,SUCCESS: 200,"New Answer with ID 37296 has been created (Test ID 1428, Question ID 10678).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Opiates (fentanyl, morphine, meperidine) can cause all of the following side effects EXCEPT:",Hypotension,False,0,SUCCESS: 200,"New Question with ID 10679 has been created (Test ID 1428). New Answer with ID 37297 has been created (Test ID 1428, Question ID 10679).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Opiates (fentanyl, morphine, meperidine) can cause all of the following side effects EXCEPT:",Apnea,False,0,SUCCESS: 200,"New Answer with ID 37298 has been created (Test ID 1428, Question ID 10679).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Opiates (fentanyl, morphine, meperidine) can cause all of the following side effects EXCEPT:",Hypoglycemia,True,100,SUCCESS: 200,"New Answer with ID 37299 has been created (Test ID 1428, Question ID 10679).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Opiates (fentanyl, morphine, meperidine) can cause all of the following side effects EXCEPT:",Respiratory depression,False,0,SUCCESS: 200,"New Answer with ID 37300 has been created (Test ID 1428, Question ID 10679).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,When administering Flumazeril (Romazicon) you should monitor the patient for all of the following EXCEPT:,Resedation / respiratory depression,False,0,SUCCESS: 200,"New Question with ID 10680 has been created (Test ID 1428). New Answer with ID 37301 has been created (Test ID 1428, Question ID 10680).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,When administering Flumazeril (Romazicon) you should monitor the patient for all of the following EXCEPT:,Seizures,False,0,SUCCESS: 200,"New Answer with ID 37302 has been created (Test ID 1428, Question ID 10680).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,When administering Flumazeril (Romazicon) you should monitor the patient for all of the following EXCEPT:,"Withdrawal symptoms (sweating, nausea, vomiting, etc)",False,0,SUCCESS: 200,"New Answer with ID 37303 has been created (Test ID 1428, Question ID 10680).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,When administering Flumazeril (Romazicon) you should monitor the patient for all of the following EXCEPT:,Retrograde amnesia (recent memory loss before/during procedure),True,100,SUCCESS: 200,"New Answer with ID 37304 has been created (Test ID 1428, Question ID 10680).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"After receiving the Flumazenil (Romazicon), Mrs. N. becomes less anxious; her oxygen saturation quickly returns to 98%, pulse 80, BP 110/70. Mrs. N. appears adequately sedated and the MD wishes to begin the case. Which one of the following  observations would alert you if Mrs. N. became over sedated?",Slurred speech,False,0,SUCCESS: 200,"New Question with ID 10681 has been created (Test ID 1428). New Answer with ID 37305 has been created (Test ID 1428, Question ID 10681).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"After receiving the Flumazenil (Romazicon), Mrs. N. becomes less anxious; her oxygen saturation quickly returns to 98%, pulse 80, BP 110/70. Mrs. N. appears adequately sedated and the MD wishes to begin the case. Which one of the following  observations would alert you if Mrs. N. became over sedated?",Turns head and responds to a loud noise,False,0,SUCCESS: 200,"New Answer with ID 37306 has been created (Test ID 1428, Question ID 10681).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"After receiving the Flumazenil (Romazicon), Mrs. N. becomes less anxious; her oxygen saturation quickly returns to 98%, pulse 80, BP 110/70. Mrs. N. appears adequately sedated and the MD wishes to begin the case. Which one of the following  observations would alert you if Mrs. N. became over sedated?",Drowsy,False,0,SUCCESS: 200,"New Answer with ID 37307 has been created (Test ID 1428, Question ID 10681).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"After receiving the Flumazenil (Romazicon), Mrs. N. becomes less anxious; her oxygen saturation quickly returns to 98%, pulse 80, BP 110/70. Mrs. N. appears adequately sedated and the MD wishes to begin the case. Which one of the following  observations would alert you if Mrs. N. became over sedated?","Cold, clammy skin",True,100,SUCCESS: 200,"New Answer with ID 37308 has been created (Test ID 1428, Question ID 10681).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The procedure is nearly over when Mrs. N.'s blood pessure suddenly drops to 75/55. You should consider all of the following actions EXCEPT:,Place the patient in the Trendelenburg position,False,0,SUCCESS: 200,"New Question with ID 10682 has been created (Test ID 1428). New Answer with ID 37309 has been created (Test ID 1428, Question ID 10682).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The procedure is nearly over when Mrs. N.'s blood pessure suddenly drops to 75/55. You should consider all of the following actions EXCEPT:,Give Versed 0.5 mg IV push,True,100,SUCCESS: 200,"New Answer with ID 37310 has been created (Test ID 1428, Question ID 10682).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The procedure is nearly over when Mrs. N.'s blood pessure suddenly drops to 75/55. You should consider all of the following actions EXCEPT:,Increase the IV fluids,False,0,SUCCESS: 200,"New Answer with ID 37311 has been created (Test ID 1428, Question ID 10682).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The procedure is nearly over when Mrs. N.'s blood pessure suddenly drops to 75/55. You should consider all of the following actions EXCEPT:,Notify the MD,False,0,SUCCESS: 200,"New Answer with ID 37312 has been created (Test ID 1428, Question ID 10682).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Possible causes of hypotension during moderate sedation include all of the following EXCEPT:,Slow heart rate,False,0,SUCCESS: 200,"New Question with ID 10683 has been created (Test ID 1428). New Answer with ID 37313 has been created (Test ID 1428, Question ID 10683).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Possible causes of hypotension during moderate sedation include all of the following EXCEPT:,Arrhythmia,False,0,SUCCESS: 200,"New Answer with ID 37314 has been created (Test ID 1428, Question ID 10683).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Possible causes of hypotension during moderate sedation include all of the following EXCEPT:,Pain,True,100,SUCCESS: 200,"New Answer with ID 37315 has been created (Test ID 1428, Question ID 10683).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Possible causes of hypotension during moderate sedation include all of the following EXCEPT:,Acute hypoxia,False,0,SUCCESS: 200,"New Answer with ID 37316 has been created (Test ID 1428, Question ID 10683).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"In vasovagal syncope, you would expect to see all of the following EXCEPT:",Bradycardia,False,0,SUCCESS: 200,"New Question with ID 10684 has been created (Test ID 1428). New Answer with ID 37317 has been created (Test ID 1428, Question ID 10684).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"In vasovagal syncope, you would expect to see all of the following EXCEPT:",Dizziness/loss of consciousness,False,0,SUCCESS: 200,"New Answer with ID 37318 has been created (Test ID 1428, Question ID 10684).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"In vasovagal syncope, you would expect to see all of the following EXCEPT:",Nausea,False,0,SUCCESS: 200,"New Answer with ID 37319 has been created (Test ID 1428, Question ID 10684).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"In vasovagal syncope, you would expect to see all of the following EXCEPT:",Respiratory distress,True,100,SUCCESS: 200,"New Answer with ID 37320 has been created (Test ID 1428, Question ID 10684).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Bradycardia is defined as a heart rate of under:,80 beats/minutes,False,0,SUCCESS: 200,"New Question with ID 10685 has been created (Test ID 1428). New Answer with ID 37321 has been created (Test ID 1428, Question ID 10685).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Bradycardia is defined as a heart rate of under:,60 beats/minute,True,100,SUCCESS: 200,"New Answer with ID 37322 has been created (Test ID 1428, Question ID 10685).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Bradycardia is defined as a heart rate of under:,50 beats/minute,False,0,SUCCESS: 200,"New Answer with ID 37323 has been created (Test ID 1428, Question ID 10685).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Bradycardia is defined as a heart rate of under:,40 beats/minute,False,0,SUCCESS: 200,"New Answer with ID 37324 has been created (Test ID 1428, Question ID 10685).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Intravenous moderate sedation is produced by administration of drugs for:,Anxiety and combative behavior,False,0,SUCCESS: 200,"New Question with ID 10686 has been created (Test ID 1428). New Answer with ID 37325 has been created (Test ID 1428, Question ID 10686).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Intravenous moderate sedation is produced by administration of drugs for:,The performance of brief diagnostic procedures or therapeutic interventions,True,100,SUCCESS: 200,"New Answer with ID 37326 has been created (Test ID 1428, Question ID 10686).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Intravenous moderate sedation is produced by administration of drugs for:,Acute onset pain,False,0,SUCCESS: 200,"New Answer with ID 37327 has been created (Test ID 1428, Question ID 10686).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Intravenous moderate sedation is produced by administration of drugs for:,All of the above,False,0,SUCCESS: 200,"New Answer with ID 37328 has been created (Test ID 1428, Question ID 10686).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,While under moderate sedation a patient has a depressed level of consciousness but:,Retains the ability to maintain a patent airway,False,0,SUCCESS: 200,"New Question with ID 10687 has been created (Test ID 1428). New Answer with ID 37329 has been created (Test ID 1428, Question ID 10687).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,While under moderate sedation a patient has a depressed level of consciousness but:,Responds appropriately to physical stimulation,False,0,SUCCESS: 200,"New Answer with ID 37330 has been created (Test ID 1428, Question ID 10687).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,While under moderate sedation a patient has a depressed level of consciousness but:,Follows verbal commands,False,0,SUCCESS: 200,"New Answer with ID 37331 has been created (Test ID 1428, Question ID 10687).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,While under moderate sedation a patient has a depressed level of consciousness but:,All of the above,True,100,SUCCESS: 200,"New Answer with ID 37332 has been created (Test ID 1428, Question ID 10687).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Deep sedation exists when the patient:,Has a decreased level of consciousness,False,0,SUCCESS: 200,"New Question with ID 10688 has been created (Test ID 1428). New Answer with ID 37333 has been created (Test ID 1428, Question ID 10688).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Deep sedation exists when the patient:,A partial or complete loss of protective reflexes,False,0,SUCCESS: 200,"New Answer with ID 37334 has been created (Test ID 1428, Question ID 10688).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Deep sedation exists when the patient:,Can no longer respond to verbal stimuli,False,0,SUCCESS: 200,"New Answer with ID 37335 has been created (Test ID 1428, Question ID 10688).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Deep sedation exists when the patient:,All of the above,True,100,SUCCESS: 200,"New Answer with ID 37336 has been created (Test ID 1428, Question ID 10688).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The most common adverse reaction from medications used for IV sedation is:,Respiratory depression,True,100,SUCCESS: 200,"New Question with ID 10689 has been created (Test ID 1428). New Answer with ID 37337 has been created (Test ID 1428, Question ID 10689).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The most common adverse reaction from medications used for IV sedation is:,Respiratory arrest,False,0,SUCCESS: 200,"New Answer with ID 37338 has been created (Test ID 1428, Question ID 10689).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The most common adverse reaction from medications used for IV sedation is:,Extrapyramidal symptoms,False,0,SUCCESS: 200,"New Answer with ID 37339 has been created (Test ID 1428, Question ID 10689).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The most common adverse reaction from medications used for IV sedation is:,Drug addiction,False,0,SUCCESS: 200,"New Answer with ID 37340 has been created (Test ID 1428, Question ID 10689).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Minimal monitoring requirements for moderate sedation include all of the following EXCEPT:,Heart rate,False,0,SUCCESS: 200,"New Question with ID 10690 has been created (Test ID 1428). New Answer with ID 37341 has been created (Test ID 1428, Question ID 10690).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Minimal monitoring requirements for moderate sedation include all of the following EXCEPT:,Blood pressure,False,0,SUCCESS: 200,"New Answer with ID 37342 has been created (Test ID 1428, Question ID 10690).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Minimal monitoring requirements for moderate sedation include all of the following EXCEPT:,Respirations,False,0,SUCCESS: 200,"New Answer with ID 37343 has been created (Test ID 1428, Question ID 10690).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Minimal monitoring requirements for moderate sedation include all of the following EXCEPT:,O2 saturation,False,0,SUCCESS: 200,"New Answer with ID 37344 has been created (Test ID 1428, Question ID 10690).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Minimal monitoring requirements for moderate sedation include all of the following EXCEPT:,Blood gases & End Tidal O2,True,100,SUCCESS: 200,"New Answer with ID 37345 has been created (Test ID 1428, Question ID 10690).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Once IV sedation is given during a procedure, vital signs and O2 saturation must be monitored and recorded every:",Q 2 hours,False,0,SUCCESS: 200,"New Question with ID 10691 has been created (Test ID 1428). New Answer with ID 37346 has been created (Test ID 1428, Question ID 10691).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Once IV sedation is given during a procedure, vital signs and O2 saturation must be monitored and recorded every:",Q 30 minutes,False,0,SUCCESS: 200,"New Answer with ID 37347 has been created (Test ID 1428, Question ID 10691).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Once IV sedation is given during a procedure, vital signs and O2 saturation must be monitored and recorded every:",Q15 minutes,False,0,SUCCESS: 200,"New Answer with ID 37348 has been created (Test ID 1428, Question ID 10691).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Once IV sedation is given during a procedure, vital signs and O2 saturation must be monitored and recorded every:",Q 5 minutes,True,100,SUCCESS: 200,"New Answer with ID 37349 has been created (Test ID 1428, Question ID 10691).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Read the following scenario and then proceed to the test questions.  Mrs. N. is having an outpatient procedure early in the morning that requires receiving moderate sedation.  She is a cooperative, alert, 63-year old woman weighing 90 pou nds (41 kg).  She has been a diabetic under good control for the last 10 years by diet.  She is not on insulin.  She had a mild case of osteoarthritis in her spine, but otherwise no significant prior health history or conditions.  Vital signs on admission are BP 100/80, Pulse 88, and Respirations 16.  Her initial pulse oximetry reading on room air is 97%.  Fentanyl (Sublimaze) and Midazolam (Versed) will be used for sedation during the procedure.   All of the following conditions except_________ suggest that Mrs. N may need a lower than usual dose of sedation medications.",A.  Age,False,0,SUCCESS: 200,"New Question with ID 10692 has been created (Test ID 1428). New Answer with ID 37350 has been created (Test ID 1428, Question ID 10692).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Read the following scenario and then proceed to the test questions.  Mrs. N. is having an outpatient procedure early in the morning that requires receiving moderate sedation.  She is a cooperative, alert, 63-year old woman weighing 90 pou nds (41 kg).  She has been a diabetic under good control for the last 10 years by diet.  She is not on insulin.  She had a mild case of osteoarthritis in her spine, but otherwise no significant prior health history or conditions.  Vital signs on admission are BP 100/80, Pulse 88, and Respirations 16.  Her initial pulse oximetry reading on room air is 97%.  Fentanyl (Sublimaze) and Midazolam (Versed) will be used for sedation during the procedure.   All of the following conditions except_________ suggest that Mrs. N may need a lower than usual dose of sedation medications.",B.  Weight,False,0,SUCCESS: 200,"New Answer with ID 37351 has been created (Test ID 1428, Question ID 10692).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Read the following scenario and then proceed to the test questions.  Mrs. N. is having an outpatient procedure early in the morning that requires receiving moderate sedation.  She is a cooperative, alert, 63-year old woman weighing 90 pou nds (41 kg).  She has been a diabetic under good control for the last 10 years by diet.  She is not on insulin.  She had a mild case of osteoarthritis in her spine, but otherwise no significant prior health history or conditions.  Vital signs on admission are BP 100/80, Pulse 88, and Respirations 16.  Her initial pulse oximetry reading on room air is 97%.  Fentanyl (Sublimaze) and Midazolam (Versed) will be used for sedation during the procedure.   All of the following conditions except_________ suggest that Mrs. N may need a lower than usual dose of sedation medications.",C.  Renal Failure,False,0,SUCCESS: 200,"New Answer with ID 37352 has been created (Test ID 1428, Question ID 10692).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Read the following scenario and then proceed to the test questions.  Mrs. N. is having an outpatient procedure early in the morning that requires receiving moderate sedation.  She is a cooperative, alert, 63-year old woman weighing 90 pou nds (41 kg).  She has been a diabetic under good control for the last 10 years by diet.  She is not on insulin.  She had a mild case of osteoarthritis in her spine, but otherwise no significant prior health history or conditions.  Vital signs on admission are BP 100/80, Pulse 88, and Respirations 16.  Her initial pulse oximetry reading on room air is 97%.  Fentanyl (Sublimaze) and Midazolam (Versed) will be used for sedation during the procedure.   All of the following conditions except_________ suggest that Mrs. N may need a lower than usual dose of sedation medications.",D.  Osteoarthritis,True,100,SUCCESS: 200,"New Answer with ID 37353 has been created (Test ID 1428, Question ID 10692).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,At the beginning of the procedure you place the pulse oximetry device on Mrs. N's finger  and observe a reading of 70%.  All of the following factors except_________ may affect the ability to get an accurate pulse oximetry reading.,A.  Skin moisture,False,0,SUCCESS: 200,"New Question with ID 10693 has been created (Test ID 1428). New Answer with ID 37354 has been created (Test ID 1428, Question ID 10693).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,At the beginning of the procedure you place the pulse oximetry device on Mrs. N's finger  and observe a reading of 70%.  All of the following factors except_________ may affect the ability to get an accurate pulse oximetry reading.,B.  Skin pigment,True,100,SUCCESS: 200,"New Answer with ID 37355 has been created (Test ID 1428, Question ID 10693).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,At the beginning of the procedure you place the pulse oximetry device on Mrs. N's finger  and observe a reading of 70%.  All of the following factors except_________ may affect the ability to get an accurate pulse oximetry reading.,C.  Fingernail polish,False,0,SUCCESS: 200,"New Answer with ID 37356 has been created (Test ID 1428, Question ID 10693).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,At the beginning of the procedure you place the pulse oximetry device on Mrs. N's finger  and observe a reading of 70%.  All of the following factors except_________ may affect the ability to get an accurate pulse oximetry reading.,D.  Hypotension,False,0,SUCCESS: 200,"New Answer with ID 37357 has been created (Test ID 1428, Question ID 10693).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Prior to the procedure and the administration of sedation, which of the following should be obtained and documented?","A.  Vital sign including BP, heart rate, respiratory rate and pain level",False,0,SUCCESS: 200,"New Question with ID 10694 has been created (Test ID 1428). New Answer with ID 37358 has been created (Test ID 1428, Question ID 10694).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Prior to the procedure and the administration of sedation, which of the following should be obtained and documented?",B.  Level of consciousness,False,0,SUCCESS: 200,"New Answer with ID 37359 has been created (Test ID 1428, Question ID 10694).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Prior to the procedure and the administration of sedation, which of the following should be obtained and documented?","C.  Verification of correct patient, procedure, side/site, National Patient Safety Goal, Universal Protocol",False,0,SUCCESS: 200,"New Answer with ID 37360 has been created (Test ID 1428, Question ID 10694).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Prior to the procedure and the administration of sedation, which of the following should be obtained and documented?",D.  All of the above,True,100,SUCCESS: 200,"New Answer with ID 37361 has been created (Test ID 1428, Question ID 10694).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Initial signs and symptoms of hypoxia include all of the following except:,A.  Anxiety,False,0,SUCCESS: 200,"New Question with ID 10695 has been created (Test ID 1428). New Answer with ID 37362 has been created (Test ID 1428, Question ID 10695).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Initial signs and symptoms of hypoxia include all of the following except:,B.  Increased pulse,False,0,SUCCESS: 200,"New Answer with ID 37363 has been created (Test ID 1428, Question ID 10695).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Initial signs and symptoms of hypoxia include all of the following except:,C.  Decreased blood pressure,True,100,SUCCESS: 200,"New Answer with ID 37364 has been created (Test ID 1428, Question ID 10695).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Initial signs and symptoms of hypoxia include all of the following except:,D.  Sweating,False,0,SUCCESS: 200,"New Answer with ID 37365 has been created (Test ID 1428, Question ID 10695).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Initial signs and symptoms of hypoxia include all of the following except:,E.  Pallor,False,0,SUCCESS: 200,"New Answer with ID 37366 has been created (Test ID 1428, Question ID 10695).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Which patient in general may require a higher dose of sedation medications than usual?,A.  A disoriented patient,False,0,SUCCESS: 200,"New Question with ID 10696 has been created (Test ID 1428). New Answer with ID 37367 has been created (Test ID 1428, Question ID 10696).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Which patient in general may require a higher dose of sedation medications than usual?,B.  A patient with a drug abuse history,True,100,SUCCESS: 200,"New Answer with ID 37368 has been created (Test ID 1428, Question ID 10696).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Which patient in general may require a higher dose of sedation medications than usual?,C.  An elderly patient,False,0,SUCCESS: 200,"New Answer with ID 37369 has been created (Test ID 1428, Question ID 10696).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Which patient in general may require a higher dose of sedation medications than usual?,D.  A patient who has a history of seizures,False,0,SUCCESS: 200,"New Answer with ID 37370 has been created (Test ID 1428, Question ID 10696).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Following administration of sedation medications, you continue to open supplies for the procedure.  Hearing the oximetry alarm and observing the pulse oximetry reading, you immediately assess Mrs. N. and find her to be somewhat restless, wi th a heart rate of 108, blood pressure 130/85, respirations 10/minute and oxygen saturation at 85% (baseline vital signs were heart rate 88, blood pressure 100/80, respirations 16/minute, pulse oximetry 97% and 0 pain). The most probable cause of Mrs. N's symptoms is",A.  Angina,False,0,SUCCESS: 200,"New Question with ID 10697 has been created (Test ID 1428). New Answer with ID 37371 has been created (Test ID 1428, Question ID 10697).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Following administration of sedation medications, you continue to open supplies for the procedure.  Hearing the oximetry alarm and observing the pulse oximetry reading, you immediately assess Mrs. N. and find her to be somewhat restless, wi th a heart rate of 108, blood pressure 130/85, respirations 10/minute and oxygen saturation at 85% (baseline vital signs were heart rate 88, blood pressure 100/80, respirations 16/minute, pulse oximetry 97% and 0 pain). The most probable cause of Mrs. N's symptoms is",B.  Hypoxia,True,100,SUCCESS: 200,"New Answer with ID 37372 has been created (Test ID 1428, Question ID 10697).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Following administration of sedation medications, you continue to open supplies for the procedure.  Hearing the oximetry alarm and observing the pulse oximetry reading, you immediately assess Mrs. N. and find her to be somewhat restless, wi th a heart rate of 108, blood pressure 130/85, respirations 10/minute and oxygen saturation at 85% (baseline vital signs were heart rate 88, blood pressure 100/80, respirations 16/minute, pulse oximetry 97% and 0 pain). The most probable cause of Mrs. N's symptoms is",C.  Hypoglycemia,False,0,SUCCESS: 200,"New Answer with ID 37373 has been created (Test ID 1428, Question ID 10697).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Following administration of sedation medications, you continue to open supplies for the procedure.  Hearing the oximetry alarm and observing the pulse oximetry reading, you immediately assess Mrs. N. and find her to be somewhat restless, wi th a heart rate of 108, blood pressure 130/85, respirations 10/minute and oxygen saturation at 85% (baseline vital signs were heart rate 88, blood pressure 100/80, respirations 16/minute, pulse oximetry 97% and 0 pain). The most probable cause of Mrs. N's symptoms is",D.  Pulmonary edema,False,0,SUCCESS: 200,"New Answer with ID 37374 has been created (Test ID 1428, Question ID 10697).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,You report your findings to the physician who orders Flumazenil (Romazicon) 0.2 mg IV push. You have a syringe labeled 0.5 mg Flumazenil in 5 cc's.  How many ml's should you administer?,A.  1 ml,False,0,SUCCESS: 200,"New Question with ID 10698 has been created (Test ID 1428). New Answer with ID 37375 has been created (Test ID 1428, Question ID 10698).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,You report your findings to the physician who orders Flumazenil (Romazicon) 0.2 mg IV push. You have a syringe labeled 0.5 mg Flumazenil in 5 cc's.  How many ml's should you administer?,B.  2 mls,True,100,SUCCESS: 200,"New Answer with ID 37376 has been created (Test ID 1428, Question ID 10698).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,You report your findings to the physician who orders Flumazenil (Romazicon) 0.2 mg IV push. You have a syringe labeled 0.5 mg Flumazenil in 5 cc's.  How many ml's should you administer?,C.  0.5 mls,False,0,SUCCESS: 200,"New Answer with ID 37377 has been created (Test ID 1428, Question ID 10698).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,You report your findings to the physician who orders Flumazenil (Romazicon) 0.2 mg IV push. You have a syringe labeled 0.5 mg Flumazenil in 5 cc's.  How many ml's should you administer?,D.  0.2 mls,False,0,SUCCESS: 200,"New Answer with ID 37378 has been created (Test ID 1428, Question ID 10698).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"If Mrs. N were to have a sudden drop in her heart rate to 35 beats/minute, which would be the most appropriate medication to give first?",A.  Atropine 0.5-1 mg IV push,True,100,SUCCESS: 200,"New Question with ID 10699 has been created (Test ID 1428). New Answer with ID 37379 has been created (Test ID 1428, Question ID 10699).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"If Mrs. N were to have a sudden drop in her heart rate to 35 beats/minute, which would be the most appropriate medication to give first?",B.  Epinephrine ( Adrenaline) 3-5 mg IV push,False,0,SUCCESS: 200,"New Answer with ID 37380 has been created (Test ID 1428, Question ID 10699).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"If Mrs. N were to have a sudden drop in her heart rate to 35 beats/minute, which would be the most appropriate medication to give first?",C.  Lidocaine 40 mg IV push,False,0,SUCCESS: 200,"New Answer with ID 37381 has been created (Test ID 1428, Question ID 10699).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"If Mrs. N were to have a sudden drop in her heart rate to 35 beats/minute, which would be the most appropriate medication to give first?",D.  Naloxone ( Narcan) 0.1 - 0.2 mg IV push,False,0,SUCCESS: 200,"New Answer with ID 37382 has been created (Test ID 1428, Question ID 10699).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"The most commonly used antagonist (reversing agent) for opiates (Fentanyl, Morphine, and Demerol) is:",A.  Flumazenil ( Romazicon),False,0,SUCCESS: 200,"New Question with ID 10700 has been created (Test ID 1428). New Answer with ID 37383 has been created (Test ID 1428, Question ID 10700).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"The most commonly used antagonist (reversing agent) for opiates (Fentanyl, Morphine, and Demerol) is:",B.  Naloxone ( Narcan),True,100,SUCCESS: 200,"New Answer with ID 37384 has been created (Test ID 1428, Question ID 10700).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"The most commonly used antagonist (reversing agent) for opiates (Fentanyl, Morphine, and Demerol) is:",C.  Midazolam (Versed),False,0,SUCCESS: 200,"New Answer with ID 37385 has been created (Test ID 1428, Question ID 10700).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"The most commonly used antagonist (reversing agent) for opiates (Fentanyl, Morphine, and Demerol) is:",D.  Atropine,False,0,SUCCESS: 200,"New Answer with ID 37386 has been created (Test ID 1428, Question ID 10700).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Mrs. N. completes the procedure without further incident.  She is being prepared for discharge.  Which of the following situations best meets the hospital criteria to discharge Mrs. N. after sedation?   Note: baseline vital signs are blood pressure (BP) 100/80, heart rate (P)88, respirations/minute (R)16, and oxygen saturation (O2 Sat) 97%","A.  BP 150/80, P 78/min, R 16, O2 Sat 94%",False,0,SUCCESS: 200,"New Question with ID 10701 has been created (Test ID 1428). New Answer with ID 37387 has been created (Test ID 1428, Question ID 10701).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Mrs. N. completes the procedure without further incident.  She is being prepared for discharge.  Which of the following situations best meets the hospital criteria to discharge Mrs. N. after sedation?   Note: baseline vital signs are blood pressure (BP) 100/80, heart rate (P)88, respirations/minute (R)16, and oxygen saturation (O2 Sat) 97%","B.  BP 90/60, P 80/min, R 14, O2 Sat 90%",False,0,SUCCESS: 200,"New Answer with ID 37388 has been created (Test ID 1428, Question ID 10701).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Mrs. N. completes the procedure without further incident.  She is being prepared for discharge.  Which of the following situations best meets the hospital criteria to discharge Mrs. N. after sedation?   Note: baseline vital signs are blood pressure (BP) 100/80, heart rate (P)88, respirations/minute (R)16, and oxygen saturation (O2 Sat) 97%","C.  BP 90/60, P 120/min, R 18, O2 Sat 97%",False,0,SUCCESS: 200,"New Answer with ID 37389 has been created (Test ID 1428, Question ID 10701).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"Mrs. N. completes the procedure without further incident.  She is being prepared for discharge.  Which of the following situations best meets the hospital criteria to discharge Mrs. N. after sedation?   Note: baseline vital signs are blood pressure (BP) 100/80, heart rate (P)88, respirations/minute (R)16, and oxygen saturation (O2 Sat) 97%","D.  BP 105/70, P 90/min, R 14, O2 Sat 97%",True,100,SUCCESS: 200,"New Answer with ID 37390 has been created (Test ID 1428, Question ID 10701).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"The following agent used for IV sedation is contraindicated in patients receiving MAO inhibitors ( Marplan, Nardil, Parnate, etc.)",A.  Morphine Sulfate,False,0,SUCCESS: 200,"New Question with ID 10702 has been created (Test ID 1428). New Answer with ID 37391 has been created (Test ID 1428, Question ID 10702).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"The following agent used for IV sedation is contraindicated in patients receiving MAO inhibitors ( Marplan, Nardil, Parnate, etc.)",B.  Demerol ( Meperidine),True,100,SUCCESS: 200,"New Answer with ID 37392 has been created (Test ID 1428, Question ID 10702).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"The following agent used for IV sedation is contraindicated in patients receiving MAO inhibitors ( Marplan, Nardil, Parnate, etc.)",C.  Fentanyl,False,0,SUCCESS: 200,"New Answer with ID 37393 has been created (Test ID 1428, Question ID 10702).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"The following agent used for IV sedation is contraindicated in patients receiving MAO inhibitors ( Marplan, Nardil, Parnate, etc.)",D.  Ativan (Lorazepam),False,0,SUCCESS: 200,"New Answer with ID 37394 has been created (Test ID 1428, Question ID 10702).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The following benzodiazepine can safely be used during pregnancy:,A.  Versed ( Midazolam),False,0,SUCCESS: 200,"New Question with ID 10703 has been created (Test ID 1428). New Answer with ID 37395 has been created (Test ID 1428, Question ID 10703).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The following benzodiazepine can safely be used during pregnancy:,B.  Valium ( Diazepam),False,0,SUCCESS: 200,"New Answer with ID 37396 has been created (Test ID 1428, Question ID 10703).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The following benzodiazepine can safely be used during pregnancy:,C.  Didrex ( Benzphetamine),False,0,SUCCESS: 200,"New Answer with ID 37397 has been created (Test ID 1428, Question ID 10703).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The following benzodiazepine can safely be used during pregnancy:,D.  Xanax (Alprazolam),False,0,SUCCESS: 200,"New Answer with ID 37398 has been created (Test ID 1428, Question ID 10703).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The following benzodiazepine can safely be used during pregnancy:,E.  None of the above,True,100,SUCCESS: 200,"New Answer with ID 37399 has been created (Test ID 1428, Question ID 10703).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The following drugs may be administered by an RN for sedation except:,A.  Ativan  (Lorazepam),False,0,SUCCESS: 200,"New Question with ID 10704 has been created (Test ID 1428). New Answer with ID 37400 has been created (Test ID 1428, Question ID 10704).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The following drugs may be administered by an RN for sedation except:,B.  Demerol (Meperedine),False,0,SUCCESS: 200,"New Answer with ID 37401 has been created (Test ID 1428, Question ID 10704).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The following drugs may be administered by an RN for sedation except:,C.  Benadryl ( Diphenhydramine),False,0,SUCCESS: 200,"New Answer with ID 37402 has been created (Test ID 1428, Question ID 10704).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The following drugs may be administered by an RN for sedation except:,D.  Morphine,False,0,SUCCESS: 200,"New Answer with ID 37403 has been created (Test ID 1428, Question ID 10704).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The following drugs may be administered by an RN for sedation except:,E.  Propofol (Dipravin) and Ketamine ( Ketalar),True,100,SUCCESS: 200,"New Answer with ID 37404 has been created (Test ID 1428, Question ID 10704).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,The following drugs may be administered by an RN for sedation except:,F.  Versed (Midazolam),False,0,SUCCESS: 200,"New Answer with ID 37405 has been created (Test ID 1428, Question ID 10704).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"When a patient receives a reversal agent, either during the procedure or in the recovery area:",A.  The recovery does not change and the patient may be discharged according to recovery criteria,False,0,SUCCESS: 200,"New Question with ID 10705 has been created (Test ID 1428). New Answer with ID 37406 has been created (Test ID 1428, Question ID 10705).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"When a patient receives a reversal agent, either during the procedure or in the recovery area:",B.  The recovery time is extended a minimum of 90 minutes and the patient is assessed during the recovery period.,True,100,SUCCESS: 200,"New Answer with ID 37407 has been created (Test ID 1428, Question ID 10705).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"When a patient receives a reversal agent, either during the procedure or in the recovery area:",C.  The patient must be admitted to the PACU,False,0,SUCCESS: 200,"New Answer with ID 37408 has been created (Test ID 1428, Question ID 10705).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,"When a patient receives a reversal agent, either during the procedure or in the recovery area:",D.  None of the above,False,0,SUCCESS: 200,"New Answer with ID 37409 has been created (Test ID 1428, Question ID 10705).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Patients may be discharged after sedation:,A.  When fully awake,False,0,SUCCESS: 200,"New Question with ID 10706 has been created (Test ID 1428). New Answer with ID 37410 has been created (Test ID 1428, Question ID 10706).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Patients may be discharged after sedation:,B.  Thirty minutes after recovery time,False,0,SUCCESS: 200,"New Answer with ID 37411 has been created (Test ID 1428, Question ID 10706).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Patients may be discharged after sedation:,C.  When the MD's discharge orders are written,False,0,SUCCESS: 200,"New Answer with ID 37412 has been created (Test ID 1428, Question ID 10706).",True
9659,Elearning-0000-876,Elearning-0000-876,FY2021 MODERATE SEDATION: NURSING,FY2021 MODERATE SEDATION: NURSING,n13986,FY2021 MODERATE SEDATION: NURSING- n13986,choice,Patients may be discharged after sedation:,D.  Vital signs are stable. The patient's documented Aldrete score is 9-10 or baseline and it has been a minimum of thirty minutes since the last dose of sedation.,True,100,SUCCESS: 200,"New Answer with ID 37413 has been created (Test ID 1428, Question ID 10706).",True
9666,Elearning-0000-882,Elearning-0000-882,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,n13992,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION- n13992,choice,Laser eye protection should be worn to prevent injury to the _________ and/or ________ which can cause temporary or permanent vision loss.,a.	Cornea / Retina,True,100,SUCCESS: 200,"New Test with ID 1429 has been created. New Question with ID 10707 has been created (Test ID 1429). New Answer with ID 37414 has been created (Test ID 1429, Question ID 10707).",True
9666,Elearning-0000-882,Elearning-0000-882,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,n13992,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION- n13992,choice,Laser eye protection should be worn to prevent injury to the _________ and/or ________ which can cause temporary or permanent vision loss.,b.	Retina / Eye Lid,False,0,SUCCESS: 200,"New Answer with ID 37415 has been created (Test ID 1429, Question ID 10707).",True
9666,Elearning-0000-882,Elearning-0000-882,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,n13992,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION- n13992,choice,Laser eye protection should be worn to prevent injury to the _________ and/or ________ which can cause temporary or permanent vision loss.,c.	Iris / Pupil,False,0,SUCCESS: 200,"New Answer with ID 37416 has been created (Test ID 1429, Question ID 10707).",True
9666,Elearning-0000-882,Elearning-0000-882,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,n13992,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION- n13992,choice,"Which of the following about Laser eye protection is NOT true?<br><br> 1)	Labeled with optical density and wavelength (appropriate for laser being used). <br> 2)	Available for all staff and patients in the Operating Room with right comfort and fit.<br> 3)	Due to the special coating, the glasses do not have to be LLD after each use.<br> 4)	Available outside on the Operating Room door for those who need to enter the room.<br> 5)	There is no need for someone who wears glasses or contacts to use safety glasses as these provide adequate protection. <br>",a.	1 and 3,False,0,SUCCESS: 200,"New Question with ID 10708 has been created (Test ID 1429). New Answer with ID 37417 has been created (Test ID 1429, Question ID 10708).",True
9666,Elearning-0000-882,Elearning-0000-882,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,n13992,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION- n13992,choice,"Which of the following about Laser eye protection is NOT true?<br><br> 1)	Labeled with optical density and wavelength (appropriate for laser being used). <br> 2)	Available for all staff and patients in the Operating Room with right comfort and fit.<br> 3)	Due to the special coating, the glasses do not have to be LLD after each use.<br> 4)	Available outside on the Operating Room door for those who need to enter the room.<br> 5)	There is no need for someone who wears glasses or contacts to use safety glasses as these provide adequate protection. <br>",b.	2 and 5,False,0,SUCCESS: 200,"New Answer with ID 37418 has been created (Test ID 1429, Question ID 10708).",True
9666,Elearning-0000-882,Elearning-0000-882,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,n13992,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION- n13992,choice,"Which of the following about Laser eye protection is NOT true?<br><br> 1)	Labeled with optical density and wavelength (appropriate for laser being used). <br> 2)	Available for all staff and patients in the Operating Room with right comfort and fit.<br> 3)	Due to the special coating, the glasses do not have to be LLD after each use.<br> 4)	Available outside on the Operating Room door for those who need to enter the room.<br> 5)	There is no need for someone who wears glasses or contacts to use safety glasses as these provide adequate protection. <br>",c.	3 and 5,True,100,SUCCESS: 200,"New Answer with ID 37419 has been created (Test ID 1429, Question ID 10708).",True
9666,Elearning-0000-882,Elearning-0000-882,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,n13992,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION- n13992,choice,Examples of Respiratory Protection include: <br><br> 1)	Smoke Evacuation<br> 2)	Holding your Breath<br> 3)	Level 1 surgical mask<br> 4)	N95 mask<br>,a.	3 and 4,False,0,SUCCESS: 200,"New Question with ID 10709 has been created (Test ID 1429). New Answer with ID 37420 has been created (Test ID 1429, Question ID 10709).",True
9666,Elearning-0000-882,Elearning-0000-882,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,n13992,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION- n13992,choice,Examples of Respiratory Protection include: <br><br> 1)	Smoke Evacuation<br> 2)	Holding your Breath<br> 3)	Level 1 surgical mask<br> 4)	N95 mask<br>,b.	2 and 3,False,0,SUCCESS: 200,"New Answer with ID 37421 has been created (Test ID 1429, Question ID 10709).",True
9666,Elearning-0000-882,Elearning-0000-882,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,n13992,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION- n13992,choice,Examples of Respiratory Protection include: <br><br> 1)	Smoke Evacuation<br> 2)	Holding your Breath<br> 3)	Level 1 surgical mask<br> 4)	N95 mask<br>,c.	1 and 4,True,100,SUCCESS: 200,"New Answer with ID 37422 has been created (Test ID 1429, Question ID 10709).",True
9666,Elearning-0000-882,Elearning-0000-882,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,n13992,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION- n13992,choice,Lasers are considered an ___________ in the Fire Triangle.,a.	Oxidizer,False,0,SUCCESS: 200,"New Question with ID 10710 has been created (Test ID 1429). New Answer with ID 37423 has been created (Test ID 1429, Question ID 10710).",True
9666,Elearning-0000-882,Elearning-0000-882,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,n13992,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION- n13992,choice,Lasers are considered an ___________ in the Fire Triangle.,b.	Ignition Source,True,100,SUCCESS: 200,"New Answer with ID 37424 has been created (Test ID 1429, Question ID 10710).",True
9666,Elearning-0000-882,Elearning-0000-882,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,n13992,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION- n13992,choice,Lasers are considered an ___________ in the Fire Triangle.,c.	Fuel,False,0,SUCCESS: 200,"New Answer with ID 37425 has been created (Test ID 1429, Question ID 10710).",True
9666,Elearning-0000-882,Elearning-0000-882,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,n13992,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION- n13992,choice,Which of the following statements is TRUE concerning Laser Safety Fire Prevention.,a.	Keep wet towels and saline on the sterile field.  Can be used to douse or smother a fire.,True,100,SUCCESS: 200,"New Question with ID 10711 has been created (Test ID 1429). New Answer with ID 37426 has been created (Test ID 1429, Question ID 10711).",True
9666,Elearning-0000-882,Elearning-0000-882,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,n13992,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION- n13992,choice,Which of the following statements is TRUE concerning Laser Safety Fire Prevention.,b.	Have an ABC Fire Extinguisher available,False,0,SUCCESS: 200,"New Answer with ID 37427 has been created (Test ID 1429, Question ID 10711).",True
9666,Elearning-0000-882,Elearning-0000-882,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION,n13992,SURGICAL SERVICES: FY2021 LASER SAFETY EDUCATION- n13992,choice,Which of the following statements is TRUE concerning Laser Safety Fire Prevention.,c.	Dry sponges and towels should be used around the incision site.,False,0,SUCCESS: 200,"New Answer with ID 37428 has been created (Test ID 1429, Question ID 10711).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Ms Jones has been taking Xeloda for 3 months and her prescription says 4 tablets in the morning and 3 tablets in the evening. During your call she tells you that she has been taking 2 tablets every 12 hours because it doesn't make her feel well. <br><br> What do you do?,A. Ask her about her side effects and tell her to continue the way she is taking them.,False,0,SUCCESS: 200,"New Test with ID 1430 has been created. New Question with ID 10712 has been created (Test ID 1430). New Answer with ID 37429 has been created (Test ID 1430, Question ID 10712).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Ms Jones has been taking Xeloda for 3 months and her prescription says 4 tablets in the morning and 3 tablets in the evening. During your call she tells you that she has been taking 2 tablets every 12 hours because it doesn't make her feel well. <br><br> What do you do?,B. Tell her that she must stop immediately and make an appointment to see the MD.,False,0,SUCCESS: 200,"New Answer with ID 37430 has been created (Test ID 1430, Question ID 10712).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Ms Jones has been taking Xeloda for 3 months and her prescription says 4 tablets in the morning and 3 tablets in the evening. During your call she tells you that she has been taking 2 tablets every 12 hours because it doesn't make her feel well. <br><br> What do you do?,C. Document your call in EMR and notify the Physician/RN directly.  Instruct the patient to contact the office to discuss dose change with the Physician.,True,100,SUCCESS: 200,"New Answer with ID 37431 has been created (Test ID 1430, Question ID 10712).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Ms Jones has been taking Xeloda for 3 months and her prescription says 4 tablets in the morning and 3 tablets in the evening. During your call she tells you that she has been taking 2 tablets every 12 hours because it doesn't make her feel well. <br><br> What do you do?,D. Do nothing because some medication is better than her not taking it at all.,False,0,SUCCESS: 200,"New Answer with ID 37432 has been created (Test ID 1430, Question ID 10712).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Mr Depp does not pick up the phone and you would like to leave a message. What information can you leave on the voicemail?,"A. Patient name, patient's DOB, doctor's name, and medication",False,0,SUCCESS: 200,"New Question with ID 10713 has been created (Test ID 1430). New Answer with ID 37433 has been created (Test ID 1430, Question ID 10713).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Mr Depp does not pick up the phone and you would like to leave a message. What information can you leave on the voicemail?,"B. Patient name, your name, your title, patient's medication, patient's medical record number, and doctor's name, and office location",False,0,SUCCESS: 200,"New Answer with ID 37434 has been created (Test ID 1430, Question ID 10713).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Mr Depp does not pick up the phone and you would like to leave a message. What information can you leave on the voicemail?,"C. Patient name, your name, your title, and clinic's name",True,100,SUCCESS: 200,"New Answer with ID 37435 has been created (Test ID 1430, Question ID 10713).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Mr Depp does not pick up the phone and you would like to leave a message. What information can you leave on the voicemail?,"D. Doctor's name, office location, patient's name, patient's DOB, date of therapy, and name of medication",False,0,SUCCESS: 200,"New Answer with ID 37436 has been created (Test ID 1430, Question ID 10713).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Ms Cruise has been on vacation and missed her first day of Gleevec therapy. She asks you if she can take 2 the following day like she used to do with her birth control. What would you recommend?,"A. Yes, you can double your dose any time you miss a dose as long as you don't take more than 2 days together.",False,0,SUCCESS: 200,"New Question with ID 10714 has been created (Test ID 1430). New Answer with ID 37437 has been created (Test ID 1430, Question ID 10714).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Ms Cruise has been on vacation and missed her first day of Gleevec therapy. She asks you if she can take 2 the following day like she used to do with her birth control. What would you recommend?,"B. No, you should never double the dose of your medication. Skip the missed dose if it's too close to your next dose or take the missed dose as soon as you remember if it's not too close to your next dose.",True,100,SUCCESS: 200,"New Answer with ID 37438 has been created (Test ID 1430, Question ID 10714).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Ms Cruise has been on vacation and missed her first day of Gleevec therapy. She asks you if she can take 2 the following day like she used to do with her birth control. What would you recommend?,"C. Yes, you can take as many doses as needed to get back on schedule.",False,0,SUCCESS: 200,"New Answer with ID 37439 has been created (Test ID 1430, Question ID 10714).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Ms Cruise has been on vacation and missed her first day of Gleevec therapy. She asks you if she can take 2 the following day like she used to do with her birth control. What would you recommend?,"D. No, don't double the dose. Skip a day as a wash out and start your therapy again from day 1.",False,0,SUCCESS: 200,"New Answer with ID 37440 has been created (Test ID 1430, Question ID 10714).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Ms Jackson has just started taking Alecensa and has told you that it's too expensive so she picked up her refill but plans on taking it every other day to make it last longer. <br><br> What do you recommend?,A. Counsel her on the side effects of therapy and let her know to call the office with any questions and document your call in EMR.,False,0,SUCCESS: 200,"New Question with ID 10715 has been created (Test ID 1430). New Answer with ID 37441 has been created (Test ID 1430, Question ID 10715).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Ms Jackson has just started taking Alecensa and has told you that it's too expensive so she picked up her refill but plans on taking it every other day to make it last longer. <br><br> What do you recommend?,B. Remind the patient that the medication is most effective when it is taken as prescribed by the physician. Notify the physician and nursing staff she is having financial barriers to therapy and look into potential solutions or financial assistance and document your call in EMR.,True,100,SUCCESS: 200,"New Answer with ID 37442 has been created (Test ID 1430, Question ID 10715).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Ms Jackson has just started taking Alecensa and has told you that it's too expensive so she picked up her refill but plans on taking it every other day to make it last longer. <br><br> What do you recommend?,"C. Let her know that instead of taking her medication every other day, she can open the capsules and only take half so that it will last her the duration of therapy.",False,0,SUCCESS: 200,"New Answer with ID 37443 has been created (Test ID 1430, Question ID 10715).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Ms Jackson has just started taking Alecensa and has told you that it's too expensive so she picked up her refill but plans on taking it every other day to make it last longer. <br><br> What do you recommend?,D. Document her change in therapy in the EMR but don't say anything to the physician or nursing staff.,False,0,SUCCESS: 200,"New Answer with ID 37444 has been created (Test ID 1430, Question ID 10715).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Mr Brown tells you that the physician has changed his therapy and he no longer needs his Cabometyx. He tells you that he met another patient in his support group that is taking the same medication and wants to give him the remaining pills.<br><br> What do you recommend?,"A. Advise him that medications should never be shared and he should call the local drug take back center, take it to a local medication drop off unit in the community, or contact the pharmacy for instructions on proper disposal.",True,100,SUCCESS: 200,"New Question with ID 10716 has been created (Test ID 1430). New Answer with ID 37445 has been created (Test ID 1430, Question ID 10716).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Mr Brown tells you that the physician has changed his therapy and he no longer needs his Cabometyx. He tells you that he met another patient in his support group that is taking the same medication and wants to give him the remaining pills.<br><br> What do you recommend?,B. Tell him it's all right as long as you can call the other patient to verify the dose of his therapy.,False,0,SUCCESS: 200,"New Answer with ID 37446 has been created (Test ID 1430, Question ID 10716).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Mr Brown tells you that the physician has changed his therapy and he no longer needs his Cabometyx. He tells you that he met another patient in his support group that is taking the same medication and wants to give him the remaining pills.<br><br> What do you recommend?,C. Instruct him to bring the medication back to the office and you will dispose of it for him.,False,0,SUCCESS: 200,"New Answer with ID 37447 has been created (Test ID 1430, Question ID 10716).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Mr Brown tells you that the physician has changed his therapy and he no longer needs his Cabometyx. He tells you that he met another patient in his support group that is taking the same medication and wants to give him the remaining pills.<br><br> What do you recommend?,"D. Tell him he can choose any of the above options, depending on what suits him the best.",False,0,SUCCESS: 200,"New Answer with ID 37448 has been created (Test ID 1430, Question ID 10716).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Ms Price is currently taking Revlimid and wants to make an appointment with you to counsel her on her medication. <br><br> Which response <u>would not</u> be appropriate?,A. Make an appointment with her to discuss her medication and counsel her.,False,0,SUCCESS: 200,"New Question with ID 10717 has been created (Test ID 1430). New Answer with ID 37449 has been created (Test ID 1430, Question ID 10717).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Ms Price is currently taking Revlimid and wants to make an appointment with you to counsel her on her medication. <br><br> Which response <u>would not</u> be appropriate?,B. Refer her to the retail pharmacy because only certain pharmacists are authorized to counsel a patient on Revlimid due to the REMS program.,True,100,SUCCESS: 200,"New Answer with ID 37450 has been created (Test ID 1430, Question ID 10717).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Ms Price is currently taking Revlimid and wants to make an appointment with you to counsel her on her medication. <br><br> Which response <u>would not</u> be appropriate?,C. Tell her that you cannot speak to her currently but you can set up a date/time to counsel her over the phone.,False,0,SUCCESS: 200,"New Answer with ID 37451 has been created (Test ID 1430, Question ID 10717).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,Ms Price is currently taking Revlimid and wants to make an appointment with you to counsel her on her medication. <br><br> Which response <u>would not</u> be appropriate?,D. Tell her you have a few minutes and can discuss her Revlimid now.,False,0,SUCCESS: 200,"New Answer with ID 37452 has been created (Test ID 1430, Question ID 10717).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,"Choose the best type of questions to use when counseling a patient from the questions below.<br><br>  I. ""Are you having any problems with your medication?""�<br> II. ""What did your provider tell you to expect while on therapy?""�<br> III. ""What side effects will you be looking out for while on this medication?""�<br> IV. ""Do you have any questions?""�<br><br>","A.	I, II, IV",False,0,SUCCESS: 200,"New Question with ID 10718 has been created (Test ID 1430). New Answer with ID 37453 has been created (Test ID 1430, Question ID 10718).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,"Choose the best type of questions to use when counseling a patient from the questions below.<br><br>  I. ""Are you having any problems with your medication?""�<br> II. ""What did your provider tell you to expect while on therapy?""�<br> III. ""What side effects will you be looking out for while on this medication?""�<br> IV. ""Do you have any questions?""�<br><br>","B.	I, II, III, IV",False,0,SUCCESS: 200,"New Answer with ID 37454 has been created (Test ID 1430, Question ID 10718).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,"Choose the best type of questions to use when counseling a patient from the questions below.<br><br>  I. ""Are you having any problems with your medication?""�<br> II. ""What did your provider tell you to expect while on therapy?""�<br> III. ""What side effects will you be looking out for while on this medication?""�<br> IV. ""Do you have any questions?""�<br><br>","C.	III, IV",False,0,SUCCESS: 200,"New Answer with ID 37455 has been created (Test ID 1430, Question ID 10718).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,"Choose the best type of questions to use when counseling a patient from the questions below.<br><br>  I. ""Are you having any problems with your medication?""�<br> II. ""What did your provider tell you to expect while on therapy?""�<br> III. ""What side effects will you be looking out for while on this medication?""�<br> IV. ""Do you have any questions?""�<br><br>","D.	II, III",True,100,SUCCESS: 200,"New Answer with ID 37456 has been created (Test ID 1430, Question ID 10718).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,What is the pharmacist's role in oral medication adherence?,A. Building a strong pharmacist-patient relationship.,False,0,SUCCESS: 200,"New Question with ID 10719 has been created (Test ID 1430). New Answer with ID 37457 has been created (Test ID 1430, Question ID 10719).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,What is the pharmacist's role in oral medication adherence?,"B. Recognizing barriers to therapy such as drug cost, inability to swallow pills, etc.",False,0,SUCCESS: 200,"New Answer with ID 37458 has been created (Test ID 1430, Question ID 10719).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,What is the pharmacist's role in oral medication adherence?,C. Increased potential for drug toxicity,False,0,SUCCESS: 200,"New Answer with ID 37459 has been created (Test ID 1430, Question ID 10719).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,What is the pharmacist's role in oral medication adherence?,D. A & B,True,100,SUCCESS: 200,"New Answer with ID 37460 has been created (Test ID 1430, Question ID 10719).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,What is the pharmacist's role in oral medication adherence?,E. All of the above,False,0,SUCCESS: 200,"New Answer with ID 37461 has been created (Test ID 1430, Question ID 10719).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,"Prior to calling a patient, make sure to do the following:","A.  Review patient's past and current course of therapy, identify correct treatment plan, appropriate dose, and need for dose adjustments",False,0,SUCCESS: 200,"New Question with ID 10720 has been created (Test ID 1430). New Answer with ID 37462 has been created (Test ID 1430, Question ID 10720).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,"Prior to calling a patient, make sure to do the following:",B. Document the topics that you would like to discuss with the patient,False,0,SUCCESS: 200,"New Answer with ID 37463 has been created (Test ID 1430, Question ID 10720).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,"Prior to calling a patient, make sure to do the following:",C. Familiarize yourself with patient's medication,False,0,SUCCESS: 200,"New Answer with ID 37464 has been created (Test ID 1430, Question ID 10720).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,"Prior to calling a patient, make sure to do the following:",D. A &C,True,100,SUCCESS: 200,"New Answer with ID 37465 has been created (Test ID 1430, Question ID 10720).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,"Prior to calling a patient, make sure to do the following:",E. None of the above,False,0,SUCCESS: 200,"New Answer with ID 37466 has been created (Test ID 1430, Question ID 10720).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,"True or False: All Adverse events, lack of compliance, or any other issue should be communicated to the physician and/or nursing staff and documented in the EMR.",TRUE,True,100,SUCCESS: 200,"New Question with ID 10721 has been created (Test ID 1430). New Answer with ID 37467 has been created (Test ID 1430, Question ID 10721).",True
9993,Elearning-0000-1764,Elearning-0000-1764,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS,n14044,2021 RPH ORAL CHEMOTHERAPY ADHERENCE CALLS- n14044,choice,"True or False: All Adverse events, lack of compliance, or any other issue should be communicated to the physician and/or nursing staff and documented in the EMR.",FALSE,False,0,SUCCESS: 200,"New Answer with ID 37468 has been created (Test ID 1430, Question ID 10721).",True
